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John J. Phelan, Jr. 
(1931–2012)
Remembered on Wall Street for his ability to both calm and transform markets, John is remem-
bered at Cold Spring Harbor Laboratory (CSHL) for his long-standing support of genetic research 
and education. After a long and successful career on Wall Street that culminated in his oversight 
role as chairman of the New York Stock Exchange throughout the 1980s, John served two terms 
as CSHL trustee from 1992 to 1999.
His tenure as head of the New York Stock Exchange saw the beginning of major technology 
changes, most notably the ascendancy of computer technologies that would later so dominate 
trading. He literally oversaw the transition from the way stocks were traded by specialists to mod-
ern computer-driven trading. John was universally praised for his calming response to the stock 
market crash of October 1987 and the market’s recovery.
A graduate of the class of 1970 from Adelphi University, John served his country as a sergeant 
in the Marines in Korea. He began his career on Wall Street in 1955, becoming managing direc-
tor of Phelan & Company in his father’s specialist fi rm. As a CSHL trustee, he was active on 
many board committees, including Executive, Audit, and Commercial Relations, of which he 
was chairman.
John and his wife, Joyce, provided seed money for the BioMedia program at the CSHL DNA 
Learning Center, which has grown into a suite of 24 websites providing free education services to 
millions of students and teachers. The couple also supported the founding of the Watson School 
of Biological Sciences, our innovative graduate school that was begun during John’s tenure and, as 
of this year, counts a total of 56 Ph.D. recipients, many of whom serve as faculty at universities in 
the United States and around the world.
We are indebted to John and his family, including his three sons, John, Peter, and David. John’s 
insight was invaluable to the development of innovative science education programs at CSHL. He 
also provided wise business counsel to the Laboratory at a time of signifi cant growth in its research 
programs. He is missed but well remembered.
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Townsend Jones Knight 
(1928–2012)
With the passing of our dear friend and Honorary Trustee Townie Knight, Cold Spring Harbor 
Laboratory also lost a very special connection to the institution’s historic roots on Long Island. A 
descendant of Major Thomas Jones, whose descendants are most famous for owning land from 
Oyster Bay on the north shore of the island to what today is Jones Beach on the south shore, 
Townie’s DNA was literally part of the Laboratory’s DNA.
In 1890, John Devine Jones donated land from an obsolete whaling enterprise to help establish 
the Biological Laboratory (Bio Lab) at Cold Spring Harbor, one precursor to the modern day Cold 
Spring Harbor Laboratory (CSHL). With an additional contribution of $5000, the Jones Labora-
tory was completed in 1893 and still stands as a state-of-the-art neuroscience research lab. Eighty 
years later, in 1970, Townie joined the Cold Spring Harbor Laboratory Board of Trustees, which 
he served in many leadership roles until 1995. He was elected Honorary Trustee in 1995 and 
continued to attend Board meetings for many years. While proudly carrying on the Jones fam-
ily legacy, Townie left his own distinguished mark on the Laboratory; he oversaw the transfer to 
CSHL of the assets and land of the Wawapex Society, established in 1892—a Jones Family legacy 
that supported the Bio Lab and the adjacent Fish Hatchery. As a consequence, CSHL manages the 
land used by the Friends of the Fish Hatchery.
Educated at Harvard College and having earned a law degree from Columbia University, 
Townie served in the Air Force before becoming a Senior Partner at the New York law fi rm Cur-
tis, Mallet-Prevost, where he specialized in international and domestic banking and corporate and 
fi nancial areas. He was generous in sharing this expertise with us as Assistant Secretary, Audit 
Committee Chairman, and an early member of the Commercial Relations Committee, on which 
he helped to oversee some of the fi rst biotechnology spin-off companies established from CSHL 
research. Townie assisted in the initiation of CSHL’s collaborative plant biology research relation-
ship with Pioneer Hi-Bred International, Inc., known today as DuPont Pioneer. He also provided 
wise legal counsel before CSHL had a lawyer on staff.
Townie and his wife Elise were always great friends and consistent supporters of the CSHL 
Annual Fund. They also understood the strategic importance of our endowment. In 1993, they 
donated a home in Lloyd Neck, establishing the Knight Trust to benefi t the CSHL endowment. 
In 2000, we were happy to honor Townie with the dedication of the Townsend J. Knight House, 
which was once a Jones family home, general store, and home to a young Townie that now serves 
as student housing for our Watson School of Biological Sciences Ph.D. candidates.
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xRobert Van Cleef Lindsay 
(1926–2012)
Rod Lindsay was one of the founding board members of the contemporary Cold Spring Harbor 
Laboratory (CSHL) that was established in 1962, beginning his relationship with us when we 
were still the Long Island Biological Association (LIBA) and the adjacent Department of Genetics 
of the Carnegie Institution of Washington, both predecessors of CSHL. From 1959 to 1965, Rod 
was treasurer of the LIBA and was later appointed chairman of the Executive Finance Committee 
of the new CSHL board—the perfect fi t for a man who spent his entire career climbing the ranks 
to become president of J.P. Morgan & Co. and its principal subsidiary, Morgan Guaranty Trust 
Company of New York. It was Rod whom we thank for engaging the Lindsay family dynasty so 
integrally in the evolution of CSHL.
Rod is remembered by his family as a Renaissance man, embodying a rare combination of 
intelligence, loyalty, humility, humor, and practicality—an exceedingly bright gentleman with 
great common sense and goodwill. He was always concerned with the morale of then Laboratory 
Director John Cairns, for when John started at CSHL, there was no endowment and the Labo-
ratory did not even have the funds for the director’s salary. It was incumbent upon Rod and his 
fellow trustees to establish and nurture the newly formed hybrid organization that merged the two 
historic organizations into one. With a degree from Yale, Rod was a lifelong student of history and 
human nature. Without him, Cold Spring Harbor Laboratory might not have survived.
Rod and his wife, Nancy, supported the construction of the Mary D. Lindsay Child Care 
Center on our campus, a project that has made an enormous impact on our ability to recruit and 
retain early-career scientists. Rod’s sister-in-law, Mary, also CSHL trustee and honorary trustee, 
was the instigator of that initiative that has literally transformed how our scientists interact with 
their children while working at the cutting edge of science.
Following in his father’s footsteps, Rod’s son Bob continues the Lindsay family support of 
CSHL and he is currently vice chairman of the Board of Trustees. Like his father, Bob is charting 
the future path of this great institution that has grown so successfully since the early guidance of 
Rod and his contemporaries. It is quite certain that Rod and Nancy are also smiling on Bob and 
wishing us continued success.
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Norton Zinder
(1928−2012)
In June 1953, Norton Zinder, then 25 years old and a newly minted Ph.D., attended Viruses, that 
year’s Cold Spring Harbor Symposium on Quantitative Biology. He was going to be, he was sure, 
the star of the show; he was going to describe transduction, a new way in which genetic informa-
tion carried by a phage passed from bacterial cell to bacterial cell. It was not to be—this was the 
Symposium where Jim Watson described the double helix. As Norton put it with considerable un-
derstatement many years later, “I was disappointed by being overshadowed by the Watson-Crick 
model of DNA.”
Zinder’s association with Cold Spring Harbor predated the 1953 Symposium. He had taken 
the Phage Course in 1949 while still a graduate student with Joshua Lederberg and had attended 
the 1951 Symposium. By the time Zinder participated in the classic 1961 Symposium on Cellular 
Regulatory Mechanisms, things were in turmoil at Cold Spring Harbor. Milislav Demerec had 
stepped down as director of the two institutions on the Cold Spring Harbor site: the Carnegie 
Institution of Washington’s Department of Genetics and the Biological Laboratory. Zinder was 
now a well-established researcher at the Rockefeller Institute and suffi ciently senior to be invited 
to become director of the Department of Genetics. Zinder decided that for the department to 
be effective, a capital investment of $500,000 was needed, but all Caryl Haskins, President of 
Carnegie, would offer was $200,000. Zinder declined the invitation and wrote an analysis of the 
situation, recommending that the two institutes be amalgamated. Whether Zinder’s suggestion 
carried any weight, his recommendation came to pass 2 years later and the Cold Spring Harbor 
Laboratory of Quantitative Biology was formed.
Zinder took on a formal role in the affairs of the Laboratory in 1967 when he became a Trustee 
representing the Rockefeller Institute. Rockefeller was one of the participating institutions that 
had pledged $5000 each to support the recently formed Cold Spring Harbor Laboratory. Zinder 
served a full term until 1973 and returned for a second stint from 1979 to 1984.
In 1966, John Cairns, Director of the Laboratory, announced his resignation, and Zinder 
played a key role in the transition of the directorship from Cairns to Jim Watson. Watson had 
joined the Trustees as the Harvard representative and prepared a document describing what he 
thought needed to be done about the Laboratory. As Zinder reported, “I said to Jim if the job was 
so easy, why didn’t he take it over. To everyone’s surprise he said he would think it over. The next 
day he accepted the post.” One of Zinder’s other roles, he claimed, was “to defuse Jim’s resigna-
tions—when upset by the Board, he would resign and it was my job to bring him back.”
Norton was interested in the social responsibilities of scientists. He was a key fi gure in the 
discussions about recombinant DNA and later chaired a committee to advise the United States 
government about the disposal of its chemical warfare stockpiles. He made few friends when 
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the National Cancer Institute committee that he chaired, reviewing the Virus Cancer Program, 
reported that only 50% of the annual $50 million program was worth supporting. He was a key 
fi gure in the establishment of the Human Genome Project (HGP), acting as chairman of the 
National Institutes of Health Human Genome Advisory Committee (1988–1999). He helped to 
mediate the short-lived rapprochement between the public project and Celera at the time of the 
2003 announcement of the completion of the HGP.
Norton Zinder was born on November 7, 1928, in New York City. He graduated from Colum-
bia University at age 18 and completed his Ph.D. in 1952. He moved to the Rockefeller Institute 
that year and remained there for the remainder of his career. He was the recipient of numerous 
awards and honors, including election as a member of the National Academy of Sciences in 1969. 
He received the Eli Lilly Award in Microbiology and Immunology from the American Society of 
Microbiology and the NAS Medal in Molecular Biology from the National Academy of Sciences.
Jan Witkowski
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1PRESIDENT’S REPORT
Cold Spring Harbor Laboratory continues to produce breakthrough science and provide outstand-
ing science education. Of particular note, 2012 saw the recruitment of six new faculty, two of 
whom, David Tuveson and Gholson Lyon, are not only outstanding scientists, but are clinicians 
who see patients. David Tuveson will oversee our exciting new Cancer Therapeutics Initiative and 
focus his research on pancreas cancer, melanoma and carcinoid tumors. He will also work closely 
with the nearby Lustgarten Foundation that focuses on pancreas cancer, where he will head its sci-
ence program. Gholson Lyon works in pediatric neurology and studies inherited neurological dis-
orders, principally in families in Utah. Molly Hammell, Jesse Gillis, Dan Levy, and Ivan Iossifov 
strengthen our basic science research, notably in the fi eld of genomics and in quantitative biology, 
an area that has emerged as a strong component of our research portfolio. CSHL continues to be 
recognized by Thomson Reuters as the leading institution in the world in molecular biology and 
genetics, evidence that our fundamental research is having great impact. One example is Adrian 
Krainer’s years of dedicated inquiry on how genes are differentially expressed—basic research that 
has now resulted in a promising drug he co-developed for the children’s genetic disorder spinal 
muscular atrophy, which now enters Phase 2 clinical trials.
As 2012 drew to a close, however, the United States approached the edge of a fi nancial precipice 
popularly called “the fi scal cliff.” Amid the fractious partisan politics surrounding that term and 
the unresolved issue of our federal budget defi cit, the implications were clear for the Laboratory. We 
faced the prospect of yet another year in which our elected national representatives would not fi nd 
a way to pass a budget, once again leaving in doubt the status of federal support for basic research.
We entered the current year, therefore, acutely aware of the urgency of attracting substantial 
new philanthropic contributions in order to avoid the possibility that critical cancer, brain and 
plant biology research be curtailed, even for a moment. That would mark an historic and tragic 
retreat. Although American philanthropy leads the world in support of basic and applied science, 
it cannot replace the substantial, stable and predictable support that historically has been provided 
by the federal government. Unfortunately, stagnant or even declining federal support of science 
is now the norm. If Cold Spring Harbor Laboratory is to remain at the forefront of research in 
molecular biology and genetics, we need a larger endowment as a buffer to variations in federal 
funding that are now occurring and will likely occur for at least the next decade.
Our nation has been without a budget for 4 years. To pay bills since approving its last budget 
in April 2009, Congress has passed a series of what lawmakers euphemistically call “continuing 
resolutions.” Failing to provide the fundamental guidance and stability that an annual budget 
provides, our leaders have thus defaulted on a constitutionally specifi ed responsibility to the elec-
torate. This failure has had a deleterious impact on many aspects of national life, including the 
pursuit of new knowledge in the biological and life sciences. These reductions are also coming 
at a time when private industry has dramatically cut back on fundamental and basic scientifi c 
research, in favor of primarily supporting applied research that leads directly to commercial prod-
ucts. American industry is increasingly looking to academia to carry out the basic research and 
discovery that will benefi t our economy.
For our Laboratory and other research institutions, the absence of macro-level budgetary 
guidance has had two broad effects. One has been an implementation of fi scal austerity, by de-
fault. The other is that the lack of guidance from the federal government has thrown into limbo 
attempts by the scientifi c community to plan the course of future, long-term research projects.
In 2012, federal support for research at CSHL, mostly through grants to individual investiga-
tors by the National Institutes of Health (NIH) and the National Science Foundation (NSF), 
amounted to $53.9 million, over 49% of the total funding that we received in support of research 
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from external sources. To state the obvious: One cannot effectively prepare a plan for future 
work when a key funding source cannot make choices and plans of its own. Even after the 112th 
Congress in its waning hours passed a tax package that averted the “cliff,” a budget still was not 
forthcoming. We therefore once again had to guess at the expected level of support for research, 
essentially fi guring out how to deal with uncertainty, including the issuance of some grants on a 
6-month basis (normally grants are awarded for 4 years and funds release 1 year at a time). Any 
scientist can tell you that half a year of funding means nothing when the experiments you are 
conducting will take several years to plan and execute.
American science will fall behind, without a doubt, if the current situation continues into the 
future. That much is certain.
My purpose in this letter is to report the present situation and to make suggestions about 
how federal funding for research might be dispensed on a more stable and predictable basis. 
I want to discuss not only the federal role in sustaining our common enterprise, but also to 
encourage members of the research community to help strike a crucial balance by acknowledg-
ing our own responsibility to make realistic plans for future work, in view of the ongoing fi scal 
constraints.
I also want to appeal to philanthropy, to those private individuals who are able to provide much-
needed support to CSHL in these austere times to fulfi ll the vision held by Carnegie, Rocke feller, 
and other great American philanthropists: that helping to advance science will secure the future 
strength of the society that our children will inherit. Fortunately for Cold Spring Harbor Labora-
tory, our Trustees and supporters have recognized this need, but we do need to broaden our base 
of philanthropic support.
Endless Frontier, Finite Funding
Science is indeed the “endless frontier,” as the great American proponent of federally supported 
basic research, Vannevar Bush, successfully argued the year the Second World War was won. But 
no one, including Bush, ever said that public funds to support the exploration of the scientifi c 
frontier would be limitless.
We in the research community must acknowledge that public funding is fi nite. Yet in the 
area of basic and applied biomedical research, as channeled through the NIH, it is important to 
establish that funding has been essentially frozen since 2003. In that year, legislators from both 
parties could boast that over the previous 5 years they had authorized a doubling of NIH funding. 
Spurred by excitement over assembly of the complete human genome sequence and the practical 
benefi ts that many expected quickly to materialize from that work, the doubling was an example 
of lay enthusiasm running ahead of scientifi c and economic common sense.
What biological scientist would not favor a doubling of the main source of research-grant fund-
ing? Actually, many of my colleagues and I were not sanguine about the prospect, much preferring 
instead a federal commitment to a steady and predictable increase in basic research funding each 
year, while keeping up with or slightly exceeding biomedical cost infl ation, which tends to run 
higher than the national consumer price index.
What some feared in 2003 has come to pass: Federal funding for the NIH has fl atlined since 
the completion of the doubling. Measured from a 1998 baseline, the 2003 NIH appropriation of 
over $27 billion represented a 100% increase in nominal dollars. But since that time, now nine 
funding cycles in the past, the NIH appropriation has actually declined over 16%, taking bio-
medical cost infl ation into account: the $30.86 billion appropriated for NIH in 2012 was over $5 
billion less than the 2003 fi gure, when infl ation is factored in.
If we had possessed the foresight and nerve in 1998 to eschew the doubling concept and had 
 instead secured commitments for modest 3% annual increases in federal support for NIH, while 
pegging base funding to infl ation, the NIH budget in 2012 would have exceeded $32 billion—
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about $1.5 billion, or 5%, more than the actual 2012 estimate. These numbers assume contin-
ued funding of science during the dramatic fi nancial crisis in 2008, but over $10 billion was 
added to the NIH budget in 2009 from economic stimulus funds, which would not have been 
necessary if continuous and predictable funding had instead occurred. With such steady sup-
port, scientists could have planned long-term projects with confi dence. As the situation exists 
now, many scientists are closing their laboratories because of lack of funding since the sudden 
spurt of NIH funding has withered and was not sustained. Fortunately, at Cold Spring Har-
bor our sources of private support have so far prevented shutting down research laboratories. 
Indeed, philanthropic support has even enabled starting new initiatives that have had a major 
impact on cancer and autism.
My point is one that prudent fi nancial advisors have been making for as long as capitalism has 
been around: a simple compounding at modest rates of annual increase is very likely to be more 
powerful than an occasional fi scal surge, inspired by what are often unrealistic expectations of 
near-term payoffs. “Slow and steady wins the race”—in science as in building a nest egg.
There are powerful reasons behind this argument as it applies to research funding, and they 
are not only about numbers. It is instructive to look back for a moment at the history of how our 
federal government came to vigorously support basic science. Prior to the Second World War, 
federal contributions were minimal, as weighed against funds provided by the nation’s great phi-
lanthropists. Most biomedical research was then conducted by scientists based in universities that 
were supported by endowment income, special research funds, and foundation grants. The year 
before the start of the Great Depression, The Rockefeller Institute had since its founding in 1902 
received some $65 million in endowment funds from the estate of John D. Rockefeller. As noted 
by the historian Paul Starr, this alone was many times the amount spent by the federal government 
on medical research during that same interval.1
Early in the 20th century, it was the Department of Agriculture that received the lion’s share of 
the government’s research attention. To the very limited extent that it invested directly in medi-
cal research, the federal government focused on the Hygienic Laboratory, once part of a hospital 
1Paul Starr, The Transformation of American Medicine (Basic Books, 1982), 339.
The Laboratory has always prospered because of philanthropic foresight and civic mindedness. Charles Robertson, 
seen here with the Watsons in 1974, seeded our endowment.
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in Staten Island, and later, after moving to Washington, D.C., the forerunner of the U.S. Public 
Health Service (PHS). Just after the turn of the 20th century, allocations were less than $50,000 
a year. During the Progressive Period, the PHS began to study infectious diseases. In 1930, the 
Hygienic Laboratory was renamed the National Institutes of Health, and in 1938 it moved to its 
present location in Bethesda, Maryland. A year prior to that, the government had established the 
National Cancer Institute (NCI). And in a major departure in 1944, for the fi rst time the NCI au-
thorized federal funds to be allocated to basic researchers not directly in the government’s employ. 
This was the precursor of the modern extramural grant program that provides core research funds 
for CSHL and many other American research institutions.
On the eve of America’s entry into World War Two, the NCI’s cancer grants and all other PHS 
activities received less than $3 million in total federal support. The Department of Agriculture’s 
research budget was almost nine times greater. The war, of course, turned the tables. Vannevar 
Bush’s Offi ce of Scientifi c Research and Development (OSRD), which played an historic role in 
developing advanced technologies that made possible the Allied victory, was split in two sections, 
one dedicated to defense technologies, the other, under the Committee on Medical Research 
(CMR), focusing on technologies to help meet the medical problems occasioned by war. From a 
new way to treat malaria, to the isolation of blood derivatives like gamma globulin, to the devel-
opment of means of mass-producing penicillin, the CMR achieved triumphs that would support 
arguments following the war for a greatly augmented federal role in biomedical research.2
Among the proudest moments in the history of Cold Spring Harbor Laboratory are those 
chronicling the roles of Demerec, Bryson, and others in laying the foundations for critical ad-
vances in penicillin production. Vannevar Bush drew a very important lesson from this and other 
wartime research efforts. It concerned the society and system that had given rise to academic 
research institutions like ours where wartime advances were made. The United States was a nation 
that had granted autonomy to scientists. Open-ended, investigator-initiated basic research had 
generated the pool of intellectual property from which real-world products were rapidly developed 
in the urgent wartime context.
Bush’s famous report, “Science: The Endless Frontier,” written in 1945 in fulfi llment of a 
request from President Franklin Roosevelt, was, however, not an argument for federal funding of 
applied research, but instead the kind of basic research that had provided the intellectual capital 
to fuel those wartime innovations. The war made clear to Bush that only the federal govern-
ment had suffi cient economic power to sustain a world-class basic-science research establishment. 
Upon this foundation the nation would prosper fi nancially and militarily. But also, importantly, 
the health and welfare of its citizens would steadily improve. This is the vision behind our mod-
ern NIH and NSF.
When Bush later recollected that “[t]he war . . . proved that things could be accomplished 
in a hurry, given unlimited funds, the intensity of war, and most important, a background of 
basic scientifi c knowledge ready for application,”3 he did not mean to suggest this was a rea-
sonable expectation for a nation in peacetime. The question in ordinary times was whether 
enough funds would be allocated and enough freedom be granted scientists so as to keep new 
discoveries coming. Today, the NCI budget represents about $16 per person per year for the 
support of all cancer research and therapy development. About the same amount per person 
supports all neuroscience research, including all research on Alzheimer’s, Parkinson’s, all other 
neurodegenerative diseases, all psychiatric disorders such as autism, schizophrenia, depression, 
acute disorders such as stroke and trauma, as well as basic brain science. So the annual invest-
ment per person is not substantial.
2ibid., 340–342.
3G. Pascal Zachary, Endless Frontier: Vannevar Bush, Engineer of the American Century (MIT Press, 1999), 288.
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Taking Responsibility
At this moment our nation is clearly limited in its capacity to fi nance basic science. Things that 
might be done today in areas in which much progress has recently been made, cancer thera-
peutics being the most notable, are not getting done because of the scarcity of resources, both 
public and private.
What can we reasonably expect? I would be pleased to see a federal commitment to present 
levels of NIH and NSF funding, adjusted for infl ation plus 3% per year. This would place CSHL 
and peer institutions on an even keel during the next decade, in which austerity is likely to pre-
vail. It is imperative that we keep up with and at least somewhat exceed the rate of biomedical 
cost infl ation. Otherwise, the nation’s science is certain to enter a period of decline. We will not 
be able to plan, as I have noted. Nor will we be able to support, and therefore will not be able 
to attract, fi rst-rate minds to enter scientifi c research. According to a recent report of the NIH-
sponsored Biomedical Workforce Committee, of which Cold Spring Harbor’s Leemor Joshua-Tor 
was a member, the number of doctoral students in basic biomedical science continues to soar, 
with over 15,000 Ph.D.s granted annually. With the success of our science, this number has risen 
quickly, from a base of about 6500 new Ph.D.s a year in the mid-1980s. The number far exceeds 
the numbers exiting basic science. In contrast, other fi elds of science such as chemistry, physics 
and behavioral and social science do not produce increasing numbers of active Ph.D.s. At the same 
time, the number of all principal investigators under age 36 in biomedicine who are receiving 
career-sustaining NIH grants has declined from 18% 2 decades ago to less than 4% today. The 
number of applications, meantime, for a shrinking number of NIH grant awards of all kinds con-
tinues to rise. Nationwide, fewer than 1 application in 6 is successful. Based upon my experience 
in reviewing grants, I estimate that 1 in 4 or 1 in 3 are of the highest quality and warrant funding. 
At Cold Spring Harbor, the success rate of proposals by our faculty is more than twice the national 
average, partly due to the philanthropic support that sustains science through times when federal 
funding is not obtained and partly due the fact that at Cold Spring Harbor, philanthropic support 
supplements federal grant support.
Under these circumstances it is imperative for research institutions to take responsibility for 
their future. The administrative team at Cold Spring Harbor Laboratory provides an example of 
how ambitious yet realistic planning 5 to 10 years out, combined with a constant effort to husband 
scarce resources, can yield a program in basic science that—as the statistics continue to show—
places our faculty’s output at the very top of the fi eld. As mentioned, CSHL’s research is the most 
infl uential in molecular biology and genetics, as measured by the impact of faculty publications.
The so-called NIH salary cap determines the maximum salary support that scientists can re-
ceive. It has been reduced substantially in recent years, and may be reduced some more. We and 
other institutions must make up the difference if we are serious about retaining faculty, for the 
NIH cap does not come close to the level of salary that we must pay our senior scientists. We do 
provide such support to all of our senior faculty, while supporting full salaries for at least the fi rst 
5 years for all junior faculty. We also pay for a large portion of our infrastructure costs, in part to 
meet conditions set but not paid for by the federal government, but mostly to keep the infrastruc-
ture capable of supporting cutting-edge science.
How do we manage this? Science at CSHL cannot be done without the proceeds from our 
 fundraising efforts plus annual spending from our endowment. The latter is frankly still too 
small to provide us with breathing room. So, we have tried to plan our future science programs 
on the basis of what we can realistically budget, given all the current constraints. It is now time 
for our political leaders do their part to keep federal support for research predictable. But as I have 
intimated, the needs of the research community will certainly exceed the government’s ability 
to provide, probably for a decade or more. At Cold Spring Harbor, we are very fortunate to re-
ceive generous support from many foundations and individuals. These sources, together with our 
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endowment draw, covered 50% of our research expenditures in 2012. Such a ratio of federal to 
private funding of research may have to be the norm for all institutions in the future, not just Cold 
Spring Harbor and other like-minded research institutions. Medical schools will have to provide 
more to their scientists, but this change also comes at a time when clinical income is dropping at 
a rapid clip.
The Power of Philanthropy
Philanthropic support has been a fundamental part of what makes Cold Spring Harbor Labora-
tory successful. It is clear to all our scientists that federal grant support provides the core funding 
needed to maintain a research program and its key infrastructure, but it is philanthropic support 
that allows our scientists to do their most innovative research. Thus we must increase philan-
thropy, growing our endowment so that key funds can be allocated when needed, not in the year 
or two that it takes to secure a federal grant, long after a new idea is stale.
Part of the logic for increasing support to Cold Spring Harbor is our track record: we have a 
long history of major accomplishments and great infl uence in both research and science educa-
tion—all achieved through prudent use of very limited funds. The seeds of our success were sowed 
by the great philanthropists of the last century. The estate of Andrew Carnegie launched our 
genetics research and sustained it for 60 years. The Carnegie Institution of Washington put the 
Laboratory on the map as one of the world’s leading centers of genetics research. CSHL’s future 
Nobelists Al Hershey and Barbara McClintock were benefi ciaries of the Carnegie largesse. When 
Carnegie monies were withdrawn in the early 1960s, the Laboratory very nearly was forced to 
close. Not long after that, Jim Watson came to Cold Spring Harbor as Director. The history of 
the intervening years was possible in large measure because of Jim’s great ability to make the case 
for philanthropic support. He also appreciated the value of defi ned research focus, most notably 
cancer research. This research expertise brought in institutionally stabilizing federal funding, 
much of it via the NCI. Since 1987, we have been designated by NCI as a National Cancer Center 
for basic research in cancer.
The reality of today, however, is that we have arrived at a point at which, even with an en-
dowment in excess of $300 million, we have little margin for disappointment, whether in the 
performance of our endowment portfolio or in levels of federal support, or, indeed, in the success 
of our fundraising efforts. CSHL has prospered because of philanthropic foresight and civic-
mindedness: that of Mr. Carnegie and his administrators, but also our local heroes including the 
Jones family, Louis Tiffany, William K. Vanderbilt, Walter Jennings and George Pratt, Marshall 
Field III, and J.P. Morgan. Without them, the Delbrück Laboratory would never have been built. 
Without them, Demerec and Hershey and McClintock, not to mention summer visitors like Sal-
vador Luria and Max Delbrück, also both Nobel laureates, or the then young turks like Norton 
Zinder and Jim Watson, might never have had the opportunity to change history, right here on 
the grounds we walk each day.
Charles Sammis Robertson’s philanthropic spirit provided the foundation for our current en-
dowment and changed the face of the institution, giving us an endowment and the opportunity 
to create the Banbury conference center, where small private gatherings of people with the power 
to change the course of science have been held regularly for over 3 decades. More recently, we 
have been privileged to have truly major support from the Simons Foundation and the Stanley 
Medical Research Institute, philanthropic support that has literally changed how we understand 
the cause of certain psychiatric disorders. Today, we are fortunate to have many other individuals, 
particularly our current Trustees, who provide signifi cant support to Cold Spring Harbor Labora-
tory and provide us with the funds that will ensure that we remain a leader in the life sciences. But 
to maintain our leadership in research and science education we will have to expand greatly the 
number of such loyal supporters.
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“Surplus wealth is a sacred trust which its possessor is bound to administer in his lifetime for 
the good of the community.” That was Andrew Carnegie’s “Gospel,” and it is one that I fervently 
hope a civic-minded few will now take to heart so that our great institution might safely navigate 
some very treacherous fi scal waters. Perhaps our nation’s leaders will also smooth out the fi scal 
waters for research funding, and together, a public-private partnership will continue to ensure that 
American science remains the most innovative in the world.
Bruce Stillman, Ph.D., F.R.S.
President and Chief Executive Officer
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Research
The year 2012 was another superb one for research at Cold Spring Harbor Laboratory. Here, 
we provide details of a handful of signifi cant investigations that led during the year to pub-
lished results in major scientifi c journals. These are suggestive of the breadth of activity at the 
Laboratory, as more than 600 scientists and technicians in 52 labs extend our knowledge of 
cancer cell biology and genetics, as well as cancer treatments; critical circuits and biochemical 
pathways in the brain that go awry in psychiatric as well as neurodevelopmental and neuro-
degenerative disorders; and genes and their pathways in plants that will help boost crop yields 
and extend range. The infl uence of CSHL faculty publications continues to be extraordi-
nary; once again we were independently rated Number 1 in impact on molecular biology and 
 genetics, worldwide.
The value of the Laboratory’s research is gaining broader recognition outside the academic 
community. 2012 was marked by the announcement of collaborative agreements with two 
companies at the top of the Fortune 500, DuPont and Pfi zer Inc. CSHL’s plant biologists 
are working with scientists at leading seed producer DuPont Pioneer to better understand 
the genetic processes that control growth and development. This work is already providing 
a basis for new ways of boosting plant yields and for extending the range of key food crops. 
Pharmaceutical giant Pfi zer is teaming with our researchers to develop technology for a next-
generation library of human short hairpin RNAs (shRNAs). These tiny molecules, which 
can turn genes on and off by engaging a biological mechanism called RNA interference, are 
extremely useful in the identifi cation of novel targets for anticancer drugs.
Decision-Making Abilities in Response to Multiple Sensory Cues Are Similar 
in Rodents and Humans
The ability of humans to make decisions in the most effi cient and unbiased way based on percep-
tual information, for example, from auditory and visual cues, is well documented. Assistant Pro-
fessor Anne Churchland published work this year showing that other mammals, in this 
case rodents, perform equally well in similar tests. Rats were trained through receiving re-
wards to respond to visual cues via the appearance of a white light on an LED screen and 
auditory cues through a speaker, either separately or in tandem. The results of the tests 
with rats were compared to similar stimuli presented to humans, with some additional 
features added that mimicked a real-life situation. Both humans and rats made accurate 
decisions in response to these combined, multisensory stimuli that were close to optimal 
based on a statistical prediction. By varying the time between the visual and auditory 
cues, the team was also able to show that the brain processes each cue in parallel, before 
fusing them together at a later stage in order to make a decision. These results suggest 
decision-making processes are evolutionarily conserved and provide a basis for researchers 
to use rodents as an animal model to study decision making in humans.
Live-Imaging Microscopy Offers Insights into Modulation of Tumor 
Response during Therapy
Assistant Professor Mikala Egeblad and her team are experts in live-imaging microscopy. 
This technique was instrumental to a study they published this year showing how cancer 
cells in mouse tumors and the noncancerous “stromal” cells around them (the tumor mi-
croenvironment) respond during chemotherapeutic treatment with the drug doxorubicin. 
They were able to watch as the tumor and the surrounding tissue changed before, during, 
Pﬁ zer
DuPont Pioneer
A. Churchland
M. Egeblad
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and after drug administration. What they saw in the resulting time-lapse movies was that there 
is regulation of the permeability, or leakiness, of the blood vessels that wind through and around 
the tumor, which impacts the local recruitment of infl ammatory cells. Resistance to doxorubicin 
correlated with intermediate-stage tumor development and the relative permeability of the blood 
vessels supplying the tumor. In mice lacking the gene for a protein involved in regulating blood 
vessel permeability, matrix-metalloproteinase-9 (MMP9), blood vessels were leakier and mice re-
sponded better to doxorubicin. The response was also improved when mice were lacking 
a gene, CCR2, important in the recruitment of infl ammatory cells. Mikala’s live-imaging 
techniques point to the possibility of boosting therapy responses using additional targeted 
factors.
Massive Analysis of the Human Transcriptome Suggests 
Redeﬁ ning the Gene
Professor Thomas Gingeras and colleagues, including Professor Greg Hannon, published 
a comprehensive analysis of the messages, or transcripts, produced across the complete 
genome of human cells. The study was part of the latest coordinated release of data from 
the Encyclopedia of DNA Elements, or ENCODE, consortium. The new data show that 
up to three-quarters of the genome is capable of being transcribed and that much of 
nonprotein-coding RNA is organized in a way that indicates it may be functional, i.e., it 
may perform biochemical actions, and that smaller functional RNA transcripts can reside 
within longer transcripts, being released as longer ones are chopped up or “processed.” 
Given the large amount of the genome that is transcribed, and the nested organization of 
many nonprotein-coding RNAs, the perceived boundaries between genes are shrinking 
and even overlapping. These observations challenge the previous understanding of what 
discrete unit makes up a gene and raises the implication that disease-associated mutations 
may lie in functional nonprotein-coding RNA transcribed from what was once thought 
to be “spacer” regions of DNA between genes.
Origin and Migration of Powerful Cortical Inhibitory Cells Determined
Chandelier cells are powerful inhibitors of the excitatory impulses from the pyramidal neurons 
of the brain’s cortex. One chandelier cell makes contact, through chemical junctions known as 
synapses, with up to 500 pyramidal neurons. Thus, they are critical for managing in-
formation fl ow in the brain. But the origins of chandelier cells had remained enigmatic 
until a study by Professor Josh Huang and colleagues was published this year. Using 
new technologies to mark and trace migrating neural cell progenitors, they located the 
starting place for chandelier cells in a previously unrecognized portion of the developing 
embryonic mouse brain they dubbed the VGZ (ventral germinal zone). In addition, they 
identifi ed a gene that is switched on at the birth of a chandelier cell called Nkx2.1, the 
product of which is a transcription factor important to other inhibitory neurons. Josh’s 
team found that after birth, chandelier cells take a stereotypical route of migration into 
the cortex, where they set up residence at very specifi c sites in cortical layers 2, 5, and 6. 
Since it is already known that the number and connective density of chandelier cells is 
reduced in schizophrenia, work on the developing brain and how its circuits are put together has 
important implications for disease research.
Proteins Involved in Small RNA Biogenesis and Function
Two proteins important in the biogenesis of gene-regulating small RNAs were the subject of new 
publications in 2012 stemming from collaborative work between the groups of HHMI Investi-
gators and CSHL Professors Leemor Joshua-Tor and Gregory Hannon. One paper detailed the 
T. Gingeras
G. Hannon
J. Huang
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structure of human Argonaute-2 (Ago2) protein bound to a microRNA (miRNA) guide. 
The structure revealed a remarkable evolutionary conservation also seen in an archebacte-
ria protein the teams had previously determined, especially in regions important for target 
recognition and activity of the protein. Structure-based understanding of how the struc-
ture is stabilized, now clear, could be important for designing therapeutic small RNAs ex-
ploiting this mechanism or for blocking Argonaute activity. A second study published this 
year involved the biochemical characterization of a protein known as Zucchini, which 
had been thought to be involved in cleaving phospholipid molecules. However, previous 
work in the Joshua-Tor and Hannon labs had implicated it in the biogenesis of genome-
protecting PIWI-interacting RNAs (piRNAs) found in cells of the germline—sperm and 
eggs. Their new results show that the mouse version of Zucchini, mZuc, does not have 
phospholipase activity, but in fact acts as a nuclease—it cuts nucleic acid chains. Structural analy-
sis reveals that the shape of the catalytic binding site is consistent with that of a nuclease. Thus, 
the evidence implies the Zucchini protein is involved in reducing long precursor RNAs to short 
piRNAs in germline cells.
A Genetic Check in the Molecular Clock That Controls Timing 
of Tomato Plant Flower Production
The timing of fl owering in plants is important for their successful reproduction. It helps attract 
pollinators such as bees. Variations in this timing can affect fl ower, fruit, and seed production, 
and consequently agricultural yield. Assistant Professor Zach Lippman and his team have 
previously shown that, in addition to external factors such as light and temperature, there 
is a molecular clock in the tomato plant responsible for controlling timing of fl owering. 
In new research published this year, they showed that a gene called Terminating Flower, 
or TMF, is responsible for acting as a check on this clock, preventing it from running too 
fast. Mutations in TMF result in the reproductive shoots, or infl orescences, of the tomato 
plant producing just a single fl ower. This is due to the plant proceeding to fl ower while 
still in the vegetative state, the phase in which leaves are still being made. When normal 
TMF is present, the tomato plant produces its characteristic multifl owered infl orescences. 
Thus, TMF is responsible for coordinating and synchronizing the tightly controlled pro-
cess of fl owering by gently slowing down. The important implication is that the genetic 
control of fl owering in plants such as tomato can be manipulated in agricultural crops to 
improve yield.
Toward the First Vertebrate Whole-Brain Image Map
Professor Partha Mitra and colleagues are working toward constructing a whole-brain wiring dia-
gram of the mouse. Earlier this year, they released the fi rst set of gigapixel (1 billion-pixel) images 
from the project (http://mouse.brainarchitecture.org). The current data set is close to 1 petabyte 
in size (uncompressed). To visualize the brain, the team labeled neuronal pathways with 
tracers, cut 20-μm-thick slices from “front” to “back,” and then imaged each slice. Using 
a semiautomated, quality-controlled, light-microscopy-based assembly, they captured 
~500 images per brain. These were then arranged to present viewers with a unique jour-
ney through a three-dimensional model of the mouse brain, along the neuronal pathways 
that represent the inputs and outputs of given brain regions. The images were produced at 
the intermediate, or “mesoscopic,” scale of detail, i.e., between the extremely fi ne detail of 
electron microscopy and the macroscopic scale of MRI-based imaging. At the mesoscopic 
scale, Partha’s team expects to produce a stereotypical map of neuronal connections, i.e., 
connections that are similar between individuals and genetically determined in a species-
specifi c manner.
L. Joshua-Tor
Z. Lippman
P. Mitra
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A Protein That Has a Central Role in Cortical Progenitor Cell Fate
Professor Linda Van Aelst and colleagues have identifi ed a protein key in determining whether 
cortical progenitor cells will proliferate, make progenitor cells, or differentiate and turn into ma-
ture cells. The progenitor cells are known as radial glial cells (RGCs), whereas the mature 
cells are pyramidal neurons, excitatory nerve cells found in the brain’s cortex. The protein 
Linda’s group shows to be central in regulating RGC proliferation and differentiation is 
called DOCK7. It previously had been shown by the Van Aelst lab to be highly expressed 
in the hippocampus and cortex of the developing rodent brain, controlling the formation 
of axons. Now they show that when DOCK7 is silenced in developing mouse embryos, 
RGCs remain in their progenitor state, but when overexpressed, RGCs differentiate prema-
turely. These two processes must be fi nely balanced for proper cortical development, and 
DOCK7 is the key protein in maintaining this balance. The team found that DOCK7 an-
tagonizes the growth of microtubules through an interaction with a protein called TACC3, 
thus affecting the movement of the nucleus within the cell. This study illuminates a pro-
cess central to cortical development and may also help further our understanding of abnormal brain 
development in conditions such as microencephaly, which is characterized by small brain size.
Genome Analyses of Two Major Agricultural Crops Pave Way 
for Higher Yields
This year, Cold Spring Harbor Laboratory researchers were at the forefront of two ambitious 
projects to study the complete genomes of two of the so-called big three agricultural crops: maize, 
better known as corn, and bread wheat. Associate Professor Doreen Ware and colleagues 
provided the most comprehensive analysis of maize to date. They analyzed genetic struc-
ture and the relationships and sequential ordering of individual genes in more than 100 
varieties of wild and domesticated corn. This revealed tremendous variation among va-
rieties, including genome size variation of up to 25%, indicating that the evolution of 
maize is still ongoing. They were also able to identify hundreds of genes that had a role in 
the domestication of wild corn and discovered that breeding efforts focused on selecting 
for hybrid vigor, a phenomenon fi rst described by CSHL plant geneticist George Schull 
in 1908, were important in this process. The consortium of scientists involved was also 
able to expand upon a previous study in which they identifi ed more than 1 million genetic 
markers.
Professor W. Richard McCombie’s team was involved in a huge and complex technical 
analysis of the genome of bread wheat. The challenge was that the bread wheat genome’s 
17 billion DNA “letters,” or nucleotides, are spread across six copies of each of its seven 
chromosomes and up to 80% consists of repeat sequences. The team overcame this using 
next-generation sequencing techniques in which the DNA was randomly broken up into 
smaller pieces and assembled for analysis by identifying the overlapping ends. They were 
then compared to known sequences from a range of grasses, including rice and barley. 
The analysis revealed 94,000 to 96,000 genes, a large number of gene fragments, and 
132,000 SNPs (single-nucleotide polymorphisms). This suggests that bread wheat under-
went rapid and signifi cant changes during the process of domestication. In both maize 
and bread wheat, newly identifi ed structural variations and expanded gene families are 
implicated in many traits important for crop growth and survival, providing an important frame-
work within which to signifi cantly improve breeding efforts.
A Striking Link between the Fragile-X Gene Product and Autism Mutations
Continuing his laboratory’s important investigations of the role in autism causation played by 
spontaneously occurring, or de novo, gene mutations, Professor Mike Wigler and colleagues 
L. Van Aelst
D. Ware
W.R. McCombie
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 pub lished results this year that revealed an interesting linkage with genes implicated in 
Fragile-X syndrome. The most common cause of inherited intellectual disability, Frag-
ile X is also counted among the autism spectrum disorders (ASDs) due to the co-occur-
rence of autism-like symptoms in some patients. It occurs when a gene called FMR1 fails 
to direct nerve cells to manufacture a protein called FMRP. Mike’s team demonstrated, 
with help from Ivan Iossifov and other computational biologists at the Laboratory, that 
~20% of the genes found to be disturbed in a sample of 343 autistic children appear to 
be regulated by the FMRP protein. The team fi nds that small de novo mutations—as 
small as a single DNA letter or areas of small insertions or deletions of genetic material 
up to 15 letters in length—could be traced in the majority of small children with ASD 
to the father’s germ cells (sperm) and that their occurrence correlated directly with the 
father’s age, older dads being more likely to contribute sperm that will result in a child with small 
autism-related de novo mutations. As Wigler points out, because of research connecting FMRP to 
neuroplasticity—the sensitization and desensitization of nerve cells to repetitive inputs—the new 
results indicate a possible convergence of mechanisms in autism.
Using DNA Barcodes and Gene Sequencing to Map Circuits in the Brain
A multiyear project conceived by Professor Tony Zador that in 2011 earned him a prestigious 
National Institutes of Health (NIH) “Transformative Research” grant this year yielded its fi rst re-
sults. The project seeks to develop a novel method to map circuits and pathways through-
out the mammalian brain at extremely fi ne resolution, that of individual neurons and 
their estimated one trillion synaptic connections. Zador and colleagues propose to use 
high-throughput DNA sequencing, which is both inexpensive and fast, to probe the con-
nectivity of neural circuits at single-neuron resolution. As set forth in a provocative paper, 
Tony and colleagues introduce a technique they called BOINC, an acronym for the bar-
coding of individual neuronal connections. Now in proof-of-concept testing, BOINC is 
designed to provide immediate insight into the computations that a neural circuit per-
forms. It consists of three steps: (1) neurons are labeled with a specifi c DNA “barcode;” 
(2) barcodes are exchanged among neurons connected across synapses, by exploiting a 
deactivated virus that can move genetic material across these gaps; and (3) barcodes from 
connected neurons are joined to make single pieces of DNA, which can then be read by DNA 
sequencers. A full set of such sequences would be analyzed computationally to reveal the synaptic 
wiring diagram of a whole mouse brain. It is a bold idea, and the Zador lab will soon be able to 
report on its success in realizing it.
A Cancer Target That May Also Be Important in Alzheimer’s Disease
Professor Yi Zhong and colleagues obtained intriguing results this year in their continuing ef-
forts to identify targets for treating Alzheimer’s disease and other neurodegenerative illnesses. 
Using the fl y brain as a model, Yi had previously studied memory loss associated with the 
 expression in brain cells of a peptide called amyloid β-42 (Aβ-42), found in human brain 
plaques. Yi’s fl ies express the human Aβ-42 gene and suffer memory defi ciencies analo-
gous to those seen in patients. In new experiments, Yi’s team demonstrated that enhanced 
activation in brain cells of the epidermal growth factor receptor, or EGFR, exacerbated 
memory loss in the Aβ-42 fruit fl y model. EGFR overexpression is a defi ning feature of 
certain cancers, notably a subset of lung cancers, which can be temporarily reversed with 
targeted EGFR inhibitors. Yi’s team showed that EGFR overexpression in fl y neurons cor-
relates with severity of memory loss in Aβ-42-expressing fl ies. The team dosed the fl ies 
with EGFR inhibitors over a week’s time, and behavioral tests showed that this prevented 
memory loss. The results were confi rmed in mouse models of Alzheimer’s also based on 
M. Wigler
A. Zador
Y. Zhong
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the human Aβ-42 gene. Other members of Yi’s team, working in a parallel but separate process, 
also identifi ed EGFR as an Alzheimer’s drug target, around the same time. That team was testing 
a library of 2000 synthetic compounds for activity against Aβ-induced memory loss in fruit fl y 
models. Of these, 45 showed positive results after two months of dosing, and three of these, tested 
in vitro, specifi cally prevented Aβ-42 from activating human EGFR.
Cold Spring Harbor Laboratory Board of Trustees
New York Governor Andrew Cuomo said it best when he visited the campus in October: “[For] 
what it does for the soul, the people it gives hope to, Cold Spring Harbor has always been synony-
mous with accomplishing the impossible.” We do this at all levels of the institu-
tion, starting with the Board of Trustees.
Led by Chairman Jamie Nicholls, we are attracting leaders of the highest 
caliber to our governance bodies. The board welcomed Charles “Casey” Cogut, 
senior corporate partner at Simpson Thacher & Bartlett LLP, with expertise in 
M&A, private equity, and governance.
Re-elected to the board for an additional 4-year term were Dr. David Botstein, 
Jacob Goldfi eld, Leo A. Guthart, Thomas D. Lehrman, Dr. Charles L. Sawyers, 
Dr. Marilyn H. Simons, Dr. James M. Stone, Paul J. Taubman, and Roy J. 
Zuckerberg. Offi cer elections continued the terms of Chairman Nicholls, Vice 
Chairs Robert D. Lindsay and Marilyn H. Simons, Dr. Leo A. Guthart, Bruce 
Stillman, Ph.D., and W. Dillaway Ayres. Paul J. Taub-
man replaced Edward Travaglianti as Secretary.
Many thanks to our friends who are retiring trustees, 
having served on the board and numerous committees 
from 2004 to 2012: Stephen Lessing, Andrew Solomon, 
and Dr. Jerome Swartz.
We mourned the passing of former CSHL trustees 
Townsend Knight, Robert Van Cleef Lindsay, and John J. Phelan. Rod 
was one of the founding members of the contemporary Laboratory, serving 
from 1959 to 1965. Townie served from 1973 to 1995, when he was named 
Honorary Trustee. John served two terms from 1992 to 1999.
Development
With the help of our board, CSHL capped another 
year of record-breaking success in fundraising with 
an Annual Fund total of $6.6 million raised. The 7th 
Double Helix Medals Dinner Gala raised $3.7 mil-
lion and honored Parkinson’s disease research activist 
 Michael J. Fox, Apple Chairman Art Levinson, and 
philanthropist Mary Lindsay, who is also a CSHL 
Honorary Trustee.
In the community, the Cold Spring Harbor Labora-
tory Association made many new friends by organiz-
ing events that included a music, art, and food festival 
called Labapalooza; the 11th Women’s Partnership Lun-
cheon featuring Professor Michael Wigler (who spoke 
about single-cell sequencing in cancer research); and 
the annual President’s Council retreat, which focused 
A. Cuomo and B. Stillman
C. Cogut
Double Helix Medal winners M.J. Fox, M. Lindsay, and A. Levinson
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this year on the topic of medical ethics. CSHL  Director of 
Research David L. Spector and Associate Professor Lloyd 
Trotman headed the agenda, which also included DNA 
Learning Center Executive Director David Micklos. CSHL 
Trustee Andrew Solomon, acclaimed writer on politics, 
culture, and society, discussed his new book, Far From the 
Tree. Other guest speakers included Drs. Gilbert Welch of 
Dartmouth, Jeffrey Berger of Stony Brook University, and 
Hans Sauer of the Biotech Industry Organization.
Of course, doing the impossible would not even be imag-
inable without private philanthropic support. In 2012, 
CSHL was grateful for new major gifts from (in alphabeti-
cal order) an anonymous donor, Jamie Nicholls and Fran 
Biondi, Mr. and Mrs. David Boies, Charitable Lead An-
nuity Trust under the Will of Louis Feil, Laurie J. Landeau Foundation, Mr. and Mrs. Robert 
D. Lindsay and Family, the Lustgarten Foundation, the  Simons Foundation, and Dr. and Mrs. 
James M. Stone.
Research Faculty
There is no clearer evidence of our ability to achieve what our Governor called “the impossible” 
than the research accomplishments of our faculty. Many are individually recognized each year by 
competitive awards and academic honors.
Professor and Howard Hughes Medical Investigator Greg Hannon was elected to the U.S. Na-
tional Academy of Sciences, which ranks among the highest honors conferred upon scientists in 
America. Dr. Hannon, a molecular biologist, is recognized the world over as among the foremost 
authorities on small RNA biology and RNA interference. RNAi, as it is known among scientists, 
is a natural cellular mechanism implicated in genome defense, in which small RNA molecules act 
to regulate gene expression. It has been exploited by scientists led by Greg and colleagues for many 
extremely valuable purposes, including hunting for cancer genes, stopping viral infections, and, 
most recently, treating diseases in clinical trials.
The AAAS council elected Professor and Howard Hughes Investigator Leemor Joshua-Tor a 
2012 AAAS Fellow, recognizing her contributions to the fi eld of nucleic acid enzymes, particularly 
Women’s Partnership for Science Luncheon
A. Solomon, G. Welch, and B. Stillman
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in the fi elds of RNA interference and DNA replication. Leemor’s laboratory studies the molecular 
basis of cell regulatory processes, using the tools of structural biology and biochemistry to exam-
ine proteins and protein complexes associated with these processes. Her efforts largely center on 
nucleic acid regulation, including the process of RNA interference and DNA replication initiation 
in papillomaviruses.
Professor Adrian Krainer received a MERIT AWARD (Method to Extend Research in Time) 
from the National Institute of General Medical Sciences. This award rewards highly productive 
scientists by extending funding for an existing research project grant. Adrian is a leader in the fi eld 
of RNA splicing, which has signifi cant implications for many human genetic diseases because a 
high proportion of disease-causing mutations affect messenger RNA (mRNA) splicing and stabil-
ity. mRNAs are the coded instructions copied from the genetic material that direct cells to manu-
facture specifi c proteins. Adrian’s current research will result in a better understanding of which 
mutations cause defective gene expression, and precisely how they do so. Already, his research has 
guided the development of a drug to treat a fatal childhood disease called spinal muscular atrophy 
(SMA). Clinical trials to test this drug were begun in 2012.
Professor Nicholas Tonks was named Vallee Visiting Professor by the Bert L. and N. Kuggie Val-
lee Foundation. This honor is conferred upon those who have demonstrated a record of exceptional 
creativity, originality, and leadership and sustained success at an elite level. A biochemist and molecu-
lar biologist, Nick is well known for having laid the foundations for the identifi cation and functional 
characterization of a superfamily of 107 regulatory enzymes called protein tyrosine phosphatases, or 
PTPs. Protein phosphatases recognize phosphorylated amino acid residues and function to remove 
them; their action is thus complementary to the class of protein kinases, which add phosphate groups 
to amino acid residues. Together, they play crucial roles in signal transduction pathways.
Anne Churchland received the McKnight Foundation Scholar award supporting neurosci-
ence research. This award addresses a basic problem which, when solved, could immediately 
and signifi cantly impact clinical issues. Anne plans to use the award to study the neural circuits 
underlying a process known as multisensory decision making—the integration of information 
from individual senses such as seeing, hearing, and touch to make more accurate decisions. Anne 
was also selected for the Janett Rosenberg Trubatch Career Development Award, which rewards 
promise and achievement in the fi eld of neuroscience for early-career professionals.
Assistant Professor Christopher Vakoc received the “A” award for pediatric leukemia research, 
one of only four to receive this honor from Alex’s Lemonade Stand Foundation. He will work on 
a project entitled “BET bromodomain inhibition as epigenetic therapy in pediatric leukemia.” 
Chris was also named a “V Scholar,” one of 17 of the “best and brightest” cancer researchers, by 
the V Foundation. His project is entitled “Therapeutic targeting of the Polycomb complex PRC2 
in acute myeloid leukemia.”
Florin Albeanu was named a Pew Scholar in Biomedical Sciences. Florin, who came to CSHL 
as a Fellow in late 2008 and was appointed a member of the faculty in 2011, studies how the brain 
A. Krainer N. Tonks C. Vakoc F. Albeanu
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encodes stimuli from the outside world, within and across sensory modalities, to generate 
specifi c perceptions that, in turn, trigger complex behaviors. He is interested in how the 
brain is shaped by sensory experience and what modifi cations occur in neuronal circuits 
that allow us to learn and remember.
Christopher Hammell was named a Rita Allen Foundation Scholar. As part of the 
cancer research program, Dr. Hammell is interested in understanding the gene regula-
tory process that gives rise to normal development in animals as well as alterations in 
these processes that give rise to diseases such as cancer. Chris also received the special 
honor of being named the Milton E. Cassel Scholar, a tribute to the memory of a long-
time president of the foundation.
CSHL once again teamed up with the National Institutes of Health (NIH) to host 
a regional conference on funding opportunities and research priorities in the neurosciences. 
Heading up the agenda were Dr. Thomas Insel, Director of the National Institute of Mental 
Health; Dr. Robert Finkelstein, Director, Division of Extramural Research at the National 
Institute of Neurological Disorders and Stroke (NINDS), and Dr. Alan L. Willard, Deputy 
Director of NINDS. Supported by the Alfred P. Sloan Foundation and organized by the CSHL 
Offi ce of Sponsored Programs, CSHL faculty members Florin Albeanu, Anne Churchland, and 
Steve Shea facilitated the discussions with faculty from Columbia, SUNY Stony Brook, New 
York University, and the Massachusetts Institute of Technology (MIT).
The laboratories of CSHL’s 52 principal investigators are supported by an active community 
of postdoctoral fellows, this year numbering nearly 160. The Postdoc Liaison Committee was 
created to give the postdoctoral community a formal organization through which to pursue its 
own agenda of enhancing the postdoctoral education experience at CSHL. Headed by an elected 
group of six, they are the primary organizers of the twice-yearly postdoctoral collaboration and 
networking retreats.
Some of committee’s most successful activities include initiation of a career development se-
ries in which faculty members educate postdocs on “real-life” topics such as how to negotiate 
for a startup package after landing a faculty position or how to hire staff of a new lab. The 
newly formed Bioscience Enterprise Club, which welcomes postdocs, graduate students, and the 
CSHL campus community at large, is off to a great start providing opportunities to learn about 
C. Hammell
Postdoc Symposium
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nontraditional science careers, develop entrepreneurial skills, and network with professionals in 
the biotech industry, clinical research, intellectual property law and tech transfer, consulting, sci-
ence education, policy, and administration.
New Faculty
CSHL continues its historic commitment to attracting and promoting world-class research fac-
ulty. According to Director of Research David L. Spector, who heads the institution’s faculty re-
cruitment efforts, “in the last year, we have strategically invested in research faculty who 
are at the forefront of cancer therapeutics, genomics of human disease, human genetics, 
computational biology, and bioinformatics. We look forward to the signifi cant impact 
that we know these exceptional scientists will have in shaping the future of biomedical 
research.”
David Tuveson, M.D., Ph.D., was appointed Professor and Deputy Director of the 
CSHL Cancer Center. Dave obtained a bachelor’s degree in chemistry at MIT, followed 
by M.D. and Ph.D. degrees at Johns Hopkins. After obtaining a faculty position at the 
University of Pennsylvania, he moved to the University of Cambridge, England, to de-
velop preclinical and clinical therapeutic strategies. CSHL recruited Dave to direct the 
Cancer Therapeutics Initiative (CTI). He serves simultaneously as Director of Research 
for the Lustgarten Foundation, the nation’s largest private foundation dedicated to funding pan-
creatic cancer research. Together with the Lustgarten Foundation, CSHL announced the opening 
of the Lustgarten Foundation Pancreatic Cancer Research Laboratory located on our Hillside 
Campus. This laboratory will focus exclusively on pancreatic cancer research, with initial studies 
centered on early detection, drug development, and drug delivery.
Dave’s team investigates fundamental aspects of cancer biology and applies this knowledge to 
the development of new therapeutic and diagnostic strategies. His lab developed the fi rst mouse 
models of pancreatic ductal adenocarcinoma (PDAC), which have been instrumental in the dis-
covery of biomarkers of early disease. They also identifi ed pathways and druggable targets in-
volved in the initiation, progression, and metastasis of PDAC and developed new therapeutic 
strategies. Following the observation made in his lab that PDAC tumors contain a defi cient and 
compressed vasculature, which limits therapeutic drug delivery and therefore effi cacy, Dave has 
uncovered several methods to correct or target these vascular defi cits and promote drug response. 
This work has led to the initiation of several clinical trials. At CSHL, he will continue the search 
for new vulnerabilities in PDAC neoplastic cells and the tumor surroundings, called 
the microenvironment. His team will evaluate candidate drug targets in an advanced 
therapeutics testing facility being developed as part of the CTI. He aims to translate his 
preclinical results into the design of pivotal investigational clinical studies.
Another scientist-clinician whom we added to the faculty this year is Assistant Profes-
sor Gholson J. Lyon, M.D., Ph.D. Gholson received a B.A. in biochemistry from Dart-
mouth College and shortly thereafter completed an M.Phil. in genetics at Christ’s Col-
lege, University of Cambridge, England. He has a Ph.D. from Rockefeller University in 
chemical biology and an M.D. from Weill Cornell Medical College. Gholson is affi liated 
with the Utah Foundation for Biomedical Research.
Here, Gholson focuses on analyzing human genetic variation and its role in severe 
neuropsychiatric disorders. He does so by studying large groups of related individuals living in the 
same geographic location. The Lyon lab is using sequencing of whole genomes and of the exome—
the small portion of the genome that encodes proteins—to fi nd mutations that distinguish disease 
syndromes, in populations from Utah and elsewhere. Gholson is interested in the discovery of 
families with rare diseases and/or increased prevalence for syndromes such as Tourette syndrome, 
ADHD, obsessive-compulsive disorder (OCD), intellectual disability, autism, and schizophrenia.
D. Tuveson
G.J. Lyon
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Joining CSHL as an assistant professor is Jesse Gillis, Ph.D. He holds a B.S. in bio-
physics from the University of Toronto, where he also earned both an M.S. and a Ph.D. 
in Neuroscience. He was recruited to CSHL from the University of British Columbia, 
where he did a postdoctoral fellowship at the Centre for High-Throughput Biology.
The Gillis laboratory is working to understand how genes interact and how this relates 
to gene function and the effect on disease. Using computational biology, he is interpret-
ing the functions of genes in the context of the networks they form, with data derived 
from gene association studies.
Promotions
Congratulations to Alexei Koulakov, who was promoted to professor. Alexei came to CSHL in 
2003 from the University of Utah, where he was an assistant professor in the department of Phys-
ics. He received his Ph.D. from the University of Minnesota and was a postdoctoral fellow at the 
Salk Institute. Alex is interested in computational and theoretical neuroscience and is probing 
neural circuits to understand the mechanisms of neural computation, the means by which vast 
networks of nerve cells in the brain encode and are able to understand messages.
Glenn Turner and Lloyd Trotman were promoted this year to associate professor. Lloyd came 
to CSHL as an assistant professor in 2007, after a postdoctoral research fellowship at Memorial 
Sloan-Kettering Cancer Center. Glenn joined CSHL in 2006 as an assistant professor, having 
received his Ph.D. and performing postdoctoral research at California Institute of Technology.
Promoted this year to assistant professor were Molly C. Hammell, who, in addition to con-
tributing her expertise in computational biology to many ongoing research collaborations among 
CSHL labs, has been manager of the CSHL Cancer Center’s Bioinformatics Shared Resource 
since 2010; Ivan Iossifov, who began at the Laboratory in 2008 as a Quantitative Biology Fellow; 
and Dan Levy, who joined Mike Wigler’s lab as a postdoctoral fellow in 2007 and was then pro-
moted to senior computer scientist.
Isabel Aznarez Da Silva, who works in the laboratory of Adrian Krainer, and Camila Dos San-
tos, who works in Gregory Hannon’s lab, were promoted to research investigators.
Departures
Assistant Professor Rob Lucito is currently Assistant 
Professor of Science Education at Hofstra North 
Shore LIJ School of Medicine and remains associ-
ated with CSHL as an adjunct professor.
Education Programs
The Watson School of Biological Sciences (WSBS) 
celebrated its 9th graduating class, awarding Ph.D.s 
to Patrick Finigan, Kyle Honegger, Elizabeth Naka-
sone, Frederick Rollins, and Zhenxun Wang.
This year’s Honorary Degree recipient was Sir 
Kenneth Murray, who was knighted by the Queen 
of England in 1993 for his discovery of hepatitis B 
antigens. His long list of achievements includes de-
veloping a life-saving hepatitis vaccine, starting the 
fi rst European biotech company, and creating the 
Darwin Trust to support biological scientists from 
J. Gillis
2012 WSBS Doctoral graduates F. Rollins, K. Honegger, E. Nakasone, 
P. Finigan, and Z. Wang
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less affl uent parts of the world. We were saddened to hear that Dr. Murray passed away 
before this  Annual Report went to print.
In August, WSBS opened its doors to the 14th incoming class of nine students: Nitin 
Singh Chouhan, William Donovan, Talitha Forcier, Yu-Jui (Ray) Ho, Irene Liao, Paul 
Masset, Annabel Romero Hernandez, and Abram Santana. These new degree candidates 
come to us from the United States, France, India, Mexico, and Taiwan.
The WSBS now counts 54 Ph.D. graduates who are thriving in the “outside world.” 
They continue to publish in top journals and secure prestigious independent positions, 
fellowships, and awards. Eleven of our graduates have secured tenure-track faculty posi-
tions, and, as such, they are now receiving federal grants and publishing papers as inde-
pendent researchers.
Current students continue to win prestigious fellowships and prizes. In 2012, Colleen Carlston 
was selected into the National Science Foundation’s East Asia and Pacifi c Summer Institutes for 
U.S. Program. In addition, she received a National Science Foundation Graduate Research Fel-
lowship. John Sheppard also was awarded a National Science Foundation Graduate Research Fel-
lowship and received a National Defense Science & Engineering Graduate Fellowship from the 
Department of Defense. Melanie Eckersley-Maslin was awarded a Keystone Symposium Travel 
Fellowship. She was also awarded an American Society for Cell Biology Travel Fellowship to at-
tend the annual conference. WSBS students have published more than 210 papers to date, many 
in the most prestigious journals.
The National Institutes of Health’s National Institute for General Medical Studies renewed the 
School’s Training Grant for a period of 5 years. Despite very tight funding, the NIH recognized 
the outstanding achievements of the program, the students, and the faculty in the funding of this 
award. The training grant funds six students and also serves as an endorsement of the School’s 
excellence.
The annual Gavin Borden Visiting Fellow Lecture “Electron transfer in times of stress: 
New roles for redox active antibiotics,” was presented on April 23 by Dianne K. Newman, Ph.D., 
Professor of Geobiology and Howard Hughes Medical Institute Investigator at the California 
Institute of Technology.
Twenty-six undergraduates (selected from 884 applicants, the largest pool to date) from 
around the United States as well Canada, Switzerland, Ireland, and the United Kingdom formed 
the 53rd cohort of the Undergraduate Research Program (URP). This year’s URP Faculty Di-
rectors were Anne Churchland and Michael Schatz. The historic 10-week program for under-
graduate students convenes in the summer, and it provides some of the fi nest college students a 
priceless opportunity to conduct sophisticated research at the side of a CSHL investigator.
Under the direction of Professor David Jackson, the Partners for the Future Program for high 
school seniors attracts the best and brightest aspiring scientists to an average of about a dozen 
of our labs each year. Established by Dr. James Watson in 1990, the program provides an op-
portunity for gifted Long Island high school students to have hands-on experience in biomedical 
research.
In August, Leemor Joshua-Tor stepped down as Dean of the WSBS after 5 years of outstanding 
leadership. As the third leader of a school known as one of the nation’s most innovative Ph.D.-
granting programs, Leemor advanced the curriculum in signifi cant ways, including the addition 
of timely courses in quantitative biology, physical biology, and imaging. She has also served during 
her term as a member of the Biomedical Workforce Task Force of the U.S. National Institutes of 
Health, which recently issued recommendations to support a future sustainable biomedical re-
search infrastructure. A structural biologist who began her career at CSHL in 1995, Leemor is an 
Investigator of the Howard Hughes Medical Institute. She has made seminal contributions to the 
understanding of how RNA interference works to silence gene expression and has advanced new 
therapeutic options for combating papillomavirus, which causes cervical cancer. She continues her 
K. Murray
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research at the Laboratory, studying the molecular basis of cell regulatory processes using the tools 
of structural biology and biochemistry.
Thank you to Adrian Krainer and Linda Van Aelst, who served as interim deans for the remain-
der of the year. I was pleased to announce the selection of Alexander A.F. Gann as the new dean, 
effective January 2013.
We recruited Dean Gann from the CSHL Press, where he served as Editorial Director. At the 
Press since 1999, he has produced publications ranging from textbooks for undergraduate and 
graduate education to laboratory manuals and books on the history of science. Alex is a co-author 
of Molecular Biology of the Gene, now in its 6th edition, and of the recently released Annotated 
Double Helix, a new edition of James D. Watson’s autobiographical classic. Alex received his Ph.D. 
from the University of Edinburgh, Scotland, in 1989, after which he continued his postdoctoral 
training at Harvard and University College, London, and lectured at Lancaster University. A 
longtime member of the WSBS faculty, he brings a unique combination of inside perspective and 
broad understanding of the impact of the digital and genomic revolutions upon higher education 
and the biological sciences.
Meetings and Courses Program
The CSHL meetings program attracted strong attendance with more than 
7100 meeting participants and almost 1300 course participants (trainees, 
teaching and support faculty). The Cold Spring Harbor Asia program, in-
cluding 18 conferences and one summer school, has to date attracted more 
than 3000 participants. This brings the anticipated year-end total for both 
U.S.- and China-based programs to nearly 11,400.
Our fl agship meeting, the Cold Spring Harbor Symposium, focused in 
2012 on plant biology for the fi rst time in the 77-year history of the series. 
Given the importance of plant research in such vital fi elds as epigenetics 
and evolution, plants naturally have been discussed at many prior sym-
posia. This year, however, they occupied center stage, with a stellar list of 
presenters that included four CSHL faculty  members.77th CSH Symposium
53rd Undergraduate Research Program
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The year saw the introduction of two new meetings, Regulatory and Noncoding RNAs and 
Epigenetics and Chromatin, which drew strong attendance and featured a high proportion of un-
published research. We anticipate these meetings will each become regular biennial series. Two 
existing meetings were merged in 2012, as well: Personal Genomes and Pharmacogenomics were 
combined as Personal Genomics and Medical Genomes.
Just how robust our programs are, and how loyal are our attending scientists, was demonstrated 
when Hurricane Sandy powered up the East Coast at the end of October. Four courses were then 
due to end and a meeting and a course were due to begin the day of the storm’s local landfall, 
October 30. We made great efforts to accommodate our guests, mostly helping them arrange for 
departures. But a hearty core group of about 65 braved the elements and held a 2-day version of 
their scheduled meeting on Nuclear Receptors and Disease.
Courses
The CSHL Courses program benefi ted greatly in 2012 from the opening of the completely re-
built Hershey Building on the main campus. This fully modern and architecturally striking 
18,000-square-foot facility was fi nished in time to host more than 10 of our annual courses, 
including a successful new course on Single-Cell Analysis and a new Workshop on Cognitive Aging. 
Covering a diverse range of topics in molecular biology, neurobiology, structural studies, and bio-
informatics, the courses teach advanced students the latest innovations that can be applied imme-
diately to their research. Instructors are drawn to teach at Cold Spring Harbor from universities, 
medical schools, research institutes, and companies worldwide.
The Hershey Building was rededicated June 8 in a ceremony that highlighted the history 
and future of scientifi c research and education at the Laboratory. Named for the late Dr. Alfred 
 Hershey, a Nobel laureate and CSHL scientist, the new facility was made possible by a $15 million 
grant provided in 2008 by the Howard Hughes Medical Institute (HHMI).
The new facility allows for a 25% increase in course offerings and participants, including a 
number of new courses in computational approaches to biological questions. Courses such as Com-
putational and Comparative Genomics and Computational Neuroscience: Vision, both offered this 
year, put a new emphasis on the computational aspects of biology, including mathematics, statistics, 
and computer science.
Harry Anand, mayor of the Village of Laurel Hollow, commended CSHL at the Hershey 
rededication ceremony, noting the Laboratory’s continuing commitment to designing and build-
ing facilities that enhance the natural beauty of the local landscape. 
James Childress, partner of Centerbrook Architects and Planners, 
led the effort to design a completely new building to replace the 
original Hershey Building, which was erected in 1979. Other 
speakers at the rededication were Dr. James D. Watson and Dr. 
Jack Dixon, Vice President and Chief Scientifi c Offi cer of HHMI.
The ceremony also honored beloved CSHL course instructors 
Dr. Gordon Sato, for whom a new Flow Cytometry Laboratory has 
been named, and Dr. Mark J. Zoller, whose name now graces one of 
the facility’s modern teaching laboratories. In attendance were Dr. 
Sato; Dr. Zoller’s widow, Ms. Karen Zoller; Senator Carl Marcel-
lino; CSHL Board Chairman Jamie Nicholls; and fellow trustees, 
faculty, employees, and friends of the Laboratory.
Now in its third year of operation, the Cold Spring Harbor Asia 
(CSHA) program, under the direction of Dr. Maoyen Chi, is head-
quartered at the Suzhou Dushu Lake Conference Center, a purpose-
built academic conference center on the outskirts of old Suzhou, Suzhou Conference Center
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within a high-technology suburb (SIP). The scientifi c program includes large symposia and meet-
ings, training workshops and Banbury-style discussion meetings. CSHA is a wholly owned sub-
sidiary of CSHL and is not beholden to outside partners in terms of our scientifi c programming. 
The 50% growth in meeting attendance between the fi rst and third year of operations bodes well 
for the future.
Banbury Center
In its 35th year of operations, Banbury Center continued to have an active role in the Labora-
tory’s educational mission. At the beginning of the year, the Conference Room underwent a 
major renovation. By autumn, it was the turn of Sammis Hall, which had gone largely untouched 
since its opening in 1981. These efforts ensure that participants in our programs have the fully 
modern and up-to-date accommodations that they expect.
Despite the renovation work, Banbury’s facilities were used intensively throughout the year, 
hosting 18 meetings as well as six lecture courses and two Watson School courses. CSHL postdocs 
came on two occasions for a retreat and the Robertson family came for their annual meeting. As 
usual, CSHL is happy to help our neighbors; this year, the Cold Spring Harbor School District 
board twice used the Banbury Center facilities.
We welcomed back the Boehringer Ingelheim Foundation, which, for several years, has brought 
its fellows for training in writing papers and giving talks. The National Institute for Mental 
Health returned for its Brain Camp, providing the brightest clinical fellows to high-level neuro-
scientists, encouraging them to think of taking up research. For the second year, Carl Cohen of 
Science Management Associates taught a “Leadership in Bioscience” workshop.
Banbury Center’s fi rst meeting on patenting was held 30 years ago, just 2 years after the 1980 
Chakrabarty case (which declared that a modifi ed microbe was patentable). In 2012, the question 
of patents was brought into sharp focus by the recent Myriad Genetics case involving patents 
covering the BRCA genes. The meeting, Patenting Genes: New Developments, New Questions, dis-
cussed this and other unresolved issues.
DNA Learning Center
DNA Learning Center (DNALC) Executive Director David Micklos received the 2012 Elizabeth 
W. Jones Award for Excellence in Education from the Genetics Society of America. David was 
recognized for bringing “the excitement of DNA science into the educational curriculum for thou-
sands of students, high school teachers, and undergraduate faculty.”
On June 6, nine fi nalist teams of high school stu-
dents representing eight public high schools, plus home 
schooling, from all of the fi ve boroughs of New York 
City, presented their submissions to the fi rst-ever NYC 
Urban Barcode Project competition. They were select-
ed from more than 200 students on 75 teams, whose re-
search posters were judged by conservation and genetic 
biologists and education experts. For most students, it 
was their fi rst independent research project. Twenty-six 
percent of contestants were African American or La-
tino, groups that are underrepresented in science.
New York City institutions, including the Ameri-
can Museum of Natural History, Genspace, New York 
Botanical Garden, Brooklyn Bridge Park, and the Urban Barcode Project grand prize winners
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Rockefeller University, partnered with the DNALC to provide facilities and mentoring to the 
student teams. Developed and executed by the DNALC with funding from the Alfred P. Sloan 
Foundation, the Urban Barcode Project was the fi rst large-scale attempt to use barcoding projects 
to encourage students to explore the urban environment beyond their doorsteps.
It was the biggest summer yet of DNA camps: 1000 5th- to 12th-grade students attended 53 
weeks of camps conducted by the Dolan DNALC, DNALC West, Stony Brook University, and 
Brookhaven National Laboratory, the Trinity School, and at the Chapin School in Manhattan. 
Students from Beijing High School 166 also attended 3 weeks of camps on bacterial genetics, 
human genomics, and DNA barcoding.
During the summer, the DNALC also extended its NYC Urban Barcode Project to the study 
of biodiversity in the unique glacial landscapes of Long Island. Six student workshops, Barcoding 
Biodiversity, explored the intertidal zone adjacent to the main campus. Naturalist photographer 
David Liittschwager joined the fi rst workshop, instructing in his methods for examining and 
photographing life in a one-cubic foot sample, which he published in the February 2010 issue 
of National Geographic. Seventy-seven students collected and processed more than 300 samples, 
resulting in 165 high-quality DNA barcodes.
DNALC staff continued in 2012 to provide essential support for the National Science Foun-
dation (NSF)-funded iPlant Collaborative project, which seeks to develop a national cyberin-
frastructure needed for data-heavy 21st-century plant research. As the iPlant infrastructure has 
expanded to support animal genomics research too, the DNALC’s DNA Subway website has been 
upgraded to support student projects using animal species. Total visits to the site grew 40% in 
2012, to more than 33,000.
This was but a fraction of the more than 4.2 million visits to the 22 DNALC websites in 2012, 
a fi gure to which is added 865,000 visits to the DNALC YouTube channel; and 568,000 down-
loads of the 3D Brain, Weed to Wonder, and Gene Screen phone apps, to gauge DNALC’s total 
cyber-impact for the year—more than 5.6 million visits!
In 2012, the team also executed a successful renovation of the museum exhibit at the Dolan 
DNALC. A fourth teaching laboratory and prep area was added, the lunchroom was enlarged, 
the basement prep laboratory was renovated, and storage and display spaces were reorganized. The 
exhibit is evolving into one based on human ancestry. One part will have the theme of “Becoming 
Human,” treating our ancient history and evolution, and the other “Being Human,” representing 
where we are today and comparing characteristics of modern populations.
CSHL Press
In 2012, the CSHL Press continued to publish seven journals and added 12 new print and fi ve 
new electronic titles to its list of 180 print books and 18 online books.
The most recent impact factor analysis continues to rank our journals Genes & Development and 
Genome Research at the top of their disciplines; Genome Research reached a new high of 13.608, after 
4 years of consecutive increases, and now ranks #2 in genetics and #2 in biotechnology. Genes & 
Development currently ranks #2 in developmental biology and #3 in genetics. In 2012, CSHL 
journal articles were electronically downloaded a remarkable 10 million times, and 38,000 books 
were shipped to 150 countries.
The fi rst and fl agship journal, Genes & Development, marked its 25th Anniversary this year. 
In celebration of this anniversary, the Genetics Society of Great Britain, one of the founders 
along with CSHL, held its annual autumn meeting in honor of the journal. The 2-day meeting, 
titled At the Cutting Edge of Molecular Biology: 25 Years of Genes & Development, was held 
November 7–8 at the Royal Society (London). The meeting brought together distinguished 
scientists from across the biological sciences, focusing on issues such as chromatin, epigenetics, 
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gene regulation, replication, checkpoints 
and DNA repair, RNA function and con-
trol, development, stem cells, and diseas-
es such as cancer, representing the broad 
scope of science covered by the  journal.
In its second year of sales, the review 
journal Cold Spring Harbor Perspectives in 
Biology continues to increase notably in rev-
enue and usage. The concept of a “new type 
of review journal” with subject collections 
that build monthly has been well received, 
as has its consistent editorial excellence. It 
received its fi rst impact factor this year. The 
newest review journal, Cold Spring Harbor 
Perspectives in Medicine, completed its fi rst year of publication with exceptional usage of collec-
tions about HIV, Alzheimer’s,  Parkinson’s, and addiction.
New print books and fi ve new e-books included Genome Science, a new and long-awaited col-
lection of laboratory exercises by the teaching staff at the DNA Learning Center. In June, a new 
edition of the laboratory manual Molecular Cloning was published. Long established as the gold 
standard for molecular biology techniques, and by far the most successful book ever published 
by the Press, with more than 200,000 copies sold, this new edition was a complete revision by 
authors Joe Sambrook and Michael Green, assisted by a dozen expert contributors. A classic of a 
different sort also reappeared, co-published by the Press and Simon & Schuster: James Watson’s 
1968 autobiographical account of the discovery of the structure of DNA, The Double Helix, which 
was named during the year as one of the Library of Congress’s 88 “Books that Shaped America.” 
CSHL Professors Alex Gann and Jan Witkowski illustrated and annotated the text with footnotes, 
photos, correspondence, and other documents that placed this most famous account of scientifi c 
discovery in its social, intellectual, and historical context.
Library and Archives
On April 1–3, Library and Archives Department Executive Director Ludmila Pollock and col-
leagues from Rockefeller University, Memorial Sloan-Kettering Cancer Center, and the Marine 
Biological Laboratory hosted a meeting at the Banbury Center called “Envisioning the Future of 
Research Libraries.” It brought together the top leaders of scientifi c research libraries from the 
United States, United Kingdom, Germany, and France, with a goal of constructing a model for 
the future (circa 2020) scientifi c research library.
In 2009, CSHL and the Wellcome Trust initiated a project to create an International Catalog 
for the History of the Human Genome Project (HGP). On May 3–5, an international meeting 
about the History of the HGP was held at the Banbury Center, where discussion centered on how 
to best present the history to different audiences, including scholarly researchers. Phase 1 of this 
project, which includes identifying all of the potential collections, creating a new, open-access 
database, and carrying out a pilot project, will be completed in 2013.
Millions of primary-source documents telling the amazing story of the biological revolutions 
of the 1950s and 1960s are now freely available on the World Wide Web thanks to an effort led 
by the Wellcome Library of Great Britain. Entitled Codebreakers: Makers of Modern Genetics, the 
resource provides public access to fi rst-hand notes, letters, sketches, lectures, photographs, and 
essays from those responsible for uncovering the structure of DNA. CSHL’s Library and Archives 
collections, which include the papers of Nobel laureates James Watson and Sydney Brenner among 
others, are a key source for Codebreakers. CSHL was very happy to participate in the project with 
CSH Perspectives in Biology The Double Helix
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partners Churchill Archives Centre Cambridge, the University of Glasgow, King’s College Lon-
don, and University College London.
Infrastructure Projects
Hurricane Recovery
The Laboratory’s preparations for Hurricane Sandy were extensive, and apart from an extended 
power outage that the Laboratory’s staffs managed with emergency power, the campus emerged 
relatively unscathed. There was, however, some damage. The Laboratory has dealt with 40–60 
fallen mature trees and the Robertson House slate roof required signifi cant repair, and due to the 
storm surge, post-storm repairs were required to the mechanical systems of the low-lying Jones 
Laboratory.
Airslie Renovations
The Laboratory undertook extensive interior renovations to the house, modernizing the kitchen 
and service areas to accommodate the numerous development activities undertaken at the Presi-
dent’s house while maintaining a livable private residence.
Wawepex Alterations
The Offi ce of Sponsored Programs—tasked with an ever-increasing workload—was overcrowded 
in the circa 1830 Wawepex Building. Interior renovations were completed to provide additional 
workspace for the department’s staff.
Sammis Hall Renovations
Built in 1981, Sammis Hall has housed Meeting and Course participants for more than two decades. 
New carpet, furnishings, fi xtures, and systems were installed to meet contemporary expectations.
Blackford Exterior Renovations
The circa 1905 Blackford Hall has been in continuous operation for more than a century and 
structural cracks and spalling in the poured concrete structure were evident. It was necessary to 
repair and stabilize the building to prevent further decay. Of particular concern was preserving the 
historic nature of the building while conserving the relatively thin four-inch-thick concrete walls. 
The project was completed with the building remaining in full operation.
Receiving Building
Construction of the new Hershey Building required that the receiving and mail-room facilities 
be relocated. These functions were temporarily housed in a trailer on-site until the new Receiving 
Building could be constructed. The 1500-square foot structure was sited close to Route 25A to 
limit truck traffi c on campus and was designed to appear as a complementary outbuilding of the 
historic Davenport House nearby.
Hershey Building Completion
After 2 years of construction, the Hershey Building was completed in the second quarter of 2012 
and hosted courses for the summer. At the same time, both the Flow Cytometry and Microcopy 
facilities moved their operations into the building.
Community Outreach
On October 5, members of the Long Island Regional Economic Development Council accom-
panied New York Governor Andrew Cuomo and Lieutenant Governor Robert Duffy to tour the 
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Hillside laboratory of Professor David Tuveson, one of our latest recruits and a distinguished pan-
creatic cancer researcher who is also the Deputy Director of CSHL’s Cancer Center.
Drs. Tuveson and Stillman briefed the dignitaries on CSHL’s new Cancer Therapeutics Initia-
tive, which New York State is helping to fund by seeding the construction of a new Advanced 
Drug Testing Facility located at the Woodbury Genome Center. The central idea in our Cancer 
Therapeutic Initiative is to create a translational pipeline that will enable us to help develop a new 
generation of cancer drugs that will be more effective and less toxic than those currently in use. 
Another objective is to signifi cantly reduce the time it takes to identify and test candidate drugs, 
to accelerate their path to the clinic.
Stuart Rabinowitz, President of Hofstra University, and Kevin Law, President and CEO of 
the Long Island Association, both co-chairs of the Long Island Regional Economic Develop-
ment Council, highlighted the importance of public support for cutting-edge science in driving 
economic development of the region and in providing new high-quality jobs. The Governor’s next 
stop that day was the Broad Hollow Bioscience Park, an incubator facility that CSHL helped to 
found and where CSHL spin-off biotech companies have made their start.
CSHL is pleased to join with Brookhaven National Laboratory, SUNY Stony Brook, Hof-
stra University, and North Shore LIJ in Accelerate Long Island, an initiative to expand on the 
success of the Broad Hollow Science Park and strengthen the bioscience economy of Long 
Island.
Receiving building Hershey building
Governor Cuomo (center) tours Hillside Laboratory
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The Governor’s visit came just a month after the visit of Lieu-
tenant Governor Duffy, who chairs the state’s regional economic 
development councils. “This is a great intersection of public health 
and economic development,” said Mr. Duffy of CSHL. “This is a 
jewel in New York State and to see the brain power and expertise 
we have here makes us all very proud.”
As I have already mentioned in brief, thanks to well-laid prepa-
ration plans and hard work—not to mention some luck associated 
with the outgoing tide—the Lab was able to ride out Hurricane 
Sandy at the end of October. By moving equipment and data stor-
age to higher ground, bringing up elevators, sandbagging, and 
using diesel-powered backup generators for electricity, all essen-
tial scientifi c operations continued through the storm and in its 
aftermath. Even attendees of the Nuclear Receptors and Disease meeting continued undaunted, 
producing a defi ant slogan that attendees and the Lab community will long remember:  “Science 
vs. Sandy. . .Science Wins!”
Our preparedness allowed us to help our neighbors. We were in constant contact with the 
leadership of Laurel Hollow village, fi refi ghters, police, friends, and residents, who benefi tted from 
our food services, WiFi access, and warm spaces. CSHL even hosted TV coverage of the 2012 
Presidential Election in Grace Auditorium, for CSHL families as well as community residents who 
were still without power more than a week after the storm.
A special thank you to those on our campus who helped us all weather the storm, in particular: 
Art Brings, Peter Stahl, Gerry Holler, Lisa Bianco, Culinary Services staff led by Jim Hope, Pay-
roll staff led by Lari Russo and Damian Desiderio, IT staff led by Sean Kelly, and the Meetings 
and Courses team with David Stewart, Maureen Morrow, and Andrea Newell. Above all, a warm 
thank you to COO Dill Ayres, who spent many a sleepless night on watch in his offi ce.
The year was a big one for CSHL in social media. The Laboratory’s Twitter following grew 
to 2500 and friends on Facebook surpassed 1000. The monthly e-mail newsletter we fondly call 
the Netletter continues to attract new subscribers—more than 7000 by year end—and we con-
sistently outperform other newsletters based on how many of our subscribers actually read the 
R.J. Duffy, W.D. Ayers, Jr., and B. Stillman
Meeting attendees defy Hurricane Sandy
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stories we deliver. The CSHL blog, Labdish, grew too, and we now host guest 
bloggers who represent the CSHL campus community from grad students to 
professors. Thanks, Michael Schatz, Anne Churchland, Clare Rebbeck, Antoine 
Molaro. Hats off to CSHL faculty who are active in social media, promoting 
their own ideas and providing perspectives on the latest developments in biol-
ogy and genetics.
Adding to our public lecture series, both on our own campus and in other 
venues, are appearances by faculty on the World Wide Web. You can visit www.
bigthink.com to watch professors Rob Martienssen and Michael Schatz explain 
how they’re applying their research to solve some very big problems. Rob de-
scribes how he’s using the principles of epigenetics that his group has uncovered 
to “persuade” a tiny weed to produce biofuel. Mike talks about his efforts to 
modify Google’s “secret sauce” to manage the DNA data deluge brought on by the revolu-
tion in genome sequencing.
We also launched the Harbor Transcript interactive iPad app this year, 
enriching the print version with additional multimedia content. We en-
courage you to download the HT and other apps produced by the DNA 
Learning Center for free.
While active in the global arena, we also pursue many local commu-
nity outreach opportunities. In addition to tours that are conducted for 
participants in the CSHL Meetings and Courses program, more than 600 
“nonscientifi c” guests participated in the CSHL Walking Tour program, 
visiting the campus from near and far, including Singapore, Italy, Japan, 
and China. The success of the program is largely due to the enthusiasm of 
guides, who this year totaled 13 graduate students and postdocs.
The Laboratory collaborated again with the Cold Spring Harbor Village Main Street Associa-
tion to celebrate DNA Day on April 21–22 with a scavenger hunt that led participants to the Cold 
Spring Harbor Library, the Cold Spring Harbor Whaling Museum, the Firehouse Museum, and 
our own DNA Learning Center. DNA Day is celebrated across the country, with educational 
events sponsored by the National Human Genome Research Institute (NHGRI), a part of the 
National Institutes of Health. The day commemorates the completion of the Human Genome 
Project in April 2003, and the discovery of DNA’s double helix, 
events closely tied to the Laboratory.
On April 17–18, fi rst graders from local public and private schools 
Goosehill Primary and Friends Academy came to main campus for 
a special science fair. At each of six “experiment” stations, the chil-
dren learned about scientifi c principles (from non-Newtonian fl uid 
dynamics to cell structure to brain anatomy!) through hands-on 
activities and instruction conceived, planned, and led by 10 WSBS 
graduate students and four DNALC instructors. About 140 stu-
dents, accompanied by 15 teachers and 120 parents, participated 
during the 2 days.
On August 8, CSHL and 13 local breast cancer organizations 
received checks from funds raised by the 2012 Long Island 2-Day 
Walk To Fight Breast Cancer. CSHL actively participates in the 
event, which attracted more than 400 participants. Each year, 
 LI2DAY earmarks $15,000 for six scholarships that are awarded to 
local high school seniors with a parent or guardian who has been 
 affected by breast cancer. Thanks to the CSHL volunteers who head 
R. Martienssen
M. Schatz
Harbor Transcript 
iPad App
2012 Long Island 2-Day Walk
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R. Sordella
A. Mills
CSHL Public Lectures
March 14–Alea Mills, Ph.D., CSHL Professor: Where Will the Future of Genetic Technology Take 
Us? Hosted by The Secret Science Club, Brooklyn, New York.
April 16–Brian Skotko, M.D., M.P.P., Board-certifi ed medical geneticist 
at Children’s Hospital Boston, Massachusetts General Hospital, Brigham 
& Women’s Hospital, and Dana Farber Cancer Institute; Instructor, Chil-
dren’s Hospital Boston, Harvard Medical School, Boston, Massachusetts: 
Keeping Children and Adolescents with Down Syndrome Healthy: Medical 
Updates for Physicians, Parents, and Educators. Co-sponsored by CSHL 
and Down Syndrome Connection of Long Island.
April 19–David Spector, Ph.D., CSHL Professor and Director of Re-
search: The Laboratory @ Your Library: Discussion of “The Immortal Life of 
Henrietta Lacks.” Hosted by the Cold Spring Harbor Library, Cold Spring 
Harbor, New York.
June 26–W. Richard McCombie, Ph.D., Professor, CSHL and Director, CSHL Stanley Institute 
for Cognitive Genomics; Diane Esposito, Ph.D., Research Investigator/Research Compliance 
Specialist, Cold Spring Harbor Laboratory; Kenneth Offi t, M.D., M.P.H., Chief, Clinical Ge-
netics Service, Memorial Sloan-Kettering Cancer Center; Kasmintan Schrader, M.B.B.S., Re-
search Fellow, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center; 
Peter K. Gregersen, M.D., Center Head, Robert S. Boas Center for Genomics and Human Ge-
netics, The Feinstein Institute for Medical Research: Follow Your Genes—Decision Making and 
Your Personal Genome. Co-sponsored by CSHL, Bank of America-Merrill Lynch, North Shore-
LIJ, and St. Johnland Nursing Center.
July 11–David Liittschwager, Photographer, National Geographic and Guest Instructor, DNALC 
Summer Camp: A World in One Cubic Foot: Portraits of Diversity.
November 18–David Spector, Ph.D., CSHL Professor and Director of Research: Henrietta Lacks 
and HeLa Cells: Impact on Biological Research and Informed Consent.
up the LI2DAY Scholarship Committee. To date, $120,000 
has been granted in LI2DAY Scholarships.
Associate Professor Raffaella Sordella participated in the 
Nassau Suffolk County Swim Across America event, swim-
ming one mile to raise money for cancer research. We salute 
Raffaella’s commitment.
Our employees lent a helping hand to the community in 
many ways. On campus, we conducted a blood drive in Au-
gust, collecting 28 pints. CSHL also participated in Daffo-
dil Days for the American Cancer Society. Members of our 
scientifi c community volunteer in many local elementary, 
middle, and high school science fairs.
001-036_Pres_High.indb   29 9/17/2013   7:35:23 AM
30   Highlights of the Year
CSHL Public Concerts
March 23: Charlie Albright, Piano
April 13: Mischa Bouvier, Baritone (w/piano)
April 27: Louis Schwizgebel, Piano
May 18: Michael Brown, Piano
August 17: Southampton Festival Chamber Orchestra
September 7: Benjamin Beilman, Violin (w/piano)
September 21: Narek Arutyunian, Clarinet (w/piano)
October 12: Sarah Wolfson, Soprano (w/piano)
Looking Forward
Thanks to the entire CSHL community for a remarkable year. The institution continues to set 
world standards in biological and genetic research and education and that is the result of hard 
work and dedication on the part of our board, faculty, students, and staff. On behalf of CSHL, 
I thank our generous donors for allowing the best and brightest scientifi c minds to push the 
boundaries of research in cancer, neuroscience, plant genetics, genomics, and quantitative biology.
Bruce Stillman, Ph.D., F.R.S.
President
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While unusually severe weather events are occurring with increasing frequency, 
it is unlikely that we will soon forget “Superstorm Sandy.” The good news for 
Cold Spring Harbor Laboratory is that we survived the storm relatively un-
scathed, experiencing no loss of scientifi c materials, animals or assets. This was 
thanks to exceptionally good preparation on the part of our facilities personnel 
and good luck with the timing of the peak storm surge. The adage, “the harder 
we work, the luckier we get” comes to mind. Perhaps most memorable will be 
our campus rallying cry, “Science versus Sandy—Science wins!”
In his President’s Message, Bruce Stillman describes a more serious and im-
mediate threat to our winning streak than the weather—the alarming decline 
in federal research funding and its implications for institutions like ours. This is 
a challenge that we have seen coming and one for which we have been planning 
and acting proactively from an operational and fi nancial perspective. The primary 
defense is to continue to do exceptional science so that we can attract more than 
our share of the shrinking federal pie. We can continue our successful efforts to generate private 
funding from foundations and generous individuals. We can continue to manage our expenses as 
aggressively as possible and maintain a lean, effi cient administration. We can grow our endow-
ment through effective investing and fundraising.
The Laboratory’s ratio of public to private funding has shifted with changing circumstances. 
During the period 2005–2012, federal funds as a percentage of our total research budget have 
declined from 59% to 43% while private funding has increased from 18% to 29%. While the 
dramatic increase in private funding has driven healthy growth in the research enterprise and 
is refl ective of excellent science and effective fundraising, it is not always a predictable revenue 
stream. In addition, many foundation grants do not come with the requisite amount of support 
for indirect or research operating costs.
Endowment is our lifeline for the future. While spending from the funds represented only 
11% of the 2012 research budget, endowment is a critical buffer against the uncertainties of 
federal and private funding. What may be less obvious is the historic role of the endowment in 
sustaining CSHL’s unique approach to research that has emphasized the nurturing of early-career 
scientists.
Since the original gift of $7 million from the Charles Robertson family in 1973, the total assets 
of the funds (net of spending, plus contributions) have grown to $313 million at the end of 2012, 
an all-time high. Investment performance is one of two keys to growth, and, for our success, we 
have a hardworking committee of our Board of Trustees to thank. The goal is to achieve healthy 
appreciation of our investment assets while maintaining an appropriate degree of liquidity, and 
avoiding undue risk and volatility.
Since assuming the chair of the Investment Committee in 2007, trustee John Phelan has over-
seen a restructuring of the portfolio’s asset allocation strategy from a plain vanilla mix of stocks 
and bonds to one designed to increase diversifi cation and decrease volatility. Toward that end, al-
location to long equity and fi xed income asset classes has been substantially reduced while we have 
added considerably to hedged equity and absolute return investments. Investment performance 
has validated the strategy. The fund returned 12.5% for the calendar year 2012 with an allocation 
that incorporated a good deal of downside protection. Fundraising is at least as critical to endow-
ment growth as investment performance. Consequently, development efforts over the next several 
W. Dillaway Ayres, Jr.
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years will place particular emphasis on endowment. These are diffi cult funds to raise, so success 
in this area will require much hard work.
The political and fi scal machinations in Washington and the prospect of the “sequester” de-
mand extraordinary measures to control operating and administrative expenses. Management has 
developed a detailed austerity plan that will kick in if necessary. Unfortunately, this takes a toll on 
our most important asset—our talented and dedicated staff.
W. Dillaway Ayres, Jr.
Chief Operating Ofﬁ cer
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Long-Term Service
The following employees celebrated milestone anniversaries in 2012:
40 years Terri Grodzicker
35 years Margaret Wallace
30 years Patty Bird, Art Brings, Dave Micklos, Cliff Sutkevich
25 years  Sadie Arana, Lisa Bianco, Jim Duffy, Julie Ehrlich, John Inglis, Bobbie Peters, 
Inez Sialiano, Pat Urena, Jan Witkowski
20 years  Robert Collins, Greg Hannon, Nancy Hodson, Randy Jones, Dick McCombie, John 
Pisciotta, Claudia Schmid, Mary Smith, Leslie Wenzel, Curtis Williams, Yi Zhong
Front row (left to right) Mary Smith, Art Brings, Patty Bird, Sadie Arana, Pat Urena, Terri Grodzicker, Bobbie Peters, Inez Sialiano, 
Nancy Hodson, Jan Witkowski, Julie Ehrlich. Second row (left to right) Yi Zhong, Randy Jones, Cliff Sutkevich. Third row (left to 
right) David Spector, Dill Ayres, James Watson, Bruce Stillman, John Inglis, Dick McCombie.
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15 Years  Benjamin Boettner, Kimberly Bronson, Peggy Calicchia, Bill Dickerson,  Robert 
 Dickerson, Robert Eifert, Joseph Houser, David Jackson, Liz Janow, Tatyana 
 Michurina, Maria Mosquera, Andrea  Newell, Aigoul Nourjanova, Jorge Ramirez, 
Wilson  Ramones, Sal Serafi no, Joseph Simorowski, Denise Weiss, Priscilla Wu
Front row (left to right) Denise Weiss, Maria Mosquera, Liz Janow, Kim Bronson, Priscilla Wu. Top row (left to right) Joseph 
Houser, Robert Dickerson, Sal Seraﬁ no, Joseph Simorowski, James Watson, Bruce Stillman, Aigoul Nourjanova, David Spector, Bill 
Dickerson, Dill Ayres.
Long-Term Service: 15 Years
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See previous page for photos of the following scientifi c staff.
Row 1:    S. Qiao (Lippman Lab); D. Bahel (Hammell Lab); C. Zepeda-Mendoza (Spector Lab); 
M. Penzo (Li Lab)
Row 2:    M. He, J. Tucciarone (Huang Lab); D. Pal (Sordella Lab); Y.K. Lee, D. Ware 
(Ware Lab); I. Falciatore (Hannon Lab)
Row 3:    A. Kepecs, E. Demir (Kepecs Lab); N. Shirole (Sordella Lab); S. Cho Lee (Martienssen 
Lab); L. Zheng (Zheng Lab)
Row 4:    I. Lindsted (Sordella Lab); C.-I. Hwang, D. Tuveson (Tuveson Lab); C. Fernandez-
Marco, (Timmermans Lab); V. Pinskiy (Mitra Lab)
Row 5:    B. Stilllman, M. Hossain (Stillman Lab); L. Trotman, T. Herzha (Trotman Lab); 
H. Oviedo (Zador Lab); H.-Y. Jeon (Krainer Lab)
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CANCER: GENE REGULATION AND 
CELL PROLIFERATION
Christopher Hammell’s lab is interested in understanding gene regulatory processes that give rise 
to robust phenotypes associated with normal development in animals (specifi cally, how the tim-
ing of developmental processes is controlled) as well as the alterations in these pathways that give 
rise to diseases such as cancer (as in the alterations in mitogenic pathways in melanoma). Ham-
mell and colleagues approach this elemental problem by using a variety of model organisms and 
patient-derived cancer cell lines. To directly identify the components that function in controlling 
normal developmental timing, they use the small nematode Caenorhabditis elegans, applying for-
ward and reverse genetic approaches. In contrast to the extreme robustness of cell-fate lineage in 
C. elegans, in which specifi cation of developmental programs is hard-wired, mutations that alter 
conserved signaling pathways in melanoma create relatively plastic developmental landscapes that 
allow these lesions to become aggressive tumors. Notably, the gene regulatory architecture of mel-
anoma cells allows them to acquire resistance to therapeutic agents. Hammell’s team is interested 
in epigenetic mechanisms that contribute to resistance, specifi cally, dramatic changes in gene 
expression patterns and intracellular signaling pathways. They are performing high-throughput 
screens to identify cellular factors that allow these re-wiring events to occur, with the idea that 
these components would make ideal therapeutic targets to complement existing clinical strategies.
In the Leemor Joshua-Tor lab, members study the molecular basis of nucleic acid regulatory pro-
cesses by using the tools of structural biology and biochemistry to examine proteins and protein 
complexes associated with these processes. They use X-ray crystallography to obtain three-di-
mensional structures of individual proteins and complexes. Biochemistry and molecular biology 
enable them to study properties that can be correlated with protein structure and function. It was 
Joshua-Tor and her team who fi rst obtained the structure of a full-length Argonaute protein, work 
that instantly solved a long-standing puzzle in the RNA interference (RNAi) fi eld. By observing 
the structure, they realized that Argonaute was the long-sought Slicer. This year, they added a 
critical insight into the mechanism of the key slicing event in RNAi, cleavage of the mRNA, by 
solving the structure of human Argonaute 2 bound to a microRNA (miRNA) guide. In looking 
at a similar process, the generation of genome protecting PIWI-interacting RNAs (piRNAs), in a 
collaboration between the Joshua-Tor and Hannon labs, this year they have determined the struc-
ture and function in fruit fl ies of Zucchini, showing it to be a key nuclease in the initial generation 
of piRNAs. Joshua-Tor and colleagues determined the three-dimensional structure of a protein 
complex called RNA-induced initiation of transcriptional gene silencing (RITS), discovering new 
details of how its various domains contribute to heterochromatin assembly and gene silencing. In 
addition, they solved the crystal structure of the complex of Gal3p–Gal80p with α-d-galactose 
and ATP, a classic transcription complex with its two ligands, in the yeast Saccharomyces cerevisiae. 
This work revealed that the Gal3p transducer of the GAL regulon interacts with the Gal80p re-
pressor in its ligand-induced closed conformation. Joshua-Tor is also well known for her work on 
the E1 helicase enzyme, which acts to unwind DNA strands during the DNA replication process.
Adrian Krainer’s lab studies the mechanisms of RNA splicing, ways in which they go awry in 
disease, and the means by which faulty splicing can be corrected. One area in which they study 
this is spinal muscular atrophy (SMA), a neuromuscular disease that is the leading genetic cause 
of death in infants. Their ability to correct an mRNA splicing defect in SMA that makes a gene 
called SMN2 only partially functional forms the basis of a potentially powerful therapeutic ap-
proach. It is possible to stimulate SMN protein production through altering RNA splicing by the 
039-067_CancerGeneReg.indb   39 9/17/2013   7:38:44 AM
40  Research
introduction of chemically modifi ed pieces of RNA called antisense oligonucleotides (ASOs) into 
the spinal cords of mice. This year, using ASOs in mice carrying a transgene of human SMN2, 
they developed a model for SMA using a technique they called TSUNAMI (shorthand for tar-
geting-splicing using negative ASOs to model illness). This method can be used as a template to 
develop models for the study of other diseases caused by splicing defects, including familiar dys-
autonomia. The Krainer lab has also worked to shed light on the abnormal glucose metabolism of 
cancer cells, sometimes referred to as the Warburg effect. They recently published results showing 
that targeting cancer cell metabolism by modulating the splicing of the gene PK-M kills cancer 
cells grown in culture. The lab’s expertise in splicing also recently uncovered a new exception to 
the usual rules regarding its mechanism. They found that at some splice sites, one or more bases 
in the U1 splicing guide RNA or its target RNA could bulge out to better facilitate a match. Some 
of the sites at which this can occur are within genes in which mutation can lead to diseases such 
as cancer.
David L. Spector’s lab studies the spatial organization and regulation of gene expression. Their 
studies are focused on live single-cell analysis of the dynamics of chromatin and the recruitment 
of members of the gene expression machinery to a stably integrated genetic locus in human cells, 
as well as the analysis of endogenous genes in mouse embryonic stem cells (mESCs). In addition, 
the Spector lab is characterizing long nuclear retained noncoding RNAs (lncRNAs) that exhibit 
altered levels of expression as mESCs transition from the pluripotent state to neural progenitor 
cells. During the past year, the team focused on characterizing a Malat1 knockout mouse that was 
developed in the laboratory. Malat1 is among the most abundant lncRNAs, and previous studies 
identifi ed a novel mechanism of 3′-end processing of this RNA. Cell biological and biochemical 
analyses indicated that Malat1 is not essential for nuclear speckle assembly/maintenance or the 
level and phosphorylation status of SR splicing factors. Although RNA-Seq analysis of the Malat1 
knockout mouse did not reveal changes in global gene expression or alternative pre-mRNA splic-
ing, 12 genes exhibited statistically signifi cant changes in expression in brain cortex. Interestingly, 
among these 12 genes, fi ve, including the lncRNA Neat1, reside adjacent to Malat1 and are up-
regulated ~1.5- to 2.3-fold. The up-regulation of Neat1 suggests a potential compensation between 
Malat1 and Neat1, which will be pursued in future studies.
Arne Stenlund and colleagues have obtained a detailed understanding of processes required for 
initiation of DNA replication from the papillomavirus, using this system to gain a general bio-
chemical understanding applicable in other systems. Papillomaviruses are a large viral family that 
induces cell proliferation at the site of infection, usually giving rise to benign tumors. But cer-
tain types of human papillomaviruses (HPVs) generate tumors that progress toward malignancy. 
Among these are HPVs that cause most cervical cancers. Members of the Stenlund lab also pursue 
studies aimed at developing an effective small-molecule inhibitor of HPVs that might someday be 
used by women who do not receive the preventive anti-HPV vaccine now available or those already 
infected with HPV who would not be helped by the vaccine.
Bruce Stillman’s lab studies the process by which DNA is copied within cells before they divide 
in two. Working with yeast and human cells, Stillman and colleagues have identifi ed many of 
the cellular proteins that function at the DNA replication fork during the S phase, the portion of 
the cell-division cycle when DNA synthesis occurs. Among these proteins are those that facilitate 
the assembly of chromatin, the protein–DNA complexes that form the chromosomes. The prime 
focus of current research, however, is the mechanism that initiates the entire process of DNA rep-
lication in eukaryotic cells. At the heart of this mechanism is a protein that binds to “start” sites on 
the chromosomes, called the origin recognition complex, ORC. Stillman’s research also focuses on 
the process by which duplicated chromosomes are segregated during mitosis. The team has found 
ORC at centrosomes and centromeres, structures that orchestrate chromosome separation during 
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mitosis. This year, Stillman’s team discovered that mutations that alter the largest protein found 
in this complex, Orc1, alter the ability of ORC to regulate both DNA replication and centrosome 
duplication. These mutations have been linked to Meier-Gorlin syndrome, a condition that results 
in extreme dwarfi sm, small brain size, and related characteristics of abnormal growth.
Acute myeloid leukemia (AML) is a particularly devastating and aggressive blood cancer that is 
currently incurable in 70% of patients. Research in Chris Vakoc’s lab seeks to understand this 
disease as well as others, such as lymphoid leukemias and epithelial tumors, by studying them at 
the level of genomic regulation. He is particularly interested in the proteins that regulate chro-
matin–DNA and associated proteins in the nucleus of the cell. To identify proteins involved in 
this process, which may also be targets for drug therapy, he deploys large-scale genetic screens 
using RNA interference (RNAi) as well as genetically engineered mouse models that display the 
hallmarks of human cancer. In collaboration with Jay Bradner at the Dana-Farber Cancer Insti-
tute, Vakoc has shown that the small-molecule drug candidate JQ1 has potent anti-AML activity. 
It works by suppressing the protein BRD4, which is a critical regulator of the potent oncogene 
c-Myc. Targeting BRD4 with JQ1 as a therapeutic strategy is currently being evaluated in clinical 
trials. More recently, Vakoc’s team identifi ed another chromatin regulator, PRC2, that if blocked 
with small-molecule inhibitors may reactivate a powerful tumor suppressor mechanism that can 
protect against AML.
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THE COUPLING OF TEMPORAL GENE EXPRESSION AND 
DEVELOPMENTAL CELL-FATE SPECIFICATION
C.M. Hammell C. Aquirre-Chen D. King
 D. Bahel M. Konta
 C. Carlston R. Perales
The temporal regulation of gene expression is an in-
dispensable characteristic of metazoan development. 
At its core, this regulation is the basis for the progres-
sive control of developmental programs and is essential 
for the coordination of animal growth. Caenorhabdi-
tis elegans, as a model organism, has provided an un-
paralleled system in which the principles of temporal 
cell-fate specifi cation can be examined. Its strength de-
rives from the fact that C. elegans development has an 
essentially invariant cell lineage and that each of the 
cell divisions occurs at a prescribed time in wild-type 
animals. The experimental tractability of C. elegans 
has led to the identifi cation of a variety of conserved 
gene products that control temporal gene expression 
and represent components of the heterochronic (hetero: 
change; chrono: timing) developmental pathway. Het-
erochronic genes can be classifi ed into two broad sub-
groups according to how they affect temporal aspects 
of development. Heterochronic mutations can alter the 
patterns in which major changes in temporal gene ex-
pression occur (Fig. 1), by lengthening or contracting 
the relative timing between individual cell divisions. 
Phenotypes associated with each class of heterochronic 
mutation are strictly elaborated within the context of 
the continued larval molting programs. Genes that 
control the patterning of cell-fate specifi cation function 
within modular regulatory programs that are limited to 
a single stage of development. Importantly, the activity 
and sequential expression of these individual modules 
are integrated into a much larger, linear gene regulatory 
network (Fig. 1A). Precocious hetero chronic mutants 
execute later stage-specifi c cell division programs at 
earlier times by skipping intermediate stages of devel-
opment and display adult-specifi c gene expression pro-
grams during larval development. Conversely, retarded 
heterochronic mutants reiterate individual cell-fate 
programs and inappropriately retain larval features in 
adult-stage animals. The modular nature and regula-
tory logic of temporal patterning genes are underscored 
by a simple regulatory strategy that is used multiple 
times throughout development. The transition from 
one pattern of larval development to the next is coordi-
nated by the sharp transcriptional induction of specifi c 
microRNAs (miRNAs) and the subsequent and rapid 
reduction of expression of their target transcripts. Tran-
sitions from the L1−L2-stage developmental programs 
are controlled by the induction of lin-4 and the subse-
quent down-regulation of lin-14 expression. Likewise, 
transitions from L2−L3- and L4−Adult-staged events 
are controlled by the  expression of the middle-timer 
miRNAs (mir-48, mir-241, and mir-84) and late-timer 
miRNA, let-7 and the subsequent down-regulation of 
their targets, hbl-1 and lin-41, respectively. This serial 
and progressive regulation of temporal patterning genes 
limits the activity of individual cell-fate specifi cation 
programs to a single larval stage. 
The mechanisms and components that ensure the 
temporal precision of miRNA-mediated expression (and 
therefore couple development processes with chron-
ological aging) are unknown. Furthermore, virtu-
ally nothing is known about how the relative timing 
of specifi c developmental events (molting cycle, cell 
cycle, cell migration, etc.) is controlled throughout 
larval development and how these specifi c develop-
mental events are coupled to the temporal patterning 
of development.
Genetic Approaches to Identify 
Components That Modulate the 
Temporal Activity of miRNAs
C. Carlston, D. King
During the past 2 years, we have leveraged the invari-
ant cell lineage, fi xed intervals of postembryonic cell 
divisions, and the genetic tractability of C. elegans to 
identify factors that coordinate temporal gene expres-
sion and the specifi cation of distinct chronological 
cell fates. To identify components that control the 
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biogenesis of miRNAs, we intentionally focused on 
fi nding suppressors of specifi c miRNA mutants that 
produce mature 21-nucleotide regulatory RNA prod-
ucts yet fail to effi ciently down-regulate their target 
transcripts. Animals harboring lin-4(ma161) or let-
7(n2853) mutations (which alter a single nucleo-
tide in the mature “seed sequence” of the miRNA) 
display specifi c retarded cell-lineage phenotypes at 
early and late stages of development and underaccu-
mulate functional lin-4 and let-7  miRNAs, respec-
tively. Phenotypes associated with these alleles are 
indistinguishable from those displayed in animals 
harboring null mutations of these genes. In addi-
tion to mutations in specifi c  heterochronic miRNAs, 
we have used a novel, antimorphic  allele of the C. 
 elegans miRNA-specifi c argonaute (alg-1[ma192]) that 
is globally compromised in miRNA activity and ex-
hibits specifi c retarded heterochronic phenotypes due 
to the inappropriate perdurance of a single miRNA 
target. Although each mutation at the cellular and 
molecular levels disrupts a specifi c regulatory interac-
tion required for normal development, each of these 
mutant animals fails to express adult-specifi c gene 
 expression programs and is developmentally retarded. 
These macroscopic defects can be easily monitored 
through the use of an adult-specifi c fl uorescent re-
porter (col-19pro::GFP) that is transcriptionally ac-
tivated at the end of the normal fourth larval stage. 
Because  lin-4(ma161),  alg-1(ma192), and let-7(n2853) 
animals reiterate specifi c larval developmental pro-
grams, they fail to express col-19::GFP. Candidate 
suppressors of each of these distinct mutants were 
identifi ed as genes that, when mutated or depleted via 
RNA interference (RNAi), recapitulate the normal 
col-19::GFP expression patterns in each mutant back-
ground. This screening step by itself is analogous to 
previous methods used to isolate heterochronic genes. 
A key element that distinguishes our strategy from 
prior screens is a refi nement procedure that isolates, 
from the suppressors identifi ed in primary screens, 
gene products that normally function to promote the 
precision of temporal miRNA expression. This sec-
ondary screening process is both powerful and direct, 
as the retarded developmental phenotypes displayed 
by each of these genetic contexts result from a com-
mon inability to express an unambiguous reporter of 
adult-specifi c expression (col-19::GFP). Suppressors 
identifi ed in an initial genetic background (i.e., in pri-
mary screens above) can be queried for their ability 
to correct phenotypes associated with the mutations 
affecting other cell-fate specifi cation events occurring 
at different larval stages (secondary screens). To date, 
we have, through ethylmethanesulfonate (EMS) mu-
tagenesis, screened ~20,000 haploid genomes of the 
lin-4(ma161) genotype for heterochronic suppressors 
and a similar number of genomes in the alg-1(ma192) 
background. We have identifi ed ~28 mutations that 
pass the primary and secondary refi nement fi lters. 
Analysis of these mutants indicates that at a mini-
mum, we have identifi ed six complementation groups 
encoding genes that function to regulate the expres-
sion of multiple heterochronic miRNAs. These efforts 
have been complemented with an RNAi-based screen 
for suppressors of the lin-4(ma161) heterochronic 
phenotypes. This genome-scale screen, querying the 
function of ~86% of the C. elegans protein-coding 
genes, has identifi ed ~10 candidate suppressors. 
The primary outcome of these efforts is the iden-
tifi cation of a conserved developmental clock that 
 directly couples gene expression governing iterated 
developmental processes (including growth, behav-
ior, and molting) to those controlling sequential 
cell-fate specifi cation. In contrast to heterochronic 
genes that are turned on or off at specifi c develop-
mental transitions, the developmental clock compo-
nents we have identifi ed are ubiquitously expressed 
throughout larval development. Importantly, they 
are also expressed in an oscillatory fashion and di-
rectly control the expression of multiple heterochr-
onic miRNAs. Components of this developmental 
Figure 1. (A) The genes regulating the heterochronic pathway 
that controls speciﬁ c cell-fate transitions are ordered into a large, 
linear gene-regulatory logic. (B) The ordered down-regulation 
of most heterochronic genes is orchestrated by the sequential 
activity of miRNAs. (C) The transcriptional regulation of miRNAs 
and the subsequent down-regulation of their targets is accom-
plished by three separate families of miRNAs.
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clock include (1) lin-42, the C. elegans homolog of 
the circadian master regulator, Period, that func-
tions to transcriptionally repress the expression of 
multiple miRNAs, (2) lin-67, encoding a conserved 
RNA-binding protein implicated in both human 
cancer and alternative mRNA splicing, and (3) pqn-
59, a ubiquitously expressed and essential C. elegans 
“prion-like” gene.
lin-42, the C. elegans Period Homolog, Is 
a Transcriptional Repressor and Negatively 
Regulates miRNA Expression
C. Aquirre-Chen, D. King, R. Perales, M. Konta
Five alleles from the EMS-based screens contain ge-
netic lesions that lie within a single complementation 
group on chromosome II. Analysis of the molecular 
lesions within this region identifi ed alterations in a 
single gene, lin-42. In addition to these genomic al-
terations in the lin-42 gene, we identifi ed lin-42 (with 
two independent RNAi clones) as a potent suppres-
sor of lin-4(ma161) heterochronic phenotypes in our 
genome-scale RNAi-based strategy. lin-42 is a large, 
complex locus that encodes the C. elegans homolog of 
the human and Drosophila Period genes implicated in 
circadian gene regulation. Through the use of tran-
scriptional reporters, we have demonstrated that the 
lin-42 locus produces multiple protein products from 
at least two promoters and that both promoters are 
temporally regulated. lin-42 is ubiquitously expressed 
in embryonic development. During the larval stages of 
development, the transcriptional activation of the two 
lin-42 promoters occurs once per larval stage, each 
peaking in expression just prior to each larval molt 
(Fig. 2). lin-42a and lin-42b/c promoter activity is cur-
tailed after animals transition into adulthood. Transla-
tional reporters indicate that in addition to the oscilla-
tory transcription patterns of the lin-42a and lin-42b/c 
promoters, the subcellular localization of each LIN-42 
isoform is temporally regulated. LIN-42A protein ac-
cumulates in the cytoplasm during the middle por-
tions of larval development and rapidly accumulates in 
the nuclear compartment as LIN-42B and LIN-42C 
expression begins. The molecular mechanisms control-
ling this temporal redistribution of LIN-42A from 
the cytoplasm to the nucleus and physical interactions 
between the LIN-42A, LIN-42B, and LIN-42C iso-
forms are an active focus of investigation in the lab. 
Analysis of lin-42 phenotypes suggests that it func-
tions throughout larval development to inhibit the pre-
cocious expression of adult-specifi c genes. Specifi cally, 
phenotypes associated with lin-42 require the expres-
sion and activity of multiple heterochronic miRNAs, 
and analysis of the small RNA expression patterns in 
lin-42 mutants indicates that LIN-42 functions to 
negatively regulate their expression. In an effort to un-
derstand the temporal regulation of lin-42 and to de-
termine the mechanism by which it controls miRNA 
expression, we constructed a series of fl uorescent re-
porters that would allow us to monitor the expression 
of multiple miRNAs in living animals throughout 
development. These constructs include the promoter 
regions of protein-coding genes or miRNAs driving 
nuclear- localized green fl uorescent protein−pest or 
mCherry−pest sequence fusions. The addition of the 
PEST sequence reduces the half-life of the transcrip-
tional reporter to ~1 h and allows the transcriptional 
activity of each gene to be monitored in real time. This 
dual-reporter system allows us to directly compare an 
expression pattern of an unknown gene to a highly 
characterized transcript of defi ned spatial and tempo-
ral pattern. Through this analysis, we found that most 
miRNAs are temporally regulated and that their ex-
pression, like the expression of lin-42, oscillates (Fig. 2). 
Because each LIN-42 protein can be localized to the 
nucleus, we hypothesized that it may function as a tran-
scriptional regulator of miRNA expression. To directly 
test this hypothesis, we immunoprecipitated LIN-42/
chromatin complexes and characterized the binding 
patterns of LIN-42 on a global scale. Consistent with 
Figure 2. (A) lin-42 and lin-4 miRNA expression peaks at the end 
of each larval molt. (B) lin-42 functions genetically to negatively 
regulate the expression of several miRNAs and does so by bind-
ing to chromatin. (C) LIN-42B binds the elements in the lin-4 and 
let-7 promoters.
039-067_CancerGeneReg.indb   44 9/17/2013   7:38:48 AM
Cancer: Gene Regulation and Cell Proliferation  45
LIN-42 directly regulating the oscillatory expression of 
multiple miRNAs, we found that LIN-42/chromatin 
interactions were enriched in the upstream regulatory 
sequences of miRNA promoters (Fig. 2). In addition 
to binding to the promoter regions of key genes that 
control developmental timing, LIN-42 binds to the pu-
tative regulatory regions of mRNAs and long intergenic 
noncoding RNAs (lincRNAs). The impact and mecha-
nism by which LIN-42 regulates C. elegans transcrip-
tion are a major focus of our laboratory.
lin-67, the C. elegans Homolog 
of the Human Proto-Oncogene Sam68, 
Controls Developmental Timing
R. Perales
Analysis of postembryonic mRNA expression pat-
terns suggests that a signifi cant number of transcripts 
are temporally regulated and that much of this regu-
lation is coupled to the molting cycles of larval de-
velopment. Although oscillatory expression patterns 
of many of these genes are maintained through both 
transcriptional (by differential expression of tran-
scription factors) and posttranscriptional mecha-
nisms (e.g., miRNAs), analysis of sequencing data 
and the isolation of additional regulators of heter-
ochronic gene expression from our screens indicate 
that RNA processing may also have a major role in 
controlling temporal gene expression. The primary 
example of this class of regulators is lin-67, which 
was isolated in our RNAi-based screens for suppres-
sors of the retarded heterochronic phenotypes of lin-
4(ma161). lin-67 encodes a highly conserved RNA-
binding protein containing a single KH domain. 
Depletion of lin-67 expression via RNAi also sup-
presses phenotypes associated with multiple miRNA 
mutants, including alg-1(ma192) and  let-7(n2853). 
lin-67 RNAi in wild-type animals results in the pre-
cocious expression of adult-specifi c fates, directly im-
plicating lin-67 function in normal temporal gene 
expression. Deletion of the lin-67 gene also results in 
fully penetrant sterile phenotype and suggests that 
lin-67 functions to control temporal gene expression 
throughout somatic development and contributes to 
germline maintenance. Translational reporters indi-
cate that GFP::LIN-67 is a nuclear protein (Fig. 3) 
that is expressed throughout development. In a man-
ner reminiscent of the temporal expression patterns 
of LIN-42, GFP::LIN-67 is expressed in an oscil-
latory fashion and accumulates once during each 
larval stage. LIN-67’s closest homolog is the proto-
oncogene Sam68, which is overexpressed in a variety 
of cancer types and is a member of the STAR (signal 
transduction activator of RNA) family of proteins. 
Sam68 has been implicated in controlling the alter-
native splicing of a variety of mRNA targets, many 
of which have been implicated in essential tumor 
maintenance, epithelial to mesenchymal transitions, 
neuronal development, and animal fertility. In ad-
dition, Sam68 functions to control the stability of 
many targets and directly contributes to aspects of 
cell cycle control and cell-fate specifi cation. The 
roles of Sam68 in both normal development (neu-
rogenesis and fertility), as well as its role in tumor 
biology, are also controlled at the posttranscriptional 
level, where phosphorylation contributes to both a 
regulated RNA-binding capacity and its differential 
nuclear and/or cytoplasmic localization. Through 
the study of the C. elegans Sam68 homolog, we in-
tend to broaden our understanding of the roles of 
the STAR family proteins to encompass the tempo-
ral regulation of gene expression by characterizing 
changes in mRNA splicing in lin-67 mutants and 
identifying the direct RNA targets of LIN-67.
Functions of PQN-59, a C. elegans “Prion-
Like” Protein, in the Heterochronic Pathway
D. Bahel
Analysis of temporal gene regulation during C. elegans 
development has revealed that many of the repetitive 
GFP::ED02D9.1bDIC
A B C
D E
composite
GFP::ED02D9.1b
seam
seam
hyp7 hyp7
hyp7
DIC
Figure 3. The C. elegans STAR family protein GFP::LIN-67 is a 
ubiquitously expressed, nuclear-localized RNA-binding factor.
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developmental events (including behavioral changes 
and molt cycles) and those involved in cell-fate speci-
fi cation are controlled by genes that directly control 
transcription or RNA metabolism. One of the surpris-
ing fi nds in our RNAi-based screens of lin-4(ma161) 
suppressors was that a C. elegans “prion-like” gene is 
essential for this process. Depletion of pqn-59 (via 
RNAi) completely suppresses the gene expression 
and cell-fate defects associated with multiple miRNA 
mutants and alters the temporal patterning of normal 
animals, again suggesting that genes identifi ed in our 
screens function throughout development. PQN-
59::GFP, like other developmental clock components, 
is ubiquitously expressed and reaches peak levels just 
prior to the end of each molting period. Our current 
hypothesis is that, like other “prion-like” proteins, 
PQN-59 can form higher-order structures and that, 
during each molting period of postembryonic devel-
opment, this structure serves as a scaffold that facili-
tates the regulated expression of downstream develop-
mental activities.
Deanna Bahel
pqn-59(tm2690)
PQN-59
712aa
UBA/TS-N Prion-Like Domain
pqn-59
GFPA
B
PQN-59::GFP
L3 molt Late L3
PQN-59::GFP
PQN-59::GFPPQN-59::GFP
Figure 4. (A) pqn-59 encodes a C. elegans “prion-like”  protein 
with an amino-terminal ubiquitin-associated domain. The 
tm2690 deletion allele of pqn-59 disrupts pqn-59 activity. 
(B) PQN-59::GFP is a ubiquitously expressed protein that func-
tions in the cytoplasm to regulate temporal gene expression.
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STRUCTURAL BIOLOGY OF NUCLEIC ACID 
REGULATORY PROCESSES
L. Joshua-Tor C. Ashar S. Goldsmith C. Kuhn S.-J. Lee A. Tocilj
 E. Elkayam E. Greene C. Kuscu C. Logan D. Wah
 C. Faehnle J. Ipsaro T. Lavy T. Schalch J. Walleshauser
We study the molecular basis of nucleic acid regula-
tory processes by using the tools of structural  biology 
and biochemistry to examine proteins and protein 
complexes associated with these processes. X-ray crys-
tallography enables us to obtain the three-dimension-
al structures of these molecular machines. Biochem-
istry and molecular biology allow us to study prop-
erties that can be correlated to protein structure and 
 function.
Mechanisms of RNAi
T. Schalch, C. Faehnle, E. Elkayam, C.-D. Kuhn, J. Ipsaro, 
C. Kuscu, J. Walleshauser, C. Ashar, E. Greene, C. Logan 
[in collaboration with G.J. Hannon, R.A. Martienssen, 
Cold Spring Harbor Laboratory; J. Partridge, St. Jude 
Children’s Research Hospital]
RNA interference (RNAi) has made an enormous 
impact on biology in a very short period of time. Not 
only are we still discovering new cellular pathways 
for the regulation of gene expression that use these 
pathways, but RNAi has become an extraordinarily 
useful and simple tool for gene silencing. Almost 
from its beginnings, people have used genetics, bio-
chemistry, molecular biology, and bioinformatics to 
study the mechanism of RNAi and related pathways. 
We argued, however, that in order to get a true mech-
anistic understanding of these pathways, we must 
understand how the components of the RNAi ma-
chinery work at a molecular level. Therefore, we em-
barked on structural and biochemical studies of key 
proteins in the RNAi pathway. During RNAi, long 
double-stranded RNA (dsRNA) is processed to yield 
short (~19–31 nucleotides) dsRNAs that  trigger the 
RNAi response. These short RNAs get incorporated 
into effector complexes called the RNA- induced 
silencing complex (RISC), wherein, in the mature 
complexes, a single-stranded RNA (ssRNA), the 
anti-sense strand of the original dsRNA, is retained 
in the complex. This short RNA (small interfering 
RNA [siRNA] or microRNA [miRNA]) then acts 
to guide the RISC complex to its target through 
base complementarity. In all cases, these complexes 
contain a small ssRNA and an Argonaute protein, 
which serve to defi ne the RISC complex. In the past 
few years, we have been studying Argonaute family 
proteins, their complexes, and their roles in various 
RNAi silencing pathways.
Human Argonaute-2 in Complex with 
the Tumor Suppressor miRNA, miR-20a
Several years ago, we determined the fi rst structure of 
a full-length Argonaute protein. This archael protein 
was composed of four domains: N, PAZ, Mid, and 
PIWI. The similarity of the PIWI domain to RNase-
H-like nucleases revealed Argonaute as the key effector 
protein in the RISC complex and it was identifi ed as 
Slicer—the enzyme that produces the endonucleolytic 
cut in an mRNA when the guide and target mRNA 
are fully complementary. Since then, a structure of a 
bona fi de eukaryotic Argonaute protein has evaded 
structure determination until recently, when the fi rst 
structure of human Argonaute-2 (hAgo2) bound to a 
heterogeneous mixture of RNAs was solved by N.T. 
Schirle and I.J. MacRae at Scripps. Ago2 is the only 
essential Argonaute protein in mammals. Shortly 
thereafter, we determined the structure of human 
Argonaute-2 in complex with the tumor suppressor 
miRNA, miR-20a (Fig. 1). The structure of human 
Ago2 shows a remarkable similarity to its bacterial 
counterparts, demonstrating the same domain orga-
nization. The RNA interacts with all domains of the 
protein as well as the interdomain linkers. The 5′ end 
of miR-20a is bound to the Mid domain, with the 
5′-nucleotide placed in a well-defi ned binding site and 
swung away from the rest of the RNA. Bases 2–8, 
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known as the “seed region” necessary for target bind-
ing, are threaded along the PIWI domain, whereas the 
3′ end is tethered to the PAZ domain. Apart from the 
fi rst nucleotide, two major kinks are visible along the 
path of the guide RNA. One is between bases 6 and 7, 
with an Ile residue from the linker that connects the 
PAZ and Mid domains, intercalating between them. 
Another kink between bases 9 and 10 has two argi-
nine residues from the PIWI domain stacked on these 
bases with an Ile residue from the linker in between 
the bases. The RNA confers great stability on human 
Ago2, which is susceptible to proteolytic digestion in 
the absence of the RNA. We continue to investigate 
features of Argonaute that arose from our structural 
work to further our understanding of the Argonaute 
proteins in their essential roles in human development 
and diseases.
Zucchini: A Nuclease Implicated 
in piRNA Biogenesis
Maintenance of germline integrity is critical to the 
reproductive success of a species. To protect against 
instability caused by mobile genetic elements, PIWI 
proteins and their associated small RNAs (Piwi- 
interacting RNAs [piRNAs]) form functional RISCs 
to repress the deleterious activity of such transpos-
able elements. Silencing by piRNAs can be divided 
into three phases: biogenesis of piRNAs, a subsequent 
effector step, and an adaptive “ping-pong” cycle. In 
primary piRNA biogenesis, long, ssRNA transcripts 
are fi rst parsed into smaller 5′- monophosphorylated 
fragments. This piRNA precursor then appears to be 
loaded into its PIWI-family partner. The 3′ ends of 
the piRNAs are formed by a Mg2+ -dependent trim-
ming activity. To mount a response commensurate to 
the quantitative load of transposons, piRNAs can be 
amplifi ed in a feed-forward “ping-pong” mechanism 
generating so-called secondary piRNAs. Once mature 
piRNAs are loaded into PIWIs, the resulting effector 
complexes are able to direct silencing at either the tran-
scriptional level or posttranscriptional level. Although 
a general scheme for piRNA biogenesis and action has 
been established, the identities and activities of many 
of the molecular players remain unknown. Zucchini 
was suggested by genetic studies as a factor involved in 
piRNA biogenesis. However, previous reports indicate 
that Zucchini may be acting indirectly as a lipase. We 
produced a soluble amino-terminal truncation of the 
mouse homolog of the protein (mZuc) and showed 
that it has single-strand-specifi c nuclease activity. In 
addition, we determined the crystal structure of mZuc 
to 1.75 Å resolution (Fig. 2). The structure of mZuc 
displays a striking architectural similarity to HKD 
nucleases and is consequently dissimilar to HKD 
lipases. Additionally, the structure revealed a long, 
positively charged groove that can accommodate sin-
gle-stranded nucleic acid substrates and a zinc fi nger 
motif that is frequently found in nucleic-acid-binding 
proteins. Taken as a whole, these biochemical and 
structural fi ndings implicate Zucchini as a primary 
Figure 1. Structure of human Argonaute-2 in complex with the 
tumor suppressor miRNA, miR-20a.
Figure 2. Structure of the mouse zucchini dimer.
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piRNA biogenic nuclease perhaps being responsible 
for generating the 5′ ends of primary piRNAs.
The Different Faces of E1: A Replicative 
Hexameric Helicase
S.-J. Lee [in collaboration with A. Stenlund, Cold Spring 
Harbor Laboratory; T. Ha, University of Illinois, Urbana-
Champaign]
During DNA replication, two complementary DNA 
strands are separated and each becomes a template for 
the synthesis of a new complementary strand. Strand 
separation is mediated by a helicase enzyme, a molecu-
lar machine that uses the energy derived from ATP hy-
drolysis to separate DNA strands while moving along 
the DNA. Our early studies focused on recognition of 
the DNA replication origin by the helicase. Our crystal 
structure of the replicative helicase E1 from papilloma-
virus bound to single-stranded DNA and nucleotide 
molecules at the ATP binding sites provided a unique 
look into the mechanism of translocation of this mo-
lecular machine along DNA. We continue to study 
this helicase and the role other domains of the protein 
might have in helicase assembly and activity. We are 
using biophysical studies in solution—in bulk and at 
the single molecular level—to understand this helicase 
in mechanistic detail and correlate our fi ndings with 
the structural framework.
A Transcriptional Switch: Revisited
T. Lavy, P.R. Kumar, H. He, D. Wah
A wealth of genetic information and some biochemi-
cal analysis have revealed an elegant model for the 
GAL regulon of the yeast Saccharomyces cerevisiae, 
a beautiful model system to understand transcrip-
tional activation in eukaryotes. While attempting to 
place these studies into a structural and biochemi-
cal framework, we discovered the involvement of a 
dinucleotide in the induction of this classical tran-
scriptional switch. Specifi cally, nicotinamide adenine 
dinucleotide phosphate (NADP) appears to jump-
start the switch, which is then sustained by the pre-
viously known transducer–repressor (Gal3p-Gal80p) 
interaction. This represents a real shift in how we 
think about the GAL transcriptional switch and our 
textbook view of how these switches work. In light of 
this discovery, we would like to fi nd the link between 
galactose induction and the metabolic state of the cell 
that is sensed by the repressor, Gal80p. Our goal is to 
further delineate the molecular interactions and pos-
sible enzymatic activities involved in induction, acti-
vation, and repression in order to provide a mechanis-
tic view of this switch. We are using a combination 
of X-ray crystallography, biochemistry, genetics, and 
metabolomics to more fundamentally understand this 
biological paradigm. The most recent addition is our 
structure of the complex among the Gal80p repres-
sor, the Gal3p transducer, and the two small molecule 
ligands—galactose and ATP. We have found that the 
interaction between the proteins occurs only when 
Gal3p is in a “closed state” induced by ligand binding. 
Comparison to the free Gal3p structure that we have 
also determined and a previously determined struc-
ture of a galactose and ATP-bound form of the very 
similar active galactokinase, Gal1p, clearly shows that 
ligand binding induces the closed state of Gal3p. Fur-
thermore, examination of the sites of Gal3p constitu-
tive mutations shows that these would favor a closed 
state for Gal3p without necessitating ligand binding. 
On the other hand, Gal80p superrepressor mutants 
appear to result from their inability to form a stable 
complex with Gal3p, rather than tighter association 
with the activator, Gal4p. We are now examining pos-
sible enzymatic activities as well as other complexes 
involved in this classic transcriptional switch.
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 F. Bezirci L. Hu K.-T. Lin A. Raimer A. Xu
 S. Brøner I. Hua Y.-H. Liu K. Sahashi L. Zepeda
Mechanisms of Constitutive and 
Alternative Pre-mRNA Splicing
RNA splicing is required for expression of most eu-
karyotic protein-coding genes. The spliceosome selects 
authentic splice sites with very high fi delity, relying 
on limited sequence information present throughout 
introns and exons. In humans, >90% of genes are ex-
pressed via alternative splicing, giving rise to multiple 
protein isoforms. The choice of alternative splice sites 
is commonly regulated to alter gene expression, either 
tissue-specifi cally or in response to a developmental 
program or to signaling pathways. The fact that mul-
tiple protein isoforms can be expressed from individu-
al genes demonstrates that the classical “one gene–one 
enzyme” paradigm is no longer valid and provides 
an explanation for the unexpectedly small number of 
protein-coding genes uncovered by genome-sequenc-
ing projects. Both constitutive and alternative splicing 
mechanisms involve numerous protein components, 
as well as fi ve noncoding RNA components that are 
part of small nuclear ribonucleoprotein (snRNP) par-
ticles. The work in our lab focuses on the identifi ca-
tion and molecular characterization of protein factors 
and sequence elements that are necessary for the ca-
talysis and fi delity of splicing and/or for the regulation 
of alternative splice site selection. We are interested in 
how the spliceosome correctly identifi es the exons on 
pre-mRNA, and how certain point mutations in either 
exon or intron sequences cause aberrant splicing, lead-
ing to various human genetic diseases. Related areas of 
interest include the remodeling of mRNP architecture 
as a consequence of splicing, which infl uences down-
stream events, such as nonsense-mediated mRNA 
decay (NMD); the various roles of alternative splicing 
misregulation in cancer; and the development of effec-
tive methods to correct defective splicing or modulate 
alternative splicing, especially in a disease context. A 
summary of some of our recently published studies is 
provided below.
Alternative Splicing and Cancer
Alternative splicing has an important role in cancer, 
partly by modulating the expression of many onco-
genes and tumor suppressors, and also because in-
activating mutations that affect alternative splicing 
of various tumor suppressor genes account for some 
of the inherited and sporadic susceptibility to can-
cer. In addition, alternative splicing controls a meta-
bolic switch characteristic of all cancer cells, known 
as the Warburg effect. Cancer cells preferentially 
metabolize glucose by aerobic glycolysis, character-
ized by increased lactate production. This distinc-
tive metabolism involves re-expression of the embry-
onic M2 isozyme of pyruvate kinase, in contrast to 
the M1 isozyme normally expressed in differentiated 
cells, and it confers a proliferative advantage to tumor 
cells. The M1 and M2 isozymes are expressed from 
a single PK-M gene through alternative splicing of a 
pair of mutually exclusive exons (exons 9 and 10, re-
spectively). We previously demonstrated that splicing 
enhancer elements that activate exon 10 are mainly 
found in exon 10 itself, and deleting or mutating these 
elements increases the inclusion of exon 9 in cancer 
cells. To systematically search for new enhancer ele-
ments in exon 10 and develop an effective pharma-
cological method to force a switch from PK-M2 to 
PK-M1, we carried out an antisense oligonucleotide 
(ASO) screen, in collaboration with Isis Pharma-
ceuticals. We found potent ASOs that target a novel 
enhancer in exon 10 and strongly switch the splicing 
of endogenous PK-M transcripts to include exon 9. 
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The ASO-mediated switch in alternative splicing leads 
to apoptosis in glioblastoma cell lines, and this is 
caused by the down-regulation of PK-M2, and not by 
the up-regulation of PK-M1, as expression of PK-M2 
cDNA in the ASO-treated cells prevents apoptosis. 
These results suggest the potential of ASO-mediated 
splicing modulation for cancer therapy.
SRSF1 (formerly SF2/ASF) is a prototypical serine- 
and arginine-rich (SR) protein, with important roles in 
splicing and other aspects of mRNA metabolism. We 
previously determined that SRSF1 is a potent oncopro-
tein with increased expression in many tumors, includ-
ing breast cancer. In collaboration with Senthil Muth-
uswamy (Ontario Cancer Institute) and Rotem Karni 
(Hebrew University, Jerusalem), we have investigated 
SRSF1’s ability to transform human and mouse mam-
mary epithelial cells in vivo and in vitro. We showed 
that SRSF1-overexpressing mouse COMMA-1D cells 
form tumors after orthotopic transplantation to re-
constitute the mammary gland. In organotypic three-
dimensional culture, SRSF1-overexpressing human 
MCF-10A cells form larger acini than control cells, 
refl ecting increased proliferation and delayed apopto-
sis during acinar morphogenesis.
We found that these effects require the fi rst RNA-
recognition motif and nuclear functions of SRSF1. 
SRSF1 overexpression promotes alternative splicing 
of BIM and BIN1 isoforms that lack pro-apoptotic 
functions and contribute to the acinar phenotype. 
We also demonstrated that SRSF1 cooperates spe-
cifi cally with MYC to transform mammary epithelial 
cells, in part by potentiating activation of the trans-
lation initiation factor oncoprotein eIF4E. Further-
more, MYC and SRSF1 show correlated expression in 
human breast tumors. SRSF1 is also up-regulated in 
lung carcinomas, where it likewise shows signifi cant 
correlation with MYC expression. We have now dem-
onstrated that SRSF1 is a direct transcriptional target 
of MYC, providing a mechanistic basis for their cor-
related expression in cancer. MYC knockdown down-
regulates SRSF1 expression in multiple lung cancer 
cell lines. MYC directly activates transcription of 
SRSF1 through two noncanonical E-boxes in its pro-
moter. The resulting increase in SRSF1 protein is 
suffi cient to modulate alternative splicing of a subset 
of its target transcripts. In particular, MYC induc-
tion leads to SRSF1-mediated alternative splicing of 
the signaling kinase MKNK2. We further showed 
that SRSF1 knockdown reduces MYC’s oncogenic 
activity, decreasing proliferation and anchorage-inde-
pendent growth. These results suggest a mechanism 
for SRSF1 up-regulation in a subset of tumors with 
elevated MYC levels and identify SRSF1 as a critical 
MYC target that contributes to its oncogenic poten-
tial by enabling MYC to regulate the expression of 
specifi c protein isoforms through alternative splicing.
As part of a systematic analysis of the SRSF1 pro-
tein-interaction network, we used immunoprecipita-
tion and quantitative mass spectrometry (i-DIRT) 
and found a novel interaction between SRSF1, the 
ribosomal protein RPL5, and the ubiquitin E3 ligase 
MDM2. We demonstrated that SRSF1 stabilizes 
the tumor suppressor protein p53 by abrogating its 
MDM2-dependent proteasomal degradation. More-
over, SRSF1 is a necessary component of the complex, 
which functions in a p53-dependent ribosomal-stress 
checkpoint pathway. Consistent with the stabiliza-
tion of p53, increased SRSF1 expression in primary 
human fi broblasts decreases cellular proliferation 
and ultimately triggers oncogene-induced senescence 
(OIS). These fi ndings underscore the deleterious out-
come of SRSF1 overexpression and identify a cellular 
defense mechanism against its aberrant function. Fur-
thermore, they implicate the RPL5-MDM2 complex in 
OIS and demonstrate a link between spliceosomal and 
ribosomal components, functioning independently of 
their canonical roles, to monitor cellular physiology 
and cell cycle progression.
Targeted Antisense Modulation of 
Alternative Splicing for Therapy and 
Disease Modeling
Spinal muscular atrophy (SMA) is a common, auto-
somal-recessive motor-neuron degeneration disorder 
caused by homozygous deletion or mutation of the 
survival-of-motor-neuron gene, SMN1. A closely re-
lated SMN1 paralog, SMN2, is present in all patients 
and differs from SMN1 by a C to T transition in exon 
7 that causes substantial skipping of this exon, such 
that SMN2 expresses only low levels of functional pro-
tein. SMN2 decreases the severity of SMA in a copy-
number-dependent manner. We previously developed 
an antisense method to increase the extent of exon-
7 inclusion during splicing of SMN2 transcripts, for 
therapeutic use in SMA. This translational research is 
being done in collaboration with Isis Pharmaceuticals. 
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Phase I clinical trials with our ASO compound, ISIS-
SMNRx, have now been completed; the drug, which 
was administered to SMA patients by lumbar punc-
ture, was well tolerated at all doses tested. Phase II 
trials to further establish appropriate dosing and begin 
to assess effectiveness are ongoing.
We also described the use of different ASOs that 
exacerbate SMN2 mis splicing to phenocopy SMA 
in a dose-dependent manner when administered to 
SMN2-transgenic Smn–/– mice. Intracerebroventricu-
lar ASO injection in neonatal mice recapitulated se-
vere SMA-like progressive motor dysfunction, growth 
impairment, and shortened life span, with α-motor 
neuron loss and abnormal neuromuscular junctions. 
These SMA-like phenotypes were prevented by in-
tracerebroventricular (ICV) injection of the above 
therapeutic ASO. We uncovered starvation-induced 
splicing changes—particularly in SMN2—which 
likely accelerate disease progression. These results 
constitute proof of principle that ASOs designed to 
cause sustained splicing defects can be used to induce 
pathogenesis and rapidly and accurately model splic-
ing-associated diseases. This approach allows the dis-
section of pathogenesis mechanisms, including spatial 
and temporal features of disease onset and progres-
sion, as well as testing of candidate therapeutics. By 
targeting splicing of endogenous genes, the method 
can potentially be used to phenocopy diseases in wild-
type animals.
Noncanonical 5′-Splice-Site Recognition
An established paradigm in pre-mRNA splicing is the 
recognition of the 5′ splice site by canonical base pair-
ing to the 5′ end of U1 small nuclear RNA (snRNA). 
We previously reported that a small subset of 5′ splice 
sites base pair to U1 in an alternate register that is 
shifted by one nucleotide. Using genetic-suppression 
experiments in human cells, we have now demon-
strated that many other 5′ splice sites are recognized 
via noncanonical base-pairing registers involving 
bulged nucleotides on either the 5′ splice site or U1 
RNA strand. By combining experimental evidence 
with transcriptome-wide free-energy calculations of 
5′ splice site/U1 base pairing, we estimate that 10,248 
5′ splice sites (~5% of human 5′ splice sites) in 6577 
genes use “bulge registers.” Several of these 5′ splice 
sites occur in genes with mutations causing genetic 
dis eases and are often associated with alternative splic-
ing. These results call for a redefi nition of an essential 
element for gene expression that incorporates these 
registers, with important implications for the molecu-
lar classifi cation of splicing mutations and for alterna-
tive splicing.
Analyzing Splicing by Next-Generation 
Sequencing
A crucial step in analyzing mRNA-Seq data is to ac-
curately and effi ciently map hundreds of millions of 
reads to the reference genome and to exon junctions. 
In collaboration with Chaolin Zhang (Columbia) and 
Michael Zhang (University of Texas, Dallas), we de-
veloped OLego, an algorithm specifi cally designed for 
de novo mapping of spliced mRNA-Seq reads. OLego 
adopts a multiple-seed-and-extend scheme and does 
not rely on a separate external aligner. It achieves high 
sensitivity of junction detection by strategic searches 
with small seeds (~14 nucleotides for mammalian ge-
nomes). To improve accuracy and resolve ambiguous 
mapping at junctions, OLego uses a built-in statistical 
model to score exon junctions by splice-site strength 
and intron size. Burrows-Wheeler transform is used in 
multiple steps of the algorithm to effi ciently map seeds, 
locate junctions, and identify small exons. OLego is 
implemented in C++ with fully multithreaded execu-
tion and allows fast processing of large-scale data. We 
systematically evaluated the performance of OLego in 
comparison with published tools, using both simulated 
and real data. OLego demonstrated better sensitivity, 
higher or comparable accuracy, and substantially im-
proved speed. OLego also identifi ed hundreds of novel 
micro-exons (<30 nucleotides) in the mouse transcrip-
tome, many of which are phylogenetically conserved, 
and we validated them experimentally.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector G. Arun S. Hearn J. Li
 J. Bergmann M. Huebner G. Ruiz Buendia
 M.S. Bodnar R.I. Kumaran C. Zepeda-Mendoza
 M. Eckersley-Maslin Z. Lazar B. Zhang
Most cellular processes can trace their beginnings 
to the nucleus, where a gene is activated resulting in 
the production of an RNA molecule, some of which 
 encode for proteins, whereas others are functional in 
the form of RNA. Although much biochemical in-
formation is available regarding many of the factors 
involved in gene expression, the spatial and temporal 
parameters that infl uence gene expression and the role 
of noncoding RNAs in regulating this multifaceted 
process are just beginning to be identifi ed. During 
the past year, our research has focused on elucidating 
various mechanisms of regulating gene expression and 
DNA repair and the role of long nuclear retained non-
coding RNAs in development and cancer progression.
Organization and Expression of Genes 
in Embryonic Stem Cells and Neural 
Progenitor Cells
M. Bodnar, M. Eckersley-Maslin, J. Bergmann, Z. Lazar
Embryonic stem (ES) cells undergo dramatic changes 
in transcription, chromatin structure, and nuclear ar-
chitecture as they transition from a pluripotent state 
to a lineage-specifi c cellular program. To better un-
derstand how the unique ES cell nuclear environment 
infl uences pluripotency, and vice versa, we have fo-
cused on the dynamic movements of the Oct4 gene 
locus during the onset of ES cell differentiation. We 
have found that the alleles of the Oct4 gene locus tran-
siently associate in the nucleus and that the timing of 
this allelic association event coincides with the repres-
sion of the Oct4 gene.
Previously, we presented evidence that a 3.6-kb 
genomic sequence in the 5′ regulatory region of the 
Oct4 gene is suffi cient to mediate pairing of a trans-
gene with the endogenous Oct4 alleles. During the 
past year, we assessed a series of DNA elements within 
the 3.6-kb region to determine if any were neces-
sary for Oct4 allele pairing to occur. On the basis of 
their roles in homologous chromosome pairing in 
other biological paradigms, Ctcf, E2A, Oct4, and 
Yy1 were identifi ed as candidate proteins capable of 
binding the 3.6-kb DNA region in a combinatorial 
fashion to mediate pairing. Putative protein-binding 
sites were identifi ed using the MatInspector program, 
and site-directed mutagenesis yielded four new DNA 
fragments, with the putative binding sites for either 
Oct4/Sox2, Ctcf, Yy1, or E2A replaced with scram-
bled DNA sequences. Each of the four mutated DNA 
fragments were individually targeted to the Col1A 
locus in KH2 ES cells via FRT-mediated recombina-
tion. ES cell lines with successfully targeted mutated 
transgenes were then differentiated using retinoic acid 
(RA), and DNA FISH (fl uorescence in situ hybrid-
ization) was performed using probes specifi c for the 
transgene, Col1A locus, and Oct4 locus. The ability of 
the mutated transgenes to associate with endogenous 
Oct4 was assessed after 1 day of RA differentiation. 
Ctcf, E2a, and Yy1 mutants were still capable of pair-
ing with endogenous Oct4 loci. In contrast, the trans-
gene with mutated Oct4/Sox2 consensus binding sites 
exhibited a reduced level of transgene pairing to a fre-
quency equivalent to the wild-type Col1A locus. These 
results demonstrated that the Oct4/Sox2 consensus 
binding sites are necessary for Oct4 allelic pairing to 
occur. Ongoing in vitro studies are confi rming this 
interaction.
Monoallelic gene expression describes the tran-
scription from only one of two homologous alleles 
of a particular gene. We previously performed an 
unbiased RNA sequencing screen to identify ran-
dom monoallelically expressed genes, taking ad-
vantage of a hybrid ESC (embryonic stem cell) line 
that is an F1 cross between C57BL/6 and CAST/Ei 
strains, so that the expressed single-nucleotide poly-
morphisms (SNPs) would refl ect from which allele 
the transcript is derived. Libraries for RNA sequenc-
ing were generated from seven single-cell ESC clones 
and seven single-cell NPC (neural progenitor cell) 
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clones from three separate differentiation experi-
ments. The libraries were amplifi ed and sequenced 
using the Illumina platform, generating ~80 million 
unique reads per clone, of which ~80% mapped to a 
custom-built C57BL/6 × CAST/Ei genome using a 
Burrows-Wheeler Aligner (in collaboration with Paul 
Flicek’s group, EBI, Hinxton, U.K.). Although only 
30 transcripts were identifi ed as monoallelic in ESCs, 
representing less than 0.29% of assessable genes, this 
increased to 478 transcripts during differentiation to 
NPCs. This corresponds to ~4% of expressed tran-
scripts. Of particular interest, genes showed varia-
tions in expression patterns between clones from true 
monoallelic expression to various levels of allelic im-
balance, implying that this regulation is rather plas-
tic yet controllable. Two methods are being used to 
validate the 478 NPC transcripts. First, polymerase 
chain reaction (PCR) amplifi cation of exonic SNPs 
followed by Sanger sequencing has been performed 
for more than 87 gene-clone combinations, giving a 
91% concordance with the RNA-Seq screen analysis. 
Second, RNA FISH was performed to validate mono-
allelic candidates at the single-cell level. Comparison 
of the 30 ESC candidates and 478 NPC candidates 
revealed only fi ve transcripts that overlapped between 
the two data sets.
Because, once established, the choice of active allele 
is maintained across cell generations, a memory must 
be in effect to maintain this monoallelic state. Three 
possible mechanisms have been investigated (DNA 
methylation, nuclear organization, and histone modi-
fi cations). Thus far, DNA methylation and nuclear 
positioning do not appear to have a role in maintain-
ing the monoallelic state. Ongoing studies are assess-
ing the role of histone modifi cations in maintaining 
the active and silent states of the respective alleles.
When the levels of expression of these transcripts 
were compared between ESCs and NPCs, the major-
ity did not show any change in expression levels, sug-
gesting that the switch to monoallelic state does not 
change total expression levels during differentiation. 
To further address whether monoallelic expression 
changes overall mRNA expression levels, quantitative 
(Q)-PCR analysis of individual NPC clones was per-
formed for four candidate genes. The relative expres-
sion in NPC clones did not correlate with the extent of 
allelic imbalance as determined by D-score. Further-
more, global analysis of expression levels (FPKM) ver-
sus D-score showed no difference between monoallelic 
transcripts versus all assessable transcripts. This lack 
of correlation between the number of active alleles and 
total level of gene expression suggests that monoallelic 
expression is not a mechanism for regulating mRNA 
levels in the cell, but instead there is transcriptional 
compensation of the single active allele, likely through 
a feedback mechanism, such that total level of expres-
sion in the cell is maintained.
Long noncoding RNAs (lncRNAs; >200 nucleo-
tides in length) represent a relatively recently studied 
class of RNAs for which functional insight is current-
ly available for only a few candidates out of potentially 
thousands. The majority of lncRNAs are expressed 
at very low levels, some as low as one copy per cell, 
and these RNAs generally exhibit poor primary se-
quence conservation over evolution. lncRNAs have 
been implicated in numerous molecular functions, 
including modulating transcriptional patterns, regu-
lating protein activities, serving structural or organi-
zational roles, altering RNA processing events, and 
serving as precursors to small RNAs. We performed 
a next-generation sequencing screen of poly(A)+ RNA 
to identify putative lncRNAs that are differentially 
expressed in mouse ESCs and NPCs. Our goal is to 
uncover new mechanisms by which lncRNAs regu-
late gene expression, differentiation, and/or nuclear 
organization. We identifi ed 638 lncRNAs expressed 
in ESCs and NPCs, of which 135 were greater than 
threefold down-regulated and 65 were greater than 
threefold up-regulated during differentiation toward 
NPCs. Of these transcripts, ~70% are enriched in the 
nucleus, indicating potential roles in the regulation of 
gene expression or nuclear organization. Using strin-
gent criteria, we generated a short list of 46 presently 
uncharacterized and moderately abundant lncRNAs.
We have begun to characterize these lncRNAs with 
respect to their expression in embryonic and adult tis-
sues, as well as to examine their subcellular localiza-
tion using RNA fl uorescence in situ hybridization 
protocols with single-molecule sensitivity. Using an-
tisense oligonucleotide (ASO) technology, we are spe-
cifi cally depleting the level of individual lncRNAs and 
are in the process of determining cellular phenotypes 
including maintenance of pluripotency and differen-
tiation potential under knockdown conditions, as well 
as by assessing global changes in gene expression pat-
terns. Furthermore, we are working on establishing 
ESC-derived cell lines that will allow us to track the 
dynamics of candidate lncRNP complexes in living 
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cells, as well as to determine the composition of spe-
cifi c lncRNP complexes on the protein level. Our 
overall aim is to provide a thorough and comprehen-
sive characterization of individual lncRNAs to dissect 
functional interactions of these RNAs with nuclear 
proteins and their mechanisms of action at the mo-
lecular level.
Probing the Function of Malat1, 
an Abundant Long Noncoding RNA, 
that Is Overexpressed in Cancer
G. Arun [in collaboration with M. Egeblad, Cold Spring 
Harbor Laboratory; J.E. Wilkinson, University of Michigan 
Medical School; A. Revenko, A. Robert MacLeod, Isis 
Pharmaceuticals]
Malat1 (metastasis-associated lung adenocarcinoma 
transcript 1), also known as Neat2 (noncoding nucle-
ar-enriched abundant transcript 2), is among the most 
abundant lncRNAs and is located on mouse chromo-
some 19qA (human chromosome 11q13.1). It is evolu-
tionarily conserved among mammals and is highly ex-
pressed in many tissues. MALAT1 is up-regulated in 
several human cancers, suggesting that it may have an 
important function during development and cancer 
progression, yet the physiological function of Malat1 
lncRNA has not been determined.
To assess the in vivo function of mouse Malat1, 
we previously established a loss-of-function mouse 
genetic model using homologous recombination in 
ES cells. Malat1-/- mice are grossly normal and fer-
tile. Offspring of heterozygous breedings follow 
Mendelian segregation, suggesting that deletion of 
Malat1 does not affect mouse pre- and postnatal vi-
ability. Breedings between Malat1 homozygotes and 
wild type produce normal-sized litters, indicating that 
Malat1-/- mice are fertile. Further cell biological and 
biochemical analyses indicated that mouse Malat1 is 
not essential for nuclear speckle assembly, regulating 
the level and phosphorylation of SR splicing factors, or 
cell proliferation. Genome-wide expression and splic-
ing profi ling demonstrated that Malat1 loss results in 
minimal alterations in global gene expression and pre-
mRNA splicing. However, deletion of Malat1 resulted 
in a nearly twofold up-regulation of a small group of 
genes in mouse brain cortex. A lack of major pheno-
type upon the loss of Malat1 transcripts could be at-
tributed to functional redundancy with other RNA 
transcripts (e.g., Neat1 lncRNA) or to compensatory 
mechanisms during development, as occurs with re-
spect to many protein-coding genes. Alternatively, 
some lncRNAs, including Malat1, could have a subtle 
role and regulate cellular processes via a fi ne-tuning 
mechanism while exhibiting more elaborate manifes-
tations upon specifi c stresses such as cancer.
To precisely identify the mechanism by which 
Malat1 functions in cancer, studies were initiated with 
the mouse mammary tumor virus long terminal repeat 
(LTR)-driven polyoma middle T antigen (MMTV-
PyMT) mouse model, which phenocopies human lu-
minal breast cancer. Similar to human breast disease, 
PyMT mice exhibit all stages of the disease from pre-
malignant to malignant stages and, more importantly, 
distant metastasis. Tumors have very high penetrance, 
and the majority (>80%) of mice exhibit lung me-
tastasis. MMTV-PyMT mice develop tumors in both 
FVB/n and C57BL/6 backgrounds, with the latter 
being delayed. The spontaneous tumors developed in 
MMTV-PyMT mice were independently subjected 
to two different Malat1 antisense oligonucleotides 
(ASOs) or scrambled ASO treatment by subcutane-
ous injection of 25 mg/kg per dose for 5 days with a 
rest period of 2 days for 6 weeks. Tumor growth was 
monitored for up to 6 weeks and at the end of the 
sixth week, the animals were sacrifi ced and mammary 
glands and lungs were harvested. Malat1 RNA levels 
were reduced by more than 60% in primary mam-
mary tumors from mice treated with Malat1 ASOs 
compared to scrambled ASO-treated mice, confi rm-
ing that the ASOs are effi cacious for in vivo studies. 
We observed slower growth of primary tumors in 
ASO1- or ASO2-treated mice, resulting in reduced 
tumor volume as compared to controls. Interestingly, 
upon ASO treatment, only two out of 18 mice devel-
oped >10 metastatic lung nodules compared to scram-
bled ASO-treated control mice in which six out of 12 
mice developed >10 macroscopic metastatic lung nod-
ules. Ongoing studies using this system will delineate 
the role of Malat1 at different stages of the disease, 
in particular during primary tumor progression and 
lung metastasis. In addition, we have recently begun 
crosses between our Malat1-/- mice and the MMTV-
PyMT mouse model. Our current results indicating a 
potential role of Malat1 in metastasis are extremely ex-
citing, and with the appropriate tools in place, we are 
poised to elucidate the role of this lncRNA in cancer 
initiation and progression.
039-067_CancerGeneReg.indb   56 9/17/2013   7:40:46 AM
Cancer: Gene Regulation and Cell Proliferation  57
Evaluation of DNA Repair Pathway Choice 
upon Zinc Finger Nuclease-Induced 
Double-Strand Breaks
R. Kumaran, J. Li, Z. Lazar [in collaboration with 
M.H. Porteus, Stanford University School of Medicine]
DNA double-strand breaks (DSBs) are the most dan-
gerous class of DNA damage. If DSBs are left unre-
paired, they can result in genomic instability or cell 
death. Therefore, cells have evolved complex DNA-
damage response pathways to repair DSBs. In mam-
malian cells, two major and mechanistically distinct 
DSB repair pathways are nonhomologous end-join-
ing (NHEJ) and homologous recombination (HR). 
NHEJ and HR can be regulated by multiple factors, 
including cell cycle phase. Although cell cycle regula-
tion of the DSB repair pathway choice on a single-
copy locus is thought to be restricted to G1 phase for 
NHEJ and to late S/G2 phase for HR, it remains un-
clear for a multicopy locus. We have investigated DSB 
pathway choice by developing and utilizing multicopy 
and single-copy DSB reporter cell systems. Using 
these systems, we initiated a DSB with a specifi c zinc 
fi nger nuclease and then visualized DSB repair as it 
relates to cell cycle phase. We showed that both the 
NHEJ and HR pathways can simultaneously be re-
cruited to repair DSBs at a specifi c site in the genome. 
The frequency of recruitment of the HR repair protein 
Rad51 is high at a multicopy versus a single-copy DSB 
substrate. Interestingly, HR can occur in G1 phase of 
the cell cycle, if donor template is available for repair. 
Our fi ndings suggest a competition between the HR 
and NHEJ repair machineries throughout interphase 
of the cell cycle, which could be a critical factor for 
the stability of mammalian genomes that are highly 
enriched with repeat sequences. Understanding the 
mechanisms of DNA repair is vital for developing 
improved treatment options for cancer, immune, and 
neurodegenerative disorders.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund S. Schuck
The papillomaviruses are a group of viruses that infect 
and transform the basal epithelium, inducing prolif-
eration of the cells at the site of infection. The result-
ing tumors (warts) are in most cases benign and will 
usually regress after some time, but certain types of 
human papillomaviruses (HPVs) give rise to tumors 
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV 
infection appears to be a necessary cause of invasive 
cervical carcinoma and thus represents one of the few 
fi rmly established links between viral infections and 
the development of cancer. An impediment to the 
study of papillomaviruses has been the inability to 
defi ne simple in vitro cell culture systems for analy-
sis of the viral life cycle. These viruses normally re-
quire specialized differentiating cells that only with 
diffi culty can be generated in cell culture. However, 
for a bovine papillomavirus (BPV-1), a convenient 
cell culture system exists where viral gene expression, 
oncogenic transformation, and viral DNA replication 
can be studied. Thus, BPV has become a useful model 
for these aspects of the viral life cycle. The DNA rep-
lication properties of the papillomaviruses show some 
unique and interesting characteristics. As part of their 
normal life cycle, these viruses can exist in a state of 
latency, which is characterized by maintenance of the 
viral DNA as a multicopy plasmid in infected cells. 
The copy number of the viral DNA is tightly con-
trolled, and the viral DNA is stably inherited under 
these conditions. Papillomaviruses therefore provide 
a unique opportunity to study plasmid replication in 
mammalian cells. In addition, the viral DNA replica-
tion machinery represents one of the most promising 
targets for antiviral therapy. In previous years, we have 
reported the characterization of the papillomavirus 
replicon and the identifi cation of the viral components 
that are required for viral DNA replication. In recent 
years, we have directed our attention toward the bio-
chemical events that are associated with initiation of 
DNA replication. We are studying the biochemical 
properties of the viral E1 and E2 proteins and how 
these two proteins interact with the viral origin of 
DNA replication and with the cellular replication ma-
chinery to generate initiation complexes. Our studies 
demonstrate that the E1 protein has all of the char-
acteristics of an initiator protein, including ori recog-
nition, DNA-dependent ATPase activity, and DNA 
helicase activity. The transcription factor E2, whose 
precise function has remained more elusive, appears 
to serve largely as a loading factor for E1. Through 
direct physical interactions with both E1 and the ori, 
E2 provides sequence specifi city for the formation of 
the initiation complex.
We are currently attempting to elucidate how the 
E1 and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication 
at the viral ori. These events include binding of the 
initiator to the ori, the initial opening of the DNA du-
plex (melting), and the assembly and loading of the E1 
replicative helicase at the replication fork. Our studies 
so far indicate that these activities are generated in an 
ordered process that involves the sequential assembly 
of E1 molecules on the ori. This sequential assembly 
generates different complexes with different properties 
that in turn recognize ori, destabilize the double helix, 
and function as the replicative DNA helicase.
Function of the Amino-Terminal Domain 
of E1 in Viral DNA Replication
The papillomavirus E1 protein is a multifunctional 
protein that carries out essential functions in viral 
DNA replication. Although E1 is well-studied, func-
tions have not been assigned to all parts of the protein. 
The function of the amino-terminal ~150 residues has 
especially remained mysterious. Although a part of 
this sequence is involved in nuclear import and export, 
these sequences account for only a fraction of the ami-
no-terminal domain. Given the parsimony that usually 
characterizes viral proteins, it is likely that additional 
functions are present in the amino-terminal domain.
To determine the function of the amino-terminal 
domain, we generated small successive deletions from 
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the amino terminus and expressed and purifi ed the 
resulting proteins from Escherichia coli. We tested 
the proteins by electrophoretic mobility-shift assay 
(EMSA) for the formation of a double-trimer (DT) 
complex on the origin of DNA replication. This com-
plex is essential for viral DNA replication. Although 
deletion of the fi rst 35 residues had no effect on DT 
formation, deletion of the fi rst 55 residues (E155–605) re-
sulted in a failure to form the DT, demonstrating that 
sequences amino-terminal to residue 55 are important 
for DT formation. However, a further deletion up to 
residue 110 restored the ability to form DT. This result 
led us to conclude that the sequences present between 
residues 55 and 110 interfere specifi cally with DT for-
mation but that these sequences are not exposed in 
the intact amino-terminal domain. To identify activi-
ties present in the amino-terminal domain, we gener-
ated fragments from this domain and expressed these 
as GST fusion proteins in E. coli. In this manner, we 
could identify a nonspecifi c DNA-binding activity that 
we initially mapped to between residues 70 and 120. 
Interestingly, this activity was not detectable in the 
context of the intact amino-terminal domain (E11–150). 
However, successive deletions from the amino termi-
nus gradually increased the DNA-binding activity 
of this fragment. These results demonstrate that the 
DNA-binding activity present in E170–120 is hidden or 
sequestered in the presence of the 55 amino-terminal 
residues. To determine whether the exposure of this 
DNA-binding activity was responsible for the failure 
to form the DT complex with E155–605, we knocked 
out the DNA-binding activity with a specifi c point 
mutation. Surprisingly, this mutation did not restore 
the ability of E155–605 to form a DT.
This result indicated that an activity other than 
DNA binding is present in the amino-terminal do-
main and is responsible for the defect for DT forma-
tion in E155–605. We performed pull-down assays to 
look for interactions between fragments from the ami-
no-terminal domain and the rest of E1. We were able 
to identify a strong interaction between the amino-
terminal domain and the oligomerization and helicase 
domain in E1. Interestingly, the region of the amino-
terminal domain involved in this interaction overlaps 
with the DNA-binding activity present in the amino-
terminal domain and is contained between residues 
70 and 120. Furthermore, this interaction shows the 
same behavior as the DNA-binding activity, i.e., the 
interaction surface is sequestered in the presence of 
the amino-terminal 55 residues. We could knock out 
the interaction between the amino-terminal domain 
and the oligomerization and helicase domain by gen-
erating a double point mutation in residues 112 and 
113. This double mutation, when introduced into the 
E155–605, restored the ability to form a DT complex. 
This result indicates that the defect in E155–605 is the 
result of an illegitimate interaction that results in 
faulty oligomerization. These results indicate that the 
amino-terminal domain most likely has a regulatory 
role in viral DNA replication, possibly by function-
ing as a negative regulator of viral DNA replication. 
This conclusion is supported by the in vivo phenotype 
of the 112/113 double mutation that results in greatly 
elevated replication of the viral genome.
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DNA REPLICATION AND CHROMATIN INHERITANCE
B. Stillman M. Hossain H. Kawakami S. Ni
 J. Jansen A. Mazurek Y.-J. Sheu
 N. Kara S. Nandi P. Wendel
Each human cell contains ~2 m of DNA in its ge-
nome, and ~2200 cells can fi t on top of a pinhead. 
When extracted, the DNA from these cells stretches 
to 4.5 km in length. These numbers indicate the na-
ture of the complex problem of copying genetic in-
formation each time a cell divides, making sure that 
DNA replication is both accurate and occurs only 
once per cell division. For 32 years at Cold Spring 
Harbor, this laboratory has been investigating the 
replication of DNA and associated chromatin struc-
tures and has identifi ed many of the key proteins that 
participate in the duplication of DNA. They include 
proteins at the DNA replication fork that cooperate 
to synthesize DNA and proteins that initiate the en-
tire process of genome duplication. This year, prog-
ress has been made on understanding how the ori-
gin recognition complex (ORC), an initiator protein 
we identifi ed 20 years ago, cooperates with Cdc6, 
Cdt1, and MCM2-7 proteins to form a prereplica-
tive complex on DNA and how it controls the initia-
tion of DNA replication. These studies also extend 
the function of ORC protein subunits in control of 
centrosome duplication that link to a rare recessive 
human syndrome called Meier-Gorlin syndrome. 
Other studies have identifi ed a new regulator of cell 
proliferation in some cancer cells that may be an ef-
fective therapeutic target for human cancer.
Origin Recognition Complex
ORC is a DNA-regulated ATPase containing six 
subunits that in yeast associate with each other dur-
ing the cell division cycle. ORC binds to origin DNA 
in the genome and forms a prereplicative complex 
(pre-RC) at these origins during the G1 phase of the 
cell division cycle, in cooperation with the Cdc6 
protein and Cdt1. Cdt1 is bound to a six-subunit, 
barrel-shaped hexamer containing the MCM2-7 
proteins, and this heptameric complex is topologically 
loaded onto double-stranded DNA by ORC-Cdc6 
ATPase proteins. In fact, two MCM2-7 hexamers are 
loaded per origin in yeast and they form a head-to-
head structure with double-stranded DNA passing 
through the middle of the barrels. Upon activation 
of DNA replication in S phase, at each origin, the 
MCM2-7 proteins bind other proteins, including 
Cdc45 and the GINS complex, to become an ac-
tive DNA helicase that unwinds the DNA in prepa-
ration for its replication. We have been investigating 
how this process  occurs and have collaborated with 
structural biologists Jingchuan Sun and Huilin Li at 
nearby Brookhaven National Laboratory, along with 
former postdoctoral fellow Christian Speck and his 
group at the MRC in London, to study the structure 
of various intermediates in the assembly of pre-RCs.
Previous cryo-electron microscope (EM) studies 
have determined the structure of ORC from yeast 
and ORC bound to DNA. The structure of an ORC-
Cdc6 complex bound to DNA was recently complet-
ed. The structure revealed that Cdc6 induces major 
structural changes in ORC, including the rotation 
of the amino terminus of Orc1 containing a bromo-
associated homology (BAH) domain to the back of 
the structure, allowing Cdc6 to enter. Cdc6 localizes 
next to the Orc1 subunit. Also adjacent to Orc1 is 
the Orc4 subunit, but it was too far from Orc1 to 
be capable of activating the Orc1 ATPase activity via 
a known arginine (R) fi nger. The ORC-Cdc6 com-
plex also bends the DNA, and we have shown that 
yeast ORC can induce supercoiling in DNA, analo-
gous to the supercoiling of DNA observed with Dro-
sophila ORC by other investigators. Thus, the ORC-
Cdc6 complex bound to DNA is primed to load the 
MCM2-7 hexamer, but additional structural changes 
are required.
In more recent studies, again in collaboration with 
Christian Speck and his colleagues in London and 
Jingchuan Sun and Huilin Li, a cryo-EM structure 
of ORC-Cdc6 bound to Cdt1 and MCM2-7 has 
shown that ORC and Cdc6 undergo further dra-
matic restructuring to form a helical, right-handed 
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structure with double-stranded DNA passing through 
the middle of the complex. The Cdt1-MCM2-7 com-
plex is bound to ORC-Cdc6 via the MCM2-7 car-
boxy-terminal ATPase domains, with their amino-
terminal collar ready to bind another MCM2-7 to 
form a double hexamer. What is remarkable about the 
structure of ORC and Cdc6 in this complex is that 
the right-handed spiral of the ORC-Cdc6 ATPase 
subunits formed a 34-Å helix with the same pitch 
as double-stranded DNA. This type of structure re-
sembles the right-handed spiral of replication factor C 
(RFC) ATPase that has primer-template DNA pass-
ing through its center. RFC is a fi ve-subunit ATPase 
that loads the ring-shaped PCNA (proliferating cell 
nuclear antigen) DNA polymerase clamp onto the 
primer-template DNA in preparation for it to activate 
DNA polymerase at a DNA replication fork. RFC 
and PCNA were discovered in this laboratory ~26 
years ago, and the X-ray crystallographic structure of 
the RFC-PCNA complex, determined by John Kuri-
yan, Mike O’Donnell, and colleagues, shows how an 
ATPase can open a ring-shaped protein to allow it to 
encircle double-stranded DNA. On the basis of the 
structure of the ORC-Cdc6 ATPase bound to Cdt1-
MCM2-7, it is likely that ORC-Cdc6 uses a similar 
ring-opening mechanism to load the MCM2-7 ring 
on DNA.
Biochemical studies using recombinant ORC, 
Cdc6, Cdt1, and MCM2-7 expressed in either baculo-
virus or Escherichia coli have shown that an assembled 
pre-RC can be activated in vitro to load Cdc45 and 
replication protein A (RPA), a single-stranded DNA-
binding protein, in the presence of extracts from cells 
arrested in S phase. These biochemical studies suggest 
that it will be possible to investigate the mechanism 
by which DNA synthesis starts at an origin of DNA 
 replication.
Previous studies by this laboratory demonstrated 
that Orc1, the largest subunit of the human ORC, 
controls centriole and centrosome duplication in a cy-
clin E/CDK2-dependent manner during the G1 phase 
of the cell division cycle. In the absence of Orc1, cen-
trioles and centrosomes reduplicate in the absence of 
ongoing DNA synthesis. Purifi ed Orc1 inhibited the 
kinase activities of both cyclin A/CDK2 and cyclin 
E/CDK2 enzymes, both of which were required for 
DNA replication and centriole and centrosome dupli-
cation. The ability of Orc1 to block cyclin A/CDK2 
activity was abrogated when a mutation in the Orc1 
Cy-motif (KRL) was made; however, cyclin E/CDK2 
inhibitory activity remained intact.
In the last year, bioinformatic analysis found that 
Orc1 has a centrosome localization signal sequence 
that is also found in pericentrin and the AKAP-450 or 
CGNAP proteins that are known to localize exclusive-
ly to centrosomes. The small bipartite sequence, called 
a PACT domain, localized to the carboxyl terminus 
of Orc1, was both necessary and suffi cient to localize 
green fl uorescent protein (GFP) to the centrosomes, 
indicating that it is an authentic centrosome localiza-
tion signal.
Also mapped within the Orc1 protein was the cyclin 
E/CDK2 and cyclin A/CDK2 inhibitory domain, 
and Orc1 was found to be localized to the amino ter-
minus of the protein that contained a previously char-
acterized BAH domain that interacts with dimethyl-
ated lysine 20 (K20) histone H4 in a nucleosome. By 
combining the CDK2 inhibitory domain (CID) with 
the PACT domain and removing most of Orc1 that is 
required for the initiation of DNA replication, the re-
combinant protein was able to localize to centrosomes 
and block hydroxyurea-induced centriole and centro-
some reduplication within a single cell division cycle. 
Both the PACT and the CID domains were required 
for blocking centriole and centrosome reduplication 
induced by inhibiting DNA replication with hydroxy-
urea.
A striking coincidence occurred because other in-
vestigators had mapped mutations in a human syn-
drome called Meier-Gorlin syndrome to genes encod-
ing components of the pre-RC, including ORC sub-
units, Cdc6, and Cdt1. This syndrome causes micro-
cephalic primordial dwarfi sm, a condition in which 
the patients are of very short stature and have propor-
tionally small head size and other abnormalities such 
as ear and patella developmental defects. For the most 
part, Meier-Gorlin syndrome patients have near-nor-
mal intelligence. Many patients had mutations in one 
of three different amino acids in the amino terminus 
of Orc1, and patients with these mutations had the 
shortest stature and smallest head size of all Meier-
Gorlin syndrome patients.
Orc1 Meier-Gorlin syndrome mutations were test-
ed for their ability to block cyclin A/CDK2 and cy-
clin E/CDK2 kinase activities. Most interesting was 
the R105Q mutant and, to some extent, the other two 
mutations, because it failed to inhibit cyclin E/CDK2 
kinase activity but retained the ability to block cyclin 
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A/CDK2 kinase activity. The mutations in Orc1 also 
failed to block hydroxyurea-induced centriole and cen-
trosome duplication in cells, correlating with the ability 
to inhibit cyclin E/CDK2 kinase activity.
Because Meier-Gorlin syndrome mutations in Orc1 
also localized to the BAH domain, they were tested for 
the ability to bind to dimethylated K20 histone H4 
peptides. All were able to do so within twofold of the 
wild-type sequence. Thus, although other investigators 
have suggested that Meier-Gorlin syndrome mutations 
cause short stature and small head size due to defects in 
binding histone H4 K20 dimethyl residues, evidence 
for this conclusion is lacking. In contrast, the new data 
suggest that the severe short stature of Meier-Gorlin 
syndrome patients with an Orc1 mutation is a result of 
defects in both DNA replication and centrosome and 
centriole duplication. Furthermore, the altered regu-
lation of centriole and centrosome duplication could 
cause defects during mitosis in proliferating cells or 
excessive duplication of centrioles that form the basal 
bodies in cells that form cilia.
The study of Meier-Gorlin syndrome mutations 
has implications for the regulation of tissue size and 
shape in humans. These patients are short and have 
proportionally small head and, hence, brain size, as 
well as other tissues and organs that are in proportion. 
These observations suggest that the mechanisms that 
form tissue size and shape must be coordinated with 
the ability of the cells to proliferate.
DDX5, a Regulator of Cell Proliferation 
in Cancer Cells
As part of a project to identify new participants and 
regulators of the initiation of DNA replication in 
human cells, an RNA interference (RNAi) screen 
was used to discover new proteins that either partici-
pate in or regulate DNA replication in human cells. 
These studies resulted in the observation that inhibi-
tion of either RPA or ribonucleotide reductase (RNR) 
in cancer cells provided the most potent inhibition of 
cell proliferation of all genes tested. Because RNAi has 
revolutionized loss-of-function genetics by enabling 
sequence-specifi c suppression of virtually any gene, 
and because tetracycline response elements (TREs) can 
drive expression of short hairpin RNAs (shRNAs) 
for inducible and reversible target gene suppression, 
we collaborated with Scott Lowe’s group to develop 
mice that had regulated and reversible inhibition of 
essential genes using RPA3, the smallest subunit of 
RPA, as the test gene. The feasibility of transgenic 
inducible RNAi for suppression of essential genes 
was demonstrated directly by targeting expression 
of RPA3 shRNAs to all tissues in mice. Transgenic 
mice were generated with TRE-driven RPA3 shR-
NAs, whose expression enforced a reversible cell cycle 
arrest. In adult mice, the block in cell proliferation 
caused rapid atrophy of the intestinal epithelium that 
led to weight loss and lethality within 8−11 days of 
shRNA induction. Upon shRNA withdrawal, villus 
atrophy and weight loss were fully reversible. Thus, 
shRPA3 transgenic mice provided an interesting tool 
to study tissue maintenance and regeneration. These 
collaborative studies developed a robust system that 
serves the purpose of temperature-sensitive alleles in 
other model organisms, enabling inducible and re-
versible suppression of essential genes in a mamma-
lian system in vivo.
During the shRNA screen for genes that encode 
proteins controlling DNA replication, a new role for 
the DEAD-box RNA helicase enzyme DDX5 in G1-
to-S phase progression was uncovered. DDX5 was 
found to regulate directly DNA replication factor 
expression by promoting the recruitment of RNA 
polymerase II to E2F-regulated gene promoters. In 
collaboration with Scott Powers, Alex Krasnitz, and 
other investigators, it was shown that the DDX5 
locus was amplifi ed in ~25% of breast cancers and 
that breast-cancer-derived cells with amplifi cation of 
DDX5 were much more sensitive to DDX5 deple-
tion than breast cancer cells and a breast epithelial 
cell line that lacked DDX5 amplifi cation. Indeed, 
inhibition of DDX5 in cells that lacked DDX5 am-
plifi cation did not affect cell proliferation. The re-
sults demonstrated a new role for DDX5 in cancer 
cell proliferation and suggest DDX5 as a therapeutic 
target in breast cancer treatment. To test whether 
depletion of DDX5 in adult animals might cause a 
problem if an antagonist of DDX5 activity were to 
be used for cancer treatment, mice expressing regu-
lated DDX5 shRNAs in all tissues were made. Upon 
addition of the inducer of the shRNAs that inhibit 
DDX5 expression, the level of the protein in bone 
marrow, small intestine, liver, and kidney decreased 
by up to 90%, and in tissues such as the heart and 
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lung, DDX5 expression decreased by 50%. Never-
theless, extensive pathology analysis of these mice by 
collaborator Dr. John Erby Wilkinson at the Uni-
versity of Michigan demonstrated that they lacked 
any side effects of inhibition of DDX5 in normal 
tissues.
As part of a survey to determine whether DDX5 in-
hibition might affect other cancers, it was found that 
inhibition of DDX5 kills human and mouse leukemia 
cells—specifi cally, a very lethal form of acute myeloid 
leukemia (AML). Unlike breast cancer cells, block-
ing DDX5 in leukemia cells caused apoptosis. DDX5 
inhibition did not affect normal blood cell biology. 
Interestingly, DDX5 did not control E2F1-regulated 
genes in these leukemia cells. Using a mouse model for 
AML developed in Scott Lowe’s laboratory and regu-
lated shRNAs that control DDX5 gene expression, it 
was found that depletion of DDX5 promotes survival 
of the mice with this lethal form of leukemia. Coupled 
with the observation that DDX5 inhibition did not 
cause problems in normal tissues, these studies sug-
gest that drugs that block DDX5 activity may be a safe 
and effective cancer therapy.
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MECHANISTIC STUDIES OF THE CHROMATIN 
AND TRANSCRIPTIONAL REGULATORY MACHINERIES 
IN HEMATOLOGICAL MALIGNANCIES
C.R. Vakoc A. Bhagwat S. Kawaoka J. Molazzo J. Roe J. Shi
 A. Hohmann F. Mercan K. Palacios-Flores C. Shen E. Wang 
Chromatin, composed of DNA in complex with pro-
tein, is the fundamental packaging system for eu-
karyotic genomes. The basic organizational unit of 
 chromatin is the nucleosome, composed of an octam-
er of core histones (H2A, H2B, H3, and H4) wrapped 
by 147 bp of DNA. In addition to protecting the ge-
netic code from genotoxic insult, the structure of chro-
matin has a profound impact on all DNA-templated 
processes, including transcription, DNA replication, 
and recombination. Hence, an elaborate regulatory 
system has evolved to animate chromatin structure 
in the wake of such fundamental cellular activities. 
Two principal categories of chromatin regulators are 
the enzymes (e.g., acetyltransferases, deacetylases, 
methyltransferases, and demethylases) and the reader 
domain-containing proteins (e.g., bromodomains, 
chromodomains, and PHD domains). 
The central long-term goal of research performed 
in our lab is to explore the mechanistic basis of chro-
matin regulation and how it relates to the control 
of gene transcription. We have had a long-standing 
interest in the relationship between DNA-binding 
“master-regulatory” transcription factors and the 
chromatin regulatory machinery, and how this in-
terplay governs cell-fate programs. The biological 
context in which we study chromatin is in the he-
matopoietic system, where a hierarchically organized 
cell lineage program is specifi ed in large part by 
transcriptional regulators. In addition, studying the 
hematopoietic system affords a number of powerful 
biochemical as well as genetic tools for evaluating 
chromatin and transcription in vivo and ex vivo. An 
approach taken by our laboratory for studying tran-
scriptional/chromatin regulators has been to com-
pare their action under normal physiologic settings 
with their role under pathologic conditions, which 
can deviate demonstrably from the cellular context 
under which these components evolved. As an ex-
ample, normal tissues in vivo generally possess robust 
gene regulatory networks, such that redundancy in 
gene function can exist under laboratory conditions, 
which can often obscure studies of molecular mecha-
nisms. In contrast, in aberrant disease states that de-
viate from normal homeostasis, the nonredundant 
function of specifi c regulators can often emerge, thus 
enabling unique insight into gene function. In addi-
tion, studying the action of chromatin regulators in 
the pathophysiology of disease affords opportunities 
to translate laboratory observations into biomedi-
cal applications, as will be illustrated below. To this 
end, we have spent the last several years working to 
investigate the function of chromatin regulators in 
the setting of hematopoietic cancer—specifi cally, 
the disease acute myeloid leukemia (AML). Interest-
ingly, the hematopoietic cell-lineage transcriptional 
program is often corrupted during leukemogenesis, 
frequently by direct somatic mutation of transcrip-
tion factors and chromatin components. The result of 
this deregulation is an acquired inability of myeloid 
progenitor cells (a type of white blood cell) to com-
plete terminal differentiation into macrophages and 
neutrophils, thereby gaining the capability of infi nite 
self-renewal normally only seen in stem cells. We seek 
to understand how chromatin regulators directly par-
ticipate in this unique pathophysiology of AML. Re-
search in our laboratory investigates how chromatin 
regulators are integrated within the oncogenic signal 
transduction cascades that drive cancer cell growth.
Our principal focus is on acute myeloid and  lymphoid 
leukemias, with an expanding interest in epithelial tu-
mors. To this end, we use genetically engineered mouse 
models of cancer that recapitulate the cardinal fea-
tures of the human disease, particularly with respect 
to therapeutic response. We have had an interest in the 
mixed-lineage leukemia (MLL) proto-oncogene and its 
leukemogenic MLL-fusion protein derivatives. MLL is 
both a “writer” and a “reader” of histone H3 lysine 4 
(H3K4) methylation: Its SET domain catalyzes H3K4 
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methylation and its third PHD domain binds to H3K4 
methylation. In leukemia, MLL is mutated via chromo-
somal translocation to form fusion proteins with cor-
rupted chromatin regulatory functions. We previously 
identifi ed how MLL uses its unique chromatin-binding 
activity to perpetuate active chromatin states through 
mitosis, a function called mitotic bookmarking. We 
continue to investigate molecular mechanisms used by 
MLL and MLL-fusion proteins to regulate transcrip-
tion in normal and transformed cell contexts. 
Through a genetic screen, we recently identifi ed 
the BET bromodomain protein BRD4 as a critical 
vulnerability in AML. BRD4 is a chromatin reader 
protein that uti lizes its tandem bromodomains to rec-
ognize acetylated forms of histone H3 and H4. We 
found that BRD4 functions as a critical upstream 
regulator of c-MYC expression, thereby sustaining 
aberrant self-renewal in leukemia. Remarkably, our 
work coincided with the development of potent small-
molecule inhibitors of BET bromodomains. Using 
these agents, we pharmacologically validated BRD4 
inhibition as a therapeutic strategy in a host of pre-
clinical animal models of leukemia, fi ndings that are 
now being translated into clinical development. Our 
lab continues to investigate the BRD4 pathway as a 
major chromatin-based signaling cascade that sustains 
c-MYC in hematopoietic malignancies. In addition, 
our genetic screening approach has revealed a plethora 
of chromatin-regulator vulnerabilities in many cancer 
types, fueling our continued efforts to understand 
and exploit these factors as candidate drug targets in 
human disease.
Role of Brd4 in Leukemia Maintenance
C. Shen, J. Shi, K. Palacios-Flores
Although prior studies in our lab have validated Brd4 
as a novel drug target in leukemia, the mechanistic 
basis for this observation remains poorly understood. 
In particular, a major unanswered question in the 
fi eld is why Myc transcription is hypersensitive to 
BRD4 inhibition. Our efforts in this area have fo-
cused in three major areas. First, we have taken an 
epigenomic approach toward understanding BRD4 
in leukemia cells, which has involved performing ge-
nome-wide location analysis of BRD4 occupancy in 
leukemia chromatin. One remarkable observation from 
this effort has been the realization that Myc harbors 
 leukemia-specifi c enhancers that harbor profound lev-
els of BRD4 occupancy. Chromosome conformation 
capture studies have verifi ed that this enhancer region 
is looped into close proximity with the Myc gene, 
thereby placing BRD4 at a site of enhancer-promoter 
contact. Our studies suggest that this enhancer is the 
genomic platform through which BRD4 communi-
cates with Myc, a function that can be interrupted 
with drug-like BRD4 inhibitors. A second major area 
of research has been to characterize BRD4-containing 
protein complexes to identify critical interacting part-
ners. We have carried out immunoprecipitation mass 
spectroscopy of BRD4 and identifi ed several enriched 
partners. One of these is the SET/PWWP domain-
containing protein NSD3. NSD3 interacts with the 
ET domain of BRD4 and is likewise essential for self-
renewal of leukemia cells. Ongoing work seeks to un-
derstand the mechanistic basis of functional collabo-
ration between BRD4 and NSD3. A third area of in-
vestigation in our laboratory is to defi ne a broader net-
work of genetic interactions of BRD4 through small 
hairpin RNA (shRNA) screening. This has involved 
identifying synthetic lethal interactions combining 
shRNA-based gene knockdown in concert with expo-
sure to small-molecule BRD4 inhibitors. The unify-
ing goal of these three efforts is to fully understand 
the mechanistic basis of BRD4 addiction in leukemia, 
such that therapeutic effi cacy of BRD4 inhibitors can 
be maximized in cancer patients.
The Chromatin Remodeling BAF Complex 
as a Mediator of Aberrant Self-Renewal 
in Leukemia
J. Shi, A. Hohmann
Efforts to understand the role of Brd4 in leukemia has 
led to the realization that leukemia-specifi c enhancer 
elements are potential hot spots of intervention for in-
terfering with aberrant self-renewal programs in leu-
kemia. Hence, we seek to identify enhancer-binding 
proteins that enable aberrant self-renewal in leukemia. 
One such factor is the ATPase/bromodomain-con-
taining protein BRG1, which we identifi ed through 
shRNA screens in search of leukemia-specifi c epigen-
etic vulnerabilities. We have found that BRG1 is a key 
factor that acts to sustain Myc expression in leukemia. 
Suppression of BRG1 leads to severe antileukemia ef-
fects in vitro and in vivo with minimal proliferation 
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effects in heterologous cell types. AML cells defi cient 
in BRG1 undergo terminal myeloid differentiation as 
a consequence of failing to maintain Myc transcrip-
tion. Notably, forced expression of Myc can rescue the 
majority of phenotypes incurred upon BRG1 inhibi-
tion. Similar phenotypes are also observed upon sup-
pression of several subunits of the BRG1-containing 
BAF complex. Furthermore, we detect a physical in-
teraction between the BAF complex and the ET do-
main of BRD4, suggesting that these factors might be 
functional partners on chromatin. Consistent with 
this notion, we fi nd that BRG1 and BRD4 colocalize 
on chromatin on a genome-wide scale, as revealed by 
chromatin immunoprecipitation-sequencing (ChIP-
Seq). This includes novel distal enhancer elements 
downstream from Myc, genomic regions that might 
impart a leukemia-specifi c reliance on both factors for 
Myc expression. Importantly, BRG1 and BRD4 stabi-
lize occupancy of one another at Myc enhancer regions 
and enable long-range enhancer-promoter looping 
interactions. Together, these fi ndings implicate col-
laboration between BRD4 and the BRG1-associated 
BAF complex as a critical regulatory interaction that 
sustains Myc transcription in the context of leukemo-
genesis, regulatory functions that can be targeted by 
small-molecule bromodomain inhibitors.
Dissecting the Interplay between 
Lysine Acetyltransferases and 
Bromodomain-Containing Proteins
J. Roe
Bromodomains are an emerging class of candidate 
drug targets in oncology. Hence, a major effort in 
our lab is to pinpoint the bromodomain vulnerabili-
ties in all cancers. However, since bromodomains en-
gage in acetyl-lysine recognition, a major unanswered 
question is regarding the nature of enzymatic lysine 
acetylation in cancer cells and how this might pro-
gram bromodomain functions. As ~20 different lysine 
acetyltransferases (KATs) are known to exist in hu-
mans, we seek to explore whether specifi c KATs are 
functionally tied to specifi c bromodomain proteins. 
Moreover, because KATs utilize acetyl-CoA as a meta-
bolic cofactor, we ultimately seek to determine whether 
histone acetylation is connected in some fashion to the 
cancer- promoting metabolic program. Through ge-
netic screens, we have pinpointed four KATs involved 
in leukemia pathogenesis. Ongoing genetic and bio-
chemical studies aim to explore the biological func-
tions of KATs in leukemia and the pathways they 
regulate.
Investigation of Transcription Factor-
Coactivator Interactions
A. Bhagwat, F. Mercan
Leukemia-specifi c enhancer elements are likely to be 
organized by sequence-specifi c transcription factors 
(TFs) that establish long-range enhancer to promoter 
communication. We have recently initiated projects 
in the lab to identify novel TFs that support leuke-
mogenesis. This is occurring through both unbiased 
genetic screens of known DNA-binding proteins and 
bioinformatic analysis of enhancer motifs that are ac-
tively engaged in leukemia cells. On the basis of the 
fi ndings described above, we hypothesize that target-
ing of chromatin regulators such as BRD4 is essen-
tially a means of disrupting enhancer function. To 
complement our efforts on chromatin regulators, we 
are now investigating additional coactivator complex-
es (Mediator, TAFs) and whether they also participate 
in transcriptional regulatory circuits that support leu-
kemia proliferation. The major goal of these studies is 
to pinpoint specifi c TF−coactivator interactions that 
are unique to leukemia maintenance.
Identifying Epigenetic Vulnerabilities 
in Therapy-Resistant Acute Lymphoblastic 
Leukemia
S. Kawaoka
We have recently extended our epigenetic screening 
platform into the aggressive blood cancer acute lym-
phoblastic leukemia of B-cell origin (B-ALL). This 
disease model is driven by the BCR-ABL oncogene and 
is associated with a dismal prognosis. We evaluated 
the role of all chromatin regulators in the proliferation 
of these leukemia cells and have pinpointed a TRIM 
domain containing protein in the pathogenesis of this 
disease. This TRIM protein acts to support survival 
of B-ALL cells largely by repressing tissue-specifi c 
enhancer function. Notably, knocking down expres-
sion of TRIM has minimal effects on heterologous 
cell types. We have recently completed genome-wide 
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studies evaluating chromatin occupancy of TRIM in 
B-ALL and are expanding these studies into other cell 
lineages. From this work, we hope to gain a general 
model for how TRIM governs leukemia-specifi c tran-
scriptional regulation.
Histone H2B Ubiquitin Ligase RNF20 
as an Oncogenic Cofactor for MLL 
Fusion Proteins
E. Wang
MLL-fusions are potent oncogenes that initiate ag-
gressive forms of acute leukemia. As aberrant tran-
scriptional regulators, MLL-fusion proteins alter 
gene expression in hematopoietic cells through in-
teractions with the histone H3 lysine 79 (H3K79) 
methyltransferase DOT1L. Notably, interference with 
MLL-fusion cofactors such as DOT1L is an emerging 
therapeutic strategy in this disease. We have identi-
fi ed the histone H2B E3 ubiquitin ligase RNF20 as 
an additional chromatin regulator that is necessary for 
MLL-fusion-mediated leukemogenesis. Suppressing 
the expression of Rnf20 in diverse models of MLL-
rearranged leukemia leads to inhibition of cell pro-
liferation, under tissue culture conditions as well as 
in vivo. Rnf20 knockdown leads to reduced expression 
of MLL-fusion target genes, including Hoxa9 and 
Meis1—effects resembling Dot1l inhibition. Using 
ChIP-Seq, we found that H2B ubiquitination (H2Bub) 
is enriched in the body of MLL-fusion target genes, 
correlating with sites of H3K79 methylation and tran-
scription elongation. Furthermore, Rnf20 is required 
to maintain local levels of H3K79 methylation by 
Dot1l at Hoxa9 and Meis1. These fi ndings support a 
model whereby cotranscriptional recruitment of Rnf20 
at MLL-fusion target genes leads to amplifi cation of 
Dot1l-mediated H3K79 methylation, thereby render-
ing leukemia cells dependent on Rnf20 to maintain 
their oncogenic transcriptional program.
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Gregory Hannon is a pioneer in the study of RNA interference (RNAi), a process in which dou-
ble-stranded RNA molecules induce gene silencing. Hannon and colleagues have elucidated key 
elements of the RNAi machinery. This past year, both the structure of human Argonaute 2 bound 
to a microRNA (miRNA) guide and the structure and function in fruit fl ies of the key PIWI-
interacting RNA (piRNA) nuclease Zucchini were solved in collaboration with the Joshua-Tor lab. 
In addition, the Hannon lab has led the way in using RNAi to study cancer biology and genetics, 
generating libraries of short-hairpin RNAs that have been widely applied in gene silencing studies. 
During the past several years, the Hannon lab has focused on roles of small RNAs in germ cells, 
which tend to have the most elaborate set of small RNA pathways of any cell type. They have 
discovered an essential role for pseudogenes in producing small RNAs that are critical for proper 
oocyte development and an elegant small RNA-based immune system that guards the genome 
against transposable elements. The Hannon lab also strives to understand the biology of cancer 
cells, with a focus on breast and pancreatic cancer. They are exploring the roles of small RNAs 
as oncogenes and tumor suppressors and in exploiting the RNAi libraries they have developed to 
identify new therapeutic targets for specifi c disease subtypes. Additionally, they are taking genetic 
approaches to understand the biology of resistance to currently used targeted therapies. Another 
research thrust of Hannon’s team exploits the power of next-generation sequencing to understand 
the biology of the mammalian genome. Their efforts range from the identifi cation of new classes 
of small RNAs to understanding human evolution and diversity. In the last year, they have placed 
a major emphasis on the evolution of the epigenome and its role in driving cell-fate specifi cation.
Robert Lucito has had an important role along with Michael Wigler in developing innovative 
technologies, including RDA, ROMA, MOMA, and CGH, that have proven valuable to cancer 
researchers worldwide. As an experimentalist, Lucito conducts studies using these techniques to 
detect copy-number changes in large sets of human ovarian and pancreatic cancer tissue sam-
ples. His lab also has turned its attention to epigenetics, specifi cally to the study of methylation 
throughout the genome. When methyl groups in suffi cient numbers attach to cytosine bases in 
DNA, the packing of DNA into the chromosomes can be altered, reducing the levels at which the 
methylated genes are expressed. Under circumstances that Lucito is exploring, this may be a means 
by which normally protective tumor suppressor genes are turned off, rendering cells tumorigenic.
Alea Mills is studying genetic pathways important in cancer, aging, and autism, identifying the 
genetic players and determining how aberrations in their functions culminate in human dis-
ease. Through innovative use of a technique called “chromosome engineering,” the Mills group 
 discovered that one of the most common genetic alterations in autism—deletion of a 27-gene clus-
ter on chromosome 16—causes autism-like features in mice. This year, they showed that autism-
like movement impairments can be identifi ed just days after birth, suggesting that these features 
could be used to diagnose autism. Previously, Mills used chromosome engineering to identify a 
tumor suppressor gene that had eluded investigators for three decades. The gene, called Chd5, was 
shown by Mills to regulate an extensive cancer-preventing network. The epigenetic role of Chd5 
in development, cancer, and stem-cell maintenance is currently being investigated. The Mills lab 
is also studying p63 proteins, which regulate development, tumorigenesis, cellular senescence, and 
aging in vivo. They succeeded in halting the growth of malignant tumors by turning on produc-
tion of one of the proteins encoded by the p63 gene, called TAp63. They recently discovered that 
a different version of p63, called ΔNp63, reprograms stem cells of the skin to cause carcinoma 
development—the most prevalent form of human cancer. Modulation of these proteins may offer 
new ways to treat human malignancies in the future.
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Scott Powers’ work focuses on gene mutations that cause cancer and factors that infl uence respons-
es to specifi c anticancer drugs. His lab uses technologies that probe the entire genome to identify 
candidate cancer genes and evaluate their functional role in cell transformation and tumor biol-
ogy. They also use whole-genome technologies to guide development of novel cancer diagnostics 
and therapeutics. Using DNA copy-number analysis, the Powers group pinpoints novel amplifi ed 
oncogenes and then applies functional studies to address the validity of candidate genes and the 
mechanisms by which they are implicated in oncogenesis. They have successfully applied this ap-
proach in liver, colon, and lung cancer. This past year, Powers and colleagues identifi ed a strategy 
for targeted molecular therapy in liver cancer based on tumor dependency on amplifi cation of the 
FGF19 oncogene. Powers has also had an important role in the development of a distinctive CSHL 
approach to functional study of cancer genes. Called integrative oncogenomics, it is a rapid, large-
scale screen for genes that are deleted or amplifi ed in human cancers and suspected of being tumor 
suppressors, in the case of deletions, or oncogenes, in the case of amplifi cations.
Michael Wigler, with James Hicks and Alex Krasnitz among others, studies human cancer and 
genetic disorders from a population genomics perspective. The cancer effort focuses on breast and 
prostate cancer (the latter jointly with Lloyd Trotman) and involves collaborative clinical studies 
(with local, national, and international collaborators) to discover mutational patterns predicting 
treatment response and outcome. The lab also develops methodology for single-cell genomic and 
RNA analysis, to detect cancer cells in bodily fl uids such as blood and urine. This last has major 
potential applications to the early detection of cancer and monitoring its recurrence and response 
to therapy during and after treatment. Single-cell analysis has also led to insights about the clonal 
evolution and heterogeneity of cancers and may lead to a better understanding of initiation, pro-
gression, and metastasis. In collaboration with Scott Lowe, now at Memorial Sloan-Kettering 
Cancer Center, they recently showed that tumor suppressor genes are often clustered in large re-
gions that are deleted in common cancers. The single-cell methods are also being applied to prob-
lems in neurobiology (with Josh Huang and Pavel Osten) and differentiation (with Chris Vakoc). 
The Wigler lab’s genetic efforts are a collaboration with Ivan Iossifov and Dan Levy of Quantita-
tive Biology at CSHL, and they are largely focused on determining the role of de novo mutation in 
pediatric disorders. They participate in a large study of autism organized by the Simons Founda-
tion and also study congenital heart disease and pediatric cancers with collaborators at Columbia 
University and Memorial Sloan-Kettering Cancer Center, respectively. In collaboration with Alea 
Mills, they helped create a mouse model for one of the most common genetic abnormalities con-
tributing to autism. Recent work has confi rmed and extended the team’s previous observations on 
the role of de novo copy-number variation in autism, with similar results in the other disorders. In 
a large-scale exome sequencing project with W. Richard McCombie and the Genome Sequencing 
Center at Washington University in St. Louis, the team has proven the contribution of small-scale 
de novo mutations to autism. Overall, results confi rm their previous genetic models for autism 
incidence. This study also uncovered a striking link between the gene that causes fragile-X syn-
drome, FMR1, and those regulated by it that are implicated in autism.
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RNA INTERFERENCE MECHANISMS AND APPLICATIONS
G. Hannon M. Andres Terre B. Czech P. Guzzardo E. Lee N.V. Rozhkov
 M. Baer M.J. Delas Vives A. Haase Y. Luo S. Shaw
 G. Battistoni C. Dos Santos J. Hahn M. Malave V. Vagin
 S. Boettcher N. Erard E. Harrison K. Marran E. Wagenblast
 D. Bressan D. Fagegaltier E. Hodges A. Molaro Y. Walle
 A. Canela I. Falciatori F. Karginov F. Muerdter K. Wasik
 K. Chang S. Fenoglio S. Knott J. Preall X. Zhou
 S. Chen W.S. Goh M. Kudla F. Rollins
Our lab continues to focus on three distinct areas. First, 
we study RNA biology, with a focus on noncoding 
RNAs. In particular, we are interested in a conserved 
pathway that protects animal germ cell genomes 
against parasitic genetic elements. Second, we study 
the roles of noncoding RNAs in cancer, mainly breast 
cancer, and use small RNAs as tools to uncover tumor-
specifi c vulnerabilities as potential therapeutic targets. 
Third, we develop technologies, mainly in the areas of 
mammalian genetics and genomics. Historically, we 
have had a particular focus on using next-generation 
sequencing to study epigenetic regulation, to identify 
disease-associated genes, and to help in the establish-
ment of new model organisms.
We said goodbye to a number of labmates this year. 
Ted Karginov accepted a position as an Assistant Pro-
fessor at the University of California, Riverside. Sev-
eral master’s and undergraduate students spent time in 
the group and then moved on to other positions. These 
include Rebecca Behrens, who joined Wolf Reik’s lab 
as a Ph.D. student; our URPs, Sarah Andersen, Abigail 
Samuels, and Francesca Aloisio, who returned to com-
plete their undergraduate degrees; and Sai Chen, who 
joined the University of Michigan Ph.D. program. Ben 
Czech received his Ph.D. from Tubingen and chose to 
return to the lab as a postdoctoral fellow. Nicholas 
Erand, who spent time with us during his master’s, 
will also return as a Ph.D. student. Giorgia Battistoni, 
who also spent part of her thesis here, will return as 
a WSBS student in the fall. Several technicians also 
left the lab, including Michael Baer for  another po-
sition and Youngjoo Yang and Christine Peterson to 
join Ph.D. programs. Joaquina Delas Vives joined the 
lab as a WSBS student. Poppy Gould came to work 
for a time during her undergraduate thesis and will 
leave us this fall to also join Wolf Reik’s lab in Cam-
bridge. Ashley Maceli, a former URP, returned as a 
technician. A selected set of laboratory projects are 
described in detail below.
The Structural Biochemistry of Zucchini 
Implicates It as a Nuclease in piRNA 
Biogenesis
A.D. Haase, S.R. Knott [in collaboration with J. Ipsaro 
and L. Joshua-Tor, Cold Spring Harbor Laboratory]
PIWI-family proteins and their associated small RNAs 
(piRNAs) act in an evolutionarily conserved innate 
immune mechanism that provides an essential protec-
tion for germ cell genomes against the activity of mo-
bile genetic elements. piRNA populations constitute a 
molecular defi nition of transposons that permits them 
to be distinguished from host genes and selectively si-
lenced. piRNAs can be generated in two distinct ways. 
Primary piRNAs emanate from discrete genomic loci, 
termed piRNA clusters, and appear to be derived 
from long, single-stranded precursors. The biogenesis 
of primary piRNAs involves at least two nucleolytic 
steps. An unknown enzyme cleaves piRNA cluster 
transcripts to generate monophosphorylated piRNA 
5′ ends. piRNA 3′ ends are likely formed by exonu-
cleolytic trimming, after a piRNA precursor is loaded 
into its PIWI partner. Secondary piRNAs arise dur-
ing the adaptive ping-pong cycle, with their 5′ termini 
being formed by the activity of PIWIs themselves. A 
number of proteins have been implicated genetically 
in primary piRNA biogenesis. One of these, Zucchini, 
is a member of the phospholipase D family of phos-
phodiesterases, which includes both phospholipases 
and nucleases. We have produced a dimeric, soluble 
fragment of the mouse Zucchini homolog (mZuc/
PLD6) and have shown that it possesses single-strand-
specifi c nuclease activity. A crystal structure of mZuc 
068-091_CancerGenet.indb   70 9/17/2013   8:24:42 AM
Cancer: Genetics  71
at 1.75-Å resolution indicates greater architectural 
similarity to PLD family nucleases than to phospholi-
pases. Considered together, our data suggest that the 
Zucchini proteins act in primary piRNA biogenesis as 
nucleases, perhaps generating the 5′ ends of primary 
piRNAs.
A Genome-Wide RNAi Screen Draws a 
Genetic Framework for Transposon Control 
and Primary piRNA Biogenesis in Drosophila
P.M. Guzzardo, F. Muerdter
piRNAs, together with Piwi-clade Argonaute proteins, 
constitute an evolutionary conserved, germline-specifi c 
small RNA silencing system. The piRNA pathway is 
implicated in gene silencing, particularly of repeti-
tive elements, as well as germline differentiation, and 
maintenance of germline stem cells. Accordingly, mu-
tations in Piwi almost universally lead to sterility and 
germ cell loss. In Drosophila melanogaster, primary 
piRNA biogenesis involves the processing of a pri-
mary transcript into mature small RNAs by factors 
that remain elusive. To search for proteins involved in 
biogenesis or downstream effector pathways, we per-
formed a comprehensive genome-wide RNAi screen of 
more than 40,000 double-stranded RNAs (dsRNAs) 
in a cell line derived from Drosophila ovaries. We iden-
tifi ed and validated 87 genes required for transposon 
silencing. We revealed novel piRNA biogenesis fac-
tors and placed previously unknown proteins at the 
effector step of the pathway. In addition, by validating 
a large subset of the candidate hits in vivo, we dem-
onstrated the strength and relevance of the primary 
data set. This study provides not only an important 
resource for the scientifi c community, but also a solid 
foundation on which future research can be built.
Structural Variations of the Genome 
in Breast Cancer
A. Canela
Structural variations including copy-number polymor-
phisms (CNV), as well as insertions, inversions, and 
translocations, have an important role in tumor develop-
ment. The mutagenic effects of translocations have long 
been seen as critical to the development of hematological 
malignancies, where the fusion genes, generated when 
the translocation joins two otherwise separated genes, 
are both drivers and indicators of tumor phenotype and 
clinical outcome. Recently, technological advances have 
allowed genome-scale analysis of rearrangements also in 
several epithelial cancers, and an increasing number of 
fusion genes have been reported. We study structural 
variation in breast cancer cells at a single-base resolution 
level by next-generation sequencing. As a fi rst approach, 
we focused in regions previously characterized by com-
parative genomic hybridization (CGH) containing co-
py-number variation as landmarks for identifying com-
plex chromosomal rearrangements. We purifi ed these 
regions in breast cancer cell lines by array-based ge-
nomic capture and deciphered them by sequencing the 
precise structure of genomic rearrangements, which led 
to detection of copy-number loss and gain in the CGH 
(in collaboration with the Wigler and Krasnitz labora-
tories at CSHL). Because not all the areas of CNV may 
contain complex chromosomal rearrangements, we used 
an unbiased approach featuring large-fragment genomic 
libraries as “jumping libraries” to scan by sequencing 
the whole genome for structural variation events. Com-
bining large-fragment genomic libraries with sequenc-
ing techniques at the transcriptome level (RNA-Seq), 
used to discover novel transcribed gene fusions, we have 
identifi ed 72 fusion gene candidates in a panel of Lumi-
nal A breast cancer cell lines. To assess the relevance of 
these fusion genes as driver mutations in breast cancer, 
we are evaluating their presence and frequency in clini-
cal samples in collaboration with Winthrop-University 
Hospital. In parallel, we are investigating whether these 
rearranged genes contribute to tumorigenesis through a 
functional approach using RNA interference (RNAi). 
RNAi screens will identify genes acting either as onco-
genes or tumor suppressors in the chromosomal rear-
rangements using the panel of Luminal A breast cancer 
cell lines and normal mammary cells. These approach-
es will reveal the importance of structural variation in 
breast cancer and will guide the design of diagnostic 
and therapeutic tools.
Investigating the Evolution and Inheritance 
of Epigenetic Reprogramming in Mammals
A. Molaro, E. Hodges, I. Falciatori, K. Marran [in collaboration 
with A. Smith, University of Southern California]
Germ cells (sperm and oocytes in mammals) lie at 
the core of heredity. Each generation they transmit 
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genetic and epigenetic (e.g., DNA methylation) in-
formation necessary to ignite a new cycle of organis-
mal growth and development. Hence, the germ cell 
genome and epigenome are under constant monitor-
ing during their maturation.
We have established the single CpG dinucleotide 
reference methylomes of developing germ cells. In 
the context of this study, we have characterized the 
dynamics of de novo methylation establishment, es-
pecially over retrotransposable elements, which are 
dependent on this modifi cation for their silencing. We 
have found that following a complete erasure of all 
epigenetic marks, a fi rst wave of default de novo meth-
ylation precedes an active wave mediated by piRNAs 
(A. Molaro et al., in prep.). However, thousands of 
repeat copies escape both of these events and are trans-
mitted in a hypomethylated state to the next genera-
tion. Interestingly, when conserved, a subset of these 
copies constitutes species-specifi c epialleles (e.g., SVA 
elements between humans and chimpanzees (Molaro 
et al., Cell 146: 1029 [2011]). These repeat copies 
have divergent regulatory sequences and display lower 
expression levels during germ cell maturation when 
compared to their piRNA-targeted counterpart. To 
gain a better understanding of the evolutionary events 
that have led to these features, we extended our pre-
vious analysis of human and chimpanzee sperm to 
gorilla and bonobo. Two to three times average in-
dependent CpG coverage methylome libraries were 
generated and assembled over the recently published 
reference genomes of these two primates. We are cur-
rently comparing these four ape sperm methylomes 
to ascertain whether changes in regulatory sequences 
are preceding or following differential epigenetic re-
programming. We will also provide an unprecedented 
insight into the ongoing mutual canalization between 
the genome and epigenome during speciation. In ad-
dition, using mouse models, we have extended our ge-
nome-wide epigenetic road maps to other chromatin 
features. In particular, using newly described surface 
markers, we isolated hundreds of thousands of pri-
mordial germ cells and subjected them to nucleosome 
footprinting. This will help elucidate understanding 
the sequence of changes in chromatin structure lead-
ing to retrotransposon reactivation and silencing dur-
ing germ cell maturation. It will also emphasize the 
connection between nucleosome positioning and de 
novo DNA methylation over regions that are naturally 
protected from reprogramming (e.g., gene promoters).
A Transcriptome-Wide RNAi Screen in the 
Drosophila Ovary Reveals Novel Factors 
of the Germline piRNA Pathway
B. Czech, J. Preall
The Drosophila genome is scarred with the ravages 
of an ancestral battle being waged in its germline 
against selfi sh genetic elements. Transposable ele-
ments mobilize in the early stages of gametogenesis, 
and if left unchecked would invade the genome and 
cause widespread disruption of essential genes, lead-
ing to collapse of the germline and sterility. The 
piRNA pathway provides a defense against selfi sh 
genetic elements by mounting a sequence-specifi c, 
RNAi–like nucleolytic surveillance mechanism. Sev-
eral key factors of this pathway have been identifi ed, 
but accumulating evidence has suggested that the 
piRNA pathway is more complex than was fi rst ap-
preciated, with possible ties to chromatin structure, 
transcriptional regulation, and RNA localization. 
We have continued our in vivo reverse genetic screen 
of unprecedented scale in order to fully describe the 
set of genes that participate in piRNA-mediated ge-
nomic defense. Approximately 8200 genes, spanning 
the entire ovarian transcriptome, were targeted by 
RNAi constructs driven by a germline-specifi c pro-
moter. Our screen has uncovered 74 genes that heav-
ily impact transposon expression. Of those, we fi nd 
16 known pathway components and 58 novel genes, 
including cohorts of genes belonging to shared pro-
cesses such as epigenetic regulation and RNA metab-
olism and previously not linked to transposon silenc-
ing. We have characterized in detail two genes, GASZ 
and Del, and identifi ed both as new piRNA biogen-
esis factors. Ongoing analysis will serve to validate 
further candidates and improve our understanding of 
their impact on the piRNA pathway. 
The Epigenetics of Breast Cancer Risk
C.O. dos Santos
During the past 3 years, we have improved the avail-
able tools for the study of mouse mammary gland 
stem cells (MaSCs) and revealed important alterations 
to DNA methylation levels after pregnancy. Through 
our studies, we identifi ed a new MaSC cell surface 
marker, CD1d, which expands our ability to isolate 
these cells nearly 10-fold over the previous strategy. 
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The CD1d surface marker preferentially enriched for 
cells with mammary reconstitution potential enabled 
the investigation of gene expression fl uctuation in be-
tween mammary stem cells and progenitor cells. The 
elucidation of this new strategy to isolate MaSCs al-
lowed the generation of a mammary gland reference 
methylome, which includes DNA methylation pro-
fi les at single-nucleotide resolution, of six distinct 
mouse mammary gland cell types. The comparison of 
cells harvested from virgin glands to those exposed to 
at least two cycles of pregnancy suggested the post-
pregnancy inheritance of hypomethylated regions 
nearby areas predictably occupied by a few transcrip-
tion factors. We are currently investigating the mecha-
nisms by which these modifi cations to DNA methyla-
tion level contribute to the well-established protection 
from breast cancer that is afforded by early pregnancy. 
Our studies may reveal additional information that 
could aid the development of screening methods for 
breast cancer risk.
How Breast Tumors Tame 
the Immune System
C. Rebbeck
We have been investigating the infl uence and re-
sponse of macrophages within a mouse breast tumor 
(tumor-associated macrophages [TAMs]). This past 
year has seen progress, identifying strongly differ-
entially expressed microRNAs (miRNAs) between 
tumor and normal macrophages. With these data, 
I won an award to investigate the expression of 
these miRNAs using in situ hybridization, look-
ing at their particular location within a tumor and 
how this changes as the tumor grows in size. I have 
been working on this technique and dual labeling 
of both miRNA probes and standard immunofl uo-
rescence (IF) for surface expression markers. In ad-
dition, RNA transcriptome data have provided can-
didate genes, which I am currently knocking down 
in situ to monitor changes within the macrophage, 
and their response to 4T1 tumor cells. In collabo-
ration with a fellow lab member, we won an award 
to sequence immune cells within a mouse mammary 
gland and to look for changes that have occurred due 
to pregnancy, which may provide protection against 
tumor development.
LaserTAG: Adding Spatial and Temporal 
Resolution to the Study of Biological 
Processes
D. Bressan
During the past year, my research mostly focused 
on the development of a new technique, named 
“LaserTAG,” for the specifi c tagging and purifi ca-
tion of proteins and their binding partners (espe-
cially nucleic acids) from complex tissue at cellular 
or subcellular resolution. The technique is based on 
the development (in collaboration with Dr. Gra-
ham Ellis-Davies at Mount Sinai School of Medi-
cine) of a photoactivable tag (LaserTAG) that can 
specifi cally cross-link, upon laser activation, with 
epitope-modifi ed proteins in vivo. Using a confo-
cal or two-photon microscope (instruments able to 
aim lasers with incredible precision), it is possible to 
“select” a specifi c area of a cell, or tissue, and cata-
lyze the cross-linking of the tag to the target protein 
only in that area without the need of fi xing, treat-
ing, and sectioning the sample. The target protein 
from the selected area can be subsequently specifi -
cally purifi ed. I am planning to use this technique 
to purify mRNAs bound to the ribosome in brain 
slices. I am particularly interested in studying RNA 
Figure 1. LaserTAG is used to “select” three small circular 
 domains (bright areas) within a cell nucleus (light gray).
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translation in the dendrites of neurons, because this 
“local translation” has been implicated in learning 
and memory.
Genomic and Epigenetic Changes Occurring 
during Carcinogenesis: A Fly Perspective
D. Fagegaltier
How cells become transformed during carcinogenesis, 
which pathways are involved in reaching a trans-
formed state, and whether each cell takes the same 
route to reach such a state are questions not fully un-
derstood. Using the Drosophila model, we are study-
ing the basic mechanisms by which genomes coordi-
nate their genetic and epigenetic responses toward a 
transformed state activated by specifi c oncogenes or 
tumor suppressors.
We have completed our fi rst aim of this STARR 
consortium project: 40 cell lines with cancer-relevant 
genotypes have been generated that express an on-
cogene or are depleted for a tumor suppressor. Such 
cell lines derive from Drosophila embryos express-
ing in specifi c cell types the oncogene-activated Ras 
or depleted for tumor suppressors (PTEN, warts), 
using a number of different Gal4 drivers (ubiquitous, 
actin5C-Gal4; blood cells, serpent-Gal4; muscle, D-
mef2-Gal4). We determined the time to confl uence, 
the ploidy of the cell lines, the ability of the cell line 
to establish tumor in vivo, and the phenotype of the 
cells (fi broblast-like, mesodermal-like, and neuronal-
like) as well as their adherent properties. The effi -
ciency of the establishment of cell lines measured by 
recording cellular heterogeneity, passage time, and 
transplantation in vivo has been recorded to evaluate 
the potency of various oncogenes and loss of tumor 
suppressor genes to drive cells toward transformation. 
Different drivers gave different effi ciency: Although 
D-mef2-Gal4 has proved ineffi cient, generating cell 
lines using serpent-Gal4 was effective at producing 
cell lines that resemble blood cells, and actin5C-
Gal4 was very effective. The potency to generate cell 
lines further depends on the nature of oncogene or 
tumor suppressor: Activated Ras (RasV12) giving rise 
to diploid cells, the tumor suppressor background 
PTEN, and the combination of RasV12;wts-RNAi 
that leads to epithelial cells represent the most effec-
tive backgrounds at generating tumorigenic cell lines 
within a few months. Our second aim is to assess the 
transcriptional and epigenetic changes that occur dur-
ing the establishment of cancerous cell lines and to 
characterize the transcriptome of the transformed cell 
lines. We have completed the latter: We generated 
RNA-Seq libraries and sequenced using next-gener-
ation sequencing the transcriptomes of a representa-
tive set of 14 endpoint cell lines covering fi ve isolates 
of RasV12 cell lines, three isolates of cells depleted 
for PTEN, two isolates of PTEN −/− ;RasV12 cell 
lines, one RasV12;warts RNAi cell line, and three 
RasV12;Pc −/− cell lines. Our downstream analyses 
reveal that cell lines expressing the same oncogene 
or depleted of the same TS show a very similar fate, 
demonstrating the robustness of such technique in 
establishing transformed cell lines. The transcrip-
tional programs of primary cancerous cells correlate 
best between cell lines expressing the same oncogene, 
or lacking the same tumor suppressor, compared to 
other cancer-relevant cell lines in this data set. This 
is exemplifi ed by the dominant epithelial nature of 
Ras-expressing cell lines. Cultures are not necessarily 
pure, however, as cells of different type can survive 
(namely, muscle, lymph, blood, or neuronal cells). We 
have identifi ed for each primary cell line, markers and 
tissue-specifi c transcription factors relevant to each of 
the one to fi ve cell types they retain. We are currently 
validating these markers in vivo.
Tissue formation during development requires that 
constant yet sequential transcriptional changes occur 
that defi ne cell fate. Signaling pathways are crucial 
to orchestrate such programs. As primary cell lines 
become tumorous, they also undergo transcriptional 
reprogramming and cell-fate decisions. We have iden-
tifi ed for each cell line the active and inactive sets of 
ligands and receptors, transcription factors, and non-
coding RNAs (ncRNAs) whose expression is specifi c 
or common to individual or sets of cell lines. Using 
next-generation sequencing, we are dissecting further 
the transcriptional changes (alterations in small and 
long noncoding RNAs, and mRNAs) and alterations 
in signaling pathways as they occur during the estab-
lishment of the cell lines. We have generated librar-
ies and sequenced the time courses of three different 
RasV12 cell lines at 9–12 different time points, com-
plementing our pilot microarray experiment on time 
courses on two Ras-expressing cell lines. The compu-
tational analyses are currently ongoing. The compre-
hensive collection of transcriptomes generated above 
will serve as a base to formulate hypotheses as to how 
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defi cient or stimulated signaling pathways appear and 
how transcription factors, ncRNAs and other path-
ways have a role in cell fate during transformation that 
can be tested experimentally in vivo. In particular, we 
will perform functional tests to discriminate driver 
from passenger alterations. We will determine wheth-
er the cells have become “addicted” to the initiating 
oncogene or loss of tumor suppressor genes and which 
other pathways are required for the cells to prolifer-
ate and maintain a transformed state. We will test the 
role of candidate genes, with a focus on chromatin-
remodeling genes, in tumorigenesis. Finally, our tran-
scriptomic studies took another exciting turn as they 
revealed that several cell lines express components of 
the piRNA processing machinery, including piwi and 
aubergine—whose functions in guarding the genome 
against the invasion of repeated selfi sh elements are 
the subject of extensive studies in the germline. We 
have validated this fi nding by immunofl uorescence: 
piwi protein is found in the nucleus, its natural lo-
cation in somatic follicle cells, whereas aubergine ag-
gregates at the nuclear periphery as well as unusually 
large cytoplasmic foci. To better characterize the role 
of such proteins outside the germline, we are currently 
cloning the small RNAs they sequester. Assessing the 
function of PIWI proteins in the context of cancerous 
cell lines prone to genomic rearrangements promises 
to uncover novel functions of the piRNA machinery. 
These studies hence not only serve as a rich source of 
information, but also will represent invaluable com-
munity resources to study cancer, cell fate, and small 
RNA functions.
Decoding ENCODE: An Integrated Analysis 
of Epigenetic States Reveals Functional 
Elements in the Genome
E. Hodges [in collaboration with F. Schlessinger and 
T. Gingeras, Cold Spring Harbor Laboratory]
Our efforts during the last year have focused on the 
in-depth analysis of genome-wide DNA meth-
ylation data produced from primary human blood 
cells. We have been specifi cally interested in char-
acterizing intergenic, cell-type-specifi c hypomethyl-
ated domains that we hypothesize to be novel cis-
regulatory elements. To accomplish this, we have 
integrated publicly available sequencing resources 
from ENCODE with our own data sets to identify 
active enhancers. Our approach allows us to classify 
these noncoding domains into functional subsets 
based on their chromatin signatures. This work has 
resulted in several new and interesting observations, 
including the identifi cation of a subclass of noncod-
ing enhancer RNAs associated with lymphocyte en-
hancer activity.
Molecular Determinants of Breast 
Cancer Metastasis
E. Wagenblast
Breast cancer is one of the most common malignant 
diseases in women, in which the metastatic disease is 
the main cause of death. Metastatic disease progres-
sion requires the acquisition of altered gene expres-
sion. However, current cancer therapies only target 
the hyperproliferative nature of the tumor and ne-
glect to inhibit metastasis formation. Therefore, the 
aim of this study was to identify and validate meta-
static regulators using cell lines and mouse models. 
For this, we isolated primary, circulating, and meta-
static tumor cells of mice that were transplanted with 
murine cell lines, which differ in their metastatic 
potential. After FACS (fl uorescence-activated cell 
sorting) of these subpopulations, we conducted in-
depth transcriptome analysis using RNA-Seq. This 
has allowed us to generate gene signatures between 
the primary tumor and circulating/metastatic cells 
within each cell line. Taking a systematic approach, we 
interrogated the metastatic potential of our top differ-
entially expressed genes using RNAi. Using in vitro 
invasion assays and in vivo metastasis mouse models, 
we screened our candidate genes individually and in 
a pooled fashion, respectively. Current efforts are ad-
dressing the biological mechanisms of our candidate 
genes.
Patterns of Epigenetic Change during 
Tumorigenesis in Mice and Humans
F. Rollins [in collaboration with A. Smith, University of 
Southern California; R. Sordella, Cold Spring Harbor 
Laboratory]
In the past year, I have been working on understand-
ing the patterns of DNA methylation in non-small-
cell lung cancer. We have been using cancer cell lines, 
and through the combination of bisulfi te conversion 
and high-throughput, whole-genome sequencing, we 
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are unraveling the epigenetic patterns of cancer cells. 
We have identifi ed a set of characteristics that not 
only are specifi c to cancer cells, but could also under-
lay some of the most basic phenotypes of cancer cells, 
including increased rates of mutation and genomic 
instability. These insights give further understanding 
to how cancer cells are different from normal cells 
and will provide a foundation for future cancer re-
search.
Role of an X-linked miRNA Cluster 
in Mouse Spermatogenesis
I. Falciatori
We identifi ed an X-linked cluster of miRNAs highly 
and specifi cally expressed in the male germline. We 
established that this cluster is specifi cally expressed in 
testis in several stages of development, but it is not 
detectable in other organs. We therefore became in-
terested in determining the function of this miRNA 
cluster during spermatogenesis. Toward this end, we 
decided to ablate this cluster at different stages during 
spermatogenesis in mice and analyze their phenotype. 
We prepared a modifi ed bacterial artifi cial chromo-
some (BAC) in which this miR cluster is fl anked by 
LoxP sites, and we are in the process of generating 
the targeted embryonic stem cells (ESCs). Mean-
while, we produced transgenic Mili-Cre or Miwi-Cre 
mice in which the Cre recombinase is expressed in 
germ cells starting at embryonic stages or only after 
meiosis, respectively. We have also purchased Stra8-
Cre mice in which Cre is expressed postnatally in the 
differentiating spermatogonia. By crossing the dif-
ferent Cre-deleter strains with the miR-fl oxed mice, 
we will generate mice in which this cluster could be 
selectively ablated at different stages of spermatogen-
esis. We will then assess their phenotype to infer the 
function of the cluster. Because miRNAs exert their 
function by down-regulating their target genes, we 
have produced a modifi ed BAC in which we added 
a TRE promoter to drive the expression of the cluster 
in embryonic stem cells under the control of tetracy-
cline. We produced transgenic ESC lines carrying this 
BAC. We are currently screening the clones that have 
the highest difference in miR expression in the pres-
ence or absence of tetracycline. We will then compare 
their mRNA profi les (by RNA-Seq) in the presence or 
absence of tetracycline to discover potential miRNA 
targets. These targets will be then validated in sper-
matogonial stem cells (SSCs).
RNAi as a Path to Target Discovery 
for Breast Cancer Treatment
K. Chang, S. Knott
Genome-Scale Screening Approach. Breast cancer is 
a heterogeneous disease that can be clinically catego-
rized into three therapeutic subgroups: estrogen receptor 
(ER)-positive, HER2-amplifi ed, and triple-negative 
(basal-like). The ER-positive (most diverse and nu-
merous) and the Her2-amplifi ed subgroups account 
for 80%–85% of all human breast cancers, whereas 
patients diagnosed with the triple-negative subtype 
have the most aggressive form of the disease and often 
have poor prognosis. Our goal is to apply genome-
wide, loss-of-function RNAi screens in cell culture to 
uncover vulnerabilities of breast cancer cells in all sub-
types and discover genes and pathways that modify re-
sponses to targeted therapies (Lapatinib, Trastuzumab, 
Tamoxifen, and Estrogen-deprivation) for de novo and 
acquired resistance. Our group has been using both es-
tablished and novel preclinical models from collabora-
tors (including Dennis Slamon, University of Califor-
nia, Los Angeles, and Rachel Schiff, Baylor College of 
Medicine) to conduct RNAi screens in order to identify 
novel therapeutic targets/drugs that can be translated 
to the clinic. This study is funded by the Stand Up 
to Cancer (SU2C) foundation. We have completed 32 
genome-wide screens representing all three therapeutic 
treatment classes through a collaborative effort with 
Stephen Elledge’s Lab (Harvard Medical School). To 
date, half of the RNAi screens have been deconvoluted 
(deep sequencing or microarray analysis), and sequenc-
ing of the remaining screens is ongoing. Candidate vali-
dations will be performed in the coming year.
Focused RNAi Screens Using an In Vivo Ap-
proach. Three-dimensional culture systems mim-
icking the spherical organization of breast epithelial 
cells recapitulate much of the morphogenetic pro-
grams of mammary development and thus are useful 
tools to address how breast cancer cells survive in a 
more physiological context than in two-dimensional 
cell culture. To further understand the determinants 
of tumor survival, we aim to study the behavior of 
breast cancer cells in a more natural environment than 
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three-dimensional in vitro systems, and to this end, 
we are developing RNAi screening in vivo using cells 
derived from human primary tumors engrafted into 
immunocompromised mice. We have acquired patient 
tumor-derived xenografts (PDXs) of different breast 
cancer subtypes from Alana Welm (University of Utah) 
and are expanding these PDXs in vivo to obtain suf-
fi cient quantities of tumor cells for in vivo screening. 
One of the challenges of regulated short hairpin RNA 
(shRNA) expression in vivo is the lack of uninduced 
(T0 or OFF state) or control cells within each tumor 
upon transgene induction, necessitating comparison 
of ON and OFF states between different tumors. To 
overcome this defi ciency, we have designed regulatable 
shRNA expression vectors that enable the creation of 
equal populations of shRNA-ON and shRNA-OFF 
cells within the same tumor. We are currently validat-
ing these vectors for background expression and level 
of shRNA inducibility. Our goal is to enable RNAi 
screening in vivo (orthotopic or subcutaneously) on 
PDX tumors for all subtypes of breast cancer.
Fourth-Generation shRNA Library Construc-
tion. We have developed a computational algorithm 
(trained on the most comprehensive shRNA sequence/
potency database available) that is capable of predict-
ing, for any RNA target, potent shRNAs with high 
confi dence. We have combined this tool with addi-
tional algorithms to reduce off-target effects and to 
ensure that the maximal number of each gene’s tran-
scripts are targeted by the predicted shRNA mol-
ecules. With these tools, we have predicted a novel 
shRNA library for each of the human, mouse, and rat 
genomes. These libraries have been licensed to a ven-
dor and are now available to the scientifi c community.
Macrostomum lignano: Building a Molecular 
Toolkit for a New Model Organism
K. Wasik
Macrostomum lignano is a cross-fertilizing hermaphro-
dite fl atworm with impressive regenerative potential. 
It can regenerate every part of its body (also gonads) 
except the nervous system. The stem cells that are re-
sponsible for this regenerative potential are called neo-
blasts and are present throughout the worm’s body. In-
terestingly, these cells seem to express PIWI proteins, 
which, in other species, repress transposable elements 
and prevent their mobilization in the germline. Study-
ing PIWIs in Macrostomum will uncover PIWI func-
tion in a stem-cell-specifi c context. To take advantage 
of Macrostomum initially for the study of PIWI biol-
ogy, we have started by making a set of basic tools to 
transform this fl atworm into a model organism.
We are currently assembling Macrostomum’s genome 
in collaboration with Michael Schatz (CSHL) and Eu-
gene Berezikov (Hubrecht Institute). We generated 
sequencing data using Ilumina and PacBio sequenc-
ers. The average contig is currently ~5 kb long, but the 
assembly is improving constantly with new data. We 
have additionally generated transcriptome data (long 
and small RNAs) and are using de novo assembly algo-
rithms to help with the genome assembly and to char-
acterize transcribed regions and their promoters.
To genetically manipulate the organism more eas-
ily, we have designed a transgenesis protocol and ob-
tained our fi rst transgenic worms. We are currently 
working on making transgenesis more effi cient.
Additionally, we have developed a protocol to sort 
neoblasts and are characterizing their transcriptome. 
We are also testing different anti-PIWI antibodies to 
perform small RNA pull-downs and immunofl uores-
cence experiments.
Finally, we are making a Macrostomum BAC li-
brary consisting of 60,000 BACs with 20-kb inserts 
that will cover most genes and 40,000 BACs with 
60-kb inserts that will cover bigger genes. This library 
will be partially sequenced to facilitate the genome as-
sembly and will also serve as a tool to manipulate the 
genetic content of M. lignano.
The Role of Long Noncoding RNAs in 
Normal Hematopoiesis and Malignant 
Transformation
L. Sabin, M.J. Delas
Precise control of gene expression is achieved through 
multiple layers of regulation that infl uence the tran-
scriptional and epigenetic states of genomic loci. Long 
noncoding RNAs (lncRNAs) have recently emerged 
as a novel class of molecules with regulatory potential. 
However, ascribing clear functional and biological 
roles to these noncoding transcripts has been challeng-
ing. Although the function of most lncRNAs remains 
unknown, many of the lncRNAs that have been char-
acterized have roles in transcriptional and epigenetic 
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regulation of gene expression, and they may act by 
physically recruiting epigenetic modifi ers and other 
protein complexes to target genomic loci. One devel-
opmental process that requires coordinated regulation 
of gene expression is hematopoiesis. During hemato-
poiesis, hematopoietic stem cells (HSCs) differentiate 
to generate both the myeloid and lymphoid lineages 
of blood cells. Importantly, the malignant transfor-
mation of various hematopoietic lineages leads to the 
development of several forms of leukemia and lym-
phoma, and the disruption or misregulation of epigen-
etic modifi cations is a common feature of cancer cells. 
Therefore, we are studying the function of lncRNAs 
in the murine hematopoietic system, with the aim of 
identifying lncRNAs that have critical roles in the epi-
genetic control of gene regulation. In particular, we 
hope to uncover lncRNAs responsible for regulating 
the processes of tumorigenesis, stem cell self-renewal, 
and differentiation. To this end, we have used high-
throughput sequencing of various cell types within the 
murine hematopoietic lineage. In total, we have per-
formed transcriptome sequencing of 26 samples, which 
include HSCs, as well as normal and transformed cells 
from both myeloid and lymphoid lineages. Despite 
having been studied for decades, the low abundance 
and complex physiological niche of HSCs in animals 
make these stem cells a challenging experimental 
model. We have established in the lab a unique in vitro 
culture system that allows us to expand HSCs for sev-
eral weeks by coculturing them with endothelial cells, 
one of the essential cell types present in their physio-
logical niche. These HSCs are able to fully reconstitute 
hematopoiesis when injected into lethally irradiated 
mice, which provides ultimate proof of their function-
ality. We can use this coculture system to study the role 
of lncRNAs in HSC self-renewal and differentiation 
using an in vitro assay, which reduces the experimental 
time. The candidate lncRNAs that will be tested in this 
loss-of-function assay are currently being selected using 
the transcriptome sequencing data, and we are test-
ing several shRNA delivery vectors to obtain optimal 
lncRNA knockdown in HSCs. To further character-
ize the functionality of promising candidates, we can 
quickly transition to the in vivo model using bone mar-
row reconstitution assays. We hope to understand how 
these molecules participate in the regulation of gene 
expression during hematopoietic regeneration.
To identify lncRNAs important in the mainte-
nance or progression of leukemia, we are using a mouse 
model of acute myeloid leukemia (AML), which is 
driven by the oncogene MLL-AF9, a common fusion 
protein found in human AML. MLL-AF9 leukemia 
cells can be manipulated and studied in culture, but 
they can also be injected into recipient animals to in-
duce leukemogenesis. Therefore, we are using shRNA 
knockdown technology to determine which candidate 
lncRNAs have important biological roles in leukemia 
both in vitro and in vivo. To test whether lncRNAs 
can be depleted by shRNA-mediated RNAi, we have 
chosen a small pilot set of candidates expressed in 
MLL-AF9 leukemia cells and have measured the ef-
fi ciency of RNAi-mediated knockdown of these candi-
dates by quantitative polymerase chain reaction (Q-
PCR). Similar to protein-coding genes, we found that 
some shRNAs potently deplete candidate lncRNAs, 
whereas others are ineffective. We therefore will use 
at least three shRNAs per candidate when perform-
ing RNAi screens in order to minimize the effects of 
ineffi cient shRNAs. We have also developed and pi-
loted competitive proliferation assays with MLL-AF9 
leukemia cells in vitro and in vivo. These assays are 
amenable to large-scale screening efforts. Therefore, 
we have compiled a catalog of the lncRNAs that are ex-
pressed most abundantly in MLL-AF9 leukemia cells 
(859 candidates) and are building an shRNA library 
that individually targets each of these candidates. We 
aim to identify lncRNAs that are important in leuke-
mogenesis using our in vivo competitive proliferation 
assay and will validate hits both in vitro and in vivo. 
We hope that this work will provide important insights 
into lncRNA function in the epigenetic control of gene 
expression during normal hematopoiesis and malig-
nant transformation.
The Role of miRNAs in Mouse Embryonic 
Stem Cell Differentiation
M. Kudla
miRNAs take part in the posttranscriptional regulation 
of gene expression. In the most well-studied ex ample, 
they inhibit translation of a set of transcripts, thus form-
ing an additional layer of control with respect to the 
regulation of transcription. The mechanism of miR-
NA-mediated inhibition has been relatively well de-
scribed. The miRNA binds its inhibition target by the 
classic nucleic acid hybridization principle. In plants, 
the rules for complementarity between miRNA and its 
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target are strictly followed, and thus, fi nding target sites 
for miRNAs is a relatively easy task. However, in mam-
mals, the rules for miRNA:transcript complementar-
ity are relaxed, and thus, determining the target site 
purely on the basis of sequence information is chal-
lenging. It has been the target of multiple bioinfor-
matics initiatives; however, the results of these ef-
forts leave a lot to be desired. Specifi cally, the high 
false-positive ratio is the reason that the experimental 
method for fi nding target sites is necessary. The RNA 
cross-linking and immunoprecipitation method has 
been developed to answer this need. In our work, we 
are using the HITS-CLIP technique to obtain infor-
mation on the impact of miRNA on the embryonic 
stem cell differentiation process. Using sophisticated 
statistical analysis and modern motif-fi nding algo-
rithms, I hope to unravel this additional layer of regu-
lation of the differentiation process.
Multiple Roles for Piwi in Silencing 
Drosophila Transposons
N.V. Rozhkov
Silencing of transposons in the Drosophila ovary 
 relies on three Piwi-family proteins, Piwi, Aubergine 
(Aub), and Ago3, acting in concert with their small 
RNA guides, the piRNAs. Aub and Ago3 are found 
in the germ cell cytoplasm, where they function in 
the ping-pong cycle to consume transposon mRNAs. 
The nuclear Piwi protein is required for transposon 
silencing in both germ and somatic follicle cells, yet 
the precise mechanisms by which Piwi acts remain 
largely unclear. We investigated the role of Piwi by 
combining cell-type-specifi c knockdowns with mea-
surements of steady-state transposon mRNA levels, 
nascent RNA synthesis, chromatin state, and small 
RNA abundance. In somatic cells, Piwi loss leads to 
concerted effects on nascent transcripts and transpo-
son mRNAs, indicating that Piwi acts through tran-
scriptional gene silencing (TGS). In germ cells, Piwi 
loss showed disproportionate impact on steady-state 
RNA levels, indicating that it also exerts an effect 
on posttranscriptional gene silencing (PTGS). Piwi 
knockdown affected levels of germ cell piRNAs pre-
sumably bound to Aub and Ago3, perhaps explaining 
its post-transcriptional impacts. Overall, our results 
indicate that Piwi has multiple roles in the piRNA 
pathway, in part enforcing transposon repression 
through effects on local chromatin states and tran-
scription but also participating in germ cell piRNA 
biogenesis.
Exploiting RNAi to Identify a Putative Target 
for Pancreatic Cancer Treatment
S. Fenoglio, M. Hemann, G. Hannon
The technology of RNAi is a powerful tool used to 
discover the factors necessary for tumor growth by spe-
cifi cally knocking down one protein per cell, reveal-
ing the phenotypic consequences of the loss of gene 
function. The development of shRNA libraries further 
extended the potential of RNAi as many genes can 
be interrogated at once in a high-throughput fashion. 
The Hannon laboratory pioneered the technology and 
is now pushing it to the limit by embracing a genome-
wide approach. At the same time, improved versions of 
shRNA libraries are designed and validated in the labo-
ratory. We are interested in performing in vivo screen-
ing to identify new putative targets for the treatment of 
pancreatic cancer by means of shRNA libraries. One of 
us (S.F.) recently transferred to the Massachusetts In-
stitute of Technology to work in the laboratory of Pro-
fessor Michael Hemann to establish a transplantable 
model system for pancreatic ductal adenocarcinoma. 
The advantage of this system is the effi ciency of the 
in vivo growth after transplant in immunocompetent 
mice, which calls for a good engraftment ability of the 
cell line, fundamental for the success of the screening. 
Combining this approach with the newly optimized 
libraries designed to improve the effi cacy of the knock 
down dramatically increases the chances of successful 
and comprehensive screening results.
Pancreatic cancer occurs at low incidence in the 
United States; nevertheless, it is currently the fourth 
leading cause of cancer-related death in the country. 
The high mortality rate is the result of poor diag-
nostic tools and ineffective therapeutic options; in 
fact, most of the patients present at diagnosis with 
an advanced and metastatic disease. For this reason, 
resection of the tumor mass is impractical in the 
majority of cases, leaving chemotherapy and radio-
therapy as the only options, which are applied with 
very low success rate. Currently, the elective treatment 
is based on gemcitabine, which being a cytosine ana-
log is an unspecifi c cytotoxic drug. Because of the 
lethality of pancreatic cancer, it is crucial to achieve 
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a better understanding of the disease in order to im-
prove treatment effi cacy.
We will perform the same screening experiment in 
an in vivo and in vitro setting. We believe that it is 
important to include the tumor microenvironment as 
a variable in the experiments, as the interactions with 
the environment shape the behavior of cancer cells in 
response to treatment, here replicated by RNAi-medi-
ated knockdown of genes.
From our efforts, we expect to fi nd both obvious 
and nonobvious candidates for pancreatic cancer treat-
ment, and we will continue by validating the best scor-
ing hits of our screening, in particular those that are 
specifi c for the in vivo setting, to increase the chances 
of a relevant clinical impact. Moreover, from our data, 
we will gain relevant insights into the biology of the 
disease, with potential for new discoveries about mech-
anisms of cancer development and clinical application 
to diagnosis.
The Final Frontier of shRNA Libraries
S. Knott
This past year, my work has mainly involved opti-
mizing the RNAi tools we use in large-scale shRNA 
screens. First, I have developed a computational algo-
rithm (trained on the most comprehensive shRNA 
sequence/potency database available) that is capable 
of predicting, for any RNA target, potent shRNAs 
with high confi dence. We have combined this tool 
along with additional algorithms to reduce target 
effects and to ensure that the maximal number of 
each gene’s transcripts are targeted by the predicted 
shRNA molecules. With these tools, we have pre-
dicted a novel shRNA library for each of the human, 
mouse, and rat genomes. These libraries have been 
licensed to a vendor and are now available to the sci-
entifi c community. Second, I have designed vectors 
to harbor pairs of hairpins, with the intent of simul-
taneously silencing two genes. These vectors have 
been designed to maximize hairpin processing and to 
allow the hairpin pairings within each cell of a com-
plex population to be extracted with next-generation 
sequencing. With these vectors, we are set to begin 
performing RNAi screens where pairs of genes are 
interrogated for their combined therapeutic benefi t. 
Our current goal is to interrogate the full pairwise set 
of druggable genes. This gene set was chosen because 
it shows the most promise for a prompt transition 
from preclinical to clinical trials. Finally, we have 
performed matched +/− gemcitabine (a chemothera-
peutic agent) genome-wide RNAi screens on six pan-
creatic cancer cell lines with the aim of identifying 
targets that sensitize the cells to chemotherapy. These 
screens have been analyzed and ~150 putative hits are 
now being validated.
Optimizing shRNA Expression to Enable 
Discovery of Targets for Melanoma Therapy
S. Shaw
Building on our existing in vitro screening technolo-
gies and in collaboration with Dr. Meenhard Herlyn 
of the Wistar Institute, we are establishing in vivo 
RNAi screening in biopsied human melanoma tumor 
cells as patient-derived xenograft (PDX) mouse mod-
els. Using this system, our goal is to interrogate cells of 
different melanoma subtypes to identify genes upon 
which these cells depend for their survival, as well as 
targets that modify their drug sensitivity or resistance. 
Essential to our efforts to conduct screens in vivo is 
the ability to drive expression of our libraries in differ-
ent primary tumor cells. We continue to expand our 
repertoire of promoters in order to facilitate optimal 
transcription and processing of shRNA transcripts in 
any cell type and to reduce variation in expression lev-
els from different viral integration sites. We are also 
identifying elements that can be used in our vectors to 
prevent promoter silencing.
Argonautes in Gene Regulation
F. Karginov
Argonaute proteins are guided by their miRNA part-
ners to mRNA targets, leading to regulation of the 
mRNA in a spatially and temporally controlled man-
ner. In recent years, it has become more evident that 
the interactions between Ago/miRNAs and mRNAs 
are further affected by ancillary RNA-binding pro-
teins, creating a combinatory system of regulation 
akin to transcription factors. We have continued to 
use transcriptome-wide technologies (CLIP) to iden-
tify the sites of interaction between Argonaute and 
mRNAs, to dissect the Ago regulatory networks and 
their integration with other RNA-binding proteins. 
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Recently, I have completed a study examining chang-
es in Argonaute occupancy as a result of acute cel-
lular stress to assess the participation of Ago in this 
process. Ago2 responds to stress by rearranging its 
set of interactions with mRNAs, in a fashion that is 
not simply a result of translation inhibition or stress 
granule assembly. The majority of Ago2-mRNA in-
teractions are strengthened; however, a smaller sub-
set of transcripts is released upon stress. Profi ling 
of transcript abundance along polysome gradients, 
taken as a measure of their translation status, shows 
a correlation between their translatability and Ago2 
association, suggesting the participation of Ago2 in 
modulating mRNA translation as part of the stress 
response.
CG5508 Is a Critical Component 
in Primary piRNA Biogenesis
V. Vagin, Y. Yang, Y. Luo
Piwi proteins and their associated small RNAs are 
essential for fertility in animals. This is due, in part, 
to their roles in guarding germ cell genomes against 
the activity of mobile genetic elements. piRNA pop-
ulations direct Piwi proteins to silence transposon 
targets and, as such, form a molecular code that dis-
criminates transposons from endogenous genes. In-
formation ultimately carried by piRNAs is encoded 
within genomic loci termed piRNA clusters. These 
give rise to long, single-stranded, primary transcripts 
that are processed into piRNAs. Despite the biologi-
cal importance of this pathway, neither the charac-
teristics that defi ne a locus as a source of piRNAs 
nor the mechanisms that catalyze primary piRNA 
biogenesis are well understood. We searched an eth-
ylmethane sulfonate (EMS)-mutant collection an-
notated for fertility phenotypes for genes involved in 
the piRNA pathway. Twenty-seven homozygous-ster-
ile strains showed transposon-silencing defects. One 
of these, which strongly impacted primary piRNA 
biogenesis, harbored a causal mutation in CG5508, 
a member of the Drosophila glycerol-3-phosphate 
O-acetyltransferase (GPAT) family. These enzymes 
catalyze the fi rst acylation step on the path to the 
production of phosphatidic acid (PA). Although 
this pointed strongly to a function for phospholip-
id signaling in the piRNA pathway, a mutant form 
of CG5508, which lacks the GPAT active site, still 
functions in piRNA biogenesis. Interestingly, the 
mutation in CG5508 causes truncation of the pre-
dicted RNA binding motif carboxy-terminal end 
without perturbing GPAT activity. CG5508 colocal-
izes on the outer mitochondrial membrane together 
with another key primary piRNA factor, endoribo-
nuclease Zucchini, and is required for its proper cel-
lular localization. PAR-CLIP analysis in the cell cul-
ture revealed Zucchini and CG5508 directly interact 
with the same set of transcripts, including primary 
piRNA precursor fl amenco, but the CG5508 trun-
cation version without the RNA-binding motif does 
not bind any transcripts. We proposed that primary 
piRNA transcripts are bound by CG5508 in order to 
be processed by Zucchini into mature piRNAs.
Quantitative Genome-Wide RNAi Screen 
Identiﬁ es Novel Factors That Affect Speciﬁ c 
Aspects of C. elegans piRNA Biogenesis
W.S. Goh
piRNAs are germline-specifi c small RNAs that load 
onto piwi proteins, and their loss leads to sterility. 
In the nematode Caenorhabditis elegans, piRNAs, or 
21Us are loaded onto the piwi protein PRG-1. piR-
NAs have a 1U bias, 5′ monophosphate and modifi ed 
3′ ribose. Unlike their 25–31-nucleotide nonnema-
tode counterparts, worm piRNAs are all 21 nucleo-
tides long and are mostly located in the intergenic or 
intronic regions of two large clusters on chromosome 
IV. Previous work in the fi eld has implicated these 
piRNAs in silencing transposons and pseudogenes, 
and triggering transgenerational germline nuclear 
RNAi. Recently, ~26-nucleotide capped piRNA pre-
cursors (pre-21Us) have been identifi ed. Because each 
piRNA is located downstream from a proximal DNA 
motif, this suggests a biogenesis model where each 
DNA motif acts as a promoter that controls expres-
sion of pre-21Us that are then processed into mature 
piRNAs. Detailed mechanisms for piRNA biogenesis 
are still unknown because no regulating factors have 
ever been identifi ed.
In the past year, I utilized a quantitative PCR-
based, genome-wide RNAi screen and identifi ed 22 
Twenty-one-u Obviously Fouled Up (TOFU) factors 
involved in the biogenesis of mature piRNAs. Unex-
pectedly, seven suppressors were also identifi ed that, 
when knocked down, increased both piRNA and 
068-091_CancerGenet.indb   81 9/17/2013   8:24:46 AM
82  Research
PRG-1 mRNA levels. To characterize the top seven 
TOFUs in detail, I sequenced both piRNAs and pre-
21Us. Although perturbations of individual TOFUs 
all led to global reductions in piRNA profi les, this 
could be accompanied by either an accumulation or 
reduction of pre-21Us. Together, my data suggest that 
different TOFUs affect specifi c aspects of the worm 
piRNA biogenesis pathway, including transcription of 
pre-21Us and their conversion to piRNAs.
Exploring Biological Function of Prokaryotic 
Argonaute Protein in Bacteria
X. Zhou
Argonaute proteins are key components of RNAi 
pathways in the eukaryotic kingdom. Despite the 
wide existence of Argonaute proteins in prokaryotes, 
such as bacteria and archaea, the biological functions 
of prokaryotic Argonaute remain unknown. There-
fore, we aim to reveal the roles of Argonaute in a 
model microorganism, Thermus thermophilus. Previ-
ous studies reported that T. thermophilus Ago, which 
is structurally highly conserved to eukaryotic Ago, 
is able to cleave RNA using a single-stranded DNA 
guide strand in vitro, indicating biological functions 
in vivo. Overexpression of His-tagged Ago and im-
munoprecipitation in T. thermophilus showed bind-
ing of small nucleic acids of ~30 nucleotides. More-
over, an increased level of Ago seems to be toxic to 
cells, indicating a potential gene-silencing pathway 
mediated by Ago. In summary, Argonaute protein is 
likely to mediate a novel gene-silencing pathway in 
T. thermophilus. Future work includes a functional 
study in Argonaute knockout/knockin mutants and 
discovery of other components of the Ago-mediated 
pathway.
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REPRESENTATION METHYLATION SEQUENCING ANALYSIS
R. Lucito N. Dimitrova K. Wrzeszczynski 
 M. Vigliotti 
In addition to genetic mutations such as amplifi ca-
tion and deletion, epigenetic aberrations are frequent 
events that can have far-reaching effects in the phe-
notype of a cancer cell. A common epigenetic modi-
fi cation is the methylation of cytosine residues that 
are next to guanine residues. It has been shown that 
methylation present in the DNA of the transcriptional 
control region can be involved in the silencing of gene 
expression of tumor suppressors in cancer. We have 
previously adapted ROMA (representational oligonu-
cleotide microarray analysis) to methylation detection 
oligonucleotide microarray analysis (MOMA). This 
methodology was useful and allowed us to identify 
genes that were methylated in the tumor cells, but only 
gave us a general idea of where in the CpG island the 
methylation had occurred. In addition, after perform-
ing the analysis, sequencing validation was required to 
determine which of the array measurements accurately 
identifi ed methylated fragments. With the develop-
ment of next-generation sequencing technologies, it is 
now possible to identify the methylation status for the 
vast majority of CpG islands. Presently, our approach 
is to sequence small MspI fragments of the genome.
We have now sequenced eight tumors and four nor-
mals. We have sequenced two of the samples on two 
different formats of the Illumina sequencers and have 
determined the coverage of each and switched to the 
newest platform. We have developed sequencing pipe-
lines for the analysis of the data and have determined 
the number of reads necessary to account for 85% of 
the CpG sequences in the genomic island sequences. 
We are presently further analyzing the data with the 
goal of identifying new regions that may serve as mark-
ers for diagnosis and also as a discovery tool to identify 
gene candidates that are involved in therapy response.
Genomic Analysis of Ovarian Cancer
K. Wrzeszczynski, M. Vigliotti, E. Lum, N. Cutter, N. Dimitrova
In the United States, there will be ~22,000 new cases 
of ovarian cancer in 2012. Of these, ~14,000 will 
succumb to the disease. To better treat these women, 
and improve survival, our goal is to determine the mo-
lecular changes that have occurred in the patients’ tu-
mors, and to be able to interpret the effects these chang-
es have on the growth and development of the tumor. 
This aberrant growth is a result of chromosomal abnor-
malities and epigenetic variations. In addition, general-
ly low rates of somatic nucleotide mutation in ovarian 
cancer as compared to other solid tumors suggest an 
increased signifi cance of copy-number and epigenetic 
aberrations. This type of regulation has been shown 
to affect the many tumor suppressors and oncogenes 
discovered in ovarian cancer. The identifi cation of ge-
netic and epigenetic alterations from primary tumor 
cells has become a common means of identifying 
genes critical to the development and progression of 
cancer. We have performed a bioinformatics analysis 
of copy-number variation and DNA methylation cov-
ering the genetic landscape of ovarian cancer tumor 
cells. We individually examined the copy-number 
variation and DNA methylation for 42 primary serous 
ovarian cancer samples using our MOMA-ROMA 
technology and 379 tumor samples analyzed by the 
Cancer Genome Atlas. We have identifi ed 346 genes 
with signifi cant deletions or amplifi cations among the 
tumor samples. Using associated gene expression data, 
we predict 156 genes with signifi cantly altered copy-
number and correlated changes in expression. Among 
these genes, CCNE1, POP4, UQCRB, PHF20L1, and 
C19orf2 were identifi ed within both data sets. We were 
specifi cally interested in copy-number variation as our 
base genomic property in the prediction of tumor sup-
pressors and oncogenes in the altered ovarian tumor. 
We therefore identifi ed changes in DNA methylation 
and expression for all amplifi ed and deleted genes. We 
predicted 615 potential oncogenes and tumor sup-
pressor candidates by integrating these multiple ge-
nomic and epigenetic data types. Genes with a strong 
correlation for methylation-dependent expression ex-
hibited at varying copy-number aberrations include 
CDCA8, ATAD2, CDKN2A, RAB25, AURKA, BOP, 
and EIF2C3. We provide copy-number variation and 
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DNA methylation analysis for more than 11,500 indi-
vidual genes covering the genetic landscape of ovarian 
cancer tumors. We show the extent of genomic and 
epigenetic alterations for known tumor suppressors 
and oncogenes and also use these defi ned features to 
identify potential ovarian cancer gene candidates.
Resistance Mechanisms in Ovarian Cancer
N. Cutter, M. Vigliotti, K. Wrzeszczynski, G. Fan 
[in collaboration with N. Tonks, Cold Spring 
Harbor Laboratory]
Epithelial ovarian cancer is the leading cause of death 
from gynecological malignancies. Currently, plat-
inum-based chemotherapy (such as cisplatin or car-
boplatin), coupled with a taxane-based drug such as 
paclitaxel, is the primary treatment for ovarian can-
cer. Approximately 25% of patients either present 
with or rapidly develop resistance to chemotherapy, 
and all recurrent tumors are resistant. Epigenetic 
modifi cations have been associated with tumor forma-
tion and progression and may contribute to therapy 
response. We have screened a number of genes and 
family members for methylation in resistant patients, 
but not in sensitive patients. We show for one such 
gene (CHD3), a member of the Mi-2 NuRD complex, 
that loss of expression is linked to chemoresistance. 
CHD3 is silenced through an epigenetic mechanism 
in both ovarian cancer cell lines and primary ovarian 
tumors. Ovarian cell lines transcriptionally silenced 
for CHD3 have an increased resistance to the chemo-
therapy drugs carboplatin and cisplatin.  Additionally, 
these cells are more invasive, have migratory ability, 
and display a transformed epithelial to mesenchy-
mal (EMT) phenotype. Taken together, we provide 
the fi rst evidence of a role for CHD3 as an important 
mediator of chemoresistance in ovarian cancer, and 
we hypothesize that EMT is one of the underlying 
mechanisms. Furthermore, CHD3 might represent a 
response predictor and potential therapeutic target for 
predicting chemoresistance in this disease.
Genomic Alterations of Phosphatases
E. Lum, G. Fan, F. Chaudhary [in collaboration 
with N. Tonks, Cold Spring Harbor Laboratory]
The goal of this collaborative study is to integrate 
gene discovery technology with experimental strategies 
de veloped in Dr Tonks’ lab for the characterization of 
the protein tyrosine phosphatase (PTP) family of en-
zymes, to investigate how tyrosine phosphorylation-
dependent signaling pathways are disrupted in cancer. 
We have taken advantage of several different forms of 
genomic data to determine which PTPs are affected 
in cancer cells.
We have used genomic copy number data, expres-
sion data, and now epigenetic DNA methylation 
data to determine which PTPs are altered in ovar-
ian cancer. We have also expanded our extension 
of analysis of PTPs in cancer into the proteins with 
which PTPs interact. An interesting gene in this 
class is the MTSS1 protein, which interacts with a 
PTP, the receptor-like PTP RPTPδ, and regulates 
cytoskeletal organization. It is known to be preferen-
tially methylated in several cancers, including breast, 
and its expression is markedly decreased in ovarian 
cancer.
We fi rst generated small hairpin RNAs (shRNAs) 
to suppress expression of the MTSS1 gene in cell cul-
ture assays, which would mimic the transcriptional 
repression caused by promoter methylation. Because 
this gene was selected based only on the comparison 
of tumor to normal, we did not have a selection for 
assay development. We surmised that because MTSS1 
possessed an actin-binding domain, the protein might 
have a role in cytoskeletal rearrangement, cell move-
ment, and invasion. Therefore, we performed an inva-
sion assay with MCF10A mammary epithelial cells, 
which are used typically as a normal line. We observed 
that very few cells migrate without the addition of 
the attractant epidermal growth factor (EGF). Fur-
thermore, RNA interference (RNAi)-mediated sup-
pression of MTSS1 enhanced migration in the pres-
ence of EGF. Evidence in the literature shows that in 
ERBB2-positive breast cancer, there is loss of MTSS1 
transcription. To determine whether ERBB2 overex-
pression synergizes with loss of MTSS1, we performed 
an invasion assay in MCF10AN cells. These cells ex-
press a chimeric ERBB2 gene in which the activity 
of the cytoplasmic PTK domain of ERBB2 is acutely 
regulated by a small molecule dimerizing agent. We 
noted that the level of invasion is highest in the cells in 
which MTSS1 was suppressed and ERBB2 activated, 
demonstrating cooperation between these two gene 
products. Our current data indicate that these effects 
are mediated via changes in tyrosine phosphorylation 
regulated by RPTPδ.
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills Y. Chang W. Li E. Vernersson-Lindahl
 G. Horev S. Paul A. Vestin
 D.-W. Hwang E. Son
Our research is focused on elucidating the genetic 
basis of human diseases such as cancer and autism. 
We have discovered genes controlling these diseases, 
revealing insight into how the encoded proteins nor-
mally work and what goes wrong in the disease state. 
These fi ndings have had a major impact in the sci-
entifi c community and have affected how clinicians 
analyze and treat these genetic diseases.
Major discoveries:
• Identifying p63 as a gene affecting development, 
cancer, and aging
• Discovering CHD5 as a gene that prevents cancer
• Revealing the genetic basis of autism
Identifying p63 as a Gene Affecting 
Development, Cancer, and Aging
We discovered a gene called p63 that no one knew 
even existed. Although p63 looked very similar to 
p53—a well-studied gene known to be defective in 
over half of all human cancers—it was not at all clear 
how p63 worked. We found that p63 is needed for 
development, as its loss in mice causes malformations 
of the limbs, skin, and palate. This work provided a 
clue to clinicians searching for the cause of a human 
syndrome in which children have birth defects of the 
hands and feet, abnormal skin, and severe cleft pal-
ate. Our work showing that p63 is needed for devel-
opment had a major impact, as it is now known that 
p63 mutations cause seven different human syndromes 
characterized by birth defects affecting the limbs, 
skin, and palate. These birth defects can be so severe 
that in utero screening for p63 mutations is sometimes 
performed in the clinic. We are currently analyzing 
mouse models of these human syndromes in an effort 
to defi ne their genetic and molecular basis.
My group also discovered that p63 affects aging. 
p63 is needed for stem cells to replenish the tissues 
of our body; when p63 is depleted, rapid aging en-
sues. These features of aging include curvature of 
the spine, hair loss, and severe skin lesions, and they 
indicate that p63 maintains youthfulness. However, 
there is a fi ne balance, as p63 must be controlled at 
just the right level. Indeed, we recently discovered that 
too much of a certain p63 protein (ΔNp63α) leads to 
carcinoma—the most prevalent type of human can-
cer (Paul et al., in press). Pathologists throughout the 
world currently use ΔNp63α as a marker for diagnos-
ing human cancers of the breast, skin, and prostate.
In contrast to the tumor-causing ΔNp63α mentioned 
above, we discovered that other classes of p63 proteins 
(TAp63 proteins) function in the opposite way: They 
prevent cancer. We showed that TAp63 proteins are 
able to shut down tumor growth, causing the tumor 
to shrink dramatically. Importantly, TAp63 is able to 
halt tumor growth even when its sister protein, p53, is 
completely absent. This work stunned the p53 cancer 
community, as it had always been assumed that hav-
ing ineffective p53 was a virtual death sentence that 
would render any anticancer therapy ineffective. Our 
work shows that this is not the case, as p63 can step in 
and do the job. We are currently working on strategies 
to activate p63 that might be feasible in the clinic.
Discovering CHD5 as a New 
Cancer-Preventing Gene
Another major breakthrough in my laboratory was 
the discovery of CHD5 as a tumor suppressor map-
ping to human 1p36—a region of our genomes that 
is often sabotaged with deletions in cancer cells. 1p36 
deletions occur in many different types of human 
cancers, including those of the epithelia and brain, as 
well as those of the blood. Although the cancer com-
munity had searched for more than 3 decades for this 
tumor suppressor, identifying this gene presented a 
major challenge. My laboratory discovered CHD5 
as a 1p36 tumor suppressor. By generating mice with 
gain and loss of the genomic region corresponding to 
1p36 using chromosome engineering technology—a 
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strategy that allows us to generate precise chromo-
some rearrangements in the mouse—we pinpointed 
a region of the genome with potent tumor suppressive 
activity. Using a series of genetic and molecular ap-
proaches, we identifi ed CHD5 as the tumor suppressor 
gene in the region and found that its product worked 
as a “circuit breaker” for a cancer-preventing network. 
In addition, we discovered that CHD5 was frequently 
deleted in human glioma. This year, we discovered 
that CHD5 uses its plant homeodomains to bind his-
tone 3, an interaction that is essential for it to function 
as a tumor suppressor (Paul et al., in press). Our work 
identifying CHD5 as a tumor suppressor has had a 
major impact in the cancer fi eld, as it is now known 
that CHD5 is mutated in human cancers of the breast, 
ovary, and prostate, as well as in melanoma, glioma, 
and neuroblastoma. Furthermore, recent reports indi-
cate that CHD5 status is a strong predictor of whether 
anticancer therapy will be effective; indeed, patients 
with high levels of CHD5 have much better overall 
survival than those with low levels.
Revealing the Genetic Basis of Autism
Our recent fi ndings revealed that one of the most 
 common genetic alterations in autism—deletion of a 
27-gene cluster on chromosome 16—causes autism-
like features (for review, see Horev et al., Proc Natl Acad 
Sci 108: 17076 [2011]). By generating mouse models 
of autism using chromosome engineering (the same 
technology that we had used for cancer gene discovery, 
discussed above), we provided the fi rst functional evi-
dence that inheriting fewer copies of these genes leads 
to features resembling those used to diagnose children 
with autism. First, “autism” mice had behaviors such 
as higher activity, resistance to change in environment, 
sleeping problems, and repetitive/restrictive behavior; 
each of these features is similar to clinical criteria used 
to diagnose autism in humans. Second, these mice had 
distinctive architectural changes in the brain that were 
detectable by magnetic resonance imaging (MRI). 
Our work provides functional evidence for the genetic 
basis of autism that was not previously appreciated. We 
believe that these models will be invaluable for pin-
pointing the genes responsible for autism. They could 
also be used for designing ways to diagnose children 
with autism before they develop the full-blown syn-
drome, as well as for designing clinical interventions.
PUBLICATIONS
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CANCER GENES
S. Powers C. Eifert J. Li M. Rajaram
 B. Gerdes A. Mofunanya Y. Wu
Cold Spring Harbor Laboratory is synonymous with 
the village-like atmosphere created by its picturesque 
research buildings. Five miles away in Woodbury, the 
Genome Center campus has a more industrial am-
bience imparted by its plentiful next-generation se-
quencing apparatuses. Here, we use these sequencing 
machines and other cancer genomic technologies to 
ask questions about cancer and develop new treatment 
strategies. For more than 15 years, the main focus of 
our research has been to utilize genomic analysis of 
human cancer to discover underlying driver genes—
genes that when altered by point mutation or DNA 
copy-number changes contribute to the selective ad-
vantage of the evolving cancer cell.
Driver Genes
A. Mofunanya, J. Li, R. Gerdes, Y. Wu
Our driver gene-screening efforts are funded by the 
National Cancer Institute (NCI)-sponsored Can-
cer Target Discovery and Development Consortium 
(www.ctd2.nci.nih.gov). The Cancer Target Discovery 
and Development (CTD2) network is a coordinated 
effort to integrate cancer genome characterization 
with molecular target discovery and validation. There 
are seven different funded centers, including one at 
CSHL, that work in complementary ways to acceler-
ate the translation of the genomic discoveries into new 
cancer treatments. The network centers each have a 
primary technology platform, be it bioinformatics, ge-
nome-wide loss-of-function screening, a specifi c can-
cer-type focus, small-molecule inhibitors, proteomics, 
or in our case, cancer-genome-focused screening. 
We are currently performing cancer-genome-focused 
screens in ovarian cancer (in collaboration with two 
other CTD2 centers) and more recently breast can-
cer. In breast cancer, we utilized genomic analysis of 
the the Cancer Genome Atlas (TCGA) breast cancer 
data set to identify 100 novel candidate oncogenic 
driver genes, which are currently being screened using 
pooled approaches for their ability to induce cancer 
when overexpressed in a normal mammary cell, as 
well as their ability to inhibit cancer when their ex-
pression is selectively silenced in human breast cancer 
cell lines.
RNAi Screen for Sensitizers 
to PI3K Inhibition
C. Eifert
Human breast cancer cells with activating mutations 
in the gene for phosphoinositol-3 kinase show a stron-
ger dependency upon PI3K/mTOR (mammalian 
target of rapamycin) signaling than do other breast 
cancers. However, it is not clear whether this selective 
oncogene dependency can form the basis of clinically 
effective treatments. Through a pooled short hairpin 
RNA (shRNA) screen, we showed that knockdown of 
two genes upstream in the PI3-biosynthetic pathway, 
PI4KB and PIP5K1A, specifi cally enhanced cell death 
induced by PI3K and dual PI3K/mTOR inhibitors in 
PIK3CA-mutant breast cancer cells.
Multiple Signaling Interactions between 
Cancer Cells and Associated Fibroblasts 
Are Involved in Promoting Tumorigenicity
M. Rajaram, J. Li [in collaboration with M. Egeblad, 
Cold Spring Harbor Laboratory]
Many fi broblast-secreted proteins can promote tumor-
igenicity, and several mechanisms by which cancer cells 
induce these proteins have been proposed. Whether 
there is a single dominant pathway underlying these 
processes that could be targeted therapeutically is un-
clear. Here, we identifi ed both new and  previously rec-
ognized fi broblast-secreted factors induced by breast 
cancer cells by comparative ge nomics (Fig. 1). Three 
of fi ve tested fi broblast-secreted factors had equally 
major roles in promoting tumorigenicity. In particu-
lar, fi broblast-secreted amphiregulin promoted breast 
cancer cell survival, whereas the chemokines CCL2 
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and CCL7 stimulated tumor cell proliferation, innate 
immune cell infi ltration, and angiogenesis. Impor-
tantly, the whole repertoire of functionally important 
fi broblast-secreted factors could not be induced by 
stimulating fi broblasts with a single factor. Simulta-
neous targeting of fi broblast-secreted amphiregulin 
and of CCR1, the CCL7 receptor, on cancer cells in 
mice was more effi cacious than blocking either alone. 
Thus, our data strongly suggest that multiple tumor–
stroma interactions should be targeted.
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Figure 1. Functional classes of selectively secreted proteins and 
autocrine/paracrine induction of ligand-receptor pairs. (A) Dia-
gram showing the functional classiﬁ cation of the 42 secreted 
proteins that are up-regulated in both tumor-supportive ﬁ bro-
blasts and primary breast cancer stroma. Most of these proteins 
had not previously been shown to have a tumor-supportive role 
as ﬁ broblast-secreted proteins, although others such as IL-1B 
have. (B) Paracrine up-regulation of the expression of ligand- 
receptor pairs upon coculture of tumor-supportive ﬁ broblasts 
with basal breast cancer cells. The fold-change in ligand expres-
sion in tumor-supportive ﬁ broblasts (x axis) is plotted against the 
fold-change in receptor expression in breast cancer cells (y axis). 
(C) Autocrine up-regulation of ligand-receptor pairs upon co-
culture of tumor-supportive ﬁ broblasts with basal breast cancer 
cells. The fold-change in tumor-supportive ﬁ broblast ligand ex-
pression (x axis) is plotted against the corresponding fold-change 
in receptor expression (y axis).
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CANCER AND HUMAN GENETICS
M. Wigler P. Andrews D. Esposito R. Kandasamy A. Leotta J. McIndoo  J. Rosenbaum B. Yamrom
 J. Alexander E. Grabowska J. Kendall B. Ma L. Rodgers J. Troge L. Zhang
 M. Bekritsky I. Hakker Y.-H. Lee S. Marks M. Ronemus Z. Wang Z. Zhu
The Genetics of Autism
We are examining the genetic basis of autism spectrum 
disorders (ASDs) by studying de novo mutations oc-
curring in affected individuals and comparing rates of 
different types of mutations in the unaffected siblings. 
The publication of Iossifov et al. (2012) summarizes 
fi ndings after studying nearly 350 simplex families 
(only one affected child, and in our study, at least one 
unaffected sibling) drawn from the Simons Simplex 
Collection (SSC). The major conclusions of that work 
are strengthened by ongoing work and parallel studies 
of the same collection being carried out in other labo-
ratories. In particular, there is statistically signifi cant 
increased incidence of de novo mutations of func-
tional consequence (copy-number changes, nonsense 
mutations, splice site mutations, and frameshifts) in 
affected children compared to siblings, whereas de 
novo mutations that are likely without effect (synony-
mous mutation) show no increase. Mutation incidence 
is higher in affected girls and increases with the age of 
the parents. Target analysis indicates strong overlap of 
autism candidates with genes expressing mRNAs that 
are associated with the fragile X mental retardation 
protein FMRP (in collaboration with Robert Darnell 
at the Rockefeller University). Recurrence analysis sug-
gests that there are on the order of 500 target genes. 
The overall incidence of new mutation, observed and 
projected, is consistent with new mutation being the 
major source of autism risk in sporadic autism, espe-
cially for females.
De Novo Mutation in Sporadic 
Human Disease
De novo mutations of varying classes have been con-
clusively linked to neuropsychiatric diseases such as 
autism, but the overall contribution to sporadic disease 
of other types has not been studied in equal depth. 
To better understand the relationship between rare, 
de novo copy-number variants (CNVs) and sporadic 
diseases with strong genetic components, we have par-
ticipated in several smaller-scale studies. In collabora-
tion with Dr. Kenneth Offi t of the Memorial Sloan-
Kettering Cancer Center, we analyzed copy-number 
variants in 116 families in which a child or young 
adult was diagnosed with sporadic cancer. Among the 
patients with testicular cancer, 7% had germline de 
novo events—a level similar to that seen in autistic 
individuals, and indicating a strong likelihood that de 
novo mutations underlie at least some types of can-
cer. Building on this effort, we have begun to perform 
whole-exome sequencing of these families to detect 
additional mutations of other classes, such as single-
nucleotide variants and small insertions and deletions.
Congenital heart disease (CHD) is one of the most 
common malformations in humans—found in nearly 
1% of live births—and is largely sporadic, with evi-
dence of a signifi cant genetic component. Utilizing 
the same approach as in our autism and cancer stud-
ies, we studied 213 families in collaboration with Dr. 
Dorothy Warburton at Columbia University Medi-
cal Center. As in the other studies, we found strong 
evidence that de novo CNVs may cause CHD, with 
greater than 10% of affected children having a germ-
line variant—a rate fi ve times higher than was seen in 
a control population. These studies reveal that rare de 
novo mutation contributes to many types of sporadic 
disorders in humans.
Algorithms for Genomic Analysis
We develop tools for genome analysis by refi ning ex-
isting methods and creating novel algorithms when 
“off-the-shelf” software is inadequate. Insertions and 
deletions (indels), as well as other genome rearrange-
ments, contribute signifi cantly to genetic variation 
and disease. Many small indels can be detected by 
existing software, but in some genomic contexts—
such as within microsatellites—indels can be diffi cult 
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to discern. To address this need, we have developed 
our own software. Large-scale rearrangements, such 
as sequence inversions, and intermediate-scale indels 
are also not handled well by openly available code, 
and we are in the process of creating computational 
tools to accurately detect these classes of variation. 
Our methods are being applied to exome sequence 
data from families of the SSC. As concrete results, we 
have identifi ed ~150 de novo mutations in 104 fami-
lies at 90,000 microsatellite loci, and we have found 
examples of de novo pseudogene formation in ~500 
families. We are also analyzing large-scale indels (also 
known as copy-number variants) in the SSC, for 
which we have helped to develop much of the existing 
software, including methods based on principal com-
ponent analysis (Lee et al. 2012).
Molecular Methods
We have continuously worked on developing methods 
to perform measurements with greater resolution, or 
more effi ciently, or to make new types of measure-
ments. In the area of genomics, this includes algorithm 
development as described above, but also bench meth-
ods. In this regard, we have efforts in three projects. 
First, we are developing copy-number measurements 
based on sequencing and driving down experimental 
costs using sample barcodes, pooled samples, and ge-
nome fragmentation. Second, we are applying similar 
strategies for single-cell DNA methods. Finally, we 
are developing methods for single-cell RNA profi ling. 
The latter incorporate the idea of varietal tagging to 
reduce the distortion caused by polymerase chain re-
action (PCR) amplifi cation.
Single-Cell Analysis of Mouse Brain Neurons
Neuronal cells of the brain are the most functionally 
diverse of any organ in the human body, but the total-
ity of that diversity is not fully understood. Moreover, 
the diversity of neurons in the brain may be increased 
by somatic mutational mechanisms occurring during 
the last few cycles of neuronal differentiation—be-
fore the neuronal fate is fi xed. With recent advances 
in single-cell sequencing technology, it is possible to 
sequence DNA and RNA from single neurons of a 
given subtype in the brain. In collaboration with Josh 
Huang and Pavel Osten at CSHL, we are exploring 
the roles of somatic mutation in mice, categorizing 
subtypes and specifi c transcription patterns, and ex-
ploring the contribution of monoallelic expression to 
neuronal diversity and cognitive-behavioral variation.
Genomic Landscape of Prostate Cancer
Prostate cancer (PCa) is the most common genitouri-
nary malignancy among men. It often presents as 
a multifocal disease characterized by tremendous 
biologic heterogeneity with a variable clinical course 
ranging from indolent to lethal disease. Current 
guidelines for prognostication and treatment strategies 
rely on clinicopathological parameters such as serum 
PSA (prostate-specifi c antigen) levels and histological 
 appearance. Developing genomic parameters such as 
copy-number variation, genome instability, and clon-
ality will enhance current methods for prognostica-
tion and disease management. We are using a single-
cell genomics approach to obtain high-resolution 
profi les of the genetic alterations that occur in single 
prostatic cancer cells. Our methods are very general 
and are applicable to many kinds of cancer and many 
types of biological samplings, including body fl uids.
In a collaboration with the laboratory of Dr. 
Ashutosh Tewari of the Weill-Cornell Medical Col-
lege, we have shown that analysis of the genomes of a 
few hundred cells can provide a landscape of the evo-
lution of prostatic neoplasia. Comparison to Gleason 
scores suggests that early stages of the disease feature 
cells with unstable genotypes, with little if any clus-
tering into emergent clones exhibiting consensus ge-
notypic markers. In contrast, advanced-stage disease 
displays not only cells with divergent and unstable 
genotypes, but also emergent clones of cells with 
common chromosomal deletions and amplifi cations. 
Efforts are under way to determine whether genome 
scores derived from single-cell genomic analysis may 
improve risk stratifi cation in PCa.
Single-Cell Viewer
We are developing interactive visualization software to 
view whole-genome copy-number data from single-cell 
sequence data. Data from hundreds of cells compris-
ing many regions within a tumor (in which the ploidy 
of nuclei has been sampled by fl uorescence-activated 
cell sorting [FACS]) can be assessed together. The 
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cells are clustered by their copy-number profi les, high-
lighting clonal differences and where those clones are 
physically located within a tumor. The entire collec-
tion of cells can be analyzed in a combined tree and 
heatmap, cells can be subdivided by tumor region to 
profi le individual sectors within a tumor, and each cell 
can be evaluated individually. It is possible to zoom 
in to any region within any of these fi gures to get a 
 detailed view of a subset of samples or a specifi c genomic 
region.
Collaborators
In addition to our external collaborators, cited above, 
virtually all of our work is performed and planned with 
collaborators at CSHL: Jim Hicks and Alex Krasnitz 
in cancer; Ivan Iossifov, Dan Levy, and Michael Schatz 
in genetics; and Josh Huang and Pavel Osten in neu-
robiology. Within the Wigler lab, Michael Ronemus 
has been largely responsible for the exome sequence 
data production pipeline; Jude  Kendall, Boris Yam-
rom, Yoon-ha Lee, Mitch Bekritsky, Peter Andrews, 
and Ewa Grabowska for algorithm development, pro-
cessing, and analysis of single-cell and genome se-
quence data; Chris Yoon for analysis of copy-number 
and genetic transmission; Anthony Leotta and Steve 
Marks for building and maintaining and querying 
databases; Ravi Kandasamy, Zihua Wang, and Zhu 
Zhu for studies of somatic mutation, monoallelic-
specifi c expression, validating sequence discovery, 
and developing copy-number and single-cell bench 
methods; and Joan Alexander for the cancer land-
scape projects.
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CANCER: SIGNAL TRANSDUCTION
Mikala Egeblad and colleagues study tumors and, in particular, the contributions of the microen-
vironment in which the cancer cells arise and live. Solid tumors are abnormally organized tissues 
that contain not only cancer cells, but also various stromal cell types and the extracellular matrix, 
and these latter components constitute the microenvironment. Communications between the dif-
ferent components of the tumor infl uence its growth, its response to therapy, and its ability to 
metastasize. Among the tumor-associated stromal cells, the lab’s main focus is on myeloid-derived 
immune cells, a diverse group of cells that can enhance angiogenesis and metastasis and suppress 
the cytotoxic immune response against tumors. Egeblad is interested in how different types of my-
eloid cells are recruited to tumors and how their behaviors, for example, their physical interactions 
with cancer cells and other immune cells, infl uence cancer progression, including metastasis. The 
lab studies the importance of the myeloid cells using mouse models of breast and pancreatic cancer 
and real-time imaging of cells in tumors in live mice. This enables them to follow the behaviors of 
and the interactions between cancer and myeloid cells in tumors during progression or treatment. 
This technique was instrumental when the lab recently showed that cancer drug therapy can be 
boosted by altering components of the tumor microenvironments, specifi cally reducing either 
matrix metalloproteinases (enzymes secreted by myeloid cells) or chemokine receptors (signal re-
ceptors on myeloid cells).
Changes in tissue architecture and cell differentiation are often the early signs of cancer, but little 
is known about the pathways that regulate them. Senthil Muthuswamy has developed a novel 
paradigm for thinking about this aspect of cancer biology. Using sophisticated model systems 
such as three-dimensional cell culture platforms and transgenic mice, his team found that proteins 
that regulate cell polarity are involved in both initiation and progression of cancer. Because cell 
polarity is found to be altered in multiple human cancers, understanding the pathways regulated 
by them can identify novel molecules and pathways that can be used either as drug targets or as 
biomarkers for cancer. In addition, Muthuswamy’s lab collaborates actively with multiple research 
teams at CSHL. For example, lab members collaborated with the Mills lab to demonstrate a 
role for p63 protein in stem cell of the skin and with the Krainer lab to investigate the role the 
splicing factor SF2 has in breast cancer. Muthuswamy’s lab has ongoing collaborations with the 
Tonks lab to investigate and identify novel opportunities for targeting tyrosine phosphatases in 
HER2-positive breast cancers and with the Spector lab to study the role noncoding RNAs have 
in breast cancer.
Darryl Pappin’s lab develops chemical and computational methods for analysis of proteins and 
peptides. These are fundamental tools for proteomics, and are vital in many fi elds of biological 
investigation. Proteins and peptides are typically analyzed via mass spectrometry, a method that 
involves fragmenting samples by colliding them with gas atoms in a vacuum. Masses of the result-
ing fragments are measured, and computer algorithms match results with known or predicted 
molecules whose amino acid sequences are either known or inferred. Pappin has developed search 
engines for mass spectrometry data that enable investigators to sift hundreds of thousands of ex-
perimental spectra at a time for database matches. He also seeks to reduce sample complexity via 
an approach he calls chemical sorting. This includes the use of chelation to enrich phosphopep-
tides from the total peptide pool and the use of specifi c affi nity-tagged small-molecule inhibitors 
to segregate classes of kinases or phosphatases for more specifi c mass spectroscopic analysis.
Despite their large variety of genetic abnormalities, cancer cells have been found to be extremely 
sensitive to the reversal of certain mutations. Raffaella Sordella and colleagues study why cells in 
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certain cancers are responsive to the inhibition of one particular gene or gene product. Why, for 
instance, do non-small-cell lung cancer (NSCLC) cells that have a particular mutation in the EGF 
(epidermal growth factor) receptor respond dramatically to its inhibition by the drug Tarceva? 
This occurs in 15%–20% of patients, the great majority of whom, within 1–3 years, develop re-
sistance. Various mutations have been implicated in about half of resistant patients. Sordella and 
colleagues have discovered a new resistance mechanism in a subpopulation of NSCLC cells that 
are intrinsically resistant to Tarceva. These tumor cells were observed to secrete elevated amounts 
of a growth factor called transforming growth factor-ß (TGF-ß), which in turn increases secre-
tion of interleukin-6 (IL-6), an immune signaling molecule. Signifi cantly, these effects were 
independent of the epidermal growth factor receptor (EGFR) pathway. The team therefore hy-
pothesizes that infl ammation is one of the factors that can render a tumor cell resistant to treat-
ment with Tarceva. In other work, Sordella collaborates with the Krainer lab to study whether 
alternative splicing has a role in the failure of p53-mediated senescence to halt oncogenesis in 
certain lung cancers.
Nicholas Tonks and colleagues study a family of enzymes called protein tyrosine phosphatases, or 
PTPs, which remove phosphate groups from proteins and other signaling molecules, such as lipids, 
in cells. Disruption of PTP function is a cause of major human diseases, and several of the PTPs 
are potential therapeutic targets for such diseases. Tonks’ group seeks to characterize fully the PTP 
family, to understand how PTP activity is controlled, and to determine how PTPs modify signal-
ing pathways, and how those pathways are abrogated in serious illnesses, including cancer, diabetes, 
and Parkinson’s disease. The overall goal is to identify new targets and strategies for therapeutic 
intervention in human disease. Tonks and colleagues have defi ned new roles for PTPs in regulat-
ing signaling events in breast cancer, identifying three PTPs as novel potential tumor suppressors. 
They have characterized the regulation of PTP1B by reversible oxidation, demonstrating that it 
is regulated by covalent modifi cation of the active site by hydrogen sulfi de (H2S) under condi-
tions of ER stress that are linked to protein-folding-related pathologies, such as Parkinson’s and 
Alzheimer’s. In addition, they have generated recombinant antibodies that recognize selectively the 
oxidized conformation of PTP1B; these antibodies display the ability to promote insulin signaling 
in cells and suggest novel approaches to therapy for diabetes. Finally, they have also discovered a 
novel mechanism for allosteric regulation of PTP1B activity, offering the possibility of developing 
small-molecule drugs that could inhibit the phosphatase and thereby modulate signaling by insulin 
and the oncoprotein tyrosine kinase HER2, potentially offering new ways to treat insulin resistance 
in type-2 diabetes and breast cancer.
Lloyd Trotman’s recent research path traces to his discovery some years ago that the loss of a single 
copy of a master tumor suppressing gene called PTEN is suffi cient to permit tumors to develop in 
animal models of prostate cancer. His team later found that complete loss of PTEN paradoxically 
triggers senescence, an arrested state that delays or blocks cancer development in affected cells. 
These fi ndings explained why many patients only display partial loss of this tumor suppressor 
when diagnosed with prostate cancer. Now the team is researching ways to restore the PTEN 
protein levels in these patients. This therapy approach could slow disease progression and thus 
greatly reduce the need for surgical removal of the prostate or of similar drastic interventions that 
carry the risks of incontinence and impotence. Their second approach to combat prostate cancer is 
to model the lethal metastatic disease in genetically engineered mice. They are developing a novel 
approach that allows for quick generation and visualization of metastatic disease. The effi cacy 
of existing and novel late-stage therapies, such as antihormonal therapy, can then be tested and 
optimized in these animals. At the same time, the Trotman lab is exploring the genetic alterations 
associated with metastatic disease and with resistance to therapy. To this end, they use single-cell 
genome sequencing techniques developed at CSHL by Drs. Wigler and Hicks.
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David Tuveson’s lab uses mouse and tissue models of neoplasia to explore the fundamental biolo-
gy of these diseases and thereby identify new diagnostic and treatment strategies. His team’s main 
focus is pancreatic cancer, a lethal malignancy that has eluded clinical solutions despite intensive 
study. The lab’s approaches at CSHL run the gamut from designing new model systems of dis-
ease to inventing new therapeutic and diagnostic platforms for rapid evaluation in preclinical and 
clinical settings. For example, they have adopted a new method of culturing tissue fragments in-
defi nitely in cell culture, enabling deep analysis with genetic and pharmacological probes. Second, 
therapeutic experiments in mouse models have revealed an important role of redox metabolism 
and stromal interactions on infl uencing therapeutic response. Tuveson’s lab also has a strong link 
to clinical trials locally and internationally, with confi rmation in early phase trials the ultimate 
goal. Collectively, their strategy in the preclinical and clinical arena is codifi ed as the “Cancer 
Therapeutics Initiative,” and this initiative will provide these same approaches to the entire CSHL 
cancer community.
Linda Van Aelst’s lab studies how aberrations in intracellular signaling involving enzymes called 
small GTPases can result in disease. They are particularly interested in Ras and Rho GTPases, 
which help control cellular growth, differentiation, and morphogenesis. Alterations affecting 
Ras and Rho functions are involved in cancer and various neurodevelopmental disorders. Van 
Aelst’s team has extended its prior study of mutations in a Rho-linked gene called oligophrenin-1 
(OPHN1), part of an effort to connect the genetic abnormalities associated with mental retarda-
tion to biological processes that establish and modify the function of neuronal circuits. In addition 
to a role for OPHN1 in activity-driven glutamatergic synapse development, lab members have 
obtained evidence that OPHN1 has a critical role in mediating mGluR-LTD, a form of long-term 
synaptic plasticity, in CA1 hippocampal neurons. Their fi ndings provide novel insight not only 
into the mechanism and function of mGluR-dependent LTD, but also into the cellular basis by 
which mutations in OPHN1 could contribute to the cognitive defi cits observed in patients. De-
fects in cortical neurogenesis have been associated with cerebral malformations and disorders of 
cortical organization. The Van Aelst team discovered that interfering with the function of the Rho 
activator DOCK7 in neuronal progenitors in embryonic cerebral cortices results in an increase in 
the number of proliferating neuronal progenitors and defects in the genesis of neurons. In an ex-
tension of these studies, the Van Aelst team this year showed that DOCK7 has a central regulatory 
role in the process that determines how and when a radial glial cell progenitor “decides” to either 
proliferate, i.e., make more progenitor cells like itself, or give rise to cells that will mature, or “dif-
ferentiate,” into pyramidal neurons. These lines of research provide novel insight into mechanisms 
that coordinate the maintenance of the neural progenitor pool and neurogenesis.
Hongwu Zheng’s lab aims to defi ne the complex biology of malignant glioma pathogenesis, with 
the ultimate goal of translating the developed knowledge into patient benefi ts. Although eerily 
similar in terms of their self-renewal capacity and distinct phenotypic plasticity, malignant glioma 
cells conspicuously lack the terminal differentiation traits possessed by their normal counter-
parts—neural progenitors. With the use of multiple approaches combining human cancer genom-
ics, animal modeling, and stem cell biology, Zheng has unraveled the causal relationship between 
aberrant differentiation and ensuing gliomagenesis. Perhaps more importantly, his team has dem-
onstrated that forced restoration of differentiation capacity within glioma cells can drastically 
attenuate their tumorigenic potential. This fi nding fi ts well with the team’s overall strategy, which 
is to target differentiation control pathways as a novel avenue for malignant glioma treatment. To 
this end, they have sought (1) to develop various animal models to recapitulate the human glioma 
pathogenesis and utilize them to trace and investigate in vivo tumor initiation/progression and (2) 
to identify key pathways/players controlling normal and neoplastic neural progenitor cell renewal 
and fate determination.
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THE INFLUENCE OF THE TUMOR MICROENVIRONMENT 
ON DRUG RESISTANCE AND METASTASIS
M. Egeblad J. Cappellani T. Kees J. Park J. Qiu R. Wysocki
 M. Fein E. Nakasone J.-H. Park M. Shields
Interactions between epithelium and stroma are es-
sential for normal organ development. The stroma is 
the supportive framework of the organs and includes 
the extracellular matrix (ECM), stromal cells such as 
fi broblasts and adipocytes, cells of the vascular sys-
tem, and immune cells. Like organs, solid tumors are 
composed of cancer cells and stroma, which is also 
known as the tumor microenvironment. As tumors 
develop and progress, dramatic changes occur in both 
the cancer cells and the microenvironment.
We study how the tumor microenvironment infl u-
ences cancer cells in the context of drug resistance and 
metastasis. We use mouse models of breast and pancre-
atic cancer together with real-time spinning-disk confo-
cal microscopy of tumor–stroma interactions in living 
mice. This allows us to study how cancer cell prolifera-
tion, migration, and survival are infl uenced by vascular 
changes or myeloid cell infi ltration in real time.
Effects of the Tumor Microenvironment 
on Response to Cancer Therapy
E. Nakasone, M. Fein, T. Kees, J.-H. Park, J. Park, J. Qiu, 
R. Wysocki
When tumors do not respond to treatment, patients die. 
Understanding the mechanisms of therapy response 
and resistance is therefore of vital concern. Surprising-
ly, little is known about how cancer cells in intact tu-
mors respond to classical chemotherapy, although these 
drugs have been used for decades. Most knowledge on 
the responses has been obtained from cell culture or xe-
nograft animal experiments, but such experiments are 
often not predictive of drug responses in patients.
We are using in vivo spinning-disk confocal im-
aging to study responses to anticancer drugs, such as 
the chemotherapeutic drug doxorubicin, in the con-
text of evolving tumor microenvironments. Imaging 
revealed that cancer cell death started ~24 h after 
doxorubicin treatment, and the cells died by necro-
sis and not apo ptosis. We further revealed that the 
microenvironment of different tumor stages partici-
pated in regulating the drug response. Early-stage and 
very late-stage lesions responded poorly compared 
to intermediate-sized, early- carcinoma-stage tumors. 
However, in vitro, sensitivity to doxorubicin was simi-
lar for cancer cells from different stages. Live imag-
ing of doxorubicin penetration further revealed that 
drug penetration was infl uenced by the tumor stage. 
Thus, the acute cell death response to doxorubicin 
correlated with the infi ltration of the drug (Nakasone 
et al. 2012). Matrix metalloproteinase (MMP) 9 is an 
ECM-degrading enzyme that regulates vascular per-
meability. We determined that the lack of MMP9 ac-
tivity increases phosphorylation of vascular endothe-
lial (VE)-cadherin, leading to loose cell-cell junctions 
between endothelial cells. We determined that both 
mouse mammary tumor virus (MMTV)-Neu and 
MMTV-PyMT tumors responded signifi cantly bet-
ter to treatment with doxorubicin in mice that lacked 
MMP9 activity (Nakasone et al. 2012).
Doxorubicin treatment also led to a new microen-
vironment, with recruitment of new myeloid-derived 
cells. Imaging revealed that myeloid cells were re-
cruited to tumors ~30 h after chemotherapeutic treat-
ment with doxorubicin and after cancer cell death 
was observed. We determined that activation of the 
chemokine receptor CCR2 on monocytes, caused by 
the CCL2 chemokine that was secreted from stromal 
cells, led to recruitment of the cells to the tumors. 
We further determined that the infi ltration of these 
CCR2-positive monocytes contributed to chemore-
sistance, as the effect of doxorubicin and cisplatin on 
tumors transplanted to mice lacking CCR2 was sig-
nifi cantly better than that of tumors in normal mice 
(Nakasone et al. 2012). Furthermore, when tumors 
recurred in mice lacking CCR2, they were of lower 
histological grade than tumors relapsing in wild-type 
mice.
Imaging intact tumors acutely after treatment with 
chemotherapy thus revealed a complex and evolving 
relationship between microenvironment and the drug 
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sensitivity of cancer cells. We are currently working on 
implementing imaging windows in our analysis, as this 
technology will allow us to image repeatedly days apart 
and therefore to study long-term response to therapy, 
including relapse.
Effects of Myeloid Cells on Breast 
Cancer Metastasis
M. Fein, J. Park
The prognosis of metastatic breast cancer is poor. 
More than a century ago, Dr. Stephen Paget observed 
that metastases develop preferentially in certain or-
gans, suggesting that factors external to cancer cells 
infl uence metastasis. Indeed, it is now recognized that 
growth factors and cytokines secreted by myeloid- 
derived cells have an important role in the formation 
of metastasis.
Traditionally, studies on metastasis have relied pri-
marily on measurements made at the endpoint of the 
process, the establishment of micro- or macrometas-
tases. However, the metastatic process is dynamic and 
characterized by the ability of cancer cells to move 
from one part of the body to another: Cells exit the 
primary tumor, invade the local tissue, enter blood or 
lymphatic vessels, and are transported to a distant site 
where they exit the vessels and move into the tissue. 
Thus, a different level of understanding of metastasis 
might be achieved using technologies that can follow 
these dynamic processes in vivo.
Our laboratory is using spinning-disk confocal 
microscopy to determine how interactions between 
myeloid-derived cells and cancer cells infl uence me-
tastasis. We are comparing the microenvironment 
of tumors formed from the metastatic 4T1 and the 
nonmetastatic 4T07 cell lines, isolated from the same 
breast tumor. We have identifi ed signifi cant differ-
ences in the types of chemokines that are secreted by 
the cancer cells and in the nature of the myeloid cell 
infi ltrate between the metastatic and nonmetastatic 
tumors. Strikingly, tumors grow slower and metasta-
sis is greatly reduced in mice that lack the receptor for 
one of the specifi c chemokines that is secreted by met-
astatic cancer cells. Ongoing studies are addressing 
how the chemokine–chemokine receptor signaling 
axis between cancer cells and myeloid-derived cells 
infl uences metastasis, and preliminary data strongly 
suggest that reactive oxygen species are involved.
Using Tumoricidal Activities of Macrophages
T. Kees, M. Shields
Tumor-associated macrophages have tumor-support-
ing activities and their infi ltration is associated with 
poor patient prognosis. However, macrophages are ca-
pable of killing tumor cells if they are activated with 
interferon-γ (IFN-γ) and agonists of receptors for 
pathogen-associated molecular patterns. We are using 
live cell imaging of co-cultures between macrophages 
and breast and pancreatic cancer cells to understand 
the mechanisms responsible for the tumoricidal ac-
tivities. We have determined that such macrophage-
mediated cancer cell killing is highly effective and 
requires direct cell-cell contact between macrophages 
and cancer cells. A mediator of cancer cell killing has 
been identifi ed and is under further investigation. Live 
imaging has also revealed that a small number of can-
cer cells survive the tumoricidal activities of macro-
phages. Such macrophage-evading cancer cells would 
be of great importance for therapeutic translation, and 
thus we used RNA sequencing to identify candidate 
genes involved in the evasion. Several candidates are 
under further investigation.
Antigen-Presenting Myeloid Cells Stably 
Engage Tumor-Speciﬁ c T Cells in the 
Tumor Microenvironment
This work was done in collaboration with M. Krum-
mel, University of California, San Francisco. Antigen 
presentation in the tumor microenvironment should 
lead to activation of tumor-specifi c T cells, and there-
by cytotoxic activities against the tumor. Although T 
cells with specifi c reactivity have been isolated from 
many solid tumors, the immune system is not capable 
of eradicating most tumors. To determine the poten-
tial inhibitory activities on T-cell responses, a fl uores-
cent- and antigen-linked transgenic model of breast 
cancer was developed. This model enabled live imag-
ing of antigen presentation in situ. The primary cells 
responsible for ingesting tumor antigens and present-
ing them to T cells were identifi ed as low-motility my-
eloid cells, with properties of both dendritic cells and 
macrophages. Marker analysis further demonstrated 
that these antigen-presenting cells were a subset of 
the myeloid cells that previously have been implicated 
in tumor remodeling. These antigen-presenting cells 
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localized along tumor margins and engaged in long-
lived interactions with tumor-specifi c T cells. In vitro, 
these myeloid cells could capture cytotoxic T cells in 
signaling-competent conjugates. Yet, the interaction 
did not support full T-cell activation or sustain cytoly-
sis of cancer cells. Thus, these antigen-presenting cells 
fail to stimulate T cells and may serve as a barrier to 
an effective T-cell response. This work demonstrated 
the behavior of tolerized T cells within tumors and 
identifi ed a target for immunotherapies.
Functional Genomic Approaches 
to Determine How Cancer Cells 
and Microenvironment Interact
This work was done in collaboration with Scott Pow-
ers here at CSHL. Fibroblasts are one of the most 
prevalent stromal cell types in solid tumors. They 
have been shown to promote cancer cell proliferation, 
angiogenesis, ECM remodeling, infl ammation, inva-
sion, and metastasis. Tumors containing a high per-
centage of cancer fi broblasts tend to be higher grade 
and are associated with poor prognosis.
With Scott Powers, we have undertaken a genome-
wide approach to identify and test genes in fi broblasts 
that are both induced upon interaction with basal 
breast cancer cells in culture and up-regulated in stro-
mal cells from primary human breast cancers. We 
identifi ed both new and previously recognized fi bro-
blast-secreted factors induced by breast cancer cells. 
Several of the up-regulated genes encode secreted 
growth factors or cytokines. Using RNA interference 
(RNAi) and a co-injection tumorigenicity assay, three 
of fi ve tested fi broblast-secreted factors had equally 
major roles in promoting tumorigenicity. Interest-
ingly, the fi broblast-secreted factors had function-
ally diverse roles in promoting tumorigenicity, such 
as stimulation of tumor cell proliferation, of innate 
immune cell infi ltration, and of angiogenesis. Rather 
than a single major mediator, these results indicate 
multiple points of intervention to prevent fi broblasts 
from supporting basal breast cancer. Additionally, we 
show that breast cancer subtypes differ markedly in 
the expression of these and other stromally secreted 
proteins. We are currently performing imaging of the 
development of tumor–fi broblast interactions in live 
mice to gain insights into how specifi c factors might 
be targeted for cancer treatment.
Collagen Architecture in Pancreatic 
Cancer Progression
M. Shields, J. Cappellani
The interstitial matrix is a major category of the ECM 
and consists of macromolecules such as fi brillar colla-
gens, fi bronectin, and proteoglycans. Type I collagen 
is the major fi brillar collagen in tissues and forms a 
scaffold that provides stability. Type I collagen also 
has signaling functions mediated by integrins and dis-
coidin domain receptors. The synthesis and proteolyt-
ic remodeling of the fi brillar type I collagen increases 
in many tumors, particularly in pancreatic tumors.
Tumors are often discovered as nodules that are 
harder than the surrounding tissue. This refl ects the 
changes in extracellular matrix stiffening and archi-
tecture. An abnormal collagen architectural structure 
correlates with tumor progression. Whereas collagen 
fi bers are curly and oriented in parallel to normal or 
hyperplastic epithelium, there is a progressive change 
in the fi bers so that they are straighter and mostly 
perpendicular to the tumor border in the late stages. 
This changed architecture may promote cell invasion 
by enabling cells to migrate along the collagen fi bers or 
by enhancing integrin signaling. Enzymes of the lysyl 
oxidase family, involved in collagen fi ber cross-linking, 
promote cancer progression and metastasis. In collabo-
ration with Dr. Weaver’s lab at University of California, 
San Francisco, we previously reported that inhibiting 
collagen cross-linking in mouse models of mammary 
carcinoma delays tumor onset and slows tumor progres-
sion. Pancreatic cancer has a very higsh level of type I 
collagen, and we are currently investigating the effects 
of collagen cross-linking in pancreatic carcinoma.
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PROTEOMICS LABORATORY AND PROTEOMICS 
SHARED RESOURCE
D. Pappin S. Bencze S. Peacock C. Ruse
 C.M. Gauss K. Rivera J. Wilson
 T. Hassan 
Testing the Putative Lipase Activity 
of Zucchini
This work was done in collaboration with J. Ipsaro, 
L. Joshua-Tor, A. Haase, and G. Hannon (Cold Spring 
Harbor Laboratory).
Recent genome-wide screens have identifi ed a num-
ber of molecules involved in Piwi-interacting RNA 
(piRNA) biogenesis and action. One of these pro-
teins, Zucchini, was identifi ed as a key biogenesis fac-
tor, but its mechanism of action remained unclear. 
This ambiguity stemmed from the bioinformatic 
categorization of Zucchini into the phospholipase D 
family of phosphodiesterases, which includes both li-
pases and nucleases. To determine the biochemical 
function of this protein, a number of in vitro studies 
were designed. Recombinantly purifi ed protein was 
incubated with liposomes, and the reaction prod-
ucts were followed by MRM-MS (multiple-reaction 
monitoring−mass spectrometry). Using this method, 
Zucchini was not found to possess detectable lipase 
activity compared to controls. Complementary bio-
chemical and structural studies in the Hannon and 
Joshua-Tor labs, respectively, have since shown this 
protein to be a nuclease.
Intact Mass Measurements 
of Methylation Targets
This work was done in collaboration with J. Ipsaro and 
L. Joshua-Tor (Cold Spring Harbor Laboratory).
Posttranslational modifi cation of proteins has long 
been established as a means to regulate protein lo-
calization and/or function. In the case of PRMT 
(protein arginine methyltransferase) targets, argi-
nine residues are able to be methylated, or in some 
cases dimethylated. These posttranslational marks 
often complete molecular epitopes that can subse-
quently be recognized by binding partners of the 
methylation target. To study the activity of one such 
methyltransferase, an in vitro methylation assay 
was performed on an array of arginine-containing 
substrates. The intact masses of these substrates 
were then assessed by ESI-MS (electrospray ioniza-
tion−mass spectrometry) to determine the extent of 
their methylation. While these studies are ongoing, 
the robustness of the ESI-MS assay unambiguously 
resolves the number of methylation events on any 
given protein target and allows for relatively rapid 
determination of the methylation profi les of a num-
ber of targets.
Mapping the Long Noncoding RNA 
Interactome
This work was done in collaboration with J. Bergmann 
and D. Spector (Cold Spring Harbor Laboratory).
In an RNA sequencing screen, we have identifi ed a 
series of nuclear-enriched long noncoding RNAs 
 (lncRNAs) expressed at moderate abundance in mouse 
embryonic stem cells (ESCs). To identify proteins in-
teracting with two of these lncRNAs, we generated 
biotinylated lncRNAs and control RNA by in vitro 
transcription. Biotinylated transcripts were purifi ed, 
folded in RNA structure buffer, and subsequently 
incubated with nuclear extracts prepared from either 
mouse AB2.2 ESCs or NIH-3T3 fi broblasts. Ribonu-
cleoprotein (RNP) complexes were pulled down with 
streptavidin Dynabeads, washed, and eluted into pro-
tein sample buffer. Proteins were separated by SDS-
PAGE and visualized by silver staining. Protein bands 
specifi cally present or markedly enriched in lncRNA 
pull-downs versus controls were excised and processed 
for in-gel tryptic digest and analysis by mass spec-
trometry. Several proteins of interest were initially 
identifi ed, and we have decided to stop further in vitro 
pull-down analysis in favor of alternative approach-
es aimed at yielding a more comprehensive lncRNA 
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interactome. To this end, we are in the process of 
generating ESC stably expressing lncRNA candidates 
tagged with a bacteriophage MS2 stem-loop cassette. 
MS2-lncRNPs will be pulled down via the MS2 coat 
protein fused to enhanced yellow fl uorescent protein 
(EYFP). We plan to use UV cross-linking followed 
by pull-down of the MS2 RNP, stringent washes, and 
subsequent two-dimensional multidimensional pro-
tein-identifi cation technology (MudPIT) proteomics 
analysis to describe the “complete” in vivo interac-
tome of our lncRNA candidates.
Role of Phosphoinositide Lipids in Signal 
Transduction
This work was done in collaboration with A.M. Naguib and 
L. Trotman (Cold Spring Harbor Laboratory).
Phosphoinositide lipids comprise a small fraction 
of total cellular lipids but perform essential roles 
in signal transduction. Among many other func-
tions, these include propagating signals through a 
variety of signaling axes. We have recently devel-
oped a mass spectrometry (MS) technique for the 
identifi cation and quantifi cation of these important 
molecules. This high-throughput, automated system 
for analysis of cellular lipid preparations is capable 
of analyzing and quantifying the entire “phos-
phoinositide lipidome” from cells. This technique 
allows the unambiguous identifi cation of phos-
phoinositide (PI), phosphoinositol phosphate (PIP), 
and phosphoinositide bisphosphate (PIP2) species 
and assessment of their relative abundance. Auto-
mation of this method allows interrogation of tens 
to hundreds of samples in a single run. Phospholipid 
composition (fatty-acid content, double-bond con-
tent, phosphorylation status) has direct implications 
for membrane thermodynamics and signaling path-
ways. Wide-scale assessment of these parameters al-
lows understanding of these vital molecules for the 
fi rst time and can be used to follow the dynamic 
alterations in their state following a variety of cel-
lular treatments. This includes (but is not restricted 
to) clinical drug application and changes in nutri-
ent abundance. Presently, we are assessing the phos-
phoinositide lipidome of a panel of cell lines under 
a variety of conditions, for the fi rst time generating 
both a catalog of this lipid species and an under-
standing of their changing composition.
Proteomic Analysis of Exosomes
This work was done in collaboration with S. Chakrabortty 
and T. Gingeras (Cold Spring Harbor Laboratory).
Intercellular transference of RNA through exosomes 
has recently emerged as a possible novel mode of com-
munication between cells and tissues of multicellular 
organisms. Exosomes are small 40−100-nm vesicles 
of endocytic origin that are secreted into the extra-
cellular milieu upon fusion of multivesicular bodies 
(MVBs) to the plasma membrane. Not only are exo-
somes secreted by many cultured mammalian cells, 
they also appear to be abundantly present in various 
body fl uids such as serum, plasma, urine, saliva, and 
cerebrospinal fl uid. Because of their endocytic ori-
gin, exosomes also contain many proteins involved in 
membrane transport and fusion (e.g., Rab proteins), 
multivesicular body biogenesis (e.g., Tsg101 and Alix), 
integrins, tetraspanins, and heat shock proteins (e.g., 
hsp70 and hsp90). Exosomes are also known to be 
enriched in raft-lipids such as cholesterol, sphingo-
lipids, and glycerophospholipids. RNA-Seq analysis 
of exosomes pointed to the presence of both mRNA 
and several classes of small regulatory RNA, including 
microRNA (miRNA). Although several annotated 
classes of short RNAs were found to be enriched in 
exosomes, the regulatory machinery in the cell in-
volved in sorting RNA to these extracellular vesicles 
is unknown. We speculate that specifi c RNA-binding 
proteins may be involved in this enrichment process. 
To address this question, mass spectrometric analysis 
of purifi ed K562 exosomes was performed. A total of 
462 proteins were reproducibly detected between the 
replicates, of which 101 were characterized as having 
RNA-binding properties along with other functional 
associations. These proteins constitute an interest-
ing collection of candidates for further analyses to 
determine their possible role in RNA enrichment in 
exosomes, or as convenient biomarkers for the extra-
cellular vesicles.
Phosphorylation of Ago2 in Senescence
This work was done in collaboration with M. Yang and N. 
Tonks (Cold Spring Harbor Laboratory).
We are looking at the tyrosine phosphorylation change 
in Ago2 in human primary cells during the process of 
oncogene-induced senescence. Previous studies with 
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mutant Ago2 transfected into 293 cells suggested that 
a specifi c tyrosine residue (Y393) might be responsive 
to oncogenic Ras stimulation and regulated by PTP1B 
(the phosphatase we are also interested in studying). 
We are attempting to determine if endogenous Ago2 
undergoes similar phosphorylation during Ras-induced 
senescence in human cell lines. To test this, we have 
immunoprecipitated Ago2 using a specifi c antibody 
and are using MRM methods to look at changes in 
specifi c phosphorylation of Y393. One technical chal-
lenge we are facing is that there are multiple S/T resi-
dues on the same tryptic peptide as Y393, which also 
seem to undergo phosphorylation (as suggested by MS 
data). This signifi cantly increases the complexity of 
our MRM transitions and measurements. We are pres-
ently trying to confi rm that the multiple phosphoryla-
tion is indeed present in the immunoprecipitation (IP). 
To do this, we fi rst immunoprecipitate Ago2 and then 
perform on-bead digestion with trypsin. The tryptic 
peptides are then treated with PTP1B (dephosphorylat-
ing only pY) or γ-phosphatase (general phosphatase) to 
see if the treatment causes a corresponding decrease in 
the signal intensity of the MRM transition masses de-
rived from potential multiple phosphorylated peptides. 
When this work is completed, we aim to have a rapid 
MRM method that can be used to follow changes in 
Y393 phosphorylation as cells move toward senescence.
Characterization of Mouse Models 
of Vascular Inﬂ ammation
This work was done in collaboration with L. Li and 
N. Tonks (Cold Spring Harbor Laboratory).
In a mouse model of vascular infl ammation, we have 
found that wild-type mice develop skin injury after 
challenge with lipopolysaccharide−tumor necrosis 
factor-α (LPS-TNF-α). Interestingly, phosphatase 
Jsp1 knockout mice were apparently free of skin le-
sions following insult. Subsequent studies have identi-
fi ed neutrophils as the cells that are responsible for the 
vascular lesion phenotype, and functional assays have 
suggested that the adhesion step is Jsp1-dependent, 
possibly through integrin signaling. To identify the 
targets of JSP1 in integrin signaling, we have prepared 
samples of mouse bone-marrow-derived neutrophils, 
with and without JSP1 and with or without integrin 
activation, for proteomic analysis. We are particularly 
interested in the phosphorylation status of Hck and 
Syk (two major kinase candidates in the integrin sig-
naling in neutrophils). MRM assays were devised to 
monitor two phosphorylation sites in each of these 
kinases, one in the activation loop that needs to be 
phosphorylated to be fully functional and the second 
in a negative phosphorylation site that needs to be 
dephosphorylated to activate the kinase. These assays 
will be used to test the hypothesis that Jsp1 dephos-
phorylates the negative phosphorylation site to acti-
vate the kinase.
Proteomic Analysis of Proximal Pulmonary 
Venous Blood to Identify Biomarkers for 
Non-Small-Cell Lung Cancer
This work was done in collaboration with R. Sordella and 
I. Tas (Cold Spring Harbor Laboratory) and B. Stiles and 
O. Elemento (Cornell University).
More than 220,000 patients are diagnosed each year 
with lung cancer in the United States, with an overall 
5-year survival of ≤15%. This is due to the advanced 
stage at diagnosis and to diffi culties in detecting early 
tumors. As in the case of prostate-specifi c antigen 
(PSA) for prostate cancer, a reliable and easily acces-
sible biomarker would prove invaluable in the early 
identifi cation of patients with non-small-cell lung 
cancer (NSCLC). We are implementing a novel strat-
egy to identify biomarkers from the serum of NSCLC 
patients by mass spectroscopy using iTRAQ (isobaric 
tagging for relative and absolute quantitation) tech-
nology. Unlike previous efforts aimed at identify-
ing serum biomarkers using peripheral blood from 
NSCLC patients, in our studies, the peripheral blood 
is being used only as reference, whereas the blood 
draining directly from the tumor (pulmonary vein) 
will instead be used for biomarker identifi cation. Be-
cause of its proximity to the cancer, the pulmonary 
venous blood (PVB) is highly enriched for tumor pro-
teins, potentially allowing for greater sensitivity of de-
tection of relevant proteins. In addition, each patient 
will serve as his/her own control, eliminating many 
of the sources of heterogeneity that have plagued 
the serum proteomic fi eld and hampered biomarker 
discovery. The proteomic signature elaborated from 
the PVB will then be validated in the  peripheral blood 
using more sensitive targeted techniques such as single- 
and multiple-reaction monitoring and the clinical 
applicability tested in an independent set of blood 
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from patients screened for lung cancer. We have now 
analyzed pulmonary venous blood, nontumor, and 
peripheral blood samples from 16 patients using the 
8-plex iTRAQ reagent and 17-step MudPIT LC-MS. 
Preliminary data analysis is being performed now, and 
we anticipate collection of data from at least 20 addi-
tional patients over the next 12 months.
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MOLECULAR TARGETED THERAPY OF LUNG CANCER EGFR 
MUTATIONS AND RESPONSE OF EGFR INHIBITORS
R. Sordella M. Camiolo T. Lindsted N. Shirole
 P. Debjani M. Pineda Z. Yao
 V. Himenez S. Senturk
There is a broad consensus that, in essence, every 
tumor contains distinct cell subpopulations charac-
terized by different morphologies, proliferation rates, 
levels of antigen expression, and metastatic potentials. 
This intratumor heterogeneity has direct clinical im-
plications for disease classifi cation and prognosis as 
well as for treatment effi cacy and the development 
of resistance to cancer therapies. Hence, obtaining a 
more detailed understanding of the origin of tumor 
clonal heterogeneity and of molecular features of dis-
tinct tumor cell populations is of fundamental rele-
vance and could facilitate the development of more ef-
fective therapies. Large-scale analyses of solid tumors 
have revealed that by the time a cancer is diagnosed, 
it is composed of billions of cells carrying a large 
number of genetic mutations. Single-tumor high-
resolution genomic maps indicate that these genetic 
lesions are not uniformly distributed but that within a 
tumor, discrete populations carry distinct mutations. 
This suggests that the evolution of genetically diverse 
populations underpins the clonal diversity observed in 
tumors.
In addition to this theory, it has been recently 
proposed that intratumor heterogeneity could be ex-
plained by the capability of phenotypically distinct 
cell populations to transit between conditional inter-
changeable cell states (i.e., degeneracy). Although the 
molecular mechanisms regulating degeneracy in tu-
mors are still largely unknown, the degeneracy theory 
differs from previous models based on the accumula-
tion of genetic aberrations as degeneracy is more rapid 
and is reversible. This implies that tumor cells can 
swiftly evolve and easily adapt to an ever-changing 
environment. To study tumor degeneracy, we used as 
a paradigm the ontogeny of a tumor cell subpopula-
tion characterized by increased expression of the sur-
face glycoprotein CD44 and the decreased expression 
of CD24.  CD44highCD24low cells have been described 
in multiple types of tumors including non-small cell 
lung carcinomas (NSCLCs), glioblastomas, and leio-
myosarcomas and tumors of the breast, colon, pros-
tate, and ovaries. These cells are characterized by 
increased seeding capacity and invasiveness and high 
self-renewal and metastatic potentials. Interestingly, in 
the context of cells harboring epidermal growth factor 
receptor (EGFR) oncogenic mutations, CD44highCD-
24low cells also have increased resistance to EGFR in-
hibitors.
An Epigenetic Switch Modulates Cancer 
Cell-State Plasticity by Regulating miR-335 
Expression
Among the many possible regulators of cell degener acy, 
we sought to investigate how microRNAs (miRNAs), 
an important class of posttranscriptional regulators, 
might be involved in regulating the ontogeny of 
 CD44highCD24low cells. miRNAs have been proposed 
to limit stochastic fl uctuation of biological systems, 
making them attractive candidates for the regulation 
of cell-state transitions and maintenance. miRNAs 
are small (~22 nucleotides) noncoding RNAs consti-
tuting a novel class of gene regulators that posttran-
scriptionally repress gene expression by initiating the 
degradation or blocking translation of target mRNAs. 
More than 1000 unique mature miRNAs have been 
identifi ed in the human genome and each may regu-
late up to 200 mRNAs. It is estimated that ~30% of 
all human gene transcripts are targeted by miRNAs, 
involving these small RNAs in the regulation of vir-
tually all cellular processes (Bartel [2004]; Griffi ths-
Jones [2006]).
We found that miR-335 has a critical role in the 
ontogeny of CD44highCD24low cells. Down-regulation 
of miR-335 was suffi cient to induce phenotypic and 
molecular features characteristic of CD44highCD24low 
cells. In particular, miR-335 repressed a molecular 
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circuitry that, when activated, leads to the epithelial-
to-mesenchymal transition (EMT) and increased mo-
tility and invasion as previously reported; it also results 
in a switch in immunotype, in cell vulnerabilities, and, 
in the case of breast cancer cells, in a transition from a 
luminal to a basal-like subtype. Importantly, miR335 
regulates the expression of genes such as TGF-β, 
WNT5a, and IL-6, which were previously shown to 
mediate important aspects of the CD44highCD24low 
cell state. Interestingly, in all CD44highCD24low cells 
examined, we observed that miR-335 and its host gene 
mesoderm specifi c transcript (MEST ) are epigenetically 
coregulated. Chromatin immunoprecipitation re-
vealed an increased binding of the transcriptional re-
pressor neuron-restrictive silencing factor (NRSF) to 
the MEST promoter region or knockdown of NRSF 
decreased DNA methylation and induced reexpres-
sion of MEST isoform 2 and miR-335 in CD44high/
CD24low cells. These fi ndings suggest that heterochro-
matin-mediated silencing of MEST is suffi cient to 
modulate miR-335 expression and CD44high/CD24low 
cell-state plasticity. In summary, our studies defi ne a 
novel mechanism that couples epigenetic inheritance 
to degeneracy of tumor cell populations. In principle, 
this could provide a molecular basis to explain the 
adaptability of tumor cells to their ever-changing en-
vironment and to drug treatment.
p53Ψ Is a Neomorphic p53 Isoform That 
Reprograms Cells toward the Acquisition 
of Metastatic-Like Features Despite 
Lacking Transcriptional Activity
p53 is a highly evolutionarily conserved transcription 
factor whose origin can be traced back to early meta-
zoans and predates the cnidarian-bilaterian diver-
gence, ~700 million years ago. Somatic p53 mutations 
occur in almost every type of cancer, at rates from 
38% to 50% depending on the tumor type. Muta-
tions are more frequent in advanced-stage cancer or in 
cancer subtypes that are highly metastatic. In cancers 
with low mutation rates, p53 is often inactivated by 
alternative mechanisms.
In response to strong cellular stresses such as DNA 
damage or oncogenic signals, p53 regulates the expres-
sion of a large cohort of genes that affect cell cycle 
arrest, senescence, and apoptosis. Recent fi ndings 
have uncovered additional roles of p53 under basal 
physiological conditions, including regulation of devel-
opment, reproduction, metabolism, and self-renewal 
capacity. In this regard, of particular interest is the re-
cent publication indicating that p53 represses at steady 
state the surface trans-membrane glycoprotein CD44.
CD44 is a trans-membrane glycoprotein essential 
for the motility of bone-marrow-derived cells, fi bro-
blasts, and certain cancer cells. In addition, CD44 
modulates cell growth by regulating the availability 
of growth factors and by altering cell metabolism. 
Hence, it is not surprising that CD44 has a critical 
role during tissue remodeling, fi brosis, and metastatic 
dissemination.
The observation that upon injury, CD44 is increas-
ingly expressed in tissues that are wild type for p53 led 
us to investigate the regulation of p53 in these cells. 
To probe a possible regulation of p53 in CD44high 
cells, we used a murine lung injury paradigm based on 
intraperi toneal naphthalene administration. Admin-
istration of naphthalene causes rapid necrotic change 
within Clara cells of the terminal and respiratory bron-
chioles due to conversion of the drug into a toxic form 
by the cell-specifi c microsomal enzyme Cyp2F2. Con-
sistent with a decreased activation of p53 in CD44high 
cells, expression analysis of known p53-regulated 
genes revealed decreased expression of Triap1, Sens1, 
Sens2, Pgam1, Pgam2, Sco1, Sco2, Tigar, and Gpx1 in 
 CD44high/CD24low cells.
Prompted by this observation, we next deter-
mined the expression of p53 in these cells. Reverse 
transcriptase−polymerase chain reaction (RT-PCR) 
analysis using primers localized in exons 6 and 8 indi-
cated a less intense and slower migrating band in the 
 CD44highCD24low cells. Sequence analysis revealed 
the existence of a novel p53 mRNA variant gener-
ated by the usage of an alternative 3′ splice acceptor 
site within intron 6 that is highly conserved across 
species. We referred to this p53 variant as p53Ψ.  We 
confi rmed this observation by RT-PCR analysis using 
primers that are specifi c for this isoform in multiple 
lung tissue samples upon injury.
p53 is mutated in more than 50% of cancers; hence, 
we undertook to determine whether p53Ψ represents 
a novel mode of regulation of p53 in human tumors. 
Notably, ~30% of early-stage NSCLC tumors are 
characterized by a CD44highCD24low immunotype.
To this end, we assessed expression of p53Ψ and 
p53FL by an RNA fl uorescence in situ hybridization 
(FISH) technique in a tissue microarray composed of 
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NSCLC tissues from 233 patient cases. The major-
ity of these tumors are early-stage adenocarcinomas. 
p53Ψ- and p53FL-specifi c probes were designed and 
validated in tumor-derived cell lines. When lung 
tumor samples were stained for p53Ψ, we observed sig-
nifi cant heterogeneity of staining. Overall, we found 
that although certain tumors were clearly enriched for 
p53Ψ (22.3%), others were devoid of p53Ψ expression. 
Interestingly, tumor cores positive for p53Ψ tended to 
be enriched for CD44high/CD24low cells.
As described above, although with different repre-
sentation, cells characterized by a CD44highCD24low 
immunotype have been described in virtually all 
tumor- derived cell lines. Because in principle these 
CD44highCD24low cells are genetically identical to the 
cells of all other immunotypes that are present in the 
main population, we undertook to determine whether 
p53Ψ was also in these cells regulated by alternative 
splicing. RT-PCR analysis of fl uorescence-activated 
cell sorting (FACS) from multiple tumor-derived cell 
lines that are wild type for p53 revealed the presence 
of p53Ψ expression exclusively in CD44highCD24low 
cells.
In summary, altogether, these observations in-
dicated the existence of a novel p53 isoform gener-
ated through an alternative splicing event that is 
conserved across species. At the molecular level, the 
use of an alternative 3′ splice site in intron 6 gen-
erates a previously uncharacterized p53 isoform that 
is incapable of sequence-specifi c DNA binding and 
trans-activation of canonical p53 target genes. Yet, 
 expression of this isoform, p53Ψ, attenuated the expres-
sion of E-cadherin but induced expression of mark-
ers associated with EMT and enhanced the invasive 
and prometastatic capacity of cells through a novel 
mechanism involving the activation of ROS by CpD. 
Although it was previously shown that p53 controls 
ROS (reactive oxygen species) levels through mul-
tiple mechanisms, the fact that ectopic expression of 
p53Ψ in p53FL cells was unable to modify the ex-
pression of Tigar, Sens1, Sens2, Gpx1, Bax, and Puma 
strongly supports the existence of a novel transcrip-
tion-independent mechanism of ROS production by 
p53Ψ. Consistent with these observations, we found 
that increased expression of p53Ψ in tumors corre-
lated with poor prognosis and that its expression was 
increased in CD44high/CD24low cells both in tumors 
and in injured tissues. In these cells, the expression of 
p53Ψ at the expense of p53FL, although antagoniz-
ing p53 tumor suppressor activities, may act to facili-
tate proliferation and invasion into damaged tissue to 
facilitate wound repair. The observation that p53Ψ is 
expressed both in highly metastatic cells and as part 
of tissue injury/repair mechanisms supports previ-
ous fi ndings suggesting tumors retain physiological 
responses of normal tissues and that the metastatic 
program is part of an abnormal activation of tissue in-
jury/repair mechanisms. In this regard, fascinatingly, 
tumors have been referred to as “wounds that never 
heal.” The remarkably similar activities of p53Ψ with 
certain p53 “gain-of-function” mutants, which also 
reduce E-cadherin expression and facilitate invasion, 
also suggests that these p53 mutations “highjack” 
a regulated and reversible program that in normal 
tissues coordinates the tissue damage response and 
contributes to the biology of p53 mutations during 
tumorigenesis. Hence, in principle, it suggests a phys-
iological origin for p53 “gain-of-function” mutants.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL 
OF SIGNAL TRANSDUCTION
N.K. Tonks G. Bencze G. Fang M. Ramesh
 F. Chaudhary N. Krishnan M. Yang
 X. Cheng L. Li X.C. Zhang
The phosphorylation of tyrosyl residues in proteins is 
a key component of the regulation of signaling path-
ways that control many fundamental physiological 
processes, including cell proliferation, differentiation, 
and survival. Protein phosphorylation is a reversible, 
dynamic process in which the net level of phosphate 
observed in a target substrate refl ects the coordinated 
activity of the kinases that phosphorylate it and the 
protein phosphatases that catalyze the dephosphoryla-
tion reaction. We study the family of protein tyrosine 
phosphatases (PTPs), which, like the kinases, com-
prise both transmembrane, receptor-linked forms and 
nontransmembrane, cytoplasmic species and represent 
a major family of signaling enzymes. Overall, the ob-
jective of the lab is to develop tools for analysis of PTP 
regulation and function and integrate them with state-
of-the-art cell and animal models, to defi ne critical 
tyrosine-phosphorylation-dependent signaling events 
in human disease and thereby identify novel thera-
peutic targets. Currently, there are four broad areas 
of research in the lab covering functional analysis of 
members of the PTP family: regulation of PTP func-
tion, in particular by reversible oxidation; development 
of novel approaches to therapeutic intervention in PTP 
function; and characterization of a knockout mouse 
model to defi ne the function of JSP1, a member of the 
PTP family that is a novel regulator of mitogen-acti-
vated protein kinase (MAPK) signaling.
During the last year, Ben Boivin left to take up a 
position as Assistant Professor in the Montreal Heart 
Institute and Ulla Schwertassek went back to Ger-
many to a position in the Fraunhofer Institute of Cell 
Therapy and Immunology in Leipzig.
Identiﬁ cation and Characterization 
of Small-Molecule Inhibitors of PTP1B
A major focus of research in the lab has been the inves-
tigation of novel approaches to therapeutic inhibition 
of PTP1B, in particular for application to HER2-pos-
itive breast cancer. The PTP1B gene is located at chro-
mosome 20q13, which is a region that is frequently 
amplifi ed in breast cancer and associated with poor 
prognosis. It has also been reported that PTP1B is 
overexpressed in breast tumors together with the on-
coprotein tyrosine kinase HER2. Mice expressing ac-
tivated alleles of HER2 in mammary glands develop 
multiple mammary tumors and frequent metastases 
to the lung; however, when such mice were crossed 
with PTP1B-knockout mice, tumor development was 
delayed and the incidence of lung metastases was de-
creased. Conversely, targeted overexpression of PTP1B 
alone was suffi cient to drive mammary tumorigenesis 
in mice. These observations illustrate that PTP1B 
plays a positive role in promoting signaling events asso-
ciated with breast tumorigenesis, which suggests that 
inhibition of PTP1B function may represent a novel 
therapeutic strategy to address HER2-induced mam-
mary tumorigenesis and malignancy.
Several potent, small-molecule inhibitors of PTP1B 
have been developed in industry and academia; how-
ever, these inhibitors, which target the active site of 
the enzyme, are highly charged and consequently have 
poor bioavailability and limited drug development 
potential. Therefore, there is a pressing need for an al-
ternative approach to generate inhibitors against PTP1B 
that do not involve the active site of the protein. We 
have identifi ed a novel allosteric inhibitor of PTP1B, a 
small-molecule natural product that binds to the non-
catalytic, carboxy-terminal portion of the phosphatase. 
We have defi ned a unique mechanism for inhibition of 
PTP1B by this molecule (Fig. 1), and, in collaboration 
with Wolfgang Peti (Brown University), we have used 
nuclear magnetic resonance (NMR) to solve the fi rst 
ensemble structure of PTP1B containing this intrinsi-
cally disordered carboxy-terminal segment. We have 
demonstrated that this PTP1B inhibitor antagonizes 
migration preferentially in HER2-positive cells. In ad-
dition, we showed that the formation of hyperplastic 
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structures in three-dimensional culture following acti-
vation of HER2 in MCF-10A cells was attenuated by 
treatment of the cells with the PTP1B inhibitor. Most 
strikingly, we have also demonstrated that the inhibi-
tor attenuates HER2 signaling in animal models. In 
tumor xenografts, in which BT474 cells were injected 
orthotopically into the fat pad of beige SCID mice, 
inhibitor treatment (at 5 mg/kg) attenuated tumori-
genesis when administered either at the time the cells 
were deposited in the mammary fat pad or following 
the appearance of palpable tumors. Finally, in mouse 
mammary tumor virus (MMTV)-NDL2 transgen-
ic mice, which express an activated mutant form of 
HER2 and develop mammary tumors and lung me-
tastases that display features of human breast cancer, 
treatment with the inhibitor resulted in extensive in-
hibition of tumor growth, and, perhaps most impor-
tantly, metastasis to the lung was essentially abrogat-
ed. These data reinforce the therapeutic potential of 
inhibiting PTP1B by this allosteric mechanism to an-
tagonize HER2-induced signaling and tumorigenesis. 
The molecule has already been tested in a Phase-1 trial 
and is extremely well tolerated; the effects observed in 
mice are achieved at ~20% of the maximum dose that 
has been administered to patients. Currently, we are 
working with scientists at the Monter Cancer Center 
at North Shore LIJ to take this inhibitor into clinical 
trials for HER2-positive cancer. Although it is an ex-
citing therapeutic candidate, it is a natural product for 
which synthesis is not straightforward. Consequently, 
more tractable, novel inhibitors of PTP1B that act 
with the same mechanism may be of benefi t. We have 
developed an assay of PTP1B that can be applied to 
high-throughput screening of libraries of small mol-
ecules. In collaboration with Fraser Glickman at The 
Rockefeller University, we have completed a screen of 
their library of 180,000 compounds and have iden-
tifi ed 350 “hits” from the screen. Of these, 28 show 
properties similar to those of the natural product, but 
their structures are distinct. These are being validated 
further for their activity in vitro, in cells, and in ani-
mal models of HER2-positive cancer.
Role of PTP1B in Oncogenic RAS-Induced 
Senescence
Oncogene expression in normal cells can cause an 
irreversible growth arrest called oncogene-induced 
senescence, which serves as a barrier to cancer ini-
tiation. Elevated reactive oxygen species have been de-
tected in the senescent cells, and they are believed 
to have a second messenger function in transducing 
signals. We demonstrated that PTP1B underwent 
redox regulation during oncogenic RAS-induced se-
nescence in IMR90 cells. Inhibition of PTP1B func-
tion was important for oncogene-induced senescence, 
and overexpressing PTP1B in RAS-expressing cells 
induced senescence bypass. We found that AGO2, an 
Argonaute protein that is required for RISC (RNA-
induced silencing complex) function in the RNA in-
terference (RNAi) pathway, was a substrate of PTP1B 
in senescent cells. Reversible oxidation of PTP1B 
during senescence caused hyperphosphorylation of 
AGO2 on its Y393 site and lowered the binding ca-
pacity of AGO2 for microRNAs (miRNAs). These 
data suggest that PTP1B is involved in the control of 
p21 expression, a key regulator of oncogene-induced 
senescence, in a manner mediated by AGO2 tyrosine 
phosphorylation.
PTP Function in Breast Cancer Models
These projects are part of a long-standing collaboration 
with Senthil Muthuswamy. Progress has been made 
on several projects, including identifying a role for 
receptor protein tyrosine phosphatase δ (RPTPδ) in 
metastasis induced by loss of the Missing in Metastasis 
gene, defi ning the role of PTPD2/PTPN14 as a posi-
tive regulator of HER signaling and the development 
Figure 1.  Structure model for PTP1B (residues 1–405) with two 
molecules of the allosteric inhibitor MSI-1436 (marked with 
 arrows) docked to the two putative binding sites. Important 
structural features within PTP1B are highlighted.
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of mouse models to explore further a tumor suppres-
sor function of PTPN23. In addition, this year we 
published a study revealing an important tumor sup-
pressor role for PTPRO (protein tyrosine phosphatase 
receptor type O) in breast cancer. We noted that when 
PTPRO, which is up-regulated in mature MCF-10A 
mammary epithelial three-dimensional structures, was 
suppressed by RNAi, the proliferation arrest that oc-
curs during acinar morphogenesis was inhibited. Fur-
thermore, we demonstrated that the receptor tyrosine 
kinase HER2 is a direct substrate of PTPRO and that 
loss of PTPRO increased HER2-induced cell prolif-
eration and transformation, together with tyrosine 
phosphorylation of HER2. Moreover, in patients with 
HER2-positive breast tumors, low PTPRO expres-
sion correlated with poor clinical prognosis com-
pared to HER2-positive patients with high levels of 
PTPRO. Thus, these data illustrate that PTPRO is a 
novel regulator of HER2 signaling and a novel prog-
nostic marker for patients with HER2-positive breast 
cancers.
Tyrosine Phosphorylation-Dependent 
Signaling in Ovarian Cancer Cells
Ovarian cancer, which is the leading cause of death 
from gynecological malignancies, is a heterogeneous 
disease known to be associated with disruption of mul-
tiple signaling pathways. Nevertheless, little is known 
re garding the role of protein phosphatases in the sig-
naling events that underlie the disease; such knowl-
edge will be essential to gain a complete understanding 
of the etiology of the disease and how to treat it. We 
have demonstrated that PTP1B was underexpressed in 
a panel of ovarian-carcinoma-derived cell lines, com-
pared to immortalized human ovarian surface epitheli-
al cell lines. Stable restoration of PTP1B in those cancer 
cell lines substantially decreased cell proliferation, mi-
gration, and invasion, as well as anchorage-independent 
survival. Mechanistically, the pro-survival insulin-like 
growth factor-1 receptor (IGF-1R) signaling pathway 
was attenuated upon ectopic expression of PTP1B. 
This was due to dephosphorylation by PTP1B of IGF-
1R β-subunit and BRK/PTK6, a SRC-like protein ty-
rosine kinase that physically and functionally interacts 
with the IGF-1R β-subunit. Restoration of PTP1B ex-
pression led to enhanced activation of BAD, one of the 
major pro-death members of the BCL-2 family, which 
triggered cell death through apoptosis. Conversely, in-
hibition of PTP1B with a small-molecular inhibitor, 
MSI-1436, increased proliferation and migration of 
immortalized HOSE (human ovarian surface epithe-
lial) cell lines. These data reveal an important role for 
PTP1B as a negative regulator of BRK and IGF-1Rβ 
signaling in ovarian cancer cells.
Characterization of Novel Kinase Inhibitors
In collaboration with Drs. Darryl Pappin and Jim 
Watson here at CSHL and Mate Hidvegi and his col-
leagues from Budapest, this lab led a project to iden-
tify the active components of Avemar®, a proprietary 
fermented wheat germ extract (FWGE) nutraceutical 
that has been shown to display signifi cant antiprolif-
erative effects and to trigger tumor cell death through 
apoptosis. Clinical data reveal signifi cant benefi ts to 
patients from treatment with FWGE, including in 
combination with existing cancer therapies. Through 
this collaboration, a novel small-molecule protein 
kinase inhibitor (CSH-4044) has now been isolated 
from FWGE and characterized. This inhibitor has 
both a unique structure and a unique specifi city for 
PIM (proviral integration site for Moloney murine 
leukemia virus) and DYRK (dual specifi city tyrosine-
regulated kinase) when assayed against a panel of 140 
distinct protein kinases. Current efforts are focused 
on testing this inhibitor in appropriate cancer models 
and optimizing its structure, both to enhance poten-
cy, specifi city, and bioavailability, as well as to improve 
drug-like characteristics. In collaboration with Dave 
Tuveson, CSH-4044 is being tested in cell and animal 
models of pancreatic cancer, using inhibition of PIM 
and DYRK as a new approach to inhibiting signaling 
downstream of KRAS. In addition, it is being tested 
in collaboration with Chris Vakoc in his leukemia 
models. It is anticipated that this study will validate 
a novel therapeutic candidate for treatment of these 
cancers.
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UNDERSTANDING LETHAL PROSTATE CANCER
L. Trotman M. Chen T. Herzka D. Nowak
 H. Cho A. Naguib W. Zheng
We focus on the fundamental understanding of the mo-
lecular mechanisms behind the transition from indolent 
to lethal metastatic prostate cancer. Our aim is to under-
stand the principles of prostate cancer progression and to 
use this information to recreate lethal disease in faithful 
mouse models that can be studied and used for preclini-
cal trials that help us develop better therapies. PTEN 
is a haploinsuffi cient tumor suppressor: Partial loss or 
degradation results in growth advantage, and in con-
trast, we found that complete loss triggers senescence ar-
rest. These fi ndings raised questions about whether and 
when senescence plays a role in human prostate cancer, 
because it was assumed that senescence is a feature of 
precancerous lesions. We now have answered this ques-
tion thanks to the past 3 years of research and revealed 
that the senescence response is a barrier to metastasis. 
Thus, we have established a biological principle that 
underlies the distinction between indolent (senescence-
competent) and lethal (postsenescent) disease.
Through a combination of mouse and human ge-
netics, we formulated molecular guidelines for each dis-
ease stage: (1) PTEN haploinsuffi ciency or protein deg-
radation triggers prostate cancer formation through 
partial AKT pathway activation. (2) In contrast, le-
thal PTEN mutant disease acquires strong pathway 
activity through, for example, deletion of PTEN and 
PHLPP1 tumor suppressors and inactivation of the 
senescence response genes p53 and Rb1. On the basis 
of these insights, we now analyze patient samples in 
order to separate them into the two categories. At the 
same time, we develop novel types of animal models 
that allow us to better model the disease.
Molecular and Genetic Analysis of Prostate 
Cancer Evolution
D. Nowak, H. Cho, T. Herzka, W. Zheng [in collaboration 
with J. Hicks and M. Wigler, Cold Spring Harbor Laboratory; 
A. Tewari, Weill Cornell Medical College, New York]
Understanding the progression from indolent to le-
thal prostate cancer remains the major challenge in 
the fi eld. Hyperactivation of the phosphoinositol-3 
kinase (PI3K)/AKT pathway is common in many can-
cer types. Our work demonstrated that loss of the ca-
pacity to mount a senescence response is critical for 
the lethal progression event. To defi ne the molecular 
changes that occur in this transition, we have reca-
pitulated the pre- and postsenescence genetics in vitro 
using primary cells and analyzed the signatures that 
are an immediate consequence of breaking the senes-
cence response by loss of p53.
Comprehensive analyses of changes in transcrip-
tion, proteome, and secretome have led to identifi ca-
tion of signature responses, which are being validated 
in human prostate cancer specimens (in collaboration 
with Dr. Tewari).
To study the genetic evolution of prostate can-
cer, we collaborate with the teams of Drs. Wigler and 
Hicks, who have developed copy-number analysis at 
the single-cell level. This approach allows us to identi-
fy the genetic makeup and to infer migration of clones 
of cells within a surgically removed prostate cancer 
sample. Through this approach, we are able to learn at 
what stage of cancer progression key criteria for break-
ing the senescence response are fulfi lled.
To validate alterations and key genetic events that 
are found in the human samples, we are developing 
more fl exible mouse modeling techniques. RNA in-
terference (RNAi) has been shown to recapitulate key 
features of gene knockout models, especially given the 
fact that the majority of tumor suppressors are found 
in hemizygous deletions in cancer. RNAi-based mod-
els of Pten/p53 loss have been generated and are being 
followed up for disease initiation and progression 
characteristics. These will serve as a platform to study 
effects of gene alterations derived from human.
Living with Lethal Genes
M. Chen, A. Naguib, T. Herzka, W. Zheng [in collaboration 
with S.-S. Tan and J. Howitt, The University of Melbourne, 
Australia]
PTEN is the major negative regulator of PI3K signal-
ing with cell-specifi c functions that go beyond tumor 
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suppression. In fact, it is surprising to fi nd a gene that 
prevents cells from growing and can cause them to 
die, yet is constitutively expressed in most healthy tis-
sues. This raises the fundamental question of how the 
PTEN gene is suppressed to allow for normal growth, 
tissue repair, and development. We are interested in 
this question because many cancer types reveal deg-
radation of PTEN protein while the gene remains 
intact. Our hypothesis is that such cancers indirectly 
target PTEN by loss of genes that are essential for 
PTEN maintenance. Thus, understanding the nor-
mal processes behind PTEN regulation may unearth 
critical cancer genes.
Ischemic injury results from insuffi cient blood fl ow 
to organs or tissues, examples of which include stroke 
and myocardial infarction. PTEN, under normal phys-
iological conditions, acts to antagonize PI3K/AKT-
mediated signaling and thereby promotes growth ar-
rest and can trigger apoptosis. However, subsequent to 
ischemic injury, limiting the ability of wounded tissue 
to renew, or promoting cell death, would be detrimen-
tal to the healing effort. To our surprise, we learned 
that nuclear seclusion of PTEN is one mechanism to 
temporarily suppress its function: In collaboration 
with experts in mouse models for stroke, we have 
demonstrated that cytoplasmic Pten is translocated 
into the nucleus of neurons following cerebral isch-
emia. Critically, this transport event is dependent on 
the surge in the Ndfi p1 protein, as neurons in Ndfi p1-
defi cient mice fail to import Pten. Ndfi p1 binds Pten, 
resulting in enhanced ubiquitination by Nedd4 E3 
ligases, an event that we previously showed to control 
import. In vitro, Ndfi p1 overexpression increases the 
rate of Pten nuclear import detected by photobleach-
ing experiments, whereas Ndfi p1–/– fi broblasts show 
very poor import rates. In vivo, Ndfi p1-mutant mice 
suffer larger infarct sizes associated with suppressed 
pAkt activation. These fi ndings have unraveled the 
fi rst physiological stimulus to trigger shuttling of 
Pten into nuclei. Moreover, they suggest that getting 
PTEN out of the cytoplasm and into the nucleus for 
a limited time after stroke is critical for neuronal sur-
vival and prevents irreversible brain damage. These 
fi ndings may thus open novel avenues for therapeutic 
intervention after stroke, centered around ensuring 
proper traffi cking of PTEN.
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CANCER MEDICINE LABORATORY/CANCER 
THERAPEUTICS INITIATIVE
D. Tuveson I.C. Chio D. Engle E.D. Olund H. Tiriac
 B. Creighton C. Hwang Y. Park K. Wright
 B. Delcuze S. Moran M. Spector K. Yu
Our laboratory uses mouse and tissue models of neo-
plasia to explore the fundamental biology of these 
diseases and thereby identify new diagnostic and 
treatment strategies. Our main focus is pancreatic 
cancer, a lethal malignancy that has eluded clinical 
solutions despite intensive study. Our approaches at 
CSHL run the gamut from designing new model 
systems of disease to developing new therapeutic and 
diagnostic platforms for evaluation in preclinical and 
clinical settings. For example, we have adopted a new 
method of culturing tissue fragments indefi nitely in 
cell culture, enabling deep analysis with genetic and 
pharmacological probes. Second, therapeutic experi-
ments in mouse models have revealed an important 
role of redox metabolism and stromal interactions 
on infl uencing therapeutic response. We also have a 
strong link to clinical trials locally and internationally, 
with confi rmation in early-phase trials our immediate 
goal. Collectively, our strategy in the preclinical and 
clinical arena is codifi ed as the “Cancer Therapeutics 
Initiative,” and this initiative will provide these same 
approaches to the entire CSHL cancer community.
Cancer Diagnostics
This work was done in collaboration with D. Pappin, 
Cold Spring Harbor Laboratory; J. Lewis, Memorial 
Sloan-Kettering Cancer Center; and R. Hynes, Massa-
chusetts Institute of Technology. The diagnosis of early-
stage cancers in most patients is challenging. Indeed, our 
failure to detect nascent malignancies when anatomical-
ly localized and potentially surgically curable refl ects the 
lethality of many cancers for which insuffi cient systemic 
therapies exist. Cervical cancer best exemplifi es this 
principle, where the introduction of gynecological ex-
aminations with histological screening led to a marked 
decrease in what had been the main cause of female can-
cer deaths worldwide. Additionally, the direct visualiza-
tion of incipient tumors with a variety of radiological 
and endoscopic modalities reduces lung and colon can-
cer mortality, respectively. These recent advances have 
established standards for preventive medicine in the 
United States, although most patients who are ultimate-
ly diagnosed with lung, bowel, and other malignancies 
are missed. Investigational approaches include the de-
velopment of blood-based biomarkers such as circulat-
ing nucleic acids, proteins, cancer cells, exosomes, and 
immune response biomarkers. These exploratory efforts 
are still under way, and other than biomarkers for un-
common cancers (e.g., b-HCG for choriocarcinoma, 
AFP for testicular cancer), they have not yet provided an 
effective approach that can be utilized in a general or se-
lected population of otherwise healthy individuals. The 
major barriers to the development of cancer biomarkers 
are the lack of sensitivity (limits of detection) and speci-
fi city (due to similarities to nonmalignant diseases). 
 Accordingly, we have initiated a new research program 
to develop methods for tumor detection in mice by tak-
ing advantage of genetic differences between mice and 
humans. These methods include a combination of bio-
chemical and radiological approaches.
Cancer Therapeutics
This work was done in collaboration with K. Yu, Cold 
Spring Harbor Laboratory/Memorial Sloan-Kettering 
Cancer Center; A. Krainer and G. Hannon, Cold 
Spring Harbor Laboratory. Novel therapies and drug 
delivery methods are being explored for pancreatic 
cancer patients.
Development of Methods to Improve 
Drug Delivery in Pancreatic Ductal 
Adenocarcinoma
Pancreatic cancer is refractory to conventional and 
 targeted agents. We and other investigators had found 
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that the drug resistance demonstrated by pancreatic 
ductal adenocarcinomas (PDACs) is caused by both 
biochemical signaling pathways in neoplastic cells and 
the biophysical compression of the tumor vasculature to 
limit angiogenesis and tumor perfusion. A sensitive 
method was developed to measure the intracellular 
active metabolite of gemcitabine, gemcitabine triphos-
phate (dFdCTP), and chemotherapy delivery was 
found to be limited to the stroma-rich tumor tissue 
due to a defi cient and compressed vasculature. Hedge-
hog inhibition and stromal digestion with pegylated 
hyaluronidase (PEG-PH20) led to both increased 
perfusion and chemotherapy delivery in PDAC tumor 
 tissues and transient increases in GEMM survival. 
These fi ndings became the basis of a clinical trial 
using the hedgehog inhibitor IPI926 in combination 
with gemcitabine for patients with metastatic PDAC, 
but unfortunately, the fi rst randomized trial was neg-
ative and the analysis is ongoing. Early-phase clinical 
trials with gemcitabine in combination with PEG-
PH20 are under way, with interim results expected 
shortly.
Interestingly, PEG-PH20 treatment also specifi -
cally increased the delivery of high-molecular-weight 
agents including 2 MDa dextran to PDAC tissue. 
Scanning and transmission electron microscopy re-
vealed that intratumoral endothelial cells had a qui-
escent morphology in untreated mice, and became 
markedly fenestrated following PEG-PH20 treat-
ment, reminiscent of the effects of vascular endo-
thelial growth factor (VEGF)(Fig. 1; Jacobetz et al. 
2012). This observation allows us the opportunity 
to evaluate novel high-molecular-weight therapeutic 
agents that are otherwise diffi cult to deliver to PDAC 
tissues, including antibodies and nucleic acids. Dr. 
Ken Yu, working with our laboratory as the CSHL 
clinical fellow and an attending medical oncologist at 
MSKCC, has written a proof-of-concept clinical trial 
to assess whether PEG-PH20 and related stromal dis-
ruption approaches will increase the effectiveness of 
biological therapeutics in pancreatic cancer patients. 
His trial will be conducted to establish whether PEG-
PH20 can increase the delivery of an FDA-approved 
anti-epidermal growth factor receptor (EGFR) anti-
body (cetuximab) in patients scheduled to undergo 
surgery for resectable pancreatic cancer. The design 
will administer PEG-PH20 2 days before surgery, 
treat with therapeutic antibody 24 h later, and then 
surgery following 24 h later. Comparisons will be 
made to patients who do not receive PEG-PH20, and 
resected tumors will be assessed for the delivery of 
the antibody and any biochemical alterations by im-
munohistochemistry (IHC). Cetuximab is the fi rst 
antibody to be considered because it binds to EGFR 
that is expressed by the majority of PDAC cells, and 
it can be easily detected through the chimeric mu-
rine portion of the antibody. Cetuximab was not 
shown to alter the effects of gemcitabine treatment in 
PDAC patients in a recent SWOG trial, potentially 
because it is not delivered optimally. Positive fi nd-
ings will motivate the assessment of additional agents 
in more advanced preclinical and clinical trials, in-
cluding neoadjuvant trials in locally advanced pan-
creatic cancer patients and mice to improve resect-
ability and survival. Besides the limitations in drug 
delivery observed in pancreatic tumors, we also lack 
effective methods that inhibit the K-RAS oncogene 
responsible for cancer initiation and maintenance. In 
the cancer therapeutics initiative, we are seeking new 
methods that will neutralize the effects of oncogenic 
K-RAS in pancreatic cancer by evaluating unusual 
nucleic-acid-based payloads targeting K-RAS. These 
approaches will comprise antisense oligonucleotides 
and short interfering RNAs (shRNAs) that were de-
veloped with Adrian Krainer’s and Greg Hannon’s 
lab, respectively.
Figure 1. 2-MDa lectin (yellow) is speciﬁ cally delivered to PDAC 
tissue following PEG-PH20 treatment, accompanied by endo-
thelial fenestrae. VEGF-A also induces fenestrae and nonspeciﬁ c 
delivery to intestinal villi. (Scale bar, 0.5 μm.)
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Development of Pancreatic Ductal 
Organoids as a Novel In Vitro Cancer 
Model for Biological Exploration and 
Medical Applications
This work was done in collaboration with H. Clevers, 
Hubrecht Institute, Utrecht, the Netherlands. We es-
tablished a method to culture matched normal and 
malignant cells from the same murine tissue in three-
dimensional “organoid” cultures. This approach was 
based on the pioneering work of Dr. Hans Clevers, 
who demonstrated that intestinal villi could be indefi -
nitely propagated in three-dimensional culture when 
forming functional organoids. The Clevers and Tuve-
son laboratories collaborated to develop a method of 
preparing and propagating pancreatic ductal organoid 
structures from normal and malignant mouse pan-
creata (Fig. 2), and we are in the process of establish-
ing conditions for growing human pancreas organoids 
from matched normal and disease tissue. These cul-
tures will enable the less costly, high-throughput as-
sessment of small-molecule and shRNA screens in cell 
culture, prior to characterization in vivo. Addition-
ally, they can be directly characterized at the genomic, 
transcriptomic, and proteomic levels to determine the 
molecular correlates of therapeutic response. This ap-
proach will be compared to routine two-dimensional 
tissue culture systems, and in parallel, they will be 
compared to the traditional patient-derived xenograft 
(PDX) models. If organoids offer advantages to PDX 
models, we will determine how to extend this to other 
organ types and how to best utilize this technology for 
patient benefi t. For example, serial organoids prepared 
from patients under therapy may reveal a model sys-
tem for interrogating drug resistance and identifying 
new targets of drug sensitivity. We also have found that 
cancer cell lines readily adapt to growth in organoid 
conditions, suggesting that this approach may work for 
circulating tumor cells.
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Figure 2. Organoids prepared from mouse pancreas tissue (4×).
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RAS AND RHO GTPASES AND THE CONTROL 
OF SIGNAL TRANSDUCTION
L. Van Aelst J. Janas C.L. Wang
 A. Kobayashi Y.-T. Yang
 Y. Tai J.-R. Yu
Research in my laboratory is focused on the role of 
Ras and Rho GTPase family members in signal 
transduction. Ras and Rho family members have key 
roles in cellular activities controlling cell growth, dif-
ferentiation, and morphogenesis. Alterations in Ras 
and Rho functions have been causally linked to both 
cancer and brain disorders, including mental retarda-
tion, schizophrenia, and epilepsy. Our interests lie in 
understanding how defects in Ras- and Rho-linked 
proteins contribute to the development of these dis-
ease processes. Toward this end, my lab has contin-
ued to defi ne the functions of selected GTPases and 
their regulators and effectors in models of cancer and 
neurodevelopmental disorders. Below are highlighted 
selected key projects that have been carried out during 
the past year.
DOCK7 Interacts with TACC3 to Regulate 
Interkinetic Nuclear Migration and Cortical 
Neurogenesis
DOCK7 is a member of the evolutionarily conserved 
DOCK180-related protein superfamily, which we ini-
tially identifi ed as a novel activator of Rac GTPases. 
Signifi cantly, sequence variations in DOCK7 have 
been reported in schizophrenia patients; however, the 
role(s) of DOCK7 in neuronal development and/or 
function has remained largely elusive. We had found 
that DOCK7 is highly expressed in major regions of 
the brain, including hippocampus and cortex, during 
early stages of development, and, importantly, that 
the protein is asymmetrically distributed in unpolar-
ized hippocampal neurons and becomes selectively 
expressed in the axon. We then obtained evidence 
for a key role of DOCK7 in controlling early steps 
of axon development in cultured hippocampal neu-
rons. Knockdown of DOCK7 prevents axon forma-
tion, whereas overexpression induces the formation 
of multiple axons. We further demonstrated that 
DOCK7 and Rac activation leads to phosphoryla-
tion and inactivation of the microtubule destabilizing 
protein stathmin/Op18 in the nascent axon and that 
this event is important for axon development. Thus, 
our fi ndings unveiled a novel pathway linking the Rac 
activator DOCK7 to a microtubule regulatory protein 
and highlight the contribution of microtubule dy-
namics to axon development.
More recently, we extended our studies to the 
characterization of DOCK7 function in the devel-
opment of cortical pyramidal neurons in the mouse 
embryonic neocortex, which interestingly led to the 
discovery of a key role for DOCK7 in cortical neuro-
genesis. Cortical pyramidal neurons primarily derive 
from radial glial progenitor cells (RGCs) located in 
the ventricular zone (VZ) of the dorsal telencephalon, 
and they migrate radially along RGC processes from 
the VZ, through the intermediate zone (IZ), to the 
cortical plate (CP) to form the six-layered neocortex. 
Notably, the genesis of neurons in the developing neo-
cortex critically relies on the ability of RGCs to switch 
from proliferative to differentiative neuron-generating 
divisions; the molecular mechanisms that control this 
switch in a correct temporal manner are, however, not 
well understood. We found that DOCK7 has a key 
role in the regulation of RGC proliferation versus dif-
ferentiation. In particular, we found that silencing of 
DOCK7 in RGCs of developing mouse embryos im-
pedes neuronal differentiation and maintains cells as 
cycling progenitors. In contrast, DOCK7 overexpres-
sion promotes RGC differentiation to basal progeni-
tors and neurons.
We further obtained evidence that DOCK7 infl u-
ences the mode of RGC division and thereby neuro-
genesis by controlling a unique property of RGCs, 
namely, interkinetic nuclear migration (INM)—a 
process where RGC nuclei undergo a cell-cycle-de-
pendent change in position along the apical-basal axis 
of the VZ, with proliferative signals apparently being 
high at the apical (ap) side and neurogenic signals 
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high at the basal (bl) side. Knockdown of DOCK7 in 
RGCs accelerates bl-to-ap INM, leading to extended 
apical residence of RGC nuclei and apical mitoses 
that produce two RGCs. Ectopic DOCK7 expression, 
on the other hand, impedes bl-to-ap INM, causing 
an extended basal residence of RGC nuclei and ec-
topic mitoses that produce two neurons. Intriguingly, 
DOCK7’s role in INM and neurogenesis does not in-
volve its GEF (guanine exchange factor) activity, but 
instead requires its interaction with the centrosome- 
and mitochondrial (MT)-associated protein TACC3. 
We found that DOCK7 exerts its effects by modulat-
ing the MT growth-promoting function of TACC3. 
Thus, DOCK7 interacts with TACC3 to control 
INM, thereby governing RGC proliferation versus 
differentiation and genesis of neurons during corti-
cal development, processes associated with numerous 
neurodevelopmental disorders.
Multifunctional Role of the X-Linked 
Mental Retardation Protein OPHN1 
at the Hippocampal CA1 Synapse
Oligophrenin-1 (OPHN1), which encodes a Rho-GT-
Pase-activating protein, was the fi rst identifi ed Rho-
linked mental retardation (MR) gene. It was initially 
identifi ed by the analysis of a balanced translocation 
t(X;12) observed in a female patient with mild MR. 
Subsequent studies revealed the presence of OPHN1 
mutations in families with MR associated with cer-
ebellar hypoplasia, lateral ventricle enlargement, and/
or epilepsy. All OPHN1 mutations identifi ed to date 
have been shown, or predicted, to result in OPHN1 
loss of function; however, the pathophysiological role 
of OPHN1 has remained poorly understood.
We have begun to unveil the function of OPHN1 
both at the pre- and postsynaptic site of the hippo-
campal CA3-CA1 synapse. We previously described 
that during early development, presynaptic OPHN1 
is important for effi cient retrieval of synaptic vesicles, 
whereas postsynaptic OPHN1 has a key role in activ-
ity-dependent maturation and plasticity of excitatory 
synapses, suggesting the involvement of OPHN1 in 
normal activity-driven glutamatergic synapse devel-
opment. Interestingly, we more recently found that 
postsynaptic OPHN1 also has a critical role in me-
diating a form of plasticity (mGluR-LTD) that relies 
on the activation of group I metabotropic glutamate 
receptors, which consist of mGluR1 and mGluR5 in 
CA1 hippocampal neurons. Alterations in this form of 
plasticity have been linked to drug addiction and cog-
nitive disorders. A key characteristic of mGluR-LTD 
is its dependence on rapid protein synthesis; however, 
the identities of the proteins mediating LTD have 
remained largely elusive. We obtained evidence that 
OPHN1 expression is translationally induced in den-
drites of CA1 neurons within 10 min of mGluR acti-
vation and that this response is essential for mGluR-
dependent LTD. Specifi cally, acute blockade of new 
OPHN1 synthesis impedes mGluR-LTD and the as-
sociated long-term decreases in surface AMPARs. In-
terestingly, the rapid induction of OPHN1 expression 
is primarily dependent on mGluR1 activation and is 
independent of fragile-X mental retardation protein 
(FMRP).
Importantly, we further demonstrated that 
OPHN1’s role in mediating mGluR-LTD is disso-
ciable from its role in basal synaptic transmission. 
mGluR-LTD and the associated long-term decreases 
in surface α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid receptors (AMPARs) are dependent 
on OPHN1’s interaction with endophilin A2/3, 
whereas regulation of basal synaptic strength requires 
OPHN1’s Rho-GAP activity and association with 
Homer 1b/c proteins. As to how OPHN1 could medi-
ate the strengthening of synapses via interactions with 
Homer 1b/c and RhoA, we previously showed that 
OPHN1 becomes enriched in spines in response to 
synaptic activity and N-methyl-D-aspartate receptor 
(NMDAR) activation, where by locally modulating 
RhoA/Rho kinase activities (i.e., in the proximity of 
AMPARs), it contributes to the stabilization of AM-
PARs, thereby facilitating synaptic maturation and 
plasticity. Homer 1b/c proteins, on the other hand, 
were shown to serve a critical role in the positioning of 
the endocytic zone (EZ) near the postsynaptic density 
(PSD). The close juxtaposition of EZ and PSD enables 
a local cycle of endocytosis and recycling in response 
to synaptic activity that maintains synaptic AMPARs 
at postsynaptic sites. Interestingly, we recently found 
that OPHN1, via its interaction with Homer 1b/c, 
contributes to the positioning of the EZ near the 
PSD and hence to the recycling of AMPARs to the 
PSD. Thus, a conceivable scenario is that OPHN1, 
via its interactions with Homer 1b/c and RhoA, reg-
ulates the recycling and stabilization of AMPARs at 
the synapse, thereby controlling activity-dependent 
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maturation and strengthening of synapses. We are 
currently further investigating this.
Together, these fi ndings point to a multifunctional 
role for OPHN1 at CA1 synapses. Independent of its 
role in activity-driven glutamatergic synapse develop-
ment, regulated OPHN1 synthesis has a critical role in 
mGluR-dependent LTD. Thus, it is conceivable that, 
on one hand, OPHN1 might have an important role in 
synapse maturation and circuit wiring during early de-
velopment; on the other hand, the regulated OPHN1 
synthesis could operate during adulthood to weaken 
synapses in response to behaviorally relevant stimuli.
Oncogenic Tyrosine Kinases Target 
Dok-1 for Ubiquitin-Mediated 
Proteasomal Degradation to Promote 
Cell Transformation
Dok-1 (also called p62dok) was initially identifi ed as 
a tyrosine-phosphorylated 62-kDa protein associated 
with Ras-GAP in Ph+ chronic myeloid leukemia blasts 
and in v-Abl-transformed B cells. This protein was 
termed Dok (downstream of kinases), because it was 
also found to be a common substrate of many recep-
tor and cytoplasmic tyrosine kinases. Subsequently, 
six additional Dok family members have been identi-
fi ed, Dok-1 to Dok-7. Among them, Dok-1 and Dok-2 
share the ability to bind to a negative regulator of Ras, 
Ras-GAP. We previously described that Dok-1 attenu-
ates growth-factor-induced cell proliferation and that 
Dok-1 inactivation in mice causes a signifi cant short-
ening of the latency of the fatal myeloproliferative dis-
ease induced by p210bcr-abl, suggesting that it possesses 
tumor suppressive activity in the context of myeloid 
leukemia. In support of this, we found in collabora-
tion with Dr. Pandolfi ’s group that mice lacking both 
Dok-1 and Dok-2 spontaneously develop a CML-like 
myeloproliferative disease. Furthermore, more recent 
studies have shown that mice with combined Dok-1, 
Dok-2, and Dok-3 knockouts also develop lung adeno-
carcinoma with penetrance and latency dependent on 
the number of lost Dok family members.
These studies thus indicate that the Dok-1 to 
Dok-3 proteins possess tumor suppressive activities 
and that their inactivation can contribute to disease/
tumor progression associated with deregulated pro-
tein kinase signaling, as, for example, in the case of 
p210bcr-abl-driven CML-like disease in mice. To date, 
however, very little is known about the regulation of 
Dok proteins by oncogenic tyrosine kinases (OTKs). 
We have focused on Dok-1 and mechanisms of its 
regulation by p210bcr-abl and other OTKs. We found 
that OTKs, including p210bcr-abl and oncogenic forms 
of Src, down-regulate Dok-1 by targeting it for deg-
radation through the ubiquitin-proteasome pathway. 
This process is dependent on the tyrosine kinase ac-
tivity of the oncoproteins and is mediated primar-
ily by lysine-dependent polyubiquitination of Dok-1. 
Importantly, restoration of Dok-1 levels strongly sup-
presses transformation of cells expressing OTKs, and 
this suppression is more pronounced in the context 
of a Dok-1 mutant that is largely refractory to OTK-
induced degradation. Together, our fi ndings indicate 
that proteasome-mediated down-regulation of Dok-1 
is a key mechanism by which OTKs overcome the 
inhibitory effect of Dok-1 on cellular transformation 
and tumor progression. Our current efforts are de-
voted to further determining the role and mode of 
action of Dok proteins in the context of lung tumori-
genesis.
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REGULATION OF MALIGNANT GLIOMA HETEROGENEITY 
AND LINEAGE DEVELOPMENT
H. Zheng B. Guo A. Vaseva
 S. Klingler L. Zhang
Malignant glioma is the most common type of brain 
tumor, and they are currently incurable. The lack of 
effective treatments highlights the urgent need for 
new therapeutic approaches and targets. The long-
term goal of our research is to defi ne the complex biol-
ogy of malignant glioma pathogenesis with the aim 
of translating this knowledge into patient benefi ts. 
Along this line, our research has been focused around 
two major areas: (1) We develop various genetically 
engineered animal models to recapitulate the process 
of human glioma pathogenesis and utilize the animal 
models as tools to investigate in vivo tumor initiation 
and progression, as well as their response to various 
therapeutic treatments; and (2) we apply an integrated 
approach combining model system, stem cell biology, 
and RNA interference (RNAi) to identify the molec-
ular and developmental pathways relevant to glioma 
pathogenesis and treatment. We are particularly inter-
ested in the genetic and epigenetic programs involved 
in regulation of normal neural progenitor and glioma 
cell-fate determination. We believe that an improved 
understanding of the developmental programs gov-
erning the self-renewal and differentiation processes 
along the neural progenitor-glial axis and, by exten-
sion, the glioma initiation cells-progeny axis will be 
instrumental in guiding future development of effi -
cient treatments targeting this dreadful disease.
Characterizing EGFR-Targeted Therapeutic 
Resistance
As a signature genetic event of malignant gliomas, 
epidermal growth factor receptor (EGFR) amplifi ca-
tion/mutation is present in ~40%–50% of human 
patient samples, making it a compelling candidate 
for targeting therapy. Surprisingly, the clinically ap-
proved small-molecule EGFR inhibitors for treating 
other types of cancers have so far shown little thera-
peutic effi cacy to malignant glioma patients in dozens 
of clinical trials. The missing concordance between 
clinical response and EGFR amplifi cation/mutation 
status in malignant glioma patients has raised uncer-
tainties about EGFR as a viable therapeutic target for 
malignant gliomas. To address the questions, we de-
veloped a novel maligant glioma mouse model driven 
by the tetracycline-induced overexpression of a ma-
lignant glioma-specifi c mutant EGFR* with concur-
rent brain-specifi c inactivation of Ink4a/Arf and Pten. 
The tightly tetracycline-controlled mutant EGFR 
expression in this case ensures a faithful model sys-
tem to mirror EGFR targeting therapy and therefore 
provides us an opportunity to dissect the resistance 
mechanism(s) under in vivo settings. Using both ge-
netic and pharmacologic approaches, we demonstrat-
ed that a large population of glioma cells, particularly 
EGFR-overexpressing cells, remains dependent on 
aberrant EGFR signaling. Inhibition of EGFR* in-
duction in the tumor cells by doxycycline treatment 
effectuated signifi cant tumor regression, validating 
EGFR as an important therapeutic target for malig-
nant gliomas. The profound response to doxycycline-
mediated EGFR* inactivation is in stark contrast to 
the unimpressive outcome of EGFR kinase inhibitor 
treatments that marginally decelerated glioma growth 
without causing any visible tumor regression. This 
fi nding suggests that lack of response to EGFR ki-
nase inhibitors in the clinic is likely due to the inabil-
ity of the inhibitors to suffi ciently suppress aberrant 
EGFR signaling in malignant gliomas. Moreover, our 
data indicate that EGFR tyrosine phosphorylation is 
not the absolute indicative of overall EGFR onco-
genic functions. Instead, low levels of EGFR kinase 
activity underdetected by phosphospecifi c EGFR an-
tibody might be suffi cient to sustain the survival of 
EGFR-dependent glioma cells. Additionally, kinase-
independent EGFR functions could also contribute 
to the refractoriness to EGFR kinase inhibitors in 
malignant gliomas. Likewise, next-generation inhibi-
tors will need to consider EGFR-kinase-independent 
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activities in order to achieve optimal effi cacy against 
malignant gliomas carrying EGFR amplifi cation and/
or mutations.
EGFR gene amplifi cation in human malignant gli-
oma occurs invariably as extrachromosomal double-
minute fragments. When devoid of selective pressure, 
the amplifi ed EGFR diminishes rapidly upon cycles 
of cell division. As a result, heterogeneous intratu-
moral EGFR amplifi cation and gene expression are 
commonly observed in human malignant gliomas. 
This heterogeneous EGFR expression pattern is also 
notably recapitulated in our inducible EGFR mouse 
gliomas, often with the high EGFR expression cells 
present in the peripheral invasive edge of the tumors 
compared to low EGFR expression subpopulations in 
the relatively solid tumor center. Although inhibition 
of EGFR* transgene induction by doxycycline in our 
system elicits rapid cell death and initial tumor re-
gression, gliomas have not regressed fully upon EGFR* 
transgene inactivation, consistent with the mosaic 
EGFR gene expression pattern observed in the devel-
oped tumors. The fi nding that only a subpopulation 
of tumor cells persisted under acute EGFR* inactiva-
tion suggests that EGFR*-dependence in iEIP tumors 
is likely cell-type-dependent. Indeed, we observed 
that the Gfap-positive iEIP glioma cell population 
was eradicated completely in the relapsed tumors, 
suggesting that the astrocyte lineage tumor cells are 
likely cell-type-sensitive to EGFR* inhibition. These 
fi ndings support a model directly linking the glioma 
plasticity with therapeutic resistance. Considering the 
ability of tumor cells to shift lineage marker expres-
sion during treatment, we reason that the sensitive 
and resistant tumor cells may simply represent alter-
nate differentiation states of the disease that rely on 
different developmental survival signaling, although 
further work will still be necessary to exclude the po-
tential contributions from the emergence of genetic 
mutation(s).
Epigenetic Regulation during Glioma 
Pathogenesis
Biologically, malignant glioma is known for its explicit 
inter- and intratumoral genetic and histological het-
erogeneity, hence the moniker of glioblastoma “mul-
tiforme.” The glioma cells within individual tumors 
often exist in distinct phenotypic states that differ in 
their differentiation as well as functional attributes, 
with generally less differentiated tumor cells possessing 
higher propagation potential. The recent identifi cation 
of glioma-initiating cells with stem-cell-like properties 
provided an important conceptual advance and indi-
cated targeting developmental programs as an avenue 
for therapeutic development. We and other investiga-
tors demonstrated that this “differentiation arrest” fea-
ture of glioma cells has a general role in sustaining their 
long-term self-renewal, further supporting the idea of 
targeting of cell fate decision pathways for glioma treat-
ment. Because epigenetic regulation as a core mecha-
nism has been implicated in controlling cellular lineage 
differentiation of the central nervous system, we set up 
a program in collaboration with Scott Lowe and Chris 
Vakoc’s groups here at CSHL to identify the epigenetic 
networks essential for maintaining the glioma cell dif-
ferentiation state. In a focused primary epigenetic screen 
of a customized small hairpin RNA (shRNA) library 
targeting epigenetic regulators, we identifi ed 10 genes 
essential for primary mouse glioma cell self-renewal. 
Starting from this small panel of chromatin modula-
tors, we are using various assays to narrow down candi-
dates into those whose suppression sensitizes the glioma 
cell to differentiation. Upon completion of this goal, we 
will develop a spectrum of differentiation-based chro-
matin modulators as therapeutic targets for future drug 
discovery and development.
Another aspect of the project is to probe the same epi-
genetic RNAi library for chromatin modulators whose 
suppression may compromise the neural progenitor cell’s 
differentiation capacity and therefore act as tumor sup-
pressor genes to prevent malignant transformation. We 
have identifi ed several interesting candidates including 
α-thalassemia/mental retardation syndrome X-linked 
(ATRX), which has been recently found frequently mu-
tated in human malignant gliomas, as well as pancreatic 
neuroendocrine tumors. Our data suggested that ATRX 
is involved in controlling gene expression along neural 
stem cell lineage differentiation. Mutations of ATRX 
have been shown to cause diverse changes in the pattern 
of DNA methylation. Given that it belongs to the SWI/
SNF family of chromatin remodeling proteins, it stands 
to reason that ATRX might provide a link between 
chromatin remodeling, DNA methylation, and gene 
expression in neural stem cell lineage differentiation. 
We are currently investigating the molecular functional 
targets responsible for its roles in neural stem cell-fate 
determination and glioma pathogenesis.
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NEUROSCIENCE
How does the brain encode stimuli from the outside world, within and across sensory modalities, 
to generate specifi c perceptions that, in turn, trigger complex behaviors? How is the brain shaped 
by sensory experience and what modifi cations occur in neuronal circuits that allow us to learn and 
remember? These are the questions guiding the work of Florin Albeanu, who is using the olfac-
tory bulb and olfactory cortex of mice as the subject of his current studies. Airborne chemicals, 
translated into neuronal signals by specifi c receptors in the nose, are sent directly to the olfactory 
bulb. Advances in optical imaging and optogenetics combined with electrophysiological record-
ings enable Albeanu and colleagues to monitor and/or alter patterns of activity at unprecedented 
synaptic and millisecond resolution, in real time, as animals are engaged in various behaviors. For 
survival, rodents need to identify the smells of objects of interest such as food, mates, and preda-
tors, across their recurring appearances in the surround, despite apparent variations in their fea-
tures. Furthermore, animals aptly extract relevant information about environment across different 
sensory modalities, combining olfactory, visual, or auditory cues. By recording neuronal activity 
in the input and output layers of the olfactory bulb, as well as feedback from olfactory cortical 
areas and neuromodulatory signals, Albeanu and his team aim to understand computations the 
bulb performs and how this information is decoded deeper in the brain. They have recently pub-
lished evidence suggesting that the mouse olfactory bulb is not merely a relay station between the 
nose and cortex, as many have supposed. Using optogenetic tools and a novel patterned illumina-
tion technique, they discovered that there are many more information output channels leaving the 
olfactory bulb for the cortex than the number of inputs received from the nose. They are currently 
investigating how this diversity of bulb outputs is generated, as well as how downstream areas, 
such as the piriform and parietal cortex, make use of such information during behaviors.
The study of decision making provides a window on the family of brain functions that constitute 
cognition. It intervenes between perception and action, and can link one to the other. Although 
much is known about sensory processing and motor control, much less is known about the cir-
cuitry connecting them. Some of the most interesting circuits are those that make it possible to 
deliberate among different interpretations of sensory information before making a choice about 
what to do. Anne Churchland’s lab investigates the neural machinery underlying decision making. 
Lab members use carefully designed paradigms that encourage experimental subjects to deliberate 
over incoming sensory evidence before making a decision. Recent results show that rats and hu-
mans have a statistically similar decision-making ability. To connect this behavior to its underly-
ing neural circuitry, they measure electrophysiological responses of cortical neurons in rodents as 
they perform designated tasks. The lab’s current focus is on parietal cortex, which appears to be 
at the midpoint between sensory processing and motor planning. Churchland and colleagues also 
use theoretical models of varying complexity to further constrain how observed neural responses 
might drive behavior. This approach generates insights into sensory processing, motor planning 
and complex cognitive function.
Joshua Dubnau and colleagues use the fruit fl y to investigate two different questions. First, Dub-
nau and his team are investigating mechanisms of memory. Since biological mechanisms of mem-
ory are highly conserved through evolution, many features of human memory are observed in 
simpler organisms such as fruit fl ies. The lab’s efforts on memory focus on understanding the gene 
pathways that are required as well as the neural circuits in the fl y brain. They have recently shown 
that short-term memory forms in one set of neurons but that long-term memories form in a differ-
ent brain area. A second area of research in the Dubnau group is focused on uncovering mecha-
nisms of neurodegeneration that underlie amyotrophic lateral sclerosis (ALS) and frontotemporal 
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lobar degeneration (FTLD). Using the fruit fl y as an experimental system, together with analyses 
of genomic data sets from mice, rats, and humans, the Dubnau group has developed a novel hy-
pothesis to explain several different neurodegenerative disorders. This year, they showed that the 
awakening of dormant transposons in the genome of some brain cells might be responsible for 
causing cell death. Ongoing work in fl ies and mice will be used to investigate this hypothesis with 
the goal of developing avenues for therapeutic intervention.
Grigori Enikolopov and colleagues study stem cells in the adult brain. They have generated sev-
eral models to account for how stem cells give rise to progenitors and, ultimately, to neurons, and 
they are using these models to determine the targets of antidepressant therapies, identify signaling 
pathways that control generation of new neurons, and search for neuronal and neuroendocrine 
circuits involved in mood regulation. Recent experiments have suggested to the team a new model 
of how stem cells are regulated in the adult brain, with a focus on stem cells’ decision on whether 
to divide—and embark on a path of differentiation—or remain quiescent. This model explains 
why the number of new neurons decreases with advancing age and may lead to impairments in 
memory and depressed mood. It also explains why multiple brain trauma and prolonged neuro-
degenerative disease may lead to accelerated decrease of cognitive abilities. In other research, the 
team has identifi ed stem cell targets of various therapies used for treating depression and devel-
oped a general platform to determine the effect of drugs and therapies and predict their action. 
The team is now focusing on the signaling landscape of neural stem cells and on their interaction 
with the surrounding niche. Enikolopov’s group is also part of a team studying biomarkers that 
permit neuronal progenitor cells to be tracked, noninvasively, in the brains of living humans and 
animals. The lab is now using these discoveries to reveal how neurogenesis is related to the course 
of diseases such as depression and Alzheimer’s and how stem cells may contribute to complex 
forms of behavior.
Hiro Furukawa’s lab is studying neurotransmission at the molecular level. Its members focus on 
structure and function of NMDA receptors, ion channels that mediate excitatory transmission. 
Dysfunctional NMDA receptors cause neurological disorders and diseases including Alzheim-
er’s disease, Parkinson’s disease, schizophrenia, depression, and stroke-related ischemic injuries. 
NMDA receptors are very large molecules whose three-dimensional atomic structure Furukawa’s 
group has undertaken to solve by dividing them into several domains. They seek to understand 
the pharmacological specifi city of neurotransmitter ligands and allosteric modulators in differ-
ent subtypes of NMDA receptors at the molecular level. Toward this end, they use cutting-edge 
techniques in X-ray crystallography to obtain crystal structures of the NMDA receptor domains 
and validate structure-based functional hypotheses by a combination of biophysical techniques 
including electrophysiology, fl uorescence analysis, isothermal titration calorimetry, and analytical 
centrifugation. Crystal structures of NMDA receptors serve as a blueprint for creating and im-
proving the design of therapeutic compounds with minimal side effects for treating neurological 
disorders and diseases. This year, the team discovered and mapped a new regulatory site in a class 
of NMDA receptors, progress that now opens the way to the development of a potentially new 
class of drugs to modulate the receptor.
To better understand neuronal circuits, Josh Huang and colleagues have developed novel means 
of visualizing the structure and connectivity of different cell types at high resolution in living ani-
mals and of manipulating the function of specifi c cell types with remarkable precision. Huang is 
particularly interested in circuits that use GABA, the brain’s primary inhibitory neurotransmitter. 
The lab’s work has direct implications in neurological and psychiatric illness such as autism and 
schizophrenia, which involve altered development and function of GABAergic circuits. Huang’s 
team also previously developed 20 different mouse lines, each of which is engineered to express 
markers of specifi c cell types, and demonstrated the exquisite specifi city of this technology by 
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imaging GABA cells. This has been used to shed new light on synapse validation, which is at 
the heart of the process by which neural circuits self-assemble and is directly implicated in neu-
rodevelopmental pathologies. Huang’s team looked closely at neurexins, proteins that interact 
with neuroligins to form the “zipper” that holds synapses together. They discovered that α and β 
neurexins respond in different ways to neural activity—the α molecules searching out compat-
ible connection partners and the β molecules securing preliminary connections that prove to be 
strong. The team’s most recent observations show that GABA also regulates the process by which 
synapses are pruned after they have been formed. The lab has also made good progress in studying 
perturbations in the developing GABAergic system in a mouse model of Rett syndrome, one of the 
autism spectrum disorders. In a recent landmark study, the team also made a major breakthrough 
in determining the origin of and the genetic mechanisms that specify the cortex’s powerful and 
enigmatic chandelier cells. This is a critical class of inhibitory brain cells, and the team showed 
that chandelier cells are born in a previously unrecognized portion of the embryonic brain, which 
they have named the VGZ (ventral germinal zone).
Adam Kepecs and colleagues are interested in identifying the neurobiological principles underly-
ing cognition and decision making. They use a reductionist approach, distilling behavioral ques-
tions to quantitative behavioral tasks for rats and mice that enable the monitoring and manipula-
tion of neural circuits supporting behavior. Using state-of-the-art electrophysiological techniques, 
they fi rst seek to establish the neural correlates of behavior and then use molecular and optoge-
netic manipulations to systematically dissect the underlying neural circuits. Given the complexity 
of animal behavior and the dynamics of neural networks that produce it, their studies require 
quantitative analysis and make regular use of computational models. The team also has begun 
to incorporate human psychophysics to validate its behavioral observations in rodents by linking 
them with analogous behaviors in human subjects. Currently, the team’s research encompasses 
study of (1) the roles of uncertainty in decision making, (2) the division of labor among cell types 
in prefrontal cortex, (3) how the cholinergic system supports learning and attention, and (4) social 
decisions that rely on stereotyped circuits. A unifying theme is the use of precisely timed cell-
type- and pathway-specifi c perturbations to effect gain and loss of function for specifi c behavioral 
abilities. Through such manipulations of genetically and anatomically defi ned neuronal elements, 
the team hopes to identify fundamental principles of neural circuit function that will be useful for 
developing therapies for diseases such as schizophrenia, Alzheimer’s disease, and autism spectrum 
disorder.
Alexei Koulakov and colleagues are trying to determine the mathematical rules by which the 
brain assembles itself, with particular focus on the formation of sensory circuits such as those in-
volved in visual perception and olfaction. The visual system of the mouse was chosen for study in 
part because its components, in neuroanatomical terms, are well understood. What is not known is 
how projections are generated that lead from the eye through the thalamus and into the visual cor-
tex, how an individual’s experience infl uences the confi guration of the network, and what param-
eters for the process are set by genetic factors. Even less is known about the assembly of the neural 
net within the mouse olfactory system, which, in the end, enables the individual to distinguish 
one smell from another with astonishing specifi city and to remember such distinctions over time. 
These are among the challenges that engage Koulakov and his team.
Dysfunction of synapse in the brain is believed to have an important role in the pathogenesis 
of major psychiatric disorders, including depression, anxiety, and schizophrenia. But what are 
the causes? Where in the brain does the dysfunction occur? How does it result in the behavioral 
symptoms of illness? To address these issues, Bo Li and colleagues are studying, in animals, nor-
mal synaptic plasticity underlying adaptive behaviors, and synaptic aberrations responsible for 
maladaptive behaviors that are related to depression, anxiety, and schizophrenia. Their long-term 
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goal is to develop methods allowing the manipulation of activity in specifi c brain circuits in 
order to change disease-related behaviors. Li’s group uses a variety of methodologies, including 
patch-clamp recording and calcium imaging of labeled neurons, two-photon imaging of spine 
morphology and tagged receptors, in vivo stereotaxic virus injection; RNAi-based gene silencing, 
activation of specifi c axon terminals using light-gated cation channels, activation or silencing of 
specifi c brain regions using transgenes, and assessment of the behavioral consequences of certain 
manipulations. A project focusing initially on a gene called ErbB4 seeks to determine the genetic 
causes of attentional defi cit, a cognitive impairment that is consistently observed in schizophrenia. 
This past year, Li and his lab members demonstrated that neurons in a tiny area of the mam-
malian brain called the central amygdala encode fear memory and control fear expression. These 
fi ndings laid the foundation for future work aimed at understanding the circuit mechanisms of 
anxiety disorders, in particular post-traumatic stress disorder (PTSD).
Partha Mitra seeks to develop an integrative picture of brain function, incorporating theory, 
informatics, and experimental work. In the ongoing Mouse Brain Architecture Project, Mitra 
and colleagues are well on their way to generating the fi rst-ever brainwide mesoscopic-scale cir-
cuit map of the entire mammalian brain. This year, they released the fi rst set of gigapixel (1 bil-
lion pixel) images from the project (http://mouse.brainarchitecture.org). The current data set is 
close to 1 petabyte in size (uncompressed). This is a fi rst step toward mapping vertebrate brain 
architecture across species and in mouse models of human disease, including knockout models of 
autism spectrum disorders. These maps will be cross-referenced to the Allen Brain Atlas of gene 
expression, a complementary landmark data set on which the Mitra lab has innovated multiple 
analyses. Related collaborative efforts include characterization of different types of GABAergic 
neurons in the mouse brain, optogenetic studies of the rodent brain, and connectivity mapping 
in marmoset and zebra fi nch brains. These individual projects fall under the new and growing 
research area of whole-brain digital/computational neuroanatomy, which the Mitra laboratory is 
helping to develop. 
Pavel Osten’s lab works on identifi cation and analysis of brain regions, neural circuits, and con-
nectivity pathways that are disrupted in genetic mouse models of autism and schizophrenia. Osten 
hypothesizes that (1) systematic comparison of many genetic mouse models will allow determina-
tion of overlaps in pathology—neural circuit endophenotypes—responsible for the manifestation 
of neuropsychiatric disorders and (2) neural circuit-based classifi cation of autism and schizophre-
nia will provide key circuit targets for detailed mechanistic studies and therapeutic development. 
Osten and colleagues have developed the fi rst systematic approach to the study of neural circuits in 
mouse models of psychiatric diseases, based on a pipeline of anatomical and functional methods 
for analysis of mouse brain circuits. An important part of this pipeline is high-throughput mi-
croscopy for whole mouse-brain imaging, called serial two-photon (STP) tomography. This year, 
they published new technology that automates and standardizes this technique, which will speed 
up and facilitate studies using STP. Other methods include viral vector-based anatomical tracing, 
transgenic and knockin “indicator” mouse lines for monitoring expression of activity-regulated 
genes, and both in vitro and in vivo two-photon imaging and electrophysiology.
Stephen Shea’s lab studies the neural circuitry underlying social communication and decisions. 
He uses natural social communication behavior in mice as a model to understand circuits and pro-
cesses that are evolutionarily conserved and therefore shared broadly across species, likely contrib-
uting to disorders such as autism. Shea and colleagues have examined how emotion and arousal 
enable mice, via their olfactory systems, to store memories of other individuals and of related 
social signals. The team has exploited the intimate relationship between memory and emotion to 
effectively create memories in anesthetized mice, allowing them unprecedented access to neuro-
biological processes that typically only occur during behavior. The lab has been making a detailed 
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analysis of the changes in neural connections that underlie odor memory. The team is particularly 
focused on an enigmatic cell type (granule cells or GCs) that has long been hypothesized to be 
crucial for memories, but has resisted direct study. They have developed methods for recording 
that are giving them the fi rst glimpse of the dynamics of these cells while the animal is learning 
an odor. The results show unexpectedly complex population dynamics among the GCs that were 
independently predicted by a model of odor learning developed in Alexei Koulakov’s lab. The two 
labs are collaborating to discern how GC population activity gets integrated by olfactory bulb 
output neurons and to pinpoint the synaptic circuit that underlies this form of learning. In paral-
lel, another member of the lab is using imaging techniques to determine how memories are stored 
among broad neuronal ensembles, at a different level of the system. This year, the lab made a key 
breakthrough, developing the ability to record from GCs in awake animals and discovering that 
their activity is dramatically modulated by state of consciousness. Finally, the Shea lab completed a 
series of studies of a different form of social recognition: auditory recognition of pup vocalizations 
by their mothers. Through this research, they have shown that a mouse model of Rett syndrome 
exhibits defi cits in communication and learning not unlike those in human patients. Grants from 
the Simons and Whitehall Foundations are allowing the lab to extend this work by directly link-
ing these defi cits to the action of the gene MeCP2 in the auditory cortex.
What is a memory? When we learn an association, information from two different sensory streams 
somehow becomes linked together. What is this link in terms of neural activity? For example, after 
a few bad experiences, we learn that the “green” smell of an unripe banana predicts its starchy 
taste. How has the neural response to that green smell changed so it becomes linked to that taste? 
What are the underlying mechanisms—what synapses change strength, what ion channel proper-
ties change? These are the questions that drive research in Glenn Turner’s laboratory. His team 
addresses these questions by monitoring neural activity using a combination of different tech-
niques. Using electrophysiological methods, they can examine individual neurons with very high 
resolution, monitoring synaptic strength and spiking output. They have also developed functional 
imaging techniques to monitor the activity of the entire set of cells in the learning and memory 
center of the fl y brain. This comprehensive view of neural activity patterns enables them to actu-
ally predict the accuracy of memory formation in separate behavioral experiments. By examining 
the effects of learning-related genes on this process, they can connect their network-level view of 
memory formation to the underlying molecular mechanisms that govern the basic cellular and 
synaptic changes that drive learning.
Anthony Zador and colleagues study how brain circuitry gives rise to complex behavior. Work 
in the lab is focused on two main areas. First, they ask how the cortex processes sound, how that 
processing is modulated by attention, and how it is disrupted in neuropsychiatric disorders such as 
autism. The lab has shown the infl uence of expectation on neuronal activity in rat sensory cortex, 
suggesting that improvements in auditory perception that result from valid temporal expectation 
arise from changes in sensory representations as early as the fi rst stages of cortical processing. This 
past year, they published new research in which the loss of a gene commonly mutated in autism, 
PTEN, is associated with hyperconnectivity in the brain’s auditory cortex. Importantly, these 
effects can be blocked by the immunosuppressant rapamycin. Second, they are developing new 
methods for determining the complete wiring instructions of the mouse brain at single-neuron 
resolution, which they term the “Connectome.” In contrast to previous methods, which make use 
of microscopy, these methods exploit high-throughput DNA sequencing. Because the costs of 
DNA sequencing are plummeting so rapidly, these methods have the potential to yield the com-
plete wiring diagram of an entire brain for just thousands of dollars.
Yi Zhong’s lab studies the neural basis of learning and memory. The team works with fruit 
fl y models to study genes involved in human cognitive disorders, including neurofi bromatosis, 
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Noonan Syndrome (NS), and Alzheimer’s disease. Mutations leading to a lack of function of the 
neurofi bromatosis 1 (NF1) gene cause noncancerous tumors of the peripheral nervous system as 
well as learning defects. The lab’s analyses of Drosophila NF1 mutants have revealed how expres-
sion of the mutant gene affects a pathway crucial for learning and memory formation. The NF1 
gene and a gene called corkscrew, implicated in NS, share a biochemical pathway. Recently, the lab 
succeeded in linking changes in this pathway due to specifi c genetic defects in NS with long-term 
memory defi ciencies. In fl y models, they discovered the molecular underpinnings of the “spacing 
effect”—the fact that memory is improved when learning sessions are spaced out between rest 
intervals. Zhong’s team also has succeeded in reversing memory defi cits in mutant fl ies, work sug-
gesting longer resting intervals for Noonan’s patients might reverse their memory defi cits. This 
year, they identifi ed a means of reversing memory loss in fruit fl ies while suppressing brain plaques 
similar to those implicated in Alzheimer’s disease by blocking epidermal growth factor receptor 
(EGFR) signaling, a pathway commonly targeted in cancer. Separately, having discovered that 
memory decay is an active process, regulated by the Rac protein, the team has proposed that Rac’s 
role in erasing memory is related to its infl uence on downstream cytoskeleton remodeling agents.
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UNDERSTANDING NEURONAL CIRCUITS IN 
THE MAMMALIAN OLFACTORY BULB
F. Albeanu F. Anselmi H.G. Chae M. Davis M. Koh G. Otazu
 A. Banerjee P.G. da Silva P. Gupta F. Marbach H. Patel
The focus of our research group is to understand how 
neuronal circuits encode and interpret inputs from 
the environment and lead to meaningful behaviors. 
Toward this end, we use optogenetic methods (such 
as fast multiphoton laser-scanning imaging of geneti-
cally encoded neuronal activity reporters or patterned 
illumination of light-gated neuronal activity switches) 
coupled with electrophysiological measurements (ex-
tracellular and intracellular recordings). We want to 
understand (1) how inputs become processed at dif-
ferent synapses of the underlying neuronal circuits, 
(2) how these representations change with the state 
of the system and its circuits (awake vs. anesthetized, 
naïve vs. learning), and (3) what changes in the ac-
tivity patterns of well-defi ned neuronal circuits con-
tribute to specifi c behaviors. The broad scope of this 
effort is observing how perceptions arise.
We use the rodent olfactory system as a model and 
monitor neuronal inputs, outputs, and feedback loops 
in different layers of the circuit. We modulate activity 
of select neuronal populations in a reversible manner 
in anesthetized and behaving animals to understand 
how fundamental sensory encoding problems are 
solved by the olfactory bulb (OB) and olfactory (piri-
form) cortex networks.
Characterizing the Input-Output 
Transform of the Olfactory Bulb
In the OB, sensory neurons expressing the same type 
of olfactory receptor converge in tight focus, form-
ing ~2000 clusters of synapses called glomeruli. The 
layout of glomeruli on the OB is highly reproducible 
across individuals, with a precision of 1 part in 1000. 
However, nearby glomeruli are as diverse in their re-
sponses to odors as distant ones, lacking an apparent 
chemotopic arrangement (Soucy et al., Nat Neurosci 
12: 2 [2009]). From each glomerulus, a few dozen mi-
tral cells (principal output neurons of the OB) carry 
the output farther to the olfactory cortex and several 
other brain areas. Such “sister” mitral cells typically 
have only one primary dendrite that projects to a sin-
gle glomerulus, but they can sample inputs on their 
primary and secondary dendrites from functionally 
diverse glomeruli via several types of interneurons 
(Fig. 1). Using optogenetic manipulations and digital 
micromirror device (DMD)-based patterned photo-
stimulation (Fig. 2), we found that sister cells carry 
different information to the cortex: Average activity 
represents shared glomerular input, and phase-specifi c 
information refi nes odor representations and is sub-
stantially independent across sister cells (Dhawale 
et al., Nat Neurosci 13: 1404 [2010]).
Activity in the OB is a rich mix of excitation and 
inhibition, via both direct inputs and feedback connec-
tions. Many different classes of interneurons interact 
with the sensory afferents and/or the output neurons 
via both short- and long-range connections. Their con-
nectivity patterns and roles in olfactory processing, 
however, remain largely unknown. We use a Cre/loxP 
approach to express reporters (i.e., synaptopHluorin, 
GCaMP6) and light-gated switches of neuronal activ-
ity (ChR2, Halorhodopsin, Arch) in different bulbar 
neuronal types. We monitor the inputs (glomerular 
activity patterns) and the outputs (mitral cell fi ring) in 
response to numerous odorants across a wide range of 
concentrations (fi ve orders of magnitude) as we system-
atically perturb the activity of the input nodes (glom-
eruli) and of different interneuron types. Patterned 
photostimulation allows us to bypass odor stimulation 
and gain precise spatiotemporal control over the inputs 
by directly activating glomerular patterns of choice. 
We record bulbar outputs via multitetrode recordings 
and patch clamp or use optical imaging readouts via 
multiphoton microscopy in vivo to understand what 
computations the OB performs.
We are currently investigating the roles of two class-
es of interneurons: short axon cells (SA) that broadcast 
long-range signals in the glomerular layer and granule 
cells (GC) that establish reciprocal synapses with mi-
tral/tufted cells and receive rich cortical feedback input.
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Short Axon Cells Implement Gain Control 
in the Olfactory Bulb
SA cells, in the glomerular layer, receive inputs from 
olfactory sensory neurons and/or external tufted (ET) 
cells and release both GABA and dopamine, synaps-
ing onto juxtaglomerular cells as far as tens of glom-
eruli away (Kiyokage et al., J Neurosci 30: 1185 [2010]). 
Computational models (Cleland et al., Trends Neurosci 
33: 130 [2007]) have suggested that SA cells may be 
involved in long-range normalization of bulb outputs, 
but to date, their function in the intact brain has not 
been investigated. We imaged GCaMP3 responses by 
wide-fi eld microscopy to odor stimulation across a wide 
range of concentrations. Odorants induced transient 
yet widespread SA responses, in contrast to focal glo-
merular patterns observed via intrinsic optical imaging.
To understand the roles played by the SA network 
on the bulb output dynamics, we recorded extracellu-
larly from mitral/tufted (M/T) cells using tetrodes in 
anesthetized mice. In conjunction, we selectively acti-
vated/inactivated SA cells by shining blue/yellow light 
either throughout the dorsal bulb surface or in specifi c 
spatial patterns in mice expressing ChR2 and Halorho-
dopsin, respectively. In parallel, we developed comple-
mentary tools to silence SA cells pharmacogenetically 
using inhibitory DREADDs and to monitor mitral cell 
activity at the population level by retrograde expres-
sion of GCaMP3. Strikingly, pairing odor presentation 
Figure 1. Main olfactory bulb wiring schematics.
Figure 2. DLP patterned illumination in ORC mice maps the parent glomeruli of mitral cells in vivo. (A Left) A DLP 
projector coupled to a system of three lenses delivered light patterns to activate individual glomeruli on the dorsal 
surface of the bulb. A CCD camera was used to visualize the bulb surface and record the position of the light stimu-
lus. (Top panel, right) dorsal surface of the bulb with a tetrode positioned in the mitral cell layer. One square light 
spot is being projected onto the surface of the bulb. (Inset) Cartoon schematic of glomeruli on the bulb, a subglomer-
ular size light spot and dual tetrodes positioned in the mitral cell layer. (a) DLP projector, with color wheel removed 
from optical path; (b) focusing lens; (c) blue excitation ﬁ lter; (d) dichroic mirror; (e) emission ﬁ lter; (f) CCD camera; (g) 
dual-tetrode; (h) olfactory bulb. (B, top) Raw voltage traces corresponding to the four channels of a tetrode showing 
light-induced changes in ﬁ ring patterns of the units recorded. (Center) Raster plot shows changes in spiking activity of 
a single isolated unit across 25 light stimulation trials, each 200 ms long; dots mark spike occurrence times; (Bottom) 
Peri-stimulus time histogram (PSTH) with 25-ms time bins, summing spikes over the trials shown in the center panel.
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at various concentrations with light indicates that SA 
cells provide both excitatory and inhibitory drive to the 
M/T cells in a stimulus-specifi c fashion (Fig. 3). At low 
odorant concentrations, for weak odor stimuli, SA cells 
provide excitatory input, whereas in response to stronger 
stimuli, both excitatory and inhibitory drives are pres-
ent. Pharmacological manipulations indicate that SA 
cells both excite and inhibit individual mitral cells in 
different contexts through a diverse machinery of elec-
trical and chemical synapses, using multiple neurotrans-
mitters. Synaptic blockade experiments in acute bulb 
slices and in vivo revealed a widespread excitatory drive 
of SA cells that is implemented by a distributed network 
of gap junctions in the glomerular layer and D1 recep-
tors. This unique morphological and chemical organi-
zation of SA cells facilitates potentiation of responses to 
weak inputs and conversely suppression of strong ones, 
thereby implementing intensity-dependent bidirectional 
control of the dynamic range of bulb outputs.
Characterization of Granule Cell Odor 
Responses in Awake Head-Fixed Mice
GCs mediate both lateral and recurrent inhibition by 
forming reciprocal synapses with M/T, the principal 
output neurons of the OB. GCs receive glutamatergic 
inputs both from M/T cells and from feedback axons 
originating in the olfactory cortex. GCs are the most 
numerous cells in the OB, outnumbering the M/T 
cells by two orders of magnitude, and further repre-
sent the main target of direct feedback from the olfac-
tory cortex.
Computational models and behavioral studies have 
suggested critical roles for these cells in olfactory pro-
cessing and learning. However, very little is known 
about their response properties in vivo, owing to tech-
nical diffi culties in electrophysiological recordings 
from these small-sized neurons. To begin character-
izing the odor response properties of GCs, we express 
a genetically encoded calcium indicator (GCaMP3) 
in the GCs (CST-Cre × Ai38) and use multiphoton 
imaging to monitor the odor-evoked responses of GCs 
in awake head-fi xed mice. GCs show robust sponta-
neous activity and are sparsely activated upon odor 
presentation, displaying a diverse range of enhanced 
and suppressed, ON, OFF, and ON-OFF responses. 
We observe odor responses in slightly more than half 
of the GCs imaged. Strikingly, to our stimulus panel 
(up to 20 odors, 100-fold mineral oil dilution), 25% 
of GCs displayed purely enhanced responses, 26% of 
GCs showed suppression, and only a small fraction 
Figure 3. Optogenetic suppression of SA cells reveals both excitatory and inhibitory drives on M/T cell output. (A) 
Homogeneous expression of DIO-Halorhodopsin AAV construct injected in DAT-Cre mice. (B) Example of full-ﬁ eld 
yellow light mask designed to avoid the recording electrode. (C) Spike raster and PSTH of an M/T cell inhibited upon 
SA cell suppression. Orange line indicates duration of yellow light presentation. (D) Example M/T cell response 
to ethyl valerate alone (top row) or when paired with full-ﬁ eld yellow light stimulation (bottom). Dark and light 
gray lines indicate duration of odor and light presentation, respectively. (E) Ratio of ﬁ ring rate during “odor” and 
“odor + light” period for 147 M/T cell odor pairs across different dilutions. (F) Percentage of M/T cell odor pairs at 
each dilution that receive excitatory or inhibitory drive from the SA cell network.
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(5%) showed both enhancement and suppression. We 
fi nd that enhanced responses are as common as sup-
pressed responses. Furthermore, a signifi cant fraction 
(~25%) of GCs exhibited characteristic enhanced 
OFF responses, independent of the stimulus duration. 
Pairwise analysis of GCs monitored simultaneously 
show low, but signifi cant, positive noise correlations 
and odor response spectra correlations. Importantly, 
neighboring GCs are as diverse in their odor responses 
as pairs of distant cells. No spatial clustering of simi-
larly responding GCs is apparent within a 350-μm 
range.
We are further characterizing how individual GC 
odor responses, as well as the diversity of responses 
across the population, change with increasing odor 
concentration and across larger odor sets. To dissect 
the contribution of the corticobulbar feedback to GC 
activity, we are currently using pharmacological and 
optogenetic manipulations of the cortical input in 
tandem with multiphoton imaging of GCs and M/Ts. 
This approach will allow us to directly assay the effects 
of these perturbations on GC dynamics, as well as on 
the OB output.
Dissecting the Spatial and Temporal Features 
of the Glomerular Code in Awake Behaving 
Animals via Optogenetics Strategies
Odorants activate precise spatiotemporal glomeru-
lar activity patterns on the OB surface. These pat-
terns constitute the fi rst representation of odor input 
into the olfactory system and hence must contain all 
meaningful attributes of the incoming odor stimu-
lus, such as odor identity, intensity, and temporal dy-
namics. Different odors activate distinct overlapping 
and nonoverlapping glomerular maps. In principle, 
these odor maps can vary in several possible features 
such as number (how many glomeruli are activated), 
space (which glomeruli), intensity (absolute and 
relative levels of activity of individual glomeruli), 
and timing (onset with respect to each other and 
the order of their activation). Previous experiments 
suggest that presenting different odorants (A vs. B), 
mixtures (A and B), or different concentrations of 
the same odorant (A) may all result in modulation of 
odor maps along many (if not all) of these features. 
It is unknown how the downstream circuitry (M/T 
cells, olfactory cortex) interprets these variations and 
assigns meaning to them in order to segregate odor 
identity from changes in concentration or compo-
nents within/from a mixture.
One way to understand how the circuit makes 
sense of changes in the glomerular activity patterns 
to extract relevant information is to systematically 
alter features of odor maps and study the concurrent 
changes in neuronal outputs and olfactory behavior. 
Hitherto, however, this has not been possible, pri-
marily due to the inability to activate and modulate 
individual glomeruli in a controlled manner using 
odorants. We are using optogenetic tools to bypass 
odorant stimulation and simulate odor-like glo-
merular activity patterns, or alter them, by directly 
activating/inhibiting glomeruli using light in trans-
genic mice that express ChR2 or Arch in all olfac-
tory system neurons (OSNs) or in a single type of 
OSN (Olf151). Furthermore, using patterned illumi-
nation, we are activating/inhibiting select subsets of 
glomeruli with single-glomerulus precision in terms 
of intensity, onset time, or duration. This approach 
confers an unprecedented ability to make feature-spe-
cifi c perturbations in a glomerular pattern of choice. 
We aim to understand what features of an odor map 
are used by a behaving mouse in naturalistic condi-
tions to identify odors and their attributes such as 
concentration, temporal fl uctuations, or spatial lo-
cation. Furthermore, we are testing the resolution at 
which mice can in principle detect variations within 
specifi c features of odor maps in a strictly controlled 
artifi cial regime. While doing so, we will also moni-
tor neuronal responses at multiple layers in the olfac-
tory system to compare the behavioral and neuronal 
detection thresholds and to understand the neuronal 
correlates of olfactory behavior.
To this end, we are training head-fi xed and water-
restricted mice to identify a target stimulus (“A”) as 
being unique from other nontarget (“not A”) stimuli 
by licking a “Left” versus “Right” water reward port 
placed on either side of the mouth (Fig. 5H, below). 
Animals are reinforced with water reward for correct 
choices and a mild air puff as punishment upon lick-
ing of the wrong port (Fig. 5H, below). We are using 
wide-fi eld imaging (intrinsic, fl uorescence) and two-
photon microscopy to monitor the glomerular input 
maps evoked by the target (“A”) and the nontarget 
stimuli (“not A”) as mice learn and perform the task. 
These activity patterns are further used as templates 
to design photostimulation masks for perturbation of 
stimulus-induced activity patterns during behavior. 
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Once the task has been learned to >85% accuracy, 
we reversibly perturb the stimulus “A” activity pattern 
and determine the behavioral threshold at which an 
altered activity pattern is classifi ed as “not A.”
Investigating the Roles of Cortical Feedback 
in Invariant Odor Perception
Invariant perception refers to the identifi cation of a 
sensory stimulus or an object of interest in a general-
ized fashion across its variable and recurring presen-
tations. This is a common feature across all sensory 
modalities and becomes particularly preeminent in 
olfaction. Natural odor scenes are composed of odor 
plumes originating from multiple sources and travel-
ing at fl uctuating intensities that span several orders 
of magnitude. Despite the turbulent nature of the 
stimulus, rodents readily identify odors essential for 
their survival against varying odor-rich backgrounds 
and faithfully track a fl uctuating odor stream to its 
source. Several models have attempted to explain in-
variant perception in different sensory modalities. 
Some of these models are based on the conventional 
view of sensory processing that relies solely on feed-
forward information fl ow, whereas others argue that 
feed-forward mechanisms are insuffi cient and suggest 
the involvement of feedback between different neuro-
nal layers. Anatomical studies show massive feedback 
projections from higher brain areas to the sensory pe-
riphery that often outnumber direct sensory inputs. 
The interplay of feed-forward and feedback signals 
has been proposed to be fundamental for learning 
and memory recall. Although rich cortical feedback 
projections innervate the OB, to date, little is known 
about their contribution to olfactory processing. Cor-
ticobulbar feedback innervates multiple bulb layers, 
but primarily targets the GCs, which form extensive 
dendro-dendritic synapses with the M/T cells. We aim 
to understand the role of corticobulbar feedback (Fig. 
4) in the identifi cation of an odor, invariant of fl uctua-
tions in its concentration and/or timing and presence 
of background odors. We are taking advantage of opto-
genetic tools and patterned illumination techniques re-
cently developed in our group to reversibly manipulate 
the activity of cortical feedback fi bers and their targets 
in awake head-fi xed mice as they learn and perform 
invariant odor perception tasks. To mimic naturalistic 
odor conditions, we are making use of custom-designed 
odor delivery systems that reproducibly deliver arbitrary 
time-varying patterns of individual odors and mix-
tures. To understand the underlying neuronal mecha-
nisms, we monitor the activity of feedback inputs and 
their targets via high-speed scanning multiphoton mi-
croscopy and multitetrode recordings.
To date, little is known about the contribution of 
cortical feedback to olfactory processing in the OB in 
response to novel or previously encountered odors. To 
examine how cortical feedback shapes input process-
ing in the OB, we use GCaMP5 to monitor the odor-
evoked responses of feedback fi bers in awake head-
fi xed mice. Feedback fi bers show rich spontaneous 
activity and diverse enhanced and suppressed odor 
responses. Suppression of feedback fi bers by odors ap-
pears to be sparser and more stimulus-specifi c com-
pared to the enhanced responses.
Pairwise analysis of simultaneously imaged bou-
tons reveals functional local diversity. An excess of 
functionally similar boutons occurs within 20-μm 
separation, likely due to local enrichment in same 
axon-boutons. However, beyond this small excess, no 
apparent spatial order is apparent within the imaged 
fi eld of view (<150 μm).
Interestingly, habituation to select sets of odors in 
our panel across several days results in a signifi cant 
increase in the fraction of suppressed versus enhanced 
responses (1.07 ± 0.06) compared to nonhabituated 
odors (0.67 ± 0.05). These results suggest that odor 
experience weakens the olfactory cortical feedback 
drive to the OB. We are currently investigating how 
cortical feedback dynamics change with olfactory 
learning by training head-fi xed mice in simple “go–
no go” odor discrimination tasks. In addition, we are 
using pharmacological and optogenetic approaches 
to modulate the corticobulbar feedback, while simul-
taneously monitoring the changes induced by these 
 manipulations onto granule cell activity patterns.
Monitoring Cholinergic Input 
in the Olfactory Bulb in Mice Engaged 
in Attention Tasks
Cholinergic inputs from the basal forebrain have been 
shown to enhance encoding and discrimination of vi-
sual, auditory, and somatosensory cues by modulating 
attention and learning processes. Although rich cho-
linergic projections innervate the mouse olfactory bulb 
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(MOB), to date, little is known about their contribu-
tion to olfactory behaviors. Pharmacological block ade 
of acetylcholine (ACh) action has been shown to im-
pair olfactory behavior, whereas augmenting acetyl-
choline (ACh) levels improved odor discrimination. 
A clear understanding of the underlying mechanisms 
of ACh action and their spatiotemporal statistics, 
however, has been limited by the low yield of record-
ings from the basal forebrain, as well as diffi culties in 
ascertaining the downstream targets of the recorded 
neurons, given the widespread and long-range nature 
of cholinergic projections.
To circumvent these issues, we are taking advan-
tage of genetically engineered mice (Chat-Cre) and 
viral strategies to target expression of calcium indica-
tors (GCaMP5 and GCaMP6) in cholinergic neurons 
and optically monitoring the activity patterns of 
the projection fi bers to the MOB in behaving ani-
mals (Fig. 5). We are pursuing two complementary 
strategies to gain access to the activity of ensembles 
of cholinergic neurons: (1) multiphoton imaging in 
awake head-fi xed mice (Fig. 5C,D), which allows 
observation of large numbers of cholinergic projec-
tions in the MOB, with axonal resolution, enabling 
precise spatiotemporal characterization of their activ-
ity patterns within, as well as across, different circuit 
layers (glomerular vs. mitral cell layer), and (2) fi ber 
optic imaging in freely moving mice (Fig. 5E–G). 
Although limited to assessment of average popula-
tion activity of cholinergic inputs, this approach can 
be easily coupled with electrophysiological means to 
simultaneously monitor the OB output (M/T cells).
Figure 4. Odor-evoked responses in corticobulbar feedback ﬁ bers. (A) Corticobulbar feedback ﬁ bers labeled with 
GCaMP5; (B) feedback ﬁ ber boutons in an optical plane 230 μm below the surface; (C) example responses to three 
different odors (ethyl tiglate, 2-heptanone, and p-anis aldehyde) for six synaptic boutons from the imaged ﬁ eld of view.
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Figure 5. Monitoring of cholinergic feedback and two forced-choice tasks. (A) Two-photon images of cholinergic 
ﬁ bers in an MOB sagittal slice (left) and the injection site (HDB, right). Awake head-ﬁ xed imaging: (B) 38-day-old 
cranial window (left); 2P ﬁ eld of view of GCaMP5-expressing cholinergic axons (right); (C) spontaneous activity; (D) 
odor-evoked responses in the MOB to same (left) and different odors (right); (E) schematic of ﬁ ber-optic based system 
and picture of the setup; (F) corticobulbar feedback signals recorded using the system in D (four repeats, shaded 
area indicates S.E.M.); (G) single-unit recordings of mitral cell odor response with respect to the respiratory cycle; (H; 
i) Schematic of the 2AFC task. Water reward on licking for odor A (left) and for odor B (right); air puff for licks dur-
ing air period. (ii) Mouse performing the task and (iii) the corresponding learning curve. (Top) Each pair of dark and 
light gray circles shows the fraction of correct licks on the left (dark gray) and right (light gray) ports. Vertical stripes 
represent training sessions. (Bottom) No-go performance upon air presentation.
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Combining insights obtained via these two approach-
es will reveal how ACh action in the OB is linked to 
the timing and nature of olfactory stimuli across dif-
ferent behavioral states. In addition, it will further aid 
informed optogenetic manipulations of ACh signals to 
understand the relevance of cholinergic inputs in shap-
ing the mitral cell output and olfactory behaviors.
Implementing Digital Holography Methods 
to Investigate in a Closed-Loop Fashion 
the Spatiotemporal Integration Rules in the 
Olfactory Bulb and Cortex
We are implementing strategies that will enable non-
invasive functional dissection of neuronal networks 
with cellular resolution in behaving animals. This 
will be brought about via a closed-loop strategy in-
volving real-time control of activity of select neurons 
with simultaneous monitoring of the concomitant 
effects of these manipulations on neuronal outputs 
within the circuit and elsewhere in the brain. Briefl y, 
we are using digital holography methods via spatial 
light modulators to optogenetically control neurons of 
interest at single-cell level and DMD-based methods 
to control cell-type-specifi c populations across large 
brain regions (Fig. 6). This allows us to both replicate 
and systematically manipulate stimulus-evoked activ-
ity patterns in a circuit. We are simultaneously using 
two-photon calcium imaging and electrophysiology 
within the same and different brain regions (OB vs. 
olfactory cortex) to dissect how the alteration of select 
circuit elements, or their specifi c properties, affects 
the output of the network. This closed-loop approach 
will make it possible to determine the spatiotemporal 
integration rules within the OB and the olfactory cor-
tex, investigate the relevance of spike-time codes, and 
reveal underlying decoding schemes.
Other Collaborative Projects 
with CSHL Groups
We are collaborating with other fellow CSHL scien-
tists on the following projects: multisensory integra-
tion of olfactory and visual information in the mouse 
Figure 6. Combined imaging and photostimulation setup. (Left) Experimental conﬁ guration, combining scanning 
two-photon imaging, DMD photostimulation, and holographic photostimulation. (Right) Schematic of the experi-
mental microscope. DMD stimulation is used to create spatiotemporal light patterns on the surface (<100 μm). Digi-
tal holography is used to photostimulate deeper (<500 μm) in the brain with cellular resolution. Calcium activity is 
monitored in an independent optical plane by two-photon imaging and by electrodes in downstream brain regions. 
(BE) Beam expander; (SM) scan mirrors; (O) objective; (PMT) photomultiplier; (SLR) camera lens; (DMD) digital mi-
cromirror device; (SLM) spatial light modulator; (CCD) charged-coupled device.
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brain (A. Churchland); sequencing the olfactory 
bulb; bridging the gap between glomerular odor re-
sponses and odor receptor sequences by determining 
the molecular identity of glomeruli (A. Koulakov and 
G. Hannon); fi ber-optic-based approach to monitor 
neuronal activity in punishment and reward neuronal 
circuits during behavior (B. Li); developing light-sheet-
based approaches for fast optical reconstruction of 
neuronal circuits (P. Osten); and optical monitoring 
and manipulation of neuronal activity in genetically 
and anatomically defi ned cortical circuits in animal 
models of cognition (A. Zador).
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INVESTIGATING NEURAL CIRCUITS FOR SENSORY 
INTEGRATION AND DECISION MAKING
A. Churchland A. Brown D. Raposo
 M. Kaufman M. Ryan
 O. Odoemene J. Sheppard
Making use of sensory information requires more 
than simply relaying incoming signals from the sen-
sory organs. It requires interpreting information, 
classifying it, drawing inferences, and ultimately 
using the context of behavioral goals to make a deci-
sion about its meaning. A decision is a commitment 
to a particular choice or proposition at the expense of 
competing alternatives. In some situations, decisions 
involve integration of evidence, i.e., they make use 
of multiple pieces of information from the environ-
ment or from memory. These decisions can provide a 
framework in which to investigate complex cognitive 
processes and open a window into higher brain func-
tion in general (Churchland and Ditterich 2012). 
Although previous experiments have begun to reveal 
how neural systems combine evidence to make deci-
sions, they have left a critical gap in our understand-
ing. Specifi cally, very little is currently known about 
the neural mechanisms that make it possible to com-
bine information from multiple sensory modalities 
for decisions. The gap is apparent, although it is clear 
from behavioral observations that neural systems can 
combine multisensory information: When parsing 
speech in a crowded room, for example, the listener 
makes use of both auditory information (the speak-
er’s vocal sounds) and visual information (the speak-
er’s lip movements). Understanding the neural 
mechanisms of multisensory integration is critical 
for two reasons. First, it is essential for a complete 
understanding of sensory perception because real-
world stimuli rarely affect a single sense in isolation. 
Therefore, understanding how the brain interprets 
incoming information requires understanding how 
the brain merges information from different senses. 
Second, it is likely of clinical importance: Several 
developmental abnormalities appear to be related to 
diffi culties in integrating sensory information. For 
example, abnormalities in multisensory processing 
are a hallmark of subjects with autism spectrum dis-
order. Impairments in multisensory processing are 
also observed in subjects with a collection of sen-
sory abnormalities known together as sensory pro-
cessing disorder and may also be evident in patients 
with Rett syndrome and dyslexia. Understanding 
the neural mechanisms of multisensory integration 
could inform treatment of those conditions. Our 
long-term goal is to understand how the brain can 
make decisions that integrate inputs from our mul-
tiple senses, stored memories, and innate impulses. 
Our current projects, described below, are a fi rst step 
toward this complete understanding of perceptual 
decision making. In the past year, we have made 
tremendous strides toward achieving that goal. We 
have successfully extended our behavioral paradigm 
for studying decision making in rats and humans to 
mice (Fig. 1A). Furthermore, we have also continued 
to record electrophysiological responses from the rats 
while they are engaged in the task (Fig. 1B). Our 
fi rst fi ndings with this new paradigm were published 
this year in the Journal of Neuroscience (Raposo et al. 
2012b). This year, work in our lab was recognized 
by several awards. We received foundation awards 
from the McKnight and Chapman Foundations and 
were also honored with an award from the Society 
for Neuroscience (Trubatch Career Development 
Award). We continue to be grateful for our support 
from the National Science Foundation, the National 
Institutes of Health, and the Marie Robertson Fund. 
This support is critical for ongoing lab projects, list-
ed below.
Role of Parietal Cortex in Multisensory 
Decision Making
This work was done in collaboration with D. Raposo, 
Champalimaud Neuroscience Program, Lisbon, Portugal, 
and M. Kaufman (Stanford University). 
The goal of this project is to gain a deeper understand-
ing of the neural mechanisms that enable integration 
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of visual and auditory inputs for decision making. To 
this end, we record from neurons in a multisensory 
area of the rat brain, the posterior parietal cortex. Be-
cause we record from neurons during multisensory 
behavior, we can draw connections between the ani-
mal’s behavior and the underlying neural mechanism. 
Although the posterior parietal cortex in rats has pre-
viously been explored in the context of navigation, our 
study is the fi rst study to record from this area on a 
decision-making task. We use a number of theoretical 
models to formalize our assumptions about how the 
neural activity we record might give rise to the behavior. 
In the past year, Dr. Raposo amassed a large body of 
electrophysiological data (Fig. 1B). He presented this 
work at the Society for Neuroscience  Annual Meeting 
(Raposo et al. 2012a).
Late in the year, David’s efforts were bolstered by 
the arrival of postdoctoral fellow Matthew Kaufman. 
Matthew’s expertise is in applying dynamical systems 
analysis to data from the motor cortex. Here, he is 
bringing that approach to the parietal cortex. His per-
spective on neural activity has moved our understand-
ing of the neural data forward greatly in the short time 
he has been in the lab.
Probabilistic Representation in the Brain: 
Insights about Neural Mechanisms that 
Allow Organisms to Cope with Stimulus 
Uncertainty
This work was done in collaboration with J. Sheppard, 
Watson School of Biological Sciences.
The goal of this project is to understand how the brain 
estimates the reliability of sensory stimuli and uses that 
estimate to guide decision making. Previous work in 
humans has established that they are easily able to es-
timate the reliability of sensory stimuli. Furthermore, 
humans use their estimates of reliability to inform the 
way they combine sensory inputs across modalities. In 
fact, humans have repeatedly been shown to do this 
in a statistically optimal way. However, very little is 
known about the neural mechanisms that make this 
combination possible. For this project, we have devel-
oped a paradigm that presents subjects, both rats and 
humans, with multisensory stimuli of varying reliabil-
ity. By measuring subjects’ decisions, we can infer the 
relative weights they assign to one sensory modality 
or the other. In the rats, we are developing a system to 
artifi cially manipulate neural signals in the brain, and 
Figure 1. Decision making in rodents (A). Schematic drawing of a rat in operant conditioning apparatus. Circles are 
“ports” where the rat pokes its nose to initiate the presentation of sensory stimuli or to report its decision about the 
stimuli. The white rectangle is the panel of light-emitting diodes that we use to present visual stimuli. (Left panel) 
Rat in the center port, where he positions himself during presentation of stimuli. (Right panel) Rat in the left or right 
port where decisions are reported and, if correct, are rewarded with a drop of juice or water. (B) Responses of two 
parietal cortex neurons with ﬁ ring rates that reﬂ ect a developing decision. Firing rates (mean ± SEM) for single neurons 
that are selective for stimulus rate during multisensory decision formation. (Dark blue trace) Responses to high-rate 
stimuli, (light blue trace) responses to low-rate stimuli. Only correct responses are included. Spike trains were con-
volved with a half Gaussian (std = 100 ms).
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we plan to investigate how these small manipulations 
impact subsequent behavior. In addition to develop-
ing the technology to make this experiment possible, 
we have devoted considerable effort to optimizing our 
protocols for collecting behavioral data. We anticipate 
that these fi ndings will be published in the coming 
year (JP Sheppard et al., in prep.).
Decision Making in Mice
A. Brown [in collaboration with O. Odoemene, 
Watson School of Biological Sciences]
We have developed a decision-making paradigm using 
mice that will allow us to take advantage of genetic 
tools. These tools will allow us to probe the neural cir-
cuitry that underlies decision making. In the past year, 
Amanda Brown built on the foundation we established 
last year. A new Watson School student,  Onyekachi 
Odoemene, will use the behavioral paradigm that 
Amanda developed. He will measure behavior along 
with electrophysiological recordings of several strains 
of transgenic mice.
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MECHANISMS OF NEURODEGENERATION 
AND MEMORY FORMATION
J. Dubnau N. Chatterjee  W. Li
 M. Cressy L. Prazak
 L. Krug H. Qin
There are two main areas of research in my lab. First, 
we use neurogenetic and genomics approaches to 
 investigate a novel hypothesis to explain neurodegen-
erative disorders such as frontotemporal lobar degen-
eration and amyotrophic lateral sclerosis. Second, we 
investigate genetic and neuronal mechanisms of mem-
ory formation using Drosophila as a model system.
Neurodegenerative Disorders and 
Endogenous Transposable Elements
N. Chatterjee, L. Krug, W. Li, L. Prazak, J. Dubnau 
[in collaboration with M. Hammell and Y. Jin, Cold Spring 
Harbor Laboratory] 
Transposable elements (TEs) are mobile genetic elements 
that provide a massive reservoir of potential genetic insta-
bility and toxicity. We have advanced the novel hypoth-
esis that deregulated TE/ERV (endogenous retrovirus) 
expression may contribute to TDP-43-mediated neuro-
degenerative disorders (Li et al. 2013a). We have found 
that TE transcripts are derepressed during the normal 
aging process and that this leads to active mobilization 
of transposons, resulting in new insertions in the genome 
of neurons (Fig. 1). We used mutations in Drosophila Ar-
gonaute 2 (dAgo2) to create a situation in which TEs 
are derepressed in the brain. Such mutants exhibit pre-
cocious TE elevation in young animals and exacerbated 
age-dependent derepression. This is accompanied by 
rapid age-dependent memory impairment and shortened 
lifespan. These fi ndings support the hypothesis that pro-
tracted loss of TE silencing contributes to age-dependent 
decline in neuronal physiological function. To investi-
gate the hypothesis that TE derepression contributes to 
neurodegenerative disorders, we focused (in collabora-
tion with Molly Hammell and Ying Jin) on TDP-43, an 
RNA-binding protein involved in a broad spectrum of 
neurodegenerative disorders, including amyotrophic lat-
eral sclerosis (ALS) and frontotemporal lobar degenera-
tion (FTLD). By mining a series of deep sequencing data 
sets of protein−RNA interactions and of gene expression 
profi les, we uncovered broad and extensive binding of 
TE transcripts to TDP-43 (Li et al. 2012). We also fi nd 
that association between TDP-43 and many of its TE 
targets is reduced in FTLD patients (Fig. 2). Finally, 
we discovered that a large fraction of the TEs to which 
TDP-43 binds become derepressed in mouse TDP-43 
disease models. We propose the hypothesis that TE mis-
regulation contributes to TDP-43-related neurodegener-
ative disease. Current efforts are focused on dissection of 
the underlying mechanisms of transposon control in the 
brain and the role of unregulated transposon expression 
in neurodegenerative disorders.
Neurogenetic Mechanisms of 
Olfactory Memory
An understanding of memory, indeed of all behav-
ioral phenotypes, will require a multidisciplinary ap-
proach to forge conceptual links between the relevant 
genetic/cell-signaling pathways and neural circuits. 
Work in genetic model systems such as Drosophila can 
contribute to our understanding in several ways. First, 
by enabling discovery of genes and genetic pathways 
underlying normal memory, as well as pathological or 
degenerative cognitive disorders, model systems pro-
vide entry points for dissection of cellular mechanisms 
that are often conserved. Second, systematic manipu-
lation of gene function within relevant anatomical cir-
cuits allows a conceptual integration of fi ndings from 
cellular, neuroanatomical, and behavioral levels.
A microRNA-Dopamine Receptor Genetic 
Module in Distinct Neural Circuits for 
Olfactory Arousal and Olfactory Memory
W. Li, M. Cressy, H. Qin
microRNAs (miRNAs) are ~21–23-nucleotide non-
coding RNA transcripts that regulate gene expression 
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at the posttranscriptional level. miRNAs regulate gene 
expression by binding to complementary sequences in 
the 3′-untranslated regions of target mRNAs. A grow-
ing number of studies demonstrate that microRNA 
biogenesis and function broadly speaking are impor-
tant for virtually all aspects of cell function, includ-
ing neuronal function. But there still are relatively few 
examples where individual miRNA genes have been 
shown to function acutely in the brain in the context 
of behavior. We have demonstrated that miR276a 
expression is required acutely in the Drosophila mela-
nogaster brain within two different neural cell types 
(Li et al. 2013b). In both circuits, the miR appears to 
target a DA1-type dopamine receptor, but the circuits 
subserve different aspects of olfactory behavior. This 
miR276a-dopamine receptor interaction is required in 
mushroom body (MB) neurons to support long-term 
olfactory memory and in ellipsoid body R4 neurons 
Figure 1. “Gypsy-TRAP” reporter detects de novo integration in neurons in aged animals. (A,B) Illustration of the 
design of “gypsy-TRAP.” A ~500-bp fragment from the ovo regulatory region containing ﬁ ve Ovo-binding sites is 
inserted between the Tub promoter and GAL80 gene (A). A mutated “gypsy-TRAP” construct contains mutations 
that disrupt each of the ﬁ ve Ovo-binding sites. (B) In the absence of gypsy insertions, GAL80 expression suppresses 
GAL4, and UAS::mCD8::GFP expression is not expressed. In the presence of gypsy integration into the “gypsy-
TRAP,” GAL80 expression is blocked, and UAS::mCD8::GFP is turned on. (C) Approximately 800 MB Kenyon cell 
neurons per brain hemisphere are labeled by MB247-GAL4-driven UAS::mCD8::GFP. (D) An example brain from 
2−4-day-old mutated “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. No green ﬂ uorescent protein (GFP)-labeled 
neurons seen. (E) An example brain from ~28-day-old mutated “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. No 
GFP-labeled neurons seen. (F) An example brain from ~2-4-day-old “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. 
No GFP-labeled neurons seen. (G) Example brains from ~28-day-old “gypsy-TRAP”; UAS::mCD8::GFP/+; MB247/+. 
Several GFP-labeled MB neurons are seen in each brain.
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in the central complex to modulate olfactory arousal. 
This may reveal a conserved functional dissection of 
memory and arousal in MB and central complex.
γ Neurons Are the Gateway for DA Input 
to Drosophila MBs for Aversive Olfactory 
Memory Formation
H. Qin, M. Cressy, W. Li, J. Coravos, S. Izzi, J. Dubnau
(MB)-dependent olfactory learning in Drosophila 
provides a powerful model to investigate memory 
mech anisms. MBs integrate olfactory (CS) inputs 
with neuromodulatory reinforcement (US), which 
for aversive learning is thought to rely on dopaminer-
gic (DA) signaling to DopR, a D1-like dopamine re-
ceptor that is expressed in MB. A wealth of evidence 
supports the conclusion that parallel and indepen-
dent signaling occurs downstream from DopR with-
in two of the three major MB neuron cell types, with 
each supporting approximately half of memory per-
formance. For instance, expression of the rutabaga 
adenylyl cyclase (rut) in γ lobe neurons is suffi cient 
to restore learning levels of rut mutants, whereas 
Figure 2. TDP-43 binding to TEs is selectively lost in FTLD patients. (A) In the human cross-linking immunopre-
cipitation-sequencing (CLIP-Seq) data from FTLD versus healthy control, 38 repeat elements showed signiﬁ cant 
(p-value ≤ 1e-5 and fold changes ≥ 2)  differential binding. Log2-fold-binding differences are shown for signiﬁ cantly 
enriched/depleted elements. (B,C,D) Peaks are shown in genome browser for one RefGene control (B) and two dif-
ferentially targeted TEs (C,D) in healthy (top) versus FTLD (bottom).
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expression of neurofi bromatisis I (NFI) in α/β neu-
rons is suffi cient to rescue NF1 mutants. Memory 
consolidation, in contrast, appears to require CREB 
and rut signaling in α/β neurons. DopR mutations 
fully eliminate memory performance, consistent 
with the hypothesis that DopR receives US inputs 
for both γ lobe and α/β lobe signaling. We have used 
spatially restricted expression of the DopR gene to 
map the neuronal cell types that receive dopaminer-
gic US information underlying this learning task. 
We have shown that DopR expression in γ neurons is 
suffi cient to fully support short-term and long-term 
memory (Qin et al. 2012). Our fi ndings support a 
model in which DA-mediated CS-US association is 
formed in γ neurons, followed by communication 
between γ and α/β neurons, to drive consolidation 
(Fig. 3). Current efforts are focused on investigation 
of the role of γ −α/β neuron signaling in memory 
stabilization/consolidation.
Suppressor Screening by Selective Breeding: 
Evolution of Adenylyl-Cyclase-Independent 
Learning in Drosophila
M. Cressy, J. Dubnau [in collaboration with P. Mitra, 
D. Valente, and K. Honneger, Cold Spring Harbor 
Laboratory]
Natural populations of animals exhibit remarkably 
narrow ranges of phenotypic variation relative to the 
extent of underlying genetic heterogeneity. The pheno-
typic effects of this hidden genetic variation can be re-
vealed, however, in response to selective pressure, envi-
ronmental stress, or the presence of strong deleterious 
mutations. The clinical severity of Mendelian genetic 
disorders, for example, can be modulated by variation 
at additional loci that on their own would have little 
clinical consequence. To investigate the modulatory 
impact of such cryptic genetic variation on a Mende-
lian trait, we used selective breeding over the course 
of more than 40 generations to evolve nearly normal 
levels of Pavlovian learning in fruit fl ies that carry null 
mutations in the rutabaga adenylyl cyclase (M. Cressy 
et al., in prep.). We constrained the starting genetic 
variability to a set of 23 loci with known impact in 
the learning assay, which provided a means to track 
the underlying genotypic response. We identifi ed eight 
loci that appear to drive the selection response. By test-
ing the effects of each of the eight loci and all di-allele 
combinations among them, we demonstrated that 
at least one locus can partially suppress the rutabaga 
learning defect on its own. Our fi ndings also support 
the conclusions that multiple genetic solutions underlie 
the selected suppression of rutabaga and that typical 
solutions involve interactions among several genes.
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Figure 3. GRASP expressed in MB-MP1 and γ KCs reveals 
putative synapses in the heel of MB lobes. In each panel, 
a  projection view of a confocal stack from a female ﬂ y MB 
lobe is presented. GRASP signals and dlg-counterstaining are 
shown. GRASP labeling is observed between  MB-MP1 neurons 
and γ neurons with c061-Gal4;MBGal80 and  L5192-LexA 
(c061-Gal4;MBGal80;UAS-mCD4::spGFP1-10,LexAop-
mCD4::spGFP11;L5192-LexA::GAD). When the two halves 
of GRASP are expressed this way in MB-MP1 and γ neurons, 
GFP labeling is observed in the heel (A). Dashes outline the 
MB heel in one hemisphere of each brain. c061-Gal4;MBGal80 
was previously reported to express in MB-MP1 dopamine neu-
rons. L5192-LexA drives LexAop-hrGFP expression in γ lobes, 
although weak GFP expression can be detected in α/β and α′/β′ 
neurons as well (D). When either c061-Gal4;MBGal80 (B) or 
L5192-LexA (C) alone are used to drive UAS-mCD4::spGFP1-10 
or LexAop-mCD4::spGFP11, no detectable GFP signal is seen. 
These data support the hypothesis that MB-MP1 neurons con-
tact γ neurons at the heel region.
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STEM CELLS, SIGNAL TRANSDUCTION, AND BRAIN FUNCTION
G. Enikolopov V. Belousov M. Matlashov N. Peunova
 D. Bilan T. Michurina O. Podgorny
 Z. Glass O. Mineyeva K. Sayed
 A. Lazutkin J.-H. Park D. Smagin
Stem cells of the adult organism ensure that a tis-
sue is properly maintained, damaged cells replaced, 
extrinsic signals correctly interpreted, and new chal-
lenges adequately met. Our research aims to iden-
tify stem cells and the changes they undergo when 
converting into fully differentiated cells. We gener-
ate animal models to study stem cells and their en-
vironment in adult tissue and the mechanisms that 
determine the division and differentiation choices of 
these cells. Our main focus is on neural stem cells 
of the adult brain. Several areas in the adult brain 
can continuously produce new neurons. These newly 
born neurons are important for learning and mem-
ory, neural tissue repair, and response to therapies. 
We are working to understand how stem cells of the 
adult brain are regulated during the life span of the 
organism, how they and their progeny affect cogni-
tive function and mood, and whether they can be 
effi ciently manipulated for therapeutic gains. We are 
also investigating stem cells in nonneuronal tissues, 
focusing on interactions between different types of 
stem cells that help coordinate tissue growth and re-
pair. We continue to work on the biological roles of 
nitric oxide, uncovering new and unexpected modes 
of its action. We consider our research not only as a 
way to understand the basic mechanisms of tissue 
maintenance, but also as an entry point for design-
ing new types of therapies to ameliorate the effects of 
aging and disease.
Neural Stem Cells and Brain Disorders
New neurons are continuously produced from neu-
ral stem cells in selected regions of the adult brain 
of animals and humans; one of these regions is the 
hippocampus, a region crucial for cognitive function. 
Adult hippocampal neurogenesis responds to a multi-
tude of extrinsic stimuli. Emerging evidence indicates 
that it may be important for behavior, pathophysiol-
ogy, brain repair, and response to drugs. Proneuro-
genic and antineurogenic stimuli may affect any step 
of the differentiation cascade or may converge on a 
few defi ned targets. Our goal is to unravel the basic 
rules and mechanisms controlling the quiescence, 
division, self-renewal, and differentiation of neural 
stem cells and their progeny. To identify and quan-
tify the cellular targets of proneurogenic and antineu-
rogenic stimuli, we developed a novel approach that 
is based on reporter transgenic mouse lines (which 
we often use in combination with other genetically 
modifi ed lines) in which neural stem and progenitor 
cells or their progeny are marked by fl uorescent pro-
teins. These genetically encoded reporters enabled us 
to dissect the neurogenesis cascade in the adult hip-
pocampal dentate gyrus (DG) into distinct steps and 
to assemble a detailed scheme of the neurogenic and 
astrogenic arms of the cascade. We are now using this 
comprehensive description of the hippocampal stem 
cell life cycle as a conceptual framework onto which 
to map the targets of various neurogenic stimuli, de-
termine the commonalities in the modes of action 
of these stimuli, and compare different strategies by 
which stem cells may be harnessed for tissue regen-
eration or cognitive enhancement.
We have already used the basic blueprint of hip-
pocampal neurogenesis to identify and compare the 
targets of antidepressant drugs, deep brain stim ulation 
of selected brain regions, electroconvulsive shock, exer-
cise, radiation, chemotherapeutic agents, trauma, abla-
tion of dopaminergic neurons, and aging. We found 
that such diverse antidepressant therapies as fl uoxetine, 
running, and deep brain stimulation converge on the 
same steps of the cascade and increase the number of 
divisions in the transit-amplifying progenitor popula-
tion. Importantly, these treatments do not affect the 
pool of stem cells; in contrast, we found that elec-
troconvulsive shock, a highly effi cient antidepressant 
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therapy, and memantine, a widely used Alzheimer’s 
disease drug, activate division of stem cells in the adult 
hippocampus. We have also found that trauma (e.g., 
moderate trauma of the cortex) and disease (ablation 
of dopaminergic neurons of the substantia nigra in a 
model of Parkinson’s disease) can activate stem cells 
of the hippocampus, even when distant regions of the 
brain are damaged. This activation may refl ect the 
induction of innate repair and plasticity mechanisms 
by the injured brain; however, it may also potentially 
lead to a premature exhaustion of the neural stem cell 
pool, particularly in the aging organism. With hip-
pocampal neurogenesis being important for the cog-
nitive function and with the continuing loss of stem 
cells during aging, we investigated whether the levels 
of neurogenesis can be modifi ed in aging animals by 
treatments that have been shown to increase the life 
span. One such treatment is restriction of calorie in-
take, shown to increase the life span of a diverse range 
of species, including mammals. Life span can also be 
signifi cantly extended by prolonged treatment with the 
mTOR (mammalian target of rapamycin) pathway in-
hibitor rapamycin, even when treatment is started late 
in life. We investigated whether these treatments affect 
neurogenesis in old animals. We determined specifi c 
subclasses of neural stem and progenitor cells and the 
steps of the neuronal differentiation cascade targeted 
by calorie restriction or rapamycin. Calorie restriction 
was found to increase the number of dividing stem and 
progenitor cells in the dentate gyrus of female mice. 
Our results suggest that restricted calorie intake may 
increase the number of divisions that neural stem cells 
undergo in the aging brain of females.
As the evidence increases that adult neurogenesis 
is important for cognitive function and mood, the 
prospect of being able to detect changes in the level 
of neurogenesis in the live brain also becomes im-
portant. During the last several years, we have been 
carrying out a broad collaboration with Dr. Helene 
Benveniste (Stony Brook University and Brookhav-
en National Laboratory), working to characterize 
changes in magnetic resonance spectra in the live 
human and animal brain indicative of changes in 
neurogenesis. By modifying known methods of ana-
lyzing in vivo spectra, we are able to reliably detect 
indicative signals in the live animal brain under nor-
mal conditions and after electroconvulsive shock. 
This approach is now being investigated in preclini-
cal and clinical trials; if successful, these trials may 
present a new approach for following aging, neuro-
logical and psychiatric disorders, or cancer.
Stem Cells in Nonneural Tissues
Adult tissues undergo continuous cell turnover and 
remodeling in response to stress, damage, or physio-
logical demand. Newborn differentiated cells are gen-
erated from dedicated or facultative stem cells or from 
self-renewing differentiated cells. Adult stem cells are 
located in specialized niches that restrict their division 
and support their undifferentiated status. We found 
that the same Nestin-based reporter lines that we de-
veloped and used to identify stem cells of the brain can 
also help to highlight stem and progenitor cells in a 
range of other tissues. This list is not limited to cells of 
neural origin and includes stem cells of such dissimilar 
structures as brain and spinal cord, hair follicles, liver, 
pancreas, skeletal muscle, testis, ciliary margin of the 
eye, anterior pituitary, skin, bone marrow, and ovary. 
This provides a means of visualizing adult stem and 
progenitor cells, tracing their lineage, isolating them, 
and studying mechanisms controlling their quies-
cence, division, self-renewal, and differentiation.
This approach is, of course, not limited to reporter 
lines based on the regulatory elements of the Nestin 
gene, and we have been using reporter lines based on 
the promoters of the Sox2, Gli1, or Lgr5 genes, alone 
or in combination (e.g., Sox2-GFP/Nestin-mCherry 
or Lgr5-mCherry/Nestin-GFP), to investigate stem 
cells in different adult tissues. Using this approach and 
working in collaboration with Dr. Alex Nikitin from 
Cornell University, we made an important discovery of 
a new population of stem cells in the ovary that nor-
mally act to repair the epithelial surface of the ovary, 
but can be easily transformed and become cells of 
origin of ovarian tumors. When an oocyte leaves the 
ovary during the ovulation, the ovarian surface epi-
thelium is ruptured and must be repaired. We found 
a small population of cells in the hilum of the mouse 
ovary that has the main characteristics of stem cells: 
They cycle slowly and express typical markers of stem 
cells, and their progeny are seen to replenish the sur-
face epithelium. Importantly, we found that these stem 
cells show increased propensity to be transformed after 
inactivation of the tumor suppressor genes Trp53 and 
Rb1, whose pathways are altered frequently in the most 
aggressive and common type of human ovarian cancer, 
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high-grade serous adenocarcinoma. Our study provides 
experimental support for the idea that susceptibility of 
transitional zones between different types of epithelia 
(of which the epithelial cells of the hilum are an ex-
ample) to malignant transformation may be explained 
by the presence of stem cell niches in those areas.
Our fi ndings support the possibility that junction-
associated stem cell niches are predisposed to cancer 
and suggest that similar junction/transitional areas in 
other organs, such as the uterine cervix, may also con-
tain cancer-prone stem cell niches, thereby explaining 
susceptibility of such regions to malignant transfor-
mation. Our fi ndings also put forward an attractive 
model for further studies of stem cell niches and of 
aberrations in the molecular and cellular mechanisms 
governing epithelium regeneration that may contrib-
ute to ovarian cancers.
Signaling in the Stem Cell Niche
Signaling pathways controlling adult neurogenesis are 
only beginning to be understood. Although the action 
of specifi c regulators of stem and progenitor cell divi-
sion (e.g., Notch, Shh, or Wnt) are studied in detail, 
more general questions—such as the source of the sig-
nals, autocrine vs. paracrine vs. hormonal regulation, 
interaction between different cell types, or specifi c sig-
naling messenger molecules—are often unknown even 
for the best-studied systems, including the brain. One 
such general mode of stem cell control is redox signal-
ing. The changes in the redox status and production 
of reactive oxygen and nitrogen species (ROS/RNS) 
change proliferation and differentiation of various class-
es of stem and progenitor cells, including neural cells.
Although the general importance of redox signal-
ing is acknowledged, the picture remains vague with 
respect to stem cells. There are gaps in understand-
ing even the most basic features of redox signaling in 
stem cells (e.g., the source of the signal, distribution 
of activity within the cell, and changes during aging 
or upon stimulation). One approach to study signal-
ing is to use genetically encoded sensors of redox sig-
naling. We have demonstrated the utility of sensors 
for superoxide/hydrogen peroxide and for the cyto-
plasmic NAD/NADH in several settings, including 
neurons in vivo and in vitro, and have generated trans-
genic animals that express these genetically encoded 
sensors. Our goal is to combine two directions of 
research—genetically encoded sensors and genetically 
encoded reporters—to gain insights into redox signal-
ing in adult neural stem cells and to observe dynamic 
changes in stem cells, their compartments, and their 
niche. We are now working to expand the panel of 
sensors and reporters to visualize multiple signaling 
events controlling stem cells.
Nitric Oxide Development, and 
Differentiation
During recent years, we discovered an essential role 
of nitric oxide (NO) in development and in stem cell 
regulation. We continue to discover the diversity of 
biological functions performed by NO. In our latest 
studies, we uncovered an important function of NO in 
multiciliated cells whose cilia beat in concert to gener-
ate directed fl ow of fl uid across tissue. We found that 
this role of NO is conserved and its basic features are 
highly similar in such diverse settings as skin of the 
frog embryo and mammalian airways. We identifi ed 
two distinct signaling pathways that control the polar-
ity of cilium distribution and cilium length and de-
termined the critical targets of NO signaling in both 
pathways. Our results suggest that some of the inborn 
and acquired human ciliopathies and related disorders 
may also be related to decreased availability of NO and 
may thus benefi t from NO-based therapies.
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MOLECULAR ANALYSIS OF NEURONAL RECEPTORS 
AND ION CHANNELS
H. Furukawa E. Karakas 
 N. Simorowski
 N. Tajima 
The research program in my lab is aimed at under-
standing the molecular basis for the functions of cell 
surface receptors or membrane proteins that initiate 
cellular signal transductions involved in neurotrans-
mission in the mammalian brain. It is hoped that this 
work will help in the design of compounds with thera-
peutic potential in neurological diseases and disorders 
including schizophrenia, depression, stroke, and Alz-
heimer’s disease. Toward this end, we are conducting 
structural and functional studies on neurotransmitter 
receptor ion channels and intramembrane enzymes, 
two classes of membrane proteins that regulate the pro-
cesses of neurotransmission and dysfunction implicated 
in neurodegenerative diseases. To achieve our goals, 
we use X-ray crystallography to determine the three-
dimensional atomic structures of target proteins and 
test structure-based mechanistic hypotheses by site-
directed mutagenesis in combination with biochemical 
and biophysical techniques. Our main accomplishment 
in 2012 was obtaining high-resolution structures of the 
ligand-binding domain (LBD) of a ligand-gated ion 
channel, N-methyl-D-aspartate receptor (NMDAR), in 
complex with antagonists. The crystal structure shows 
overall conformational alteration in LBD upon binding 
to two types of antagonists compared to the agonist-
bound form. We are currently validating functional hy-
potheses using a combination of techniques including 
electrophysiology, isothermal titration calorimetry, and 
analytical ultracentrifugation.
Structural Studies on NMDAR
NMDARs belong to the family of ionotropic gluta-
mate receptors (iGluRs) that mediate the majority of 
excitatory synaptic transmissions in the mammalian 
brain. They are voltage-sensitive calcium ion chan-
nels composed of two copies each of the GluN1 and 
GluN2 subunits, which bind glycine and glutamate, 
respectively. Calcium signals facilitated by NMDARs 
have pivotal roles in cellular signal transduction, re-
sulting in neuroplasticity essential for learning and 
memory formation. Dysfunctional NMDARs are im-
plicated in various neurological disorders and diseases 
including depression, schizophrenia, Parkinson’s dis-
ease, and Alzheimer’s disease. The four distinct GluN2 
subunits (A–D) control pharmacological prop erties of 
the NMDAR ion channels and show different spa-
tial and temporal expression patterns; thus, there has 
been great interest in creating subtype-specifi c com-
pounds that can target specifi c neuronal circuits. The 
NMDAR subunits are modular and are composed of 
distinct protein domains, including the amino-termi-
nal domain (ATD), ligand-binding domain (LBD), 
transmembrane domain (TM), and carboxy-terminal 
domain (CTD) (Fig. 1).
Figure 1. Domain organization of NMDAR subunits. NMDAR sub-
units are modular proteins composed of distinct domains includ-
ing amino-terminal domain (ATD), ligand-binding domain (LBD), 
transmembrane domain (TM), and carboxy-terminal domain (CTD). 
Shown here are schematic presentations of the glycine-binding 
GluN1 subunit and the L-glutamate-binding GluN2B subunit. Allo-
steric modulators such as phenylethanolamine and zinc bind ATD.
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The focus of our current studies is the ATD and 
LBD domains, which mediate allosteric regulation 
and activation in the NMDAR ion channels upon 
binding to polyamine-based compounds and neu-
rotransmitters, respectively. Despite intensive efforts 
in structural studies of NMDARs during the past 
decade, we still have no insight into how GluN2 tar-
geting antagonists bind and mediate the inhibition of 
NMDAR ion channels. Furthermore, there was until 
now no understanding of how GluN2 antagonist com-
pounds such as AP5 and PPDA, which have completely 
distinct chemical structures, could mediate similar 
antagonistic effects on NMDAR ion channels (Fig. 
2C). To answer these questions, we have conducted 
X-ray crystallographic studies on the GluN1/GluN2A 
subtype in complex with the GluN2 antagonists AP5 
and PPDA. Crystals have been created by mixing 
GluN1 and GluN2A LBD proteins in the presence 
of GluN2 antagonists such as PPDA and AP5 and in 
the presence of GluN1 agonist glycine. These crystals 
diffracted X rays to 1.9 Å (for AP5 crystal) and 2.1 
Å (for PPDA crystal). The high-resolution structures 
that resulted from the high-resolution diffraction data 
unambiguously showed lig and-binding modes as well 
as overall protein conformational changes (Figs. 2B 
and 3).
Figure 2. Crystal structure of GluN1/GluN2A LBD. (A) LBD was designed by excising (using scissors) the part of the 
extracellular domain. (B) Preliminary crystal structure of GluN1/GluN2A LBD in complex with glycine and AP5 at 
1.9 Å. GluN1 and GluN2A LBDs have a bilobed “clam-shell-like” structure and the ligands bind at the cleft of the 
structures. (C) Chemical structures of the two classes of antagonists, AP5 and PPDA.
Figure 3. Antagonist binding site. Binding sites of AP5 (A) and PPDA (B) show two different modes of antagonist 
recognition. Dots represent polar interaction.
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The crystal structures identifi ed the antagonist 
binding site at the cleft of the clam-shell-like struc-
ture. As shown in Figure 3, the binding of AP5 (Fig. 
3A) and PPDA (Fig. 3B) involves different residues. 
The binding of AP5 is mediated mainly by hydrophil-
ic interactions between the α-carboxyl and phosphine 
groups. Binding of PPDA is mediated mainly by hy-
drophobic interaction between hydrophobic residues 
deep in the LBD cleft. However, in both cases, the 
clamshell-like architecture of LBDs is forced open 
similarly to the agonist (glutamate)-bound form, indi-
cating that the antagonism of NMDAR involves con-
formational alteration. Based on the crystal structures, 
we will design hybrids of AP5 and PPDA to increase 
potency of the antagonists. Such reagents may be test-
ed in animal models for neurological disorders and 
diseases to determine any potential therapeutic values.
Structure and Function of γ-Secretase
γ-Secretase is an intramembrane protease involved in 
the initiation of Notch signaling, which is critical for 
cell differentiation and stem cell maintenance as well 
as production of β-amyloid involved in the pathology 
of Alzheimer’s disease. The formation of neurotoxic 
β-amyloid oligomers and deposition of β-amyloid fi -
brils are hallmarks of Alzheimer’s disease. Further-
more, overactivation of Notch signaling is frequently 
observed in various forms of cancer. Thus, pharma-
cological regulation of γ-secretase activity may be 
an effective strategy in the treatment of those major 
diseases.
γ-Secretase is a multimeric protein complex of 
four transmembrane proteins including presenilin, 
nicastrin, APH-1, and PEN-2 (Fig. 4). Together, the 
protein complex mediates an unusual molecular 
event called regulated intramembrane proteolysis, in 
which the transmembrane substrate is proteolyzed 
within the biological membrane. This multimem-
brane protein com plex cleaves a number of single 
transmembrane substrates, including Notch ligand 
and amyloid precursor protein. The mechanistic un-
derstanding of intramembrane proteolytic activities 
in γ-secretase is limited due to a complete absence of 
any atomic structure. My research program is aimed 
at obtaining an atomic map of γ-secretase to gain in-
sight into intramembrane proteolysis, substrate spec-
ifi city, inhibition, and functional modulation.
In 2012, we continued to spend much effort to-
ward understanding the mechanism of substrate 
recognition mediated by a γ-secretase component, 
nicastrin. Using the recombinant proteins that have 
been successfully expressed and purifi ed by my 
group (as reported in 2011), we have conducted 
screening for crystallization conditions with mini-
mal success. Several potential reasons for our unsuc-
cessful crystallization attempts are that (1) nicastrin 
contains 20 glycosylation sites that could interfere 
with crystallization, (2) a substantial portion of 
nicastrin is intrinsically unstructured, and (3) the 
nicastrin protein is not stable for the long period of 
time (weeks), needed for crystallization. To circum-
vent these problems, we have found a way to pre-
pare nicastrin proteins with minimal glycosylation 
(enzymatic removal of glycosylation, incorporation of 
mutations to putative glycosylation sites, and usage 
of a GlnT− cell line that homogeneously glycosylates 
proteins). To create crystal contacts, we also made 
monoclonal antibodies for nicastrin. These antibodies 
will be complexed with the purifi ed nicastrin proteins, 
which will be used to facilitate crystallization. Thus 
far, we have a preliminary crystal for nicastrin com-
plexed with antibodies. We will further optimize the 
crystallization conditions so that the sample could be 
Figure 4. Components of γ-secretase. γ-Secretase is a protease 
complex composed of four integral membrane proteins: pre-
senilin (PS), nicastrin (NCT), APH-1, and PEN-2. Wild-type PS 
contains active-site aspartyl residues within the transmembrane 
domains and becomes active only when it forms a complex with 
three other components. A single transmembrane substrate such 
as amyloid precursor protein (APP) is proteolytically processed 
within the membrane. The extracellular and cytosolic domains 
form neurotoxic β-amyloid oligomers or act as a transcriptional 
regulator, respectively. NCT and APH-1 are considered impor-
tant for substrate recognition, whereas PEN-2 has a critical role 
in proteolyzing PS at the cytosolic loop, thereby converting PS 
into the active form.
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used for crystallographic studies. Overall, the struc-
tural and functional studies of γ-secretase have great 
potential for the development of compounds that 
can be used to lower the level of neurotoxic amyloid 
oligomers in Alzheimer’s disease, as well as to alleviate 
overactive Notch signaling in cancer.
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ASSEMBLY AND FUNCTION OF GABA INHIBITORY 
CIRCUITS IN THE NEOCORTEX
Z.J. Huang Y. Fu S. Kelly Y. Lin A. Paul J. Tucciarone
 M. He K. Krishnan J. Lu  H. Taniguchi P. Wu
Our research aims to understand the organization, 
development, and function of neural circuits in the 
cerebral cortex and their implications in neuropsychi-
atric disorders. We have pioneered the use of mouse 
engineering toward a genetic dissection of GABAer-
gic inhibitory circuitry in the neocortex. We recently 
achieved the genetic targeting of major classes and 
lineages of cortical interneurons. Our strategy and 
tools are enabling a systematic and comprehensive 
analysis of GABAergic circuits throughout the mam-
malian brain. We have made discoveries in the cellular 
and molecular mechanisms underlying the specifi city 
and activity-dependent development of GABAergic 
synapses, and in the role of GABAergic inhibition 
in regulating the critical period of neural plasticity. 
More recently, we have further developed strategies 
for cell-type-based genomic analysis in brain tissues. 
Genetic targeting of distinct neuron types establishes 
entry points for studying cortical circuits and builds 
a solid middle ground that coherently connects to 
system neuroscience, on the one hand, and molecular 
and development neuroscience, on the other hand. We 
aim to discover the genetic principles underlying the 
assembly and organization of cortical circuits and to 
provide insight into how altered development of these 
circuits contributes to mental disorders.
Origin and Organization of Chandelier 
Cells in the Mouse Neocortex
Diverse GABAergic interneurons regulate the func-
tional organization of cortical circuits and derive from 
multiple embryonic sources. It remains unclear to 
what extent embryonic origin infl uences interneuron 
specifi cation and cortical integration due to diffi cul-
ties in tracking defi ned cell types. Using genetic fate 
mapping, we followed the developmental trajectory of 
chandelier cells (ChCs), the most distinct interneu-
rons that innervate the axon initial segment of pyra-
midal neurons and control action potential initiation. 
A single ChC innervates hundreds of pyramidal neu-
rons and might exert decisive infl uence in their fi ring, 
but the developmental origin and cortical organization 
of ChCs have been unclear. We discovered that ChCs 
mainly derive from the ventral germinal zone of the 
lateral ventricle during late gestation and require the 
homeodomain protein Nkx2.1 for their specifi cation. 
They migrate with stereotyped routes and schedule 
and achieve specifi c laminar distribution in the cor-
tex. The developmental specifi cation of this bona fi de 
interneuron type likely contributes to the assembly 
of a cortical circuit motif. Our fi ndings demonstrate 
protracted neurogenesis and a novel progenitor source 
in the Nkx2.1 lineage that gives rise to a functionally 
powerful and evolutionarily expanding class of corti-
cal interneuron. Genetic targeting of ChCs provides 
an entry point to studying cortical circuit assembly, 
organization, and dysfunction.
Impact of GABAergic Deﬁ ciency 
in Synaptic Transmission and Behavior
The rate-limiting enzyme for GABA synthesis, 
GAD67, is altered in several neuropsychiatric disor-
ders, including autism, bipolar disorder, and schizo-
phrenia (SZ). GAD67 expression is activity depen-
dent, and its reduction in disease states is thought 
to result from decreased engagement of inhibitory 
circuitry. Although this common pathophysiological 
feature may be a major contributor to disease pro-
cesses, whether and how GAD67 defi ciency leads to 
impaired inhibitory synaptic transmission have not 
been examined. This is in part due to confounds 
from developmental compensation and the diversity 
of inhibitory interneurons. We have produced a cell-
type-restricted molecular defi cit, similar to what is 
observed in SZ, by specifi cally knocking out one al-
lele of the gene for GAD67, Gad1, in PV interneurons 
in juvenile mice. This manipulation led to substantial 
defi cits in synaptic transmission from parvalbumin 
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(PV) interneurons to pyramidal neurons assayed by 
paired recording in prefrontal cortex: IPSC (induced 
pluripotent stem cells) amplitude and decay time both 
decreased, producing a supralinear reduction in over-
all IPSC charge transfer. Single-cell recordings re-
vealed a concurrent disinhibition of pyramidal neuron 
spiking and increased excitation/inhibition balance in 
PV cells. In adult mice, synaptic defi cits recovered, 
possibly through a homeostatic response to increased 
feedback excitation of the PV cell network. These re-
sults suggest that GAD67 levels directly contribute to 
the strength of synaptic inhibition. In SZ specifi cally, 
GAD67 defi ciency in PV cells likely contributes to 
cortical network dysfunction, but the reversibility ob-
served in our model suggests nonpermanent damage 
to inhibitory circuitry.
Distinct DNA Methylation Signatures 
in Glutamatergic and GABAergic Neurons 
of the Cerebral Cortex
Epigenetic regulation at 5-methylcytosine (5mC) in 
the mammalian genome is essential for numerous bio-
logical processes including brain development, func-
tion, and plasticity. A key obstacle in genomic and 
epigenomic analysis in the brain is cellular heteroge-
neity; genomes of distinct yet highly intermingled cell 
types are largely inaccessible to sequencing technology. 
To address this issue, we have developed an integrated 
genetic targeting and molecular tagging system that 
establishes “genetic access” to the methylomes and 
transcriptomes of specifi c cell types. This is achieved 
by cell-type-specifi c expression of an epitope-tagged 
histone protein (H2B-GFP fusion protein) through 
mouse engineering. Using fl uorescence-assisted cell 
sorting (FACS) of dissociated cortices and whole-
genome bisulfi te sequencing, we have analyzed the 
DNA methylomes of two cardinal neuron types, the 
glutamatergic and GABAergic neurons. In collabora-
tion with the Wigler lab here at CSHL, we achieved 
10× whole genome coverage per cell type, allowing us 
to interrogate ~90% of the CpG sites in the mouse 
genome. These results identify extensive genome-wide 
methylation differences in two cardinal neuron types 
in the postnatal cortex. Furthermore, we have demon-
strated, to our knowledge for the fi rst time, develop-
mental dynamics in methylation in a defi ned cell type 
during cortical maturation.
Our approach establishes a cell-type-based experi-
mental paradigm for epigenomic analysis in complex 
tissues and sets the stage for analysis of neuronal sub-
types during both brain development and behavioral 
plasticity.
Cell-Type-Based Analysis of microRNA 
Proﬁ les in the Mouse Brain
microRNAs (miRNAs) are implicated in brain devel-
opment and function, but the underlying mechanisms 
have been diffi cult to study—in part due to the cel-
lular heterogeneity in neural circuits. To systemati-
cally analyze miRNA expression in neurons, we have 
established an miRNA tagging and affi nity purifi ca-
tion (miRAP) method that is targeted to cell types 
through the Cre-loxP binary system in mice. Our 
studies of the neocortex and cerebellum reveal the ex-
pression of a large fraction of known miRNAs with 
distinct profi les in glutamatergic and GABAergic neu-
rons and subtypes of GABAergic neurons. We further 
detected putative novel miRNAs, tissue- or cell-type-
specifi c strand selection of miRNAs, and miRNA 
editing. Our method thus will facilitate a systematic 
analysis of miRNA expression and regulation in spe-
cifi c neuron types in the context of neuronal devel-
opment, physiology, plasticity, pathology, and disease 
models and will be generally applicable to other cell 
types and tissues.
MeCP2 Regulates the Maturation 
of GABAergic Interneurons and Timing 
of Critical Period Plasticity in Primary 
Visual Cortex
Rett syndrome (RTT) in several ways epitomizes the 
challenge for understanding neuropsychiatric dis-
orders. RTT is caused by mutations in the MeCP2 
gene encoding a chromatin and transcription regula-
tory protein. Although MeCP2 is broadly expressed 
in the developing and mature brain, RTT is char-
acterized by a specifi c set of postnatal symptoms in-
cluding language and cognitive defi cits, stereotyped 
behaviors, and a myriad of sensory and neurological 
phenotypes. MeCP2 mutations likely impact gene 
regulation in multiple neuronal and glial cell types 
and in multiple brain regions; the initial impact may 
further result in compensatory changes, including 
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maladaptive  activity- and experience-dependent syn-
aptic plasticity, leading to altered developmental tra-
jectory of circuit formation and function. Although 
numerous mouse models of genetic etiology have been 
established, it has been diffi cult to identify primary 
molecular and cellular changes and trace their impact 
on circuit alterations that underlie behavioral defi cits. 
Using MeCP2-null mice, we examined experience- 
dependent development of neural circuits in the pri-
mary visual cortex where GABAergic interneurons 
regulate a critical period of plasticity. The maturation 
of GABAergic neurons was accelerated upon vision 
onset, indicated by elevated GABA synthetic enzyme 
GAD67 and perineuronal nets, both associated with 
PA-positive interneurons. These changes correlated 
with a precocious critical period and defi cient visual 
function—the orientation tuning of individual binoc-
ular neurons remained mismatched through the two 
eyes in mature animals. Our results trace molecular 
and cellular changes through aberrant circuit develop-
ment to functional defi cits in a model of neuropsychi-
atric disorder.
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NEUROBIOLOGY OF COGNITION AND DECISION MAKING
A. Kepecs B. Brangers L. Desban D. Kvitsiani S. Ranade
 L. Calcaterra B. Hangya M. Lorenc J. Sanders
 E. Demir J. Hirokawa H.J. Pi A. Vaughan
The long-term goal of our research is to identify the 
computational and neurobiological principles under-
lying cognition and decision making. Using a reduc-
tionist approach, we translate psychological questions 
into the language of neuroscience by distilling them 
to quantitative behavioral tasks for rodents that enable 
the monitoring and manipulation of neural circuits 
mediating cognitive behaviors. We use state-of-the-art 
electrophysiological techniques to establish the neural 
correlates of behavior and then use molecular and op-
togenetic manipulations to systematically dissect their 
underlying neural circuits. Given the complexity of 
animal behavior and the dynamics of neural networks 
producing it, our studies require quantitative analysis 
and computational models to guide and sharpen the 
neurobiological questions. In addition, we started in-
corporating human psychophysics into our research to 
validate our behavioral observations in rodents by link-
ing them with analogous behaviors in human subjects.
In terms of topics, our approach is multifaceted. We 
study (1) the roles of uncertainty and confi dence in deci-
sion making, (2) the division of labor between different 
cell types in the prefrontal cortex, (3) how the choliner-
gic system supports sustained attention, and (4) social 
decisions that rely on shallow, stereotyped circuits. A 
unifying theme is the use of cell-type- and pathway-
specifi c perturbations to effect gain and loss of function 
for specifi c behavioral abilities. Through such manipu-
lations of genetically and anatomically defi ned neuronal 
elements, we hope to identify fundamental principles of 
neural circuit function that will be ultimately useful for 
developing therapies for diseases such as schizophrenia, 
Alzheimer’s disease, and autism spectrum disorder.
Neural Basis of Decision Conﬁ dence
J. Hirokawa, J. Sanders [in collaboration with A. Lak, 
University of Cambridge; G. Costa, and Z.F. Mainen. 
Champalimaud Neuroscience Program, Portugal]
If you are asked to evaluate your confi dence in your 
decision—how sure are you that you made the correct 
choice—you can readily answer. What is the neural 
basis for such judgments? Previously, we discovered 
neurons in the orbitofrontal cortex (OFC) that signal 
decision confi dence, and we are pursuing these obser-
vations by trying to establish the causal neural circuit 
basis for estimating and acting on decision confi dence.
As a fi rst step, we designed a new behavioral task 
for rats, in which we could measure confi dence behav-
iorally on a trial-by-trial basis. Briefl y, rats are trained 
on a simple olfactory decision task, and by delaying 
reward, we found that the time they are willing to 
wait for an uncertain reward is proportional to deci-
sion confi dence, as predicted by theory. To further 
refi ne the role OFC in confi dence, we are trying to 
“read out” confi dence reports, i.e., predict the timing 
of leaving decisions on a trial-by-trial basis based on 
neural activity (establish correlation). To demonstrate 
that OFC is necessary for confi dence reports, we used 
both excitotoxic lesions and pharmacological inacti-
vation techniques and found that confi dence reports 
were disrupted without changing decision accuracy. 
To establish the suffi ciency of OFC for confi dence 
reporting, we are preparing gain-of-function experi-
ments. Because there is no obvious map in the pre-
frontal cortex, we cannot use electrical microstimu-
lation. Instead, we will use optogenetic activation of 
neurons defi ned by projection target using retrograde 
viruses and attempt to inject extra “uncertainty” into 
the brain by activating the appropriate population of 
neurons. Our ultimate aim is to defi ne the neural cir-
cuits for computing and using decision confi dence.
From Metacognition to Statistics: 
Conﬁ dence Judgments in Humans
J. Sanders, B. Hangya
In our rodent studies of confi dence, we use a compu-
tational framework to interpret behavioral and neural 
data. We are also interested in understanding the degree 
to which the theoretical concept of decision confi dence 
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corresponds to the human notion of subjective confi -
dence. In statistics, the confi dence associated with a 
hypothesis test is a measure of the quality of evidence, 
and we believe that the subjective notion of confi dence 
describes a similar process at work in the brain.
Our fi rst goal was to develop a new confi dence-
reporting task that provides both implicit and ex-
plicit measures of decision confi dence and is suitable 
for both rodents and humans in order to make direct 
comparisons. We designed a perceptual discrimina-
tion task where subjects choose which of two Pois-
son click streams is clicking faster and rate their con-
fi dence in their choices. On each trial, we store the 
precise time of each click the subject heard in each 
ear and acquire three measures: a reaction time (how 
long the subject collected evidence before choosing), 
a choice (which side they thought was faster), and a 
confi dence report (how much they believe in the hy-
pothesis that their choice was correct). Using several 
previously described models of choice and confi dence, 
we tried to design a computer program that could 
“listen” to the same click trains and respond with the 
same reaction time, choice, and confi dence. To our 
surprise, we discovered that standard models of per-
ceptual decision making failed to reproduce the basic 
patterns from our normative model, that confi dence 
refl ects the strength of perceived evidence. Currently, 
we are examining a broader range of models to fi t our 
psychophysical data.
We have also developed other behavioral tasks test-
ing confi dence associated with general knowledge, 
only suitable for humans. We fi nd that all these tasks 
share the basic patterns of confi dence that are predict-
ed by statistical confi dence. On the basis of these re-
sults, we are now in a position to use these quantitative 
measures of decision confi dence in humans, through 
collaborations, with neuroimaging and genetic ap-
proaches. Moreover, by showing that a single confi -
dence measure is applicable to humans and rodents, 
our results strengthen the case for using the rat as a 
model system for studying decision confi dence.
Integration of Decision Conﬁ dence and 
Reward Size in the Orbitofrontal Cortex
J. Hirokawa
Making optimal decisions requires integrating infor-
mation from multiple sources. For instance, perceptual 
decisions involve an evaluation of the uncertainty about 
a stimulus, whereas free-choice paradigms require an 
estimation of the reward value of each option. Can rats 
combine experienced reward value and decision un-
certainty to make optimal choices? And how does the 
brain dynamically compute and integrate these differ-
ent estimates to make predictions?
We designed a reward-biased psychometric deci-
sion task to investigate interaction of reward esti-
mates based on decision uncertainty and reward his-
tory. We found that the animals’ choice was biased 
by the reward size and the extent was proportional 
to the amount of evidence of the correctness for the 
chosen option, suggesting that decision confi dence 
and reward size were optimally integrated behavior-
ally. Multiunit recording from the OFC revealed that 
the largest population of neurons combined “decision 
uncertainty” with “small reward size” information to 
yield an integrated negative reward value representa-
tion. However, different portions of neurons still rep-
resenting decision confi dence were little affected by 
the reward size manipulation, and some other neurons 
represented reward size independent of decision confi -
dence. These results show that rat OFC has the capac-
ity to integrate different types of reward expectations 
for a chosen option that may contribute to maximiz-
ing future reward acquisition.
Microtraits in Rodent Models of Psychiatric 
Diseases
L. Desban, J. Hirokawa [in collaboration with F. Henn, Cold 
Spring Harbor Laboratory]
Basic research on psychiatric disorders requires the use 
of animal models. Usually, animal models are validat-
ed mainly on the basis of genetic insights and simple 
behavioral measures. However, in the case of cogni-
tive diseases, this has become challenging because it 
is unclear how to map human behavioral defi cits to 
animal models. To overcome these issues, we are tak-
ing a different approach to this challenge, based on 
the emerging fi eld of computational  psychiatry.
We focus on microtraits that can be easily quanti-
fi ed using psychometric tasks and can be directly re-
lated to humans, e.g., reward sensitivity, learning rate, 
and decision confi dence.
For instance, our psychometric olfactory discrimi-
nation task enables us to measure several important 
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parameters of decision making: sensitivity to reward 
and punishment, accuracy of the discrimination, inte-
gration of the stimuli, fl exibility, reward history, and 
decision confi dence. We are currently using this task 
to study two rodent models for cognitive disorders: 
spontaneously hypertensive rats (SHR) for attention-
defi cit/hyperactivity disorder (ADHD) and congenital 
learned helplessness (cLH) rats for major depressive 
disorder (MDD). Our goal is to test both model rats in 
our task, determine behavioral microtraits, and eventu-
ally relate them to specifi c neural circuits such as OFC.
Division of Labor between Distinct 
Interneuron Subtypes during Behavior
D. Kvitsiani, S. Ranade, B. Hangya [in collaboration with 
Z.J. Huang, Cold Spring Harbor Laboratory]
The anterior cingulate cortex (ACC) in humans and 
rodents has been implicated in a variety of goal-direct-
ed behaviors including reward processing, inhibitory 
response control, confl ict monitoring, and foraging 
decisions. Electrophysiological recordings from ACC 
show great diversity of neuronal responses to a specifi c 
behavioral variables. On the other hand, we know that 
the mammalian cortex is composed of a variety of cell 
types, among which GABAergic interneurons exhibit 
the largest diversity in connectivity, morphology, and 
intrinsic physiology. Does the anatomical and molecular 
variety of interneuron subtypes map onto the diversity 
of neuronal responses in behaving animals? To address 
this issue, we use optogenetics as a means to identify 
extracellularly recorded neurons in freely moving mice, 
focusing on inhibitory interneurons, which exhibit the 
largest diversity of cell types in the cortex. We tested 
the overarching hypothesis that neurons belonging to 
the same subtype share fundamental commonalities in 
response properties during behavior, whereas distinct 
subtypes specialize in distinct functional roles.
We showed that Pv and a subtype of Som neurons 
form functionally homogeneous populations showing a 
double dissociation between both their inhibitory im-
pact and behavioral correlates. Of a number of events 
pertaining to behavior, a subtype of Som neurons selec-
tively responded at reward approach, whereas Pv neu-
rons responded at reward, leaving encoding preceding 
stay duration. These behavioral correlates of Pv and 
Som neurons defi ned a behavioral epoch and a decision 
variable important for foraging (whether to stay or to 
leave), a crucial function attributed to ACC. Further-
more, Pv neurons could fi re in millisecond synchrony, 
exerting fast and powerful inhibition on principal cell 
fi ring, whereas the inhibitory impact of Som neurons 
on fi ring output was weak and more variable, consistent 
with the idea that they respectively control the outputs 
of and inputs to principal neurons. These results sug-
gest a connection between the circuit-level function of 
different interneuron types in regulating the fl ow of in-
formation and the behavioral functions served by the 
cortical circuits. Moreover, these observations bolster 
the hope that functional response diversity during be-
havior can in part be explained by cell-type diversity.
Function of VIP Interneurons 
in Cortical Microcircuits
H.J. Pi, B. Hangya [in collaboration with Z.J. Huang, 
Cold Spring Harbor Laboratory]
We are interested in understanding how the diversity 
of cortical inhibitory interneurons underlies distinct 
neural circuit dynamics that direct perception and be-
havior. As part of this broader project, we have begun 
to study vasoactive intestinal peptide (VIP)-express-
ing interneurons. Although VIP neurons constitute 
less than 2% of total cortical neuronal population, 
previous studies indicate that VIP might have a dis-
tinct function in the local cortical column. VIP neu-
rons are mostly bipolar, and their processes are verti-
cally oriented. Interestingly, these neurons specifi cally 
target other inhibitory neurons and avoid pyramidal 
cells. Therefore, we hypothesized that VIP neurons 
regulate a disinhibitory circuit and tested it in two 
functionally different cortical regions: auditory and 
medial prefrontal cortices.
Using a combination of in vivo and in vitro physi-
ology, we showed that VIP interneurons mediate dis-
inhibitory control in multiple areas of the neocortex. 
By combining optogenetic activation with single-cell 
recordings, we examined the functional role of VIP 
interneurons in awake mice and investigated the un-
derlying circuit mechanisms in vitro in auditory and 
medial prefrontal cortices. We identifi ed a basic dis-
inhibitory circuit module in which activation of VIP 
 interneurons transiently suppresses most somatostatin- 
expressing and a fraction of parvalbumin-expressing 
inhibitory interneurons, specialized to control the in-
put and output of principal cells, respectively. In the 
120-184_Neurosci.indb   156 9/17/2013   7:59:50 AM
Neuroscience  157
auditory cortex, we found that reinforcement signals 
(punishment and reward) strongly activated VIP neu-
rons, and in turn, VIP recruitment modulated the 
tone-responsiveness of a functional subpopulation of 
principal neurons. We propose that this disynaptic 
disinhibitory mechanism represents a cortical circuit 
motif that enables long-range inputs to modulate the 
gain of local circuits.
Neural Representation of Social 
Decisions and Rewards
E. Demir, L. Calcaterra, B. Brangers [in collaboration 
with R. Axel, Columbia University]
Mice, like humans, are social animals. To interact, 
cooperate, and compete with others, mice have to col-
lect information about each other’s identity, fertility, 
and likely intent. We would like to understand how 
social information is represented, computed, and used 
by mice. In rodents, a main source of information for 
social decision making and reward valuation is the 
chemosensory system. The neural circuits supporting 
these tend to be shallow, from sensory input to motor 
actions, and highly stereotyped, enabling the system-
atic dissection of this system.
We started our studies by recording from part of 
the amygdala that processes information from the 
vomeronasal system and detects behaviorally signifi -
cant chemical cues, such as pheromones. We have 
designed a behavioral task that presents different uri-
nary proteins to our mice while we are performing 
electrophysiology in the medial amygdala. More-
over, we characterized molecular markers that en-
able us to further dissect the social amygdala circuit. 
Currently, we are carrying out optogenetic experi-
ments as well as electrophysiological recordings to 
map behavioral relevance onto specifi c medial amyg-
dala neurons.
We are also interested in understanding the basic 
rules that mice use to choose the appropriate mat-
ing partner for themselves. For this purpose, we are 
developing psychophysical social behavior tasks to 
combine with our electrophysiology studies. This 
system improves stimulus delivery precision and rep-
ertoire. To deliver social stimuli and determine their 
“value” for a mouse, we developed a new behavioral 
setup, the “mouse carousel.” In the future, we plan 
to characterize social preferences and neural circuits 
using this behavioral paradigm.
Optogenetic Dissection of Nucleus 
Basalis during Sustained Attention
B. Hangya, S. Ranade, M. Lorenc
The nucleus basalis (NB) is a vitally important yet 
poorly understood neuromodulatory system that is 
thought to have signifi cant roles in cognitive functions, 
including learning, memory, and attention. Cognitive 
defi cits in Alzheimer’s disease, Parkinson’s dementia, 
age-related dementias, and normal aging are corre-
lated with the extent of deterioration of NB cholin-
ergic neurons. Yet, despite the association of NB with 
higher cognitive functions and a host of disease states 
in humans, it is surprising how little we understand 
about its function during behavior. Previous research, 
mostly using lesions, pharmacology, and microdialy-
sis, revealed that NB can have strong and confusingly 
diverse effects on downstream targets and behavior. 
However, there are no functional studies that reveal 
what NB neurons actually do during behavior. To over-
come these challenges, we combine optogenetic and 
electrophysiological approaches to record from iden-
tifi ed cholinergic projection neurons in NB during 
behavior. We have successfully developed visual and 
auditory versions of sustained attention tasks for mice. 
In these tasks, mice report target stimuli occurring at 
uncertain times. Performance and reaction time are 
used as indicators of attention. We manipulate tem-
poral expectancy by using specifi c distributions for 
stimulus timing, thus modulating attention in a tem-
porally precise, graded manner, also refl ected in the 
reaction times of the animals. At present, our efforts 
are focused on recording from identifi ed cholinergic 
neurons to assess their role in sustained auditory at-
tention and optogenetic manipulations of cholinergic 
neurons to infl uence behavioral variables.
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THEORETICAL AND COMPUTATIONAL NEUROSCIENCE
A. Koulakov B. Kolterman Y. Wei
Our laboratory develops theories of neural computa-
tion. We work in parallel on three topics. First, we 
 formulate mathematical models for combining ge-
netic information and experience (nature and nur-
ture) during formation of connections between 
neurons. Our models describe how genes can help 
build neural networks and how neural activity adds 
a layer of plasticity to the network topology that re-
fl ects learning and experience. These models have 
been tested on circuits that are formed in the visual 
system and can be rewired through genetic, surgical, 
and pharmacological manipulations. This year, we 
have applied our theory to the visual maps of ocu-
lar dominance observed in visual cortices of many 
higher vertebrates, such as humans. We were able to 
relate the orientation of ocular dominance patterns 
to the distribution of molecular labels that control 
establishment of connectivity between the cortex 
and thalamus. Second, we have been developing the 
neural network theory for olfactory processing. We 
previously argued that information about smells can 
be represented in the olfactory system in the form of 
temporal sequences. This year, we proposed a net-
work model for the processing of temporal sequenc-
es by the olfactory cortex. Our model is consistent 
with the known features of anatomy and physiology 
of the piriform cortex. Finally, we have attempted to 
apply neural network theory to the networks regu-
lating gene expression in cells. We considered the 
impact of fusion of two cells that reside in differ-
ent confl icting states. We argued that this event may 
make cells into spurious attractors—meaning they 
occupy abnormal states inaccessible during normal 
cell differentiation. Our mathematical formalism 
allowed a precise defi nition of the Waddington epi-
genetic landscape through the Lyapunov function of 
the underlying network. Finally, we argued that the 
phenomenon of collision of two or more networks 
and the resulting dynamics may be more general 
and apply outside of biology to processes in econom-
ics, politics, and society.
Odors in the Olfactory Bulb Are Deﬁ ned 
by a Short Discrete Temporal Sequence: 
Recognition by Brute Force Conversion 
to Spatial Patterns
A. Koulakov, B. Kolterman [in collaboration with 
H. Sanders and J. Lisman, Brandeis University, Waltham, 
Massachusetts; D. Rinberg, HHMI Janelia Farm, 
Ashburn, Virginia and New York University]
Recordings in awake behaving rodents have recently 
revealed new properties of olfactory coding. Mitral 
cells, the principal neurons in the olfactory bulb, re-
spond to odorants by fi ring bursts of action potentials 
called sharp events. The time of the onset of the sharp 
event for a particular mitral cell occurs at a precise 
moment with respect to the sniff cycle for a given 
odor, but sharp events occur at different times for dif-
ferent cells and for different odors. In this project, we 
studied the onset of sharp events and found that they 
occur phase-locked to the ongoing gamma frequency 
oscillation. Because there are not many gamma cycles 
during a single sniff, the signature of an odor is a dis-
crete sequence that is relatively short. These fi ndings 
suggest a new class of solutions to the problem of odor 
recognition. Specifi cally, the cortex might contain a 
small number of modules, each forming a persistent 
snapshot of what occurs in a certain gamma cycle. The 
collection of these snapshots forms a spatial pattern 
that represents the entire sequence and that could be 
recognized by standard attractor-based mechanisms. 
We show that such a “brute force” solution can occur 
in a neurally plausible way.
An Exactly Solvable Model of Random 
Site-Speciﬁ c Recombinations
Y. Wei, A. Koulakov
The Cre-Lox system is used as a genetic tool to con-
trol site-specifi c recombination events in genomic 
DNA. If multiple recombination sites are organized 
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in a  compact cluster within the same genome, a se-
ries of stochastic recombination events may generate 
substantial cell-specifi c genomic diversity. This di-
versity is used, for example, to distinguish neurons in 
the brain of the same multicellular mosaic organism, 
within the brainbow approach to neuronal connec-
tome. Thus, every cell in an organism could be iden-
tifi ed on the basis of a relatively short unique DNA 
barcode. Here we study an exactly solvable statistical 
model for site-specifi c recombination operating on a 
cluster of recombination sites. We consider two types 
of recombination events: inversions and excisions. 
Both of these events are available in the Cre-Lox sys-
tem. We derive three properties of the sequences gen-
erated by multiple recombination events. First, we de-
scribe the set of sequences that can in principle be gen-
erated by multiple inversions operating on the given 
initial sequence. Second, we demonstrate that after a 
large number of stochastic inversions, every sequence 
that can be generated is generated with equal prob-
ability. Finally, we derive equations for the probability 
of fi nding a sequence as a function of time in the limit 
when excisions are much less frequent than inversions, 
such as in shuffl on sequences.
The Problem of Colliding Networks and 
Its Relation to Cell Fusion and Cancer
A. Koulakov [in collaboration with Y. Lazebnik, 
Cold Spring Harbor Laboratory]
Cell fusion, a process that merges two or more cells 
into one, is required for normal development and has 
been explored as a tool for stem cell therapy. It has 
also been proposed that cell fusion causes cancer and 
contributes to its progression. These functions rely on 
a poorly understood ability of cell fusion to create new 
cell types. We suggest that this ability can be under-
stood by considering cells as attractor networks whose 
basic property is to adopt a set of distinct, stable, self-
maintaining states called attractors. According to this 
view, fusion of two cell types is a collision of two net-
works that have adopted distinct attractors. To learn 
how these networks reach a consensus, we model cell 
fusion computationally (Fig. 1). To do so, we simulate 
patterns of gene activities using a formalism developed 
to simulate patterns of memory in neural networks. 
We fi nd that the hybrid networks can assume attrac-
tors that are unrelated to parental attractors, imply-
ing that cell fusion can create new cell types by nearly 
instantaneously moving cells between attractors. We 
also show that hybrid networks are prone to assume 
spurious attractors, which are emergent and sporadic 
network states. This fi nding means that cell fusion 
can produce abnormal cell types, including cancerous 
types, by placing cells into normally inaccessible spu-
rious states. Finally, we suggest that the problem of 
colliding networks has general signifi cance in many 
processes represented by attractor networks, including 
biological, social, and political phenomena.
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Figure 1. Simulated cell fusion can change cell types. The state of 
this network is represented by an array in which activated genes 
are indicated in light gray, inhibited genes in dark gray, and genes 
with basal activity in white. The entire network contains 2304 
(482) genes, and thus its state is visualized by a 48 × 48 array. 
(A) Fusion of two cells of the same type leads to a  hybrid of the 
same type. (B) Fusion of two cell types (sun and bell) results in a 
hybrid that belongs to another cell type (heart). (C) Interpretation 
of middle cells. Cell fusion can transport a cell from one attractor 
(bell) to the basin of another (heart) by creating an intermedi-
ate product (bell + sun) with another cell (sun). This mechanism 
bypasses the need to overcome the hills of the epigenetic space.
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THE FUNCTION AND PLASTICITY OF CENTRAL SYNAPSES 
IN ADAPTIVE AND MALADAPTIVE BEHAVIORS 
RELATED TO PSYCHIATRIC DISORDERS
B. Li S. Ahrens H. Li M. Penzo
 K. Delevich M. Mirrione Z. Perova
 S. Ghosh R. Paik M. Stephenson-Jones
Understanding the relationship among synapse, cir-
cuit, and behavior has been the focus of research in 
my lab. We are particularly interested in understand-
ing the synaptic and circuit mechanisms underlying 
cognitive functions, as well as synaptic and circuit 
dysfunction that may underlie mental disorders, in-
cluding anxiety, depression, schizophrenia, and au-
tism. To address these questions, we use in vitro and 
in vivo electrophysiology, two-photon imaging, and 
molecular, genetic, optogenetic, and chemical-genetic 
methodologies to probe and manipulate the function 
of specifi c neural circuits in the rodent brain and de-
termine their role in behavior, such as learning and 
expression of fear, learned helplessness, and attention. 
We are currently undertaking three major lines of re-
search, which are summarized below.
Experience-Dependent Synaptic 
Modiﬁ cation in the Central Amygdala 
Fear Circuit
The amygdala is essential for fear learning and ex-
pression. The central amygdala (CeA), once viewed 
as a passive relay between the amygdala complex and 
downstream fear effectors, has emerged as an active 
participant in fear conditioning. However, how CeA 
contributes to the learning and expression of fear is 
unclear. We have found in mice that fear conditioning 
induces robust plasticity of excitatory synapses onto in-
hibitory neurons in the lateral subdivision of CeA (CeL). 
This experience-dependent plasticity is cell-specifi c, 
bidirectional, and expressed presynaptically by inputs 
from the lateral amygdala. In particular, prevent-
ing synaptic potentiation onto somatostatin-positive 
(SOM+) neurons impairs fear memory formation. 
Furthermore, activation of these neurons is neces-
sary for fear memory recall and suffi cient to drive fear 
responses. These fi ndings support a model in which 
the fear-conditioning-induced synaptic modifi cations 
in CeL favor the activation of somatostatin-positive 
neurons, which inhibit CeL output, thereby disinhib-
iting the medial subdivision of CeA and releasing fear 
expression (Fig. 1). Our ongoing study on this project 
is revealing the mechanisms by which the inhibitory 
circuits of CeL respond to fear conditioning and con-
tribute to both the learning and expression of fear. Al-
though fear conditioning modifi es multiple synapses, 
the fear-conditioning-induced potentiation of excit-
atory synaptic transmission onto SOM+ CeL neurons 
appears to be crucial, as suppression of this potentia-
tion severely impaired fear memory. Our results also 
support a model in which CeA stores fear memory in 
series with lateral amygdala. Such serial organization 
of fear memory allows the regulation of fear condi-
tioning at multiple levels. Moreover, as transmission 
is potentiated following fear conditioning, both at the 
auditory thalamus–lateral amygdala synapses and at 
the lateral amygdala–CeL synapses, the signal carry-
ing conditioned stimulus (CS) information can be re-
liably transmitted from the auditory thalamus to CeA 
via lateral amygdala while maintaining specifi city.
These fi ndings delineate cellular and circuit mech-
anisms that may explain previously reported observa-
tions: (1) pharmacological inactivation of CeL during 
conditioning impairs fear learning; (2) fear condition-
ing is followed by the appearance of two functionally 
distinct cell populations in CeL, the CeLon and CeLoff 
neurons, which show opposite responses to CS; and 
(3) the appearance of CeLon neurons is associated with 
(medial division of CeA) activation, rather than in-
hibition. Further studies will be required to elucidate 
the detailed cellular and molecular changes in distinct 
CeL inhibitory circuits during fear conditioning and 
to determine how they are related to fear memory ac-
quisition, consolidation, and expression.
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The Habenula Circuitry in the Learned 
Helplessness Model of Depression
The cellular basis of depressive disorders is poorly 
understood. Recent studies in monkeys indicate that 
neurons in the lateral habenula (LHb), a nucleus that 
mediates communication between forebrain and mid-
brain structures, can increase their activity when an 
animal fails to receive an expected positive reward or 
receives a stimulus that predicts aversive conditions 
(i.e., disappointment or anticipation of a negative 
outcome). LHb neurons project to, and modulate, 
dopamine-rich regions, such as the ventral tegmen-
tal area (VTA), that control reward-seeking behavior 
and participate in depressive disorders. We have found 
that in two learned helplessness models of depression, 
excitatory synapses onto LHb neurons projecting to 
the VTA are potentiated. Synaptic potentiation cor-
relates with an animal’s helplessness behavior and is 
due to an enhanced presynaptic release probability. 
Depleting transmitter release by repeated electrical 
stimulation of LHb afferents, using a protocol that 
can be effective for patients who are depressed, mark-
edly suppresses synaptic drive onto VTA-projecting 
LHb neurons in brain slices and can signifi cantly re-
duce learned helplessness behavior in rats. Our results 
indicate that increased presynaptic action onto LHb 
neurons contributes to the rodent learned helplessness 
model of depression.
This study provides insights into cellular mecha-
nisms that may explain previously reported phenom-
ena—the increase in LHb metabolic activity observed 
in humans who are depressed and in animal models 
of depression—and that lesion or pharmacological 
silencing of the LHb can modulate depression-like 
symptoms in animal models. Our fi ndings suggest an 
aberrant cellular process that has not previously been 
examined in the context of mood disorders and that 
may be crucial in the etiology of depression. Future 
studies aimed at determining the changes in molecu-
lar signaling that underlie the synaptic hyperactivity 
onto LHb neurons may lead to novel and effective 
treatments able to reverse some forms of depressive 
disorders.
The Thalamic Reticular Nucleus Circuit 
that Controls Attention
Considerable evidence supports a role of the tha-
lamic reticular nucleus (TRN) in sensory processing 
and cognitive functions such as attention. Dysfunc-
tion of TRN has been implicated in schizophrenia, 
a mental disorder in which cognitive defi cit is a core 
feature; however, the mechanisms by which TRN 
dysfunction occurs and leads to disease symptoms 
are unclear. We have probed and manipulated the 
so matostatin (SOM+) class of TRN neurons, which 
express ErbB4, a gene that has been linked to schizo-
phrenia. We found that ErbB4 defi ciency in these 
neurons selectively strengthened excitatory synapses 
driven by cortical inputs, thereby enhancing the feed-
forward modulation of thalamic neurons, and spe-
cifi cally impaired behavioral performance in a task 
that engages rule selection but not input selection, 
attentional processes dependent on activity of SOM+ 
TRN neurons.
Rule selection and input selection represent dis-
tinct attentional processes that likely require the 
coordinated action of cortical and subcortical struc-
tures. We found that suppression of SOM+ TRN 
neurons (by the chemical-genetic method) impaired 
performance in both the input-selection and rule-
selection tasks, indicating that these neurons are in-
dispensable. On the other hand, increasing cortical 
Figure 1. The yin and yang of the central amygdala. Image shows 
neurons in the lateral subdivision of the central amygdala (CeL). 
Darkly labeled cells are somatostatin-positive (SOM+)  neurons, 
which promote fear; brightly labeled cells are another set of 
 neurons known as PKC-delta+ cells, which inhibit fear.
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drive onto SOM+ TRN neurons (caused by ErbB4 
defi ciency) markedly improved input selection, but 
severely impaired rule selection. These results, al-
though paradoxical at fi rst glance, are in fact con-
sistent with Francis Crick’s attentional searchlight 
hypothesis, in which TRN neurons act as the 
“beam” of the searchlight to enhance the activity 
of thalamocortical neurons. Indeed, activation of 
TRN neurons promotes the generation of burst-
ing activity in the thalamus, which may facilitate 
information processing and improve behavioral per-
formance. Through this mechanism, the increased 
cortical drive onto TRN neurons may improve per-
formance in the input-selection task, in which dis-
tractors may interfere with information processing 
in the thalamus through a bottom-up process. In 
contrast, in the rule-selection tasks, both auditory 
and visual stimuli have been learned to be associ-
ated with reward, and therefore either stimulus can 
be voluntarily attended through a top-down pro-
cess. In a given trial, attending to the inappropriate 
stimulus (under the current rule) results in perfor-
mance error. This problem becomes exaggerated in 
the ErbB4 mutant mice, in which the aberrantly en-
hanced cortical-TRN inputs might render the TRN 
neurons more responsive to false signals originating 
from the cortex.
These results uncover a critical role of a cortico–
TRN synaptic circuitry in goal-directed attention, and 
provide insights on cellular and circuit mechanisms by 
which TRN dysfunction may occur and contribute to 
a consistently observed cognitive impairment in major 
psychiatric disorders. Our results suggest that either ab-
errantly increased or decreased TRN neuronal activity 
can result in impairment in rule selection, a key aspect 
of executive control. The rule-selection task used in our 
study mimics, to some extent, the Stroop task, a test 
commonly used to assess cognitive defi cit in schizo-
phrenia. The fi nding that ErbB4 defi ciency selectively 
impairs rule selection but not input selection, parallels 
a clinical observation, that schizophrenia specifi cally 
affects performance in the Stroop task and does not 
impair attentional functions in general. Deletion of a 
single copy of ErbB4 is suffi cient to produce a robust 
effect, suggesting that ErbB4 signaling is exquisitely 
regulated in SOM+ TRN neurons in order to properly 
maintain TRN function. Thus, our fi ndings reveal 
circuitry and cellular mechanisms that may underlie a 
form of cognitive defi cit observed in mental disorders.
In Press
Haohong Li, Penzo M, Taniguchi H, Kopec CD, Josh Huang Z, Li B. 
2013. Experience-dependent modifi cation of a central amygdala 
fear circuit. Nat Neurosci 16: 332–339.
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INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra C. Bergano F. Mechler A. Tolpygo
 N. Franciotti S. Michelsen K. Weber
 P. Grange A. Mukherjee C. Wu
 G. Havkin V. Pinskiy Y. Zhang
 J. Jones C. Powell 
We study complex neurobiological systems using a com-
bination of experimental and computational approach-
es. The primary area of experimental work in our labo-
ratory is the Mouse Brain Architecture (MBA) project, 
with a goal to generate the fi rst brain-wide mesoscale 
connectivity map in the mouse. In collaborative studies, 
we also apply the methods developed for the MBA proj-
ect to multiple other species, including zebra fi nch, mar-
moset, macaque monkey, and human. Our neuroinfor-
matics research involves the development and applica-
tion of analytical tools to large volumes of neurobiologi-
cal data. A specifi c area where we have concerted our 
efforts is the development of informatics infrastructures 
for data and knowledge integration for the various brain 
connectivity projects. We have several major ongoing 
collaborations with research groups, both inside and 
outside CSHL. At CSHL, we joined with Josh Huang 
on a project on GABAergic interneuron expression in 
mouse models of autism. Outside CSHL, we participate 
in the Brain Architecture Project, with collaborators at 
multiple institutions, notably Harvey Karten (Univer-
sity of California, San Diego), Kathy Rockland (Mass-
achusetts Institute of Technology), Michael Hawrylycz 
(Allen Institute of Brain Research), and Jin Hyung Lee 
(University of California, Los Angeles). Laboratory 
personnel continuing in the Mitra laboratory in 2013 
are Pascal Grange (Postdoctoral Fellow), Jamie Jones 
(Laboratory Technician), Sandra  Michelsen (Admin-
istrator), Vadim Pinskiy (Postdoctoral Fellow), Alex 
Tolpygo (Laboratory Manager), Gregor Havkin (Com-
putational Science Manager), Caizhi Wu (Research As-
sociate), Kevin Weber (Laboratory Technician), Neil 
Franciotti (Laboratory Technician), and Caitlin Powell 
(Laboratory Technician). Christin Bergano (Laboratory 
Technician), Amit Mukherjee (Postdoctoral Fellow), 
Yingbin Zhang (Computational Science Manager), 
and Ferenc Mechler (Computational Science Analyst) 
joined us during the last year.
Mouse Brain Architecture Project
V. Pinskiy, A. Tolpygo, C. Wu, J. Jones, K. Weber, 
C. Bergano, N. Franciotti, G. Havkin, Y. Zhang, 
A. Mukherjee, F. Mechler
The function of the brain is served and constrained 
by its wiring. Understanding this fundamental depen-
dence is hindered by our crucially incomplete knowl-
edge of mammalian brain connectivity. We have set 
out to address this problem in the MBA project by a 
comprehensive mapping of the patterns of neural con-
nectivity between brain regions. The MBA project is 
in its third year, currently funded by National Insti-
tutes of Health (NIH) grants (a running Transforma-
tive-R01 and an RC1 Challenge Grant completed last 
year) and support from CSHL.
Using a pair of anterograde tracing methods and 
a pair of retrograde tracing methods, we map brain 
connectivity in the C57BL/6J mouse line in four dif-
ferent ways and align these results to the Allen Brain 
Atlas. For tracers, we use classical histochemical labels 
as well as genetically engineered viruses that cannot 
jump synapses and express fl uorescent protein in the 
cytoplasm of the invaded neuron. For anterograde 
tracing, we use biotinylated dextran amine (BDA) and 
adeno-associated viruses (AAVs); for retrograde trac-
ing, we use cholera toxin subunit B (CTB) and a mod-
ifi ed rabies virus (RRV). Computer-guided precision 
injections are targeting one of 262 predetermined sites 
systematically mapped on a three-dimensional grid 
that covers the entire brain volume. The project aims 
to cover all combinations of injection sites and tracer 
types with repeated injections (at least two animals), 
which requires processing ~2100 mouse brains in the 
MBA pipeline. We now have ~50% completion of this 
plan (Fig. 1), with a signifi cant subset of processed 
brains already released for public access on the MBA 
web portal (http://mouse.brainarchitecture.org).
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We also made progress in the continued develop-
ment of the automated data processing pipeline. We 
developed algorithms and software for two-dimen-
sional image registration (Fig. 2), three-dimensional 
volume reconstruction (Fig. 3), and three-dimen-
sional cell detection and density estimation (not 
shown).
In addition to the MBA core data sets, we are con-
tinuing to process and post auxiliary data sets. One 
consists of four complete Nissl-stained brains imaged 
at high-depth resolution using dense optical section-
ing to be used for our own reference brain. Other no-
table examples include a web-posted tutorial on the 
myelin-stained mouse brain by Kathleen Rockland, 
and a set of web-based instruction modules meant for 
clinical neurologists developed in  collaboration with 
Dr. Joseph Safdieh at the Weill Medical College of 
Figure 1. Pipeline statistics. Summary of the brains injected in cortical (left) and subcortical (right) sites for three 
successive states of production in the MBA project (brains injected, sectioned, and stained). Injection sites (left) are 
rendered in two dimensions by multidimensional scaling of the cortex and stereotaxic projection of subcortical sites. 
Planned sites (black circles) are overlaid by one of four colored symbols that indicate grades of completion (1, 2, 3, 
or 4 tracers by dot; gray circle, triangle, and square, respectively). 
Figure 2. Two-dimensional registration. Section images are aligned 
by rigid transformation. This operation can be applied to sections of 
different image modalities (dark ﬁ eld for sections with ﬂ uorescent 
tracer; bright ﬁ eld for Nissl-stained alternate sections)
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Cornell University. We expect that the MBA project, 
with its publicly accessible data and the open source 
pipeline technologies, has the potential to impact the 
entire neuroscience community and directly address 
several items on the agendas of at least eight of the 20 
NIH institutes. One indirect but quantifi able indica-
tor of the scientifi c impact of the project and the inter-
est it continues to generate is the number of unique 
visitors to the MBA portal (22,781 during June 1−Dec 
12). Of these, 22% are returning visitors who main-
tain continuing engagement with the data on the por-
tal. For more on the Brain Architecture Project, see 
our website: http://brainarchitecture.org.
Alterations in Brain-Wide GABAergic 
Neuroanatomy in Autism Mouse Models
V. Pinskiy, A. Tolpygo [in collaboration with K. Krishnan 
(Huang Lab), Z. Collins (intern), S. Mukhopadhyay 
(Wigler Lab), Cold Spring Harbor Laboratory]
With support from the Simons Foundation Autism 
Research Initiative (SFARI), we joined with Josh 
Huang in a collaboration to address the developmental 
neuroanatomy of dysfunctional inhibition implicated 
in autism spectrum disorders (ASDs). In a systematic 
brain-wide approach, we generated whole-brain maps 
of genetically targeted key subpopulations of inhibi-
tory neurons. The project focuses on four GABAergic 
neuron subtypes: neurons expressing parvalbumin 
(PV), somatostatin (SOM), corticotrophin-releasing 
hormone (CRH), and vasointestinal peptide (VIP). 
We aim to quantify the distribution and long-range 
projection patterns of the inhibitory neurons in two 
genetic mouse models of ASD (16p11.2(df) and 
CNTNAP2 −/−  mutants) and assess how they differ 
from the C57/B6 wild-type controls, both in adult-
hood and during postnatal development. The project 
was started in the summer of 2011. In the fi rst year, 
the MBA pipeline processed brains of wild-type ani-
mals that the Huang lab had genetically engineered 
to express green fl uorescent protein (GFP) in the nu-
clei in each of the fi ve selectively targeted  GABAergic 
neurons. This soma-label data set is well suited for 
cell density estimation, but not for tractography. In 
the past year, the Huang lab succeeded in engineer-
ing animals that simultaneously express nuclear GFP 
and a diffuse cytoplasmic red fl uorescent protein (td-
Tomato) that helps us to visualize axon projections. 
With these animals, we are now able to simultane-
ously quantify both neuron density and the axonal 
projection pattern of selectively targeted GABAer-
gic neurons in the same animal. Figure 4 shows 
the sparse distribution of the somatostatin-positive 
(SOM+) GABAergic bitufted interneurons in dual-
labeled wild-type mouse.
In the next phase of this project, we will focus on 
breeding and processing dual-labeled ASD animals. 
Eventually, we would like to quantify how the ASD 
genotypes differ from the wild type in the brain-
wide distribution and projection pattern of select 
subtypes of GABAergic neurons and to gain insight 
into the postnatal development of pathological inhi-
bition in ASD.
Figure 3. Three-dimensional reconstruction of whole brain. Left 
lateral view of a volume rendered mouse brain that was recon-
structed from ﬂ uorescent section images. The brain was double 
injected in the left primary motor cortex (MOp) with ﬂ uores-
cent anterograde adeno-associated virus (supragranular site with 
GFP-AAV and the infragranular site with RFP-AAV) to highlight 
efferent projections from MOp.
Figure 4. Sparse brain-wide distribution of (SOM+) GABAer-
gic bitufted interneurons in an adult (p56) dual-labeled C57/B6 
animal. (SOM-Ires-Cre:HG:Ai14 C57/B6 knockin). Bright specks 
indicate labeled neurons in the low-magniﬁ cation ﬂ uorescent 
image of a representative coronal section (~Bregma –3.60).
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Mapping Long-Range Neuronal Circuits 
in the Postmortem Human Brain
V. Pinskiy, C. Powell
This is a method development project, supported by 
the G. Harold and Leila Y. Mathers Charitable Foun-
dation, with the aim of developing a practical method 
of studying long-range connectivity in postmortem 
human tissue. Our approach has three steps: (1) Use 
electrophoretic DiI tracing of fi ber tracts in thick brain 
sections, (2) resection the stained specimen into thin 
sections, and (3) digitally scan high-resolution images 
of the thin, large-format, whole sections. Each process-
ing step is trivial in small specimens, but scaling them 
up to cope with the size of the human brain poses for-
midable technical challenges. Our past and current ef-
forts, outlined below, were and are focused on fi nding 
innovative ways of overcoming these challenges.
• Tractophoresis. We have improved the tractopho-
retic apparatus to cope with long-term current ap-
plication and prevent dehydration and shrinkage by 
adding a dual-phase gel heat trap and silicone oil 
insulation around the tissue and the polyacrylamide 
conductive gel phase.
• Embedding and Sectioning. We implemented an old 
method of embedding the brain in oxidized agarose 
base that forms covalent cross-links with the tissue, 
providing adequate mechanical support of the spec-
imen. We recently acquired a refurbished whole-
body cryomicrotome that, unlike vibrotomes, can 
section specimens of human brains; it is waiting to 
be adjusted and tested.
• Imaging. To image the large slides required by human 
brain specimens, we have acquired a large-format 
confocal slide scanner (TISSUEscope by Huron 
Technologies). TISSUEscope maintains high spa-
tial resolution while accommodating a broad range 
of slide sizes (25 × 75 mm to 150 × 200 mm). It 
is being adjusted and tested for large-format high-
throughput use. We are currently running initial 
trials with whole sheep brains. Our plan is to con-
tinue making improvements on the performance of 
the tractophoretic and imaging apparatus and then 
begin working with Dr. Hof of Columbia University 
on high-throughput digitization of human samples 
from his extensive collection.
Computational Analysis of Brain-Wide 
Gene Expression
P. Grange
A Matlab toolbox for computational neuroanatomy. 
The main objective of this collaboration with the 
Allen Institute (AI) is to use mapped gene expression 
energies to study coexpression patterns of genes related 
to addiction and to identify the footprint of those pat-
terns in mouse neuroanatomy. The mapping is to the 
Allen Reference Atlas (ARA), a volumetric map of the 
adult mouse brain with 200-μm voxel resolution. We 
developed computational techniques to identify sets 
of genes that mark brain regions as annotated in the 
ARA. In particular, we imposed positivity constraints 
on sets of genes and optimized the fi tting scores, 
which measure how well an expression profi le follows 
the shape of a given brain region. The solutions tend 
be sparse (they involve few genes). We allow for a pa-
rameter to increase the sparsity (using an L1-L2 opti-
mization scheme). Of the 12 main regions of the left 
hemisphere in the ARA, the midbrain is the one for 
which optimal sets of genes bring the largest improve-
ment with respect to single genes (Grange and Mitra 
2012). We incorporated these new developments in 
a Matlab toolbox, BrainGeneExpressionAnalysis 
(BGEA), available from our web portal: http://brain-
architecture.org/allen-atlas-brain-toolbox. BGEA also 
includes work on coexpression networks in the brain, 
marker genes, and the estimation of the brain-wide 
density of certain cell types. We plan to adapt these 
methods to the ARA of the human brain (mindful 
of the limitations inherent in the nonvoxelized na-
ture of this atlas) and to the atlas of the zebra fi nch 
brain (currently under development at the Mello lab, 
O regon Health and Science University).
Applications to databases of condition-related 
genes. The methods of the BGEA toolbox were 
 applied to databases of genes related to nicotine ad-
diction (NicSNP), and to autism (AutRefDB, main-
tained by collaboration at MindSpec). The 288 genes 
we analyzed from NicSNP are not more coexpressed 
than expected by chance (Grange et al. 2013). How-
ever, we have identifi ed a collective behavior in sets 
of autism-related genes: These autism gene sets are 
signifi cantly coexpressed, and signifi cantly better 
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 fi tted to the cerebellar cortex than sets of genes of 
the same size, with a particular enrichment in the 
granular layer.
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IDENTIFICATION OF DISRUPTED BRAIN CIRCUITS IN MOUSE 
MODELS OF AUTISM AND SCHIZOPHRENIA
P. Osten G. Fitzgerald E. Szelenyi
 Y. Kim N. Takada
 C. Mende J. Taranda
 A. Nagendran K.U. Venkataraju
 A. Narasimhan J. Zambratto
 R. Palaniswamy 
Gaining an understanding of the brain regions and 
circuits that govern behavior is a central goal of sys-
tems neuroscience. During the last 4 years, research 
in our laboratory has been focused on the develop-
ment of a novel method for mapping behavior-evoked 
neuronal activation in the mouse brain at cellular 
resolution. Our approach is based on the visualiza-
tion of the immediate-early gene c-fos, a molecular 
marker of neuronal activation, by serial two-photon 
(STP) tomography in transgenic c-fos-GFP mice. 
Whole-brain STP tomography data sets are analyzed 
by a pipeline of computational methods that detect 
the activated green fl uorescent protein (GFP)-labeled 
neurons, warp their distribution to a reference brain 
volume registered to the Allen Mouse Brain Atlas, 
identify activated brain regions by statistical tests, and 
plot anatomical connectivity between the activated 
regions using the Allen Mouse Connectivity database 
(Figs. 1–3). This method opens the door to system-
atic screening of mouse brain circuits under normal 
conditions and in genetic and other mouse models of 
human brain disorders.
Mapping Social Behavior in the 
Mouse Brain by STP Tomography
To demonstrate the power of our methods in study-
ing brain functions underlying complex behaviors, we 
decided to map whole-brain activation evoked during 
social behavior—the so-called “social brain circuit”—
in normal (wild-type) mice (Fig. 3). These experiments 
were done by comparison between three groups of mice: 
(1) A “home-cage group” of nonhandled mice, which 
served as a baseline control; (2) an “object group” that 
was allowed to explore a novel object added to the home 
cage environment for 90 sec, and (3) a “social group” 
that was allowed to interact with a conspecifi c ovariec-
tomized female in the home cage for 90 sec. The com-
parison between the social and object group revealed 
all regions previously determined by other methods to 
be involved in rodent social behavior and a number of 
additional brain regions (Fig. 3; note the high level of 
statistical signifi cance for many core circuit regions, 
with FDR-corrected values <10−5). Because our c-fos 
data are registered in the Allen Brain Atlas format, we 
used the anatomical anterograde projection data from 
the Mouse Connectome project (http://connectivity.
brain-map.org) to draw a connectivity matrix between 
all signifi cantly activated brain areas (Fig. 3). These 
data represent the fi rst comprehensive map of social-be-
havior-evoked neuronal activation in the mouse brain. 
We conclude that STP-tomography-based visualization 
of c-fos-GFP induction represents a highly sensitive 
method for mapping behavior-evoked brain activation 
in the mouse brain. This work was presented at last 
year’s SFN meeting in San Diego and the manuscript 
is in preparation.
The Study of Brain Circuits in Genetic 
Mouse Models of Autism
The goal of this work is to identify brain-circuit-based 
endophenotypes related to autism in genetic mouse 
models using our c-fos-GFP-based brain screening 
described above. Recently, we have discovered that 
mice carrying a deletion of the 16p11.2 locus, which 
is associated with autism, schizophrenia, developmen-
tal delay, seizures, and obesity, have increased seizure 
propensity and abnormal neuronal circuit activation 
in two distinct brain circuits. One circuit centers on 
the subiculum, which is the main output of the hippo-
campus, and several downstream connected regions, 
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Figure 1. Mapping brain activation. (A) Brain activation causes the induction of c-fos-GFP. (B,C) The brain is imaged 
by STP tomography. (D) c-fos-GFP cells are computationally detected. (E) The data sets are warped to a “reference” 
brain. (F) The distribution of c-fos-GFP cells is compared by statistical analyses. (G) Results are tabulated in a spread-
sheet of brain regions, with FDR-corrected q values for each region.
Figure 2. Brain Atlas–based analysis of c-fos-GFP data. (A) 367,378 c-fos-GFP cells detected in one mouse brain data 
set. (B) Anatomical segmentation showing the hippocampus (H), prelimbic (PL), infralimbic (IL), and piriform (PC) 
cortex. (C) Visualization of c-fos-GFP cell counts in the hippocampus (38,170), prelimbic (3305), infralimbic (3827), 
and piriform (10,910) cortex.
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including the nucleus accumbens, amygdala, entorhi-
nal cortex, and thalamus (mammillary body, dorsal 
premammillary nucleus, and tuberomammillary nu-
cleus). These structures are involved in memory, as 
part of the Papez circuit, goal-oriented behaviors, and 
defensive behaviors, as well as control of arousal, sleep, 
and circadian rhythm. A second subcircuit is formed 
by areas of the prefrontal cortex (PFC), centered on 
the orbital area and including infralimbic, prelimbic, 
and cingulate cortices, which control emotional pro-
cessing, decision making, empathy, and autonomic 
functions.
Our ongoing work on this project is focusing on the 
characterization of the circuits in the PFC, which we 
consider to be the primary candidate area for neuro-
nal defi cits related to at least some clinical manifesta-
tions of autism. We have also initiated collaborations 
with researchers at Seaside Therapeutics (Cambridge, 
Massachusetts) and Roche (Basel, Switzerland) to 
begin testing novel therapeutic strategies. We focus on 
two candidate drugs: CTEP, a selective mGluR5 in-
hibitor, and R-baclofen, a GABA-B receptor agonist. 
Both drugs are currently being tested in clinical trials 
in children with fragile-X syndrome (FXS), the most 
common cause of inherited intellectual disability and 
autism. We will test the effects of these drugs using 
our c-fos-GFP-based brain screening in the Fmr1 KO 
mouse model of FXS, as well as in the 16p11.2 df/+ 
mouse model. These experiments will allow us to test 
the translational strength of our methods, because we 
will be able to compare the outcomes of our assays 
in the Fmr1 KO mice to the outcomes of the ongo-
ing clinical trials in children with FXS. In addition, 
the studies in the 16p11.2 df/+ mice will test whether 
FXS-targeted treatments may have broader indica-
tions in other genetic forms of autism.
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Figure 3. Social brain circuit in the mouse. Brain regions with signiﬁ cantly higher c-fos induction in the social group 
versus the object group are shown in an approximate layout of a sagittal view of the mouse brain. Connectivity is 
plotted based on data from the Mouse Connectome project (www.connectivity.brain-map.org). Statistical signiﬁ -
cance is gray-scale coded as shown in the upper left inset. Note the high signiﬁ cance for well-established areas in 
social behavior, such as amygdala (MEA, BMA, BLA), cortical amygdala (COA), or paraventricular hypothalamus 
(PVH). The abbreviations used are based on the Allen Brain Atlas (www.mouse.brain-map.org).
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NEURAL CIRCUITRY FOR SOCIAL COMMUNICATION
S. Shea B. Cazakoff G. Ewall
 K. Crump B. Lau
 H. Demmer K. Tranchina
 D. Eckmeier 
The overarching research goal in our laboratory is to 
understand how processing in specifi c brain circuits 
works to support natural communication behaviors. 
We aim to reveal neural mechanisms that allow or-
ganisms to detect and recognize familiar individuals, 
to gather information about their identity and social 
status, and to select appropriate behaviors.
Mice are capable of acquiring detailed profi les on 
one another from the smells and sounds experienced 
during their social encounters. These dossiers may in-
clude information on a mouse’s sex, genetic identity, 
reproductive state, levels of distress, or sexual interest, 
or even recently consumed foods—details that are in-
dispensable for survival and mating success. Initially, 
we are working to understand the neuronal activities 
and mechanisms in primary sensory brain areas that 
support these forms of communication. In the future, 
we anticipate moving deeper into the brain to ascer-
tain where the sensory data from those regions are 
collected and integrated into hormonal and electrical 
signals that promote appropriate behavioral choices.
The scientifi c benefi t of this approach is twofold. 
First, we want to identify fundamental principles for 
how the brain controls complex behavior. To this 
end, it is our belief that the nervous system’s func-
tion is best interpreted in the context of the behav-
iors it was evolutionarily designed to perform. Thus, 
it is advantageous to use natural behaviors such as 
intraspecifi c communication. Second, impairment 
of social perception and cognition are core features 
of the autism spectrum disorders (ASDs); for ex-
ample, patients may have diffi culty perceiving and 
interpreting communication gestures such as speech, 
facial expressions, and “body language.” This broad 
feature is recapitulated in many mouse models of 
ASD that carry genetic variants identifi ed in human 
ASD populations. Therefore, if we can ascertain the 
neural circuit substrates of social behavior in normal 
mice, we can make and test predictions for how the 
circuitry is affected in the mouse models. The results 
are likely to tell us more about the synaptic modifi ca-
tions that occur in human autism.
There are two broad areas of research in the lab. 
The primary focus is on neural circuits that facilitate 
detection, discrimination, and memories for olfactory 
cues. In particular, we are interested in how these cir-
cuits help an animal fl exibly select appropriate behav-
ioral decisions toward potential mates, rivals, offspring, 
predators, and food sources. Our approaches range 
from detailed in vivo synaptic physiology in anesthe-
tized animals, to functional imaging and physiology 
in head-fi xed mice, to recording and manipulating 
neural activity in awake, freely behaving animals. We 
ultimately hope to uncover the neural encoding of so-
cial cues during a live encounter with another mouse.
The secondary focus of our research program 
is aimed at understanding the plasticity of cortical 
circuits that enable vocal communication between 
mice. Specifi cally, we have been working on how this 
circuitry and the attendant behavior are altered in 
mice that have impaired function of the gene MeCP2, 
which is mutated in humans with Rett syndrome.
Noradrenaline Stores Olfactory Memories 
through Dynamic Regulation of Inhibition
H. Demmer, D. Eckmeier [in collaboration with 
A. Koulakov, Cold Spring Harbor Laboratory]
How do we remember individuals whom we have 
previously encountered? Substantial evidence indi-
cates that many animals remember each other based 
on olfactory cues. Memories are especially strong for 
individuals encountered during key life events such 
as mating with a new partner or the birth of a litter of 
young. These important events typically evoke mas-
sive release of the neurochemical noradrenaline (NA), 
initiating a heightened state of emotion and arousal. 
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This surge appears to cause long-lasting modifi ca-
tions to the responses to odorants in the olfactory 
bulb, which is the fi rst processing station for scent in 
the mammalian brain. Indeed, it was hypothesized 
that the coincidence of an odor stimulus with a surge 
of NA is minimally suffi cient to store a memory. 
We exploited the intimate relationship between 
NA, olfactory bulb activity, and behavior to create 
and study olfactory memories in the anesthetized 
mouse. We discovered that indeed, when NA release 
is evoked by stimulating locus coeruleus (the source 
of most NA) while the sleeping mouse sniffed an 
odorant, neural responses to that odor underwent 
specifi c long-term alterations. Remarkably, once 
awake, the mouse’s subsequent behavior toward the 
odorant was also changed. In other words, the mouse 
seemed to remember the odor and treat it as though 
it were familiar. Memories are widely believed to be 
stored as changes to the synaptic connections among 
the neurons in our brains. How are olfactory memo-
ries for individuals stored mechanistically among the 
specifi c synaptic connections of the various neuronal 
types in the olfactory bulb? To answer this question, 
Dr. Heike Demmer developed techniques for mak-
ing technically challenging targeted recordings from 
a specifi c type of inhibitory neuron (granule cells) 
that seems to regulate odor perception and behavior 
by inhibiting the mitral cells that form the output of 
the olfactory bulb. She then made these recordings 
during the induction of NA-dependent plasticity to 
examine how they contribute to memories. The data 
provide the fi rst evidence that naturalistic stimula-
tion of NA release in vivo suppresses granule cells, 
thus transiently increasing the excitability of mitral 
cells by relieving them from inhibition. In our model, 
this temporary disinhibition of mitral cells is a key 
trigger for the synaptic plasticity that likely underlies 
memory. Indeed, this controlled disinhibition leads 
to a selective long-term increase in inhibition onto 
cells that respond to the learned odor, and we propose 
that this is a critical substrate for odor learning (Fig. 
1). To test this proposal, we are planning to use dis-
inhibition of mitral cells by optogenetics techniques 
to recreate the neural dynamics that we now know 
are set up by NA and assess its suffi ciency for plastic 
changes.
Dr. Dennis Eckmeier has been taking a different 
approach to observe population mechanisms of NA-
dependent memory formation with functional neural 
imaging. He uses a technique in which the sensory 
neurons that provide input to the olfactory bulb are la-
beled with a fl uorescent activity sensor that allows him 
to monitor the strength of activation in foci called 
“glomeruli.” By plotting the response strength of each 
of these glomeruli before and after NA release, Dr. 
Eckmeier has shown that NA weakens the response 
to paired odors (Fig. 2). This effect is only observed 
in cases where NA is released during odor perception 
by stimulation of a brainstem structure called locus 
coeruleus (LC). These data surprisingly establish the 
synaptic input to the main olfactory bulb (MOB) as 
a target of noradrenergic modulation and present an 
opportunity to observe how memories shape sensory 
representations of large ensembles of neurons, as op-
posed to single cells.
Figure 1. LC stimulation strengthens GC inhibition onto MC. 
(A,B) Pairing an odor with LC stimulation potentiates recurrent 
inhibition. Note the prolonged AHP postpairing. Potentiation 
was not seen after pairing LC stim with blank controls. (C) These 
effects were consistent for a population of cells.
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Granule Cells of the Olfactory Bulb Exhibit 
Dramatically State-Dependent Activity
B. Cazakoff, B. Lau, K. Crump [in collaboration with 
A. Koulakov, Cold Spring Harbor Laboratory]
The granule cells in the olfactory bulb are widely 
considered to be critical for olfactory discrimination 
and learning; however, their activity patterns in vivo 
are poorly understood. Moreover, their electrophysi-
ological properties in awake animals are completely 
unknown. This is due to the fact that the granule 
cells do not yield to conventional recording tech-
niques. Therefore, we applied the techniques devel-
oped by Heike Demmer to mice that are awake with 
their heads fi xed but running freely on a foam ball 
and receiving water rewards from a lick tube. CSHL 
Undergraduate Research Program student Kerensa 
Crump initially set up this approach during her 10-
week research internship this year, and the work has 
subsequently been expanded by Watson School of 
Biological Sciences student Brittany Cazakoff and 
postdoctoral fellow Dr. Billy Lau. Collectively, they 
have found that the activity patterns of granule cells 
in awake mice are dramatically different from those 
observed under anesthesia, which was the condition 
for all previous studies of granule cells (Fig. 3). Ms. 
Cazakoff ’s thesis will be focused on expanding this 
paradigm to include discrimination of odors and as-
sociative learning to study how the fi ring patterns of 
granule cells refl ect experience with and behavioral 
signifi cance of an odor. In this study, and the study of 
NA-dependent memories, we are collaborating with 
CSHL professor Dr. Alexei Koulakov to test some 
surprising predictions that emerge from his model 
of population changes in granule cell activity during 
odor learning. So far, these unusual predictions have 
been consistent with our data.
Vocal Communication Is Impaired 
in a Mouse Model of Rett Syndrome
B. Lau, G. Ewall [in collaboration with J. Huang and 
K. Krishnan, Cold Spring Harbor Laboratory]
Far outside the range of our hearing, in the ultrasound 
range, mice are constantly holding conversations with 
one another in a language that is poorly understood at 
best. Many types of vocalizations are emitted by males 
and females, juveniles, and adults in a variety of be-
havioral contexts. We would like to better understand 
the perceptual signifi cance of these calls to the mice 
and how they are used to guide behavioral choices. 
One form of vocalization that is reasonably well un-
derstood is the ultrasonic distress vocalization (USV). 
Young mice before having vision and full mobility will 
occasionally become separated from the nest. This is 
stressful for them and they will therefore call out to 
their mother with a very high frequency peep. New 
mothers develop sensitivity to these cries and respond 
by moving toward their source (phonotaxis) to retrieve 
the pup. Moreover, females who have never given birth 
do not innately show approach responses to pups or 
Figure 2. LC stimulation suppresses population responses to paired odors. (A) Scatterplot of the responses of glom-
eruli from ﬁ ve mice, plotting late trials over early trials from after and before control sham LC stimulation. (B) Scat-
terplot of the responses of glomeruli from ﬁ ve mice, plotting post-LC stimulation response strength over pre-LC 
stimulation response strength. (C) Distribution of suppression ratios for all glomeruli in control animals (open bars) 
and LC-stimulated animals (gray bars). 
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their calls; however, they can learn to perform the be-
havior with experience.
We are collaborating with CSHL professor Dr. Josh 
Huang and his postdoctoral fellow Dr. Keerthi Krish-
nan to examine how this behavior is affected in mice 
that are missing one copy of a gene called MeCP2. Im-
pairments in the function of this gene are understood 
to cause the autism spectrum disorder Rett syndrome, 
and the Huang lab’s fi ndings regarding mutations in 
MeCP2 suggest that they may affect inhibitory net-
works in the auditory cortex that may be important 
for development of pup call sensitivity. Indeed, we fi nd 
that females who possess only a single copy of MeCP2 
are not able to develop profi ciency at gathering pups 
(Fig. 4). Future studies will assess whether the impair-
ment of the gene only in the auditory cortex is enough 
to produce the learning defi cit. In accordance with this 
possibility, we are also measuring responses to auditory 
stimuli in the cortex of mutant and wild-type animals 
to determine the circuit basis of the aberrant behavior.
Neural Activity during Social Encounters
D. Eckmeier
We have begun experiments that are ultimately 
aimed at recording individual neurons during social 
encounters and other behavioral assays involving 
the perception of social and nonsocial information. 
There are two broad related goals to this approach. 
The fi rst goal is to examine the encoding of social 
information such as body odors and vocalizations 
in primary sensory structures of awake animals. We 
hypothesize that activity in response to these signals 
may be labile to associative learning, attention, and 
arousal which we may be able to manipulate in the 
context of social encounters. The second goal is to 
record from neurons in deep brain neuromodulato-
ry centers during these encounters as well. Neurons 
that release noradrenaline and dopamine are likely 
responsive to social signals and may modulate encod-
ing of sensory data and associative plasticity. Under-
standing the context- dependent activity patterns of 
these neurotransmitters is therefore critical to devel-
oping models of how they affect behavior. Critical to 
this approach is the development of techniques for 
observing neural activity with implantable probes 
that are suffi ciently lightweight and low profi le to not 
interfere with normal social behaviors, yet are also 
Figure 4. MeCP2 +/− mutants exhibit impaired maternal behav-
ior. MeCP2 mutants and wild-type littermates were housed in 
a cage with a pregnant mother to assess their ability to learn 
maternal gathering behavior. Mutants took longer to gather (A) 
and made more errors (B) than their wild-type counterparts. 
*p < 0.05, ANOVA.
Figure 3. GC spontaneous and sensory-driven activities are 
highly state dependent. (A) Histogram comparing mean spon-
taneous ﬁ ring rates between anatomically identiﬁ ed GCs re-
corded under anesthesia (isoﬂ urane [10/140 or ketamine/
xylazine {4/14}], black bars) and in awake animals within the 
GC layer neurons (open) and anatomically identiﬁ ed as GCs 
(gray). (B) Comparison of mean spontaneous and odor-evoked 
respiration phase coupling strength  between GCs recorded 
under anesthesia and in wakefulness. (C) Raw trace from an 
anatomically identiﬁ ed GC as the mouse transitions to anes-
thesia. *p < 0.05, ANOVA.
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stable enough to allow steady, low-noise recordings 
during highly interactive behaviors such as mating. 
Our initial experiments make use of fi xed silicon 
probes etched with a high-density array of electrical 
contacts. The data show that these probes can be used 
to record multiple isolated neurons in the socially sig-
nifi cant modulatory nucleus locus coeruleus. We are 
now using these probes in awake animals to assess the 
structure of LC output during social learning with 
high temporal resolution.
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NEURAL CODING AND MEMORY FORMATION 
IN THE DROSOPHILA OLFACTORY SYSTEM
G. Turner R. Campbell T. Hige
 E. Gruntman K. Honegger
The brain has a tremendous capacity to form dif-
ferent memories. These memories are, under normal 
circumstances, highly accurate for particular stimuli 
and situations. This is precisely the facility that is 
lost in diseases such as Alzheimer’s and other de-
mentias. Our overall goal is to understand how the 
brain forms such precise memories: How does the 
specifi city arise? How does the brain derive such tre-
mendous capacity for forming different memories? 
We address these questions by studying olfactory 
memory formation in Drosophila. Just like Pavlov’s 
dogs, Drosophila learn to form associations between 
smells and reward or punishment. A specifi c area of 
the fl y brain, known as the mushroom body (MB), 
is essential for the fl ies to form olfactory memories. 
We are investigating how the neural activity patterns 
in this brain area are used to form specifi c olfac-
tory memories. To achieve this, we monitor activity 
using both electrophysiological and functional im-
aging techniques. We have found that MB neurons 
exhibit highly odor-specifi c responses, and activity 
patterns are relatively sparse across the population of 
MB neurons. This specifi city is thought to underlie 
the accuracy of memory; modifying the synapses of 
highly odor-specifi c neurons would lead to relatively 
precise memories. Sparse representations by highly 
stimulus-specifi c neurons are a general feature of 
brain areas involved in learning and memory, in-
cluding hippocampus and cerebellum in humans.
Using the simplicity and genetic manipulability of 
Drosophila, our goal is to understand several funda-
mental properties of neural responses in learning- 
and memory-related brain areas: What mechanisms 
give rise to the stimulus specifi city? What exactly is 
meaningful about the activity patterns? Is it simply 
which cells respond or does the precise timing of ac-
tivity matter? How are these response patterns modi-
fi ed by learning? Ultimately, what are the roles of the 
many genes implicated in learning on network-level 
activity in the brain?
Robust Sparse Coding in the 
Mushroom Body
K. Honegger, R. Campbell
Theoretical studies indicate that sparse representa-
tions are useful for learning and memory. Howev-
er, it is crucial to distinguish between truly sparse 
representations and weak responses observed sim-
ply because the stimuli tested are suboptimal (i.e., 
not those the system evolved to detect) or because 
strongly responsive cells are spatially segregated. In 
this study, we used imaging to establish that odor 
representations are genuinely sparse in the MB. We 
showed that natural stimuli which have intrinsic 
meaning to the fl y do not elicit qualitatively distinct 
responses from artifi cial, monomolecular odors. Ad-
ditionally, there is no evident spatial segregation of 
responses which would suggest that olfactory in-
formation is channeled into distinct anatomical 
pathways. Rather, odors evoke responses in a small 
fraction of the MB population, with cells randomly 
distributed throughout the MB. This format is likely 
useful for memory storage and recall. It is a simple 
way to minimize the overlap between representations 
of different stimuli: If each odor evokes a response in 
10% of the MB neurons, and for each odor the 10% 
are randomly distributed across the population, the 
representation of any two odors will overlap by only 
1%. Consequently, any changes in the properties 
of neurons that respond to one of the odors should 
only have a tiny effect on the representations of other 
odors. Overall, this format optimizes the circuit to 
form accurate memories with specifi c odors. We ex-
amined this explicitly in the next project.
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A Population Code for Odor 
Identity in the Drosophila Mushroom 
Body
R. Campbell, K. Honegger, E. Demir, H. Qin, W. Li
Do the neuronal response patterns in the MB convey the 
specifi city of memory formation? If so, what features of 
neural activity underlie that specifi city? To address these 
fundamental questions, we tested whether we could use 
the activity patterns we measure in the MB to predict 
the odor specifi city of fl ies’ memories. We examined this 
in the following two contexts: when fl ies learn (1) fi ne 
discriminations between highly similar odors and (2) an 
association with one odor and then generalize that as-
sociation to a different but related odor. To assess the 
odor specifi city of the memories, we used the standard 
Pavlovian conditioning protocol, training fl ies to form 
an association with one odor and testing the specifi city 
of those memories by giving fl ies a choice between that 
odor and a second odor. We compared this behavioral 
measure with the specifi city of the response pattern of 
~150 MB neurons to these odors. We found that we 
could use the MB activity patterns to accurately predict 
the specifi city of memory formation subsequently mea-
sured in behavioral experiments. To evaluate the features 
of neural activity that underlie accurate memory forma-
tion, we developed techniques to track activity of ~80% 
of the 2000 neurons in the MB. The unprecedented 
scope of these experiments enabled us to fi nd the small 
differences between different odor representations. We 
found that, even when fl ies are forced to choose between 
two odors that are near the limit of their discrimina-
tion ability, there are neurons that respond to only one 
odor of the pair, so that binary differences are present 
between the two odor representations. These differences 
are suffi cient to train a biologically realistic model net-
work to respond specifi cally to different odors. We have 
also used the activity patterns we measure in the MB to 
predict generalization of odor memories. There are two 
important conclusions from this study: (1) Analog dif-
ferences between odor representations in the olfactory 
receptor neurons are converted to binary differences in 
the MB and (2) a simple learning scheme of changing 
synaptic strength of all neurons that respond to an odor 
is suffi cient to accurately determine odor identity. These 
results show how a simple coding scheme can enable ac-
curate but generalizable memory formation.
Dendritic Claws of Mushroom 
Body Neurons Integrate the Olfactory 
Code
E. Gruntman
How is it possible to recognize an odor as a unifi ed 
smell (e.g., coffee) when it has a large number of 
different components, which in turn have many dif-
ferent chemical features? One idea is that olfactory 
receptor neurons (ORNs) in the nose (fl y’s anten-
nae) each recognize a particular feature of an odor, 
and the overall combination of activated ORNs con-
veys the identity of the odor. But are there neurons 
at deeper layers of the brain that read this combi-
natorial code and respond to specifi c combinations 
of co-active inputs? In this work, we show that the 
integration of these different inputs occurs on the 
dendritic trees of individual MB neurons. We ad-
dressed this issue by examining odor responses of 
individual dendritic input sites, making this one of 
a handful of studies to examine sensory responses 
of dendrites in vivo. To achieve this, we expressed 
a calcium-sensitive fl uorescent protein in single MB 
neurons, and then used two-photon imaging to con-
struct an odor tuning curve for each dendritic input 
site. By comparing tuning curves for different den-
dritic sites, we directly showed that some MB neu-
rons integrate combinations of different inputs. To 
evaluate how these inputs are integrated, we used op-
togenetic techniques to control activity of the input 
neurons. Our results provide an elegant explanation 
for why MB neurons are so odor selective: They not 
only receive different types of inputs, but require 
those different inputs to be co-active in order for the 
MB neuron to spike. Examining the time course of 
synaptic summation showed a rapid initial depolar-
ization that quickly plateaued at a level well below 
spike threshold. Summation of inputs from differ-
ent dendritic sites is also strongly sublinear. Never-
theless, if suffi cient numbers of different input sites 
are activated, membrane potential can reach spike 
threshold. Contrary to prevailing models for gener-
ating stimulus-specifi c responses, which rely mainly 
on supralinear summation of coincident inputs, 
our results show a surprising variant: a demand for 
strong multiple concurrent inputs due to sublinear 
summation.
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Decoding Sparse Representations
T. Hige
Sparse representations are useful for learning and 
memory, but how do downstream neurons integrate 
this information? Ultimately, the information in lay-
ers with sparse representations must be converted into 
a behavioral response. How does this process occur, 
and how do neurons downstream from a sparsely re-
sponding brain area integrate that information? In 
Drosophila, this process appears to occur immediately 
after the MB, as the 2000 MB neurons converge onto 
an estimated 35 output neurons. Individual members 
of this output population can be labeled with green 
fl uorescent protein (GFP) using the genetic tools 
available in Drosophila, making this an excellent sys-
tem to determine the basic principles of information 
processing downstream from sparse representations. 
Using GFP-targeted intracellular recordings, we have 
characterized the odor responses of one of these MB 
output neurons. In contrast to the highly odor-spe-
cifi c tuning of MB neurons, this output cell responds 
to a broad array of different odors. These functional 
properties are refl ected in the cell’s anatomy: It has 
very extensive dendritic processes within the output 
lobes of the MB, suggesting that it receives highly 
convergent input from many MB neurons. Although 
the neuron responds to almost all tested odors, it nev-
ertheless responds distinctly to different odors, sug-
gesting that this neuron is capable of carrying odor-
specifi c information. However, the odor-tuning prop-
erties of this neuron vary among individual fl ies; the 
same neuron has very different tuning curve shapes in 
different animals. One explanation for this variability 
is that it refl ects synaptic plasticity that operates on 
a developmental timescale. Our working hypothesis 
is that the tuning curves of the MB output neurons 
are a product of the prior olfactory experience of the 
individual fl y. We are currently testing this by exam-
ining the role of olfactory experience in shaping the 
response properties of these neurons.
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NEURAL CIRCUITRY OF UNDERLYING NORMAL AND 
ABNORMAL PROCESSING IN THE CORTEX
A. Zador K. Borges S. Koh A. Reid
 B. Burbach F. Marbach Q. Xiong
 D. Gizatullina H. Oviedo H. Zhan
 S. Jaramillo H. Oyibo P. Znamenskiy
 J. Kebschull I. Peikon 
My laboratory is interested in how neural circuits un-
derlie cognition, with a focus on the cortical circuits 
underlying auditory processing and decision making. 
To address these questions, we use a combination of 
molecular, electrophysiological, imaging, and behav-
ioral approaches.
Sequencing the Connectome
D. Gizatullina, J. Kebschull, H. Oyibo, I. Peikon, H. Zhan
[in collaboration with J. Dubnau, A. Koulakov, G. Hannon, 
Cold Spring Harbor Laboratory and L. Enquist, Princeton 
University]
The brain is a complex network, consisting of billions 
of neurons connected by trillions of synapses. The de-
tails of these connections—which neurons form syn-
aptic connections with which other neurons—are cru-
cial in determining brain function. Malformation of 
these connections during prenatal and early postnatal 
development can lead to mental retardation, autism, 
or schizophrenia; loss of specifi c connections later in 
life is associated with neurodegenerative diseases such 
as Alzheimer’s. An effi cient method for determining 
the brain’s wiring diagram would transform neurosci-
ence research. Inspired in part by the success of the 
Allen Brain Atlas, the Human Genome Project and 
other major efforts, there is growing excitement in 
neuroscience to determine the complete connectivity 
diagram—the “connectome”—of the brain. So far, the 
complete connectome has been established for only 
one organism, the tiny worm Caenorhabditis elegans, 
with 302 neurons connected by ~7000 synapses. How-
ever, determining the connectome of even this simple 
nervous system was a heroic task, requiring more than 
50 person-years of labor to collect and analyze the 
electron micrographs. All current approaches to de-
termining the connectome are based on microscopy. 
Unfortunately, microscopy is poorly suited to the study 
of neural connectivity because brains are macroscopic 
structures, whereas the synaptic connections between 
neurons require electron microscopy. Reconstructing 
the complete wiring diagram of such a brain is akin to 
piecing together the complete roadmap of the United 
States from a collection of postage-stamp-sized pho-
tographs. To circumvent the considerable challenges 
associated with determining the connectome based on 
microscopy, we are developing an entirely novel ap-
proach based on high-throughput DNA sequencing 
technology. Sequencing technology has not previously 
been applied in the context of neural connectivity. The 
appeal of using sequencing is that it is already fast—
sequencing hundreds of millions of individual pieces 
of DNA in a single day is now routine—and, like mi-
croprocessor technology, getting faster exponentially. 
Moreover, the cost of sequencing is plummeting: Pre-
dictions are that it will be possible to sequence an entire 
human genome (~3B nucleotides) for $1000 within a 
few years. Thus, by converting brain connectivity from 
a problem of microscopy to a problem of sequencing, 
we render it tractable using current techniques. An in-
expensive and rapid method for deciphering the wiring 
diagram of a neural circuit of an entire brain would 
have a profound impact on neuroscience research. 
Knowing the neuronal wiring diagram would provide 
a foundation for understanding neuronal function and 
development, in the same way that knowing the com-
plete genomic sequence provides the starting point for 
much of modern biological research in the postgenom-
ic era. Moreover, many neuropsychiatric diseases such 
as autism and schizophrenia are thought to result from 
disrupted neuronal connectivity, but identifying the 
disruptions even in mouse models is a major challenge 
given current technology. Our approach may help to 
usher in an era when understanding the connectivity 
of a new mouse model of neuropsychiatric disease is 
the routine fi rst step to analyzing its defi cits.
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Role of Inhibitory Interneurons 
in Auditory Cortex Function
A. Reid, T. Hromadka
Fast synaptic inputs to neurons in the auditory cortex 
are either inhibitory or excitatory. Cortical interneu-
rons are tremendously diverse. One inhibitory inter-
neuron subclass, defi ned molecularly by the expres-
sion of parvalbumin (PV+), seems ideally positioned 
to mediate the fast component of the characteristic 
barrage of inhibition elicited by a sound. We are test-
ing the hypothesis that PV+ inhibitory interneurons 
mediate fast sound-evoked inhibitory synaptic cur-
rents in the auditory cortex. Our proposal seeks to 
establish a causal link between a physiological prop-
erty—the fast sound-evoked inhibition that contrib-
utes to receptive fi eld dynamics—and a component 
of the underlying cortical circuitry. We approach the 
problem at three different levels, from brain slices 
through in vivo physiology to behavior. Although we 
are currently focusing on the role of one particular 
interneuron subclass (PV+), our approach combining 
electrophysiological and molecular tools can readily 
be generalized to other subclasses and can be extended 
to probe the circuitry underlying other sensory- and 
behaviorally elicited neuronal responses.
Processing of Spatial Information 
in the Auditory Cortex
S. Koh
In vision and somatosensation, spatial information 
is already present at the receptor level. In contrast, 
spatial information is not available at the cochlear 
level and must be computed using information from 
both hemispheres. A subpopulation of neurons in 
the primary auditory cortex conveys sound location 
and sound motion information, but little is known 
at the neural circuit level due to technical diffi culties 
of identifying neurons during in vivo recordings. We 
have previously developed a technique called PINP 
(photostimulation-assisted identifi cation of neuro-
nal populations) that allows us to “tag” subpopula-
tions of neurons based on their axonal projections. 
The tag is a light-gated ion channel channelrhodop-
sin-2 (ChR2), which can be triggered by a brief fl ash 
of blue laser with millisecond precision. We inject 
herpes simplex virus (HSV), which can be taken up 
by axons and travels in a retrograde fashion in order 
to deliver ChR2 specifi cally to the neurons project-
ing to the infected area. ChR2-tagged neurons can 
be identifi ed during in vivo recording by responsive-
ness to a fl ash of blue light. We are using PINP to test 
the hypothesis that layer-3 ACx neurons projecting 
to the contralateral ACx are more sensitive to audi-
tory spatial information than other subpopulations in 
ACx. Layer-3 neurons seem to be ideal candidates, 
deduced from the following facts: (1) Many layer-3 
ACx cells project to contralateral ACx, unlike visual 
and somatosensory cortex, where layer-3 cells pre-
dominantly project to ipsilateral cortical areas; and 
(2) processing of spatial information requires inputs 
from both hemispheres.
Circuits Underlying Auditory 
Representations and Decisions
S. Jaramillo, P. Znamenskiy, K. Borges
We are studying the circuits underlying auditory rep-
resentations, and how these representations give rise 
to decisions. We train rats and mice to perform well-
controlled auditory tasks and then use electrical and 
optogenetic methods to monitor and perturb neural 
activity. Using this approach, we recently found that 
the auditory cortex mediates the perceptual effects of 
acoustic temporal expectation (Jaramillo and Zador 
2011). We are now extending this approach to study 
the role of the auditory thalamus, cortex, and striatum 
in these behavioral processes.
Local and Long-Range Circuitry 
in the Auditory Cortex
H. Oviedo
We are studying the underlying mechanisms of the 
prefrontal cortex’s (PFC) ability to select relevant 
 signals and suppress irrelevant ones. Diminished in-
hibitory infl uence from PFC to the auditory cortex 
impairs our ability to ignore irrelevant sounds. To in-
hibit the auditory cortex, the PFC must send excitatory 
output via pyramidal neurons that target local inhibi-
tory neurons in the auditory cortex. Little is known 
about the anatomical and physiological properties of 
this projection. Because of the variety of inhibitory 
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neurons and differences in their computational roles, 
we are examining the role of the most prevalent types 
we can target with transgenic mice: parvalbumin, 
somatostatin, and vasoactive intestinal polypeptide. 
Our approach is to use channelrhodopsin-2-assisted 
circuit mapping to investigate the top-down inhibi-
tory control of auditory cortical activity.
Role of Corticostriatal Plasticity 
in Auditory Decisions
Q. Xiong, P. Znamenskiy
Corticostriatal plasticity has a key role in reinforce-
ment learning, but how associations between stimuli 
and motor responses are established remains unclear. 
Recent work from our group demonstrated a causal 
role of corticostriatal neurons in driving choices dur-
ing an auditory discrimination task, inspired by the 
classic random dot motion task used by Newsome 
and colleagues in macaques, in which subjects were 
required to choose the left or the right response port 
depending on the perceived frequency of a sound. We 
are testing the hypothesis that changes in the strength 
of corticostriatal synapses underlie the association 
between sound and action required to perform this 
task. Our results indicate that changes in the strength 
of a specifi c subset of corticostriatal synapses encode 
the arbitrary association between stimulus and motor 
response. Since all sensory cortical areas send projec-
tions to the striatum, our fi ndings suggest a general 
mechanism for the formation of arbitrary sensorimo-
tor transformations.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong J. Beshel Y. Shuai C. Xu
 S. Khurana A. Sodsiri
Food Odor Value Coding in the Fly Brain
J. Beshel
Stimulus valuation is a critical step in determining 
how we relate to the world. Yet the way the brain com-
putes and represents value remains a matter of much 
debate. The assessment of potential food sources pro-
vides an expedient framework to address value rep-
resentation in the brain given its ubiquity in nature. 
Under normal conditions, most animals, including 
Drosophila, are extremely discerning about what food 
sources to approach, even when given the choice be-
tween multiple viable options; odors are one of the 
most important sensory cues all animals use to track, 
evaluate, and select among available foods. Drosoph-
ila are an unparalleled model organism with which 
to study such questions given their complex behav-
ior and relatively tractable nervous system, as well as 
the wealth of genetic tools available to both observe 
and manipulate targeted neural populations. We fi rst 
established Drosophila’s partiality for differing food 
odors behaviorally. We then examined with single-cell 
resolution, using in vivo two-photon calcium imag-
ing, the relationship between observed food-odor 
values and activity in targeted subsets of olfactory 
and neuromodulatory neural populations. We were 
specifi cally interested in the role of Drosophila neu-
ropeptide F (dNPF) neurons, the functional homolog 
of mammalian orexigenic neuropeptide Y, which is a 
prominent regulator of food-related appetitive behav-
iors. We show that dNPF activity precisely defi nes a 
hierarchy of odor value with a perfect correlation be-
tween neural activity and behavior: The greater the 
odor-evoked dNPF response, the greater the attrac-
tion to that odor. The neuron’s activity also explic-
itly accounts for behavioral changes observed due to 
alterations in motivational state, in this case hunger, 
by increasing its activity accordingly. We confi rmed 
that dNPF activity is necessary for the attraction we 
observe to food odors as genetically disrupting the 
dNPF pathway abolishes odor attraction. Consistent 
with these results, stimulating dNPF activity was suf-
fi cient to drive asymptotic levels of the food-odor ap-
proach regardless of the satiety state. Taken together, 
these experiments describe how the value of a specifi c 
class of stimuli, food odor, is fl exibly represented in 
the brain.
Rac-Dependent Forgetting in Fruit Fly
Y. Shuai, A. Sodsiri, Y. Ai
The biological process underlying forgetting is not 
well known. We intend to study the molecular and 
cellular mechanisms of forgetting by using Drosophila 
olfactory associative memory as a model. The paired 
odor-shock conditioning paradigm is well character-
ized in the fruit fl y. Labile memory forms generated 
after single-session conditioning are vulnerable to for-
getting. They will decay within a few hours and are 
prone to disruption by interference from new learn-
ing and reversal learning. We have shown in our re-
cent study that both decay and interference-induced 
forgetting are regulated by Rac small-G protein ac-
tivity in the mushroom body (MB). We hypothesize 
that Rac-dependent forgetting is an adaptive strategy 
that can actively modulate the transience of memory. 
We seek to further determine (1) how Rac activity is 
regulated during forgetting and (2) how Rac forget-
ting affects established memory traces. For the fi rst 
question, we take advantage of a fl uorescence reso-
nance energy transfer (FRET)-based Rac activity 
probe. We combine in vivo imaging of Rac activity 
with transgenic RNA interference (RNAi) to screen 
for Rac regulators in the adult MB. The initial screen 
focused on the guanine nucleotide exchange factor 
(GEF) and GTPase-activating proteins (GAPs), two 
families of proteins known to regulate RhoGTPase 
activity. Screening through ~40 GEF and GAP can-
didates has uncovered one GEF and one GAP that 
can up- and down-regulate Rac activity in the MB, 
respectively. We are now in the process of evaluating 
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their signifi cance during forgetting. For the second 
question, we combine live animal calcium imaging by 
GCaMP3 with acute genetic manipulation of Rac ac-
tivity to probe the cellular effect of Rac forgetting. We 
are testing the hypothesis that collapse of a memory 
stabilization network involving the α′/β′ subtype of 
MB neurons subserves forgetting.
NF1 and Memory in Drosophila
C. Xu
Neurofi bromatosis 1 (NF1) is a genetic disorder af-
fecting one in 3500 people in the population. Affected 
individuals manifest overgrowth of various types of 
tissue and ~40% of the patients show cognitive de-
fects. The mutated gene responsible for the NF1 disor-
der is called neurofi bromin, and it is conserved among 
species. When the neurofi bromin gene is deleted, 
the Drosophila animal model has both learning and 
long-term memory phenotypes with aversive associa-
tive conditioning. In contrast to the aversive condi-
tioning, appetitive conditioning is more effective in 
forming long-term memory by single training trails, 
whereas aversive conditioning needs many trails. It is 
not known whether appetitive memory also requires 
neurofi bromin. We are currently investigating this 
question with neurofi bromin mutant fl ies.
Decision Making in Drosophila Larvae
S. Khurana
Decision making, and its underlying mechanisms, 
whether in the context of learning or sensory response, 
is one of the key areas of inquiry in contemporary neu-
roscience. Understanding of the behavior involved in 
state transition from one repetitive behavioral pattern 
to another has been relatively unexplored. Using au-
tomated tracking of larvae of Drosophila melanogaster, 
we are studying the behavioral patterns of locomotion, 
sensory responses, and conditioning to explore various 
steps involved in the orientation strategies. Although 
automated tracking has been increasingly used in neu-
roscience, including the larvae of fruit fl y, the focus of 
the fi eld has been to explore only one or a few simple 
parameters of behavior. We are looking at changes of 
behavior in the form of the most measurable behav-
ioral parameters from one step to another, i.e., state 
transitions, something that has not been explored. In 
larvae, there are two broad phases: repetitive locomo-
tion patterns, called fast phases, where the curvature 
of tracks is relatively small under most circumstances, 
and slow phases, where animals slow down and explore 
their environment. Exploration of slow phases, its fi ne 
structure, and relation of one slow phase as a function 
of previous slow and fast phases, conditions that can 
elicit changes in fast phase and its state dependence, 
has revealed a pattern of transitions where a previous 
history of the animal infl uences its next step orienting 
to or away from a stimulus. We are currently complet-
ing the streamlining of automation for this analysis, 
which generates a large amount of data, similar to ge-
nomic analysis from relatively few experiments, and 
gearing toward two kinds of manipulations to explore 
the meaning of such patterns. The fi rst set of experi-
ments involves the manipulation of stimulus param-
eters, the behavioral arena, and the state of animal to 
reveal changes in this orientation strategy. The second 
set involves a conditional knock-out and knock-in of 
various neurotransmitters, neuromodulator systems, 
and brain regions, using the inducible UAS-GAL4 
system to explore the underlying mechanisms regulat-
ing the different phases and transitions. We hope that 
in the long run, application of this detailed behavioral 
approach to various disease model systems, including 
mammalian systems, will be useful in the exploration 
of various facets of neuropsychiatric disorders and the 
application of combinatorial drug therapy needed for 
many such disorders.
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PLANT BIOLOGY
David Jackson and colleagues study genes and signals that regulate plant growth and architecture. 
They are investigating a unique way in which plant cells communicate, by transporting regulatory 
proteins via small channels called plasmodesmata. These channels, which direct the fl ow of nutri-
ents and signals through growing tissues, are regulated during development. The team discovered 
a gene, CCT8, that controls the transport of a transcription factor, SHOOTMERISTEMLESS 
(STM), between cells in the plant stem cell niche, or meristem. STM is critical for stem cell main-
tenance, and studies of the CCT8 gene indicate that movement of STM between cells is required 
for this function. The lab also continues to identify other genes that control plant architecture 
through effects on stem cell maintenance and identity. Recent examples include discovery of a 
subunit of a heterotrimeric G protein that is conserved throughout animals and plants, and their 
studies indicate that this gene controls stem cell proliferation. In animal systems, the G protein 
interacts with a class of receptors that are called GPCRs (G-protein-coupled receptors), but they 
have found that in plants, the same protein interacts with a completely different class of receptors. 
Their discovery helps explain how signaling from diverse receptors is achieved in plants. This past 
year, they also demonstrated that weak mutations in one of the receptor proteins can enhance seed 
production in maize, which could lead to yield increases. Separately, the lab has characterized 
system-wide networks of gene expression in infl orescence development, using “next-gen” profi ling 
methods, and is developing a collection of maize lines that can drive expression of any reporter or 
experimental gene in any tissue type—tools of great interest to maize researchers that are being 
made available to the broader scientifi c community, enabling experiments never before possible in 
crop plants.
Zachary Lippman’s research focuses on identifying genes that cause tomato plants to produce 
their fl owers in an elegant repetitive zigzag arrangement on a branching structure called an “in-
fl orescence.” Proceeding from a base of knowledge they have built regarding a universal growth 
habit represented by tomato, called sympodial growth, Lippman’s lab is addressing the question 
of zigzag fl ower patterning by focusing on the fundamental question of how plants are able to 
stop making leaves and start making fl owers. Of particular interest is how these “reproductive 
phase transitions” have contributed to the evolution of diverse infl orescence branching patterns 
in tomato’s larger Solanaceae family, which includes plants that make just one fl ower in each in-
fl orescence, to plants whose infl orescences produce dozens of branches and hundreds of fl owers. 
Using classical and modern genetic techniques, Lippman is dissecting the gene networks that are 
responsible for the variation in infl orescence branching found in nature. He hopes to leverage 
these discoveries to improve crop yields in several Solanaceous plants such as pepper, eggplant, and 
potato. Already, a collaboration between Lippman’s group and scientists at Hebrew University 
has identifi ed a gene called fl origen, which is responsible for making fl owers in plants, and can be 
altered using simple genetic tricks to push hybrid tomato plants to increase their yield by as much 
as 60%. Using a systems-biology approach and next-generation sequencing technology to capture 
the transcriptome of stem cells at fi ve different stages of maturation enabled the lab to identify 
nearly 4000 genes that represent the “maturation clock” in tomato plants. Most recently, the team 
built on this with the discovery of a gene, Terminating Flower or TMF, that acts as a key regula-
tor on this clock, slowing fl owering down so it does not happen too precociously. This year, the 
Lippman lab was also involved in sequencing the “Heinz” tomato and its wild ancestor in order to 
better understand the evolution of the domesticated variety.
Epigenetic mechanisms of gene regulation—chemical and conformational changes to DNA 
and the chromatin that bundles it—have had an important impact on genome organization and 
185-211_PlantGenete.indb   185 9/17/2013   8:11:17 AM
186  Research
inheritance and on cell fate. These mechanisms are conserved in eukaryotes and provide an ad-
ditional layer of information superimposed on the genetic code. Robert Martienssen, a pioneer 
in the study of epigenetics, investigates mechanisms involved in gene regulation and stem cell fate 
in yeast and model plants including Arabidopsis and maize. He and colleagues have shed light on 
a phenomenon called position-effect variegation, caused by inactivation of a gene positioned near 
densely packed chromosomal material called heterochromatin. They have discovered that small 
RNA molecules arising from repeating genetic sequences program that heterochromatin. Mar-
tienssen and colleagues have described a remarkable process by which “companion cells” to sperm 
in plant pollen grains provide them with instructions that protect sperm DNA from transposon 
damage. This year, they published research showing that some of these instructions, or epigenetic 
marks, could be inherited in the next generation. With collaborators in Mexico, Martienssen has 
also coaxed Arabidopsis, a fl owering plant, to produce egg cells without meiosis, an important 
step toward a long-time goal of plant breeding: generating clonal offspring to perpetuate hybrid 
vigor. The lab has also showed that when RNA polymerase II has transcribed a stretch of DNA, 
the RNA interference mechanism causes the enzyme to release its hold on the DNA and fall away. 
This allows the replication fork to progress smoothly and the DNA strands to be copied; histone-
modifying proteins, which follow right along, establish heterochromatin. Martienssen’s group also 
continues to work on problems related to the creation of plant-based biofuels.
The growing tips of plants, called meristems, contain a population of stem cells that serve as a 
persistent source of daughter cells from which new organs, such as leaves, arise. Marja Timmer-
mans and colleagues are studying the genetic networks that regulate plant stem cell activity. Using 
genomic approaches, they have defi ned gene expression signatures that distinguish indeterminate 
stem cells from their differentiating derivatives. They have also worked out the mechanism that 
suppresses stem-cell fate to allow cells to differentiate and have shown that this process requires 
a highly conserved epigenetic gene silencing mechanism. In particular, Timmermans’ group has 
shown that specifi c DNA-binding proteins mediate the recruitment of Polycomb repressive com-
plexes to stem cell factors, an action that stably represses their expression in differentiating organs. 
This work addresses a major unresolved question in the fi eld of epigenetics: how Polycomb pro-
teins, which do not bind DNA themselves, recognize defi ned targets. Plant stem cells also produce 
signals important for the patterning of lateral organs. The lab has discovered that small RNAs can 
traffi c from cell to cell and are among the stem-cell-derived signals. They have found that polarity 
in leaves is established via opposing gradients of mobile small RNAs that act as morphogen-like 
signals. Their most recent fi ndings identifi ed a third small RNA gradient involved in maintenance 
of organ polarity. These fi ndings illustrate the complexity with which small RNAs generate devel-
opmental patterns. Currently, they are investigating parameters of small RNA mobility and the 
unique patterning properties of resulting small RNA gradients. Mathematical modeling predicts 
such gradients might serve to generate robustness during development.
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DEVELOPMENTAL BIOLOGY: STEM CELLS, SIGNALING, 
AND CONTROL OF PLANT ARCHITECTURE
D. Jackson R. Balkunde A. Farahani L. Sahl Q. Wu
 P. Bommert S. Hiraga C. Schwoyer F. Yang
 C. Brooks B. Il Je S. Vi T. Zadrozny
 A. Eveland M. Pautler Y.G. Wolfenson
Our research aims to identify genes, signals, and path-
ways that regulate plant growth and development. 
All organisms develop by carefully controlling the 
fl ow of information (“signals”) that passes between 
cells and tissues. We are particularly interested in dis-
covering these signals and fi nding out how they are 
transmitted, and how they function. In one project, 
we are investigating a unique way in which plant cells 
communicate, by transporting regulatory proteins via 
small channels called plasmodesmata. These channels, 
which direct the fl ow of nutrients and signals through 
growing tissues, are regulated during development. We 
discovered a chaperone protein-encoding gene CCT8 
that controls the transport of the transcription factor 
SHOOTMERISTEMLESS (STM) between cells in 
the plant stem-cell niche, or meristem. STM is critical 
for stem-cell maintenance, and studies of the CCT8 
gene indicate that movement of STM between cells is 
required for this function. We also continue to identify 
other genes that control plant architecture through ef-
fects on stem-cell maintenance and identity.
Recent examples include discovery of a subunit of a 
heterotrimeric G protein that is conserved throughout 
animals and plants, and our studies indicate that this 
gene controls stem-cell proliferation. In animal sys-
tems, the G protein interacts with a class of receptors 
that are called GPCRs (G-protein-coupled receptors), 
but we have found that in plants, the same protein 
interacts with a completely different class of receptors. 
Our discovery helps explain how signaling from di-
verse receptors is achieved in plants. This past year, 
we also demonstrated that weak mutations in one of 
the receptor proteins can enhance seed production in 
maize, which could lead to yield increases. Separately, 
our lab has characterized system-wide networks of 
gene expression in infl orescence development, using 
“next-gen” profi ling methods, and we are developing 
a collection of maize lines that can drive expression of 
any reporter or experimental gene in any tissue type. 
These tools are of great interest to maize researchers 
and are being made available to the broader scientifi c 
community, enabling experiments never before pos-
sible in crop plants.
Regulation of the Cell-to-Cell Trafﬁ cking 
of the Transcription Factor KNOTTED1
R. Balkunde
Cell-to-cell communication functions in specifying 
cell fate and coordinating development in all multi-
cellular organisms. A special paradigm for such com-
munication in plants is the selective traffi cking of sig-
naling macromolecules, e.g., transcription factors and 
small RNAs, through plasmodesmata (PDs), channels 
that traverse the cell wall and connect all plant cells. In 
addition to cell-fate specifi cation, PDs are involved in 
viral movement, transport of metabolites, and cell-to-
cell spread of RNA interference (RNAi), which points 
to their fundamental importance in coordinating 
plant defense, metabolism, and development. Despite 
the discovery of PDs more than 100 years ago, and 
our increasing recognition of their functional signifi -
cance, the underlying components and mechanisms 
of PD traffi cking remain poorly understood. Hence, 
we are taking an unbiased genetic strategy to dissect 
these molecular components and mechanisms, using a 
transgenic reporter system.
Ethylmethanesulfonate (EMS) mutagenesis screen-
ing using a “trichome rescue” system followed by 
 Illumina high-throughput sequencing identifi ed a mu-
tation in a gene encoding CCT8, a chaperonin sub-
unit. This led to an exciting discovery that chaperonin 
facilitates KN1 cell-to-cell traffi cking and stem-cell 
maintenance in Arabidopsis, which clearly supports 
the functional relevance of chaperonin-mediated traf-
fi cking through PDs. These results suggest that chap-
eronin dependency is a general mechanism for protein 
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traffi cking and highlight the importance of conforma-
tional changes for PD traffi cking. In addition to their 
traffi cking and stem-cell defects, cct8 mutants exhibit 
another striking phenotype in leaf polarity where the 
leaves are curled upward. An exciting possibility is that 
this could result from altered traffi cking of a leaf po-
larity signal. Alternatively, it could result from altered 
protein folding or misexpression of one or more polar-
ity regulators.
Current efforts are focused on understanding leaf 
polarity defects of cct8 mutants and on identifying 
new traffi cking regulators. Our efforts to detect ad-
ditional KN1 traffi cking regulators have resulted in 
identifying potential mutants with interesting devel-
opmental defects (Fig. 1). We will clone these addi-
tional mutants using next-generation sequencing. We 
have also initiated a new screening approach for traf-
fi cking mutant identifi cation. Here, we will be using 
the activation tagging approach to identify additional 
genes that regulate PD traffi cking.
Illuminating Maize Biology: Using 
Fluorescent Proteins for High-Throughput 
Analysis of Protein Localization and 
Function in Maize
Q. Wu, S. DeBlasio, A. Goldshmidt, T. Zadrozny 
[in collaboration with A. Chan, J. Craig Venter Institute; 
A. Sylvester, University of Wyoming]
Recent advances in sequencing technology have gen-
erated genome sequences from nearly all groups of 
organisms. These massive data sets have revolution-
ized the types of biological questions that can now 
be addressed. Despite the ability to predict the func-
tion of some proteins by comparative bioinformat-
ics, experimental validation remains necessary to as-
sign function defi nitively. One effective approach to 
validate gene function is to develop visualization and 
biochemical tools associated with fl uorescent protein 
(FP) technology.
FP technology is a powerful tool that can be used 
to noninvasively mark protein expression and localiza-
tion to study various subcellular processes in vivo. We 
have successfully optimized this technology for maize 
and have created a public resource of cellular biomark-
ers that we and other members of the plant commu-
nity use for both small-scale analysis of individual 
genes and global expression and functional profi ling. 
To date, we have generated more than 100 stable, na-
tively expressed, maize FP fusion lines that highlight 
most subcellular compartments, and these lines have 
allowed us to study various cellular pathways includ-
ing hormone signaling, cytoskeletal behavior, vesicle 
traffi cking, and stem-cell maintenance and differen-
tiation. We are also using these lines to immunopre-
cipitate tagged proteins to identify previously unchar-
acterized components of these important pathways. 
In the case of FP-tagged transcriptional regulators, 
chromatin immunoprecipitation (ChIP) is being used 
to identify putative DNA-binding sites and/or to con-
fi rm gene targets that have been detected by transcrip-
tional profi ling of the respective mutant.
To study maize development on a broader scale, 
we are optimizing the LhG4 two-component trans-
activation expression system for use in maize. This 
system relies on the transcription factor LhG4 being 
expressed by a cell- or tissue-specifi c promoter to 
drive the expression of a reporter in trans, via its 
pOp-binding sites. The reporter can be any gene, 
such as GUS, FPs, an FP fusion protein, a gene of 
interest for tissue-specifi c expression, a silencing 
construct for transcriptional knockdowns, or a gene 
encoding a toxin for tissue ablation experiments. 
We have already generated several constitutive, 
meristem- and leaf-specifi c promoter LhG4 drivers, 
Figure 1. Trafﬁ cking mutants with interesting developmental phenotypes. 
(Inset) Close-up of the short apex, showing the enlarged meristem.
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including pUBIQUITIN, pRAMOSA3, pWUSCHEL, 
and pYABBY14, as well as a pOp responder line, pOp-
FT, as a means to test the specifi city of the system 
with a readout in fl owering time. We are now work-
ing to create additional vascular-, root-, and embryo-
specifi c LhG4 driver lines and other responder lines. 
Our goal is to produce an array of cell- and tissue-
specifi c LhG4 lines, which we will use to (1) isolate 
specifi c cell types by FACS (fl uorescence-activated 
cell sorting) for transcriptional profi ling and (2) 
drive the misexpression of developmentally regulated 
genes in order to better understand the changes that 
occur within stem-cell niches during differentiation 
and development. Data on the characterization of 
our FP and LhG4 transgenic lines, including con-
focal micrographs, movies, and recent publications, 
can be found on our website: http://maize.jcvi.org/
cellgenomics/index.php.
Control of Shoot Meristem Size and 
Phyllotaxy by the Maize Glutaredoxin 
Abphyl2
F. Yang, M. Pautler [in collaboration with V. Llaca, DuPont 
Crop Genetics, Wilmington, Delaware; R. Johnston, 
Cornell University, Ithaca, New York; B. Ha Lee, Sogang 
University, Korea; H. Sakai, DuPont Crop Genetics, 
Wilmington, Delaware]
Phyllotaxy is a major taxonomic indicator and affects 
plant architecture and light capture effi ciency. Auxin 
and its polar transport through PINFORMED1 
(PIN1) proteins are crucial for controlling phyllotac-
tic patterns. Recently, our studies on ABPH1 in maize 
have shown that cytokinin hormone signaling, as well 
as its cross-talk with auxin, has an important role in 
this process. abphyl1 (abph1) mutants change maize 
phyllotaxy from alternate to decussate and develop 
an enlarged shoot apical meristem (SAM). Here, a 
similar phyllotaxy mutant, Abph2, is described. Abph2 
is caused by a dominant mutation and also has an 
enlarged SAM and a decussate leaf pattern that be-
comes visible at leaf ~4−5 stage. Map-based cloning 
brought Abph2 into a region of ~20 kb on chromo-
some 7, containing fi ve predicted genes in the reference 
B73 genome. However, direct sequencing of the open 
reading frames of these fi ve genes, as well as their tran-
script level analysis by reverse transcriptase−polymerase 
chain reaction (RT-PCR), did not give any obvious 
clues as to the identity of the Abph2 gene. Therefore, 
a bacterial artifi cial chromosome (BAC) library gen-
erated from the Abph2 mutant was screened using 
probes located within the 20-kb mapping interval. 
BAC sequencing revealed a 4.5-kb fragment inserted 
into the 20-kb mapping interval. This inserted frag-
ment contained a predicted glutaredoxin gene identical 
to a gene (named Msca1) located ~800 kb upstream. A 
transgenic line containing this 4.5-kb fragment fused 
with yellow fl uorescent protein (YFP) tag phenocopied 
the dominant Abph2 phyllotaxy defect, demonstrat-
ing that the inserted glutaredoxin gene (named Abph2 
thereafter) is the cause of the decussate leaf phenotype. 
Meanwhile, putative knockout lines of the dominant 
Abph2 mutation were screened by EMS mutagenesis. 
Sequencing the Abph2 gene in these knockout lines 
found two point mutations, leading to conserved 
amino acid changes in each line, further supporting 
that the inserted glutaredoxin gene is Abph2.
RNA in situ hybridization indicated that the Abph2 
transcripts accumulate in P0 leaf primordia and vascu-
lature. However, this expression pattern was unaltered 
in Abph2 mutants. More careful investigation showed 
that Abph2 transcripts start to accumulate in embryos 
from 12 days after pollination (DAP), but we detected 
a misexpression of Abph2 at 18 DAP when approxi-
mately four leaves have been initiated. In Abph2 mu-
tant embryos, the Abph2 transcripts were detected in 
the entire meristem, compared to a P0-localized ex-
pression pattern seen in wild type. This altered expres-
sion pattern likely explains the altered phenotype in 
the mutant.
The Abph2 gene is identical to Msca1. Loss-of-
function mutation in Msca1 leads to male sterility 
but a normal phyllotaxy. A detailed meristem size 
comparison revealed a signifi cant decrease in msca1 
mutants. This fi nding demonstrates that Msca1 pro-
motes meristem growth. Abph2/Msca1 encodes a CC-
type glutaredoxin protein, similar to the Arabidopsis 
ROXY1 and 2 genes. Recently, ROXY1 and 2 were 
found to interact with basic leucine zipper (bZIP) 
transcription factors, including PERIANTHIA 
(PAN), which is related to FASCIATED EAR4 
(FEA4) recently cloned in our lab. Loss of FEA4 
function results in a larger meristem, as well as al-
tered phyllotaxy, similar to Abph2. Using yeast two-
hybrid and bimolecular fl uorescence complementa-
tion (BiFC) assays, we confi rmed that ABPH2 and 
FEA4 interact, and msca1 fea4 double-mutant analy-
sis showed a synergistic interaction. These fi ndings 
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suggest that these genes may defi ne a new pathway in 
meristem proliferation control.
The Regulation of Meristem Size in Maize
B. Il Je, M. Pautler, P. Bommert, Q. Wu, A. Eveland 
[in collaboration with M. Komatsu and H. Sakai, 
Dupont Crop Genetics]
All plant organs derive from populations of stem cells 
called meristems. These stem cells have two pur-
poses: to divide to replace themselves and to give rise 
to daughter cells, which will differentiate into lateral 
organs. Consequently, plant meristems must precisely 
control the size of the stem-cell niche via a network of 
positive and negative feedback signals. A loss of func-
tion in a negative regulator of stem-cell fate can result 
in an enlarged or fasciated meristem phenotype and 
a dramatic alteration in the morphology of the maize 
ear and tassel.
Maize is an excellent genetic model system because 
of a large collection of developmental mutants and a 
sequenced reference genome. Our lab has undertaken 
a forward genetic approach to identify key regulators 
of stem-cell homeostasis and meristem size. Two pre-
viously cloned mutants, fasciated ear2 and thick-tassel 
dwarf1, encode orthologs of the Arabidopsis thaliana 
genes CLAVATA1 and CLAVATA2, indicating the 
well-known CLAVATA-WUSCHEL regulatory feed-
back loop is conserved from dicots to monocots. Work 
published this year has shown that natural variation in 
FEA2 can enhance maize seed yield traits. However, 
little else is known about the control of this important 
developmental process in maize. Here, we describe 
our progress in identifying additional genes contrib-
uting to stem-cell niche homeostasis.
Plant growth and development depend on the bal-
ancing of meristem proliferation that is controlled by a 
negative feedback loop between the CLAVATA path-
way and the WUSCHEL homeobox gene. CLAVATA 
signaling involves a secreted peptide, CLAVATA3 
(CLV3), and its perception by cell surface leucine-rich 
repeat (LRR) receptors, including the CLV1 recep-
tor kinase and an LRR receptor-like protein, CLV2. 
However, the signaling mechanisms operating down-
stream from these receptors are not fully understood, 
especially for the LRR receptor-like proteins, which 
lack an intracellular signaling domain. Here, we de-
scribe our progress in understanding the downstream 
signal of the CLAVATA pathway by characterizing 
COMPACT PLANT2 (CT2).
ct2 is a classical mutant of maize that exhibits a 
fasciated infl orescence phenotype as well as semi-
dwarfi sm. ct2 mutants have a range of phenotypes, 
including a semidwarf stature and shorter and wider 
leaves. The mutants also show striking infl ores-
cence defects, including strongly fasciated ears. Via 
a map-based cloning approach, we discovered ct2 to 
encode the α subunit of a heterotrimeric GTPase, a 
membrane-associated protein involved in the trans-
duction of extracellular signals to induce specifi c cel-
lular responses by activating downstream effectors. 
We made a CT2 fusion with YFP driven by its en-
dogenous promoter, and see localization to plasma 
membrane. ct2 is epistatic to fea2 with respect to 
spikelet density, which correlates with meristem size, 
suggesting they act in a common pathway. In coim-
munoprecipitation experiments (Co-IPs), we found 
that FEA2 and CT2 interact, implicating hetero-
trimeric G-protein signaling in the CLAVATA sig-
naling pathway. To gain a better understanding of 
the cross-talk between G-protein signaling and the 
CLAVATA pathway, we are using fl uorescence reso-
nance energy transfer (FRET) and other biophysical 
methods to investigate the factors that affect signal 
transmission between FEA2 and CT2. The prelimi-
nary FRET data suggest that FEA2 and CT2 inter-
act with each other directly. This research introduces 
a new paradigm in G-protein signaling, because G 
proteins interact exclusively with seven-pass trans-
membrane receptors in mammals and fungi.
Another fasciated ear mutant that we recently 
cloned is fasciated ear 3 ( fea3). fea3 shows an over-
proliferation of the infl orescence meristem. We cloned 
this gene using map-based cloning, and the mutant 
results from the insertion of a partial retrotransposon 
into an exon of the FEA3 locus. We confi rmed this 
identity by isolation of new alleles of fea3 from an 
EMS-targeted mutagenesis. fea3 encodes a predicted 
LRR receptor-like protein related to fea2. In situ hy-
bridization and red fl uorescent protein (RFP)-tagged 
transgenic plants show that FEA3 is expressed in the 
organizing center of the shoot meristem, and it is also 
expressed in the root apical meristem. FEA3 protein is 
localized in the plasma membrane. To ask if FEA3 re-
sponds to a CLV3-related (CLE) peptide, we tested its 
sensitivity to different peptides. fea3 mutants showed 
reduced peptide sensitivity, but interestingly, they 
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responded to a different CLE peptide compared to 
FEA2. Double mutants of fea2/fea3 and td1/fea3 have 
additive and synergistic fasciated phenotypes (Fig. 2), 
indicating that they act in independent pathways that 
converge on the same downstream target to control 
meristem size. These results indicate that the function 
of FEA3 as a receptor protein is in a new pathway dis-
tinct from that of TD1 and FEA2.
Another mutant, fasciated ear4, is a semidwarfed 
maize mutant with fasciated ears and tassel (Fig. 3). 
These phenotypes are caused by enlarged vegetative 
and infl orescence meristems, which have lost control 
of the pathways normally regulating meristem size. 
We had previously mapped fea4 to a small region of 
chromosome 6 containing 30 genes. Sequencing of 
candidate genes in the reference allele revealed a bZIP 
transcription factor with an EMS-induced base transi-
tion causing a premature stop codon. Two additional 
alleles also contained mutations in the gene consistent 
with EMS mutagenesis. We subsequently obtained a 
series of transposon-induced mutant alleles through a 
collaboration with DuPont-Pioneer, confi rming that 
we have identifi ed a novel gene required for the con-
trol of meristem size in maize.
We have subsequently investigated the function of 
fea4 through several parallel approaches. We used in 
situ hybridization to determine the expression pat-
tern of fea4 during different stages of development. 
During vegetative development, fea4 is expressed in 
the peripheral zone of the SAM and is dramatically 
excluded from the stem-cell niche and the site of leaf 
initiation. This unique expression pattern suggests 
that fea4 does not act by directly infl uencing the stem 
cells in the central zone of the SAM, but rather by 
infl uencing the process of differentiation in the pe-
ripheral zone. We have generated transgenic plants 
expressing a translational fusion of YFP with FEA4 
under the control of the native promoter. These trans-
genic plants express the fusion protein in the nucleus 
of cells in the expected domain, closely matching 
the mRNA expression pattern (Fig. 3). These stable 
transgenic lines will be useful in the future for func-
tional genomics and proteomics experiments, such 
as ChIP-Seq and immunoprecipitation (IP)-mass 
spectrometry (MS). We have also obtained a global 
picture of transcriptional changes in the mutant by 
Illumina mRNA-sequencing and are beginning to 
follow up on downstream genes that may mediate 
fea4 action. Additional approaches include making 
double-mutant combinations between fea4 and other 
meristem regulation mutants. So far, these analyses 
have suggested that fea4 acts outside of the canonical 
meristem size regulation pathways, consistent with a 
role in buffering the balance between division and 
differentiation.
In addition, we are in the process of mapping ad-
ditional fasciated ear mutants from nontargeted EMS 
mutagenesis screens. Our current approach involves 
creating F2 mapping populations and rough mapping 
by bulked segregant analysis. We take advantage of 
the precise quantitative genotyping capability of the 
Sequenom MassArray system to look for areas of the 
genome that are linked to the phenotype. We have de-
termined rough positions for several of these mutants 
and are proceeding with fi ne mapping and molecular 
cloning.
Figure 3. (A) Scanning electron micrograph of a fasciated ear4 
ear primordium showing a massively fasciated inﬂ orescence 
meristem. (B) Confocal microscope image showing expression of 
YFP-FEA4 in the nucleus of cells in the inﬂ orescence meristem.
Figure 2. fea (mutant ears); fea2; fea3 double mutants are more 
severe than single mutants.
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Deﬁ ning the Regulatory Networks 
Controlling Inﬂ orescence Architecture 
in Maize
A.L. Eveland, A. Goldshmidt, M. Pautler, S. Hiraga 
[in collaboration with D. Ware, Cold Spring Harbor 
Laboratory; E. Vollbrecht, Iowa State University; 
K. Morohashi and E. Grotewold, The Ohio State University]
Infl orescences bear the fruits and grains that we eat, 
and thus understanding the genetic and regulatory 
basis for how these structures are formed has clear 
agronomic importance in determining yield. Infl ores-
cence architecture among cereal crops is diverse, yet 
characterized by a unique morphology, where fl owers 
are borne on short, determinate branches called spike-
lets. In maize, these spikelets are paired, an exclusive 
feature of the tribe Andropogoneae, which includes 
other important cereal and bioenergy crops. Varia-
tions in infl orescence branching patterns arise from 
position and developmental fate of differentiating 
stem-cell populations called meristems. The coordi-
nated actions of key developmental regulators, as well 
as genetic interactions between them, modulate meri-
stem initiation and determinacy during maize infl o-
rescence development. Our goal is to understand the 
mechanisms by which these regulators act to control 
infl orescence architecture, what other factors and/or 
biological processes are involved in this regulation, 
and how these regulatory networks coordinate devel-
opment in space and time. Infl orescence architecture 
in maize is largely determined by grass-specifi c meri-
stem types and, therefore, fi ndings from this work 
can be translated to other important cereal crops with 
comparable infl orescence architectures. The primary 
objective of this work is to improve our understanding 
of how infl orescence architecture is modulated at the 
molecular level so that we can identify control points 
for targeted improvement of important agronomic 
traits such as yield. We are using systems-level analy-
ses to elucidate the gene networks that control identity 
and determinacy of axillary meristems, which contrib-
ute to specifi c branching patterns found among grass 
infl orescences. Our approach integrates large-scale 
genomics datasets, such as gene expression profi les 
achieved by high-throughput RNA sequencing, with 
discrete morphological features in development. Here, 
we characterized the precise timing of developmental 
transitions at the molecular level in maize male and 
female infl orescences, tassel and ear, respectively, by 
associating spatiotemporal dynamics in gene expres-
sion with morphological changes resulting from ge-
netic perturbations in a pathway controlling branch-
ing. The latter includes loss-of-function mutants in 
three important regulators of the ramosa (ra) path-
way, which controls stem-cell fate and the decision 
to branch. Using a k-means clustering approach, we 
classifi ed genes with similar expression profi les during 
development into coexpression signatures and identi-
fi ed predominant signatures that coincided with key 
stages of infl orescence development (Fig. 4a). One 
Figure 4. Spatiotemporal expression signatures during maize inﬂ orescence development; arrows denote clusters 
enriched for ra1 modulated genes (a). RA1 and KN1 cotarget TFs (b), which show speciﬁ c coexpression signatures 
during development (c).
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particular signature was strongly enriched for genes 
that were altered in ra mutants and included many 
known determinacy factors previously shown to work 
together in other developmental contexts. Here, these 
determinacy factors were further coexpressed across 
ra mutant backgrounds in a developmentally depen-
dent manner, revealing a grass-specifi c module for 
spikelet pair meristem determinacy that also includ-
ed genes of unknown function, many of which were 
grass specifi c. The latter represent candidate genes for 
novel regulators of meristem determinacy. Functional 
characterization of these candidates is currently under 
way, including in situ hybridizations and analysis of 
loss-of-function mutant alleles and crossing these to 
ra mutants to reveal potential genetic interactions. To 
expand our coexpression network and gain insight 
into the mechanisms of gene regulation in the ramosa 
pathway, we identifi ed in vivo gene targets of the RA1 
transcription factor (TF) on a genome-wide scale using 
chromatin immunoprecipitation followed by high-
throughput sequencing (ChIP-Seq). We used trans-
genic ra1 mutant maize lines expressing RA1 tagged 
with either HA or YFP tags in two parallel experi-
ments to identify ~1000 high-confi dence target genes 
that were bound in both. Of these, about one-fourth 
showed altered expression in the ra1 background, sug-
gesting that they are modulated targets of RA1. We 
also showed that RA1 acts as both an activator and a 
repressor of gene expression, which is interesting given 
that it possesses two EAR repressor domains shown 
to confer repressive function. Strikingly, activated and 
repressed targets are exclusively coexpressed, suggest-
ing that the mechanism of RA1 action is dependent 
on spatiotemporal context. We further integrated 
ChIP-Seq data available for the KNOTTED1 (KN1) 
TF to determine whether RA1, which imposes deter-
minacy on spikelet pair meristems, and KN1, which 
maintains indeterminacy in all shoot meristems, share 
common targets. This revealed the potential for com-
binatorial binding for these two TFs at multiple loci in 
the maize genome, including 176 bound and modu-
lated targets. Targets shared between RA1 and KN1 
networks were enriched for TFs and suggest points of 
regulation that interface meristem maintenance and 
determinacy (Fig. 4b,c). We are further investigating 
potential regulatory motifs that are enriched within 
the binding sites of RA1 to resolve consensus TF 
binding sites for RA1 and/or cofactors that may be 
involved in regulation of its downstream targets. Be-
cause ra1 has been implicated as an important locus 
in the domestication of modern maize and is found 
only in Panicoid grasses, these data are being used 
in comparative analyses with other grasses to further 
understand RA1 function and the evolution of grass 
infl orescence architecture.
Control of Branching and Determinacy 
in Plant Shoots
Y.G. Wolfenson, S. Goldshmidt, L. Sahl, S. Vi, S. Hiraga
RAMOSA (RA) genes in maize function to impose 
determinacy on axillary meristem growth; conse-
quently, ra loss-of-function mutants (ra1, ra2, and 
ra3) have more highly branched infl orescences. RA1 
encodes a C2H2 putative transcription factor that 
appears to have had a key role in maize domestica-
tion and grass evolution. RA2 also encodes a puta-
tive transcription factor, a LOB domain protein, 
whereas RA3 encodes a predicted metabolic enzyme, 
a trehalose phosphate phosphatase. The disaccharide 
trehalose is not abundant in plant tissues and may 
have a regulatory role because it has been implicated 
in stress protection, control of sugar signaling, and 
regulation of photosynthetic rates. This is the fi rst 
indication that trehalose has a specifi c developmen-
tal function. RA3 is expressed in a localized domain 
at the base of axillary infl orescence meristems, and 
it localizes to nuclear and cytoplasmic compart-
ments, suggesting that its effect on development is 
not simply metabolic. Interestingly, genetic and mo-
lecular studies suggest that both RA2 and RA3 are 
required for proper RA1 expression and act upstream 
of RA1. All three genes are expressed in overlapping 
domains; RA2 is expressed in the axillary infl ores-
cence meristems themselves, whereas RA1 and RA3 
expression is only at the base of the axillary infl ores-
cence meristems, suggesting that they may control a 
mobile signal that regulates meristem determinacy. 
The RAMOSA (RA) genes therefore defi ne a bound-
ary domain that surrounds the developing branch 
meristem, rather than being deployed in the meri-
stem itself. These data support the hypothesis that 
RA genes may serve as mediators of signals, maybe 
a sugar signal, originated at the boundary domain 
and regulating determinacy. RA3 itself may have a 
transcriptional regulatory function, because it affects 
the expression of specifi c genes.
To fi nd specifi c genes that are differentially ex-
pressed in the RA-specifi c domain, we are using FACS 
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followed by mRNA-Seq. pWUSCHEL::RFP:NLS and 
pRA3::RFP:NLS reporter lines crossed to ra mutants 
are used for this purpose. The pWUSCHEL reporter 
is a marker for cells of the organizing center of the 
meristem. We expect that cell-specifi c profi ling will 
enable identifi cation of genes that act directly in the 
RAMOSA signaling pathway.
In another approach, we will use yeast one-hybrid 
analysis to identify transcription factors that regulate 
RA3 gene transcription. The RA3 promoter was cloned 
into a reporter vector and integrated into the yeast ge-
nome. This strain provides a host for library screening. 
A cDNA library of DNA-binding proteins, which are 
expressed as fusions to the yeast GAL4 transcription 
activation domain (GAL4 AD prey proteins), will 
then be screened, in collaboration with Lifang Zhang 
(Ware lab). After screening, further analysis of identi-
fi ed transcription factors will be done in order to learn 
more about their role in determinacy. Furthermore, 
testing whether RA3 gene transcription is affected by 
other factors, such as sugars, could be done in the yeast 
reporter system. These studies will therefore contrib-
ute additional information about RAMOSA-mediated 
determinacy pathways.
The Arabidopsis thaliana genome contains a family 
of 10 genes related to RA3. Null mutants of all AtTPPs 
were tested, and the AtTPPI mutant was found to have 
an interesting phenotype that is connected to develop-
ment and determinacy. Its late-fl owering phenotype is 
accompanied by reduced size and shorter roots, as well 
as fusion of the cauline leaves to the main stem. In ad-
dition, double mutants with superman, an ra1 homo-
log, show increased indeterminacy, suggesting conser-
vation of this developmental module. A close paralog 
of AtTPPI, AtTPPJ, has a similar expression pattern. 
We identifi ed T-DNA insertions, and tppi;tppj double 
mutants show enhanced phenotypes, as well as defects 
in fl oral development, including additional and abnor-
mal sepals and petals (Fig. 5).
Additionally, we opted for genetic approaches to 
identify factors that act in the same pathway with 
RA3 to control spikelet pair meristem determinacy, 
by screening for enhancer/suppressor modifi ers of the 
ra3 phenotype. Typically, ra3 mutants in a B73 back-
ground have three to eight branches only at the base of 
the ear. We mutagenized ra3 mutants and looked for 
plants that have more branches and/or have branches 
at the upper part of the ear. So far, we have identifi ed 
several enhancers (Fig. 6) and are in the process of 
making mapping populations and mapping by bulk 
segregant analysis.
Natural Variation and Inﬂ orescence 
Architectures
S. Vi, S. Goldshmidt, P. Bommert
Maize infl orescence architectures have been a target 
for extensive selection by breeders since maize domes-
tication, hence different maize inbreds vary greatly in 
these particular traits. The genetic basis underlying 
this diversity is largely unknown and is of great inter-
est for both fundamental and applied science. Now 
with the wealth of genomic data, we are equipped to 
study them. To identify natural variation relevant to 
infl orescence traits, we looked for inbred backgrounds 
Figure 5. Floral defects in tpp mutants.
Figure 6. Modiﬁ ers of ramosa3 branching phenotype. Note the 
differences in the number of branches on ears of the modiﬁ ers.
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that can enhance/suppress the phenotypes of the mu-
tants on which we work. We focused on the 25 NAM 
(nested association mapping) founder inbreds because 
they were selected to capture the diversity of maize 
germplasm and because of the genetic tools available 
for these inbreds. We have crossed these 25 inbreds to 
our collection of mutants (often in B73 background) 
and screened the F2 for plants with suppressed/en-
hanced phenotype compared to the mutant in the 
original inbred background.
So far, we have identifi ed a suppressor of ramosa3 
(ra3) coming from the Mo17 inbred and an enhanc-
er coming from the Ki11 inbred (Fig. 6), as well as 
an enhancer of fea2 coming from the NC350 inbred. 
Segregation ratios suggest one semidominant locus for 
the Mo17- derived suppressor, two or more loci for the 
Ki11- derived enhancer, and one recessive locus for the 
NC350- derived enhancer. We are now in the process of 
rough mapping by bulked segregant analysis in F2 pop-
ulations. Additionally, because the natural modifi ers are 
often the result of quantitative trait loci (QTL) rather 
than single-gene effects, we also plan to cross the mu-
tants to the corresponding NAM-founder/B73 RILs, in 
order to identify and map potential modifying QTL.
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PLANT DEVELOPMENTAL BIOLOGY, STEM CELLS, AND FLORAL 
BRANCHING SYSTEMS
Z. Lippman K. Jiang C. MacAlister S. Thomain
 K. Liberatore S. Park 
In plants, self-maintained populations of undiffer-
entiated cells called shoot apical meristems (SAMs) 
produce all above-ground organs and guide overall 
morphology. The basic structure of a fl owering plant 
can be reduced to two phases of meristem growth: 
the vegetative phase and the reproductive phase. Ini-
tial SAM growth following germination produces 
a shoot with leaves and lateral (axillary) meristems, 
which form in the axils of leaves. Axillary meristems 
can themselves give rise to shoots, leaves, and addi-
tional leaf-producing axillary meristems. The SAM 
then gradually enters the reproductive phase by tran-
sitioning to an infl orescence meristem (IM), which 
initiates fl owers and axillary meristems that can 
 either produce additional fl ower-producing axillary 
meristems or immediately become fl owers.
Although useful for understanding basic principles 
of meristem activity and potential, this simplifi ed 
framework fails to explain the vast architectural diver-
sity in the plant kingdom, especially the remarkable 
variation in the number and arrangement of branches. 
This is because branching variation traces back dif-
ferences in meristem production, growth, and size. In 
other words, when and where meristems form, wheth-
er they begin growing immediately or experience dor-
mancy, how long they grow, how large they become, 
and the number of additional meristems they generate 
all depend on plant-specifi c sensitivities to the envi-
ronment and differential regulation of physiological 
and genetic programs.
Our research aims to expose and understand the ge-
netic and molecular mechanisms guiding branching, 
especially within infl orescences, which are responsible 
for plant reproductive success. For reasons outlined 
below, we use tomato as a model system to address the 
hypothesis that the rate at which meristems transition to 
a reproductive state (meristem maturation), along with 
meristem size, is responsible for evolutionary differences 
in infl orescence architecture and fl ower production and 
provides a foundation for improving crop yields.
Origins of Tomato Plant Architecture
Although a generic protein hormone called fl origen 
is responsible for fl owering induction in all angio-
sperms, the reproductive transition causes the SAM 
to gradually change fate over time, and the impact of 
this “meristem maturation” on shoot branching dif-
fers dramatically between different plants. One of 
the most poorly understood differences in meristem 
behavior following the reproductive transition in-
volves “monopodial” versus “sympodial” growth. In 
monopodial plants such as Arabidopsis and maize, the 
infl orescence meristem continues to grow apically fol-
lowing the reproductive transition, and most axillary 
meristems soon become fl owers. In contrast, in sym-
podial plants such as tomato and related nightshades 
(Solanaceae), meristems end growth by forming a ter-
minal fl ower, but not before new axillary meristems 
are initiated that themselves undergo reproductive 
transitions and fl oral termination.
This meristem initiation and termination of sym-
podial plants results in compound shoots derived 
from distinct types of meristems (Fig. 1). In tomato, 
the primary shoot meristem (PSM) from the embryo 
produces 7–12 leaves before switching to reproduc-
tive growth. The PSM then gradually enlarges until it 
ends growth by differentiating into the fi rst fl ower of 
the primary infl orescence. At the base of this fl ower, 
an axillary meristem initiates and quickly transitions 
into a fl ower itself, but not before giving rise to a new 
axillary meristem at its base. These “sympodial in-
fl orescence meristems” (SIMs) undergo rapid reitera-
tion and termination to form a zigzag infl orescence 
of several fl owers. Vegetative growth then continues 
from the axillary meristem in the axil of the last PSM 
leaf. This “sympodial vegetative meristem” (SYM) 
generates three leaves before transitioning to the fi rst 
fl ower of the next infl orescence. A new SYM then 
forms in the axil of the last leaf produced by the pre-
vious SYM, and this process reiterates to produce a 
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compound vegetative shoot. Axillary meristems host-
ed by lower leaves produce primary, sympodial, and 
axillary meristems in turn. Thus, tomato undergoes 
multiple fl owering transitions throughout life to pro-
duce many multifl owered infl orescences. However, 
infl orescence structure varies considerably in related 
Solanaceae. For example, pepper and petunia produce 
only a single IM per reproductive transition, resulting 
in single-fl owered infl orescences; however, in many 
Solanaceous trees, IMs proliferate to generate dozens 
of branches and hundreds of fl owers.
Meristem Maturation Drives Inﬂ orescence 
Diversity in Tomato and Related 
Nightshades
C. MacAlister, S.J. Park, K. Jiang
The basis for the remarkable range of infl orescence 
complexity in the Solanaceae family remains poorly 
understood; however, we previously showed that 
mutations in the homeobox transcription factor 
gene COMPOUND INFLORESCENCE (S) and the 
fl oral specifi cation complex encoded by the F-box gene 
 ANANTHA (AN) and its transcription factor partner 
FALSIFLORA (FA) cause highly branched infl ores-
cences by delaying (s mutants) or blocking (an and 
fa mutants) fl ower formation. We have now explored 
the basis for simple infl orescences like those of pepper 
and petunia by studying a unique and previously un-
characterized tomato mutant called terminating fl ower 
(tmf ), whose primary infl orescence is composed of a 
single fl ower.
Mutants of tomato have been described that cause 
infl orescences to become highly branched (e.g., s), but 
tmf is the only known mutant that produces a single-
fl ower infl orescence. We identifi ed the TMF gene by 
positional cloning using tools from our sequencing 
of the wild tomato species, S. pimpinellifolium (Sato 
et al. 2012), and found that it encodes a small tran-
scriptional cofactor that functions to prevent the SAM 
from precociously differentiating into a fl ower during 
the vegetative phase of growth. TMF is expressed 
most when the meristem is in the vegetative phase 
and is dramatically down-regulated in reproductive 
meristems to promote fl ower formation. We fi nd that 
TMF functions independently of the fl origen pathway 
and maintains vegetative identity by repressing preco-
cious activation of the highly conserved AN-FA fl ower 
specifi cation complex. Thus, TMF defi nes a previous-
ly unknown step in the fl owering process that allows 
precise synchronization of a gradual fl origen-guided 
fl owering transition with fl ower formation. Indeed, 
by driving AN expression precociously, we can trans-
form all multifl owered infl orescences of tomato into 
solitary fl owers, recreating the shoot organization and 
infl orescence architectures of tomato relatives such as 
pepper, petunia, and tobacco. Thus, by timing AN ac-
tivation, TMF synchronizes fl ower formation with the 
gradual reproductive transition, which, in turn, has a 
key role in determining simple versus complex infl o-
rescences (MacAlister et al. 2012).
Inﬂ orescence Architecture and the Control 
of Meristem Size
K. Liberatore, C. MacAlister
Even within domesticated tomato, infl orescence ar-
chitecture varies dramatically from a single zigzag 
branch of fl owers to dozens of branches with hundreds 
of fl owers. Most branching traces back to mutations 
Figure 1. Tomato plant architecture. (A) Tomato plant and meri-
stems. (B) Diagram of tomato shoot growth. Meristems terminate 
in ﬂ owers, and growth continues from specialized axillary (sym-
podial) meristems. (Ovals) Leaves; (arrows) side shoots. (C–E) 
Sequential meristem images (C,D) and inﬂ orescence (E) show-
ing zigzag reiteration of SIMs. White dot indicates SYM. Bars, 
200 μm.
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in the S gene, but there are also varieties with weaker 
branching that trace back to an increase in meristem 
size, referred to as “fasciation.” Meristem size is tightly 
controlled through a process of “meristem mainte-
nance,” which continuously replenishes stem cells lost 
to lateral organ formation, and thus, the control of 
meristem size is a major developmental program regu-
lating infl orescence branching.
A deep understanding of meristem maintenance 
in plants has developed from analysis of Arabidopsis 
fasciated mutants that exhibit thickened and fused 
stems, increased fl ower and fl oral organ number, and 
larger seed pods. Most knowledge comes from de-
tailed analyses of three clavata (clv) mutants and their 
underlying genes: CLV1, 2, and 3. Our lab recently 
identifi ed the genes responsible for two fasciated mu-
tants, fasciated and branched (fab) and fasciated infl o-
rescence (fi n), which produce mildly branched infl o-
rescences and fasciated fl owers and fruits (Fig. 2). fab 
was found to be defective in the ortholog of the clas-
sical membrane receptor kinase CLAVATA1 (CLV1), 
providing the fi rst functional link to the CLV pathway 
in tomato. Interestingly, however, fi n was found to be 
defective in a gene of unknown function encoding a 
putative transmembrane protein, suggesting that it 
may act as a receptor or as a cofactor in a receptor 
complex. Tellingly, fab;fi n double mutants show re-
markable synergism, developing extremely enlarged 
meristems that rarely produce infl orescences, and the 
few fl owers that do form give rise to extremely large 
fruits lacking seeds. This synergism suggests that the 
FIN gene acts in a separate pathway parallel to the 
CLV pathway. The discovery of FIN has raised many 
unanswered questions regarding the control of meri-
stem size in sympodial plants. For example, to what 
extent are meristem maintenance mechanisms shared 
or different between monopodial and sympodial 
plants? Do the relevant genes and pathways vary for 
different types of meristems? Can changes in meri-
stem size affect infl orescence branching and fl ower 
production? On the basis of our early fi ndings, it is 
our expectation that the CLV pathway is not the main 
mechanism controlling meristem size in tomato and 
related sympodial plants, and we are currently per-
forming deeper genetic and molecular analyses to bet-
ter understand the functions of FIN relative to FAB.
A Role for FIN Genes in Pollen Tube 
Development
C. MacAlister
FIN encodes an unknown protein of 373 amino acids 
with a predicted amino-terminal signal peptide and a 
transmembrane domain. FIN is a member of a deeply 
conserved plant-specifi c gene family (one to six mem-
bers in all species), including four members in Arabi-
dopsis. Given the vast genetic resources in Arabidop-
sis, we asked whether an analysis of the four FIN-like 
(FINL) genes might facilitate and expedite our studies 
in tomato. By analyzing insertion lines disrupting the 
expression of the three FIN-like family members in 
Arabidopsis, we have found that fi nl1;fi nl2 double mu-
tants are pollen-sterile. Although double-mutant pol-
len is produced and is capable of germination and tube 
elongation on the stigma and style, growth quickly 
becomes disorganized, tube growth arrests upon en-
tering the ovary, and ovules are not targeted for fertil-
ization (Fig. 3). Two proteomics screens in Arabidopsis 
have identifi ed FINL2 as a component of the plasma 
membrane, and our fl uorescent reporters confi rm an 
association with membrane compartments in the cell. 
Curiously, a large-scale interaction screen has revealed 
a physical interaction between FINL2 and two plant 
glutamate-like receptors (GLRs). Plant GLRs are ho-
mologs of mammalian ionotropic glutamate receptors 
(iGluRs) that function in calcium fl ux and neuronal 
signaling. Excitingly, recent work has identifi ed Ara-
bidopsis GLRs as important regulators of the calcium 
fl ux necessary for pollen tube growth, providing a 
link to our fi nl pollen defects. We are now working 
Figure 2. ﬁ n mutants have enlarged meristems. (A,B) Scanning 
electron micrographs of wild-type (WT) (A) and ﬁ n (B) meri-
stems of the same magniﬁ cation. (C) Enhanced fruit size in ﬁ n.
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to characterize the role of FINLs and their interaction 
with GLRs in pollen tube growth and guidance. Be-
cause a relationship between meristem maintenance 
and pollen tube development has never been report-
ed, our studies of the FIN gene family across systems 
should provide new knowledge that unites these seem-
ingly disparate sporophytic and gametophytic devel-
opmental pathways under a common novel mecha-
nism with dual impacts on reproductive growth.
Single-Gene Heterosis, Flowering, and 
Tomato Yield
K. Jiang, S.J. Park
By demands of modern agriculture, “determinate” 
 tomato varieties have been developed with increased 
infl orescence, fl ower, and fruit production from a 
more compact, bushy plant. This determinacy is 
based on a mutation in a major fl owering gene known 
as SELF PRUNING (SP), which normally functions 
to repress fl owering in opposition to the fl origen hor-
mone. Interestingly, we previously exposed a remark-
able example of single-gene heterosis in tomato that 
increased yield up to 60% from having only one func-
tional copy of the fl origen gene, SINGLE FLOWER 
TRUSS (SFT ), in the sp mutant background (Park 
et al. 2012). The resulting semideterminate plants 
generate more infl orescences, fl owers, and fruits, 
and we hypothesized that these yield improvements 
stemmed from a dose-dependent suppression of sp-
imposed determinacy.
To test this hypothesis, we profi led gene expression 
dynamics by RNA-Seq from developing meristems at 
precise stages of meristem maturation from wild-type, 
sft mutants, and sft/+ heterozygous plants. Using our 
previously established meristem maturation clock, we 
found that sft/+ heterozygous plants exhibit a clear 
semidominant molecular dosage effect in the SAM 
just after germination, resulting in an intermediate rate 
of meristem maturation between wild-type and sft ho-
mozygous mutants. Likewise, sympodial meristems of 
sft/+ heterozygotes experience a dose-dependent delay 
in maturation, indicating that an sft-induced dosage 
effect is sensed in all sympodial shoots, enabling a few 
more sympodial shoots and infl orescences to form 
prior to sp -imposed determinacy. These fi ndings sug-
gest that having only one functional copy of fl origen 
weakly represses meristem termination in a semidomi-
nant manner in the primary and subsequent sympodi-
al and axillary shoots, translating to cumulative yield 
overdominance for fl ower and fruit production. The 
critical role of sympodial growth in fl origen-mediat-
ed single-gene heterosis was illustrated by a parallel 
experiment in Arabidopsis, a monopodial plant hav-
ing only a single fl owering transition. In Arabidopsis 
ft/+;tfl 1 plants (the equivalent of tomato sft/+;sp), we 
observed semidominant maturation of shoot growth 
similar to that of tomato; however, this dosage effect 
failed to translate into cumulative heterosis, because 
Figure 3. ﬁ nl1;2 double-mutant pollen fails to target ovules. (A) ﬁ nl1 single-mutant pollen tubes stained dark 7 h after 
pollination (7hap). At this advanced time point, wild-type tubes have grown all the way down the fruit. Arrowhead 
marks a pollen tube leaving the transmitting tract to target an ovule. (B,C) ﬁ nl1;2 double-mutant pollen 7hap. Growth 
ends in a disorganized mass of tubes that do not progress down the transmitting tract of the style and fail to target 
ovules.
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there is only one fl owering event that can sense the 
change in fl origen dosage compared to the multiple 
sympodial fl owering transitions in tomato. Our cross-
species fi ndings provide a framework for further ex-
ploration of single-gene overdominance in which 
localized dosage effects of highly pleiotropic growth 
factors such as fl origen gradually progress into global 
transgressive effects.
On the basis of the fi nding that suppressing sp with 
fl owering mutations such as sft can improve yield 
through mutant heterozygosity, we have character-
ized new fl owering mutants that suppress sp. Impor-
tantly, these mutants also produce a semideterminate 
growth habit with more infl orescences and fl owers 
like sft/+ heterozygosity. Two of these suppressor of sp 
(ssp) mutants have been found to result from defects 
in a transcription factor that physically interacts with 
fl origen in the SAM to induce fl owering. A third 
mutant was found to be a new weak allele of SFT, 
which leads to a plant that is only mildly late fl ower-
ing, causes reversion to a typical three-leaf sympo-
dial growth structure, and increases fl ower and fruit 
production in each infl orescence. On the basis of the 
principle that heterosis can be caused by heterozygous 
mutations in fl owering genes, our ssp mutants provide 
a new set of tools to create semideterminate tomato 
varieties that can boost yield both in the fi eld and 
under greenhouse conditions. In addition to mixing 
and matching our mutants in different homozygous 
and heterozygous combinations to generate novel 
shoot architectures not found in existing breeding 
germplasm, we are also exploring the molecular basis 
for SSP-induced semideterminacy by profi ling gene 
expression dynamics of each new mutant by RNA-
Seq during meristem maturation. Early results sug-
gest that differences in the local balance of SP activity 
relative to both SFT and SSP are crucial for modu-
lating quantitative differences in determinacy among 
different types of tomato meristems. Future work will 
focus on investigating the potential breeding value of 
all tomato fl owering mutants in diverse commercial 
tomato types.
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EPIGENETIC INHERITANCE AND REPROGRAMMING 
IN PLANTS AND FISSION YEAST
R. Martienssen J. Calarco A. Hocher J. Ren
 S. Castel Y. Jacob B. Roche
 A.-Y. Chang H.S. Kim A. Schorn
 K. Creasey C. LeBlanc A. Shimada
 F. DeSousa Borges S.C. Lee J. Simorowski
 M. Donoghue A. Molla-Morales C. Tang
 E. Ernst A.C. Pastor U. Umamaheswari
 P. Finigan U. Ramu C. Underwood
 J.-J. Han M. Regulski F. Van Ex
Plants and fi ssion yeast provide excellent model or-
ganisms to address the question of how epigenetic 
information is propagated to daughter cells, includ-
ing transposon regulation, heterochromatic silenc-
ing, and gene imprinting, important both for plant 
breeding and for human health. We are investigating 
the role of RNA interference (RNAi) in the inheri-
tance of heterochromatic silencing in the fi ssion yeast 
Schizosaccharomyces pombe and in the plant Arabi-
dopsis thaliana, as well as continuing our work on 
Zea mays. In fi ssion yeast, we have found additional 
evidence that DNA replication promotes spreading 
of heterochromatin and that RNAi promotes repli-
cation by releasing RNA polymerase II (RNA pol 
II). In plants, we have found that the genome under-
goes reprogramming of DNA methylation in pollen 
guided by DNA glycosylases and small RNA. Our 
results suggest a model for imprinting, transposon 
control, and the origin of epialleles. In plant genom-
ics, we have completed the methylome of maize, and 
demonstrated its impact on epigenetic inheritance 
and gene expression. We have also identifi ed the 
gene rearrangement underlying the classical mutant 
of maize, Tunicate 1, which has been the subject of 
controversy in connection with the origin of corn. 
We continue to develop duckweeds as a source of 
biofuel and have characterized the genome of Lemna 
gibba as well as genes involved in lipid accumula-
tion. This year, we said good-bye to Chunlao Tang, 
Patrick Finigan, and Antoine Hocher. We welcomed 
visiting fellow Atsushi Shimada, postdocs Hyun-Soo 
Kim, Filipe Borges, and Seung-Cho Lee, and master’s 
student Alex Canto Pastor.
RNAi Promotes Heterochromatic 
Silencing and Spreading through 
Transcription, Replication, and Repair
J. Ren, S. Castel, H.-S. Kim, A.-Y. Chang, B. Roche [in 
collaboration with B. Arcangioli, Institut Pasteur, Paris, 
France; Z. Cande, University of California, Berkeley]
Heterochromatin comprises tightly compacted re-
petitive regions of eukaryotic chromosomes and has 
widespread roles in chromosome integrity, stability, 
and silencing. The inheritance of heterochromatin 
requires RNAi, which guides histone modifi cation 
during the DNA replication phase of the cell cycle. 
However, the underlying mechanism is poorly un-
derstood. In S. pombe, the alternating arrangement 
of origins of replication and noncoding RNAs tran-
scribed during S phase in the heterochromatic peri-
centromeric region provokes the collision of RNA 
polymerase with replication machinery. We propose 
that it is resolved by cotranscriptional RNAi, allow-
ing replication to complete and couple the spread-
ing of heterochromatin with fork progression. In 
the absence of RNAi, stalled forks are repaired by 
homologous recombination without histone modi-
fi cation. The molecular basis of this model and its 
genome-wide impact will be further investigated 
and may explain the participation of RNAi and DNA 
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replication in heterochromatin inheritance in other 
systems.
Programmed Replication Fork Pauses Control 
Imprinting and Spreading in Fission Yeast
S. Castel [in collaboration with M. Zaratiegui, Rutgers 
University; B. Arcangioli, Institut Pasteur, Paris; S. Lambert, 
Institut Curie-CNRS, Orsay, France; Y. Shi, Harvard Medical 
School]
In the fi ssion yeast S. pombe, a chromosomal imprint-
ing event controls the asymmetric pattern of mating-
type switching. The orientation of DNA replication at 
the mating-type locus is instrumental in this process. 
However, the factors leading to imprinting are not 
fully identifi ed and the mechanism is poorly under-
stood. We have found that the replication fork pause 
at the mat1 locus (MPS1), essential for imprint forma-
tion, depends on the lysine-specifi c demethylase Lsd1. 
We have demonstrated that either Lsd1 or Lsd2 amine 
oxidase activity is required for these processes, work-
ing upstream of the imprinting factors Swi1 and Swi3 
(homologs of mammalian Timeless and Tipin, respec-
tively). We have also shown that the Lsd1/2 complex 
controls the replication fork terminators found within 
the rDNA repeats. These fi ndings reveal a role for the 
Lsd1/2 demethylases in controlling polar replication 
fork progression, imprint formation, and subsequent 
asymmetric cell divisions. Previously, we demonstrat-
ed that Lsd1 is localized at heterochromatin boundar-
ies and is required to prevent spreading of pericentro-
meric heterochromatin into the surrounding euchro-
matin. A role in replication fork pausing may account 
for this activity.
Reprogramming of DNA Methylation 
in Pollen Guides Epigenetic Inheritance 
via Small RNA
J.P. Calarco, F. Borges, M.T.A. Donoghue, F. Van Ex [in 
collaboration with J. Becker, J. Feijo Instituto Gulbenkian 
de Ciencia, Portugal; F. Berger, Temasek Life Sciences 
Laboratory, Singapore]
Epigenetic inheritance is more widespread in plants 
than in mammals, in part because mammals erase epi-
genetic information by germline reprogramming. We 
sequenced the methylome of three haploid cell types 
from developing pollen—the sperm cell, the vegetative 
cell, and their precursor, the postmeiotic microspore—
and found that unlike in mammals, the plant germ-
line retains CG and CHG DNA methylation. How-
ever, CHH methylation is lost from retrotransposons in 
microspores and sperm cells and restored by de novo 
DNA methyltransferase guided by 24-nucleotide small 
interfering RNA (siRNA), both in the vegetative nu-
cleus and in the embryo after fertilization. In the veg-
etative nucleus, CG methylation is lost from targets of 
DEMETER (DME), REPRESSOR OF SILENCING 
1 (ROS1), and their homologs. These targets include 
imprinted loci and recurrent epialleles that accumulate 
corresponding small RNA and are premethylated in 
sperm. Thus, genome reprogramming in pollen con-
tributes to epigenetic inheritance, transposon silencing, 
and imprinting, guided by small RNA.
Widespread Transposon Control by miRNAs 
and Epigenetically Activated Secondary 
siRNAs in the Absence of DNA Methylation
K.M. Creasey, J. Simorowski, U. Ramu, M. Regulski 
[in collaboration with J. Kendall, Cold Spring Harbor 
Laboratory; B. Meyers, University of Delaware; V. Colot, 
IBENS, Paris, France]
Transposons in Arabidopsis give rise to abundant 21-nu-
cleotide “epigenetically activated” small interfering 
RNAs (easiRNAs) in DECREASE IN DNA METH-
YLATION1 (ddm1) and DNA METHYLTRANSFER-
ASE1 (met1) mutants, as well as in pollen from wild-
type plants, in which heterochromatin is lost during 
reprogramming. easiRNA biogenesis is dependent on 
ARGONAUTE1 (AGO1), DICER-LIKE4 (DLC4), and 
RNA-DEPENDENT RNA POLYMERASE6 (RDR6 ), 
resembling 21-nucleotide trans-acting siRNAs (tasi-
RNAs) and other secondary siRNAs in this respect. 
However, specifi city of targeting has remained a mys-
tery. We have found that specifi city is provided by tar-
geted cleavage of thousands of transposon transcripts 
by at least 50 microRNAs (miRNAs), some of which 
are themselves encoded by transposons, but most of 
which are highly conserved with well-known roles in 
plant development. Interestingly, the loss of easiRNAs 
in ddm1 rdr6 is compensated by the gain of 24-nucle-
otide heterochromatic siRNAs (hetsiRNAs) and sub-
sequent restoration of DNA methylation. This suggests 
that RDR6-directed easiRNA production acts antago-
nistically to RDR2-directed hetsiRNA production, 
185-211_PlantGenete.indb   202 9/17/2013   8:11:42 AM
Plant Biology  203
thereby inhibiting RNA-directed DNA methylation 
(RdDM) and transcriptional gene silencing. Wide-
spread targeting of transposons may refl ect the evo-
lutionary origin of miRNA in genome surveillance.
Epigenetic Transposon Regulation 
in Response to Drought Stress
F. Van Ex, F. Borges, J. Calarco, A. Hocher, M. Donoghue
Both DNA methylation and histone modifi cations 
have been linked to drought stress response in dif-
ferent plant species. Recent work has also shown that 
heat stress can lead to the reactivation of previously si-
lent retrotransposons. However, little is known about 
the regulation of transposons after a prolonged expo-
sure to drought stress. The drought-related miRNA 
(miR845b) is conserved in monocots and dicots. 
Although miR845b is absent in normal leaf tissue in 
Arabidopsis, we have found that it is very abundant in 
sperm cells of pollen. Interestingly, target prediction 
of this miRNA reveals exclusively retrotransposons as 
putative targets. To assess whether miR845b actually 
regulates these transposons, we developed sensor lines 
consisting of a green fl uorescent protein (GFP) gene 
transcriptionally fused to the sequence of the predict-
ed transposon target. Consistent with the absence of 
miR845b, we were able to detect activity of the sen-
sor line in leaf tissue. In pollen, GFP expression was 
limited to the VN and pollen cytoplasm. No activity 
of the sensor was detected in sperm cells, where levels 
of miR845b are abundant. Our preliminary fi ndings 
through RNA-Seq analysis reveal a signifi cant up-reg-
ulation of a specifi c copia retrotransposon in drought-
stressed plants.
Epigenome Dynamics during the Cell Cycle 
in Arabidopsis and Maize
C. LeBlanc, C. Underwood, Y. Jacob [in collaboration 
with B. Thompson, G. Allen, and L. Hanley-Bowdoin, 
North Carolina State University]
Our aim is to understand how epigenetic marks are 
transmitted through DNA replication and cell divi-
sion in plants by analyzing the Arabidopsis DNA meth-
ylome during the cell cycle (G1, early S, mid S, late S 
and G2). To do this, genomic DNA extracted from 
nuclei by fl uorescence-activated cell sorting (FACS) was 
subjected to bisulfi te treatment and conversion and se-
quenced on the HiSeq platform. We are also studying 
transcriptional activity during the cell cycle via RNA 
polII binding. We have performed RNA polII chro-
matin immunoprecipitation sequencing (ChIP-Seq) 
with DNA extracted from maize root tips at different 
stages of the cell cycle. We are also generating RNA-
Seq libraries to analyze the maize transcriptome from 
different stages of the cell cycle in root tips. Finally, 
we are making histone H3K56ac ChIP-Seq libraries 
to determine whether this acetylation is enriched dur-
ing S phase in maize.
The Sperm Cell-Speciﬁ c Histone H3 
AtMGH3 Reprograms the Euchromatic 
Epigenome in the Male Germline 
of A. thaliana
Y. Jacob, C. LeBlanc
Large-scale reprogramming events in the germline 
of eukaryotes reset the epigenome before fertil-
ization and formation of the zygote. In the model 
plant A. thaliana, resetting of the epigenome in 
the male and female reproductive tissues has been 
shown to involve both changes in DNA methyla-
tion and histone exchange. We have analyzed the 
subgenomic deposition of the male-specifi c histone 
H3 AtMGH3/HTR10 (Fig. 1). AtMGH3 is expressed 
specifi cally in sperm cells during pollen development 
and is removed from the early embryo and the en-
dosperm after fertilization. Our results suggest that 
deposition of AtMGH3 in the male germline is con-
fi ned to the euchromatin. Disruption of heterochro-
matin in the ddm1 mutant leads to mislocalization 
of MGH3 and/or structural defects in the nucleus of 
sperm cells (Fig. 1). Taken together, our results sug-
gest that AtMGH3 reprograms euchromatin in the 
male germline and that DDM1 spatially controls the 
deposition of AtMGH3.
Pod Corn Is Caused by Rearrangement 
at the Tunicate1 Locus
J.-J. Han [in collaboration with D. Jackson, Cold Spring 
Harbor Laboratory]
Pod corn (Zea mays var tunicata) was once regarded 
as ancestral to cultivated maize, and it was prized by 
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pre-Columbian cultures for its magical properties. Tu-
nicate1 (Tu1) is a dominant pod corn mutation in which 
kernels are completely enclosed in leafl ike glumes. We 
have found that Tu1 encodes a MADS box transcrip-
tion factor normally expressed in leaves whose 5′ 
regulatory region is fused by a 1.8-Mb chromosomal 
inversion to the 3′ region of a gene expressed in the 
infl orescence. Both genes are further duplicated, 
accounting for classical derivative alleles isolated 
by recombination, and Tu1 transgenes interact with 
these derivative alleles in a dose-dependent manner. 
In young ear primordia, TU1 proteins are nuclearly 
localized in specifi c cells at the base of spikelet pair 
meristems. Tu1 branch determination defects resem-
ble those in ramosa mutants, which encode regulato-
ry proteins expressed in these same cells, accounting 
for synergism in double mutants discovered almost 
100 years ago. The Tu1 rearrangement is not found 
in ancestral teosinte and arose after domestication of 
maize.
The Maize Methylome Inﬂ uences mRNA 
Splice Sites and Reveals Widespread 
Paramutation-Like Switches Guided 
by Small RNA
M. Regulski [in collaboration with J. Kendall, D. Ware, and 
J. Hicks, Cold Spring Harbor Laboratory; A. Rafalski and 
S. Tingey, Dupont Pioneer, Wilmington, Delaware]
The maize genome, with its large complement of 
transposons and repeats, is a paradigm for the study 
of epigenetic mechanisms such as paramutation 
and imprinting. We have determined the genome-
wide map of cytosine methylation for two maize 
inbred lines, B73 and Mo17. CG (65%) and CHG 
(50%) methylation (where H = A, C, or T) is high-
est in transposons, whereas CHH (5%) methyla-
tion is guided by the 24-nucleotide siRNA, but not 
the 21-nucleotide siRNA. CG methylation in exons 
(8%) deters Mutator transposon insertion, whereas 
CHG methylation at splice acceptor sites appears to 
inhibit RNA splicing. Using the methylation map as 
a guide, we used low-coverage sequencing to show 
that parental methylation differences are inherited 
by recombinant inbred lines and infl uence gene ex-
pression. However, frequent methylation switches, 
guided by siRNA, persist for up to eight generations, 
suggesting that paramutation is much more common 
than previously supposed. The methylation map will 
provide an invaluable resource for epigenetic studies 
in maize.
Developing Lemnaceae (Duckweeds) 
as a Source of Hydrocarbon Biofuels
E. Ernst, S.-C. Lee, A. Molla-Morales, A. Pastor [in 
collaboration with D. Pappin, Cold Spring Harbor 
Laboratory; J. Shanklin and J. Schwender, Brookhaven 
National Laboratories; V. Citovsky, SUNY Stony Brook]
The aquatic monocotyledonous Lemnaceae are the 
fastest growing fl owering plants, capable of produc-
ing 64 grams of biomass per gram starting weight in a 
week. They offer an attractive alternative to corn and 
algae as biofuel feedstocks because of their low lignin 
content, robust growth in open ponds, and excellent 
metabolic characteristics. Lemnaceae are cultivated 
aquatically, typically on animal wastewater, and thus 
they do not contribute to resource competition for 
the growth of food crops. In overwintering or starved 
DAPI
DAPI
ddm1
Col
MGH3-GFP
MGH3-GFP
Figure 1.  A mutation in ddm1 disrupts the nuclear structure of 
sperm cells in Arabidopsis. We previously demonstrated that the 
chromatin remodeler DDM1 is strongly expressed in sperm cells 
of Arabidopsis pollen. Sperm cells from Col (wild-type) plants 
and ddm1 mutant pollen expressing fusions of the male germ 
cell histone H3 (MGH3) with green ﬂ uorescent protein (GFP) 
were visualized using high-resolution OMX microscopy and 
stained for DNA using DAPI (4′-6-diamidino-2-phenylindole). 
The GFP signal is associated with euchromatin in wild type, but 
it is redistributed in ddm1 mutants, along with DNA, to the pe-
riphery of the nucleus.
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Lemnaceae plants, starch accumulation is comparable 
to corn kernels, up to 60%–75% of dry weight. We 
propose to design new strains of Lemnaceae to divert a 
substantial portion of accumulated carbon from starch 
to oil and alkane metabolism, as these products pos-
sess an energy density approximately eightfold higher 
than that of starch. We have sequenced the genome of 
Lemna gibba, and a database of gene annotation and a 
genome browser are available (http://www.lemna.org). 
Duckweed species have been reported to contain lipid 
up to 9% of dry weight, but there is limited informa-
tion about composition of neutral lipids and enzymes 
responsible for their synthesis and degradation. We 
have characterized the proteome of lipid droplets in 
order to identify structural proteins and enzymes for 
synthesis and degradation of triacylglycerol in vegeta-
tive tissues of duckweeds. The composition of triacyl-
glycerol (TAG) was analyzed using liquid chromatog-
raphy–tandem mass spectrometry (LC-MS/MS) with 
isolated lipid droplets (LDs). We also tested whether 
environmental stresses increase expression of genes as-
sociated with TAG synthesis and LD production. We 
are currently developing methods to knock down ex-
pression of genes encoding enzymes involved in starch 
synthesis and TAG hydrolysis using artifi cial miRNA 
and transcriptome data.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans A. Benkovics A. Husbands K. Petsch
 M. Dotto M. Javelle E. Plavskin
 C. Fernandez-Marco M. Lodha D. Skopelitis
Specifi cation of adaxial–abaxial (upper/lower) polarity 
in the developing leaf drives the fl attened outgrowth of 
the leaf blade and directs the differentiation of distinct 
cell types within the leaf ’s adaxial/top and abaxial/ 
bottom domains. Both are important innovations in the 
evolution of land plants that maximize photosynthesis 
while minimizing water loss to the environment. In ad-
dition to being a key developmental process, adaxial–
abaxial patterning is of particular interest from a mech-
anistic point of view and has proven to be an excellent 
model to study small RNA-mediated gene regulation. 
We previously showed that patterning of this develop-
mental axis involves a cascade of opposing small RNAs, 
in which microRNA (miRNA) miR390 triggers the 
biogenesis of the TAS3-derived 21-nucleotide tasiR-
ARF on the adaxial side of developing leaves. These 
confi ne the accumulation of abaxial determinants, in-
cluding AUXIN RESPONSE FACTOR3 (ARF3) and 
miR166, to the lower side of leaves. miR166, in turn, 
demarcates the abaxial side by repressing expression 
of class III homeodomain leucine zipper (HD-ZIPIII) 
transcription factors that specify adaxial fate.
Importantly, our analysis of the TAS3 trans-acting 
short interfering RNA (tasiRNA) pathway in Arabi-
dopsis demonstrated that tasiR-ARF functions as a 
mobile positional signal in adaxial–abaxial pattern-
ing. Movement of this small RNA from its defi ned 
source of biogenesis in the two uppermost cell layers 
of leaves creates a gradient of accumulation that dis-
sipates abaxially. The tasiR-ARF gradient generates a 
sharply defi ned expression domain of the abaxial de-
terminant ARF3 on the bottom side of leaf primor-
dia, suggesting that small RNAs can establish pattern 
through a morphogen-like activity. This work provid-
ed the fi rst direct evidence that small RNAs are mo-
bile and can function as instructive signals in devel-
opment, thereby revealing a novel patterning activity 
of small RNAs. We are currently studying the role of 
this specifi c small RNA pathway and the properties of 
mobile small RNAs, in general, in maize, Arabidopsis, 
and the moss Physcomitrella patens.
Dissecting Small RNA Mobility in Plants
D. Skopelitis, C. Fernandez-Marco
Given the scope of miRNA-regulated gene networks, 
the cell-to-cell movement of small RNAs has impor-
tant implications with respect to their potential as 
instructive signals in development or in response to 
physiological and stress stimuli. We are using artifi -
cial miRNAs targeting easy-to-score reporter genes to 
study parameters of miRNA movement, such as tis-
sue specifi city, directionality, dose dependence, and 
the kinetics of movement. To investigate miRNA 
mobility in multiple distinct developmental contexts, 
we are expressing an artifi cial miRNA targeting a 
cell-autonomous green fl uorescent protein (GFP) 
reporter (miR-GFP) from a number of promoters 
with distinct spatiotemporal patterns of expression. 
Expression of miR-GFP from the epidermis-specifi c 
ATML1 promoter, mesophyll-specifi c RBCS pro-
moter, or vasculature companion cell-specifi c SUC2 
promoter showed that miRNAs move bidirectionally 
between all three cell layers and that the number of 
cells across which a small RNA moves is determined 
in part by its abundance. Moreover, analysis of GFP 
fl uorescence in the vasculature supports the idea that 
miRNA-mediated gene regulation is a dose-depen-
dent process and depends on the relative abundance 
of the miRNA versus the target mRNA. No GFP 
silencing was observed in the symplastically isolated 
stomata, suggesting that miRNA movement occurs 
via plasmodesmata, small channels that connect most 
plant cells.
Interestingly, production of miR-GFP in young 
leaf primordia surrounding the shoot apical meristem 
(SAM) resulted in silencing of GFP inside the SAM, 
demonstrating that miRNAs traffi c from determi-
nate organs into the shoot stem-cell niche. In addi-
tion, miR-GFP was able to move from the vascula-
ture below the SAM into the niche. These fi ndings 
suggest that miRNAs may function as mobile signals 
between differentiated tissues and stem cells, possibly 
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integrating environmental/physiological cues and 
plant development. Analyses of miRNA mobility in 
other developmental contexts are still ongoing. In ad-
dition, with the knowledge that miRNAs can traffi c 
from the epidermis into underlying tissue layers, we 
are carrying out forward genetic screens to identify 
factors infl uencing this process.
Small RNA Gradients Create Stable 
Developmental Boundaries
A. Benkovics, D. Skopelitis, C. Fernandez-Marco
Mathematical modeling of the tasiR-ARF–ARF3 in-
teraction predicts that small RNA gradients resulting 
from mobility are uniquely suited to generate sharply 
defi ned boundaries of target gene expression. To test 
this, we are using a line expressing a miR166-insen-
sitive HD-ZIPIII reporter (PHB*-YFP) that is ac-
tive throughout the leaf and induces an adaxialized 
leaf phenotype. In this background, we expressed a 
modifi ed version of miR166 (miR166*) that specifi -
cally cleaves the PHB*-YFP transcripts. Given the im-
portance of miRNA dosage to gene silencing, we are 
expressing miR166* in an inducible manner in the 
adaxial or abaxial epidermis. This allows us to quan-
titatively measure the relationship between miRNA 
gradients and the spatial patterning of their targets. 
The fi rst results show that miR166* expression from 
the abaxial epidermis is suffi cient to suppress the 
PHB*-YFP leaf defects, indicative of movement of this 
small RNA. Efforts to visualize the PHB*-YFP and 
miR166* expression domains are ongoing.
This question is also being addressed using a differ-
ent reporter system. The pARF3:ARF3-GUS reporter 
in an rdr6 mutant background, which lacks the tasiR-
ARF gradient, is expressed throughout the developing 
leaf. In this background, we are expressing an arti-
fi cial miRNA targeting ARF3, again from different 
leaf-specifi c promoters and in an inducible manner, to 
modulate the position, direction, and steepness of the 
small RNA gradient. Target gene expression is being 
monitored by GUS histochemistry, and miR-ARF3 
expression patterns will be determined by in situ hy-
bridizations. The fi rst observations suggest that small 
RNA gradients indeed generate sharply defi ned do-
mains of target gene expression and provide evidence 
for dose dependence in the miRNA gradient–target 
gene interaction.
Considering that patterning of the adaxial–abax-
ial axis involves two opposing small RNA gradients, 
these might serve to confer robustness onto the leaf 
development program by stabilizing the adaxial–ab-
axial boundary throughout organogenesis and under 
a range of environmental conditions. Our preliminary 
results suggest that the adaxial–abaxial boundary as 
visualized by an abaxial reporter is less sharp in sgs3 
mutants, which lack the tasiR-ARF gradient, than 
in wild-type plants. We are also comparing variabil-
ity in leaf parameters under normal and mild stress 
conditions between wild-type and sgs3 mutant plants. 
The outcome of these experiments will reveal whether 
small RNA gradients provide robustness to the leaf 
developmental program under a range of environmen-
tal conditions.
The START Domain Regulates HD-ZIPIII 
Activity and Organ Polarity
A. Husbands [in collaboration with V. Yong and 
H. Djaballah, Memorial Sloan-Kettering Cancer Center, 
New York]
Based on our previous observations regarding the ex-
pression and function of miR166 and tasiR-ARF, it 
is evident that adaxial–abaxial patterning involves a 
cascade of positional signals. The mobile signals that 
pattern the newly formed leaf are distinct from those 
that maintain polarity during subsequent develop-
ment. This project aims to identify additional signals 
in adaxial–abaxial patterning.
The adaxial promoting HD-ZIPIII transcription 
factors contain a predicted START lipid-binding 
domain. Modeling of the START domain of the 
HD-ZIPIII member PHABULOSA (PHB) suggests 
structural similarity to human PC-TP, a phospha-
tidylcholine-binding START domain. This model 
and sequence conservation with other START do-
mains was used to predict amino acids in PHB criti-
cal for START domain ligand binding. To assess the 
importance of the START domain to PHB function, 
we generated transgenic Arabidopsis lines that ex-
press START domain variants of a PHB-YFP fusion 
protein. These PHB-YFP reporters also carry silent 
mutations in the miR166-target site, which normally 
leads to the formation of severely adaxialized leaves. 
Lines expressing a PHB-YFP variant in which sev-
eral residues lining the ligand-binding pocket of the 
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START domain are mutated show a wild-type phe-
notype, as do lines that express a variant in which the 
START domain is deleted entirely. These fi ndings 
reveal positive regulation of HD-ZIPIII activity by 
an unknown ligand and show that the START do-
main is required for proper function of HD-ZIPIII 
proteins.
Experiments to determine the mechanism through 
which the START domain controls HD-ZIPIII func-
tion are ongoing. Ligand binding does not appear to 
affect the subcellular localization of these transcrip-
tion factors, as confocal imaging showed that the 
PHB-YFP derivatives correctly localize to the nu-
cleus. We are currently investigating whether ligand 
binding affects PHB’s ability to bind DNA, activate 
transcription, or to interact with required protein 
partners. As part of these analyses, we developed a 
yeast-based assay and conducted a high-throughput 
screen for chemical compounds that bind the HD-
ZIPIII START domain and modulate protein activ-
ity. Using yeast growth as a readout, we identifi ed 
compounds that reduced yeast growth (antagonists) 
and others that promoted growth (agonists). Valida-
tion experiments in yeast and plants are under way to 
eliminate false positives and demonstrate that these 
chemicals act via modulation of HD-ZIPIII activ-
ity. Finally, we have generated plants expressing a 
biotin-tagged form of the START domain and will 
be performing immunoprecipitations and mass spec-
trometry to identify the endogenous ligand bound by 
HD-ZIPIII proteins. These latter experiments will be 
carried out in early 2013 in collaboration with the 
CSHL proteomics facility.
tasiRNA Pathways in Maize and New Players 
in Leaf Polarity
M. Dotto [in collaboration with M. Hammell, Cold Spring 
Harbor Laboratory; M. Aukerman, M. Beatty, R. Meeley, 
DuPont-Pioneer]
Small RNAs control the activities of a wide variety of 
genetic elements, including genes that encode proteins, 
transposons, and viruses. These diverse functions are 
achieved by distinct classes of small RNAs generated 
through discrete genetic pathways. tasiRNA biogen-
esis is triggered when TAS transcripts are targeted by 
either a single 22-nucleotide miRNA (one-hit model) 
or two 21-nucleotide miRNAs (two-hit model). These 
miRNA-guided cleavage events trigger conversion of 
the tasiRNA precursor transcript into long double-
stranded RNAs (dsRNAs) by RDR6 and SGS3/LBL1 
and set the register for the subsequent production of 
phased 21-nucleotide tasiRNAs by DCL4. Only the 
TAS3 pathway is conserved across land plant evolu-
tion. The binding of two miR390-loaded AGO7 
complexes triggers the biogenesis of TAS3-derived 
tasiRNAs, a subset of which are the tasiARFs. We 
previously identifi ed four TAS3 loci in the maize ge-
nome; however, additional TAS loci described in other 
species are not conserved in maize. We used a deep-
sequencing and bioinformatics approach to perform a 
genome-wide search for clusters of phased small RNA 
in combination with a comparison of the small RNA 
content between wild-type and lbl1 mutant  apices. 
This approach identifi ed fi ve novel TAS loci, all 
 belonging to the TAS3 family. No TAS loci triggered 
by 22-nucleotide miRNAs were identifi ed. In-depth 
target analyses indicate that the tasiARFs are the only 
functional tasiRNAs in the maize vegetative apex, 
where they regulate expression of ARF3 homologs. 
This study also revealed unexpected contributions for 
LBL1 in the regulation of miRNAs and 24-nucleo-
tide transposon- and retrotransposon-derived small 
interfering RNAs (siRNAs), illustrating substantial 
crosstalk among small RNA pathways. The mecha-
nisms underlying these regulatory networks remain to 
be elucidated.
In a separate approach, we are characterizing small 
RNAs associated with diverse AGO proteins. Using 
a specifi c peptide antibody, we analyzed the small 
RNAs associated with ZmAGO10 by deep sequenc-
ing the small RNAs present in immunoprecipitates. 
We found that the immunoprecipitation fraction was 
enriched for just a subset of small RNAs: miR394, 
miR166, and tasiARFs. We had previously shown 
the function of the latter two in the specifi cation of 
maize leaf polarity. However, miR394 remains poorly 
characterized. In situ hybridization showed that this 
miRNA also accumulates in a polar pattern, estab-
lishing a gradient on the adaxial side of developing 
leaves. This presents the possibility that organ polarity 
is regulated also by a fourth small RNA signal. We are 
currently characterizing the maize single and double 
mutants in components of this pathway: mir394a 
and mir394b, the two F-BOX proteins predicted as 
targets, and both ZmAGO10 genes. It was reported 
that AGO10 in Arabidopsis associates exclusively with 
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miR166. We are currently analyzing how structural 
differences between these miRNA precursors and the 
AGO10 proteins in both species account for the dif-
ferential AGO10/miR394 binding in maize.
Effects of Natural Variation Present in 
Maize Inbreds on the tasiRNA Pathway
K. Petsch
Mutants that disrupt tasiRNA biogenesis exhibit de-
fects in adaxial–abaxial patterning. Interestingly, the 
severity of these phenotypes is greatly dependent on 
the inbred background. tasiRNA pathway mutants, as 
well as other small RNA biogenesis mutants, typically 
exhibit weaker phenotypes when introgressed into B73 
as opposed to other inbred backgrounds, such as W22, 
Mo17, and A619. To understand how inbred back-
ground infl uences expressivity of tasiRNA pathway 
mutants, we are using the severe ragged1 allele of leaf-
bladeless1 (lbl1-rgd1). In the B73 inbred background, 
lbl1-rgd1 conditions a classical leaf polarity phenotype 
with most leaves developing as radial, abaxialized or-
gans. In W22, however, lbl1-rgd1 embryos lack a shoot 
meristem and germinate with just a root. We have gen-
erated an F2 population to map loci that contribute to 
the variable expressivity of lbl1-rgd1 in the two inbreds. 
This identifi ed a major modifi er locus on chromosome 
8, which we are fi ne-mapping in collaboration with 
DuPont. In addition, we are generating NIL popula-
tions to further defi ne the effect of this locus on the 
lbl1-rgd1 phenotype and to identify the causative gene.
In a complementary approach, we performed a 
transcriptome analysis of lbl1-rgd1 embryos and non-
mutant siblings in B73 and W22. This identifi ed 214 
genes that are differentially expressed in lbl1-rgd1 
embryos in both backgrounds. These include known 
tasi RNA targets and genes showing differential ex-
pression across the adaxial–abaxial axis, as well as 
genes predicted to function in the embryonic shoot 
meristem. Most notably, ~30% of genes that are down-
regulated in W22 mutant embryos have “meristem-as-
sociated” functions. Further investigation into specifi c 
genes is ongoing. Importantly, this study identifi ed 40 
genes within the chromosome-8 modifi er region that 
are expressed in the developing embryo and show dif-
ferential expression between the inbreds or between 
lbl1-rgd1 and nonmutant siblings. By combining these 
approaches, we hope to gain a better understanding 
of the factors contributing to natural variation in ta-
siRNA pathway function.
Ancestral Role of the tasiRNA Pathway
E. Plavskin [in collaboration with R. Quatrano, Washington 
University, St Louis, Missouri; M. Hasebe, National 
Institute for Basic Biology, Okazaki, Japan]
The diversity of multicellular organisms raises the 
question of how so many varied morphologies evolved. 
A number of studies have demonstrated that novel 
structures often arise through the hijacking of exist-
ing developmental pathways for new functions. The 
pathways controlling leaf development seem to be no 
exception, as many of them have been shown to be 
conserved in the moss Physcomitrella patens, whose an-
cestors diverged from the lineage of fl owering plants 
~100 million years before leaves fi rst evolved in the lat-
ter. Thus, studying the role of leaf polarity pathways 
in moss provides a unique opportunity to explore the 
evolution of complex novel structures.
We are focusing on the miR390-dependent ta-
siRNA pathway. The genes involved in biogenesis of 
tasiRNAs as well as the tasiRNA targets are conserved 
between maize, Arabidopsis, and P. patens. Elucidat-
ing the function of this pathway in Physcomitrella may 
lead to an understanding of its ancestral role in plant 
development. For this, we are taking advantage of the 
unique ability of this moss to be transformed by ho-
mologous recombination and characterizing knock-
outs of genes involved in tasiRNA biogenesis, as well 
as the targets of the moss tasiR-ARFs. Our results in-
dicate a role for tasiRNA regulation in plant architec-
ture during the fi lamentous stage of growth. sgs3 loss-
of-function mutants display increased branching and 
decreased formation of caulonema, long runners that 
allow the moss plants to rapidly spread (Fig. 1). These 
phenotypes are consistent with a defective response 
to the plant hormone auxin, which is evolutionarily 
more ancient than the land plant lineage itself. Fur-
ther experiments demonstrated that tasiRNAs are im-
portant for setting a threshold for auxin response and 
that deregulation of their targets results in a perturbed 
response to nitrogen deprivation.
Much like fi lamentous runners in moss, forma-
tion of lateral roots in dicots is regulated by auxin 
and modulated by nitrogen levels in the substrate; in 
addition, a link between lateral root outgrowth and 
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tasiRNA biogenesis has recently been demonstrated. 
It is exciting to hypothesize that tasiRNAs and their 
targets may be part of an ancient mechanism for regu-
lating plant architecture in response to auxin signal-
ing and environmental inputs such as soil nutrient 
content. To address this experimentally, we are now 
exploring lateral root formation in Arabidopsis mu-
tants with perturbed tasiRNA biogenesis.
High-Resolution Gene Expression Atlas 
for the Maize Shoot Apex
M. Javelle [in collaboration with M. Scanlon, Cornell 
University, Ithaca, New York; G. Muehlbauer, University 
of Minnesota, Minneapolis; J. Yu, Kansas State University, 
Manhattan; P. Schnable, Iowa State University, Ames]
Plants have the distinctive ability to form new organs 
throughout their lifetime, which can span hundreds 
or even thousands of years. The growing tip of a plant 
contains a population of stem cells that are located 
within a specialized niche, termed the shoot apical 
meristem (SAM). These stem cells divide to maintain 
the SAM and to generate daughter cells from which 
lateral organs, such as leaves and fl owers, arise. The 
gene regulatory networks controlling meristem inde-
terminacy and organogenesis remain largely obscure. 
To gain insight into such networks, we have generated 
a high-resolution gene expression atlas for the maize 
shoot apex. Functional domains of the meristem 
were isolated by laser microdissection and analyzed 
by RNA deep sequencing. These include the whole 
meristem, the stem-cell-containing SAM tip, the 
newly initiating leaf (P0), the epidermal layer of the 
SAM (L1), and the subepidermal region (L2). Because 
gene networks controlling meristem maintenance and 
leaf development are largely interconnected, we fur-
ther compared expression profi les in an ontogenic 
series of leaf primordia, P1, P2, and P3. We identi-
fi ed 502 genes that show strong differential expression 
between the L1 and the L2. Using CAST clustering, 
we further identifi ed genes that specifi cally mark the 
meristem, the P0 or developing leaf primordia. Most 
notably, this analysis identifi ed 177 genes that spe-
cifi cally mark the stem cell domain of the meristem, 
and several genes that mark the presumptive organiz-
ing center. This comprehensive data set allows us to 
precisely predict genes involved in meristem mainte-
nance, leaf initiation, and/or leaf patterning and to 
assess the distinct contributions of the L1 and L2 to 
these processes. Reverse genetic resources available for 
maize are being used to directly test the function of 
select genes in these processes.
Several known regulators of meristem indetermi-
nacy and organ initiation are under the control of 
miRNAs. To gain insight into small RNA-controlled 
gene networks required for SAM function, we charac-
terized the precise expression patterns of eight highly 
conserved plant miRNAs by in situ hybridization. 
Each shows a distinct expression pattern suggesting 
diverse contributions of small RNAs and the path-
ways they target to the regulation of SAM function. 
miRNAs appear to function predominantly during 
leaf initiation and leaf development, and only one 
miRNA has been shown to function in the stem-cell 
region of the SAM. Using the gene expression atlas, 
we analyzed the expression domains of individual 
precursor genes. Only 41 out of 144 precursor genes 
are expressed within the shoot apex, and their level of 
expression generally shows a good correlation with the 
level of the corresponding mature miRNA. However, 
a few exceptions highlight instances of more complex 
Figure 1. Physcomitrella sgs3 mutants show altered ﬁ lamentous 
tissue architecture. (A,B) Wild-type and sgs3 plants after 15 days 
of growth on solid media. Caulonemal runners (arrowheads) are 
visible in wild-type plants (A) but absent in sgs3 (B). Wild-type 
primary ﬁ laments (C) have dramatically fewer branches than in 
sgs3 (D). Both the lack of caulonema and the failure to suppress 
branching in this tasiRNA biogenesis mutant suggest a perturbed 
auxin response. Scale bar, 1 mm.
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regulation of miRNA processing, stability and/or mo-
bility. To complete our understanding of miRNA ac-
tion within the shoot apex, we are currently overlaying 
these small RNA expression patterns with expression 
data from validated miRNA target genes. This rich 
resource will be used to guide functional genomics ex-
periments to address the role of new candidate genes 
in meristem function.
Establishment of Determinacy during 
Lateral Organ Development
M. Lohda
Stem cell activity in the SAM is maintained in part 
by the class I KNOX homeobox genes. To give rise 
to differentiating structures, such as leaves, KNOX 
expression needs to be maintained in a stable “off” 
state throughout lateral organ development. We had 
previously shown that this process is mediated by 
the transcription factors AS1 and AS2, which form 
heterodimers that bind specifi c sites in the KNOX 
promoters. We have now uncovered the mechanism 
via which AS1-AS2 maintain the stable repression of 
KNOX genes during leaf development.
We found that KNOX gene silencing also requires 
the activities of the Polycomb repressive complexes, 
PRC2 and PRC1. PRC2 has histone H3K27 trimeth-
ylation (H3K27me3) activity, and we have shown that 
this repressive chromatin mark is enriched at the BP 
and KNAT2 loci in leaves of Arabidopsis. Mutations 
in the PRC2 component CURLY LEAF (CLF) lead 
to reduced levels of this repressive H3K27me3 mark 
at the KNOX loci and to ectopic KNOX expression 
in developing leaves. PRC1 is a downstream compo-
nent in the Polycomb pathway that maintains long-
term silencing. In plants, this complex contains LIKE 
HETEROCHROMATIN PROTEIN1 (LHP1), 
which recognizes the H3K27me3 signature deposited 
by PRC2. We found that LHP1 is present at the si-
lenced KNOX loci and that mutations in LHP1 lead 
to KNOX misexpression in developing leaves. Impor-
tantly, levels of H3K27me3 and LHP1 at the KNOX 
loci are dramatically reduced in as1 and as2 mutants, 
identifying these DNA-binding proteins as upstream 
components in the KNOX silencing pathway. We were 
further able to show that AS1 and AS2 interact physi-
cally with PRC2 and that the AS1-AS2 complex medi-
ates the recruitment of PRC2 to the KNOX promoters.
Genome-wide H3K27me3 profi ling studies predict 
that as many as 20% of Arabidopsis genes are marked 
with H3K27me3 and regulated by PRC2. However, 
how PRC2, which does not bind DNA specifi cally, 
recognizes defi ned targets remained a major outstand-
ing question in the fi eld. This work showed that PRC2 
is recruited to select targets by the sequence-specifi c 
DNA-binding factors AS1 and AS2. This recruitment 
mechanism resembles the Polycomb response element 
(PRE)-based recruitment of PRC2 originally defi ned 
in fl ies and provides the fi rst such example in plants. 
Moreover, these data provide a framework for the cellu-
lar memory system underlying the somatically heritable 
repression of stem-cell-promoting homeobox genes that 
is required for cellular differentiation in leaves.
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Thomas Gingeras and colleagues study where and how functional information is stored in ge-
nomes. These efforts help explain the biological and clinical effects of disease-causing gene mu-
tations in humans and other organisms. Gingeras is a leader of the ENCODE (ENCyclopedia 
of DNA Elements) and the mouseENCODE and modENCODE (model genome ENCODE) 
projects of the National Institutes of Health. His research has altered our understanding of the 
traditional boundaries of genes, revealing that almost the entire lengths of genomes in organisms 
ranging from bacteria to humans can be transcribed into RNA (pervasive transcription) and that 
most RNA products made by a cell are not destined to be translated into proteins (noncoding, or 
ncRNAs). In fact, ncRNAs are proving to be involved in a variety of other important biological 
functions. Some have been shown to be critical components in the pre- and posttranscriptional 
and translational processes, as scaffolds upon which large protein complexes are assembled and as 
extracellular signals. The initial studies that led to these observations were this year extended to 
cover the entire human genome.
There has been a growing appreciation in recent years that gene function is frequently context-
dependent, with a large part of that context provided by the activities of other genes. But trying 
to understand how genes interact to produce function is a hugely complicated problem and one 
that appears likely to become more so as genomic information becomes more detailed. Jesse Gillis 
and colleagues are computational biologists who are presently challenging an oft-taken approach 
to the problem in which the functions of genes are interpreted in the context of networks derived 
from gene association data. Such networks consist of millions of interactions across thousands of 
genes, derived from protein-binding assays, RNA coexpression analysis, and other sources. His-
torically, many attempts to understand gene function through networks have leveraged a biologi-
cal principle known as “guilt by association.” It suggests that genes with related functions tend 
to share properties (e.g., physical interactions). In the past decade, this approach has been scaled 
up for application to large gene networks, becoming a favored way to grapple with the complex 
interdependencies of gene functions in the face of fl oods of genomics and proteomics data. Gillis’ 
work centers on identifying the limits of the approach and making fundamental improvements 
to its operation, as well as applying those improvements to neuropsychiatric gene network data.
Gholson Lyon’s lab focuses on analyzing human genetic variation and its role in severe neuropsy-
chiatric disorders and rare diseases, including Tourette syndrome, ADHD, obsessive compulsive 
disorder (OCD), intellectual disability, autism, and schizophrenia. By recruiting large groups of 
related individuals living in the same geographic location, for example, Utah, his lab can study 
the breadth and depth of genetic variants in a similar environmental background. Utilizing the 
exome, the parts of the genome that code for protein, and whole-genome sequencing, his lab 
looks for mutations that segregate with syndromes in the various populations. A second focus of 
the Lyon lab is to study the mechanistic basis of a new rare disease that they described in 2011. 
This is the fi rst human disease involving a defect in the amino-terminal acetylation of proteins, 
a common modifi cation of eukaryotic proteins carried out by amino-terminal acetyltransferases 
(NATs). The team has been using several different cellular model systems to better understand the 
disease pathophysiology and the basic process of amino-terminal acetylation.
The insights of W. Richard McCombie and colleagues have led to the introduction and opti-
mization of novel methods of high-throughput genome sequencing. His team has made it possible 
to catalog variation among individual organisms in a way that would have been unthinkable 5 
years ago. They have brought online a new generation of Illumina sequencers and optimized their 
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function to a level at which eight to 10 trillion DNA bases can be sequenced in a month. McCom-
bie’s team has been involved in international efforts culminating in genome sequences for maize, 
rice, and this year for bread wheat, three of the world’s most important food crops. They have 
also had an important role in projects to sequence the fl owering plant Arabidopsis thaliana, the fi s-
sion yeast Schizosaccharomyces pombe, as well as Homo sapiens and other important genomes. Mc-
Combie’s group is currently involved in several important projects to resequence genes in patient 
samples that are of special interest to human health, including DISC1, a strong candidate gene 
for schizophrenia, looking for genetic variants implicated in bipolar illness and major recurrent 
depression. With Sloan-Kettering Cancer Center, they are using a method called hybrid selec-
tion, developed with Greg Hannon, to look at mutations in samples collected from patients with 
prostate cancer.
Using multidisciplinary approaches that combine computational analysis, modeling and predic-
tion with experimental verifi cation, Doreen Ware’s lab seeks a deeper understanding of the evo-
lution of genome sequences in plants and their implications for agricultural improvement. By 
looking comparatively across the genomes of plants in the same lineage, they seek answers to the 
following questions: How are genes conserved and lost over time? What are the fates of duplicated 
genes? What is the impact of structural variation on phenotypic variation? Ware’s team also stud-
ies gene regulation in plants, focusing on gene regulatory networks, targeting transcription factors 
and microRNA genes with the objective of understanding how these parts of the plant genome 
work together in determining spatial and temporal expression of genes. The lab had an important 
role in the project to produce a haplotype map reference genome of maize, spearheading the most 
comprehensive analysis of the crop yet. This has provided important information on the variation 
of the reference genome, as well as comparative data showing changes in the genome acquired 
through domestication and breeding. They have devoted special attention to examining diversity 
within maize, grape, and tomato, aiming to accelerate the development of strategies to introduce 
new germplasm that is needed to meet demands of increasing population and a changing environ-
ment. The lab also has brought fully sequenced genomes into an integrated data framework, to 
enhance the power of their comparative studies. This past year, Ware was named as its principal 
investigator for the National Science Foundation-funded Gramene project, a comparative genom-
ics resource for agriculturally important crops and models to support sustainable food and fuel 
production. Ware, as principal investigator for plants, has also helped lead an effort funded by 
the Department of Energy to the create out of many separate streams of biological information a 
single, integrated cyber-“knowledgebase” for plants and microbial life.
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GENOME ORGANIZATION AND REGULATION 
AND FUNCTIONAL ROLES OF NONCODING RNAS
T.R. Gingeras P. Batut J. Drenkow F. Schlesinger
 S. Chakrabortty M. Fastuca L.-H. See
 C. Davis S. Jha C. Xue
 A. Dobin W. Lin C. Zaleski
Human-ENCODE Project
P. Batut, S. Chakrabortty, C. Davis, A. Dobin, J. Drenkow, 
M. Fastuca, S. Jha, W. Lin, F. Schlesinger, L.-H. See, C. Xue, 
C. Zaleski
Living cells make many types of primary and pro-
cessed RNAs that are found either in specifi c subcel-
lular compartments or throughout cells. A complete 
catalog of these RNAs is not yet available and their 
characteristic subcellular localizations are also poorly 
understood. Because RNA represents the direct out-
put of the genetic information encoded by genomes 
and a signifi cant proportion of a cell’s regulatory capa-
bilities are focused on its synthesis, processing, trans-
port, modifi cation, and translation, the generation 
of such a catalog is crucial for the identifi cation and 
characterization of functional genomic regions.
Our laboratory has been involved in all three phas-
es of the Encyclopedia of DNA Elements (ENCODE) 
project (2002–present). This project endeavors to 
identify and characterize the functional elements 
present in the human genome sequence. The raw and 
mapped data and elements for the 5 years of phase 
II of ENCODE are available at the ENCODE Data 
Coordination Center, DCC (www.genome.ucsc.edu/
ENCODE/dataSummary.html). These data, as well 
as additional data on all intermediate processing steps, 
are available on the RNA Dashboard: www.genome.
crg.cat/encode_RNA_dashboard. This genome-wide 
compilation of subcellular localized and product-
precursor-related RNAs has recently been published 
(see Nature 2012) and also can be found in the four 
manuscripts listed below. These data serve as a pub-
lic resource and reveal new and detailed facets of the 
RNA landscape that include the following:
• A total of 62.1% and 74.7% of the hu man genome 
is transcribed into either processed or primary 
transcripts, respectively, with no cell line showing 
more than 56.7% of the union of the expressed 
transcriptomes across all cell lines. The consequent 
reduction in the length of intergenic regions leads 
to a signifi cant overlapping of neighboring gene re-
gions and prompts a redefi nition of a gene.
• Isoform expression by a gene does not follow a min-
imalistic expression strategy, resulting in a tenden-
cy for genes to express many isoforms simultane-
ously, with a plateau at ~10–12 expressed isoforms 
per gene per cell line.
• Coding and noncoding transcripts are predomi-
nantly localized in the cytosol and nucleus, respec-
tively, with a range of expression spanning six orders 
of magnitude for polyadenylated RNAs and fi ve or-
ders of magnitude for nonpolyadenylated RNAs.
• Approximately 6% of all annotated coding and 
noncoding transcripts overlap with small 5-capped 
and -uncapped RNAs and are likely to be precur-
sors to these small RNAs. The subcellular local-
izations of both annotated and unannotated short 
RNAs are highly specifi c.
• We have contributed to the GENCODE consor-
tium a most complete human long noncoding 
RNAs  (lncRNA) annotation to date, produced 
with in the framework of the ENCODE project 
and comprising 9277 manually annotated genes 
producing 14,880 transcripts. Our analyses indi-
cate that lncRNAs are generated through pathways 
similar to those of protein-coding genes, with simi-
lar histone modifi cation profi les, splicing signals, 
and exon/intron lengths. In contrast to protein-
coding genes, however, lncRNAs display a striking 
bias  toward two-exon transcripts; they are predom-
inantly localized in the chromatin and nucleus, 
and a fraction appear to be preferentially processed 
into small RNAs.
• Analysis of the RNA from subcellular fractions 
obtained through RNA-Seq in the cell line K562 
revealed that, consistent with cotranscriptional 
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spliceosome assembly and splicing, we have found 
signifi cant enrichment of spliceosomal small nucle-
ar RNAs (snRNAs) in chromatin-associated RNA 
compared with other cellular RNA fractions and 
other nonspliceosomal snRNAs. These data are in 
agreement with a ‘’fi rst-transcribed, fi rst spliced’’ 
rule, yet more downstream exons carry other char-
acteristics, favoring rapid cotranscriptional intron 
removal.
Model Genome (mod-) ENCODE: 
Human–Fly–Worm Comparative 
Analyses of Transcriptomes
C. Davis, A. Dobin, C. Xue, C. Zaleski
A major effort to compare the transcriptional char-
acteristics of Drosophila and Caenorhabditis elegans to 
those of the human transcriptome has been under way 
during the last year. In collaboration with members of 
the modENCODE groups, detailed analyses have re-
sulted in a signifi cant set of insights on the similarities 
and differences observed in the transcriptomes of each 
of the three species. The results of these comparative 
analyses are currently being summarized in a manu-
script that is in preparation.
Mouse-ENCODE Project: Human–Mouse 
Comparative Analyses of Transcriptomes
C. Davis, A. Dobin, C. Xue, C. Zaleski
Approximately 80% of the human genome can be as-
sociated with specifi c and individual biochemical ac-
tivities, but it is still unclear which of these activities 
is specifi c to human biology. The mouse ENCODE 
consortium has endeavored to determine how much 
of these activities has been conserved in orthologous 
and syntenic regions. Genomic analyses for more than 
100 mouse cell and tissue types have been conducted. 
As a result, as with the human genome, a large frac-
tion of the mouse genome is associated with transcrip-
tional activities, transcription factors, or a chromatin 
state indicative of transcriptional regulatory function. 
Comparative analyses of the functional annotations in 
the human and mouse genomes show that there has 
been both considerable conservation and a surpris-
ingly large degree of divergence in gene expression 
patterns, RNA splicing, chromatin organization, and 
transcriptional regulatory mechanisms since the last 
common ancestor of these two mammals. Interest-
ingly, different groups of genes have a distinct rate of 
conservation in their expression patterns and a cor-
responding degree of divergence in their cis-regulatory 
sequences. A number of unannotated intergenic po-
tentially enhancer regions are clearly conserved.
Software and Database Development
A. Dobin, C. Zaleski
Recent advances in sequencing technologies have made 
transcriptome analyses at the single-nucleotide level al-
most routine. Accurate alignment of high-throughput 
RNA-Seq data is a challenging and heretofore unsolved 
problem because of the noncontiguous transcript struc-
ture, relatively short read lengths, and constantly in-
creasing throughput of the sequencing technologies. 
Several critical problems have been found to affl ict 
previously published approaches, such as high map-
ping error rate for contiguous and especially spliced 
alignments; mapping biases (some types of alignments 
are artifi cially favored over others); low sensitivity for 
unannotated transcripts; poor scalability with the read 
length; restrictions in the number of junctions, mis-
matches and indels per read; inability to detect nonlin-
ear transcripts such as chimeric RNAs; and, crucially, 
very high demands on computational resources owing 
to the low mapping throughput.
To align our large (exceeding 80 billion reads) EN-
CODE transcriptome RNA-Seq data set, we devel-
oped and published the spliced transcripts’ alignment 
to a reference (STAR) software based on a previously 
undescribed RNA-Seq alignment algorithm that uses 
sequential maximum mappable seed search in uncom-
pressed suffi x arrays, followed by a seed clustering and 
stitching procedure. Unlike many other RNA-Seq 
mappers, STAR is not an extension of a short-read 
DNA mapper; it was developed as a stand-alone C++ 
code. STAR is capable of running parallel threads on 
multicore systems with close to linear scaling of pro-
ductivity with the number of cores. STAR is very fast: 
On a modern but not overly expensive 12-core server, 
it can align 550 million 2 × 76-nucleotide reads per 
hour with the human genome, surpassing all other 
existing RNA-Seq aligners by a factor of 50. At the 
same time, STAR exhibits better alignment precision 
and sensitivity than other RNA-Seq aligners for both 
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experimental and simulated data. In addition to unbi-
ased de novo detection of canonical junctions, STAR 
is capable of discovering noncanonical splices and chi-
meric (fusion) transcripts. Using Roche 454 sequencing 
of reverse transcriptase–polymerase chain reaction (RT-
PCR) amplicons, we experimentally validated 1960 
novel intergenic splice junctions with an 80%–90% 
success rate, corroborating the high precision of the 
STAR mapping strategy.
Importantly, STAR can align the full range of 
sequence lengths currently attainable by emerging 
third-generation sequencing technologies. To dem-
onstrate STAR’s ability to align long reads, we have 
mapped the long (0.5–5 kb) human mRNA sequences 
from GenBank. The accuracy of STAR alignments is 
similar to or higher than that of BLAT, which is the de 
facto standard expressed sequence tag (EST)/mRNA 
aligner. At the same time, STAR outperforms BLAT 
by more than two orders of magnitude in alignment 
speed, which is important for high-throughput se-
quencing applications.
The algorithm extensibility to long reads shows 
that STAR has a potential to serve as a universal 
alignment tool across a broad spectrum of emerging 
sequencing platforms. STAR can align reads in a con-
tinuous streaming mode, which makes it compatible 
with novel sequencing technologies such as the one 
recently announced by Oxford Nanopore Technolo-
gies. As these sequencing technologies and protocols 
evolve, new mapping strategies will have to be de-
veloped, and the STAR core algorithm will be able 
to provide a fl exible framework to address emerging 
alignment challenges.
The infrastructure of the Gingeras’ laboratory 
analyses has been dependent on the continued devel-
opment and maintenance of the large databases col-
lected for each of the ENCODE projects. Notable 
achievements in these areas include the following:
• Implemented a new database system to track se-
quencing samples and subsequent data fi les. TDM 
(transcriptome data manager) is a MySQL database 
with a web-based interface utilizing HTML, Java-
script, Flash, and Apache web services.
• Continued management and organization of se-
quencing data consisting of “raw” fastq fi les and 
genome-mapped data fi les, including bam, bigwig, 
contig, and other formats in a growing repository 
almost 30 TB in size.
• Update of lab website to a “Google Site.” Content 
was updated, and the Google Site implementa-
tion allows anyone (with permission) to access 
and update the site without programming knowl-
edge.
• Migration of our sequencing production pipe-
line to the new CSHL compute cluster. All codes 
within the pipeline were updated to accommodate 
new resources and restrictions and fully tested 
with live data.
Novel Exon Detection by Hierarchical 
RNA-Seq Clustering
F. Schlesinger
The transcriptome, the collection of all RNAs, of 
human cells contains a complex population of RNAs 
in addition to protein-coding mRNAs and known 
structural noncoding RNAs. RNA-Seq—the analysis 
of the transcriptome using high-throughput DNA se-
quencing—is a powerful method to unravel this com-
plexity and to study the whole transcriptome, which 
represents the crucial molecular intermediate between 
genome sequence and function. However, due to the 
interleaved and overlapping nature of RNA transcripts 
and isoforms in the genome, gaining an accurate pic-
ture of complex genomic regions from short-read se-
quencing is a major challenge.
To address this, we developed a signal segmenta-
tion method based on maximum likelihood read 
count statistics, hierarchical segmentation, and model 
selection. It can identify individual, potentially over-
lapping transcriptional elements (exons, transcription 
start sites, splice junctions, etc.) from different types 
of RNA-Seq data by fi nding nested regions of signifi -
cant signal enrichment, without arbitrary conditions 
on length, expression level, or location in the genome. 
Applying these and other methods to the large data 
collections generated by ENCODE allowed them to 
identify a large number of new transcripts, especially 
in samples of nuclear and nonpolyadenylated RNAs. 
We are following up on these predictions by using 
high-throughput single-molecule full-length cDNA 
sequencing on the PacBio RS platform in combina-
tion with custom hybridization capture probes. This 
allows us to avoid the error-prone assembly of short 
reads and observe the full structure of individual tran-
scripts directly.
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In addition to identifying these novel transcripts 
themselves, a key question is what regulatory elements 
in the genome sequence control their transcription. 
To this end, we focused on the transcription start sites 
(TSS) of novel RNAs, outside of known promoter re-
gions. We analyzed chromatin immunoprecipitation 
(ChIP) data and found cell-type-specifi c enrichment 
of histone marks and DNA-binding proteins, associ-
ated with active transcription, around the predicted 
TSS of the novel RNAs, confi rming the predictions. 
Interestingly, the chromatin profi les at these TSS fall 
into two general classes: The fi rst, showing the ca-
nonical promoter histone signature, includes many 
internal and divergent antisense transcripts as well 
as thousands of long intergenic RNAs. The others 
show a more enhancer-like chromatin state and often 
overlap predicted or experimentally confi rmed en-
hancers. These transcripts, from a subset of enhancer 
RNA (eRNA) regions, occur specifi cally in cell types 
in which the enhancer is active and are linked to dif-
ferential DNA methylation of these intergenic regu-
latory elements. By integrating the different types of 
ENCODE RNA data, we could characterize in de-
tail the properties of eRNA transcription start sites, 
which are specifi cally and directionally positioned at 
cryptic promoter-like sites within the enhancer re-
gion, as well as the properties of the RNA itself. In 
collaboration with the Hannon lab here at CSHL, we 
analyzed how this intergenic transcription contrib-
utes to cell-type-specifi c DNA hypomethylation of 
the enhancers and their epigenetic state during cell 
differentiation.
Transposons and Evolution 
of Transcriptional Regulation 
in the Drosophila Clade
P. Batut, A. Dobin
Regulatory changes are thought to have a central role 
in the evolution of development and cellular physiolo-
gy, as well as in disease. Consistent with this, the regu-
latory circuitry underlying biological processes is very 
fl uid on evolutionary timescales. This has been illus-
trated by multispecies studies of transcription factor 
binding, which have revealed strikingly fast dynamics 
of binding-site evolution. The evolution of other types 
of regulatory elements and the impact of such changes 
on transcriptional programs are currently the focus of 
intense investigation.
To explore transcriptional regulation in an evolu-
tionary framework, we have developed RAMPAGE 
(RNA annotation and mapping of promoters for the 
analysis of gene expression), a high-throughput ap-
proach for genome-wide promoter discovery, quan-
titative promoter expression profi ling, and transcript 
characterization. On the basis of 5′-complete cDNA 
sequencing, RAMPAGE offers exceptional promoter 
specifi city, large-scale multiplexing capabilities, and 
accurate transcript quantifi cation. Promoter activ-
ity profi ling throughout the full Drosophila melano-
gaster life cycle has revealed widespread use of alter-
native promoters implementing distinct regulatory 
programs. Indeed, more than 40% of all expressed 
genes were found to have at least two promoters, and 
these generally had very distinct expression dynamics. 
Transposable elements, long proposed to have a cen-
tral role in the evolution of their host genomes through 
their ability to regulate gene expression, contribute at 
least 1300 promoters shaping the developmental tran-
scriptome of D. melanogaster. The co-option of trans-
posons to distribute stereotyped regulatory modules 
throughout genomes is a clear example of what may 
be called regulatory recycling mechanisms.
Transcriptional profi ling throughout embryogen-
esis, at high resolution and in multiple species, has 
expanded our view of recycling processes by reveal-
ing that species-specifi c transcription start sites are 
often created by conserved promoters that become 
bidirectional. Together, transposons and bidirectional 
promoters account for ~25% of D. melanogaster pro-
moters that are not shared with D. erecta. Current 
analyses of two additional species (D. simulans and D. 
pseudoobscura) are shedding further light on the evolu-
tionary dynamics of these phenomena. Although the 
internal organization of core promoters is well con-
served across the Drosophila clade, there is signifi cant 
plasticity in the genomic landscape of promoters: The 
birth and death of these elements are both very active 
evolutionary processes. The developmental expression 
profi les of individual genes are highly plastic as well, 
which is in agreement with recent studies in Drosophila 
and mammals. Strikingly, these analyses have revealed 
more than 1000 promoters driving the expression of 
noncoding RNAs that are functionally conserved in 
all four species, which last shared a common ancestor 
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more than 25 million years ago. As a class, these pro-
moters also show clear hallmarks of purifying selec-
tion at the sequence level, which unambiguously es-
tablishes their functionality and biological relevance.
RNA-Mediated Intercellular Signaling
S. Chakrabortty, A. Dobin
Intercellular transference of RNA through exosomes 
has recently emerged as a possible novel mode of com-
munication between cells and tissues of multicellular 
organisms. Exosomes are small 40–100-nm vesicles 
of endocytic origin that are secreted into the extra-
cellular milieu upon fusion of multivesicular bodies 
(MVB) to the plasma membrane. Not only are exo-
somes secreted by many cultured mammalian cells in-
vestigated, they also appear to be abundantly present 
in various body fl uids such as serum, plasma, urine, 
saliva, and cerebrospinal fl uid. Recently, exosomes 
have been shown to contain RNA molecules, includ-
ing mRNA and microRNA (miRNA).
We have characterized short RNAs isolated from 
exosomes, and their parent K562 whole cells were se-
quenced in duplicate. Approximately 1000 and 1250 
small RNA genes from exosomes and whole cells, 
respectively, can be detected with 90% or higher re-
producibility. One particular category, called miscel-
laneous RNA, was more abundant in exosomes than 
in their source cells. Miscellaneous RNA comprises 
mainly four classes of RNA, namely, 7SK RNA, 7sl 
RNA, Vault RNA, and Y RNA. Y RNA, more spe-
cifi cally, Y5 RNA, was determined to be the domi-
nant component of miscellaneous RNA present in 
exosome. Together, Y RNAs and miRNA are the two 
most enriched classes of short RNAs in exosomes, 
constituting ~70% of the enriched small RNA popula-
tion in exosomes. A second class of RNAs enriched in 
exosomes is miRNAs, which map as an exact copy of 
the mature 21-nucleotide miRNA (Guide) sequence. 
Interestingly, many of the exosomal miRNAs have 
been previously identifi ed as regulating oncogenes 
(e.g., Mir17-92 cluster) and tumor suppressors (e.g., 
Mir193b) with established roles in cancer.
The capability of exosomes to mediate intercel-
lular RNA transfer has been unambiguously dem-
onstrated by two different approaches. First, lipid 
labeling of cell membranes followed by live-cell 
time-lapse microscopy was performed using dyes 
PKH67 and PKH26 (Sigma). Live-cell time-lapse 
imaging  revealed the presence of red vesicles (from 
donor cells) within green recipient cells, consistent 
with exosome transfer. Confocal microscopy com-
bined with Z-stacking analysis was performed to 
confi rm that the red vesicles were internalized by the 
recipient cell and not merely sticking to the cell mem-
brane. Second, a RNA-Seq-based approach was used 
to examine the ability of exosomes to transfer RNA 
into another cell. Human K562 cells were cocultured 
with mouse B-lymphocyte cells (HB-84, ATCC) in 
a transwell culture across a membrane of 1-μm pore 
size for 24 and 48 h (in duplicate per time point). As 
a parallel approach, preisolated K562 exosomes were 
directly added to mouse HB-84 cells and incubated 
for 24 and 48 h (in duplicate per time point). Short 
RNAs were extracted from the recipient mouse cells 
and analyzed by RNA-Seq. The data were mapped to 
a combined genome of human and mouse. Reads that 
mapped to the mouse genome as well as to both the 
human and mouse genomes were discarded, and only 
those reads that were uniquely mapped to human 
 genome were used for further downstream analysis. 
A total of 464 and 892 annotated human short RNA 
genes were reproducibly detected in the mouse cells 
after 24- and 48-h coculture, respectively. Although 
all the categories of annotated short RNA genes that 
were previously identifi ed in exosomes were detected 
in each assay and time points, transfer RNAs were 
found to be most abundant among them.
Although several annotated classes of short RNAs 
were found to be enriched in exosomes compared to 
their source cells, the regulatory machinery in the 
cell involved in sorting RNA to these extracellular 
vesicles is unknown. We hypothesized that specifi c 
RNA-binding proteins may be involved in this en-
richment process. To address this question, mass 
spectrometric analyses of purifi ed K562 exosomes 
(two bio-reps) were performed. A total of 462 pro-
teins were reproducibly detected between the rep-
licates, of which 101 are characterized as having 
RNA-binding protein properties along with other 
functional associations. These proteins constitute an 
interesting collection of candidates for further analy-
ses to determine their possible role in RNA enrich-
ment in exosomes or as convenient biomarkers for 
the extracellular vesicles.
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GENE NETWORK ANALYSIS
J. Gillis
My research centers on using computational methods 
to understand gene function. Computational biology 
has taken up the challenge of determining gene func-
tion mainly by attempting to interpret the activities of 
genes in the context of networks derived from gene as-
sociation data. As data sets characterizing genes grow 
in size and complexity, it seems self-evident that com-
putation can assist in inference as to gene function. 
Gene network analysis intended to provide insight 
into complex disorders is a dominant interest in the 
fi eld. Gene associations (of various sorts) are believed 
to encode functional interaction, and this interaction 
is frequently shown to be able to substantially predict 
gene function across all functions. This approach, 
commonly called “guilt by association” (GBA), is em-
bedded in everything from prioritization of de novo 
variants to uncovering novel molecular phenotypes or 
mechanisms of disease. My research focuses on iden-
tifying limitations in the GBA approach and making 
fundamental improvements to its operation for the 
interpretation of neuropsychiatric genomics data. I 
joined CSHL in June 2012. Postdocs Wim Verleyen 
and Sara Ballouz will be joining my lab in early 2013.
“Guilt by Association” Is the Exception 
Rather Than the Rule in Gene Networks
In the past 10 years, GBA has been scaled up for ap-
plication to large gene networks, becoming a favored 
way to grapple with the complex interdependencies 
of gene functions in the face of fl oods of genomics 
and proteomics data. However, there is a growing 
realization that scaled-up GBA is not a panacea. In 
this study, we report a precise identifi cation of the 
limits of GBA and show that it cannot provide a way 
to understand gene networks in a way that is simul-
taneously general and useful. Our fi ndings indicate 
that the assumptions underlying the high-throughput 
use of gene networks to interpret function are fun-
damentally fl awed, with wide-ranging implications 
for the interpretation of genome-wide data. We show 
that functional information within gene networks is 
typically concentrated in only a very few interactions 
whose properties cannot be reliably related to the rest 
of the network. In effect, the apparent encoding of 
function within networks has been largely driven by 
outliers whose behavior cannot even be generalized 
to individual genes, let alone to the network at large. 
Although experimentalist-driven analysis of interac-
tions may use prior expert knowledge to focus on the 
small fraction of critically important data, large-scale 
computational analyses have typically assumed that 
high-performance cross-validation in a network is due 
to a generalizable encoding of function. Because we 
fi nd that gene function is not systemically encoded in 
networks, but dependent on specifi c and critical in-
teractions, we conclude it is necessary to focus on the 
details of how networks encode function and what in-
formation computational analyses use to extract func-
tional meaning. We explore a number of consequences 
of this and fi nd that network structure itself provides 
clues as to which connections are critical and that sys-
temic properties, such as scale-free-like behavior, do 
not map onto the functional connectivity within net-
works.
Assessing Identity, Redundancy, 
and Confounds in Gene Ontology 
Annotations Over Time
The Gene Ontology (GO) is a key means by which sys-
tems biologists operationalize gene function, making it 
a heavily relied upon tool in innumerable analyses and 
data interpretation exercises. GO annotations are often 
used as a gold standard, but the approach has widely ap-
preciated imperfections. Ironically, it is very diffi cult to 
assess the properties of GO itself, since there is no other 
comprehensive gold standard against which to hold it. 
Broadly speaking, assessment of GO has focused on 
three distinct attributes: the accuracy of annotations 
assigned to GO, GO’s structure independent of anno-
tation, and the utility of GO and its annotations for the 
interpretation of data. Despite misgivings about the in-
completeness of GO annotations, the use of GO “sets” 
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as representing “functions” is now endemic. This is put 
to use in numerous applications such as “gene group 
enrichment,” gene network analysis, and gene function 
prediction. It is essential to understand the extent to 
which such applications are valid.
The statement “the differentially expressed genes 
were enriched for genes with functions in cell growth” 
does not necessarily mean the same thing today as it 
did 5 years ago, because the defi nition of “cell growth 
genes” has changed in GO. Valid experimental results 
often become obsolete over time, but the reported 
facts of the experiment should not. But that is what 
happens when GO changes. This is of course to be ex-
pected, and the problem can be ameliorated by report-
ing which version of the gene annotations was used. 
We fi nd that genes can alter their “functional iden-
tity” over time, with 20% of genes not matching to 
themselves (by semantic similarity) after 2 years. We 
consider ensuring independence of GO from the data 
sets to which it is being applied as an absolute mini-
mum standard, and our results show that at least some 
protein interaction data do not meet this standard. We 
discovered that many entries in protein interaction da-
tabases are due to the same published reports that are 
used for GO annotations, with 66% of assessed GO 
groups exhibiting this confound. In our experience, 
among systems biologists, there seems to be a broadly 
appreciated disjunction between the true utility of 
GO and how often it is used, even if this is rarely ac-
knowledged in the peer-reviewed literature. The use 
of GO annotations is often regarded as a minimally 
interesting validation of results, but not safe to use for 
discovery purposes. We believe the problems we have 
identifi ed are among the underlying sources of these 
mixed feelings about GO. If it is “too easy” to obtain 
interesting results using GO, and those results do not 
consistently hold up, then GO’s use for such purposes 
is limited.
Assessing the First Computational Gene 
Function Prediction Assessment
The computational assignment of gene function re-
mains a diffi cult but important task in bioinformat-
ics. The establishment of the fi rst critical assessment of 
functional annotation (CAFA) was aimed at increasing 
progress in the fi eld. We present an independent as-
sessment of the results of CAFA, aimed at identifying 
challenges in assessment and at understanding trends 
in prediction performance. We found that well-accept-
ed methods based on sequence similarity (i.e., BLAST) 
have a dominant effect. Many of the most informative 
predictions turned out to be either recovering existing 
knowledge about sequence similarity or “post-dictions” 
already documented in the literature. These results in-
dicate that deep challenges remain in even defi ning 
the task of function assignment, with a particular dif-
fi culty posed by the problem of defi ning function in a 
way that is not dependent on either fl awed gold stan-
dards or the input data itself. In particular, we suggest 
that using the GO (or other similar systematizations of 
function) as a gold standard is unlikely to be the way 
forward.
Schizophrenia Coexpression to Prioritize 
Candidate Variants
RNA coexpression data is commonly used to con-
struct gene networks, but it is often considered to be 
more diffi cult to interpret than protein interactions. 
This is in part due to the lack of consensus on meth-
ods for constructing networks from expression profi les 
and the relatively poor performance of coexpression 
for function prediction, as measured by its ability to 
recapitulate data with GO, KEGG, or other databases. 
On the other hand, coexpression affords a major ad-
vantage over current large-scale protein interaction 
databases: It can be used to create “condition-specifi c” 
networks. Our preliminary results show that by ap-
propriate consideration of data pretreatment, ag-
gregation, and network construction, coexpression 
networks become a powerful tool for gene function 
analysis, on par with or better than protein interaction 
networks in terms of overall properties, while provid-
ing condition specifi city. We leverage these properties 
to examine the role of de novo schizophrenia variants 
in the most comprehensive analysis to date of coex-
pression patterns in schizophrenia, combining seven 
studies of prefrontal cortex in affected individuals and 
unaffected controls.
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HUMAN GENETICS AND GENOMIC MEDICINE
G. Lyon M. Doerfel J. O’Rawe
 P. Kota Y. Wu
Our laboratory focuses on analyzing human genetic 
variation and its role in severe idiopathic neuropsy-
chiatric disorders. We do this by studying large pedi-
grees living in the same geographic location, where 
one can study the expressivity and segregation of vari-
ants in a similar environmental background and with 
fewer population stratifi cation concerns. Toward this 
end, we collect pedigrees in Utah and elsewhere, 
and then use exome and whole-genome sequencing 
to fi nd mutations that segregate with syndromes in 
the pedigrees. We focus on the discovery of families 
with rare diseases and/or increased prevalence of syn-
dromes such as intellectual disability, autism, and 
schizophrenia.
X-Linked Malformation and Infantile 
Lethality Syndrome
M. Doerfel, Y. Wu [in collaboration with T. Arnesen, 
Norway]
We have previously identifi ed a lethal X-linked dis-
order of infancy comprising a combination of dis-
tinctive craniofacial features producing an aged 
appearance, growth failure, hypotonia, global de-
velopmental delays, cryptorchidism, and acquired 
cardiac arrhythmias. The fi rst family was identifi ed 
in Ogden, Utah, with fi ve affected boys in two gen-
erations of family members. A mutation was identi-
fi ed as a c.109T>C (p.Ser37Pro) variant in NAA10, 
a gene encoding the catalytic subunit of the major 
human amino-terminal acetyltransferase (NatA). 
This same mutation was identifi ed in a second un-
related family, with three affected boys in two gen-
erations. This X-linked malformation and infantile 
lethality syndrome has provisionally been named 
Ogden Syndrome, in honor of the hometown where 
the fi rst family resides. This is the fi rst human dis-
ease likely involving a defect in the amino-terminal 
acetylation of proteins, a common (yet vastly under-
studied) modifi cation of eukaryotic proteins carried 
out by amino-terminal acetyltransferases (NATs). 
There is signifi cantly impaired biochemical activity 
of the mutant hNaa10p, suggesting that a reduc-
tion in acetylation of some unidentifi ed proteins by 
hNaa10p might contribute to this disease. There is 
currently very limited knowledge on the functional 
importance of Nt-acetylation at the protein level and 
at the organismal level. We have begun to study these 
processes in mammalian cell culture and yeast, along 
with setting up collaborations involving other model 
organisms.
The Characterization and Analysis of an 
Idiopathic Intellectual Disability Syndrome 
via Whole-Genome Sequencing Analysis
J. O’Rawe, Y. Wu [in collaboration with A. Rope and 
J. Swensen, University of Utah]
We have delineated a new idiopathic syndrome with 
intellectual disability and distinctive facial dysmor-
phology. The propositi are two affected male broth-
ers, aged 10 and 12, respectively, with severe intellec-
tual disability, autism-like behavior, attention defi cit 
issues, and very distinctive facial features, including 
broad, upturned nose, sagging cheeks, downward-
sloping palpebral fi ssures, relative hypertelorism, 
high-arched palate, and prominent ears. Their par-
ents are nonconsanguineous and are both healthy, 
and family history does not demonstrate any other 
members with anything resembling this current 
syndrome. X-chromosome inactivation assays reveal 
skewing in the mother, suggesting the possibility of 
an X-linked disorder. High-density genotyping arrays 
in the mother, father, and two sons have not revealed 
previously known copy-number variants (CNVs) that 
might contribute to the phenotype. Whole-genome 
sequencing has led to the identifi cation of several rare 
variants that are currently being characterized fur-
ther, including in other unaffected members of the 
extended family.
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Expansion of Collection Efforts in Utah
Work done in collaboration with R. Robison and 
C. Johnson, Utah Foundation for Biomedical Research 
and K. Wang, University of Southern California
I have worked during the past year to collect dozens of 
additional families in Utah with severe neuropsychiat-
ric disorders, as part of an Institutional Review Board 
(IRB)-approved protocol at the Utah Foundation 
for Biomedical Research (UFBR). We are collecting 
blood for DNA, RNA, and peripheral blood mononu-
clear cells, with these cells to be used in future experi-
ments to make and characterize pluripotent stem cells. 
For now, we are obtaining genotyping on genomic 
DNA, and we have recently initiated whole-genome 
sequencing of ~50 samples to a depth of  >30× on the 
Illumina HiSeq platform, in an effort to understand 
the genetic basis of these disorders. The illnesses we 
are studying include intellectual disability, autism, 
schizophrenia, and other childhood-onset neuropsy-
chiatric disorders.
Toward More Accurate Variant Calling 
for “Personal Genomes”
J. O’Rawe, Y. Wu [in collaboration with K. Wang, 
University of Southern California]
To facilitate the clinical implementation of genomic 
medicine by next-generation sequencing, it will be 
critically important to obtain accurate and consistent 
variant calls on personal genomes. Multiple software 
tools for variant calling are available, but it is un-
clear how comparable these tools are or what their 
relative merits in real-world scenarios might be. We 
sequenced 15 exomes from four families using the Il-
lumina HiSeq 2000 platform and Agilent SureSelect 
v.2 capture kit, with ~120× mean coverage. We ana-
lyzed the raw data using near-default parameters with 
fi ve different alignment and variant calling pipelines 
(SOAP, BWA-GATK, BWA-SNVer, GNUMAP, 
and BWA-SAMTools). We additionally sequenced a 
single whole genome using the Complete Genomics 
(CG) sequencing and analysis pipeline, with 95% of 
the exome region being covered by 20 or more reads 
per base. Finally, we attempted to validate 919 single-
nucleotide variants (SNVs) and 841 indels, includ-
ing similar fractions of GATK-only, SOAP-only, and 
shared calls, on the MiSeq platform by amplicon se-
quencing with ~5000× average coverage. SNV con-
cordance between fi ve Illumina pipelines across all 15 
exomes is 57.4%, whereas 0.5%−5.1% variants were 
called as unique to each pipeline. Indel concordance 
is only 26.8% between three indel calling pipelines, 
even after left-normalizing and intervalizing genomic 
coordinates by 20 bp. Eleven percent of CG variants 
that fall within targeted regions in exome sequencing 
were not called by any of the Illumina-based exome 
analysis pipelines. On the basis of targeted amplicon 
sequencing on the MiSeq platform, 97.1%, 60.2%, 
and 99.1% of the GATK-only, SOAP-only, and shared 
SNVs can be validated, but only 54.0%, 44.6%, and 
78.1% of the GATK-only, SOAP-only and shared 
indels can be validated. Additionally, our analysis of 
two families, one containing four individuals and the 
other containing seven, demonstrates additional ac-
curacy gained in variant discovery by having access 
to genetic data from a multigenerational family. Our 
results suggest that more caution should be exercised 
in genomic medicine settings when analyzing indi-
vidual genomes and that more scrutiny should occur 
when interpreting positive and negative fi ndings, es-
pecially for indels. 
Identifying Disease Mutations in Genomic 
Medicine Settings: Current Challenges and 
How to Accelerate Progress
Work done in collaboration with K. Wang, University 
of Southern California
The pace of exome and genome sequencing is accel-
erating, with the identifi cation of many new disease-
contributory mutations in research settings, and it is 
likely that whole-exome or whole-genome sequencing 
could have a major impact in the clinical arena in the 
relatively near future. However, the human genomics 
community is currently facing several challenges, in-
cluding phenotyping, sample collection, sequencing 
strategies, bioinformatics analysis, biological valida-
tion of variant function, clinical interpretation and 
validity of variant data, and delivery of genomic in-
formation to various constituents. In light of this, I 
worked with my collaborator Kai Wang on a compre-
hensive review of these challenges and summarized 
the bottlenecks for the clinical application of exome 
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and genome sequencing. We also suggested ways for 
moving the fi eld forward, including the need for clin-
ical-grade sample collection, high-quality sequenc-
ing data acquisition, digitalized phenotyping, rigor-
ous generation of variant calls, and comprehensive 
functional annotation of variants. Additionally, we 
suggested that a “networking of science” model en-
couraging much more collaboration and online shar-
ing of medical history, genomic data, and biological 
knowledge, including among research participants 
and consumers/patients, will help establish how cer-
tain mutations may contribute to the development of 
certain phenotypes.
A Proposal for an Analytic-Interpretive Split 
(or a So-Called “Distributive Model”) Across 
Both Clinical and Research Genomics
Work done in collaboration with J. Segal, New York 
Genome Center
I have been working on a policy piece related to 
the fi eld of clinical genomics. In brief, the United 
States federal government mandates that any labora-
tory performing tests on human specimens “for the 
purpose of providing information for the diagnosis, 
prevention, or treatment of any disease” must satisfy 
the conditions set forth in the Clinical Laboratory 
Improvement Amendments (CLIA) of 1988. Most 
laboratories in academic research settings do not 
have suffi cient standards in place to qualify them for 
CLIA approval. At the time CLIA was enacted, the 
separation of the clinical and research worlds seemed 
a fairly straightforward proposition. But today, the is-
sues we face from a regulatory and ethical standpoint 
around genomics stem from the simple question: 
What do we do when it becomes diffi cult to draw 
a clear line of distinction between these two types 
of laboratory practices, particularly when researchers 
are working directly with families? Families affl icted 
with rare genetic disorders now have a reasonable 
expectation of defi nitive and potentially actionable 
results on the order of days to months, and all such 
families regardless of diagnosis are candidates for a 
relatively standardized genomic (rather than disease-
specifi c mechanistic) analysis.
Clearly, history has shown that the quality of un-
regulated diagnostics is susceptible to perverse market 
forces, as many prior poor practices can be tied direct-
ly to economic confl icts of interest. At a minimum, 
CLIA erects standards to protect laboratories from 
these forces and provides an enforcement structure. 
The fi eld would be prudent to embrace this protec-
tion, in light of the ongoing commoditization of se-
quencing and its associated potential for severe price 
competition.
As a solution, we are proposing an analytic-in-
terpretive split (or a so-called “distributive model”) 
across clinical genomics. This split model simply 
means that one laboratory performs sample process-
ing/sequencing and then downstream laboratories 
can perform the interpretation and reporting. Thus, 
together, the laboratories perform all the functions 
that make up a laboratory test. The practical effect 
of this split would be to turn an exome or genome 
sequence into a discrete deliverable clinical unit that 
could be used for multiple purposes by downstream 
labs. The raw data, if individually approved, could be 
uploaded to electronic health records or other online 
sources, allowing its use in downstream investigative 
analysis. Another overlooked benefi t of performing 
more standardized genome sequencing would be its 
effect on resultant data sets, and the community’s 
resultant confi dence therein. Enacting the type of 
split described herein allows organizations to lever-
age their strengths in sequencing or bioinformatics, 
thus lowering costs across the entire process. It will 
also help to provide guidance to the many rapidly 
proliferating laboratories devoted to clinical genomic 
data mining. However, it is essential that we think of 
these companies as laboratories, even if they may be 
separate from the wet lab. Their postanalytic process-
ing would simply be an extension of a prior wet-lab 
process, and thus included as a core component of a 
medical test.
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DEVELOPMENT OF NEXT-GENERATION SEQUENCING TECHNOLOGY
W.R. McCombie E. Antoniou G. Cheang E. Ghiban S. Lata S. McCarthy R. Solomon
 N. Azamy A. DeSantis M. Gierszewska D. Lewis P. Mocombe S. Teng
 M. Bell P. Deshpande M. Kolli J. Marchica S. Muller J.C. Yao
 Y. Berstein S. Ethe-Sayers M. Kramer S. Mavruk J.S. Parla
In 2012, we continued to expand our sequencing capac-
ity, but we focused primarily on improving effi ciency, 
analyzing data, and developing new technologies to 
meet the challenges we have found in our work to date. 
In the cognitive genomics area, we completed the anal-
ysis and submitted for publication the results of our 
fi rst large-scale study: the sequencing of the Disrupted-
In-Schizophrenia 1 (DISC1) gene in more than 1500 
individuals. We have also sequenced ~62 genes that 
interact with DISC1 in the same samples, and analysis 
of these data is ongoing. We continued the analysis of 
several extended pedigrees that were highly burdened 
with psychiatric disorders. In collaboration with scien-
tists at Trinity College, Dublin, we also carried out a 
project to sequence the exomes of families that have a 
schizophrenic child and unaffected parents.
In all of these projects, we anticipate the need for a 
very effi cient way to test a small number of genes for 
variants in a large number of people and have made 
signifi cant strides this year in developing a method to 
carry this out.
In cancer genetics, we submitted our study of Bar-
rett’s esophagus and esophageal cancer for publica-
tion, and in plant genomics, we made a signifi cant 
contribution to the fi rst version of the gene content of 
wheat, which was published in 2012.
Targeted Resequencing of the Human 
DISC1 Gene Using Long-Range PCR 
and Illumina Sequencing
J.S. Parla, M. Kramer, S. McCarthy, J.C. Yao, E. Ghiban, W.R. 
McCombie [in collaboration with D. Blackwood, D. Porteous, 
P. Thompson, and I. Deary, University of Edinburgh; 
P. Visscher and A. McRae, University of Queensland]
DISC1 has been an important gene in understanding 
the genetics of psychiatric disorders. In previous annual 
reports, we described the sequencing of this region in 
more than 1500 individuals (221 bipolar disorder, 240 
schizophrenia, 192 major depression, and 889 controls).
In 2012, our collaborators used TaqMan assays to 
check for segregation of interesting, rare single-nu-
cleotide variants in extended family members. There 
was evidence of segregation of the noncoding variant 
rs16856199 with depression in family members of the 
probands, but the result was not replicated in a second 
population sample set. Samples from the Lothian Birth 
Cohort (LBC) had quantitative measures of mood, in-
telligence, and cognitive aging. Our collaborators found 
nominal associations in the LBC sample for burden of 
minor alleles in conserved transcription-factor-binding 
sites with measures of depression, as well as burden of 
minor alleles in coding or CpG regions with cognition. 
Finally, pairwise epistatic analysis of DISC1 single-nu-
cleotide polymorphisms (SNPs) indicated nominally 
signifi cant interactions in cases versus controls.
There were two main fi ndings of the study. A rela-
tively common SNP in an intron of the DISC1 gene 
(rs16856199) is nominally associated with major de-
pression. In addition, we identifi ed several extremely 
rare variants that appear to be seen only or almost ex-
clusively in psychiatric patients. One of these, R37W, 
has been seen by another group of investigators in an-
other patient and not in more than 10,000 controls in 
a variety of projects. Several of these variants appear 
to largely segregate with illnesses in other members of 
the family of the individual we originally sequenced. 
We completed fi nal analysis of the data in 2012 and 
the manuscript was submitted to Molecular Psychiatry.
Targeted Resequencing of the DISC1 
Interactome Using Solution-Based Hybrid 
Selection and Illumina Sequencing
S. Teng, S. McCarthy, M. Kramer, W.R. McCombie 
[in collaboration with D. Blackwood, D. Porteous, 
P. Thompson, and I. Deary, University of Edinburgh; 
A. McRae, University of Queensland]
The DISC1 Interactome is a term we use to describe 
the network of genes that interact with DISC1. These 
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genes converge on pathways critical for neuronal signal-
ing and genes important in the treatment of schizo-
phrenia, bipolar disorder, and major depression. 
Structural rearrangements in several genes that inter-
act with DISC1, such as PDE4B and NDE1, have been 
implicated in psychiatric and cognitive disorders; 
therefore, it is possible that mutations in other genes 
constituting the DISC1 interactome may also be of 
large effect and signifi cantly increase the risk of psy-
chiatric disorders. In collaboration with the Universi-
ty of Edinburgh, we resequenced, in 1554 samples, the 
exons, promoters, and conserved regions of 262 genes 
that are known to directly interact with DISC1 or that 
are part of functional biological pathways related to 
DISC1 interactome activity.
To specifi cally enrich and resequence the 262 genes 
of the DISC1 interactome, in the previous year, we 
worked with Roche NimbleGen to develop a custom 
solution capture probe set that took advantage of a bal-
anced probe-target selection. This probe set selectively 
targeted 13 Mb (0.4%) of the human genome rep-
resenting each exon, promoter, and conserved region 
20 kb proximal and distal of all DISC1 interactome 
genes. Exons of every isoform were obtained from 
Ref-Seq and the UCSC Gene List (hg18). Promoters 
were defi ned as 2 kb upstream of each gene, whereas 
conserved regions were defi ned as runs of 10 bp or 
greater with an average score equal to or greater than 
0.3 based on phastCons 44-way nucleotide-wise (Siepel 
et al., Genome Res, 15: 1034 [2005]) conservation values.
During fall 2012, we fi nished sequencing the 
DISC1 interactome in 1554 individuals representing 
241 patients with schizophrenia, 222 patients with bi-
polar disorder, 192 cases with unipolar depression, and 
899 healthy controls. About one-third of these were 
done in 2011 and the rest were carried out in 2012. 
Given the target size and HiSeq 2000 sequencing ca-
pacity, we sequenced 16 barcoded samples across three 
lanes of a HiSeq 2000 fl owcell and achieved greater 
than 20× coverage for 80% of the target in more than 
95% of the samples.
We took advantage of the sample overlap between 
the DISC1 sequencing and interactome projects and 
used our previous Sanger sequencing validations in 
the TRAX/DISC1 region to determine sensitivity and 
specifi city and to establish variant fi ltering criteria. In 
total, we have detected 317,807 single-nucleotide vari-
ants (SNVs), of which 248,415 have a minor allele fre-
quency of less than 1%. Approximately 1.8% of these 
rare variants are nonsynonymous. We are currently 
evaluating additional data-quality measures and im-
plementing several association approaches to analyze 
the frequency distribution of variants between cases 
and controls. In addition to burden and main effect 
analyses, we aim to analyze epistatic interactions be-
tween genes, perform multivariant analysis of avail-
able cognitive information, and use expression data to 
prioritize variants and genes for functional follow-up.
Investigation of Bipolar Disorder Genetics 
Using Exome Capture and Resequencing
J.S. Parla, S. Muller, G. Cheang, M. Kramer, E. Ghiban, W.R. 
McCombie [in collaboration with J. Potash, University of 
Iowa; P. Zandi, F. Goes, R. Karchin, and A. Chakravarti, 
Johns Hopkins School of Medicine]
Bipolar disorder I (BP) is a major mental illness with a 
signifi cant genetic component. Approaches that are ca-
pable of effectively identifying and studying rare vari-
ants associated with BP are necessary. We are applying 
exome capture and massively parallel sequencing to-
ward fi nding rare genetic variants that contribute to BP. 
In 2012, we scaled up exome capture and sequencing in 
this project to ~100 samples per week and brought our 
sample data set totals to 62 family subjects, 497 bipolar 
cases, and 470 controls. Our production workfl ow was 
predominantly two samples per exome capture and four 
exome-captured samples per HiSeq 2000 lane, but the 
end of 2012 marked our positive validation of a higher-
throughput workfl ow with six exome-captured samples 
per HiSeq 2000 lane. In 2013, we anticipate further 
developments in our production sample preparation 
and sequencing workfl ow to support increased sample 
pooling at both the exome capture and sequencing lev-
els. Our goal is to increase sample multiplexing while 
still maintaining a minimal exome coverage threshold 
of 80% at 20× sequencing depth per sample.
Our production workfl ow also involves a standard-
ized GATK-based sequence analysis pipeline that 
produces capture performance metrics and SNV and 
small indel calls. Once the sequence data are fully pro-
cessed through our analysis pipeline, we will maintain 
a shared repository enabling all three institutions to ac-
cess the full genotype and variant call data. With the 
close of 2012, we started reviewing the changes and 
updates made to the GATK package by the Genome 
Sequencing and Analysis (GSA) group at the Broad 
Institute to determine which of the changes we should 
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apply to our standardized analysis pipeline. Once the 
pipeline updates and parameter adjustments are vali-
dated for this project’s aims and the full study sample 
set, the updated pipeline will go into use immedi-
ately. In addition to the sequence analysis pipeline for 
identifying high-confi dence genetic variants, we have 
implemented a standard sample data QC workfl ow 
that involves gender validation, principal component 
analysis to test for any population or otherwise broad 
inconsistencies, and Mendelian testing for the samples 
known to be genetically related. Another QC measure 
we plan to add to our sample QC is testing for Hardy-
Weinberg equilibrium of observed allelic frequencies.
The bioinformatics analysis of the genetic variants 
identifi ed to date in this study has been more family-
focused due to our need for signifi cantly greater num-
bers of case-control subjects to perform association 
analysis. We began with a variant segregation analysis 
with the family samples to identify candidate genes. To 
further investigate our family linkage fi ndings, addi-
tional families and extended pedigrees were chosen to 
genotype 37 SNVs contributing to the linkage signals 
we observed for the 10 top-ranked candidate genes we 
identifi ed. The results of those genotyping assays did 
not support signifi cant association of those genes with 
BP, thus underscoring the need for greater numbers of 
study subjects and further refi nement of our analysis 
strategy. Those candidate genes were also assessed in 
the case-control subjects for possible corroboration of 
phenotype association, using several variant weight-
ing and pathway analysis approaches, and the fi ndings 
have not supported association. We expect to obtain 
more robust results with increased data sets, which we 
plan to fi nalize in 2013. However, this is a challenge 
faced by the fi eld as a whole. It is likely that very large 
numbers of samples will need to be analyzed to fi nd 
signifi cant signals. With this in mind, we have been 
focusing considerable effort on developing ways to se-
quence relatively small regions of the genome, such as 
~100 genes in thousands of people.
Highly Multiplexed Targeted Resequencing 
of Sub-Million Base Genomic Targets
J.S. Parla, P. Deshpande, S. Ethe-Sayers, J. Marchica, 
M. Kramer, E. Ghiban, W.R. McCombie
We and other investigators are fi nding potentially 
important candidate genes for complex traits such as 
schizophrenia, bipolar disorder, and autism through 
genome and exome sequencing projects. However, 
there is a great remaining challenge in the fi eld to 
demonstrate the signifi cance of variants in these genes 
or genomic regions in very large numbers of individu-
als. As of now, technology does not exist to allow the 
sequencing of a small part of the genome (0.5 million 
to 5 million bases) in large numbers of individuals 
(1000s to 10,000s). We are making a focused effort to 
develop this capability.
To address the apparent incompatibility between 
the genetic discovery and large-scale population study 
phases, we have been developing a method that adapts 
the highly successful solution exome capture meth-
odology to signifi cantly smaller genomic targets. Our 
goals for developing our microtargeting technique 
include the minimal modifi cation of existing com-
mercial solution exome capture techniques and the es-
tablishment of maximal sample multiplexing capability 
at the capture level, which should support a straight-
forward experimental design and candidate validation 
strategy. We have initiated the development of our 
method with the commercial capture platform with 
which we have had the most success (namely, SeqCap 
EZ from Roche NimbleGen), and a selection of fi ve 
human genes that were identifi ed in a preliminary 
analysis of pilot exome data we produced for one of our 
bipolar disorder projects. The fi nal approved probe de-
sign targeted a cumulative 637,760 bp of the fi ve full-
length genes and was predicted to capture 92.6% of 
the target given a 100-base offset window accounting 
for library insert length. In 2012, we successfully vali-
dated signifi cant sample multiplexing at the capture 
level, with up to 96 uniquely barcoded samples per 
NimbleGen custom capture and one 96-plex capture 
per HiSeq 2000 lane. Our workfl ow produced ~80% 
of sequence reads mapping on or near the target probe 
regions, ~90% of the target covered at ≥20× sequence 
depth, and ~200× mean target depth per sample per 
capture. These results indicated that the HiSeq 2000 
data capability per lane supported even greater num-
bers of samples than 96. Thus, by the end of 2012, we 
started considering additional ways to increase sam-
ple multiplexing, beyond just maximizing our use of 
available sample library barcodes. One possible meth-
od we started testing involves sample pooling prior to 
barcoding and then barcoding each pool of samples. 
This layered approach allows the pooling of greater 
numbers of samples in capture and sequencing while 
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still maintaining barcode uniqueness in the sample 
pools. This method is dependent on intuitive sample 
pooling (e.g., pooling cases and controls separately) 
and a modifi ed sequence data analysis pipeline with 
parameters adjusted for input data containing more 
than one sample. An alternative sample layering ap-
proach we hope to evaluate in 2013 also involves pre-
barcode sample pooling, but the pooling is performed 
in a two-dimensional matrix-dependent manner that 
supports the direct pairing of an observed genotype 
with a specifi c sample, granted that the variant is ob-
served uniquely from each dimension of the matrix 
(i.e., from one row and one column only). Notably, the 
latter method is more intuitively relevant for study-
ing rare genetic variants, and if we are able to validate 
both of the sample-layering methods described above, 
then we could choose among them accordingly, de-
pending on the aims of specifi c projects.
Exome-Based Sequencing of Parent 
Offspring Trios with Schizophrenia
S. McCarthy, J. Gillis, M. Kramer, W.R. McCombie 
[In collaboration with D. Morris and A. Corvin, 
Trinity College, Dublin]
During the past 6 years, there has been a resurgence 
of interest in understanding the impact of rare varia-
tion underlying disease risk and causality, especially 
for psychiatric conditions such as autism and schizo-
phrenia. This rapidly growing interest has been infl u-
enced by the below-expected contribution of common 
variation to the genetic risk of diseases prevalent in 
the population and by the work done here at CSHL, 
which has shown that the rate of new novel muta-
tions, in the form of copy-number variants (CNVs), 
is signifi cantly greater in autism, bipolar disorder, 
and schizophrenia. In addition, advances in genomic 
technologies and DNA sequencing here at the Labora-
tory have enabled us to search for de novo mutations 
at an unprecedented throughput and at a resolution 
that allows us to identify single genes that can provide 
signifi cant insight into the pathobiology of all genetic 
diseases.
In collaboration with Trinity College Dublin, we 
used hybrid selection to target and resequence the 
human exome in 42 parent-offspring patients with 
schizophrenia in search of de novo mutations that could 
affect the function of protein-coding genes potentially 
underlying the pathobiology of the disease. The exomes 
of each proband and parent were captured using Roche 
NimbleGen SeqCap EZ v2 probes and sequenced to 
a mean depth of 20x over 80% of the exome target 
using Illumina’s HiSeq 2000. We identifi ed 47 de novo 
single-nucleotide mutations with, on average, 1.12 de 
novo events per trio, which is not different from our 
expectations. Interestingly, a prominent feature of our 
data was the overlap between genes with de novo mu-
tation and genes implicated in autism and intellectual 
disability (p <10−3). The overlap with autism was the 
greatest of 203 Neurocarta phenotypes (defi ned by 20 
or more associated genes) and determined by de novo 
mutations that possibly affect the function of CHD8, 
MECP2, MKL2, AUTS2, HUWE1, and MLL2. This 
fi nding supports previous genetic and epidemiologi-
cal studies that suggest a shared genetic component 
between schizophrenia and autism. However, in con-
trast to CNVs, this work highlights single genes for 
in-depth functional analysis.
Notably, several of the genes with de novo muta-
tions have a signifi cant role in reading and editing of 
chromatin and methylated DNA, for example, CHD8, 
MECP2, and MLL2. We therefore tested the hypoth-
esis that genes with likely functional de novo variants 
were enriched in chromatin remodeling. Five genes—
CHD8, MECP2, MLL2, TDRD5, and NUP98—sig-
nifi cantly clustered (p = 8.5 × 10−3) among a list of 
433 curated chromatin remodelers (provided by Chris 
Vakoc), suggesting that perturbations of epigenetic 
mechanisms that control gene expression could be sig-
nifi cant risk factors in the neurodevelopment of psy-
chiatric illnesses. In light of studies demonstrating 
that novel antidepressants target the epigenetic mech-
anisms controlling the expression of genes associated 
with depression, our results suggest possible avenues 
for developing novel antipsychotics and therapeutics 
for improving the cognitive defi cits in mental illness.
Finally, we combined the power of next-generation 
sequencing in schizophrenia trios with a meta-analysis 
of gene expression data to analyze the coexpression 
patterns of our genes with likely functional de novo 
variants. Surprisingly, we found that our genes dem-
onstrated signifi cantly lower coexpression with other 
genes in the prefrontal cortex compared to the other 
brain and nonbrain regions. This reduced coexpression 
is lower than that of randomly selected genes and sup-
ports hypotheses that genes with loss-of-function mu-
tations express lower connectivity. Our novel analysis 
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demonstrates the potential of combining orthogonal 
and complementary genomic analyses to elucidate the 
function of genes for which little is known. Going 
forward, we aim to expand this study of de novo vari-
ants in additional trios with schizophrenia and priori-
tize genes based on their role in chromatin remodeling 
and the neurodevelopment of psychiatric diseases using 
neurons derived from patient-specifi c induced pluripo-
tent stem cells.
Discovery of Genetic Variation Underlying 
Major Depressive Disorder and Co-Morbid 
Edema
W.R. McCombie, S. McCarthy, M. Kramer, E. Ghiban [In 
collaboration with D. Blackwood, M. Ayub, D. Porteous, 
and P. Thompson, University of Edinburgh]
Major depressive disorder (MDD) is a debilitating dis-
order that affects more than 10% of the US popula-
tion. Despite having a genetic component, uncovering 
genetic variants in MDD has been limited. We are 
analyzing four families burdened with MDD and a 
crippling co-morbidity, idiopathic edema, which is 
an unexplainable swelling of the face, extremities, 
breasts, and abdomen.
A previous linkage analysis by our collaborators of 
four pedigrees co-morbid for MDD and idiopathic 
edema identifi ed three potential regions of interest on 
chromosomes 7, 8, and 14. Of the 47 affected individ-
uals examined, 28 had both MDD and unexplained 
swelling, whereas eight had MDD only and 11 had 
unexplained swelling only.
Beginning in late 2011 and continuing in 2012, 
we sequenced the entire genome of 19 members across 
these four families to discover genetic variation that 
may increase the risk of MDD and pinpoint variants 
that could be implicated in the causality of idiopathic 
edema. Of these 19 individuals, 12 have both major 
depression and edema, three have edema but not de-
pression, one has depression but not edema, and three 
are controls with neither depression nor edema. Illumi-
na libraries were constructed and 100-bp paired-end 
sequences were obtained on the HiSeq 2000. Reads 
were aligned to the human reference (UCSC hg19) 
and variants relative to the reference were detected. 
For each of the samples sequenced, the mean coverage 
is greater than 30×, and more than 80% of the ge-
nome is represented by at least 20 reads. As a fi rst step, 
we determined the intersection of variants in affected 
individuals within each family, eliminating variants 
found in unaffected relatives. We are continuing to 
analyze these data by prioritizing genes with segregat-
ing variants for validation and looking for any overlap 
among families. We are also expanding the analysis 
by grouping individuals across families by diagnosis.
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PLANT GENOME ORGANIZATION, EVOLUTION, AND FUNCTION
D. Ware J.-M. Chia Y.K. Lee S. Pasternak S. Wei
 A. Eveland C. Liseron-Monﬁ ls J. Stein K. Youens-Clark
 Y. Jiao Z. Lu J. Thomason L. Zhang
 M. Karey Monaco C. Noutsos P. Van Buren Z. Zhang
 S. Kumari A. Olson L. Wang 
Our lab has dual goals of conducting plant genom-
ics research and developing genomics resources and 
discovery tools for use by the broader research com-
munity. Research includes a broad range of activities 
in physical, statistical, and functional genomics in 
both model systems and crop plants, with applica-
tions in agriculture. Our lab also contributes to two 
large-scale multi-institutional cyberinfrastructure col-
laboratives that are designed to serve broader research 
and educational communities. During the past year, 
we were joined by visiting scientist Zhiming Zhang 
and postdoctoral researchers Yinping Jiao and Chris-
tophe Liseron-Monfi ls. Jer-Ming Chia has advanced 
his career, taking a position in the industry sector.
Gramene
Y. Jiao, S. Kumari, M. Karey Monaco, S. Pasternak, J. Stein, 
J. Thomason, S. Wei, K. Youens-Clark [in collaboration 
with P. Jaiswal, Oregon State University; P. Kersey and 
H. Parkinson, EMBL-European Bioinformatics Institute; 
L. Stein, Ontario Institute of Cancer Research; C. Taylor, 
American Society of Plant Biologists; E. Buckler, USDA, 
Cornell University; S. McCouch, Cornell University]
Gramene is a collaborative project that leverages se-
quence and functional information from plant refer-
ence genomes to promote research and translational 
genomics in agriculture and its various applications, 
including food and biofuel production. The Gramene 
website (http://www.gramene.org) serves as a portal 
to multiple genome browsers and manually curated 
databases of genes, proteins, biochemical pathways, 
quantitative trait loci (QTL), ontologies, germplasm, 
and genetic diversity data. In the last year, our group 
completed several milestones on the Gramene proj-
ect, including its 35th and 36th releases since 2012. 
Of the many improvements made, we increased the 
number of partial and complete sequenced genomes 
in our Ensembl genome browser to 23 scientifi cally 
and economically important species including rice, 
corn, tomato, potato, sorghum, barley, soybean, poplar, 
grape, banana, and the unicellular green alga Chlam-
ydomonas reinhardtii. Gramene is also home to refer-
ence sequences for three cultivated and eight wild spe-
cies of rice, making it the single most comprehensive 
genus-level (Oryza) resource in plants. Gramene is also 
positioning itself as a principal resource for conducting 
population-based genetics research. We added several 
new diversity/phenotype data sets covering Arabidopsis, 
rice, and maize, and have added new tools for querying 
single-nucleotide polymorphisms (SNPs) and visualiz-
ing genome-wide association studies. In addition, we 
used the Ensembl 69 infrastructure to include multi-
species views from whole-genome alignments, synteny 
maps, browsable phylogenetic gene trees highlighting 
Gene Ontology functional descriptors, and SNP views 
that display diversity data in the context of functional 
impacts on gene structure. All of this work has contrib-
uted to signifi cantly increased traffi c on the Gramene 
website over the last year from users all over the world. 
Our databases are created in partnership with the 
 European Bioinformatics Institute (EBI), and they are 
now also available through the Ensembl Plants portal. 
In the next year, we will continue to add new reference 
genomes, data sets, and functionalities to this resource.
PLANT GENOME RESEARCH
In the last decade, the decoding of complete plant ge-
nomes has borne fruit for scientists who seek to un-
derstand the complexities of plant function and evolu-
tion, and to affect economically important traits. The 
generation of reference genomes spans many disci-
plines, starting in the laboratory with scientists who 
generate the raw sequence data. From there, it is the 
responsibility of computational biologists and bioin-
formaticians, like those in our lab, to help interpret the 
output. This includes assembly of raw sequence reads 
into overlapping segments, or contigs, and scaffolding 
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these to properly represent their order and orientation 
within chromosomes. Another step is annotation—
the discovery and description of genes and other func-
tional elements, as well homologies to other genomes. 
In addition, this information must be faithfully com-
municated and visualized, for example, in web-based 
platforms such as Gramene. All of these activities are 
rapidly evolving with the advent of new sequencing 
technologies, algorithms, and data-handling require-
ments. For example, high-depth sequencing of RNA 
transcripts at low cost is providing new evidence that 
informs genome annotation, and it is spurring the 
 development of new software to model and perform 
this task. Low-cost sequencing is also transforming the 
types of questions that can be asked, moving beyond 
the generation of a single reference for a given species. 
Ongoing projects within the maize, rice, and Arabidop-
sis research communities are now sequencing hundreds 
and even thousands of genotypic backgrounds within 
species, gathered from carefully constructed popula-
tions, wild populations, and breeding germplasms. 
Information on genetic variation is helping scientists 
to understand the genetic basis of phenotypic traits 
and questions about the origins of domesticated crop 
species. New technologies are also driving research in 
epigenetics, the study of heritable traits that are not 
caused by changes in underlying genome sequence. 
Epigenetic mechanisms include modifi cation of DNA 
by methylation and various forms of histone modifi ca-
tions, which can cause changes in gene expression and 
other phenotypes. Both of these modifi cation types 
can be studied with new sequence technologies and 
analysis methods. Our lab is engaged in many of these 
areas of inquiry. For some species such as maize, we 
are beginning to see how the provision of genome se-
quence, annotation, genetic variation, epigenetic varia-
tion, and transcript expression is converging to bring 
about deeper understanding of genome function.
Updating the Maize Reference 
Genome and Annotation
A. Olson, S. Pasternak, J. Stein [in collaboration with 
J. Glaubitz, Cornell University; E. Buckler, USDA, 
Cornell University; R. Fulton and R. Wilson, Washington 
University; The Maize Genome Sequencing Consortium]
Work continues on refi ning the assembly and annota-
tion of the B73 reference sequence. The RefGen_v2 
assembly and annotations are hosted on Gramene and 
these have been deposited in GenBank along with 
contigs assembled from Roche/454 sequencing of a 
whole-genome shotgun library. RefGen_v3 incorpo-
rates some of these contigs in order to increase cover-
age of missing gene space. Contigs were selected based 
on alignment to FLcDNA sequences and inserted into 
gaps in the RefGen_v2 assembly guided by a genetic 
map and synteny to rice and sorghum. Approximately 
500 genes were added or improved with new annota-
tion. A number of unplaced physical map contigs were 
also anchored based on these maps. The RefGen_v3 
assembly will be released following acceptance by 
GenBank. Work on RefGen_v4 is also under way. To 
improve the maize genome sequence, we are adding 
additional depth to the existing capillary sequence 
using the Illumina 2000. We are resequencing 17,173 
BACs (bacterial artifi cial chromosomes) that consti-
tuted the minimal BAC tiling path from the origi-
nal B73 sequencing project by pooling the BACs in 
pools of 96 and generating Illumina data to greater 
than 150× coverage per clone. This increased depth, 
density of read pairs, and differential bias compared to 
capillary sequencing will serve as an excellent resource 
to further improve the maize sequence. These data, 
once completed, will be made available through pub-
lic databases prior to completion of the RefGen_v4 
assembly.
Tackling Wheat
J. Stein, S. Pasternak, A. Olson [in collaboration with 
J. Dvorak and M.C. Luo, University of California, Davis; 
O. Anderson, University of California, Davis/USDA-ARS, 
Albany; B.S. Gill, Kansas State University; W.R. McCombie 
and M. Schatz, Cold Spring Harbor Laboratory]
One of the great frontiers in plant genomics is to 
determine the complete sequence of bread wheat, 
Triticum aestivum. From its early domestication in 
the Fertile Crescent, large-scale cultivation of wheat 
enabled the rise of human civilization and the forma-
tion of city-based societies. Today, it remains one of 
the most important food crops worldwide, grown on 
more land area than any other crop, and is a leading 
source of calories and protein in the human diet. Bet-
ter understanding of the wheat genome will enhance 
future breeding efforts to perpetuate its critical role 
in feeding the world. Consistent with its superlative 
nature, wheat also represents the most challenging 
plant genome to be attempted to date by scientists. 
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At 16,000 million base pairs, its nuclear genome is 
twice the size of human, eight times the size of maize, 
and 40 times the size of rice. One explanation for its 
imposing size is that wheat is hexaploid—i.e., it con-
tains not one but three genomes, termed A, B, and 
D, that were brought together through hybridization 
of closely related diploid species during domestica-
tion. Because the three genomes are actually quite 
closely related, it is diffi cult to assign genes to their 
appropriate genome. Making matters more complex, 
the wheat genome is also one of the most repetitive, 
with ~90% of its content bloated with transposable 
elements that obscure the discovery of functioning 
genes. These facts have necessitated multiple interna-
tional initiatives to sequence wheat, overseen by the 
International Wheat Genome Sequencing Consor-
tium (IWGSC), wherein individual chromosomes 
have been divvied up for work by individual labs. 
Our lab is a collaborator on the National Science 
foundation (NSF)-funded project to physically map 
chromosomes 1D, 4D, and 6D of bread wheat (cul-
tivar Chinese Spring) and all seven chromosomes of 
the closely related species Aegilops tauschii. This latter 
species is highly informative because it is the diploid 
progenitor of the wheat D genome. Now complete, 
the project has produced physical maps containing 
almost three-quarters of a million BACs, positioned 
relative to one another by a restriction enzyme fi n-
gerprinting method. The project has also produced 
the fi rst high-resolution genetic map of Ae. tauschii, 
with more than 7000 sequenced markers that are an-
chored to the physical map. These maps are sched-
uled for public release this year via the Gramene web 
portal. Gramene will also display comparative maps 
between the D genome and other grass reference ge-
nomes to enable study of gene function and evolu-
tion (Fig. 1). Together, the information and physical 
reagents produced by this project will help lead the 
way for future research in wheat genomics. Funded 
by a second NSF grant, CSHL is pioneering the dis-
covery of wheat genes by using ultra-high-through-
put sequencing technologies and rapidly releasing 
these data to the scientifi c community. In this whole-
genome shotgun approach, enormous quantities of 
sequence data can be generated in a cost-effective 
manner. To date, the McCombie lab has deposited 
more than 850 gigabases (~200-fold coverage) of Ae. 
tauschii to the NCBI Sequence Read Archive (SRA). 
Similar numbers have been deposited for Triticum 
monococcum, the diploid progenitor of the wheat AA 
genome. Efforts are under way in our lab to assem-
ble these sequences and build scaffolds to describe 
the gene content of these genomes. Using physical/
genetic maps such as those described above, and by 
comparative mapping to other grass species, we have 
positioned many of the genes to their location in the 
genome. Results will be released via a browser within 
Gramene. Work by CSHL complements extensive 
research efforts taking place worldwide that together 
will ultimately tackle the wheat genome.
The Maize Methylome
Z. Lu, A. Olson, S. Pasternak [in collaboration with 
R. Martienssen, J. Hicks, W.R. McCombie, M. Regulski, 
and J. Kendall, Cold Spring Harbor Laboratory; 
Scott Tingey and Antoni Rafalski, Pioneer/DuPont]
DNA methylation has an important role in the regu-
lation of gene expression and control of transposable 
elements. The patterns of DNA methylation, referred 
to as the methylome, must be faithfully propagated 
Figure 1. Pairwise comparative map between genomes of Aegil-
ops tauschii (the wheat D genome) and rice (Oryza sativa). The 
matrix shows collinear genes based on the integrated genetic 
and physical map for Ae. tauschii produced by the NSF-funded 
wheat D genome-mapping project (PI Jan Dvorak; co-PIs, Do-
reen Ware and others). Genetic distances for Ae. tauschii are 
shown with each tick-mark corresponding to 10 cM. Physical 
distances are plotted with each tick-mark corresponding to 10 
Mb for Ae. tauschii and 2 Mb for rice.
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for proper development in plants and animals. We 
are collaborating with the Martienssen lab and Du-
Pont to sequence the methylome of two maize inbred 
lines, B73 and Mo17 (Fig. 2). The genomic DNA is 
treated with bisulfi te, which converts unmethylated 
cytosine to thymine. Sequencing using next-gener-
ation Illumina GA2 paired-end reads, followed by 
mapping back to the maize genome, resulted in iden-
tifi cation of the methylome in single-base resolu-
tion. We have generated 20×–30× coverage over the 
mappable portion of the maize genome. Alignment 
with RNA sequences indicates that the methylation 
patterns are correlated with gene expression, small 
RNA, and alternate splicing. Diversity in cytosine 
methylation patterns was observed in transposable 
elements and especially in genes and was found to be 
largely heritable in recombinant inbred lines (RILs). 
However, signifi cant deviations from heritability 
were observed, many of which were conserved in dif-
ferent RILs. In the future, this will help us to reveal 
the roles of DNA methylation in gene regulation and 
other biological functions.
Maize HapMap
J.-M. Chia [in collaboration with E. Buckler, USDA, Cornell 
University; M. McMullen, USDA, University of Missouri, 
Columbia]
Maize breeders have long exploited the diversity in 
maize for improving its yield through selective breed-
ing programs, contributing to its current position at 
the apex of the production crop list. We are in an era in 
which traditional crop breeding techniques are being 
supplemented, and in some cases supplanted, by mo-
lecular breeding approaches that speed up the breeding 
process. Understanding the diversity in maize and how 
it impacts agronomic traits is crucial in implementing 
these new approaches and will be an important plat-
form for sustainable agriculture in the future.
In the previous 2 years, we sequenced more than 
100 inbred lines of the Zea mays genus and wild rela-
tives. The volume of sequences generated per inbred 
line is approximately fi ve times the size of the genome, 
and from these sequences, we have identifi ed vari-
ant loci. Given the complexity of the genome, these 
variations were scored using carefully designed pop-
ulation genetics-based fi lters that leverage the care-
fully  constructed maize breeding populations. In total, 
more than 55 million SNPs were identifi ed. This work 
culminated in two journal publications in Nature Ge-
netics that give insight into the fl uidity of the maize 
genome and factors contributing to the domestication 
and improvement of maize as a crop. This extensive 
variation data set is also displayed and annotated in 
the Gramene browser.
Tracking the Wild Tomato
Jer-Ming Chia, Shiran Pasternak [in collaboration with 
Z. Lippman, Cold Spring Harbor Laboratory]
This work also contributed to the Tomato Genome 
Sequencing Project under the direction of principal 
investigator Giovanni Giuliano (ENEA CR Casaccia, 
Italy), which included multiple coprincipal investiga-
tors and researchers from the United States and inter-
nationally.
To explore variation between the tomato and its near-
est red-fruited relative, together with the Lippman 
lab, we sequenced, analyzed, and assembled a Sola-
num pimpinellifolium genome using Illumina short 
reads. We focused on identifying SNP and insertion/
Figure 2. Distribution of methylated sites within the maize nu-
clear genome. Feature density is given in 1 Mb bins. Coverage 
tracks show average read depth. CpG/CHG/CHH tracks show 
average methylation level. MF track is the methylation ﬁ ltration 
density. Repeats track shows repeat density. Gene track repre-
sents gene density.
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deletion (indel) variation by aligning the quality-
trimmed reads to the pseudomolecule reference of 
the cultivated tomato, S. lycopersicum cv. Heinz. This 
revealed surprisingly low genome-wide diversity, sup-
porting an extremely close evolutionary relationship 
with Heinz that is consistent with S. pimpinellifolium 
serving as the foundation for tomato domestication. 
Assembling the reads into sequence contigs, we see no 
large structural variations between the two genomes. 
This extensive molecular marker database, which is 
now available, makes it possible to access S. pimpinel-
lifolium variation data for crop improvement. In par-
ticular, the diversity in the undomesticated species for 
adaptation and disease resistance will be particularly 
valuable.
Computational Prediction 
and Analysis of Core Promoter 
Elements in Plant Genomes
S. Kumari
Transcription initiation, essential to gene expression 
regulation, involves recruitment of the basal tran-
scription factors to the core promoter elements 
(CPEs). The distribution of currently known CPEs 
across plant genomes is largely unknown. We have 
developed high-throughput in silico methods for 
motif prediction using the publicly available CREAD 
suite of tools. Our computational pipeline system-
atically identifi ed transcription regulation motifs at 
the whole-genome level, including TATA, CCAAT, 
INR, BRE, CG-box, DPE, MTE, and Y-Patch mo-
tif-containing genes across plant genomes. DNA 
free-energy profi les of eight plant genome promot-
ers suggested that monocot core promoters have 
lower DNA free energy than dicot core promoters. 
Functional classifi cation of TATA-containing and 
TATA-less genes based on annotated gene ontologies 
showed enrichment in distinct molecular functions 
and biological processes. Studies on the prediction 
of core promoter elements will help us to understand 
the architecture of core promoters and the mecha-
nisms by which basal transcription machinery func-
tion. This study contributes to our long-term goal 
of elucidating the gene regulatory networks that act 
at the interface of development and response to the 
environment.
PLANT SYSTEMS BIOLOGY
Exploring the Gene Regulatory Network 
Guiding Arabidopsis Stele miRNA Expression
L. Zhang, S. Kumari, Y. Koung Lee, C. Liseron-Monﬁ ls, 
C. Noutsos [in collaboration with S. Brady, University of 
California, Davis]
Plant roots not only serve to physically anchor plants 
to the soil, but also are responsible for uptake of 
water and critical nutrients, and therefore must re-
spond quickly to various environmental stresses such 
as drought, waterlogging, and heavy metal pollution. 
microRNAs (miRNAs) have a central role in plant 
development and in the response to environmental 
stress. We are interested in studying the gene regula-
tory network (GRN) that regulates miRNA expres-
sion in the root. Most miRNAs are transcribed by 
RNA polymerase II, and their transcription  process 
is regulated by transcription factors (TFs). To sys-
tematically resolve points of cross-talk among TFs, 
miRNAs, and their targets in a comprehensive GRN, 
we make use of a gene-centered yeast one-hybrid 
(Y1H) experimental system. The roots of the model 
plant Arabidopsis have rotational symmetry: The stele 
is the central part of the root and is important for 
nutrient transfer. We have developed an automated, 
enhanced Y1H (eY1H) system and a near- complete 
TF library from the Arabidopsis stele (Fig. 3). Using 
this system, we have screened more than 100 pro-
moters of stele-expressed miRNAs, their targets, and 
some highly connected TFs. The resulting network, 
together with published protein–protein interac-
tion data, enabled us to uncover several interest-
ing subnetworks for cytokinin signaling and heavy 
metal homeostasis. To validate in vivo the protein 
and DNA interactions that resulted from the eY1H 
data set, we screened more than 250 T-DNA inser-
tion mutants from Arabidopsis and obtained 80 ho-
mozygous gene-perturbed lines for TFs, miRNAs, 
and miRNA targets. From these, we characterized 
their molecular phenotype by quantifying TF ex-
pression by quantitative real-time PCR (polymerase 
chain reaction) and miRNA expression by Taqman 
miRNA assays. Our results showed that perturba-
tion in planta of ~80% of TFs and 70% of  miRNAs 
 tested displayed molecular phenotypes in the Ara-
bidopsis root. The GRN derived from the root stele 
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will provide a framework for modeling adaptive re-
sponses to environmental conditions at the whole-
plant level. This will facilitate identifi cation of 
candidate genes for improving germplasm that can 
sustain more detrimental conditions, thus addressing 
global food security and growing demand for renew-
able energy resources.
Developmental Networks Controlling 
Inﬂ orescence Architecture in Maize
A.L. Eveland (with contributions by S. Kumari) 
[in collaboration with D. Jackson, Cold Spring 
Harbor Laboratory]
The goal of this work is to integrate genetics and 
 genomics data sets to elucidate molecular networks 
that determine the morphology (architecture) of 
maize infl orescences. Because infl orescences bear the 
fruits and grains that we eat, understanding the ge-
netic and regulatory basis for how these structures are 
formed has clear relevance to important agronomic 
traits such as grain yield and harvesting ability. Our 
data sets represent maize infl orescence primordia 
sampled during key developmental transitions and in 
perturbed ge netic backgrounds. The latter includes 
loss-of-function mutants in three important regula-
tors of the RAMOSA (RA) pathway, which controls 
stem cell fate decisions and ultimately the decision to 
branch. We have established a robust system to inves-
tigate the networks that modulate branching, includ-
ing characterization of precise timing of developmen-
tal events and associated spatiotemporal changes in 
gene expression. We integrated genome-wide mRNA-
Seq data to resolve coexpression networks during key 
stages of maize infl orescence development and are 
working to expand these networks by incorporating 
additional data sets, such as genome-wide TF occu-
pancy profi les and cis-regulatory information.
Primary objectives for this project included the 
following: (1) Establish a comprehensive pipeline for 
mRNA-Seq and chromatin immunoprecipitation se-
quencing (ChIP-Seq) data analysis in maize by evalu-
ating and optimizing available software for mapping 
and quantifi cation. This also included testing various 
statistical methods to extract biological relevance. 
(2) Characterize genome-wide expression signatures 
specifi c to a given developmental event or branching 
phenotype. We made use of known developmental 
marker genes and their spatiotemporal transcription-
al responses to genetic perturbation in order to test 
our experimental system and establish a proxy for 
Figure 3. An Arabidopsis eY1H transcription factor resource. (a) Schematic of root stele cell types. (b) Stele cell-type 
expression proﬁ les of the transcription factors present in our collection. (c) Family categorization of transcription factors 
within the resource. “Other” represents families with fewer than eight members. (GRAS) Gibberellic acid–insensitive, 
repressor of GA1 and scarecrow; (DOF) DNA-binding with one ﬁ nger; (GATA) GATA DNA motif; (HSF) heat shock 
factor; (CO-like) Constans-like; (ARF) auxin response factor; (MADS) MCM1, Agamous, Deﬁ ciens, and SRF box; (HB), 
homeobox; (BZIP), basic leucine zipper. (From Gaudinier et al. 2011. Nature Methods 8:1053–1055.)
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developmental staging. (3) Evaluate and implement 
clustering approaches to identify candidate genes that 
are coexpressed with key regulators and/or coincide 
with specifi c developmental events. Our results from 
this included identifi cation of candidate genes (spe-
cifi cally, developmentally regulated TFs and novel 
genes of unknown function) that are potentially in-
volved in stem cell maintenance and determinacy. 
We continue to interrogate coexpression clusters for 
enrichment of functional processes and cis-regulatory 
motifs that lie within proximity to the transcriptional 
start site of coexpressed genes (with S. Kumari). (4) 
Identify targets of the RA1 TF using ChIP-Seq and 
integrate results with data from parallel mRNA-Seq 
experiments. Based on this approach, we showed that 
one-third of genes with altered expression levels in the 
ra1 mutant are also bound by RA1. We are incorpo-
rating additional ChIP-Seq data sets as they become 
available to investigate combinatorial binding of TFs 
associated with the branching pathway. The ChIP-
Seq data also provide in vivo confi rmation for binding 
sites of developmental regulators in maize, informa-
tion that is being leveraged in efforts to resolve cis-reg-
ulatory modules across the maize genome (S. Kumari, 
D. Ware).
In the next phase, we will further prioritize can-
didates from this work by overlaying the Arabidopsis 
regulatory network information (see previous sec-
tion). The resulting hypotheses can be tested in Arabi-
dopsis, for example, responses to stress, and ultimately 
translated to agronomic systems. Additionally, can-
didate genes that are maize- and/or grass-specifi c are 
of high priority as they may contribute to the unique 
morphology of maize infl orescences and/or features 
shared among other grasses. We will further use com-
parative genomics approaches, including both compu-
tational and integration of analogous RNA-Seq data 
sets from closely related grasses such as sorghum, to 
identify candidate genes that may contribute to grass-
specifi c aspects of infl orescence architecture.
CYBERINFRASTRUCTURE PROJECTS
The iPlant Collaborative
L. Wang, J. Lu, C. Noutsos, J. Stein, Y. Koung Lee
This project is in collaboration with Cold Spring Har-
bor Laboratory and employs more than 100 staff. It is 
headquartered at the University of Arizona, under the 
direction of principal investigator Stephen Goff. Dozens 
of collaborators are located at more than 20 institutions.
Driven by the large-scale generation of data, rang-
ing from genomics to imaging, research in biology 
is increasingly information-based. Lagging behind 
is the ability of individuals to make effi cient use 
of this information due to limitations in data ac-
cess and storage, computational infrastructure, and 
available tools. To tackle big questions in biology, 
researchers also need effective ways to collaborate 
that reach across institutional and disciplinary lines. 
The iPlant Collaborative (http://iplantcollaborative.
org) is an NSF-funded cyberinfrastructure project 
that provides public access to high-performance 
computing, data storage, and tools via customized 
web-based interfaces. Having completed the fi rst 
5-year grant, the iPlant Collaborative has made ex-
tensive progress toward meeting these goals and has 
been recommended for renewing for another 5 years. 
Work in the last year has culminated in the develop-
ment of multiple platforms that are now being used 
by the research and educational communities. Staff 
at CSHL directly contributed to some of these cyber-
infrastructure platforms or have built upon them to 
provide ready access to needed software and analysis 
tools by plant scientists and educators. Within our 
lab, these platforms include the Discovery Environ-
ment (DE), Atmosphere, and the Taxonomic Name 
Resolution Service (TNRS). The DE is perhaps the 
most visible portal to iPlant tools and services. This 
web-based platform supports an “app store” model of 
user-extensible tools, automated workfl ows, and data 
storage. Users can take advantage of existing tools 
integrated by iPlant staff and user community or add 
their own tools to use privately or share. Although 
users may not be aware, the underlying infrastruc-
ture is providing access to iPlant’s massive data store 
at the University of Arizona and the Texas Advanced 
Computing Center (TACC). Computationally inten-
sive tasks are handled by supercomputers located at 
TACC and other centers within the Extreme Science 
and Engineering Discovery Environment (XSEDE). 
So far, well over 300 tools have been integrated into 
the DE that enable a broad range of research activi-
ties, including genome/transcriptome assembly, an-
notation, RNA-Seq quantifi cation, variant detection, 
genome-wide association studies (GWAS), and phy-
logenetics. Members of our lab have had important 
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roles in contributing to workfl ow design, tool integra-
tion, validation, and documentation. Atmosphere is 
iPlant’s cloud infrastructure platform that addresses 
the growing need for confi gurable and cloud-enabled 
computational resources by the plant research com-
munity. From Atmosphere’s web interface, users can 
launch a virtual machine (VM) with preconfi gured 
working environments and ready-to-use software 
precustomized. Users can also create their own ap-
plications and environments as VMs and share with 
others via Atmosphere. As with the DE, Atmosphere 
is a gateway to access iPlant’s core infrastructure 
resources, such as the high-performance and grid 
computing environment and big data storage system. 
Using the Atmosphere platform, we created a VM 
to be used in the fi elds of ecological and functional 
genomics. The VM includes various binary tools 
and R statistics packages used in ecology and genet-
ics research and for plotting complex data in graphs. 
Our lab contributed directly to the development of 
the Taxonomic Name Resolution Service (TNRS), 
a platform to help standardize taxonomic names for 
all plant species—a nontrivial task. Erroneous and 
synonymous taxonomic names are a major challenge 
for virtually every fi eld of plant biology. Large organ-
ismal databases (GBIF, SpeciesLink, VegBank, SAL-
VIAS, TraitNet, GenBank, TreeBASE) are plagued 
by taxonomic error and uncertainty. In some data-
bases, up to 30% of names do not match to any pub-
lished name. Furthermore, 5%–20% of published 
names may be synonymous. Correcting and har-
monizing taxonomy is the time-consuming and ad 
hoc responsibility of the individual researcher. The 
TNRS tool overcomes this barrier, enabling higher-
quality comparative biodiversity science. The TNRS 
is available to other researchers wishing to perform 
similar taxonomic name resolutions on their data 
sets, enabling a wider community to expand the 
public scientifi c knowledge base. The TNRS is cur-
rently available at http://tnrs.iplantcollaborative.org 
and is described in a recent publication in BMC Bio-
informatics. A major mission of iPlant is to promote 
adoption of the cyberinfrastructure through training 
workshops and outreach at academic institutions and 
scientifi c meetings. In 2012, members of our lab par-
ticipated as instructors in several tools and services 
workshops focused on transcriptomics, GWAS, and 
phylogenetics using the DE, Atmosphere, and Data 
Store platforms.
KBase, the Department of Energy Systems 
Biology Knowledgebase
S. Pasternak, J. Thomason, S. Kumari, J.-M. Chia
The Department of Energy Systems Biology Knowl-
edgebase (KBase, www.kbase.us) is a cyberinfrastruc-
ture collaborative led by principal investigator Adam 
Arkin of Lawrence Berkeley National Laboratory 
(LBNL), with co-principal investigators Rick Stevens 
of Argonne National Laboratory (ANL), Robert Cot-
tingham of Oak Ridge National Laboratory (ORNL), 
and Sergei Maslov of Brookhaven National Labora-
tory. In addition to Doreen Ware at CSHL, participat-
ing investigators include Pamela Ronald of the Univer-
sity of California, Davis, Matthew DeJongh of Hope 
College in Michigan, Gary Olsen of the University of 
Illinois at Urbana-Champaign, and Mark Gerstein of 
Yale University. KBase is a software and data environ-
ment designed to accelerate large-scale collaborative re-
search in fi elds that impact bioenergy. KBase leverages 
the power of high-performance and cloud-based com-
puting resources across the DOE system of labs. Built 
on this foundation is a community-driven, extensible, 
and scalable open-source software framework and ap-
plication system. This free and open-access infrastruc-
ture will handle the anticipated rapid growth in data 
volumes and computing requirements necessary for 
predictive modeling in microbes, microbial commu-
nities, and plants. Future functionality will focus on 
metabolic engineering, regulatory modeling, improved 
 annotation, complex querying of microbial communi-
ties, assembly, and network-based functional ortholog 
prediction. Doreen Ware serves as the Plants Science 
Team Lead for KBase. In addition to providing do-
main expertise in plant genomics, members of our lab 
are making signifi cant contributions to software de-
velopment for this project. The Genotype Phenotype 
Workbench provides a platform for users to explore 
various data sets stored in KBase using genome-wide 
association studies as a starting point. The workbench 
is designed for seamless visual interaction across stored 
“omics” data sets. The Network Workbench enables 
users to explore KBase networks using dynamic vi-
sualizations. Users navigate among sets of genes and 
clusters over a variety of network data sets available for 
microbes, plants, and metagenomic communities. The 
IRIS interface allows users to run all of the KBase com-
mand line scripts and useful UNIX tools from a web-
based interface without downloading any software. 
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The interface allows users to keep track of results and 
history by means of the KBase IRIS server. The next 
release of KBase will offer a unifi ed environment en-
abling users to view, query, and download data for mi-
crobes, plants, and microbial communities. Users will 
also be able to apply a series of powerful demonstration 
workfl ows, including genome annotation, metabolic 
modeling, and phenotype analysis.
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Gurinder S. “Mickey” Atwal and colleagues are applying insights from the physical and com-
putational sciences to the study of population genetics and human disease. In collaboration with 
colleagues at the Institute for Advanced Study, Princeton, Atwal has modeled the process by 
which genetic variants, or alleles, have evolved in the last 100,000 years of human history. This 
has recently led to surprising insights about the role in female fertility played by p53, a master 
tumor suppressor gene, and furthered our understanding of how complex gene networks evolve. 
Recently, Atwal has analyzed the physical organization of the cancer genome and its role in medi-
ating tumorigenesis across numerous tissue types.
Ivan Iossifov focuses on the development of new methods and tools for genomic sequence analy-
sis and for building and using molecular networks, and he applies them to specifi c biomedical 
problems. He studies the genetics of common diseases in humans using two main tools: next-
generation sequencing and molecular networks representing functional relationships among ge-
netic loci. These approaches in combination enable the kind of large-scale studies necessary for 
furthering our understanding of the complex etiology of disorders such as autism, bipolar disorder, 
and cancer.
Alexander Krasnitz and colleagues use mathematical and statistical tools to discover key genetic 
elements involved in cancer and to understand how cancer cells evolve. Array-based comparative 
genome hybridization, a technique honed in the Wigler lab, and, more recently, sequencing ex-
periments, have revealed subtle patterns of frequent and widespread aberration in cancer genomes. 
Krasnitz hypothesizes that aberrant genomic loci observed to recur in a range of cancer types are 
under selection and therefore are enriched in important cancer genes. He has developed a novel, 
comprehensive methodology to discover such “epicenters” and has used it to analyze multiple ge-
nome data sets in breast, liver, ovarian, and prostate cancer. The results have been shared with can-
cer biology labs across CSHL, and they have been a key enabling agent of functional studies using 
mouse models and RNA interference. Krasnitz has begun to apply advanced statistical methods 
to the latest generation of experimental data, which have characterized tumor samples down to the 
level of single cells. With such data, he and colleagues seek to learn how specifi c tumors evolve and 
how cancer cells migrate in metastasis.
There is increasing evidence that rare and unique mutations have a signifi cant role in the etiology 
of many diseases such as autism, congenital heart disease, and cancer. Dan Levy’s group develops 
algorithms to identify these mutations from large, high-throughput data sets comprising thou-
sands of nuclear families. After earlier working with high-resolution CGH arrays, Levy’s group 
now uses targeted sequence data. Levy has developed methods for identifying de novo mutations 
(i.e., those seen in a child but not in his or her parents) by simultaneously genotyping the entire 
family; the team is currently focused on building algorithms to detect copy-number variants and 
multiscale genomic rearrangements. Although their copy-number methods are based on “read” 
density, there are classes of mutations that require analysis at the level of the read. Thus, they 
are developing algorithms to identify insertions, deletions, inversions, transpositions, and other 
complex events. Other projects in the Levy lab include analysis of single-cell RNA, phylogenetic 
reconstruction from sparse data sets, and disentangling haplotypes from sperm and subgenomic 
sequence data.
Michael Schatz is a computational biologist and an expert at large-scale computational examina-
tion of DNA sequencing data including the alignment, assembly, and analysis of next-genera-
tion sequencing reads. These methods have been used to reconstruct the genomes of previously 
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unsequenced organisms, probe sequence variations, and explore a host of biological features across 
the tree of life. Recent improvements in sequencing technologies are challenging our capacity to 
store and analyze the huge volume of DNA sequence data being generated. Consequently, Schatz 
is particularly interested in capitalizing on the latest advances in distributed and parallel comput-
ing, especially cloud computing technologies, to advance the state of the art in bioinformatics and 
genomics. In a recent breakthrough, Schatz was able to create a hybrid software-based solution 
to eliminate errors in so-called third-generation sequencing. This makes it remarkably easier to 
compile, align, and analyze full-genome sequences.
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QUANTITATIVE BIOLOGY
G.S. Atwal R. Aboukhalil W. Liao
 Y. Cai Y. Mo
 B. Fendler S. Thomain
 J. Homburger
Fueled by data generated from recent technological 
developments in DNA sequencing, our lab is primar-
ily focused on population genetics, cancer biology, 
and high-performance computing. We often tackle 
scientifi c questions analytically and computationally 
by invoking theoretical concepts from statistical 
physics and machine learning. Previous work in our 
lab, in collaboration with colleagues at the Cancer 
Institute of New Jersey and Weill Cornell Medi-
cal College, has established the association between 
single-nucleotide polymorphisms (SNPs) in the p53 
tumor suppressor pathway and female infertility in 
mice and humans. This hypothesis was fi rst gener-
ated through computational investigations of hap-
lotypic diversity and positive selection in genes in 
the TP53 pathway, where we detected signatures of 
recent positive selection in SNPs present at high fre-
quencies in various human populations. Selected al-
leles in SNPs in the LIF, Mdm2, Mdm4, and Hausp 
genes, each of which lies in the p53 molecular net-
work, were found to be enriched in women undergo-
ing in vitro fertilization (IVF) treatment. Moreover, 
some of these SNPs have been demonstrated to be 
associated with estrogen-driven cancer risk, high-
lighting the pleiotropic character of genetic variants 
in the p53 pathway. More recently, we have begun to 
investigate the association of SNPs in p63 and p73, 
and the initial results are encouraging, although we 
await an increase in sample numbers before the re-
sults can be deemed to be statistically signifi cant. 
Following up on these earlier investigations, we have 
begun exploring the contribution of multiple alleles 
from both a population genetics and human disease 
perspective. This systems biology approach has led 
to the development of new computational tools that 
can address the vast complexity of genomics data. In 
addition, our lab has continued research in the use of 
information theory and other machine learning tools 
to address the tsunami of data generated by next-gen-
eration sequencing. Suyash Shringapure, a former vis-
iting re searcher from Carnegie Mellon, now at Stan-
ford University, continues to collaborate with us and 
Bud Mishra (New York University). Bernard Fendler 
is a postdoctoral associate with training in theoreti-
cal physics. Willey Liao, Yifan Mo, and Ying Cai 
are graduate students from the Applied Mathemat-
ics and Statistics department at Stony Brook. Yifan 
Mo graduated in December and took a postdoctoral 
position at Memorial Sloan-Kettering Cancer Cen-
ter. Julian Homburger was an URP student during 
the summer of 2012 and continues to work with us 
remotely. Sophie Thomain carried out a rotation in 
our lab during the summer. Robert Aboukhalil, a 
graduate student in the Watson School, joined the 
lab, following up on his earlier research as an URP 
student in the same lab.
Conserved Colocalization of Tumor 
Suppressor Genes
B. Fendler, R. Aboukhalil [in collaboration with S. Lowe, 
Memorial Sloan-Kettering Cancer Center; S. Powers, 
D. Esposito, and W. Xue, Massachusetts Institute of 
Technology]
During the last decade, several studies have dem-
onstrated, across many eukaryotic species, that ge-
nomes contain chromosomal regions in which func-
tionally related genes physically cluster. Although it 
is well known that operons, ubiquitous in prokary-
otes, allow multiple genes to be transcribed at once 
into a polycistronic mRNA, operons are rare in eu-
karyotes. However, there is evidence to suggest that 
genes within the same biological pathway may be 
clustered more than expected by random rearrange-
ments (possibly because of coregulation), although 
the extent to which genes colocalize in eukaryotes is 
largely unknown.
Tumor suppressor genes (TSGs) are central to our 
understanding of human tumorigenesis. However, 
our knowledge of the physical distribution of TSGs 
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throughout the genome, and the implications that 
this has for tumor development, is poor. We carried 
out an integrative analysis of the known TSGs and 
demonstrated signifi cant colocalization of these genes 
into conserved clusters throughout the genome. We 
provide evidence of natural selection enforcing this 
colocalization in 46 species, ranging from mammals 
to worms. Analysis of 5659 human expression ar-
rays reveals that proximal TSGs exhibit signifi cant 
positively correlated coexpression, after correcting for 
batch effects by singular value decomposition. Finally, 
we analyzed copy-number variation from 1199 tumor 
samples across 11 different tissue types and showed 
that the probability of TSG deletion grows with the 
number of TSGs in the cluster. These results demon-
strate that the evolution of the physical distribution of 
TSGs bears signifi cantly on the risk of cancer develop-
ment.
Web Tool for Multispecies Gene 
Colocalization Analysis
R. Aboukhalil, B. Fendler [with technical assistance 
from P. Andrews, Cold Spring Harbor Laboratory]
The evolutionary pressures that underlie the large-
scale functional organization of the genome are not 
well understood in eukaryotes. Recent evidence sug-
gests that functionally similar genes may colocalize 
(cluster) in the eukaryotic genome, suggesting the 
role of chromatin-level gene regulation in shaping the 
physical distribution of coordinated genes. However, 
few of the bioinformatics tools currently available 
allow for a systematic study of gene colocalization 
across several evolutionarily distant species. Further-
more, most tools require the user to input manually 
curated lists of gene position information, DNA se-
quence, or gene homology relations between species. 
With the growing number of sequenced genomes, 
there is a need to provide new comparative genom-
ics tools that can address the analysis of multispecies 
gene colocalization. We built Kerfuffl e, a web tool 
designed to help discover, visualize, and quantify the 
physical organization of genomes by identifying sig-
nifi cant gene colocalization and conservation across 
the assembled genomes of available species (currently 
up to 47, from humans to worms). This is the fi rst 
such web tool from the newly installed web server 
set up in the Quantitative Biology group. Kerfuffl e 
only requires the user to specify a list of human genes 
and the names of other species of interest. Without 
further input from the user, the software queries the 
e!Ensembl BioMart server to obtain positional in-
formation and discovers homology relationships in 
all genes and species specifi ed. Using this informa-
tion, Kerfuffl e performs a multispecies clustering 
analysis, presents downloadable lists of clustered 
genes, performs Monte Carlo statistical signifi cance 
calculations, estimates how conserved gene clusters 
are across species, plots histograms and interactive 
graphs, allows users to save their queries, and gener-
ates a downloadable visualization of the clusters using 
the Circos software. These analyses may be used to 
further explore the functional roles of gene clusters 
by interrogating the enriched molecular pathways 
associated with each cluster.
Cell-Type-Speciﬁ c Spatiotemporal 
Gene Expression Dynamics Reﬂ ects the 
Cerebellar GABAergic Circuit Development
Y. Cai [in collaboration with Huang Lab, Cold Spring 
Harbor Laboratory]
We have analyzed the temporal gene expression dy-
namics of two GABAergic neuron subtypes in de-
veloping mice. The objective was to unravel the 
cell-type-specifi c molecular correlates of a developing 
 circuit—counter to the prevailing wisdom that ex-
pression landscape remains relatively static through-
out postnatal development. We developed methods 
based on random matrix theory to determine the sig-
nifi cance of principal component analyses of tempo-
ral expression profi les. A number of distinct temporal 
patterns, from day 0 to day 56, were found for a large 
subset of genes corresponding to distinct biological 
pathways. In addition, the research (1) uncovered 
groups of novel cell-type-specifi c genes; (2) captured 
the phasic expression dynamics of ion channels, re-
ceptors, cell adhesion molecules, gap junction pro-
teins, and transcription factors; (3) revealed the ac-
tive developmental modulation of different molecular 
pathways involved in circuit formation; and (4) yield-
ed evidence of hundreds of genomically clustered and 
developmentally coexpressed transcripts, suggesting 
the involvement of chromatin regulatory forces in 
early postnatal development, as well as maintenance 
of cell type identity in the adult stages.
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Maximally Informative Models 
and Diffeomorphic Modes
This work was done in collaboration with J. Kinney, 
here at Cold Spring Harbor Laboratory.
Motivated by data-rich experiments in transcription-
al regulation and sensory neuroscience, we consider 
the following general problem in statistical inference. 
A system of interest, when exposed to a stimulus S, 
adopts a deterministic response R of which a noisy 
measurement M is made. Given a large number of 
measurements and corresponding stimuli, we wish to 
identify the correct “response function” relating R to 
S. However, the “noise function” relating M to R is un-
known a priori. Here, we show that maximizing like-
lihood over both response functions and noise func-
tions is equivalent to simply identifying maximally 
informative response functions, those that maximize 
the mutual information I[R;M] between predicted 
responses and corresponding measurements. More-
over, if the correct response function is in the class of 
models being explored, maximizing mutual informa-
tion becomes equivalent to simultaneously maximiz-
ing every dependence measure that satisfi es the data 
processing inequality. We note that experiments of 
the type considered are unable to distinguish between 
parametrized response functions lying along certain 
“diffeomorphic modes” in parameter space. We show 
how to derive these diffeomorphic modes and observe, 
fortunately, that such modes typically span a very 
low-dimensional subspace. Therefore, given suffi cient 
data, maximizing mutual information can pinpoint 
nearly all response function parameters without re-
quiring any model of experimental noise.
Recent Coselection in Human Populations
This work was done in collaboration with S. Shringapure at 
Stanford University and B. Mishra at New York University.
A variety of selective forces, including diverse habitats 
and diseases, have been acting on human populations 
since their earliest migration out of Africa. Studying 
recent natural selection through statistical analysis of 
human genetic polymorphisms is therefore an impor-
tant way of illuminating this recent human history. 
In the last few years, a number of methods have been 
proposed for detecting recent natural selection. These 
methods have found a large of number of genes in 
human populations showing strong signals of recent 
natural selection, but they are incapable of detect-
ing networks of genes (not necessarily syntenic) that 
might have responded to shared selective forces. For 
instance, because many of these genes are involved in 
various common biological pathways and networks, 
we hypothesize that selection pressure on one gene in 
a network will result in a simultaneous selection pres-
sure on other genes in the network. We have analyzed 
SNP data from the HapMap project to fi nd candi-
dates for recent coselection in human populations.
Our methodology is built upon a novel “entro-
pic test,” based on haplotype statistics and extended 
to the joint analysis of pairs of SNPs. The underly-
ing idea, formulated using information theoretic en-
tropy concepts, is that the joint genetic diversity, or 
inverse linkage disequilibrium, around coselected al-
leles would be reduced with respect to the rest of the 
genome. We demonstrate the effi cacy of the coselec-
tion test by analyzing large-scale computer simula-
tions of Wright-Fisher models, incorporating the ef-
fects of neutral drift arising from fi nite sampling in 
each generation, and joint positive selection of pairs 
of alleles in large populations. We analyzed SNP data 
from the HapMap project (Phase 3) to fi nd candidate 
SNP pairs that exhibit statistical signatures of recent 
coselection in the 11 HapMap populations. Our re-
sults indicate that a number of functionally coherent 
gene pairs have undergone coselection in the HapMap 
populations. We also observe that the selected gene 
pairs are population specifi c, suggesting that these 
pairs may be involved with local adaptation.
Exome Studies of Rare Variants 
in Neuropsychiatric Disorders
J. Homburger [in collaboration with D. Lewis and 
D. McCombie, Cold Spring Harbor Laboratory]
Large genome-wide association studies have so far 
failed to identify genetic variants that explain much 
of the estimated heritability of complex human traits. 
Next-generation sequencing technologies have made 
whole-exome studies feasible, allowing the study of 
rare variants in the human population. The common 
disease rare variants hypothesis argues that much of 
the heritability of diseases could be due to multiple rare 
variants of moderate to large effect. However, novel 
statistical methods will be needed to fi nd associations 
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between rare variants and disease. Studies must deal 
with issues such as locus heterogeneity and the excess 
of rare variants in the humane genome due to recent 
population expansions. We determined the effi ciency 
of two commonly used statistical tests for rare variants 
(the weighted sums approach and variable threshold 
approach) and attempted to develop new statistical 
techniques with increased power. Toward this goal, 
we simulated a whole-exome data set based on param-
eters observed in the Exome Sequencing Project. We 
ran simulations under multiple experimental condi-
tions, changing the parameters of samples chosen and 
number of disease-causing variants. Both the weighted 
sums test and variable threshold test performed poorly 
as the number of disease-causing variants increased. 
To deal with the issue of locus heterogeneity, we also 
proposed a new test based on the mutual exclusion of 
disease-causing variants.
Novel Foxo1-Dependent Transcriptional 
Programs Control Treg Cell Function
Y. Mo, W. Liao [in collaboration with M. Zhang, University 
of Texas at Dallas; and M. Li, Memorial Sloan-Kettering 
Cancer Center]
Regulatory T (Treg) cells, characterized by expression 
of the transcription factor forkhead box P3 (Foxp3), 
maintain immune homeostasis by suppressing self-
destructive immune responses. Foxp3 operates as a 
late-acting differentiation factor controlling Treg cell 
homeostasis and function, whereas the early Treg-cell-
lineage commitment is regulated by the Akt kinase 
and forkhead box O (Foxo) family of transcription 
factors. However, whether Foxo proteins act beyond 
the Treg-cell-commitment stage to control Treg cell ho-
meostasis and function remains largely unexplored. 
The Li lab showed that Foxo1 is a pivotal regulator 
of Treg cell function. Treg cells express high amounts 
of Foxo1 and display reduced T-cell-receptor-induced 
Akt activation, Foxo1 phosphorylation, and Foxo1 
nuclear exclusion. Mice with Treg-cell-specifi c dele-
tion of Foxo1 develop a fatal infl ammatory disorder 
similar in severity to that seen in Foxp3-defi cient 
mice, but without the loss of Treg cells. Yifan Mo 
and Willey Liao conducted a systematic genome-
wide analysis of Foxo1 binding sites, revealing 300 
Foxo1-bound target genes, including the proinfl am-
matory cytokine Ifng, that do not seem to be directly 
regulated by Foxp3. These fi ndings show that the 
evolutionarily ancient Akt–Foxo1 signaling module 
controls a novel genetic program indispensable for T-
cell function.
Modeling Morphogenesis in Leaf Polarity
S. Thomain [in collaboration with the Timmermans Lab, 
Cold Spring Harbor Laboratory]
The adaxial-abaxial polarity is essential for leaf func-
tioning in plants. The polarity is sharply defi ned by a 
precise establishment of gene expression patterns with 
cells across the adaxial-abaxial axis. Previous work in 
the Timmermans Lab has shown that two short RNAs 
(miR166 and tasiR-ARF) may act as morphogens in 
establishing the leaf polarity. However, it is not clear 
whether these two opposite gradients of small RNA 
are suffi cient to explain the sharp spatial expression 
pattern in leaves. We fi rst modeled the dynamic be-
havior of the morphogen using a minimal network 
of the relevant genes, whereby tasiR-ARF inhibits 
ARF3/4 and miR166 inhibits HD-ZIPIII. A fi xed-
point analysis indicated that the system is stable with 
respect to small perturbations, although the infl uence 
of stochastic noise has yet to be determined. We next 
investigated the positional information carried by the 
morphogens using tools from information theory in 
an effort to determine how a cell optimally predicts 
its position in the adaxial-abaxial axis using the two 
opposing morphogens. The analysis from simulations 
of the stochastic concentration gradients indicated 
that the two RNA gradients were indeed suffi cient to 
convey enough information to induce two cell fates. 
Further work remains to supplement the simulations 
with actual RNA-Seq data from each cell layer.
Network Inference in Cancer
B. Fendler, Y. Cai
An important challenge in cancer systems biology 
is to uncover the complex network of interactions 
between genes (tumor suppressor genes and onco-
genes) implicated in cancer. Next-generation se-
quencing provides unparalleled ability to probe the 
expression levels of the entire set of cancer genes and 
their transcript isoforms. However, there are onerous 
statistical and computational issues in interpreting 
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high-dimensional  sequencing data and inferring the 
underlying genetic network. In this study, we ana-
lyzed RNA-Seq data from lymphoblastoid cell lines 
derived from a population of 69 human individuals 
(Yoruban population) and implemented a probabi-
listic framework to construct biologically relevant 
genetic networks. In particular, we used a graphi-
cal lasso analysis, motivated by considerations of the 
maximum entropy formalism, to estimate the sparse 
inverse covariance matrix of RNA-Seq data. Reverse 
engineering the network of genetic isoforms revealed 
a layer of genetic regulatory complexity not exhibited 
by traditional microarrays. Gene ontology, pathway 
enrichment and protein–protein path length analysis 
were all carried out to validate the biological context 
of the predicted network of interacting cancer gene 
isoforms.
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DE NOVO MUTATION IN AUTISM
I. Iossifov E. Dalkic
We study the genetics of common diseases in humans, 
using two main tools: next-generation sequencing and 
molecular networks representing functional relation-
ship among genetic loci. These tools in combination 
enable the large-scale studies that are necessary for 
furthering our understanding of the complex etiol-
ogy of disorders such as autism, bipolar disorder, and 
cancer. We focus on both developing new methods 
(for sequence analysis and for building and using 
molecular networks) and applying them to specifi c 
biomedical problems.
Exome Sequencing Reveals De Novo Gene 
Disruptions in Children on the Autistic 
Spectrum
The genetic component of autism can be transmitted 
or acquired through de novo mutation. Previous stud-
ies have focused on large-scale de novo copy-number 
events, either deletions or duplications, and have 
identifi ed a large number of autism candidate genes. 
Because copy-number events often span many genes, 
discerning which of the genes in the target region con-
tribute to the disorder requires complex network anal-
ysis and inference. In contrast, with high-throughput 
DNA sequencing, we can readily search for de novo 
single-nucleotide and small-insertion or deletion mu-
tations that affect a single gene. Such mutation is fair-
ly common, ~100 new mutations per child, but with 
only a few—on the order of one per child—falling in 
coding regions.
We are collaborating in an ongoing large project 
for sequencing the exomes of 2800 families from 
the Simons Simplex Collection (SSC). Our prelimi-
nary analysis (Iossifov et al. 2012) of ~350 of these 
families, as well as the reports of three other groups, 
demonstrated the power of identifying de novo muta-
tions through exome sequencing to implicate autism 
genes. The following were among the major results: 
(1) strong evidence for the role of likely gene-disrupt-
ing (LGD) mutations (nonsense, splice site, and frame 
shifts), with affecteds having twice as many LGDs 
compared to unaffected siblings; (2) the identifi ca-
tion of 127 de novo LGD mutations across the four 
reports with fi ve genes (CHD8, DYRK1A, KATNAL2, 
POGZ, SCN2A) having two de novo mutations in un-
related individuals (“double hits”); (3) estimation of a 
total number of ~400 autism target genes, with a pre-
diction of ~100 double hits after the entire set of 2800 
families had been processed; and (4) the discovery of 
a strong association between the target LGD muta-
tions in autism and in vivo targets of the RNA-bind-
ing translational regulator FMRP (encoded by FMR1, 
which results in fragile-X syndrome when silenced or 
mutated). Our preliminary assessment has not seen 
evidence for a role of de novo missense mutations or 
inherited LGD variants in autism pathogenesis, but 
with a greater sample size, we hope to detect such 
effects (if present). We expect to present the results 
of the joint analysis of ~1000 families by November 
2012.
Ongoing Projects
• Whole-exome sequencing of the SSC. The SSC 
comprises 2800 families with one child with au-
tism spectrum disorder diagnosis and with at least 
one unaffected child. Such a collection is ideally 
suited for identifi cation of de novo mutations with 
a strong effect on the disorder. The recent improve-
ments of the techniques for enrichment of coding 
genomic sequences and of the new-generation se-
quencing technology made whole-exome sequenc-
ing for large numbers of samples feasible. The gen-
erated data are of high quality and can be used to 
identify de novo single-nucleotide, short-indel, and 
copy-number mutations. This project is being done 
in collaboration with Michael Wigler and Richard 
McCombie here at CSHL.
• Analysis of the overall sharing of parental genome 
by concordant and discordant autistic siblings. 
The goal is to test the hypothesis that a substan-
tial proportion of the inherited autism is caused by 
a dominant mutation inherited from the mother, 
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with different mothers having different affected 
loci. So far, we see a suggestive increase of the shar-
ing of the mothers’ genome in a cohort of ~300 
multiplex families from the AGRE collection with 
microsatellite markers. The next step is to see if the 
signal is preserved and hopefully statistically sig-
nifi cant in a larger set of 700 families genotyped 
with a 10K single nucleotide polymorphism (SNP) 
array. This project is being done in collaboration 
with Michael Wigler and Kenny Ye.
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IN SILICO CANCER GENOMICS
A. Krasnitz E. Glassberg
 M. Kato
 G. Sun
Research in our group is focused on in silico cancer 
genomics. In the last few years, there has been explo-
sive growth in the volume, as well as the quality and 
detail, of cancer-related genomic data available for 
analysis. This development came about through rapid 
accumulation of public data sets generated by individ-
ual laboratories worldwide, through large-scale can-
cer genome projects such as TCGA and ICGC, and 
with the advent of new experimental methodologies, 
especially next-generation sequencing and single-cell 
genomics. We see our goal in channeling this fl ood 
of data into a number of clinically relevant applica-
tions, including pinpointing and prioritizing targets 
for functional analysis, discovery of genomic mark-
ers for clinical outcome and molecular classifi cation of 
cancer, and elucidating the clonal structure of tumors 
and its relation to progression, invasion, metastasis, 
and response to treatment. All of our work is done 
in close coordination with experimental studies per-
formed by the Wigler, Hicks, Powers, Lowe (presently 
at the Memorial Sloan-Kettering Cancer Center), and 
Stillman laboratories at CSHL.
Recurrence Analysis of Genomic 
Interval Data
Large collections of intervals are a common form of 
data in high-throughput genomics. In the context 
of ChIP-Seq (chromatin immunoprecipitation–high-
throughput sequencing) or CLIP-Seq (cross-linking 
immunoprecipitation–Seq) analysis, these intervals 
represent fragments of DNA or RNA. DNA copy-
number analysis yields intervals of the genome cor-
responding to gains or losses of copy number. In all 
cases, a common goal is inference of contiguous ge-
nomic regions covered by the intervals with a high 
degree of recurrence. We call such regions cores. In 
cancer, genomes display complex patterns of DNA 
copy-number alteration, but recurrent aberrations are 
observed within a given cancer type. Detection and 
quantitative characterization of the cores in a given 
malignancy are potentially benefi cial in two ways. 
First, it is plausible that at least some of the recurrence 
owes to selective pressure on regions harboring cancer-
related genes. Focusing on these regions may therefore 
facilitate cancer gene discovery. Second, once the cores 
are known, the genome of a tumor can be described 
in a drastically simplifi ed fashion by indicating the 
presence or absence of copy-number alteration in any 
given core. This simplifi ed form of the data is better 
suited for further analysis, such as fi nding subtypes 
in a given type of cancer or discovering associations 
between genomic properties and clinical parameters.
We designed and implemented a method for iden-
tifying cores in large collections of genomic interval 
data. A descriptive name for the method is cores of re-
current events (CORE). Central to CORE is the no-
tion of explanatory power. We say that a core explains 
an event and quantify its explanatory power by means 
of a numerical value between 0 and 1. The explanation 
is a measure of how closely the event is matched by the 
core. We then seek a set of cores that jointly provide 
the best possible explanation of the data, subject to 
additional criteria of statistical signifi cance. Figure 1 
shows an example of CORE analysis applied to a set 
of 257 copy-number profi les of breast tumors. Cores 
delineate regions of recurrent somatic copy-number 
variation in breast cancer, such as whole-arm amplifi -
cation of chromosome 1 and deletion of chromosome 
16 or narrow amplifi cation containing the ERBB2 on-
cogene on chromosome 17. In the course of 2012, we 
created a software implementation of CORE as an R 
package and applied CORE to a number of problems 
in genomics, as discussed below.
Structure of Tumor Cell Populations 
from Single-Cell Sequencing
Recent studies of cancer genomes on a single-cell level 
have revealed the complexity of the disease and the 
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Figure 1. Regions (cores) of recurrent copy-number aberration identiﬁ ed in a published set of 257 breast tumor 
samples. The 44 ampliﬁ cation (22 deletion) cores are shown above (below) the corresponding chromosomes. Darker 
shades of gray correspond to higher degrees of recurrence. Genomic positions of four validated driver genes (MYC, 
CCND1, IGF1R, and ERBB2) are indicated by vertical bars.
presence of multiple genealogically related cell popu-
lations in a tumor. Detailed knowledge of the clonal 
structure of a cancer potentially is of high clinical 
value: Multiplicity of clones or of lesions in most ad-
vanced clones is a possible measure of progression; spa-
tial pattern of clone dispersal in a tumor may signal 
elevated propensity to invade; and lesions observed in 
individual clones but not in the bulk tissue may point 
to targets for therapy. DNA copy-number profi ling of 
cells from low-coverage sequencing is an accurate, eco-
nomically feasible technological approach to the study 
of cancer subpopulation structure. Novel multiplex 
sequencing techniques, developed by the Wigler lab at 
CSHL, permit simultaneous sequencing of dozens of 
single-cell DNA specimens and their subsequent copy-
number profi ling at up to 50-kb resolution. Optimal 
use of these data forms for robust reconstruction of 
cancer cell phylogenies is a challenging computational 
problem requiring new and robust informatics and sta-
tistical tools. At present, no such robust algorithmic 
methods and software tools exist for computational 
reconstruction of tumor population structure and ge-
nealogy from such single-cell copy-number data. In-
deed, phylogenetic analysis can only be performed if 
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the biological entities to be analyzed are specifi ed in 
terms of a well-defi ned set of characters. If the genome 
sequence of each entity is known in detail, the set of 
characters is formed by residues at individual genomic 
positions. However, no obvious choice of a character 
set for phylogeny exists if the entities are given as DNA 
copy-number profi les. As a remedy, we used CORE to 
transform copy-number profi les of single cells into a 
form suitable for phylogeny. As a result of this transfor-
mation, each profi le is characterized in terms of pres-
ence or absence in it of archetypal copy-number events 
recurrent in the single-cell populations. The entire set 
of copy-number profi les of single cells sampled from 
a tumor is summarized as an incidence table, essential-
ly a matrix with cores as columns, single cells as rows, 
and elements quantifying, on a scale between 0 and 1, 
how well a given core is matched by a copy-number 
event in a given cell. Distances among cells as rows 
of this matrix can be readily computed and used for 
distance-based phylogeny. This methodology was used 
successfully to reconstruct the cell population struc-
ture in a number of samples from breast and prostate 
cancers. In particular, in one of the cases of breast can-
cer, we observed that aneuploid cells from the primary 
site and those from the liver metastasis form separate 
branches of a phylogenetic tree. A similar analysis, ap-
plied to a case of prostate cancer, shows that some of 
the cells from an area with pathological characteristics 
of carcinoma in situ bear close genomic similarity to 
those from a region affected by frank carcinoma.
Markers of Response to Anthracycline 
Therapy in Breast Cancer
Anthracyclines are a class of chemotherapeutic drugs 
that are effective and widely used in treatment of a 
number of cancers, in particular those of the breast. 
Sensitivity to these agents varies widely across the en-
tire population of patients and likely depends on the 
pattern of genomic alterations in the tumor. Knowl-
edge of genomic biomarkers of response to anthracy-
clines will help tailor treatment options to the needs 
of individual patients. With this goal in mind, we 
recently applied CORE to DNA copy-number pro-
fi les derived by the Hicks lab at CSHL from breast 
tumors of ~250 patients enrolled in a clinical study. 
The study was conducted by the Bartlett group at the 
Ontario Institute for Cancer Research. To discover 
markers of sensitivity to anthracyclines, we performed 
CORE analysis of the set of profi les and computed 
the incidence table. Next, we evaluated each core as a 
prospective marker of sensitivity and found dramati-
cally higher benefi t from treatment in patients positive 
for a narrow amplifi ed region of chromosome 8. None 
of the marker-positive patients treated by anthracy-
clines have suffered a relapse in 5 years past treat-
ment, whereas the marker-positive patients who were 
not treated displayed a markedly higher rate of relapse 
than the remainder of the cohort. This marker will 
be further examined as part of a clinical study being 
planned by our collaborators.
CORE and Nucleosome Positioning in Yeast
Nucleosomes—octamers of basic histone proteins 
wrapped with ~147 bp of DNA and connected by 
a short stretch of linker DNA—form the primary 
level of chromatin architecture. Chromatin serves to 
condense DNA by ~10,000-fold, allowing large mol-
ecules of DNA to be contained within the nuclei of 
eukaryotic cells. Chromatin also modulates the ac-
cessibility of varying regions of DNA, thus regulat-
ing gene expression, DNA replication, recombination 
and repair, chromosome segregation, and other criti-
cal cellular processes. Thus, there is signifi cant bio-
logical interest in elucidating nucleosome positions 
within the genome. In some species, such as yeast, 
nucleosomes tend to occupy fi xed positions across the 
entire population, facilitating the determination of 
these positions. A method of choice for this purpose 
exploits protection by nucleosomes of DNA against 
digestion by micrococcal nuclease (MNase). With a 
suitable choice of digestion regime, DNA fragments 
left intact will roughly correspond to nucleosomes. 
Once the fragment boundary coordinates have been 
determined by paired-end sequencing, nucleosome 
positions must be inferred from this input set of ge-
nomic intervals. CORE—as a method to identify 
accumulations of intervals with roughly coincident 
boundaries—lends itself naturally to nucleosome-po-
sitioning analysis. Moreover, an important advantage 
of CORE over other approaches to this problem is 
that the sizes of the core regions delineating the nu-
cleosomes are entirely data-driven rather than fi xed 
at 147 bp. Thus, CORE is better suited to discover 
partial unwinding of nucleosomes, a phenomenon 
closely related to gene regulation. With this motiva-
tion, we initiated, in collaboration with the Ptashne 
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lab at Memorial Sloan-Kettering Cancer Center and 
the Hicks lab at CSHL, CORE analysis of two mas-
sive sets of fragments of MNase-digested yeast DNA, 
one sequenced on the Illumina, and the other on 
the SOLiD platform. Our initial results show ample 
promise to justify further investigation. We fi nd, 
in particular, that the spacing between consecutive 
nucleosome centers averages to 165 bp, correspond-
ing to the expected 18 bp of linker DNA per nucleo-
some. We further see strong evidence for nucleosome 
phasing downstream from transcription start sites 
(TSS) in genic regions, and substantially less in in-
tergenic regions upstream of TSS, where regulatory 
elements tend to be located. Our ongoing work aims 
at optimizing CORE as a tool to study this important 
aspect of chromatin structure.
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COMPUTATIONAL GENETICS
D. Levy
The data-rich environment at CSHL generates a wealth 
of opportunities for the application of mathematics 
and computation to further our understanding of bi-
ology and genetics. The primary activities of our lab 
are algorithm development, data analysis, and genetic 
theory, with a focus on sporadic human diseases such 
as autism, congenital heart disease, and cancer.
Collaborations
The work on autism genetics was done in collabora-
tion with Michael Wigler, Ivan Iossifov, and Michael 
Ronemus. Copy number from exome sequence is the 
work of Kith Pradhan in collaboration with Chris 
Yoon. Peter Andrews implemented methods for exact 
sequence matching, haplotype phasing, and data pro-
cessing. Single-cell methods for the haplotype study 
are the work of Ravi Kandasamy. Swagatam Mukho-
padhyay contributed the implementation and analysis 
in our genetic modeling of autism.
Autism Genetics and New Mutation
Our efforts in autism, in collaboration with Michael 
Wigler and Ivan Iossifov, bridge between genetic the-
ory and large-scale data analysis. In 2007, Zhao et al. 
(Proc Natl Acad Sci 104: 12831 [2007]) proposed a 
 genetic theory of autism where new (or “de novo”) 
mutations serve as an entry point for highly delete-
rious genetic lesions. This theory was supported by 
early studies showing an excess of de novo copy-num-
ber variations (CNVs) in autistic children and sug-
gested a strategy for uncovering the set of genes whose 
disruption may result in autism. The Simons Simplex 
Collection (SSC) includes genetic samples and phe-
notypic data from families with exactly one child af-
fected with an autism spectrum disorder (ASD). All 
3000 families have samples collected from the mother, 
the father, the affected child, and typically at least one 
unaffected sibling. By identifying mutations that are 
present in the autistic child but absent in the parents 
and comparing to the observed rate in the unaffected 
siblings, we can infer a contributory rate for new mu-
tations and identify likely genetic targets.
From 2008 to 2011, we generated and analyzed 
thousands of high-resolution CGH (comparative ge-
nome hybridization) arrays with 2.1 million data 
points per individual and, in the process, developed 
a set of tools to reduce system noise and uncover rare 
and de novo CNVs. The resulting study, published 
in 2011 by Levy et al. (Neuron 70 : 886 [2011]), in-
cluded 1000 SSC families and established a rate of 
de novo CNV of 8% in autistic children compared 
to 2% in their unaffected siblings. De novo CNVs 
were more frequent and larger in affected girls than 
affected boys, and we found evidence for excess trans-
mission of rare variants to the affected children. In 
collaboration with Dorothy Warburton at Columbia 
University Medical Center, we conducted a similar 
study of 300 children with congenital heart disease 
(CHD) and found strong evidence of a causal role for 
de novo CNVs, with 10% of affected children having 
a de novo variant.
Although copy-number variants provide an excel-
lent signal to background (4:1), even with the high 
resolution of the microarrays and the sophisticated 
informatics for denoising and analysis, most observ-
able CNVs disrupt more than one gene. This neces-
sarily complicates the effort of identifying causal 
genetic targets. With the availability of low-cost 
targeted sequencing methods, the SSC data analysis 
effort switched to identifying de novo point muta-
tions and small insertion or deletion events (indels) 
in the exome. Our results from the fi rst 350 families, 
published in Iossifov et al. (2012), are in agreement 
with the results of the other groups studying exomic 
mutation: de novo “loss-of-function” variants, those 
that severely impair gene function, occur in 20% of 
affected children and in only 10% of their siblings. 
Both the CNV and exome studies estimate that ~500 
genes are likely involved in ASD.
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Copy Number from Exome Sequence
Although we are no longer generating copy-number 
microarrays, we do have more than 1000 families with 
greater than 40x sequence coverage on the exome. 
The principal utility of these data is for its sequence 
content, but there is evidence that we can also ex-
tract  copy-number variants. The primary challenge 
in identifying CNVs from exome capture data is that 
the capture process distorts coverage in ways that vary 
from sample to sample. Our initial expectation was 
that capturing and sequencing the family together 
would result in the same systemic distortion for all 
members in the family. That proved to not be the case. 
Even samples captured together showed variability in 
their coverage distortion, likely resulting from differ-
ences in sample handling prior to applying the capture 
protocol (sample acquisition, DNA extraction, etc.).
Fortunately, the variability expressed in an in-
dividual sample is often recapitulated on a popula-
tion level, and we can use our library of samples to 
identify the major elements of systemic noise. Our 
normalization procedure is coupled to a hidden Mar-
kov model (HMM) that integrates over all the copy-
number possibilities for a given sample and returns 
a probability for each copy state for each region of 
the genome. We then modify the expected coverage 
based on the results of the HMM, repeat our nor-
malization procedure, and iterate until the results are 
unchanged. After identifying likely regions of CNV, 
we apply statistical tests over the segmented events 
in each family to determine the plausibility of the 
CNV. These results include tests for goodness of fi t, 
rarity of the event in the population, and its pattern 
of  inheritance.
There are four objectives to our present copy-num-
ber study. The fi rst is to increase the number of de 
novo copy-number variants associated with ASD. The 
second is to look for an imbalance in small de novo 
CNVs—events that were too small to detect using 
CGH technology, but might be within our reach 
using the sequence data. The third is to test the claims 
with respect to rare inherited copy-number events and 
their unequal distribution to autistic children. And 
fi nally, we would like to combine the CNV analysis 
in the larger context of sequence data, for example, 
identifying SNPs that occur opposite a deletion and 
establishing parent of origin for de novo copy-number 
changes.
Insertions and Deletions by Exact Match
We are also developing an algorithm for identifying 
large genomic rearrangements—deletions, insertions, 
translocations, and inversions—by cataloging discon-
tinuities in the mapping of reads against the reference 
genome. The majority of existing methods for fi nding 
such events approach the problem one read at a time, 
typically identifying a target region by anchoring a 
mate-pair and then fi tting the misaligned read using a 
scoring algorithm with a mismatch/gap penalty. Elab-
orations on this method make a secondary correction 
to obtain consensus among gapped mappings per sam-
ple. These methods are reasonably good provided the 
event is small and occurs in an uncomplicated region.
Our algorithm uses all the reads over the whole 
population to make inferences about genomic rear-
rangements. Thanks to Moore’s law, computational 
methods that were impractical at the dawn of genomic 
analysis are now feasible, fast, and useful. Suffi x arrays 
require vast amounts of memory but perform very fast 
lookups for a query sequence of all its unique maxi-
mal exact matches (MEMs) to the human genome. By 
cataloging and indexing all reads in a sample by their 
MEMs, in particular those with two distinct matches 
into the reference genome, we identify and label re-
currently observed discontinuities. Integrating this 
information across all samples, we can recognize com-
mon events, spurious rearrangements resulting from 
sequence homology, and global discrepancies within 
the reference. With all reads indexed and anchored 
to the reference genome, we reassemble rare and de 
novo discontinuities within an individual or family. 
Early versions of this method using fi xed width exact 
matching and applied to the SSC exome data success-
fully identifi ed large deletions, inversions, and inser-
tions, and small indels, as well as rare and de novo 
pseudogenes.
Genetic Models of Autism
Autism is often described as the most highly heritable 
neurological disorder. Concordance for autism among 
identical twins is as high as 90%. There are several 
other interesting statistics in the epidemiology of au-
tism that are less often noted. If a family has a single 
child with autism, the risk to the next born male child 
is ~20%. This elevated risk has led to an explanation 
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that autism is a multifactorial disorder and that sev-
eral gene disruptions are needed to produce an autism 
phenotype. That claim, however, is belied by another 
statistic: Given two children in the family with au-
tism, the risk to a third-born male child is 50%.
One model that fi ts these data is to postulate two 
risk classes for autism: Nearly all families have a very 
low risk of having a child with autism, whereas a small 
percentage of families have a very high risk. We have 
been exploring simple genetic models that recapitulate 
the observed risk statistics, both for boys and girls, as 
well as observations that stem from genetic analyses of 
ASD families. Our model includes parameters such as 
de novo mutation rates, variability of penetrance, as-
sortative mating, and the number and type of genetic 
targets. Combinatorics allows for fast simulations of 
infi nite populations, providing a means for quickly 
exploring the space of possible models consistent with 
the observable measures. One result is that a simple 
model with two gene classes and different selection 
profi les for males and females is suffi cient to match 
observable risk and mutation rates.
Phasing from Haploid Cells 
and Subgenomic Data
Single nucleotide variants (SNVs) occur in the human 
genome at a rate of about one every 1000 bp. Two 
SNVs that are 1000 bp apart may both reside on the 
maternal copy of the chromosome, both on the pater-
nal copy, or one on each. This information is known as 
the phase of the variants. Current high-throughput se-
quencing technologies typically require that the DNA 
be fragmented into pieces signifi cantly smaller than 1 
kb. This makes it diffi cult to obtain phase informa-
tion because no single sequence read will contain both 
positions. Recent developments in sequencing small 
quantities of DNA invite new methods for obtaining 
this information. The two methods we are exploring 
include sequencing single haploid cells (sperm or egg) 
and genomic dilutions of large DNA fragments. By 
sequencing many such samples in independent wells, 
we can reconstruct a picture of the original genome 
with information about variant phasing.
The problems of phasing from small quantities 
of DNA are many. Single-cell sequencing methods 
are still in their infancy, and the resulting coverage 
is sparse and uneven. Recombination in the haploid 
cells scrambles phase information, occasionally con-
founded by more than one haploid cell entering a se-
quencing well. Furthermore, there are genomic posi-
tions that appear heterozygous due to copy-number 
polymorphism in a single parental haplotype.
We have constructed an algorithm for integer hap-
lotype phasing (INHAPH) that simultaneously solves 
the problem of phasing the genome and reconstruct-
ing the identity of the fragments in each sample well. 
INHAPH is an expectation maximization algorithm 
that treats the observations of each well as the output 
of an HMM. The transitions of this model are deter-
mined by the type of data: For haploid cells, transi-
tions depend on recombination rates; for subgenomic 
sequencing, transitions are determined by the expect-
ed number of fragments and their average length. The 
emission probabilities are drawn from the latest guess 
of parental haplotype phasing. Having analyzed each 
well in this way, we then update the parental haplo-
type phasing and repeat. For the case of single-cell 
sperm sequencing, INHAPH reconstructs the paren-
tal haplotypes, fi nds recombination points in each 
sperm, and determines whether each well contained 
one or two sperm cells.
We are currently running INHAPH on a few 
hundred sperm cells from a single individual. Re-
sults are good: At positions where we can determine 
phase and make a comparison, there is near perfect 
agreement between the INHAPH phasing and that 
inferred from family information. This provides us 
with confi dence in the second half of the output—the 
detailed information about recombination observable 
in our samples. From these data, we are examining the 
personal recombination map against recombination 
maps drawn from large populations, identifying copy-
number variants, and testing for gene conversions and 
segregation distortion.
Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, 
Yamrom B, Lee Y-H, Narzisi G, Leotta A, et al. 2012. De novo 
gene disruptions in children on the autistic spectrum. Neuron 74: 
285–299.
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COMPUTATIONAL SEQUENCE ANALYSIS
M.C. Schatz E. Biggers S. Marcus
 A. Gupta G. Narzisi
 R. Gupta D. Nettem
 J. Gurtowski A.H. Wences
 H. Lee 
Our lab develops novel computational analysis meth-
ods to study the information content in biological 
sequences and the dynamics of biological processes. 
These include methods for assembling sequence data 
into complete genomes, for aligning sequences to dis-
cover variations or measure transcription levels, and 
for mining these data to discover relationships be-
tween an organism’s genome and its traits. We then 
apply these methods to study several biological sys-
tems, for example, to discover mutations associated 
with human diseases such as cancer and autism or 
to reconstruct the genomes of important agricultural 
crops and biofuels. In the past year, our lab has grown 
by several new members. Dr. Shoshana Marcus start-
ed as a computational postdoctoral researcher after 
completing her Ph.D. in computer science at the City 
University of New York. Her thesis was on developing 
novel algorithms for advanced sequence alignment, 
and she is currently researching methods for genome 
assembly using emerging third-generation sequencing 
technology. Avijit Gupta, Rushil Gupta, and Deepak 
Nettem joined as master-degree students in computer 
science at Stony Brook University to research methods 
for large-scale genome assembly using cloud com-
puting. Over the summer, Eric Biggers joined as an 
undergraduate researcher from Macalester College to 
develop new algorithms for analyzing heterogeneous 
genomes, focusing on the assembly of the pineapple 
genome. Alejandro Wences was a year-long visiting 
undergraduate student from the Genomics Institute 
of the University of Mexico in Cuernavaca, and he is 
researching methods for improving genome assembly 
by merging multiple assemblies into a single consen-
sus sequence. In the past year, our lab has continued 
working on several projects studying the genetics of 
autism and of several important biofuel species and 
developing algorithms for genome assembly and large-
scale sequence analysis. In addition, CSHL  Assistant 
 Professor Zachary Lippman and I were awarded a 3-year, 
$850,000 grant from the National Science Foundation 
(NSF) to study the genes and gene networks respon-
sible for fl ower development in tomato and other re-
lated species. I was also funded to be a member of 
the NSF-sponsored iPlant consortium to develop 
algorithms and systems to empower plant research. 
Finally, CSHL Professor Greg Hannon and I were 
awarded a $500,000 instrumentation grant from the 
National Institutes of Health (NIH) to fund a major 
upgrade to the CSHL computing capacity, and along 
with funds from the Stanley Institute, we purchased 
a 1600-core cluster “Black-n-Blue.” This cluster is 
substantially faster and more powerful than the previ-
ous cluster “BlueHelix” and will be a critical asset for 
CSHL in managing the fl ood of biological data cre-
ated on campus. In May, I was awarded for the second 
time the CSHL Winship Herr Award for Excellence 
in Teaching for contributions to the CSHL course in 
Quantitative Biology, co-taught by M. Atwal. In the 
past year, I have been interviewed by the editors of 
Nature, Nature Biotechnology, Nature Methods, Wired 
Magazine, and The New York Times, especially to de-
scribe my work applying third-generation sequencing 
technology from Pacifi c Biosciences to human and 
plant genetics.
Hybrid Error Correction and De Novo 
Assembly of Single-Molecule 
Sequencing Reads
Single-molecule sequencing instruments can generate 
multi-kilobase sequences with the potential to greatly 
improve genome and transcriptome assembly. How-
ever, the error rates of single-molecule reads are high, 
which has limited their use thus far to resequencing 
bacteria. To address this limitation, we introduced a 
correction algorithm and assembly strategy that uses 
short, high-fi delity sequences to correct the error in 
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single-molecule sequences. We demonstrated the util-
ity of this approach on reads generated by a PacBio 
RS instrument from phage, prokaryotic, and eu-
karyotic whole genomes, including the previously 
unsequenced genome of the parrot Melopsittacus un-
dulatus, as well as for RNA-Seq reads of the corn 
(Zea mays) transcriptome. Our long-read correction 
achieves >99.9% base-call accuracy, leading to sub-
stantially better assemblies than current sequencing 
strategies: In the best example, the median contig size 
was quintupled relative to high-coverage, second-gen-
eration assemblies. Greater gains are predicted if read 
lengths continue to increase, including the prospect of 
single-contig bacterial chromosome assembly.
Genomic Dark Matter: The Reliability 
of Short-Read Mapping Illustrated 
by the Genome Mappability Score
Genome resequencing and short-read mapping are 
two of the primary tools of genomics used for many 
important applications. The current state of the art in 
mapping uses the quality values and mapping qual-
ity scores to evaluate the reliability of the mapping. 
These attributes, however, are assigned to individual 
reads and do not directly measure the problematic re-
peats across the genome. Here, we present the genome 
mappability score (GMS) as a novel measure of the 
complexity of resequencing a genome. The GMS is 
a weighted probability that any read could be un-
ambiguously mapped to a given position, and thus, 
it measures the overall composition of the genome 
itself. We have developed the Genome Mappability 
Analyzer to compute the GMS of every position in 
a genome. It leverages the parallelism of cloud com-
puting to analyze large genomes and enabled us to 
identify the 5%–14% of the human, mouse, fl y, and 
yeast genomes that are diffi cult to analyze with short 
reads. We examined the accuracy of the widely used 
BWA/SAMtools polymorphism discovery pipeline in 
the context of the GMS and found discovery errors 
are dominated by false-negatives, especially in regions 
with poor GMS. These errors are fundamental to the 
mapping process and cannot be overcome by increas-
ing coverage. As such, the GMS should be considered 
in every resequencing project to pinpoint the “dark 
matter” of the genome, including known clinically 
relevant variations in these regions.
De Novo Gene Disruptions in Children 
on the Autistic Spectrum
Exome sequencing of 343 families, each with a single 
child on the autism spectrum and at least one unaffected 
sibling, reveal de novo small indels and point substitu-
tions, which come mostly from the paternal line in 
an age-dependent manner. We do not see signifi cantly 
greater numbers of de novo missense mutations in af-
fected versus unaffected children, but gene-disrupting 
mutations (nonsense, splice site, and frame shifts) are 
twice as frequent, 59 to 28. On the basis of this differ-
ential and the number of recurrent and total targets of 
gene disruption found in our and similar studies, we es-
timate between 350 and 400 autism susceptibility genes. 
Many of the disrupted genes in these studies are associ-
ated with the fragile X protein, FMRP, reinforcing links 
between autism and synaptic plasticity. We fi nd FMRP-
associated genes are under greater purifying selection 
than the remainder of genes and suggest that they are 
especially dosage-sensitive targets of cognitive disorders.
Answering the Demands 
of Digital Genomics
The continuing revolution in DNA sequencing and 
biological sensor technologies is driving a digital trans-
formation to our approaches for observation, experi-
mentation, and interpretation that form the foundation 
of modern biology and genomics. Whereas classical 
experiments were limited to thousands of hand-col-
lected observations, today’s improved sensors allow 
billions of digital observations and are improving at 
an exponential rate that exceeds Moore’s Law. These 
improvements have made it possible to monitor the 
dynamics of biological processes on an unprecedented 
scale, but they have proportionally greater quantitative 
and computational requirements. The exponentially 
growing digital demands have motivated extensive re-
search into improved algorithms and parallel systems. 
Recently, a great deal of research has been focused 
on applying emerging scalable computing systems to 
genomic research. One of the most promising is the 
 Hadoop open-source implementation of MapReduce: 
It is specifi cally designed to scale to very large data sets, 
its intuitive design supports rich parallel algorithms, 
and it is naturally applied to analysis of many bio-
logical assays. There has also been success accelerating 
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numerically intensive genomics applications using het-
erogeneous processors such as graphics processing units 
(GPUs) and fi eld-programmable gate arrays (FPGAs). 
These are promising early results, but it is clear that 
continued computational research will become even 
more important in the years to come.
The Rise of a Digital Immune System
Driven by million-fold improvements in biotechnol-
ogy, biology is increasingly shifting toward high-reso-
lution, quantitative approaches to study the molecular 
dynamics of entire populations. One exciting applica-
tion enabled by this new era of biology is the “digi-
tal immune system.” It would work in much the same 
way as an adaptive, biological immune system: by ob-
serving the microbial landscape, detecting potential 
threats, and neutralizing them before they spread be-
yond control. With the potential to have an enormous 
impact on public health, it is time to integrate the 
necessary biotechnology, computational, and organi-
zational systems to seed the development of a global, 
sequencing-based pathogen surveillance system.
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QUANTITATIVE BIOLOGY FELLOW
Quantitative Biology Fellows are independent researchers who enter this position soon after re-
ceiving a Ph.D. They come from the fi elds of mathematics, physics, engineering, or computer 
science and spend 3–5 years at CSHL applying techniques from these disciplines to important 
questions in biology.
Justin Kinney completed his Ph.D. in Physics at Princeton University in 2008 and began his 
term as a Quantitative Biology Fellow in 2010. His research focuses on developing next-generation 
DNA sequencing as a tool for dissecting the structure and function of large macromolecular com-
plexes. Of particular interest to his lab is the biophysical basis of transcriptional regulation—how 
simple interactions between proteins and DNA allow promoters and enhancers to modulate genes 
in response to physiological signals.
In 2010, Kinney and colleagues published a paper demonstrating Sort-Seq, a novel sequencing-
based method that can measure the functional activity of hundreds of thousands of slightly mu-
tated versions of a specifi c DNA sequence of interest. Using a novel information-theoretic analysis 
of the resulting data, Kinney et al. were able to quantitatively measure, in living cells, the protein–
DNA and protein–protein interactions controlling mRNA transcription at a chosen promoter. 
Kinney continues to develop this approach using a combination of theory, computation, and 
experiment. From a biological standpoint, Sort-Seq allows researchers to investigate important 
but previously inaccessible biological systems. Kinney’s lab is currently using Sort-Seq to address 
open problems in transcriptional regulation, DNA replication, and immunology. These experi-
ments also present new challenges for the fi eld of machine learning, and a substantial fraction of 
Kinney’s efforts are devoted to addressing the theoretical and computational problems relevant to 
the analysis of Sort-Seq data.
Transcriptional Regulation, Biophysics, 
Machine Learning
J.B. Kinney
My lab pursues a combination of experiments, com-
putation, and theory centered on the question of 
how elementary interactions between biological mol-
ecules allow the cell to regulate gene expression. Our 
experimental effort is focused largely on producing 
massive DNA sequence data sets that probe the inner 
workings of specifi c transcriptional regulatory se-
quences. To analyze these data, we use custom-writ-
ten optimization software and high-performance 
computing. Some aspects of this analysis further 
touch on basic issues in machine learning and bio-
physics that have yet to be fully explored. So, in ad-
dition to our experimental and computational work, 
a portion of our effort is devoted to addressing basic 
but pertinent theoretical questions in biophysics and 
machine learning.
Programmable Inducibility in the Escherichia 
coli Transcriptional Regulatory Code
In collaboration with Rob Phillips (California Insti-
tute of Technology) and Curtis Callan (Princeton), 
my lab is pursuing experiments to investigate how 
the DNA sequence of promoters in the bacterium E. 
coli determines the quantitative aspects of transcrip-
tional regulation. These experiments have, thus far, 
focused on the E. coli lac promoter. Decades of study 
have led to a detailed biochemical and structural un-
derstanding of how the lac promoter functions. The 
quantitative effects that the DNA sequence has on 
the lac promoter regulatory program, however, are 
not understood nearly as well. Indeed, it has proved 
exceedingly diffi cult to translate structural mod-
els into quantitative predictions about sequence-
dependent activity. It seems likely that techniques 
that can directly probe the sequence dependence of 
protein–DNA and protein–protein interactions will 
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be needed to complement structural understanding 
before a complete description of the transcriptional 
regulatory code can be obtained. During my Ph.D. 
work, I helped to develop an experimental technique 
called “Sort-Seq” aimed at addressing this need. 
Sort-Seq uses ultra-high-throughput DNA sequencing 
and fl ow cytometry to provide precise quantitative 
information about how the biophysical mechanisms 
of a given transcriptional regulatory sequence are af-
fected by DNA mutations (Kinney et al., Proc Natl 
Acad Sci 107: 9158 [2010]).
This assay was fi rst tested on the E. coli lac promoter. 
Our initial analysis of the resulting data appeared to 
be consistent with the widely accepted model that the 
sequence of the RNA polymerase (RNAP)-binding site 
of the lac promoter encodes the energy with which 
RNAP binds DNA and that a protein–protein interac-
tion of fi xed energy between RNAP and the transcrip-
tion factor CRP is the mechanism of transcriptional 
up-regulation. After repeating these experiments with 
Daniel Jones, a graduate student from Rob Phillips’ 
lab, we noticed, however, that the energy of the CRP-
RNAP interaction was not fi xed, but rather, it exhib-
ited substantial dependence on the sequence of the 
RNAP-binding site. Thus, by adjusting the sequence 
of the lac promoter RNAP-binding site, it is possible 
to independently vary two parameters: transcriptional 
activity in the absence of CRP and the fold-change 
by which CRP up-regulates transcription. We be-
lieve that this “programmable inducibility” may be 
a major and previously unappreciated component of 
the E. coli transcriptional regulatory code. Our current 
experimental work is now focused on deciphering this 
inducibility code, e.g., so that promoters with speci-
fi ed inducibility can be designed for applications in 
synthetic biology. We are also investigating the struc-
tural mechanism by which programmable inducibility 
is achieved.
Formal Diagrammatic Methods 
for Biochemical Systems
Analysis of Sort-Seq data requires fi tting mathemati-
cal models that refl ect hypothesized biophysical 
mechanisms for how a regulatory sequence of inter-
est functions. But in doing so, my colleagues and I 
began to realize that, for all but the simplest systems, 
simply specifying and communicating models was 
problematic. This is because transcriptional regula-
tory systems, even if defi ned by just a small num-
ber of proteins, binding sites, and interaction rules, 
typically result in an exponentially large number of 
possible multiprotein–DNA complexes. Thermody-
namic modeling of such systems requires that one 
compute the free energy of every possible complex, 
but this combinatorial explosion often makes listing 
the energy of each complex unfeasible.
One day, Phillips suggested to me that it might 
be possible to create formal diagrammatic methods 
for defi ning and analyzing biophysical models of 
transcriptional regulation, similar to how Feynman 
diagrams are used in quantum fi eld theory. I was in-
trigued by this suggestion because such a diagram-
matic method would also be applicable to a wide 
variety of other biochemical systems. And although 
Feynman diagrams are essentially just a bookkeep-
ing device, it is diffi cult to overstate the importance 
of good bookkeeping when trying to fi gure out what 
a quantitative theory predicts.
I am currently fi nishing a proposal for one such 
diagrammatic technique. In this proposal, models 
of biochemical systems in thermal equilibrium are 
defi ned by diagrams representing elementary molec-
ular components and interactions. Formal manipu-
lations of these diagrams allow one to construct all 
possible multimolecule complexes. Even though the 
number of possible complexes can be very large, they 
can often be represented compactly by a small num-
ber of “compressed” diagrams. The grand partition 
function of the system can then be directly read from 
these compressed diagrams.
These diagrams, in fact, are literally the Feynman 
diagrams for a specifi c class of quantum fi eld theo-
ries. These fi eld theories, however, are unusual in a 
number of respects. In the simplest formulation, they 
have no dynamics and no space. The evaluation of 
individual Feynman diagrams is therefore trivial; the 
only challenge is counting them all. Use of these dia-
grams further allows one to solve the theory exactly, 
not just perturbatively. The connection to quan-
tum fi eld theory has important advantages. First, 
it provides a rigorous mathematical foundation for 
the stated diagrammatic methods. Moreover, these 
fi eld theories closely resemble the Doi-Peliti formal-
ism for the master equation, making it likely that 
these techniques can be extended in a natural way in 
order to treat nonequilibrium systems. Finally, this 
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connection suggests a straightforward manner in 
which computerized operator algebra might be used 
to study biochemical systems that are too large or 
complicated for analytical treatment.
Mutual Information as an Objective 
Function in Machine Learning
As is often the case in high-throughput biology, it 
is diffi cult to characterize and control noise in the 
Sort-Seq assay. Therefore, the fact that parametrized 
models can be fi t to Sort-Seq data without having to 
model such noise is important. In my Ph.D. work, I 
helped show that maximizing the mutual informa-
tion between a model’s predictions and measure-
ments provides a way of doing this. Specifi cally, in 
the large data limit, maximizing mutual information 
is mathematically equivalent to maximizing likeli-
hood when the quantitative form of experimental 
noise is uncertain (Kinney et al., Proc Natl Acad Sci 
104: 501 [2007]).
Alternatively, maximizing mutual information can 
be justifi ed from the simple fact that it satisfi es the 
data processing inequality (DPI), a fundamental re-
lationship in information theory. However, there are 
other dependence measures that also satisfy DPI. This 
raises the question of whether maximizing a different 
DPI-satisfying measure will always lead to the same 
optimal model. In a preprint recently submitted to 
the arXiv (Kinney and Atwal 2012), Gurinder Atwal 
(CSHL) and I showed that in many cases, the answer 
to this question is “yes”: When the correct model is 
in the space of models being considered, maximizing 
mutual information is provably equivalent to simul-
taneously maximizing all dependence measures that 
satisfy DPI. Thus, there exists a well-defi ned class of 
“DPI-optimal” models, all of which explain the data 
equally well according to every one of a large class 
of objective functions. Maximizing mutual infor-
mation, however, often leaves certain model param-
eters unconstrained. These directions in parameter 
space were termed “diffeomorphic modes,” because 
movement along them generates continuous invertible 
transformations of model predictions; such transfor-
mations affect neither mutual information nor any 
DPI-satisfying dependence measure. In our preprint, 
Atwal and I show that diffeomorphic modes result not 
from defi ciencies of mutual information as an objec-
tive function, but rather from fundamental insensi-
tivities of the type of experiments considered. Indeed, 
diffeomorphic modes are of a fundamentally different 
nature than other directions in parameter space; con-
straints on these modes do not depend on the number 
of data points and can only arise from separate cali-
bration experiments.
In a separate arXiv preprint (Kinney and Atwal 
2013), Atwal and I addressed the issue of “equitability” 
raised in a recent paper by Reshef et al. These authors 
argued that a measure of association between two sto-
chastic variables should depend only on the relative 
signal-to-noise level, not on the underlying form of 
the relationship. Specifi cally, if y = f (x) + noise, then a 
dependence measure D[x,y] should not depend on the 
specifi c functional form of f, but only on its amplitude 
relative to the amplitude of the noise. This proposal is 
sensible, but Reshef et al. come to the surprising con-
clusion that mutual information does not satisfy this 
defi nition of “equitability,” and that a new statistical 
measure they propose, called the “maximal informa-
tion coeffi cient” (MIC), does. In our preprint, Atwal 
and I show that this conclusion is incorrect. Specifi -
cally, we prove that no dependence measure D[x,y] 
is able to satisfy the technical defi nition of equitabil-
ity that Reshef et al. propose. However, the heuristic 
notion of equitability is still of value, and we show 
that it can instead be formalized in terms of a simple 
self-consistency condition closely related to DPI. We 
further prove that mutual information satisfi es this 
revised defi nition of equitability while MIC does not. 
This fi nding was supported by a reexamination of the 
simulation evidence presented by Reshef et al.
PUBLICATIONS
Kinney JB, Atwal GS. 2012. Maximally informative models and dif-
feomorphic modes in the analysis of large data sets. arXiv:1212.
3647 [q-bio.QM].
In Press
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SCIENCES DEAN’S REPORT
Throughout a busy year at the Watson School of Biological Sciences (WSBS), the achievements 
of the graduate program continued to grow. The quality of the scientifi c publications produced by 
our students, even as they continue to graduate in times well below the national average, remains 
extremely impressive, as does the success of our alumni in getting excellent jobs. These measures 
reinforce the value of the program and its unique place in graduate education in the United States.
There have been a number of changes to the administrative staff at the WSBS this year. After 
completing her term of 5 years as Dean of the Watson School, Leemor Joshua-Tor, Ph.D., stepped 
down on July 31, 2012. She remains on the faculty of the WSBS as a Professor at Cold Spring Har-
bor Laboratory (CSHL) and Investigator of the Howard Hughes Medical Institute. As the third 
Dean of the WSBS, Dr. Joshua-Tor enhanced the curriculum in signifi cant ways, adding courses 
in quantitative biology, physical biology, and imaging. Her outstanding leadership ensured that 
the School remained at the leading edge of graduate education and, by contributing to the nation-
al debate on graduate education, she further advanced the infl uence of the school in that arena as 
well. I was appointed the Lita Annenberg Hazen Dean of the WSBS as of January 1, 2013. In the 
interim—from August 1 to the end of 2012—two senior members of the WSBS Executive Com-
mittee, Adrian R. Krainer and Linda Van Aelst, stepped in to lead the WSBS temporarily as acting 
Deans. They both did an excellent job in this capacity, and I am immensely grateful to them. 
In September 2012, Ms. Dawn Meehan Pologruto, who had been a major presence in the 
WSBS administration since 2003, most recently as the Director of Recruitment and Student Af-
fairs, departed to raise her two young sons. In November, Keisha John, Associate Director for Re-
cruitment and Undergraduate Research, also left the WSBS, taking a position as Assistant Dean 
at Florida State University. We were sorry to see them go, as both had contributed so much to the 
success of the school over the years. 
On the other hand, we were very pleased to recruit Kimberly Creteur to the WSBS adminis-
tration in November, where she immediately took on responsibility for the admissions process of 
both the graduate and URP programs. Kimberly received her Bachelor’s degree and fi rst Master’s 
degree from Vanderbilt University, where she also worked in the admissions offi ce. Subsequently, 
she worked in the Athletics departments of the University of Massachusetts and the University of 
Georgia doing marketing and promotion. She then received a second Master’s degree in counsel-
ing from Hofstra University, where she again worked in the admissions offi ce. 
Dr. Alyson Kass-Eisler, who has been with the WSBS since 2003, and Ms. Kimberley Geer, 
who has been the WSBS Administrative Assistant since 2007, were marvelous in ensuring that 
the programs at the WSBS were seamlessly administered and managed through all these changes.
Faculty Changes
Six new faculty members joined the Watson School in 2012: Jesse Gillis, Molly Hammell, Ivan 
Iossifov, Dan Levy, Gholson Lyon, and David Tuveson. 
Jesse Gillis, an Assistant Professor, studies gene networks under the principle of “guilt by asso-
ciation” (GBA), which states that genes with related functions tend to share properties. His work 
centers on identifying the limits of the GBA approach and making fundamental improvements 
to its operation, as well as applying those improvements to neuropsychiatric gene network data. 
Molly Hammell, an Assistant Professor and former CSHL Research Investigator, uses computa-
tional algorithms to integrate multiple types of genomic and transcriptomic profi ling data into 
models of regulatory rewiring events in human disease. The ultimate goal is to understand how 
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human diseases such as cancer, take advantage of the cell’s innate propensity for plasticity to re-
wire regulatory networks into programs that serve the needs of cancer cells. Ivan Iossifov, an Assis-
tant Professor and former Quantitative Biology Fellow, focuses on understanding the genetics of 
complex phenotypes (i.e., human disease) and biomedical text mining. Dan Levy, an Assistant 
Professor and former CSHL Research Investigator, works on the synthesis of data from a range of 
mutational modalities into a coherent picture of autism genetics. He is also interested in determin-
ing the contribution of de novo and rare inherited mutations to the etiology of sporadic disease 
through mathematical modeling and computer simulation. Gholson Lyon, an Assistant Professor, 
focuses on analyzing human genetic variation and its role in severe neuropsychiatric disorders. A 
second focus of his laboratory is to elaborate the mechanistic basis of a new rare disease that he 
described in 2011, called Ogden Syndrome—the fi rst-described human disease involving a defect 
in the amino-terminal acetylation of proteins. David Tuveson, Professor, investigates pancreatic 
cancer and melanoma by generating mouse models that mimic the human diseases closely and by 
participating in clinical trials with experimental therapeutics. The goals of the laboratory are to 
identify the essential components of malignant transformation of pancreatic cells and melanocytes 
in vivo and to translate this knowledge into effective tumor detection and treatment strategies.
These new faculty members have already participated in WSBS activities. Each of them has 
given a Research Topics talk to the fi rst-year students. They are also serving as members of thesis 
committees and expert qualifying examiners and have lectured in WSBS core courses. We look 
forward to their growing participation as members of the faculty.
Two faculty members also departed the School this year. Yuri Lazebnik was one of the fi rst in-
structors of the Scientifi c Exposition and Ethics Core Course and a guest lecturer in the Scientifi c 
Reasoning and Logic and Specialized Disciplines: Cellular Structure and Function Courses. He 
served as thesis committee member and was a thesis research mentor to a WSBS student. Yuri was 
also the Director of the Partners for the Future Program from 2001 to 2008. Robert Lucito was a 
guest lecturer in the Specialized Disciplines: The Genome Course. He was also a member of the 
Qualifying Exam and Admissions Committees and an academic mentor to three WSBS students. 
We will miss them both and wish them every success in their future endeavors.
The Ninth WSBS Graduation
On April 29, 2012, we celebrated the Watson School’s ninth graduation ceremony. Five stu-
dents were awarded the Ph.D. degree: Patrick Finigan and Fred Rollins from the Entering Class 
of 2006, Kyle Honegger and Zhenxun Wang from the Entering Class of 2007 and  Elizabeth 
Nakasone from the Entering Class of 2008. Carrie Clendaniel from the Entering Class of 
2008 was awarded a Masters degree, but did not attend the ceremony. An honorary degree was 
 bestowed upon Sir Kenneth Murray, who also gave the commencement address. Dr. Murray, 
together with his late wife and scientifi c partner, Noreen Murray, was at the forefront of devel-
opments in recombinant DNA technology in the 1970s, and late in that decade, he was a co-
founder of one of the fi rst biotechnology companies, Biogen, where he was instrumental in the 
development of a vaccine for hepatitis B, the fi rst genetically engineered vaccine approved for 
human use. With royalties from this breakthrough, Kenneth and Noreen Murray established 
the Darwin Trust of Edinburgh in 1983. During the last 30 years, this Trust has supported 
more than 300 graduate students and 50 undergraduates, as well as endowing faculty positions 
and supporting building projects.
As with each graduation, we extended a special welcome to the family members and friends 
of our students who attend the ceremony. Among these special guests were Beth’s family mem-
bers who traveled from Hawaii and brought beautiful and traditional handmade leis for this 
special event.
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Teaching Award
At the graduation ceremony this year, Michael Schatz was presented with the 
seventh annual Winship Herr Faculty Teaching Award, named in honor of the 
School’s founding dean. Michael, an instructor in the Specialized Disciplines 
Course in Quantitative Biology, was also the winner last year. He was chosen by 
the students for this award, based on his enthusiasm and creativity in teaching. 
The winner of this award is nominated and voted on by the students. Below are 
some of what they had to say about Michael:
“His lectures were challenging to some of the students but they were very successful 
because of  Michael’s great preparation.”
“He made sure we remembered the key concepts and came up with analogies that 
most of us will never forget.”
Admissions 2012
The School received 274 applications for the 2012/2013 academic year and is deeply indebted 
to the marvelous work of its Admissions Committee in reviewing, interviewing, and selecting 
candidates for our doctoral program. The Admissions Committee for the 2012 entering class com-
prised Gregory Hannon (Chair), Mickey Atwal, Anne Churchland, Leemor Joshua-Tor, Adrian 
R. Krainer, Zachary Lippman, W. Richard McCombie, Stephen Shea, Nicholas Tonks, and Linda 
Van Aelst.
Michael Schatz
2012 graduates: (Left to right) CSHL President Bruce Stillman, Fred Rollins, Kyle Honegger, Beth Nakasone, Patrick Finigan, Zhenxun 
Wang, WSBS Dean Leemor Joshua-Tor, Chancellor Emeritus Jim Watson
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2012 WSBS DOCTORAL RECIPIENTS
Student
Thesis 
advisor
Academic 
mentor
Current 
position
Eyal Gruntman Glenn Turner Joshua Dubnau Postdoctoral fellow, Janelia Farm; advisor is 
Michael Reiser
Kyle Honegger Glenn Turner John R. Inglis Postdoctoral fellow with Dr. Glenn Turner, 
CSHL
Elizabeth Nakasone Mikala Egeblad Alea A. Mills Medical student at the John A. Burns School 
of Medicine at the University of Hawaii
Maria Luisa Pineda Raffaella Sordella Adrian R. Krainer CEO, Envisagenetics
2012 THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2006
Eyal Gruntman, June 14, 2012
Integration properties of Kenyon cells in the Drosophila 
melanogaster mushroom bodies.
Thesis Examining Committee
Chair: Stephen Shea
Research Mentor: Glenn Turner
Academic Mentor: Josh Dubnau
Committee Member: Anthony Zador
Committee Member: Yi Zhong
External Examiner:  Cori Bargmann, 
 The Rockefeller University
ENTERING CLASS OF 2007
Kyle Honneger, March 9, 2012
Neural coding in the Drosophila mushroom body.
Thesis Examining Committee
Chair: Adam Kepecs
Research Mentor: Glenn Turner
Academic Mentor: John R. Inglis
Committee Member: Anthony Zador
Committee Member: Josh Dubnau
Committee Member: Pavel Osten
External Examiner:  Leslie Vosshall, 
The Rockefeller University
Maria Pineda, June 22, 2012
Substrate specifi city of receptor tyrosine kinases is critical 
for selective signaling.
Thesis Examining Committee
Chair: Gregory J. Hannon
Research Mentor: Raffaella Sordella
Academic Mentor: Adrian R. Krainer
Committee Member: Scott Lowe
Committee Member: Darryl Pappin
External Examiner:  Vivek Mital, 
Weill Cornell Medical College
ENTERING CLASS OF 2008
Elizabeth Nakasone, February 24, 2012
A stromal CCL2/CCR2 signaling axis regulates 
chemotherapeutic response in a mouse model of 
breast cancer.
Thesis Examining Committee
Chair: Linda Van Aelst
Research Mentor: Mikala Egeblad
Academic Mentor: Alea A. Mills
Committee Member: Scott Lowe
Committee Member: David L. Spector
External Examiner:  Valerie M. Weaver, University 
 of California, San Francisco
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DOCTORAL THESIS RESEARCH
Student Academic mentor Research mentor Thesis research
ENTERING CLASS OF 2007
Megan Bodnar
Starr Centennial Scholar 
Nicholas Tonks David L. Spector The nuclear choreography of chromatin dynamics, 
gene expression, and gene repression in embryonic 
stem cells.
Ralph Burgess
Starr Centennial Scholar 
Bruce Stillman Gregory Hannon Recombination hot spots: Characterizing fi ne-scale 
variation in the frequency of meiotic recombination 
across the mammalian genome.
Joseph Calarco
NSERC Scholar 
David H. Koch Fellow 
David Jackson Robert 
Martienssen
Transposable element (TE) regulation in the 
fl owering plant Arabidopsis thaliana.
Saya Ebbesen
NIH Predoctoral Trainee (ARRA) 
Starr Centennial Scholar
David J. Stewart Scott Lowe In vivo identifi cation and character ization of 
novel tumor suppressors relevant to human breast 
cancer.
Paloma Guzzardo
Leslie C. Quick, Jr. Fellow 
NIH Predoctoral Trainee 
William Randolph Hearst Student
Adrian R. Krainer Gregory Hannon Dissecting the piRNA pathway in the Drosophila 
ovarian somatic sheet.
Marek Kudla
George A. and Marjorie H. Anderson 
Fellow 
David Jackson Gregory Hannon CLIP method as a way of direct readout of 
microRNA target sites.
Hassana Oyibo 
Farish-Gerry Fellow 
William Randolph Hearst Student
Hiro Furukawa Anthony Zador Reconstruction of connectivity of neurons by 
reading of oligonucleotide labels (ROC-N-ROL).
Michael Pautler 
NSERC Scholar 
William R. Miller Fellow
Robert Lucito David Jackson The RAMOSA pathway and infl orescence 
branching in maize.
Yevgeniy Plavskin 
Alfred Hershey Fellow 
NIH Predoctoral Trainee
Jan A. Witkowski Marja 
Timmermans
The evolution of the miR390-dependent 
tasiRNA pathway and its function in bryophyte 
development.
Joshua Sanders 
Edward and Martha Gerry Fellow
Bruce Stillman Adam Kepecs Trans-regional coordination of activity in the 
mouse brain
Petr Znamenskiy 
David and Fanny Luke Fellow
Terri Grodzicker Anthony Zador Pathways for attention and action in the auditory 
system.
ENTERING CLASS OF 2008
Philippe Batut 
Florence Gould Fellow 
Zachary Lippman Thomas Gingeras Transposons and evolution of transcriptional 
regulation in the Drosophila clade.
Mitchell Bekritsky 
Starr Centennial Scholar
W. Richard 
McCombie
Michael Wigler High-throughput microsatellite genotyping.
Dario Bressan 
Robert and Teresa Lindsay Fellow 
Z. Josh Huang Gregory Hannon A genomic approach toward the elucidation of 
connectivity patterns at cellular resolution in 
complex neural networks.
Melanie Eckersley-Maslin 
Genentech Foundation Fellow 
Gregory Hannon David L. Spector Making the choice: Mechanistic insights into 
random autosomal monoallelic expression in 
mammalian cells.
Sang Geol Koh 
George A. and Marjorie H. Anderson 
Fellow
Glenn Turner Anthony Zador Attention-dependent information routing in the 
mouse auditory cortex.
Katie Liberatore 
Starr Centennial Scholar and 
National Science Foundation 
Predoctoral Fellow
Adrian R. Krainer Zachary Lippman Infl orescence development and heterosis.
Ozlem Mert 
George A. and Marjorie H. Anderson 
Fellow
John R. Inglis Scott Lowe Characterization of the role of E2F7 in oncogene-
induced senescence and tumorigenesis.
Zinaida Perova 
Charles A. Dana Fellow
Linda Van Aelst Bo Li The role of medial prefrontal cortex in behavioral 
depression.
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DOCTORAL THESIS RESEARCH (continued)
Student Academic mentor Research mentor Thesis research
Felix Schlesinger 
Crick-Clay Fellow
Gregory Hannon Thomas Gingeras Classifi cation of novel transcription start sites.
Nilgun Tasdemir 
Robert and Teresa Lindsay Fellow II
Josh Dubnau Scott Lowe Investigating the molecular overlaps between 
epigenetic reprogramming and transformation.
Elvin Wagenblast 
Starr Centennial Scholar 
Boehringer Ingelheim Fellow
Jan A. Witkowski Gregory Hannon Role of stem/progenitor cells in mammary gland 
and breast tumors.
Susann Weissmueller 
Annette Kade Fellow 
Raffaella Sordella Scott Lowe In vivo identifi cation and characterization of 
tumor suppressor genes in hepatocellular 
carcinoma.
ENTERING CLASS OF 2009
Stephane Castel 
Cashin Fellow NSERC Scholar
Lloyd Trotman Robert 
Martienssen
RNAi-mediated heterochromatin in S. pombe.
Kristen Delevich 
NIH Predoctoral Trainee 
Stephen Shea Bo Li Elucidating the role of Disrupted-in-
Schizophrenia-1 in development of prefrontal 
cortical circuits.
Silvia Fenoglio 
Elisabeth Sloan Livingston Fellow 
Linda Van Aelst Gregory Hannon RNAi screening to identify putative therapeutic 
targets for the treatment of pancreatic cancer.
Wee Siong Goh 
A*STAR Fellow Delbrück Fellow  
Hiro Furukawa Gregory Hannon Determining piRNA primary biogenesis, and MIWI 
and late piRNA function in mice using Caenorhab-
ditis elegans as a model system for genetic screening.
Ian Peikon 
Dr. John and Consuelo Phelan Student
Mickey Atwal Anthony Zador Reverse engineering the brain.
Kaja Wasik 
George A. and Marjorie H. Anderson 
Fellow 
Jan A. Witkowski Gregory Hannon A screen for novel components of the piRNA 
pathway in Drosophila melanogaster.
Cinthya Zepeda Mendoza 
Gonzalo Rio Arronte Fellow 
Thomas Gingeras David L. Spector Analysis of higher-order chromatin organization 
at the mouse syntenic region of human 1p36 
upon genomic copy number changes.
ENTERING CLASS OF 2010
Arkarup Bandyopadhyay
Goldberg Lindsay Fellow
Zachary Lippman Florin Albeanu Identity and intensity encoding of odors in 
rodents.
Colleen Carlston 
John and Amy Phelan Student 
Hiro Furukawa Christopher 
Hammell
Identifi cation and characterization of noise-
suppressor genes that act via microRNAs in 
Caenorhabditis elegans larval development.
Matthew Koh 
George A. and Marjorie Anderson 
Fellow 
Bo Li Florin Albeanu Roles of olfactory bulb inhibitory microcircuits in 
shaping the temporal response properties of mitral 
cells.
Lisa Krug 
NIH Predoctoral Trainee 
Stephen Shea Josh Dubnau Mechanisms of transposon regulation in the 
central nervous system.
John Sheppard 
Bristol Myers Squibb/NIH 
Predoctoral Trainee
Josh Dubnau Anne Churchland Neural mechanisms of multisensory decision 
making.
Jack Walleshauser 
Barbara McClintock/NIH 
Predoctoral Trainee
Christopher 
Hammell
Leemor Joshua-Tor Structural basis for TUT4 uridylation of 
pre-let-7/lin28 complex.
ENTERING CLASS OF 2011
Robert Aboukhalil 
NIH Predoctoral Trainee 
Starr Centennial Scholar 
Proposal defense: May 2013
Josh Dubnau Mickey Atwal 
Michael Wigler
Using single-cell RNA-Seq to investigate tumor 
heterogeneity and evolution.
Brittany Cazakoff 
Edward and Martha Gerry Fellow 
Proposal defense: January 2013
Christopher 
Hammell
Stephen Shea Dynamic granule cell processing of odor 
information.
Joaquina Delas Vives 
La Caixa Fellow 
Proposal defense: January 2013
Nicholas Tonks Gregory Hannon Functional role of long noncoding RNAs in 
hematopoiesis.
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DOCTORAL THESIS RESEARCH (continued)
Student Academic mentor Research mentor Thesis research
Anja Hohmann 
David H. Koch Fellow 
Proposal defense: January 2013
John Inglis Christopher Vakoc Exploring the role of bromodomain-containing 
protein 9 (Brd9) in the maintenance of acute 
myeloid leukemia.
Justus Kebschull 
David and Fanny Luke Fellow 
Genentech Foundation Fellow 
Proposal defense: February 2013
Marja Timmermans Anthony Zador Grasping the brain.
Fred Marbach 
Farish-Gerry Fellow 
Proposal defense: April 2013
Josh Dubnau Anthony Zador A study of auditory corticostriatal cells in the 
behaving mouse.
Onyekachi Odoemene 
NIH Predoctoral Trainee 
William Randolph Hearst Scholar 
Proposal defense: March 2013
Stephen Shea Anne Churchland The role of neural inhibition in perceptual 
decision making.
Sophie Thomain 
George A. and Marjorie H. Anderson 
Fellow 
Proposal defense: February 2013
Josh Dubnau Zachary Lippman Characterization of a new meristem maintenance 
pathway in tomato and Arabidopsis thaliana and 
its relation to pollen tube growth.
Charles Underwood 
William R. Miller Fellow 
Proposal defense: February 2013
Michael Schatz Robert 
Martienssen
Epigenetic inheritance through mitosis and 
meiosis in Arabidopsis thaliana.
Entering Class of 2012
On August 27, 2012, the Watson School welcomed its 14th class. This year, nine students joined 
the School: Nitin Singh Chouhan, William Donovan, Talitha Forcier, Tyler Garvin, Yu-Jui (Ray) 
Ho, Irene Liao, Paul Masset, Annabel Romero Hernandez, and Abram Santana.
Academic Mentoring
The Watson School takes pride in the level of mentoring afforded its students. One critical com-
ponent of this is our two-tiered mentoring approach: Each student receives an academic as well 
as a research mentor. Because WSBS students select a research mentor only in June, right before 
their qualifying exam—some 10 months after they arrive—it is a particular responsibility of the 
academic mentor to monitor students during the intensive coursework of the fi rst term, during 
their rotations, and to help them identify a suitable research mentor. Almost the fi rst thing enter-
ing students do is select, by mutual agreement, a member of the research or nonresearch faculty 
to serve as their academic mentor. And even after the students choose their research mentors, the 
academic mentors remain important advisors and advocates and serve as members of the students’ 
thesis committees. This program continues to receive much support from the faculty who volun-
teer to be academic mentors, and it has rightfully become a vital ingredient in our success. The 
Academic Mentors for the Entering Class of 2012 are:
STUDENT MENTOR STUDENT MENTOR
Nitin Singh Chouhan Florin Albeanu Irene Liao David Jackson
William Donovan Christopher Hammell Paul Masset Jan A. Witkowski
Talitha Forcier W. Richard McCombie Annabel Romero Hernandez Adrian R. Krainer
Tyler Garvin Zachary Lippman Abram Santana Lloyd Trotman
Ray Ho Michael Schatz
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2012 Entering Class: (Front row from left to right) Paul Masset, William Donovan, Tyler Garvin, Abram Santana, Nitin Chouhan, 
Ray Ho. (Back row from left to right) Annabel Romero Hernandez, Irene Liao, Talitha Forcier.
ENTERING CLASS OF 2012
Nitin Singh Chouhan, Indian Institute of Science Education and 
Research (IISER); Pune M.S. Awarded: IISER, Pune (2011); 
Summer Undergraduate Research Program: Freie University, 
Berlin, Germany (2010); Ranked Top 1% IIT-JEE Exam 
(2006); IISER, Pune Fellowship (2006–2011)
Academic Mentor: Florin Albeanu
William Donovan, Brown University; Summer Undergraduate 
Teaching and Research Award: Brown University (2011)
Academic Mentor: Christopher Hammell
Talitha Forcier, Cornell University; Convair Alumni Association 
Endowment: Cornell University; Frank and Mary Ann Tataseo 
Scholarship: Cornell University; Jules and Joann Tanzer 
Scholarship: Cornell University; Tanner Dean’s Scholarship: 
Cornell University
Academic Mentor: W. Richard McCombie
Tyler Garvin, University of Southern California; Dean’s List 
Awarded: University of Southern California (2009); Summer 
Undergraduate Research: Sandia National Laboratories (2010)
Academic Mentor: Zachary Lippman
Yu-Jui Ho, National Taiwan University; M.S. Awarded: Cornell 
University (2010); Outstanding Achievement Scholarship, 
Taiwan Post Company (2006)
Academic Mentor: Michael Schatz
Irene Liao; University of California, Berkeley; Howard Hughes 
Medical Institute Biology Fellows Program, University of 
California, Berkeley (2009); Departmental Citation for 
Genetics and Plant Biology, University of California, Berkeley, 
Department of Plant and Microbial Biology (2009); Sponsored 
Projects for Undergraduate Research (SPUR), University of 
California, Berkeley, College of Natural Resources (2007 
2007–2009); Phi Beta Kappa, University of California, 
Berkeley (2009); Research Training Program, Smithsonian 
Institution’s National Museum of Natural History, Washington 
D.C. (2008); Golden Key International Honour Society, 
University of California, Berkeley (2007); College of Natural 
Resources Dean’s List, University of California, Berkeley 
(2006–2009)
Academic Mentor: David Jackson
Paul Masset, University of Cambridge; M. Cog Sci Awarded: 
EHESS, ENS, Universite Paris Descartes (2012); B.A. and 
M. Eng. Awarded: University of Cambridge (2011); Cambridge 
iGEM Team: Finalist, “Best Wiki”, and Gold Medal 
Awarded (2010); Cambridge European Trust Bursary; Trinity 
College Engineering Essay Prize; Honourable Mention: 37th 
International Physics Olympiads; 2nd place in Physics: Belgian 
Francophone Physics Olympiad (2006); 4th place in Chemistry: 
Belgian Francophone Physics Olympiad (2006)
Academic Mentor: Jan A. Witkowski
Annabel Romero Hernandez, Instituto Politecnico Nacional, 
Mexico; M.S. Awarded: Centro de Investigación y de Estudios 
Avanzados del IPN (2011); National Council on Science 
and Technology Scholarship (2009–2011); Lazaro Cardenas 
Medal: Instituto Politecnico Nacional, Mexico (2009); 
Awarded top student in class: Instituto Politecnico Nacional, 
Mexico (2005–2008); Fundacion TELMEX-IPN Scholarship 
(2005–2008)
Academic Mentor: Adrian R. Krainer
Abram Santana, University of California, Santa Cruz; Minority 
Access to Research Careers (MARC) Scholarship Award 
(2011–2012); Society for the Advancement of Chicanos and 
Native Americans in Science (SACNAS): Poster Award in 
Chemistry (2011); SACNAS National Conference Travel 
Award (2011); Initiative for Maximizing Student Diversity 
(IMSD) Summer Research Experience Award (2011); Frank 
and Sarah McKnight Prize in Chemistry Semi-Finalist: 
University of Texas Southwestern Medical Center; Deans 
Honors: University of California, Santa Cruz
Academic Mentor: Lloyd Trotman
274
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The Fall Term Curriculum
Our faculty continues to do an outstanding job developing and delivering the curriculum. We 
are extremely grateful for their considerable time and effort in maintaining the high-quality 
coursework that we strive to provide. The Curriculum Development and Integration Commit-
tee (CDIC)—Adrian Krainer (Chair), David Jackson, Leemor Joshua-Tor, Nicholas Tonks, and 
Glenn Turner—continues to carefully monitor and develop the curriculum. In addition to the 
outstanding course instructors and guest lecturers from within the Laboratory, our courses also 
continue to attract an impressive array of guest lecturers from other institutions.
Recruiting Efforts
As in years past, Dawn Pologruto organized most of the recruitment efforts, sending our faculty 
and students traveling the length and breadth of the country to talk about the WSBS graduate and 
undergraduate programs. Keisha John did most of the traveling again this year, making special 
recruitment visits aimed at enhancing diversity. The table below details recruitment fairs and confer-
ences we attended, together with the names of faculty, students, and administrators who represented 
WSBS on these occasions. To further raise awareness of our programs, we also mailed more than 
15,000 letters to colleges and universities in the United States and abroad. We are grateful to all the 
students and faculty members who enthusiastically go on recruitment trips on behalf of the WSBS.
2012 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Event Location Date WSBS Attendees/Titles
Hunter College: MARC/RISE 
Program Visit and Information 
Session
Cold Spring Harbor 
Laboratory
January 19 Kristen Delevich, Graduate Student 
Chris Hammell, Assistant Professor 
Keisha John, Associate Director of 
Recruitment and Undergraduate Research 
Dawn Pologruto, Director of Admissions 
and Student Affairs
Vassar College: Genetics and 
Bioinformatics Course Visit 
and Information Session
Cold Spring Harbor 
Laboratory
February 23 Kristen Delevich 
Molly Hammell, Research Assistant 
Professor 
Dawn Pologruto 
Michael Schatz, Assistant Professor
SUNY, Farmingdale: Biology 
Club Visit
Cold Spring Harbor 
Laboratory
March 23 Hassana Oyibo, Graduate Student
The National Conference on 
Undergraduate Research 
(NCUR): Graduate School Fair
Weber State University March 29–30 Keisha John
College of William and Mary: 
Visit and Information Session
Cold Spring Harbor 
Laboratory
March 30 Kristen Delevich 
Chris Hammell 
Molly Hammell 
Elizabeth Nakasone, Graduate Student 
Dawn Pologruto
American Association of Cancer 
Research: Annual Meeting
Chicago, Illinois March 31–April 4 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
Experimental Biology: Annual 
Meeting
San Diego, California April 21–25 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
American Society for 
Microbiology: Annual Meeting
San Francisco, California June 16–19 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
(continued)
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2012 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE (continued)
Event Location Date WSBS Attendees/Titles
Special Libraries Association: 
Annual Meeting
Chicago, Illinois July 15–18 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
American Society of Plant 
Biologists: Annual Meeting
Austin, Texas July 20–25 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
University of Medicine and 
Dentistry, New Jersey: Summer 
Internship Program Visit
Cold Spring Harbor 
Laboratory
July 30 Eugene Plavskin, Graduate Student
Brookhaven National Laboratory: 
Graduate School Fair and 
Undergraduate Research 
Program Symposium
Brookhaven National 
Laboratory
August 8 Keisha John
Hunter College: Minority Access 
for Research Careers (MARC) 
Program Research Talk and 
Information Session
Hunter College September 12 Chris Hammell, Assistant Professor 
Anja Hohmann, Graduate Student
Massachusetts Institute of 
Technology: Career Fair
Massachusetts Institute of 
Technology
September 21 Stephane Castel
The Johns Hopkins University: 
Information Session
The Johns Hopkins 
University
September 25 Keisha John
Morgan State University MBRS-
RISE Program: Graduate Career 
Workshop and Information 
Session
Morgan State University September 26 Keisha John
Cornell University: Information 
Session
Cornell University October 2 Hassana Oyibo, Graduate Student 
Eugene Plavskin
Cornell University: Graduate and 
Professional School Day
Cornell University October 3 Hassana Oyibo 
Eugene Plavskin
Society for Advancement of 
Chicanos and Native Americans 
in Science (SACNAS)
Seattle, Washington October 11–14 Keisha John
University of Cambridge: 
Information Session
University of Cambridge October 11 Anja Hohmann
Society for Neuroscience: 
Annual Meeting; Graduate 
School Fair
New Orleans, Louisiana October 13–17 Keisha John
California Institute of Technology: 
Career Fair
California Institute of 
Technology
October 16 Megan Bodnar, Graduate Student
Massachusetts Institute of 
Technology: Information Session
Massachusetts Institute of 
Technology
October 26 Keisha John
California Forum for Diversity in 
Graduate Education: Graduate 
School Fair
San Francisco State 
University
November 3 Keisha John
American Society for Human 
Genetics: Annual Meeting
San Francisco, California November 6–10 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
Annual Biomedical Research 
Conference for Minority 
Students (ABRCMS)
San Jose, California November 7–11 Keisha John; Cinthya Zepeda Mendoza, 
Graduate Student
University of Puerto Rico, Rio 
Piedras: MARC Program 
Information Session
University of Puerto Rico, 
Rio Piedras
November 21 Alea Mills, Professor
American Society for Cell Biology: 
Annual Meeting
San Francisco, California December 15–19 CSHL Meetings and Courses and 
Press personnel attended with WSBS 
information for distribution
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Interinstitutional Academic Interactions
WSBS students account for approximately half of the total number of graduate students here 
at CSHL. The balance comprises visiting graduate students from other institutions who have 
decided to conduct some or all of their thesis research in the laboratories of CSHL faculty. The 
vast majority of these visitors are from Stony Brook University (SBU), via a program established 
between CSHL and SBU more than 30 years ago.
Over the years, we have also established relationships with other institutions around the world, 
thereby enabling their students to conduct research here at CSHL. Currently, we have visiting stu-
dents from institutions in Germany, France, Mexico, and India, to name a few. The Watson School 
provides a contact person for these students and maintains relationships with administrations from 
their home institutions. These students are fully integrated into the CSHL community and receive 
all necessary assistance as they navigate the complexities of performing doctoral research away from 
their home institutions. Those students who joined us this year are listed in the table below.
STUDENT CSHL RESEARCH MENTOR AFFILIATION AND PROGRAM
Naishitha Anaparthy James Hicks Stony Brook, Molecular and Cellular Biology
Deanna Bahel Christopher Hammell Stony Brook, Molecular and Cellular Biology
Debjani Pal Raffaella Sordella Stony Brook, Molecular and Cellular Biology
Jayon Lihm Seungtai Yoon Stony Brook, Applied Mathematics and Statistics
Yiyang Wu Gholson Lyon Stony Brook, Genetics
Tomoki Nomakuchi Adrian R. Krainer Stony Brook, Medical Scientists Training Program
Robert Wysocki Mikala Egeblad Stony Brook, Medical Scientists Training Program
Nitin Sirole Raffaella Sordella Stony Brook, Genetics
Eric Szelenyi Pavel Osten Stony Brook, Neuroscience
Graduate Student Symposium
Each year, the students participate in three Graduate Student Symposia held in January, May, and 
October at the Laboratory’s Genome Research Center in Woodbury. This year, each Symposium 
consisted of fi ve sessions where senior students each gave 15-minute talks. Coffee breaks, lunch, 
and a wine and cheese reception at the end of the day rounded out the program and provided op-
portunities for more informal interactions. The Graduate Student Symposium is open to the entire 
Laboratory community, and, as in previous years, all in attendance found the Symposia to be very 
worthwhile. We are grateful to the two student chairs of the Symposium, Jia-Ray Yu (SBU) and 
Cinthya Zepeda-Mendoza (WSBS), and to Keisha John for providing administrative oversight.
Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also departures. The following graduate students 
and postdoctoral fellows departed from the Laboratory during 2012:
Postdoctoral Fellows
Benjamin Boettner Tomas Hromadka Toma Marinov Chunlao Tang
Peter Bommert Mamoru Kato Sylvain Mitelheiser Hiroki Taniguchi
Santanu Chattopadhyay Hironori Kawakami Kate Revill Emma Vernersson Lindahl
Stacy DeBlasio Akiko Kobayashi Ulla Schwertassek Kazimierz Wrzeszczynski
Heike Demmer Ying Lin Puja Singh Yao, Zhan
Xinglong Gu Yilei Liu FNU Sneh Lata Zhang, Bin
Graduate Students
Ralph Burgess Benjamin Czech Elizabeth Nakasone Yu-Ting Yang
Ying Cai Zhen Gong Maria Pineda Taekyung Yun
Matthew Camiolo Miao He Vadim Pinskiy
Deblina Chatterjee Wanhe Li Yi Su
Michael Cressy Yifan Mo Matthew Titmus
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Executive Committee
The School’s Executive Committee, which meets monthly, provides year-round direction for the 
School and its students through its invaluable policy recommendations. I wish to thank faculty 
members Mickey Atwal, Mikala Egeblad, Adrian Krainer, David Spector, David Stewart, and 
Linda Van Aelst, who served on the Executive Committee through 2012. In December, Mickey 
Atwal and Adrian Krainer were elected to a second term. SBU student representative Deblina 
Chatterjee successfully defended her thesis in June and was replaced by Ioana Rus. Mitchell 
Bekritsky was the WSBS student representative. We are thankful to Deblina, Ioana, and Mitch 
for their contributions to discussions and for providing useful suggestions and feedback.
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher 
of Molecular Biology of the Cell, who died of cancer in 1991) brings to CSHL an eminent researcher 
and educator to give the Gavin Borden Lecture, which is designed specifi cally for the graduate 
students at the Laboratory. Dr. Dianne K. Newman, Professor of Geobiology at the California 
Institute of Technology and Investigator of the Howard Hughes Medical Institute, was this year’s 
Gavin Borden Fellow. Her lecture, “Electron transfer in times of stress: New roles for redox active 
“‘antibiotics,’” provided a unique look at how bacteria adapt to their environment. In addition, the 
students joined Dr. Newman during a roundtable lunch and discussion, where she shared insights 
into her personal scientifi c journey.
The Watson School Continues to Beneﬁ t from Generous Benefactors
We are extremely grateful for the generous donors, whose one-time gifts or continued support 
made our 2012 programs possible, including the Annenberg Foundation, Lita Annenberg Hazen 
Foundation, Bristol-Myers Squibb Corporation, Mr. and Mrs. Richard M. Cashin, Mr. and Mrs. 
Landon Clay, Lester Crown, the Dana Foundation, Henriette and Norris Darrell, the Samuel 
Freeman Charitable Trust, the William Stamps Farish Fund, the Genentech Foundation, Mr. 
and Mrs. Alan Goldberg, Florence Gould Foundation, William Randolph Hearst Foundation, 
Dr. Mark Hoffman, Annette Kade Charitable Trust, Estate of Gale Kavaliauskas, Mr. David H. 
Koch, Mr. and Mrs. Robert D. Lindsay and Family, Mr. and Mrs. David Luke III, Marjorie A. 
Matheson, Mr. and Mrs. William R. Miller, OSI Pharmaceuticals Foundation, Estate of Edward 
L. Palmer, Mr. and Mrs. John C. Phelan, the Quick Family, Estate of Elisabeth Sloan Livingston, 
the Starr Foundation, Universidad Nacional Autonoma de Mexico, and the Roy J. Zuckerberg 
Family Foundation.
We are also very fortunate to hold a prestigious National Research Service Award Predoctoral 
Training Grant from the National Institutes of Health, National Institute of General Medical Sci-
ences. The School successfully competed for renewal of this award in 2012.
Student Achievements
The WSBS students continue to impress with their accomplishments. They publish their re-
search fi ndings in prestigious international journals—more than 220 to date. In addition, our 
current students and alumni have been successful in receiving prestigious awards and fellow-
ships. In 2012,
• WSBS student Colleen Carlston was selected to join the National Science Foundation’s 2012 
East Asia and Pacifi c Summer Institutes for U.S. Program. She also received a National Sci-
ence Foundation Graduate Research Fellowship.
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• WSBS student Melanie Eckersley-Maslin was awarded a Keystone Symposium Traveling 
 Fellowship. She was also awarded an American Society for Cell Biology travel fellowship to 
attend the annual conference.
• WSBS student John Sheppard was awarded a National Science Foundation Graduate Research 
Fellowship and received a National Defense Science & Engineering Graduate Fellowship from 
the Department of Defense.
• WSBS graduate Hiroshi Makino was awarded a fellowship from the Uehara Memorial Foun-
dation (Japan). He also received a fellowship from the Japan Society for the Promotion of 
Science.
• WSBS graduate Elizabeth Murchison was the recipient of the Eppendorf award for Young 
 European Investigators and the MRC Jewellery Heirloom Award.
2012 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS
Borges F, Gardner R, Lopes T, Calarco JP, Boavida LC, Slotkin RK, Martienssen RA, Becker JD. 2012. FACS-based 
purifi cation of Arabidopsis microspores, sperm cells and vegetative nuclei. Plant Methods 8: 44. 
Calarco JP, Borges F, Donoghue MT, Van Ex F, Jullien PE, Lopes T, Gardner R, Berger F, Feijó JA, Becker JD, 
Martienssen RA. 2012. Reprogramming of DNA methylation in pollen guides epigenetic inheritance via small 
RNA. Cell 151: 194–205.
Calarco JP, Martienssen RA. 2012. Imprinting: DNA methyltransferases illuminate reprogramming. Curr Biol 22: 
R929–R931. 
Djebali S, Lagarde J, Kapranov P, Lacroix V, Borel C, Mudge JM, Howald C, Foissac S, Ucla C, Chrast J, Ribeca P, 
Martin D, Murray RR, Yang X, Ghamsari L, Lin C, Bell I, Dumais E, Drenkow J, Tress ML, Gelpí JL, Orozco M, 
Valencia A, van Berkum NL, Lajoie BR, Vidal M, Stamatoyannopoulos J, Batut P, Dobin A, Harrow J, Hubbard T, 
Dekker J, Frankish A, Salehi-Ashtiani K, Reymond A, Antonarakis SE, Guigó R, Gingeras TR. 2012. Evidence for 
transcript networks composed of chimeric RNAs in human cells. PLoS One 7: e28213. 
Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee Y, Narzisi G, Leotta A, Kendall J, 
Grabowska E, Ma B, Marks S, Rodgers L, Stepansky A, Troge J, Andrews P, Bekritsky M, Pradhan K, Ghiban 
E, Kramer M, Parla J, Demeter R, Fulton LL, Fulton RS, Magrini VJ, Ye K, Darnell JC, Darnell RB, Mardis ER, 
Wilson RK, Schatz MC, McCombie WR, Wigler M. 2012. De novo gene disruptions in children on the autistic 
spectrum. Neuron 74: 285–299.
Dow LE, Premsrirut PK, Zuber J, Fellmann C, McJunkin K, Miething C, Park Y, Dickins RA, Hannon GJ, Lowe SW. 
2012. A pipeline for the generation of shRNA transgenic mice. Nat Protoc 7: 374–393. 
Glaser SP, Lee EF, Trounson E, Bouillet P, Wei A, Fairlie WD, Izon DJ, Zuber J, Rappaport AR, Herold MJ, Alexander 
WS, Lowe SW, Robb L, Strasser A. 2012. Anti-apoptotic Mcl-1 is essential for the development and sustained 
growth of acute myeloid leukemia. Genes Dev 26: 120–125.
Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, Park J, Sinha P, 
Bissell MJ, Frengen E, Werb Z, Egeblad M. 2012. Imaging tumor-stroma interactions during chemotherapy reveals 
contributions of the microenvironment to resistance. Cancer Cell 21: 488–503.
Preall JB, Czech B, Guzzardo PM, Muerdter F, Hannon GJ. 2012. Shutdown is a component of the Drosophila piRNA 
biogenesis machinery. RNA 18: 1446–1457. 
Raposo D, Sheppard JP, Schrater PR, Churchland AK. 2012. Multisensory decision-making in rats and humans. 
J Neurosci 32: 3726–3735.
Sanders JI, Kepecs, A. 2012. Choice ball: A response interface for two-choice psychometric discrimination in head-fi xed 
mice. J Neurophysiol 108: 3416–3423. 
Shi J, Wang E, Zuber J, Rappaport A, Taylor M, Johns C, Lowe SW, Vakoc CR. 2012. The Polycomb complex PRC2 
supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene 32: 
930–938.
(continued )
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Alumni in Faculty and Senior Positions
To date, 54 students have received their Ph.D. degree from the WSBS. Of these graduates, 12 
currently hold tenure-track faculty positions and one holds an independent research position. 
Twenty-eight of our former students are pursuing postdoctoral research and eight of our alumni 
completed their postdoctoral studies and have moved into positions in administration, education, 
industry, management consulting, and journal editing.
2012 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS (continued)
Simpson D, Muthuswamy S, Tansey WP. 2012. Impact of epithelial organization on Myc expression and activity: 
Response. Cancer Res 72: 1036. 
Wang Z, Chatterjee D, Jeon HY, Akerman M, Vander Heiden MG, Cantley LC, Krainer AR. 2011. Exon-centric 
regulation of pyruvate kinase M alternative splicing via mutually exclusive exons. J Mol Cell Biol 4: 79–87.
Wang Z, Jeon HY, Rigo F, Bennett CF, Krainer AR. 2012. Manipulation of PK-M mutually exclusive alternative 
splicing by antisense oligonucleotides. Open Biol 2: 120–133.
Zador AM, Dubnau J, Oyibo HK, Zhan H, Cao G, Peikon I. 2012. Sequencing the connectome. PLoS Biol 10: 
e1001411. Review.
Watson School student
WSBS GRADUATES IN FACULTY AND SENIOR POSITIONS
Name Current position
François Bolduc Assistant Professor, University of Alberta, Canada
Darren Burgess Assistant Editor, Nature Reviews Cancer and Nature Reviews Genetics, UK
Amy Caudy Assistant Professor, University of Toronto, Canada
Michelle Cilia Research Molecular Biologist, United States Department of Agriculture, The Boyce Thompson 
Institute and Adjunct Assistant Professor, Cornell University
Catherine Cormier Scientifi c Liaison, Arizona State University
Yaniv Erlich Whitehead Fellow, Whitehead Institute
Rebecca Ewald Project Manager, Roche Diagnostics, Inc.
Elena Ezhkova Assistant Professor, Mount Sinai School of Medicine
Ira Hall Assistant Professor, University of Virginia School of Medicine
Christopher Harvey Assistant Professor, Harvard University
Keisha John Assistant Dean, Director—Offi ce of Graduate Fellowships and Awards at The Graduate 
School, Florida State University
Zachary Lippman Assistant Professor, Cold Spring Harbor Laboratory
Marco Mangone Assistant Professor, Arizona State University
Patrick Paddison Assistant Member, Fred Hutchinson Cancer Research Center
Emiliano Rial-Verde Engagement Manager, McKinsey & Co., Inc., Geneva, Switzerland
Ji-Joon Song Assistant Professor, Korea Advanced Institute of Science and Technology (KAIST), South Korea
Niraj Tolia Assistant Professor, School of Medicine at Washington University, St. Louis
Wei Wei Assistant Professor, University of Chicago
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WSBS Family Events
Finally, we celebrated some personal occasions. Three students from the Entering Class of 2008 
were married this year. On January 8, Mitchell Bekritsky married his fi ancée Rikki Stern in 
Florida. On August 26, two students, Zina Perova and Jiahao Huang, were married in New York 
City. On November 17, Marek Kudla, from the Entering Class of 2007, and his wife Manuela, 
 welcomed daughter Milena Trzebinska-Kudla to their family. Our congratulations and best wishes 
to all of them.
Alexander Gann
Professor and Dean
Zina and Jiahao with Dr. and Mrs. James Watson
Milena Trzebinska-Kudla Rikki and Mitch
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SPRING CURRICULUM
Topics in Biology
ARRANGED BY Leemor Joshua-Tor, Alyson Kass-Eisler, and Jan A. Witkowski
FUNDED IN PART BY  The Daniel E. Koshland, Jr. Visiting Lectureship; the David Pall Visiting Lectureship; 
the Fairchild Martindale Visiting Lectureship; the Lucy and Mark Ptashne Visiting 
Lectureship; the Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference 
Center to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory 
faculty. These courses include morning or evening lectures as well as afternoon sessions during 
which students read assigned papers. These intensive courses are modeled on the Cold Spring 
Harbor Laboratory Lecture Courses held each summer at the Banbury Conference Center. In 
Spring 2012, one of our own faculty members, Florin Albeanu, developed a new Topics in Biol-
ogy course on Optical Methods. The course included a large hands-on component, in which the 
students built their own microscopes, and for practical purposes, it was held on our main campus. 
The other Topics in Biology course in Spring 2012 was the Evolution course, taught once again by 
Nipam Patel and held at the Banbury Conference Center.
Optical Methods
Attended by the entering classes of 2008 and 2011
INSTRUCTORS Florin Albeanu, Cold Spring Harbor Laboratory
  Adam Kampff, Champalimaud Neuroscience Programme, Portugal
VISITING LECTURERS Florian Engert, Harvard University
  Tom Mrsic-Flogel, University College London
TEACHING FELLOWS  Francesca Anselmi, Cold Spring Harbor Laboratory
  Rob Campbell, Cold Spring Harbor Laboratory
Optical imaging techniques are widely used in all areas of modern biological research. Our aim 
for this course was to give students an introduction into widely used basic and advanced optical 
methods. Given the experimental nature of the topic, a central aim of our course was to offer stu-
dents a practical hands-on experience. This included both the use of commercially available sys-
tems and, more importantly, a primer on custom building and adapting optical setups to address 
specifi c biological needs. The course began with an overview of basic optics (diffraction, refrac-
tion, refl ection, resolution limits) and the components needed to build a microscope (lens com-
binations and photodetectors, such as photodiodes, PMTs, and CCD cameras). We introduced 
basic illumination techniques including Koehler, phase contrast, differential interference contrast 
(DIC), and dark fi eld. One day was dedicated to discussing and measuring various sources of 
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noise (dark, read-out, shot noise). We further provided an 
overview of more advanced optical methods ranging from 
intrinsic optical imaging and bioluminescence to patterned 
illumination and superresolution. We continued by giving 
detailed theoretical and experimental description of wide-
fi eld (epifl uorescence) and laser-scanning fl uorescence mi-
croscopy (confocal and multiphoton). The course concluded 
with lectures from invited speakers on biological applications 
of multiphoton microscopy, bioluminescence, and digital 
holography. In the lab sessions, the students constructed op-
tical rail systems using a combination of lenses, irises, and 
light sources to understand the principles of bright-fi eld mi-
croscopy. They further adapted their custom-built setups for 
epifl uorescence and added CCD cameras as detectors. They 
acquired pictures and real-time movies of samples ranging 
from tissue paper, pollen grains, fl y wings, blood, and cheek 
cells to planaria and transgenic Caenorhabditis elegans. The 
students built a scanning fl uorescence microscope and fur-
ther modifi ed it into a confocal system by introducing an aperture and descanning the beam. 
Different groups focused on different aspects of this project, from wiring up electronic circuits for 
the photodetector to writing scanning software in Matlab and Labview to actually assembling the 
optical components and operating the system. The course ran from Sunday, March 25, through 
Saturday, March 31.
Evolution
Attended by the entering classes of 2009 and 2010
INSTRUCTOR Nipam Patel, University of California, Berkeley
VISITING LECTURERS Rob DeSalle, American Museum of Natural History
 David Jablonski, University of Chicago
 Mike Palopoli, Bowdoin College
 Dan Rokhsar, University of California, Berkeley
TEACHING FELLOWS April Dinwiddie, Yale University
 Stephen Fairclough, University of California, Berkeley
The fi eld of evolutionary biology touches upon all other areas of the biological sciences, since 
every form of life and every biological process represents an ongoing evolutionary “experiment.” 
Our aim in this course was to both discuss our understanding of the mechanisms of evolution 
and explore how evolutionary data can be used to further our understanding of various biological 
problems. The course began with a discussion of the diversity of organisms that currently exist, 
as well as methods for understanding the evolutionary relationships among these organisms. The 
students then went on to study how paleontological data are collected and used to understand 
the history of life on Earth and to examine how DNA sequence data can be used to understand 
the evolutionary history of organisms, genes, and genomes. Within this molecular and genetic 
framework, the focus shifted to the mechanisms of evolutionary change and how variation within 
Optical methods participants. (From left to right) Sang 
Geol-Koh, Melanie Eckersley-Maslin, Silvia Fenoglio, 
Mitchell Bekritsky, Zina Perova, Josh Sanders
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At the American Museum of Natural History: Front (from left to right): April Dinwiddie, Silvia Fenoglio, Colleen 
Carlston, Kaja Wasik, Kristen Delevich, Cinthya Zepeda-Mendoza, David Jablonski. Rear (from left to right): Arkarup 
Bandyopadhyay, Wee Siong Goh, Stephen  Fairclough, Ian Peikon, Stephane Castel, Lisa Krug, Jack Walleshauser, 
John Sheppard, Matthew Koh.
populations leads to the evolution of new species. Finally, we discussed how morphological chang-
es are brought about through evolutionary changes in development and gene regulation. The hope 
was that this course would provide the student with a general overview of evolutionary biology and 
how to use evolutionary data to gain further insight into all manner of biological problems. The 
course ran from Sunday, March 4, to Saturday, March 10, and included a class favorite fi eld trip 
and curator tour at the American Museum of Natural History in New York City.
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Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Micklos
INSTRUCTORS Amanda McBrien (Lead) Erin McKechnie
 Jennifer Galasso Bruce Nash
 Elna Gottlieb Jermel Watkins
As science plays an increasing role in society, there is also an increasing need for biologists to 
educate nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral 
program offers its students unique teaching experiences through the Laboratory’s Dolan DNA 
Learning Center, where students teach laboratory courses to high school and middle school stu-
dents. From these teaching experiences, they learn how to communicate with nonbiologists and to 
inspire and educate creative young minds.
The teaching module entailed pairs of students teaching one morning or afternoon a week for 
12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the Watson 
School students the didactic process; it was not until the fi fth week that the graduate students 
taught on their own. At the end of the 12 weeks, the students were very excited about their teach-
ing experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research 
that leads to a unique contribution to human knowledge. After the fall course term, students par-
ticipate in laboratory rotations. These rotations provide students and faculty the opportunity to 
get to know each other and to explore possibilities for doctoral thesis research. At the end of each 
rotation, students make short presentations of their studies to the other students and their rotation 
advisors. These talks give students an opportunity to share their laboratory experiences and to 
learn how to give a scientifi c presentation. With this latter goal in mind, in addition to the research 
mentors, the instructors of the Scientifi c Exposition and Ethics Core Course and members of the 
School’s Executive Committee attend the talks and give individual feedback to students on their 
presentations. This year, 20 WSBS faculty members served as rotation mentors, some mentoring 
more than one student.
ROTATION MENTORS Florin Albeanu Gregory Hannon Michael Schatz
 Mickey Atwal Z. Josh Huang Stephen Shea
 Anne Churchland Adam Kepecs David L. Spector
 Mikala Egeblad Adrian R. Krainer Christopher Vakoc
 Hiro Furukawa Bo Li Michael Wigler
 Christopher Hammell Zachary Lippman Anthony Zador
 Molly Hammell Robert Martienssen
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CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientiﬁ c 
Reasoning and Logic
INSTRUCTORS Gregory Hannon (Lead) Leemor Joshua-Tor
 Alexander Gann Bo Li
 Christopher Hammell Nicholas Tonks
GUEST LECTURERS Hiro Furukawa Senthil Muthuswamy
 Molly Hammell David Tuveson
 Justin Kinney Linda Van Aelst
 Robert Martienssen
The SRL core course was revamped last year with regard to content and instructor participation. 
This year, only one module changed, with Christopher Hammell joining the team. Each module 
of the course has been designed to cover a different general theme, and proceeds with the goal of 
considering an open, still unanswered, scientifi c question. In addition, the fi rst two modules of the 
course were combined into one longer module so that an integrated theme could be tackled using 
two different approaches: molecular biology and structural biology.
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core 
course, which forms the heart of the curriculum, students (1) acquire a broad base of knowledge 
about the biological sciences, (2) learn the scientifi c method, and (3) learn how to think critically.
The beginning of the course is divided into four to fi ve modules. For each module, students 
read an assigned set of research articles (generally four articles) and at the end of the module, 
provided written answers to a problem set that guided them through several of the articles. Twice 
weekly, students attended lectures related to the module’s topic that included concepts and funda-
mental information as well as experimental methods. During each week, the students met among 
themselves to discuss the assigned papers not covered by the problem set. Each week, students 
spent an evening discussing the assigned articles with faculty.
In the fi nal part of the course, students participated in a mock study-section in which real 
National Institutes of Health R01 grants were reviewed and critiqued. This allowed the students 
to evaluate the questions before the answers were known, evaluate routes toward discovery before 
knowing where they will end, and make critical judgments about how to proceed in the face of an 
uncertain outcome. The module topics for this course were as follows:
Topic Instructor(s)
Mechanism and Structure of Gene Regulation Alex Gann
Leemor Joshua-Tor
Gene Regulatory Logic and the Construction of Multicellular 
Organisms: Insights from Flies, Plants, and Worms
Christopher Hammell
The Brain: Wiring, Plasticity, and Maladaptation Bo Li
Signal Transduction and the Search for Novel Therapeutics Nicholas Tonks
Study Section Gregory Hannon
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The Darrell Core Course on Scientiﬁ c Exposition and Ethics
INSTRUCTORS David J. Stewart (Lead)
 Alea A. Mills
 Arne Stenlund
TEACHING ASSISTANT Andrea Eveland
GUEST LECTURERS Diane Esposito
 Jan A. Witkowski
VISITING LECTURERS Olga Akselrod, The Innocence Project
 Keith Baggerly, University of Texas, M.D. Anderson Cancer Center
 Michael Beilski, The Center for Biotechnology
 Robert Charrow, Greenberg Traurig, LLC
 Avner Hershlag, North Shore University Hospital
 Amy Harmon, The New York Times
 Boyana Konforti, Editor, Nature Structural & Molecular Biology
 Tung-Tien (Henry) Sun, New York University
The Scientifi c Exposition and Ethics (SEE) core course 2012 was taught by the same instructor 
team as last year, with David Stewart taking the lead role, joined by Alea Mills and Arne Stenlund. 
This year, one CSHL postdoctoral fellow, Andrea Eveland, participated in the course as a teaching 
assistant. As usual, the course hosted expert guest lecturers who covered topics including scientifi c 
presentations, the editorial review process, the ethical and legal responsibilities of scientists, DNA 
profi ling and postconviction appeals, and reproductive genetics.
This core course offered instruction in the fundamental elements of scientifi c exposition—writ-
ing skills and public speaking—and ethics. The ability to communicate effectively and to appreciate 
the intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of 
example-based lectures and discussion groups. Writing skills included the fundamentals of modern 
scientifi c English and the organization and preparation of papers, research abstracts, and grant ap-
plications. Oral presentation skills were taught by instructors with different modes of presentation. 
Together with instructors, students critiqued formal seminar presentations at the Laboratory.
Instruction and discussions about ethics included the ethical implications of biological discov-
ery for society as well as the nature and boundaries of ethical behavior of scientists and their rights 
and responsibilities. A primary objective of the course was that students consider exposition and 
ethics integral aspects of scientifi c research.
Research Topics
ORGANIZERS Kimberley Geer
 Alyson Kass-Eisler
This core course provided students with an in-depth introduction to the fi elds of research that the 
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, 
at which faculty members and CSHL fellows presented their current research topics and methods 
of investigation each Wednesday evening over dinner. The students learned how to approach im-
portant problems in biology. These seminars, together with the annual fall Laboratory In-House 
symposium, provided students with a basis for selecting laboratories in which to do rotations.
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Specialized Disciplines Courses
The students in the Entering Class of 2012 took a total of four Specialized Disciplines courses this 
fall: Cellular Structure and Function, Genetics and Genomics, Systems Neuroscience, and Quantita-
tive Biology.
Cellular Structure and Function
INSTRUCTORS Linda Van Aelst (Lead)
 Raffaella Sordella
GUEST INSTRUCTORS Darryl Pappin
 David L. Spector
 Bruce Stillman
VISITING LECTURERS Gregg Gundersen, Columbia University
 Aron Jaffe, Novartis
 Alexey Khodjakov, Wadsworth Laboratory
 Sandy Simon, The Rockefeller University
 Marc Symons, The Feinstein Institute for Medical Research
With the complete genome sequence available for many organisms, there is now an increasing 
emphasis on understanding the function of the gene products. This understanding requires an 
increasing appreciation of the structure and function of the cell, as well as dynamic associations 
within the cell. This course provided a basic overview of the structural and functional organiza-
tion of cells, with particular emphasis on cellular compartmentalization and communication. 
Topics of focus included the cytoskeleton, cell adhesion and signaling, membrane transport, gene 
expression, and nuclear organization. In addition, the course provided insight into the basic tool-
box of the cell biologist of the 21st century.
Genetics and Genomics
INSTRUCTORS Thomas Gingeras (Lead)
 Zachary Lippman
GUEST LECTURERS Josh Dubnau
 Marja Timmermans
This course placed modern genetics and genomics into the context of classical genetics. His-
tory, technique, and perspective of genetic inference were described around four levels of anal-
ysis: forward genetics, natural genetic variants, gene interaction, and genomics. Emphasis was 
on integrating classical with modern questions of genetic analysis: How are genes mapped and 
“cloned”? How do gene mutations help to defi ne biological processes? How are more complex 
traits genetically dissected into simpler (underlying) components? What concepts and techniques 
are used to organize genes into pathways and networks? What defi nes a gene and what gene varia-
tion exists in natural populations? What are the functional consequences of gene variation, and 
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how is it detected? How are genomes organized and coordinately regulated? How can genomic 
information be catalogued, organized, and mined? These questions and concepts were fl eshed out 
using examples from the literature.
Quantitative Biology
INSTRUCTORS Mickey Atwal (Lead)
 Michael Schatz
GUEST LECTURERS Ivan Iossifov
 Justin Kinney (CSHL Fellow)
 Alexander Krasnitz
With the advent of high-throughput technologies in biology, it has become necessary for biologi-
cal researchers to be able to analyze and interpret high-dimensional data and frame hypotheses 
mathematically. To this end, the aim of this course was to equip the students with basic training 
in modern statistical methods. By the end of the course, the students were able not only to answer 
many of the simple statistical questions that arise in data analyses, but also to become familiar 
with the more complex techniques used by fellow computational biologists.
Topics included error fl uctuations, calculating the signifi cance of an experimental result, 
Bayesian inference, information theory, power calculations, dimensional reduction, and DNA 
sequence analyses. In addition, this course introduced mathematical modeling, motivated by the 
classic examples in quantitative biology such as the Delbrück-Luria experiment, Hopfi eld’s kinetic 
proofreading, and Kimura’s neutral theory of population genetics.
For the fi rst time, a 2-day Quantitative Biology boot camp, in which students were provided 
with the quantitative skills useful to their other coursework, was given at the very beginning of 
the fall semester.
Systems Neuroscience
INSTRUCTORS Adam Kepecs (Lead)
 Glenn Turner
GUEST INSTRUCTORS Anne Churchland
 Alexei Koulakov
 Stephen Shea
 Anthony Zador
This course introduced students to neuroscience, with a focus on learning and plasticity from its 
cellular basis, through development, to systems and behavior. Both experimental and theoretical 
viewpoints were explored. The course started with the basics of electrical signaling in neurons: 
ion channels, action potentials, and synaptic transmission. The cellular basis of learning, includ-
ing Hebb’s postulates and LTP (long-term synaptic potentiation), was discussed. The course 
explored the consequences of synaptic learning rules by examining how experience shapes the 
wiring of the nervous system during development and investigated how such building blocks 
translate into whole-organism behavior.
The course then examined classical conditioning and asked how changes in synaptic transmis-
sion could underlie such behavior. Associative learning computational models of the learning 
265-298_wsbs.indd   289 9/17/2013   8:18:18 AM
290  Watson School of Biological Sciences
process were discussed. From behaviors that focus on simple memories, the course turned to be-
haviors that require making perceptual decisions. This was accomplished by covering some basic 
concepts of perceptual neuroscience, such as neuronal “receptive fi elds,” and we used these to 
discuss current results and models of perceptual decision making.
Finally, the course turned to the learning of behaviors through reward and punishment, what is 
known as reinforcement learning. It concluded with a discussion of the role of dopamine in reward 
and learning, the theory of reinforcement learning, and pathologies of reward-seeking behavior.
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POSTDOCTORAL PROGRAM
PROGRAM DIRECTOR Nicholas Tonks
PROGRAM ADMINISTRATOR Alyson Kass-Eisler
Cold Spring Harbor Laboratory (CSHL) is proud of its rich tradition in postdoctoral education 
and has a deep commitment to the postdoctoral experience. CSHL has long been recognized 
as a place for nurturing young scientists, with postdoctoral researchers being an integral part 
of the discovery process. Current fi elds of research expertise include genetics; molecular, cel-
lular, and structural biology; neuroscience; cancer; plant biology; genomics; and quantitative 
biology. The postdoctoral community at CSHL is diverse and international, arriving at the 
Laboratory with many different backgrounds and with needs that change during the course of 
the postdoctoral years. The Postdoctoral Program Offi ce works closely with the fellows and the 
Laboratory’s administration to coordinate and organize educational and career development 
activities. Alyson Kass-Eisler, the Postdoctoral Program Offi cer, and Nicholas Tonks, the Scien-
tifi c Director of the Postdoctoral Program, provide the day-to-day support for the postdoctoral 
program, which is overseen by the Dean of the Watson School of Biological Sciences (WSBS).
In January 2011, Bruce Stillman held his annual Town Hall meeting with postdocs. One sug-
gestion that came from the meeting was the establishment of a Postdoctoral Liaison Committee 
(PDLC)—an elected group of postdocs who would help share information and ideas between the 
administration and the postdoctoral community. In 2012, new members Jonathan Ipsaro and 
Benjamin Roche joined returning members Kate Creasey, Santiago Jaramillo, Dawid Nowak, and 
Kate Revill. The PDLC has been hard at work organizing two successful retreats this year aimed 
at fostering networking and collaboration. The PDLC also oversees and distributes funds to two 
career development groups as described below. These groups are primarily composed of postdoc-
toral fellows, but they also include graduate students.
Today’s postdocs face a number of challenges, including a very diffi cult job market. CSHL 
works hard to give its postdocs the upper hand when it comes to competing for the scarce jobs 
that are available. More and more, it has become our responsibility to introduce a diversity of 
career opportunities that are available and to provide the tools to our postdocs to prepare for 
these positions. Thanks to the assistance of PDLC and these career development groups, 2012 
was an extremely exciting year for us!
The Career Development Program (CDP) is interested in providing programming geared 
toward careers in academia. A six-part series was organized called “Conversations with Faculty,” 
in which CSHL faculty and administration gave the postdocs career insights in an informal and 
interpersonal format. Sessions included The Postdoc Experience, with Christopher Hammell 
and Gregory Hannon; Going on the Job Market: Applicant Perspective, with Stephen Shea 
and postdoc Ted Karginov; Going on the Job Market: Search Committee Perspective, with 
Thomas Gingeras, Marja Timmermans, and Anthony Zador; Transitioning from Postdoc to PI: 
 Negotiations, with Adrian Krainer, Nick Tonks, and David Spector; First Year as PI: A CSHL 
Perspective, with Anne Churchland and Michael Schatz; and First Year as PI: A Perspective 
from Outside CSHL, which featured CSHL alumni Elena Ezhkova (Assistant Professor, Mount 
Sinai School of Medicine) and Mikel Zaratiegui (Assistant Professor, Rutgers University).
The CDP also hosted another extremely well-received workshop on preparing for the Chalk 
Talk, an integral part of the academic job search. In this session, Martine Mirrione, a postdoc 
in Bo Li’s laboratory, presented her future research plans in front of Alea Mills, Pavel Osten, 
Marja Timmermans, and Tony Zador, who served as the mock hiring panel.
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Together, we have also been working on building connections with local colleges and uni-
versities to provide teaching experience opportunities for interested postdocs. The fi rst of these 
connections has been made with Molloy College, and a CSHL postdoc has already started 
teaching as an Adjunct Professor. Finally, the CDP started a new series called “Getting to Know 
Your Faculty,” where CSHL faculty members share stories of their journey throughout their 
career and highlight the person behind the scientifi c concepts and publications. The fi rst guest 
was CSHL President Bruce Stillman.
The Bioscience Enterprise Club (BEC) is most interested in providing information for non-
academic careers, and they have also been organizing a series of seminars and workshops. The 
areas of interest include biotechnology, intellectual property, law, regulatory affairs, and venture 
capitalism. This year’s presentations included How to be Successful as a Scientist Working in a 
Start-up, with Melinda Thomas, Entrepreneur-in-Residence for the City of New York; Careers 
in Medical/Healthcare Communications, with Kakuri M. Omari, Ph.D., Scientifi c Director, 
and Julianne Dunphy, Ph.D., Vice President, Scientifi c Director at Publicis Healthcare Commu-
nications Group; Translating Your Talent into a Career: Decoding the Job Search Process, with 
Barbara Gebhardt, President of Opus Scientifi c; Entrepreneurial Science: From Sunless Tan-
ning to Sickle Cell Disease, with Steven Isaacman, Ph.D., Founder and CEO of Nanometics 
LLC; Launching a Successful Venture Capital Backed Start-up, with Irvin Barash, President, 
Vencon Management, Inc.; and Startups vs. Biotech?, with Mark Fasciano, Ph.D., Managing 
Director, Canrock Ventures. Mark Lesko, Executive Director of Accelerate LI, a regional col-
laboration among the major academic and research organizations on Long Island to accelerate 
an innovation-based economy, also participated in the session. They were joined by a writer for 
Newsday, leading to a mention of the club in the paper! Finally, the BEC hosted Michael Bielski 
from the Fundamentals of the Bioscience Industry Program, a course for scientists interested in 
gaining entrepreneurial experience, located at Stony Brook University.
To celebrate National Postdoc Appreciation week, we planned a faculty/postdoc volleyball 
game, barbeque, and fair highlighting the career development initiatives. Unfortunately, the 
weather did not cooperate, forcing the cancellation of the volleyball game. We still enjoyed an 
indoor barbeque, and it was a great opportunity for the community to fi nd out about the ongo-
ing programs we have been running.
Through the Laboratory’s Human Resources department, the postdocs have had access to 
free jobseeker webinars hosted by the Higher Education Research Consortium. The 2012 we-
binars included The Campus Visit, Insider Tips for Finding a Job Outside Academia, and Ask 
The Experts: Answers to Your Toughest Academic Job Search Questions.
Seven years ago, the WSBS initiated a prize for the best posters by a postdoctoral fellow and 
the best poster by a graduate student at the Laboratory’s annual In-House Symposium. Each 
“prize” is given in the form of an educational grant of $500. In addition to providing a forum 
for the postdoctoral fellows to show off their research, and potentially win a prize, it gives the 
entire scientifi c community a chance to come together and share ideas beyond the walls of their 
individual laboratories. It has been a great success for both the presenters and the Laboratory 
community as a whole. This year, the postdoctoral prize, for the second year in a row, was won 
by Tim Kees from Mikala Egeblad’s laboratory.
During the past couple of years, we have increasingly widened the role of postdoctoral fel-
lows in the curricular activities of the School. Our fellows have been involved in preparing our 
students for the challenging fall term curriculum by working as one-on-one tutors during the 
summer. Throughout the fall term, postdoctoral fellows are used as tutors for all aspects of the 
curriculum, providing one-on-one tutoring, group tutoring, and participating in discussion 
sessions. The Scientifi c Exposition and Ethics (SEE) course takes advantage of the expertise of 
our postdoctoral community by hiring fellows as teaching assistants (TAs). These fellows serve 
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as an integral part of the course by providing their expertise in discussions, editing the students’ 
written work, and critiquing oral presentations. In fall 2012, Andrea Eveland, a postdoctoral 
fellow from David Jackson’s laboratory, was the TA for the SEE course.
A new program called “Demystifying Science,” which started in 2011, enlists postdoctoral 
fellows who bring their expertise and teaching interests to the educationally diverse staff of the 
Laboratory. In the 2012 sessions, geared toward a general audience, postdocs have talked about 
Exploring the 3rd Dimension: The Neurobiology of Depth Perception, by Dennis Eckmeier; 
Seeing Scents: Watching Brain Cells Decipher the World, by Rob Campbell; The Clockwork 
Automaton: Machines in Biology, by Swagatam Mukhopadhyay; Mixed Messages in Human 
Disease, by Jackie Novatt; Reading and Writing Minds: How Neuroscience Can Revolution-
ize Communication, by Santiago Jaramillo; Evolution: What’s New and Who Cares?, by grad-
uate student Eugene Plavskin; and Turning Villains into Heros: Immune Cells in Cancer, by 
Tim Kees.
Since 2003, all postdoctoral fellows and graduate students at the Laboratory have been en-
rolled in a special initiative of the New York Academy of Science (NYAS), the Science Alliance. 
The Science Alliance for graduate students and postdoctoral fellows is a consortium of universi-
ties, teaching hospitals, and independent research facilities in the New York City metro area 
that have formed a partnership with NYAS. The aim of the Alliance is to provide career and 
professional development monitoring for postdoctoral fellows and graduate students in science 
and engineering, through a series of live events and a dedicated web portal. In addition, the 
Science Alliance gives graduate students and postdoctoral fellows the opportunity to network 
with their peers across institutions and with key leaders in academia and industry. This year, 
the Science Alliance meetings and workshops included Writing For Biomedical Publication; 
From Idea to IPO; Writing About Science for the Public; Introduction to Scientifi c  Teaching; 
 Leveraging the Scientifi c Mindset in the Entrepreneurial World; PepsiCo Journey through Sci-
ence Day; From Scientist to CSO: Leadership & Management Development for Careers in 
Business and Industry; Making the Leap: A Non-Academic Career Planning & Job Search 
Boot Camp; and Communicating Science to the Public.
On December 6, the Offi ce of Sponsored Programs, the Development Department, and the 
Postdoc Program Offi ce held a very popular course on Grant Writing. The sessions included 
Introduction to Grants and External Funding; The Grant Application; Protecting Human 
Research Subjects/Use of Laboratory Animals in Research; The Grant Abstract/Public Sum-
mary; Peer Review Panel Discussion; Effective Writing Skills; Fellowships, Career Develop-
ment Awards & Resources for Postdocs; and a Fellowship Discussion Panel featuring postdocs 
Olga Anczukow-Camarda, Jan Bergmann, and Leah Sabin, who all currently hold competitive, 
individual fellowships.
Finally, a most important measure of our postdoctoral program’s success is the ability of 
postdoctoral fellows to secure positions at the end of their training. In 2012, the Laboratory’s 
departing postdoctoral fellows went on to positions at Arnold & Porter, Bayer HealthCare 
Pharmaceuticals, Cell Press, Fraunhofer Institute for Cell Therapy and Immunology, H3 Bio-
medicine Inc., Kyushu University, Max-Planck Florida Institute, Memorial Sloan-Kettering 
Cancer Center, Roche Pharmaceuticals, Rutgers University, University of Montreal, and Vellore 
Institute of Technology, just to name a few.
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UNDERGRADUATE RESEARCH PROGRAM
PROGRAM DIRECTORS Anne Churchland
 Michael Schatz
PROGRAM ADMINISTRATOR Keisha John
Established more than 50 years ago, the CSHL Undergraduate Research Program (URP) plays 
a major role in providing and setting the standard for meaningful hands-on undergraduate 
research training in biology. The 10-week program begins the fi rst week of June. During the 
fi rst week, the students are oriented to the campus, receive a guided historical tour of campus, 
and a tour of all facilities and resources available to them, ensuring a smooth transition into 
the Laboratory community and research. The URPs work, live, eat, and play among CSHL 
scientists, and they have a very busy academic and social calendar throughout the remaining 
9 weeks of the summer. The students receive training in Scientifi c Research, Science Communi-
cation,  Career Preparation, and Bioinformatics and Computational Biology, all while interact-
ing socially with fellow program participants and members of the CSHL community at large in 
formal and informal activities. Some of these activities in 2011 were a pizza party with Dr. and 
Mrs. Watson, dinner with Dr. and Mrs. Stillman, BBQ and pool parties, volleyball games, de-
signing the URP T-shirt, competing in the annual Scavenger Hunt, and the ever-famous URP 
vs. PI volleyball match.
The students’ scientifi c development is the most important component of the program; there-
fore, in the beginning of the summer, the URPs write an abstract and present a talk on their 
proposed research. The URP participants work alongside scientists and become increasingly inde-
pendent throughout the summer. Concluding the program in August, the URPs prepare a fi nal 
report and present their results in a 15-minute talk at the URP Symposium. As in previous years, 
the program directors and faculty mentors were highly impressed with the accomplishments of the 
URP students.
The URPs present their talks in the James Library.
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The following 26 students, selected from 884 applicants, took part in the 2012 program:
Francesca Aloisio, University of Texas, Austin
Advisor: Dr. Gregory Hannon
Funding: Howard Hughes Medical Institute
Using RNA-FISH to characterize the localization of novel 
lincRNAs in the mouse hematopoietic system.
Sarah Anderson, University of North Carolina, 
Chapel Hill
Advisor: Dr. Gregory Hannon
Funding: Libby Fellowship
Characterizing the role of pachytene piRNAs in mice.
Marta Andres Terre, University of Pennsylvania, 
Universitat de Barcelona
Advisor: Dr. Marja Timmermans
Funding: 30th Anniversary URP Scholar
Defi ning the developmental profi le of miRNA mobility.
Dhruba Banerjee, University of California, Berkeley
Advisor: Dr. Florin Albeanu
Funding: National Science Foundation Scholarship
Top-down control of invariant odor perception.
Alexandra Batchelor, University of Cambridge, 
United Kingdom
Advisor: Dr. Adam Kepecs
Funding: Clare College Watson Scholarship
How does cocaine affect optimal decision making?
Eleanor Batty, Brown University
Advisor: Dr. Anne Churchland
Funding: National Science Foundation Scholarship
Encoding of head movement in the posterior parietal cortex.
Eric Biggers, Macalester College
Advisor: Dr. Michael Schatz
Funding: National Science Foundation Scholarship
Assembling the pineapple genome.
Jeetayu Biwas, Brandeis University
Advisor: Dr. Darryl Pappin
Funding: Former URP Fund Scholarship
Human thymosin b-4: Searching for the mechanism 
behind the mystery.
Michael Bocek, University of Washington
Advisor: Dr. Mikala Egeblad
Funding: Robert H.P. Olney Fellowship
Extending the Brainbow system for live tumor 
imaging studies.
Rachel Charney, McMaster University, Canada
Advisor: Dr. Pavel Osten
Funding: Burroughs Wellcome Fellowship
The neurobiological effects of fever on wild-type mice and 
the 16p11.2 autistic mouse model.
Zachary Collins, George Washington University
Advisor: Dr. Partha Mitra
Funding: Former URP Fund Scholarship
Mapping GABAergic neuron subtypes in mouse models of 
autism spectrum disorders.
Karensa Crump, Binghamton University
Advisor: Dr. Stephen Shea
Funding: Alfred L. Goldberg Fellowship
Granule cell activity in the main olfactory bulb of awake mice.
David Ding, University of Oxford, United Kingdom
Advisor: Dr. Lloyd Trotman
Funding: Dorcus Cummings Scholarship
In vitro studies of IL-6 signaling in prostatic cancers and 
metastases.
Emily Glassberg, Dartmouth College
Advisor: Dr. Alexander Krasnitz
Funding: National Science Foundation Scholarship
A novel computational strategy to determine nucleosome 
positioning in S. cerevisiae.
Servan Gruninger, University of Zurich, Switzerland
Advisor: Dr. Josh Dubnau
Funding: William Shakespeare Fellowship
Tracking transposition events of the gypsy retrotransposon in 
neural cells of Drosophila melanogaster.
Julian Homburger, Cornell University
Advisor: Dr. Mickey Atwal
Funding: National Science Foundation Scholarship
Associations between rare variants and complex disease.
Nathan Huey, Kenyon College
Advisor: Dr. W. Richard McCombie
Funding: Steamboat Foundation Scholarship
Identifying mutational burden within the DISC1 interactome 
in a case-control study for psychiatric disorders.
Scott Johnson, University of Maryland, Baltimore County
Advisor: Dr. Robert Martienssen
Funding: William Townsend Porter Foundation Scholarship 
Uncovering the role of the centromere in the Arabidopsis male 
germline development.
Marissa LaMoure, University of Texas, Austin
Advisor: Dr. Bruce Stillman
Funding: James D. Watson Undergraduate Scholarship 
Elucidating the Orc2–BubR1 interaction.
Ryan Lee, California State University, San Bernardi
Advisor: Dr. Yi Zhong
Funding: Garfi eld Fellowship
Mapping a complete neural value circuit.
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Rebecca Marton, University of Notre Dame
Advisor: Dr. Christopher Hammell
Funding: University of Notre Dame URP Scholarship
Development of a high-throughput RNAi screen to identify 
modulators of heterochronic miRNA activity.
James Morton, Miami University
Advisor: Dr. Thomas Gingeras
Funding: National Science Foundation Scholarship
A computational analysis of allele-specifi c expression.
Helen Mueller, Columbia University
Advisor: Dr. Alea Mills
Funding: National Science Foundation Scholarship
Chd5 expression in fetal stem cells.
Amanda Raimer, Widener University
Advisor: Dr. Adrian R. Krainer
Funding: National Science Foundation Scholarship
Splicing variability of spinal muscular atrophy.
Ian Stephens, Trinity College, Dublin, Ireland
Advisor: Dr. Z. Josh Huang
Funding: Trinity College
Genetic targeting of cortical pyramidal neuron subtypes 
using mouse engineering.
Edward Twomey, Seton Hall University
Advisor: Dr. Leemor Joshua-Tor
Funding: Joan Redmond Read Fellowship
Characterization of Gtsf1 involvement in the piRNA pathway.
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PARTNERS FOR THE FUTURE
PROGRAM DIRECTOR David Jackson
PROGRAM ADMINISTRATOR Michele Borriello
The Partners for the Future Program, established by Dr. James Watson in 1990, provides an op-
portunity for talented Long Island high school students to have hands-on experience in biomedical 
research at Cold Spring Harbor Laboratory. This highly competitive program is open to Long Island 
high school students in their junior year. Each high school science chairperson may nominate up 
to three students. The top candidates are interviewed by CSHL scientists. Students selected for the 
program are paired with a scientist mentor and spend a minimum of 10 hours per week, September 
through March of their senior year, conducting original research. At the conclusion, the students 
present their projects to an enthusiastic audience of the students, scientifi c mentors and colleagues, 
CSHL administrators, parents, and teachers. Although the students learn a great deal about modern 
biology and state-of-the-art research techniques, the main advantage of the program is that they are 
exposed to day-to-day life in a lab. Interacting with scientists and support staff, the students learn 
to defi ne and pursue a research goal while solving problems that may occur along the way. The 
2012–2013 Partners for the Future were chosen from among 49 nominations . They are listed below.
Partner High School Laboratory CSHL Mentor
Zachary Graziano Earl L. Vandermeulen High School Z. Josh Huang Josh Huang
Meghan Joline Miller Place High School Florin Albeanu Gonzalo Hugo
Mallory Rutigliano St. Anthony’s High School Christopher Hammell Cristina Chen
Rebecca Molinsky The Wheatley School Alexander Krasnitz Guoli Sun
Lina Kim Mineola High School Doreen Ware Lifang Zhang
Meher Walia Syosset High School Adrian R. Krainer Mads Jensen
Ariana Cyrstal Farahani Friends Academy David Jackson Yael Galon-Wolfenson
Morgan Lange Harborfi elds High School Molly Hammell Molly Hammell
Razvan Tohanean Mineola High School Partha Mitra Swagatam Mukhopadhyay
Emaad Khwaja Huntington High School Gregory Hannon Gregory Hannon
Elias Blinkoff Glen Cove High School Adam Kepecs Sachin Ranade
Michelle Long Syosset High School Mikala Egeblad Juwon Park
Alain Sherman Roslyn High School Alea A. Mills Guy Horev
Steven Trezza West Hempstead High School Robert Martienssen Evan Ernst
Partners for the Future participants
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ACADEMIC AFFAIRS
The Cold Spring Harbor Laboratory Meetings and Courses Program attracts scientists from all 
over the world to communicate, learn, and critique the latest ideas and approaches in the biological 
sciences. The program consists of advanced laboratory and lecture courses as well as large meet-
ings and biotechnology conferences that are held almost year-round. The Meetings and Courses 
Program at the Laboratory attracted strong attendance, with more than 7100 Meeting partici-
pants and almost 1300 course participants (trainees, teaching, and support faculty). The Cold 
Spring Harbor Asia (CSHA) program, including 18 conferences and one summer school, has 
to date attracted more than 3000 participants, bringing the anticipated year-end total for both 
United States– and China-based programs to almost 11,400.
This year, the Laboratory held 27 academic meetings that brought together scientists from 
around the world to discuss their latest research. The Symposium this year focused on plant biol-
ogy, highlighting the tremendous research progress achieved in recent years, and was intended to 
provide a broad synthesis of the current state of the fi eld, setting the stage for future discoveries 
and application. The fi rst Symposium in this historic series that focused exclusively on the botani-
cal sciences attracted more than 300 participants, including notable plant biologists such as David 
Baulcombe, Philip Benfey, Joanne Chory, John Doebley, Joseph Ecker, Mark Estelle, Sarah Hake, 
Ottoline Leyser, Marjori Matzke, and Craig Pikaard.
Cold Spring Harbor Laboratory meetings are unique in assembling a program with very few 
invited speakers. Instead, meeting organizers are encouraged to select talks from abstracts that 
are submitted on the basis of scientifi c merit, ensuring that the latest fi ndings will be presented 
and that young scientists will have the chance to describe their work. The introduction of several 
 successful new meetings occurred in 2012 with Regulatory and Noncoding RNAs, Epigenetics 
and Chromatin, and the merger of the Pharmacogenomics and Personal Genomes meetings. The 
annual meetings on The Biology of Genomes and Retroviruses were again oversubscribed, and 
many others attracted strong or record attendances. In the immediate aftermath of Hurricane 
Sandy, the Laboratory played host to a diminished but resilient meeting on Nuclear Receptors and 
Disease under the slogan “Science beats Sandy.” Many of these meetings have become essential for 
those in the fi eld and are held on a biannual basis. Partial support for individual meetings is pro-
vided by grants from the National Institutes of Health (NIH), the National Science Foundation 
(NSF), other foundations, and companies. Core support for the meetings program is provided by 
the Laboratory’s Corporate Sponsor Program.
The Courses program covers a diverse array of topics in molecular biology, neurobiology, struc-
tural studies, and bioinformatics. The primary aim of the courses remains to teach advanced 
students the latest advances that can be immediately applied to their own research. Courses are 
always being evaluated and updated to include the latest concepts and approaches. Increasingly, 
many courses feature a strong computational component as biology grows ever more interdisci-
plinary, incorporating methodologies from computer science, physics, and mathematics. 
The opening in June 2012 of the new Howard Hughes Medical Institute (HHMI)–funded 
Hershey Laboratory provided valuable additional space for cell biology and computational courses 
and is proving to be very popular with instructors and course participants alike. This expansion 
also allowed for the hosting of a new 2-week laboratory course on Single Cells, due to be held 
annually, and a discussion course on Cognitive Aging, anticipated to repeat on a biennial basis.
Instructors, course assistants, and course lecturers come from universities, medical schools, 
research institutes, and companies around the world to teach at CSHL. Their excellence and dedi-
cation make the course program work well indeed. We would especially like to thank Drs. Joaquin 
Espinosa, Kat Hadjantonakis, Jason Mitchell, Mark Reimers, Jaime Rivera-Perez, David Skuse, 
and Jeff Smith all of whom retired after many years of service.
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Grants from a variety of sources support the courses. The core support provided through the 
recently renewed grant from the HHMI remains critical to our course program. The courses are 
further supported by multiple awards from the NIH and the NSF, and additional support for in-
dividual courses is provided by various foundations and other sources. The courses also depend on 
equipment and reagents that are loaned or donated by a large number of companies, partnerships 
that are invaluable in ensuring that the courses offer training in the latest technologies.
Now in its third year of operation, the CSHA program, under the direction of Dr. Maoyen 
Chi, is headquartered at the Suzhou Dushu Lake Conference Center, a purpose-built academic 
conference center on the outskirts of old Suzhou, within a high-technology suburb (SIP). CSHA’s 
scientifi c program includes large symposia and meetings, training workshops, and Banbury-style 
discussion meetings. CSHA is a wholly owned subsidiary of CSHL and is not beholden to outside 
partners in terms of our scientifi c programming. In 2012, 18 scientifi c conferences and one sum-
mer school were held in Suzhou, predominantly attracting scientists from the Asia/Pacifi c region. 
Attendance by junior Asian scientists continues to be one of the challenges faced by the program, 
but the 50% growth in attendance between the fi rst and third year of operations bodes well for the 
future. This program is described in more detail in a separate Annual Report.
Alumni Notes: The 2012 Nobel Prize in Physiology or Medicine was awarded jointly to Dr. 
Shinya Yamanaka, who participated in the 1994 course on immunocytochemistry and frequently 
attended our Translational Control and Mouse Molecular Genetics meetings, and Dr. John Gur-
don, a frequent lecturer in the Xenopus course and a speaker at several CSHL Symposia, most 
recently at the 2012 Organ Development meeting.
The meetings and courses program staff is comprised of a lean team of talented professionals, 
many who wear multiple “hats.” They handle the complexities of database design, programming, 
web and multimedia design, educational grants management, marketing and recruitment, confer-
ence and course administration, audiovisual services, and other activities.
Terri Grodzicker
Dean of Academic Affairs
David Stewart
Executive Director, 
Meetings and Courses Program/ 
President, Cold Spring Harbor Asia
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77TH COLD SPRING HARBOR LABORATORY 
SYMPOSIUM ON QUANTITATIVE BIOLOGY
The Biology of Plants
May 30–June 4 319 Participants
ARRANGED BY  Terri Grodzicker, Rob Martienssen, David Stewart, and Bruce Stillman
Cold Spring Harbor Laboratory
The Cold Spring Harbor Symposia on Quantitative  Biology 
bring together scientists from all over the world to present and 
evaluate new data and ideas in rapidly moving areas of biolog-
ical research. Each year, a topic is chosen that appears to be 
at a stage where general and intensive scrutiny and review are 
needed. Criteria for selection of topics are numerous, but they 
include the rate of progress in a given fi eld, how recent research 
is highlighting connections between fundamental biological 
mechanisms, and the potential applications of the new discov-
eries to human health and society. Cold Spring Harbor Labora-
tory selected the theme of The Biology of Plants for the historic 
77th Symposium in the series.
Plants are integral to human well-being, and many species have been domesticated for more 
than 10,000 years. Evidence of plant scientifi c investigation and classifi cation can be found in 
ancient texts from cultures around the world (Chinese, Indian, Greco-Roman, Muslim, etc.), 
whereas early modern botany can be traced to the late 15th and early 16th centuries in Europe. 
During the past several decades, plant biology has been revolutionized fi rst by molecular biology 
and then by the genomic era. The model organism Arabidopsis thaliana has proved to be an in-
valuable tool for investigation into fundamental processes in plant biology, many of which share 
commonalities with animal biology. Plant-specifi c processes from reproduction to immunity and 
second messengers have also yielded to extensive investigation. With the genomes of more than 
30 plant species now available and many more planned in the near future, the impact on our un-
derstanding of plant evolution and biology continues to grow. Our increased ability to engineer 
plant species to a variety of ends may provide novel solutions to ensure adequate and reliable food 
production and renewable energy even as climate change impacts our environment.
The decision to focus the 2012 Symposium on plant science refl ected the enormous research 
progress achieved in recent years, and it was intended to provide a broad synthesis of the current 
state of the fi eld, setting the stage for future discoveries and application. This is the fi rst Symposium 
in this historic series that focused exclusively on the botanical sciences. The Symposium spanned a 
broad range of areas of investigation including genetics, biochemistry, molecular and cell biology, de-
velopmental biology, physiology, and population/evolution studies at levels ranging from the single 
cell to the entire organism and from single genes to genomes; plant-specifi c processes and pathways 
featured broadly throughout the meeting. Effort was made to balance fundamental biological dis-
coveries with applications relevant to societal well-being including improved crops, fuel, and habitat.
In arranging this Symposium, the organizers were dependent on the guidance of a broad cadre 
of advisors including Drs. Phil Benfey, Joanne Chory, Nam-Hai Chua, Jeff Dangl, Joe Ecker, and 
Chris Somerville. Opening night speakers included Sarah Hake, Craig Pikaard, Joanne Chory, 
R. Martienssen, S. Hake
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and Jeff Dangl. Rob Martienssen delivered a compelling Dorcas Cummings Lecture on “Send in 
the Clones” to Laboratory friends, neighbors, and Symposium participants in advance of the an-
nual dinner parties.
This Symposium was attended by almost 320 scientists from more than 20 countries, and 
the program included 65 invited presentations and 169 poster presentations. To disseminate the 
latest results and discussion of the Symposium to a wider audience, attendees were able to share 
many of the Symposium talks with their colleagues who were unable to attend using the Leading 
Strand video archive, and interviews by Gemma Bilsborough, Inês Chen, Kate Creasey, Emi-
lie Marcus, Richard Sever, and Jan Witkowski with leading experts in the fi eld were  arranged 
during the Symposium and distributed as free video from the Cold Spring Harbor  Symposium 
interviews website.
Funds to support this meeting were obtained from the National Science Foundation, the 
 Gordon & Betty Moore Foundation, and the Gatsby Charitable Foundation. Financial support 
from the corporate sponsors of our meetings program is essential for these Symposia to remain a 
success, and we are most grateful for their continued support.
PROGRAM
Introduction
B. Stillman, Cold Spring Harbor Laboratory
Germline
Chairperson: X. Chen, University of California, Riverside
Signaling
Chairperson: J. Ecker, The Salk Institute for Biological Studies, 
La Jolla, California
Epigenetics
Chairperson: D. Baulcombe, University of Cambridge, 
United Kingdom
Plant Pathogen Responses
Chairperson: S. Harmer, University of California, Davis
Domestication and Evolution
Chairperson: P. Benfey, Duke University, Durham, North 
Carolina
Timing
Chairperson: O. Leyser, University of Cambridge, 
United Kingdom
Photosynthesis, Metabolism, and Biofuels
Chairperson: S. Jacobsen, University of California, 
Los Angeles
Small RNAs
Chairperson: U. Grossniklaus, University of Zürich, 
Switzerland
Dorcas Cummings Lecture: Send in the Clones
R. Martienssen, Cold Spring Harbor Laboratory
Stem Cells, Polarity, and Nuclear Organization
Chairperson: D. Shippen, Texas A&M University, 
College Station
Development and Abiotic Stress
Chairperson: D. Bergmann, Stanford University, 
California
Summary
V. Chandler, Gordon & Betty Moore Foundation, 
Palo Alto, California
Z. Lippman, D. Zamir, D. Ware Y. Plavskin, J. Ecker
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PTEN Pathways and Targets
March 13–16 109 Participants
ARRANGED BY Suzanne Baker, St. Jude Children’s Research Hospital
 Lewis Cantley, Beth Israel Deaconess Medical Center/Harvard Medical School
 Pier Paolo Pandolfi , Beth Israel Deaconess Medical Center/Harvard Medical School
 Ramon Parsons, Columbia University
This fourth conference was a dynamic discussion forum, bring-
ing together top scientists studying the PTEN/PI3 kinase path-
way using biochemical and molecular approaches as well as in 
vivo model systems. An exciting series of talks and poster presen-
tations addressed the complex regulation of this signal transduc-
tion cascade and its critical role in normal development, cancer, 
aging and metabolism, and other pathological disease states. The 
conference provided the opportunity for researchers of all lev-
els to get together to discuss their latest research fi ndings and 
technical approaches toward the analysis of the PTEN path-
way. Particular emphasis was placed on pathway regulation and 
cross-talk, emerging complex mechanisms of PTEN regulation, 
human cancer pathogenesis, disease models, and therapy.
A total of 76 investigators presented in the nine scientifi c sessions, with 45 platform and 31 poster 
presentations. The seven platform and two poster sessions were marked by dynamic and enthusiastic 
exchanges of new results. In the scientifi c sessions, many audience members participated in the ques-
tion and answer sessions, and the poster sessions were well attended.
The sessions are listed below in the Program. Essential funding for the meeting was provided 
by the National Cancer Institute, a branch of the National Institutes of Health, and by Novartis.
PROGRAM
PI3 K and Upstream Regulation of PTEN Signaling
Chairperson: P. Vogt, The Scripps Research Institute, La Jolla, 
California
Downstream Targets of PTEN
Chairperson: A. Toker, Beth Israel Deaconess Medical Center, 
Boston, Massachusetts
mTORC1 and Intersecting Pathways
Chairperson: B. Manning, Harvard School of Public Health, 
Boston, Massachusetts
PI3 K/PTEN Signaling In Development and Disease
Chairperson: S. Baker, St. Jude Children’s Research Hospital, 
Memphis, Tennessee
S. Baker, H. Dbouk
R. Parsons, B. Hopkins
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Complex Mechanisms of PTEN Regulation
Chairperson: P.-P. Pandolfi , Beth Israel Deaconess Medical 
Center/Harvard Medical School, Boston, Massachusetts
Modeling PI3 K/PTEN Signaling in Vivo
Chairperson: J. Zhao, Harvard Medical School, Boston, 
Massachusetts
Therapeutic Inhibitors of PI3 K Signaling
Chairperson: J. Engelman, Massachusetts General Hospital, 
Boston
G. Mills, N. Sonenberg J. Den Hertog L. Trotman, S. Muthuswamy
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Systems Biology: Global Regulation of Gene Expression
March 20–24 273 Participants
ARRANGED BY Martha Bulyk, Brigham & Women’s Hospital and Harvard Medical School
 Marian Walhout, University of Massachusetts Medical School
 Brad Bernstein, Massachusetts General Hospital/Harvard Medical School/Broad Institute
 Timothy Hughes, University of Toronto, Canada
Systems Biology aims to understand the emergent properties of molecular networks in cells by 
using systematic and global approaches. One of the most actively researched areas of systems 
biology in recent years has been global regulation of gene expression, which coordinates complex 
metabolic and developmental programs in organisms. This eighth conference, like the ones in 
previous years, captured the continuing rapid progress and many new discoveries in this young 
and exciting fi eld. This meeting featured 46 talks and 109 poster presentations covering a broad 
range of topics. The speakers, poster presenters, and other conference attendees were composed 
of a mix of students, postdocs, and PIs at all levels. Two keynote speeches were exciting high-
lights of the meeting. The fi rst was presented by Dr. Michael Levine, who has been a leader 
in the area of transcriptional regulation for many years. Dr. Levine described the identifi cation 
and analysis of gene regulatory sequences in Drosophila and presented new ideas on the signifi -
cance of paused RNA polymerase at promoters. The second keynote was presented by Dr. Robert 
Kingston, a leader in the fi eld with a long history of the development of new approaches to the 
study of chromatin and gene regulation. Dr. Kingston presented a new technique for identify-
ing the genomic loci associated with noncoding RNAs, as well as a recently published structure 
of a nucleosome-associated BAF domain. This year’s meeting featured new techniques utilizing 
second-generation sequencing; for example, several presentations included systematic dissection 
of regulatory sequences by assaying thousands of synthesized variants. Many of the presentations 
also described new approaches to the analysis of data from established techniques, such as ChIP-
Seq. Relative to previous years, the analyses generally involved much larger data sets due to ongo-
ing increases in sequencing volume, systematic efforts such as ENCODE and modENCODE, and 
ever-expanding resources on the binding specifi cities of transcription factors. Many presentations 
focused on the diffi cult problems of relating transcription factor sequence preferences to their in-
vivo-binding sites and of relating the in-vivo-binding sites of transcription factors and chromatin 
proteins to gene expression outputs. The three-dimensional architecture of chromosomes also 
featured prominently. Representation of DNA-binding and RNA-binding activities and the role 
of long ncRNAs continued to be topics of interest. It was clear that much remains to be done in 
understanding virtually all levels of global gene regulation; however, many of the presented studies 
featured tight integration of experimental and computational work, so clearly, the mission of this 
conference in bringing together experimental and computational scientists is succeeding.
This meeting was funded in part by the National Cancer Institute, a branch of the National 
Institutes of Health; the National Science Foundation; and Roche.
PROGRAM
Keynote Speaker
M. Levine, University of California, Berkeley
Developmental Networks
Chairperson: S. Teichmann, MRC Laboratory of Molecular 
Biology, Cambridge, United Kingdom
Transcriptional Regulatory Networks
Chairperson: S. Churchman, Harvard Medical School, Boston, 
Massachusetts
Keynote Speaker
R. Kingston, Massachusetts General Hospital, Boston
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Chromatin
Chairperson: J. Dekker, University of Massachusetts Medical 
School, Worcester
Epigenomics
Chairperson: T. Hughes, University of Toronto, Canada
Cis-Regulatory Logic
Chairperson: H. Bussemaker, Columbia University, 
New York
Cellular Responses
Chairperson: B. Andrews, University of Toronto, Canada
Posttranscriptional Regulation
Chairperson: M. Walhout, University of Massachusetts 
Medical School, Worcester
Variation and Evolution
Chairperson: A. Stark, Research Institute of Molecular 
Pathology, Vienna, Austria
Discussion during poster session
O. BahcallF. Schlesinger, T. Gingeras
P. Freddolino, G. Fundenberg
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Neuronal Circuits
March 28–31 194 Participants
ARRANGED BY Cori Bargmann, The Rockefeller University
 Dmitri Chklovskii, Janelia Farm Research Campus
 Carl Petersen, Ecole Polytechnique Federale de Lausanne
In the quest to understand the brain, neuronal circuits rep-
resent a central level of description. Establishing connectiv-
ity in neuronal circuits seems as essential for solving the 
brain as having a geographic map for planning one’s travel. 
Although such realization has motivated Cajal to describe 
a variety of neuronal circuits using Golgi stains, his con-
tributions were technologically limited. With the recent 
appearance of novel molecular genetic, imaging, and com-
putational techniques, a comprehensive description of the 
wiring diagram, an old dream of neuroscientists, is about 
to become a reality. Because technological advances have 
been made in different organisms and systems, we wanted 
to create a forum that brings together researchers working 
on different topics, yet focusing on neuronal circuits. The 
2008 meeting on “Neuronal Circuits: From Structure to Function” included six broad slide ses-
sions covering the olfactory system, the visual system, methods, behavior learning and memory, 
motor systems and the cortex, and a very interactive poster session.
For the second meeting of this kind, the response of the fi eld was very enthusiastic. The meet-
ing brought together 194 participants from all over the world, most of whom made either oral 
or poster presentations. Invited talks were given by Cori Bargmann, The Rockefeller University; 
Tobias Bonhoeffer, Max-Planck Institute of Neurobiology; Karl Deisseroth, Stanford University; 
Winfried Denk, Max-Planck Institute for Medical Research; Jeff Lichtman, Harvard University; 
Eve Marder, Brandeis University; Edvard Moser, Center for the Biology of Memory; Sacha  Nelson, 
Brandeis University; Clay Reid, Harvard Medical School; Massimo Scanziani, University of Cali-
fornia, San Diego; Kristin Scott; University of California, Berkeley; Stephen Smith, Stanford 
Medical School; Charles Stevens, The Salk Institute; Karel Svoboda, Janelia Farm Research Cam-
pus,  Howard Hughes Medical Institute; Gabor Tamas, University of Szeged, Hungary/HHMI; 
Rachel Wilson, Harvard Medical School; and Rafael Yuste, Columbia University/HHMI. The 
meeting provided an important clearinghouse for ideas and approaches and helped scientists in 
the fi eld get the most up-to-date information, as well as enabling them to meet, to network, and 
to establish collaborations. Based on the uniformly enthusiastic comments of the participants, the 
intensity of the oral and poster sessions, and the large crowds that stayed up late every night at the 
bar to discuss science, the meeting was a great success.
A highlight of the meeting program was the inaugural Larry Katz Memorial Lecture; thanks to 
the generous donation of many colleagues in the fi eld, 25 excellent nominations were received all 
over the world. A committee composed of the three organizers and Cori Bargmann selected two 
speakers: Andrea Hasenstaub of Salk Institute for Biological Studies, and Feng Zhang of Stanford 
University. Both gave wonderful talks about their graduate studies.
This meeting was funded in part by the National Institute of Neurological Disorders and 
Stroke, a branch of the National Institutes of Health.
D. Chklovskii, C. Petersen, C. Bargmann 
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PROGRAM
Information Processing
Chairperson: D. Chklovskii, HHMI/Janelia Farm Research 
Campus, Ashburn, Virginia
Chemosensation and Decision Making
Chairperson: C. Bargmann, HHMI/The Rockefeller 
University, New York
Vision/Hearing
Chairperson: A. Konnerth, Technical University Munich, 
Germany
Innate and Learned Behaviors
Chairperson: M. Feller, University of California, Berkeley
Locomotion and Technology
Chairperson: R. Friedrich, Friedrich-Miescher-Institute, Basel, 
Switzerland
Development and Plasticity
Chairperson: Y. Dan, University of California, Berkeley
Larry Katz Lecture
W. Hong, Stanford University, California
H. Oyibo A. Reid, T. Hromadka I. Pikon, J. Bargmann
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Evolution of Caenorhabditis and Other Nematodes
April 3–6 129 Participants
ARRANGED BY Dee Denver, Oregon State University
 Mark Blaxter, University of Edinburgh
This meeting was well attended by researchers representing 11 coun-
tries. The keynote speaker was Marie-Anne Félix, who discussed diverse 
aspects of key advances that her lab and collaborators have made in our 
understanding of nematode evolution, ranging from the discovery of 
many critical new species in the model genus Caenorhabditis to the 
mutational and selective forces shaping natural variation in nematode 
developmental processes. Scientifi c sessions included eight presenta-
tions, and the poster session included 26 additional presentations of the 
topics listed in the program below as well. The conference was preceded 
by an NSF-supported workshop of the NemaSym Research Coordina-
tion Network, focusing on symbiotic nematode–bacteria interactions, 
which included several presentations on diverse nematode-related symbioses, as well as discussions 
on how to move forward in understanding these interorganismal relationships. During a meeting 
planning session, extensive enthusiasm was expressed about the 2012 meeting at Cold Spring Har-
bor, new organizers were recruited, and it was agreed to meet again at the Wellcome Genome Cam-
pus in Cambridge, England (as in 2010) and then hopefully return to Cold Spring Harbor in 2016.
This meeting was funded in part by the National Human Genome Research Institute, a branch 
of the National Institutes of Health; the National Science Foundation; and the Nathan A. Cobb 
Nematology Foundation. The Nathan A. Cobb Nematology Foundation provides all nematolo-
gists and friends the opportunity to build self-sustaining endowments for the advancement of 
nematology. The endowments provide grants to students for study, travel, and participation in an-
nual meetings of nematological and related societies. For more information about the Foundation 
and its endowments, visit http://nematologists.org/na_cobb_foundation.php.
PROGRAM
Biodiversity and Phylogenetics
Chairpersons: H. Bik, University of California, Davis; 
T. Moens, Ghent University, Belgium
Keynote Speaker
M.-A. Félix, Ecole Normale Supérieure, Paris, France
Genomes and Transcriptomes
Chairpersons: J. Spieth, Washington University, St. Louis, 
Missouri; M. Berriman, Wellcome Trust Sanger Institute, 
Hinxton, United Kingdom
Discussion Session: Multi-Caenorhabditis genomes analysis
Population and Evolutionary Genomics I
Chairperson: A. Cutter, University of Toronto, Canada
Panel Discussion: Future Directions for Our Research 
Community
Sex and Recombination
Chairpersons: J. Anderson, University of Oregon, Eugene; 
M. Rockman, New York University, New York
Parasitism, Pathogenesis, and Symbiosis
Chairpersons: H. Schulenburg, University of Kiel, Germany; 
D. Bird, North Carolina State University, Raleigh
Evolution of Molecular, Cellular, and Developmental 
Pathways
Chairperson: M. Mitreva, Washington University, St. Louis, 
Missouri
Population and Evolutionary Genomics II
Chairperson: A. Cutter, University of Toronto, Canada
From Genotype to Phenotype
Chairpersons: J. Kammenga, Wageningen University, The 
Netherlands; M. Viney, University of Bristol, United Kingdom
D. Denver, M. Blaxter
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Automated Imaging and High-Throughput Phenotyping
April 10–14 104 Participants
ARRANGED BY Philip Benfey, Duke University
 Anne Carpenter, Broad Institute of Harvard and Massachusetts Institute of Technology
 Robert Waterston, University of Washington
 Uwe Ohler, Duke University
This second conference proved to be as successful as the fi rst. 
A total of 41 investigators presented in the seven scientifi c ses-
sions, with many of the other 104 registered attendees present-
ing in the poster session. The one poster and seven platform 
sessions were marked by dynamic and enthusiastic exchanges 
of new results. In the scientifi c sessions, many audience mem-
bers participated in the question and answer sessions, and the 
poster session was well attended. The meeting Sessions are list-
ed below in the program.
An additional session engaged the community in discussion 
of the future directions for this fi eld. During this session, there 
was a high level of enthusiasm to hold another meeting at Cold 
Spring Harbor on the same topic.
This meeting was partially supported by LemnaTec GmbH 
and Molecular Devices.
Poster Session in Bush Auditorium
P. Benfey, B. Peshlov
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PROGRAM
Microscopy and Technology
Chairperson: S. Fraser, California Institute of Technology, 
Pasadena
Single Cell and Subcellular Phenotyping I
Chairperson: A. Carpenter, Broad Institute of Harvard and 
Massachusetts Institute of Technology, Cambridge
Models for Development and Behavior
Chairperson: C. Godin, University of Chicago, Illinois
Developmental Phenotyping
Chairperson: R. Waterston, University of Washington, Seattle
Discussion Session: Current Challenges/Outlook/ 
Planning for Next Meeting
P. Benfey, Duke University, Durham, North Carolina
A. Carpenter, Broad Institute of Harvard and MIT, 
Cambridge
R. Waterston, University of Washington, Seattle
U. Ohler, Duke University, Durham, North Carolina
Cellular Phenotyping: Differentiation and Migration
Chairperson: J. Kovacevic, Carnegie Mellon University, 
Pittsburgh, Pennsylvania
Data Mining, Modeling, Management, and Visualization
Chairperson: U. Ohler, Duke University, Durham, North 
Carolina
Organ(Ismal)/Behavioral Phenotyping
Chairperson: P. Benfey, Duke University, Durham, 
North Carolina
A. Assadi, A. Sangari
T. Chen
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Molecular Pathways in Organ Development and Disease
April 17–21 125 Participants
ARRANGED BY Sharon Dent, University of Texas M.D. Anderson Cancer Center
 Jonathan Epstein, University of Pennsylvania School of Medicine
 Guillermo Oliver, St. Jude Children’s Research Hospital
Recent advances in stem cell biology are impressive and have 
strengthened our collective optimism that gene and stem-cell-
based therapies may eventually become realistic approaches in 
the treatment of many diseases, particularly those that have a 
signifi cant pathological effect on organs and specifi c organ sys-
tems. Central to that goal is a clear understanding of the genes 
and mechanisms controlling vertebrate organogenesis in health 
and disease. Accordingly, the specifi c goal of this new confer-
ence was to bring together a diverse group of scientists working 
in various animal models and interested in studying different 
molecular, cellular, and genetic aspects of vertebrate organogen-
esis in basic and translational settings.
This meeting provided a forum in which researchers working 
in various animal models (mice, zebrafi sh, chicken) in diverse 
aspects of organ development presented their latest fi ndings and an overview of the fi eld. In this 
setting, the conference provided the opportunity for an important exchange of information and 
ideas and to help to establish fruitful collaborations. Six major topics were chosen for detailed 
discussion, each including basic and disease-oriented presentations as a refl ection of the most ad-
vanced and interesting areas of study in the fi eld of vertebrate organogenesis. These topics were all 
ultimately united by the use of approaches that pursue answers to key biological questions in the 
intact organism rather than in simplifi ed cell culture and ex vivo studies.
PROGRAM
Keynote Speakers
L.B. Buck, Fred Hutchinson Cancer Research Center, Seattle, 
Washington: Deconstructing Smell.
J.B. Gurdon, Wellcome Trust/CR UK, Cambridge, United 
Kingdom: The Stabilization of Cell Differentiation.
Signaling Pathways/Morphogenesis
Chairperson: O. Pourquie, IGBMC, Illkirch, France
Regulation of Gene Expression
Chairperson: J. Epstein, University of Pennsylvania School of 
Medicine, Philadelphia
Evolution
Chairperson: C. Tabin, Harvard Medical School, Boston, 
Massachusetts
Gene Regulatory Networks/Computational Biology
Chairperson: S. Fraser, California Institute of Technology, 
Pasadena
J. Epstein, S. Dent, G. Oliver
Y. Serinagaoglu, R. Deckelbaum
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Stem Cells in Development
Chairperson: Y. Sasai, RIKEN Center for Developmental 
Biology, Kobe, Japan
Epigenetics
Chairperson: S. Dent, University of Texas M.D. Anderson 
Cancer Center, Houston
Cancer and Disease
Chairperson: S. Piccolo, University of Padua, Italy
E. Fuchs M.-I. Chung Wine and cheese reception
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Gene Expression and Signaling in the Immune System
April 24–28 351 Participants
ARRANGED BY Doreen Cantrell, University of Dundee
 Sankar Ghosh, Columbia University College of Physicians & Surgeons
 Dan Littman, HHMI/New York University School of Medicine
 Mark Schlissel, University of California, Berkeley
This meeting was held for the sixth time in 2012, in the bright sunshine and 
mild temperatures of springtime. More than 350 registrants, including ~30% 
from outside of the United States and many fi rst-time attendees, participated in 
a highly engaging and interactive 4-day meeting. 
Although there are many immunology meetings, the unique aspect of this 
Cold Spring Harbor meeting is its focus on molecular and biochemical aspects 
of the development and function of the immune system. In addition, this meet-
ing attracts a broad range of scientists who use the immune system as a model to 
study basic principles of biological regulation. 
Talks were presented by a mix of invited speakers and investigators selected from 
a group of more than 250 submitted abstracts. There were a signifi cant number 
of women and junior investigators who were asked to give talks. Most speakers 
focused almost exclusively on their unpublished work. A number of exciting talks, 
such as the presentation by Alexander (Sasha) Rudensky (Memorial Sloan-Ketter-
ing Cancer Center), explained a long-standing biological phenomenon, namely, 
the ability of a mother to carry a fetus that is not immunologically identical during pregnancy. His 
work showed that induced T-regulatory cells are critical for the suppression of the maternal immune 
response. Steve Smale presented exciting studies that showed by using the technology of RNA-Seq 
that the composition of the infl ammatory gene expression program in macrophages is determined by 
not just transcription, but also the process of splicing of transcripts and their export to the cytosol. 
Such talks highlighted the relevance of the data discussed at this meeting not just to immunology, but 
to the broader scientifi c community. 
Oral presentations were supplemented by three afternoon poster sessions that were extremely 
well attended and provided a forum for all meeting participants (including many graduate stu-
dents and postdocs) to share their most recent data. In addition, attendees took advantage of 
walking tours of the CSHL campus, an engaging piano recital, and an evening performance by 
the Yale-based music group “The Cellmates” led by Richard Flavell.
Support for this meeting was obtained from the NIH/NIAID as well as from corporate sponsors.
PROGRAM
SESSION 1: Developmental Decisions
Chairperson: I. Weissman, Stanford University School of 
Medicine, California
SESSION 2: Regulation of Immune Cell Development
Chairperson: S. Smale, University of California School of 
Medicine, Los Angeles
SESSION 3: Poster Session I
SESSION 4: Chromatin Structure and Epigenetic 
Regulation
Chairperson: S. Ghosh, Columbia University, New York
SESSION 5: Antigen Receptor Gene Assembly and 
Modifi cation
Chairperson: M. Schlissel, Brown University, Providence, 
Rhode Island
M. Schlissel
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D. Cantrell, R. Sever
SESSION 6: Poster Session II
SESSION 7: Signal Transduction in Immune Cells
Chairperson: D. Cantrell, College of Life Sciences, Dundee, 
United Kingdom
SESSION 8: Regulation of Lymphocyte Function I
Chairperson: R. Germain, National Institute of Allergy and 
Infectious Diseases/NIH, Bethesda, Maryland
SESSION 9: Regulation of Lymphocyte Function II
Chairperson: D. Littman, HHMI/New York University School 
of Medicine, New York
SESSION 10: Innate Immunity
Chairperson: J. Hoffmann, IBMC, Strasbourg, France
F. Alt, D. Baltimore R. Flavell fronting the Cellmates Caricaturist in action
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Molecular Chaperones and Stress Responses
May 1–5 220 Participants
ARRANGED BY Andrew Dillin, HHMI/University of California, Berkeley
 F. Ulrich Hartl, Max-Planck Institute for Biochemistry, Germany
 Jonathan Weissman, HHMI/University of California, San Francisco
This meeting continued the rich tradition of a forum where 
cutting-edge analysis of molecular mechanisms of protein fold-
ing is presented in the context of its biological importance and 
health relevance. The high attendance, large number of posters 
(131 posters over three sessions), and lively audience participa-
tion in the sessions and in the informal activities that followed 
are testament to the success of the meeting and to the successful 
balance of the sessions. The fi eld of chaperone research is evolv-
ing and this meeting is evolving with it and is proving to be the 
cornerstone meeting for this rich and exciting fi eld.
In addition to well-established biochemical and biophysical 
methods for studying chaperone function, this meeting featured 
presentations using single-molecule methods and advanced com-
putational approaches to the study of signaling networks involved in control of chaperone gene ex-
pression. This year’s meeting featured two new sessions: one on Therapeutics of Protein Misfolding, 
chaired by Dr. Jeff Kelly, and the other on Chaperones and Proteolysis, chaired by Dr. Dan Finley. 
The former provided a forum to discuss new approaches to entering the clinic using the knowledge 
base found within the chaperone fi eld and the latter for work of special relevance to the prospects 
of linking chaperone function to emerging fi elds of protein degradation. Among the cutting-edge 
themes explored in this meeting were presentations of single-molecule studies of protein interactions 
and folding in vitro and new approaches to attempt in vivo; talks on protein traffi cking in the cell 
that emphasized the fl uidity of subcellular compartmentalization, when it comes to intracellular 
protein turnover; and connections between ribosomes and chaperones and novel signaling pathways 
involved in protein-folding homeostasis. An entire section was devoted to aging, illustrating how this 
fi eld is beginning to impact the thinking within the gerontology community.
This meeting was funded in part by the National Institute on Aging, a branch of the National 
Institutes of Health, and Enzo Life Sciences.
A. Dillin, J. Weissman
Poster session in Bush Auditorium
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PROGRAM
Protein Folding and Chaperone Biochemistry
Chairperson: S. Marqusee, University of California, Berkeley
Quality Control and Protein Traffi cking
Chairperson: K. Nagata, Kyoto Sangyo University, Japan
Therapeutics of Protein Misfolding
Chairperson: J. Kelly, Scripps Research Institute, La Jolla, 
California
Protein Folding and Disaggregation Machines
Chairperson: S. Marqusee, University of California, Berkeley
Stress Signaling and Aging
Chairperson: L. Sistonen, Åbo Akademi University, Turku, 
Finland
Chaperone Networks in Development and 
Disease
Chairperson: A. Bertolotti, MRC Laboratory of Molecular 
Biology, Cambridge, United Kingdom
Chaperones and Proteolysis
Chairperson: D. Finley, Harvard Medical School, Boston, 
Massachusetts
R. Morimoto, T. Gidalevitz, A. Ben-Zvi Wine and cheese reception
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The Biology of Genomes
May 8–12 541 Participants
ARRANGED BY Carlos Bustamante, Stanford University
 Susan Celniker, Lawrence Berkeley National Laboratory
 Joel Hirschhorn, Broad Institute of Harvard and Massachusetts Institute of Technology
 Christopher Ponting, University of Oxford
This meeting marked the 25th annual gathering of genome scientists at the Cold Spring Harbor 
Laboratory. Just over 540 people from around the world attended the meeting, with more than 360 
abstracts presented describing a broad array of topics relating to the production, analysis, and inter-
pretation of genomes from diverse organisms. The meeting built upon the remarkable progress in the 
sequencing, functional annotation, and analysis of genomes from many human individuals, “model 
organisms,” and other animals including new genomic studies of pigeons, plants, microbiomes, and 
prokaryotes. Talks from the ENCODE and modENCODE consortium described their efforts to 
determine the function of every base in the human, worm, and fl y genomes. Many investigators 
reported on their application of the most recent generation of DNA-sequencing technologies to 
determine sequence variants within populations that convey differences in molecular function and 
organismal phenotype and in susceptibility to disease, including cancer and complex disease. The 
new data are also providing important insights into functional genomic elements and population 
structure for humans and other species. Many groups are generating transcriptome, transcription-
factor-binding site, and epigenomic maps to illuminate transcriptional complexity and regulation. 
Whole-genome single-cell sequencing and single-cell transcriptome analyses were also announced.
Session topics are listed below in the Program. There were numerous reports on progress in 
using next-generation sequencing technologies, with mounting expectation for further advances 
as these continue to be applied widely. Susan Wessler and Debbie Nickerson gave the Keynote 
Presentations on transposable elements and on human genetic variation, respectively.
The ELSI (Ethical, Legal, and Social Implications) panel was moderated by Vence Bonham. 
The area of discussion was Genomic Literacy for the Public and the panelists included Wayne 
Grody, Kimberly Kaphingst, and Jon Miller.
This meeting was funded in part by the National Human Genome Research Institute, a branch 
of the National Institutes of Health; Complete Genomics; Illumina; Omicia; and OpGen. The 
Genome Research poster prize was sponsored by Oxford Nanopore Technologies Ltd.
PROGRAM
High-Throughput Genomics and Genetics
Chairpersons: B. Cohen, Washington University School of 
Medicine, St. Louis, Missouri; S. Quake, HHMI/Stanford 
University, California
Genetics of Complex Traits
Chairpersons: B. Voight, University of Pennsylvania Perelman 
School of Medicine, Philadelphia; E. Dermitzakis, University 
of Geneva Medical School, Switzerland
Functional and Cancer Genomics
Chairpersons: E. Ostrander, National Human Genome 
Research Institute/NIH Bethesda, Maryland; P. Spellman, 
Oregon Health & Science University, Portland J. Watson, E. Birney
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Computational Genomics
Chairpersons: S. Myers, Oxford University, United Kingdom; 
L. Pachter, University of California, Berkeley
ELSI Panel and Discussion: Genomic Literacy for the Public
Moderator: V.L. Bonham, National Human Genome 
Research Institute/NIH, Bethesda, Maryland, Panelists: 
W.W. Grody, University of California School of Medicine, 
Los Angeles; K. Kaphingst, Washington University School 
of Medicine, St. Louis, Missouri; J.D. Miller, University of 
Michigan, Ann Arbor
Evolutionary Genomics
Chairpersons: D. Odom, University of Cambridge, United 
Kingdom; P. Wittkopp, University of Michigan, Ann Arbor
Genetics and Genomics of Nonhuman Species
Chairpersons: A. Stathopoulos, California Institute of 
Technology, Pasadena; L. Herrera Estrella, National 
Polytechnic Institute, Irapuato, Mexico
Guest Speakers
S.R. Wessler, University of California, Riverside: The Success 
Strategies of Transposable Elements that Rapidly Diversify 
Genomes.
D. Nickerson, University of Washington, Seattle: Human 
Genetic Variation: A Walk on the Rare Side.
Population Genomic Variation
Chairpersons: D. Bachtrog, University of California, Berkeley; 
J. Novembre, University of California, Los Angeles
Y. Hu, X. Ni W. Kent, A. Hinrichs D. Spector and A. Krainer pose for M. Macaluso
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The Cell Cycle
May 15–19 256 Participants
ARRANGED BY Sue Biggins, Fred Hutchinson Cancer Research Center
 Jacqueline Lees, Massachusetts Institute of Technology Center for Cancer Research
 David Toczyski, University of California, San Francisco
This 11th biannual meeting is internationally recognized 
for its ability to bring together scientists who study cell 
cycle regulation in eukaryotes ranging from yeast to hu-
mans. As usual, the meeting began with a keynote talk 
from a leader in the fi eld. We were fortunate to have the 
Director of Cold Spring Harbor Laboratories, Dr. Bruce 
Stillman, tell us about the initial discovery of the origin 
recognition complex and the regulation of origin fi ring 
that ensures accurate duplication of chromosomes. He 
also talked about subsequent and unexpected roles for the 
origin recognition complex in the cell cycle. After the key-
note talk, the evening session continued with fi ve talks 
focused on the cross-talk between nuclear and cytoplas-
mic events. The remainder of the meeting was organized 
around seven lecture sessions and two poster sessions, which focused on the major stages of 
the cell division cycle, with an emphasis in each session on the molecular mechanisms that 
govern cell cycle progression. Many of these sessions emphasized the long-standing problems in 
cell cycle control, including the transcriptional mechanisms controlling entry in the cell cycle, 
the mechanisms that initiate and control chromosome duplication, the events that trigger the 
complex events of chromosome segregation in mitosis, and the numerous checkpoint systems 
that ensure that cell cycle events occur in the correct order. Cutting-edge techniques to address 
problems as well as talks that emphasized computational modeling and quantitative approaches 
were represented. The meeting ended with a new session on cell cycle decisions that brought 
together talks from yeast to human cancer. There were also a number of talks and posters 
about quiescence and other specialized states of the cell cycle. The meeting also connected cell 
cycle regulation with cancer biology with reports about the functions of oncogenes and tumor 
suppressors in cell cycle control. As always, major model systems for cell cycle analysis were 
represented, and the striking phylogenetic conservation of cell cycle regulatory mechanisms was 
readily evident. It was another landmark meeting for the cell cycle fi eld, and the participants 
continue to look forward to equally exciting meetings in future years.
PROGRAM
Nucleocytoplasmic Cross-Talk
Chairperson: S. Bell, HHMI/Massachusetts Institute of 
Technology, Cambridge
Keynote Address: The Origin Recognition Complex: 
Chromosome Duplication and Separation
B. Stillman, Cold Spring Harbor Laboratory
G0-G1 Control
Chairpersons: N. Dyson, Massachusetts General Hospital 
Cancer Center, Charlestown; B. Andrews, University of 
Toronto, Canada
S. Biggins, J. Lees, D. Toczyski
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S Phase
Chairpersons: P. Jallepalli, Memorial Sloan-Kettering Cancer 
Center, New York; H. Ulrich, Cancer Research UK London 
Research Institute, United Kingdom
Kinetochores and the Spindle Checkpoint
Chairpersons: E. Nigg, University of Basel, Switzerland; 
F. Uhlmann, Cancer Research UK London Research 
Institute, United Kingdom
DNA Damage Response
Chairpersons: T. Paull, University of Texas, Austin; M. Jasin, 
Memorial Sloan-Kettering Cancer Center, New York
Cell Cycle Regulation by the Ubiquitin Pathway
Chairpersons: J. Pines, University of Cambridge, United 
Kingdom; M. Pagano, New York University Medical Center, 
New York
Mitosis and Cytokinesis
Chairpersons: A. Amon, HHMI/Massachusetts Institute 
of Technology, Cambridge; B. Earnshaw, University of 
Edinburgh, United Kingdom
Cell Cycle Decisions
Chairpersons: M. Fuller, Stanford University School of 
Medicine, California; G. Evan, University of Cambridge, 
United Kingdom
M. Mechali, S. Prasanth F. Uhlman
T. Maresca, T. Fakagasa S. Bell
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V. KewalRamani, P. Cannon
Retroviruses
May 21–26 420 Participants
ARRANGED BY Paula Cannon, University of Southern California
 Vineet KewalRamani, National Cancer Institute
Drs. Paula Cannon and Vineet KewalRamani are long-time attendees 
who in many ways have “grown-up” at this meeting and within its dis-
tinct community of scientists. Indeed, it is a characteristic feature of the 
Retroviruses meeting that a high number of repeat attendees come each 
year, where friendships and collaborations are both instigated and re-
newed.
In keeping with this theme, the organizers chose to recognize with 
keynote talks the contributions of one of the strongest supporters of the 
meeting, Dr. Jonathan Stoye. Jonathan took us on a tour of his many con-
tributions to retrovirology by posing the question “Germ-line retrovirus-
es–good or bad?” in a generous and entertaining talk that garnered many 
laughs along the way. His work has encompassed mouse retroviruses, pig 
viruses and xenotransplantation, and the ongoing standoff between retro-
viruses and their hosts.
A second keynote speaker was Dr. Maxine Linial, who has made many important contributions 
to our understanding of retrovirology with more recent research on molecular aspects of foamy 
retrovirus replication. Like Dr. Stoye, Maxine is a former organizer of the Retroviruses meeting. 
Maxine’s talk was all the more extraordinary because she delivered it despite a life-altering event 
that resulted in her losing her sight. The power of her words, accompanied by a simple easel of 
paper, reminded the audience that you do not need a polished PowerPoint presentation to convey 
important insights about scientifi c discoveries. The fi nal keynote speaker was Dr. John Mellors, an 
AIDS clinician at the interface of patient care and basic research on anti-HIV drugs. John’s talk 
was a thought-provoking opinion piece that put into perspective both his own insights and the 
broader community of clinicians who deal with the consequence of retrovirology’s most notorious 
family member. John’s talk ran over the allotted time as audience members kept him on the stage 
with questions about drug treatments for HIV and the possibility of a “cure.”
As is usual, the meeting was organized into 13 sessions (10 oral, 3 poster) with the emphasis on 
unpublished, basic research. The sessions consisted of traditional areas that focused on specifi c 
aspects of the retrovirus life cycle, but they were also mixed up a little to refl ect new themes that 
A. Andrew, C. Valmas E. Campbell, P. Green
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are emerging in the study of retroviruses and to showcase, for example, 
the contribution of retrovirology to studies of evolution and innate im-
munity. A signifi cant number of abstracts focused on a newly discovered 
host-cell factor that can limit HIV replication, the SAMHD1 restriction 
factor. The oral session included a presentation by Nadine Laguette, who 
was the fi rst author on one of the two original papers describing this 
factor. Nadine presented her work as the recipient of the sixth annual 
Andy Kaplan prize in Retrovirology. Other highlights of the submitted 
research presentations included the identifi cation of a new retroelement 
“Steamer” in steamer clams; the fi nding that the host restriction factor, 
BST2/tetherin, which is targeted by the HIV-1 Vpu protein, also activates 
NF-kB; the description of a new antiviral restriction factor, Schlaffen 
11, which disrupts HIV protein translation by interfering with tRNA 
synthesis; several presentations that used state-of-the-art techniques of 
imaging to provide new insights, including a talk from Walter Mothes’ 
lab that used intravital imaging to investigate mouse retrovirus infections 
in vivo; a presentation by Alan Frankel that described reconstitution in 
vitro of the HIV nuclear export complex and its visualization by elec-
tron microscopy; advances in our structure/function understanding of 
TRIM5 restriction of HIV-1 by several groups; recognition that CPSF6 
and TNPO3 interact in regulating early steps of HIV replication; and the 
identifi cation of CD169/Siglec-1 as a trans-receptor for HIV-1 replication 
that regulates virus interactions with dendritic cells. As always, the Retro-
viruses meeting provided both descriptions of new discoveries in the fi eld 
and education about new techniques of scientifi c investigation that could 
be applied to other work.
This meeting was funded in part by the National Institute of Allergy and Infectious Diseases, 
a branch of the National Institutes of Health, and Gilead Sciences, Inc.
Evolution
Chairpersons: H. Fan, University of California, Irvine; 
R. Gifford, Aaron Diamond AIDS Research Institute, 
New York
Uta Von Schwedler Prize For Retrovirology
Awarded by: V. Planelles, University of Utah, Salt Lake City
To: O. Cingöz, Tufts University, Boston, Massachusetts
Entry, Reverse Transcription, and Uncoating
Chairpersons: S. Hughes, National Cancer Institute/NIH, 
Frederick, Maryland; S. Sarafi anos, University of Missouri 
School of Medicine, Columbia
Cytoplasmic Traffi cking, Nuclear Entry, and Integration 
Site Selection
Chairpersons: L. James, Medical Research Council, 
Cambridge, United Kingdom; M. Yamashita, Aaron 
Diamond AIDS Research Center, New York
Keynote Address: 40 Years in Retrovirology, A Reminiscence
M. Linial, Fred Hutchinson Cancer Research Center, Seattle, 
Washington.
Assembly and Maturation
Chairpersons: O. Pornillos, University of Virginia, 
Charlottesville; V. Vogt, Cornell University, Ithaca, New York
Keynote Address: Germ-line Retroviruses—Good or Bad?
J. Stoye, MRC National Institute for Medical Research, 
London, United Kingdom
TRIM5α and Innate Antiviral Factors
Chairpersons: E. Campbell, Loyola University Chicago, 
Maywood, Illinois; J. Young, Salk Institute for Biological 
Studies, La Jolla, California
Tetherin, VPU, and NEF
Chairpersons: E. Barker, Rush University Medical Center, 
Chicago, Illinois; L. Wu, Ohio State University, Columbus
RNA Traffi cking, Incorporation, and Interacting Factors
Chairpersons: J. Lingappa, University of Washington, Seattle, A. 
Telesnitsky, University of Michigan Medical School, Ann Arbor
Keynote Address: Can We Eradicate HIV from the 
 Individual and from the World?
J. Mellors, University of Pittsburgh, Pennsylvania
J. Witkowski, J. Stoye
Y. Lazebnik, G. Melikyan
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SAMHD1
Chairpersons: R. Koenig, Paul-Ehrlich-Institut, Langen, 
Germany; J. Skowronski, Case Western Reserve University 
School of Medicine, Cleveland, Ohio
Sixth Annual Andy Kaplan Prize
Awarded by: N. Landau, New York University School of 
Medicine
To: N. Laguette, CNRS, Montpellier, France
Integration and Latency
Chairpersons: V. Pathak, National Cancer Institute/
NIH, Frederick, Maryland; B.M. Peterlin, University of 
California, San Francisco
Second Annual Daniel Wolf Prize
Awarded by: S. Goff, Columbia University, New York, 
To: Jury-selected poster presenter at the 2012 
Retroviruses meeting
APOBEC3 Proteins, VIF, and Cell Biology
Chairpersons: P. Bates, University of Pennsylvania, 
Philadelphia; K. Bishop, National Institute for Medical 
Research, London, United Kingdom
It’s been a long day! I. Rouzina, A. Hulme
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Glia in Health and Disease
July 19–23 188 Participants
ARRANGED BY Dwight Bergles, Johns Hopkins University
 William Talbot, Stanford University
Glial cells constitute the majority of cells in the human nervous sys-
tem, but their roles in the healthy and diseased brain are still poorly un-
derstood. In this summer’s meeting, students and scientists from across 
the world gathered to discuss recent progress in the fi eld. The talks 
focused on exciting, unpublished results. There was lively discussion 
in the oral sessions, poster sessions, and informal settings. Sessions 
focused on the development of glia, genetic analysis of glial function, 
myelination, axon–glial interactions, microglia function, astrocyte 
function at synapses and blood vessels, and roles of glia in CNS dis-
ease. Vertebrate and invertebrate systems were well represented, and 
the meeting featured excellent presentations using diverse approaches, 
ranging from genomics to in vivo imaging in mammals, to central 
questions in glial biology. One of the highlights of the meeting was 
the keynote address from Prof. Klaus Nave, who presented exciting 
new information on signaling and metabolic transactions between axons and myelinating oligoden-
drocytes. As in the previous meetings in 2006, 2008, and 2010, there was again a sense of excitement 
that our understanding of the function of glia is quickly moving forward, with glia having central 
roles in normal brain development, function, and disease.
This meeting was funded in part by the National Institute of Neurological Disorders and 
Stroke, a branch of the National Institutes of Health.
PROGRAM
Glial Development
Chairpersons: R. Lu, University of Texas Southwestern Medical 
Center, Dallas; A. Brand, University of Cambridge, United 
Kingdom
Myelinating Cells
Chairpersons: D. Lyons, University of Edinburgh, United 
Kingdom; L. Feltri, State University of New York, Buffalo
Genetic Analysis of Glial Function
Chairpersons: M Götz, LMU Munich, Germany; 
M. Freeman, HHMI/University of Massachusetts 
Medical School, Worcester
Glial Function at Synapses
Chairpersons: B. Barres, Stanford University School of 
Medicine, California; A. Volterra, Université de Lausanne, 
Switzerland
D. Bergles, W. Talbot
K. Nave, R. Armstrong
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Gliovascular Interactions
Chairpersons: S. Charpak, INSERM, Paris, France; 
B. MacVicar, University of British Columbia, Vancouver, 
Canada
Keynote Speaker
K.-A. Nave, Max-Planck Institute of Experimental 
Medicine
Axon–Glial Interactions
Chairpersons: M. Rasband, Baylor College of Medicine, 
Houston, Texas; M. Bhat, University of North Carolina, 
Chapel Hill
Microglia Function in Health and Disease
Chairpersons: B. Stevens, Children’s Hospital, Harvard 
Medical School, Boston, Massachusetts; R. Ransohoff, 
Cleveland Clinic, Ohio
Role of Glia in CNS Injury and Disease
Chairperson: R. Armstrong, Uniformed Services University of 
the Health Sciences, Bethesda, Maryland D. Parkinson, H. Colognato
A. Brand, E. Peco M. Katz, Q. Aftab
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Mechanisms and Models of Cancer
August 14–18 464 Participants
ARRANGED BY Dafna Bar-Sagi, New York University Medical Center
 Karen Vousden, Beatson Institute for Cancer Research
 William Weiss, University of California, San Francisco
 Eileen White, Rutgers University/The Cancer Institute of New Jersey
Molecular alterations affecting tumor suppressor genes and oncogenes continue as a central focus 
driving human cancers. The last few years have witnessed an explosion in molecular cataloging of 
mutation, expression analyses, and epigenetic regulation that illuminates distinct human cancer 
types. This allows us to understand both commonalities and differences among and within cancer 
types, as well as presenting opportunities to test targeted agents against pathways not previously 
realized to be active in a specifi c subset of cancers. In addition, the cancer community contin-
ues to focus signifi cant effort on understanding interactions between tumor cells and other cell 
types within the tissue microenvironment, and on abnormalities that alter tumor cell metabolism, 
both of which infl uence malignant progression, invasion, and metastasis. Since our last meet-
ing, there has been increased appreciation of the role for epigenetic abnormalities in cancer and 
further comparisons between neoplastic transformation and cellular reprogramming. This fourth 
meeting convened an international group of investigators whose collective work focused on these 
themes. Oral and poster presentations provided numerous examples of how new insights have 
been gained from application of interdisciplinary approaches that utilize genetics, developmental 
biology, genomics and proteomics, and model organisms (principally sophisticated mouse models) 
to advance the development of rational therapeutics. A keynote address by Jackie Lees identifi ed 
fascinating new roles for the RB pathway in cancer, whereas a keynote address by Chuck Sherr 
provided an educational and entertaining overview of a distinguished career in science. Eight oral 
sessions and two poster sessions focused on the topics listed below in the Program.
This conference was funded in part by the National Cancer Institute, a branch of the National 
Institutes of Health. The meeting will be held again in the summer of 2014.
SESSION 1: Tumor Suppressor Networks
Chairpersons: C. Prives, Columbia University, New York; 
J. Lees, MIT Center for Cancer Research, Cambridge, 
Massachusetts
Keynote Speaker
J. Lees, MIT Center for Cancer Research, 
Cambridge, Massachusetts
W.-X. Zong, E. White N. Chandiramani, M. Blank, R. Navab
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SESSION 2: Signaling Mechanisms
Chairpersons: K. Cichowski, Brigham and Women’s Hospital, 
Harvard Medical School, Boston, Massachusetts; R. Marais, 
Paterson Institute of Cancer Research, Manchester, United 
Kingdom
SESSION 3: Poster Session I
SESSION 4: Genomics/Epigenomics
Chairpersons: L. Chin, University of Texas M.D. Anderson 
Cancer Center, Houston; A. Melnick, Weill Cornell Medical 
College, New York
SESSION 5: Cancer Development and Metabolism
Chairpersons: S. Lowe, Memorial Sloan-Kettering Cancer 
Center, New York; J. Brugge, Harvard Medical School, 
Boston, Massachusetts
SESSION 6: Poster Session II
SESSION 7: Therapeutics I
Chairpersons: J. Maris, Children’s Hospital of Philadelphia, 
Pennsylvania; F. DeSauvage, Genentech, South San 
Francisco, California
SESSION 8: Tumorigenesis
Chairpersons: M. Vander Heiden, Massachusetts Institute of 
Technology, Cambridge; T. Jacks, HHMI/Massachusetts 
Institute of Technology, Cambridge
SESSION 9: Therapeutics II
Chairpersons: B. Neel, Ontario Cancer Institute, Toronto, 
Canada; C. Sherr, HHMI/St. Jude Children’s Research 
Hospital, Memphis, Tennessee
Keynote Address: Notes from the Fossil Record
C. Sherr, HHMI/St. Jude Children’s Research Hospital, 
Memphis, Tennessee
SESSION 10: Tumor Microenvironment/Metastasis
Chairpersons: G. Bergers, University of California, San 
Francisco; M. Karin, University of California, San Diego
S. Lowe, E. Manchado
S. Muthuswamy, U. Guha H. Varmus, D. Tuveson L. Siskind, L. Obeid
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Bacteria, Archaea, and Phages
August 21–25 196 Participants
ARRANGED BY Petra Levin, Washington University
 Patricia Kiley, University of Wisconsin, Madison
 Mark Goulian, University of Pennsylvania
This meeting featured 79 oral presentations and 85 poster pre-
sentations. It reinforced the power of basic research in bacteria 
and phages to provide critical insights into areas of biology 
ranging from ecology and evolution, to signal transduction 
and genetic regulatory mechanisms, to pathogenesis. The 
2012 meeting featured presentations covering all of these top-
ics and continued the historical strength of phage meetings in 
combining long-term themes of molecular microbiology with 
cutting-edge approaches and exciting new research areas. The 
keynote lecture by Jonathan Beckwith, a pioneer in molecu-
lar biology, focused on the contribution of a technology he 
pioneered, lac fusions, to our understanding of diverse areas 
of bacterial physiology including transcription, translation, se-
cretion, and cell division. Another highlight was the Sternberg 
Lecture by Elie Diner, which focused on his Ph.D. work on 
specialized contact-dependent inhibition systems.
The opening session focused on transcriptional and translational regulation. Session chair Ann 
Hochschild focused on new work from her laboratory employing E. coli as a tool to study pro-
tein–protein interactions involved in the formation of protein aggregates similar to those of  prion 
proteins. Recent National Academy inductee Gisela Storz chaired the session on stress response 
and global regulation; she spoke about her work on the role of very small proteins in different 
S. Maloy, J. Watson, W. Szybalski, B. Stillman at the Milestones in Microbiology Awards
P. Kiley, P. Levin, M. Goulian
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aspects of bacterial physiology. William Dowhan presented recent work investigating the role 
of lipids as determinants of membrane protein topology. The session on bacterial pathogenesis 
and host–microbe interactions was chaired by Gautam Dantas, who discussed the role of envi-
ronmental microbes as reservoirs for antibiotic resistance. Lyle Simmons presented recent fi ndings 
from his laboratory on DNA replication fi delity and mismatch repair. National Academy member 
Rich Lenksi gave a somewhat retrospective talk on his pioneering work in experimental evolution. 
Another celebration was for the long, continuous participation of Wisconsin’s Waclaw Szybalski, 
whose generous support of the CSHL library was warmly recognized. Valéry de Crécy-Lagard, 
who chaired the session on genomics and genome organization, discussed comparative genomics 
as an effective tool for identifying gene function. The fi nal session of the meeting, Physiology, was 
chaired by John Kirby, who spoke about his laboratory’s work on a developmentally regulated sig-
nal transduction system in Myxococcus xanthus. Session talks and posters were presented by a mix 
of PIs, postdoctoral fellows, and graduate students whose high-quality presentations are a unique 
aspect of this meeting.
This meeting was funded in part by the National Institute of Allergy and Infectious Diseases, 
a branch of the National Institutes of Health; MedImmune; Nature Reviews Microbiology; and 
Promega.
PROGRAM
The Nat L. Sternberg Thesis Prize Award Announcement
Transcription and Transcriptional Regulation
Chairperson: A. Hochschild, Harvard Medical School, Boston, 
Massachusetts
Stress Response and Global Regulation
Chairperson: G. Storz, National Institute of Child Health and 
Human Development/NIH Bethesda, Maryland
Cell Surfaces and Cell Cycle Control
Chairperson: W. Dowhan, University of Texas-Houston 
Medical School
Bacterial Pathogenesis and Host–Microbe Interactions
Chairperson: G. Dantas, Washington University School of 
Medicine, St. Louis, Missouri
DNA Structure, Repair, and Dynamics
Chairperson: L. Simmons, University of Michigan, Ann Arbor
Evolution, Ecology and Environmental Biology
Chairperson: R. Lenski, Michigan State University, Lansing
Genomics and Genome Organization
Chairperson: V. de Crécy-Lagard, University of Florida, 
Gainesville
Keynote Address: From Lac Fusions 1964 to Lac Fusions 
2012: Is This Progress?
J. Beckwith, Harvard Medical School, Boston, Massachusetts
Physiology
Chairperson: J. Kirby, University of Iowa, Iowa City
R. Washburn, J. Beckwith A. Krainer, K. Tilly J. Roberts, A. Hochschild
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Regulatory and Noncoding RNAs
August 28–September 1 277 Participants
ARRANGED BY Gregory Hannon, Cold Spring Harbor Laboratory
 Elisa Izaurralde, Max-Planck Institute for Developmental Biology, Germany
 Michael Terns, University of Georgia
RNAs have a central role in gene expression. In addition to their function as messengers, RNAs 
perform many diverse and multifaceted roles across a spectrum of biological processes required 
for cell viability and function. Moreover, prokaryotic and eukaryotic genomes are pervasively 
transcribed to generate many additional RNAs of unknown function. In this summer’s meeting, 
students and scientists from across the world engaged in interdisciplinary discussion of the roles 
of noncoding RNAs with the aim of enhancing our understanding of gene regulation and func-
tion. There was lively discussion in the oral sessions, the poster sessions, and in informal settings. 
Sessions focused on recent and unpublished discoveries in the fi elds of long and short noncoding 
RNAs. The meeting featured excellent presentations on the role of noncoding RNAs in diverse 
organisms ranging from prokaryotes to humans and using diverse experimental approaches in-
cluding genomics, genetics, and cellular, molecular, and structural biology. There was a sense of 
excitement that our understanding of the function of noncoding RNAs is quickly moving forward 
and that this meeting provided an excellent framework for bolstering discussions in this emerging 
and exciting fi eld of noncoding RNAs.
PROGRAM
Keynote Speakers
J. Doudna, HHMI/University of California, Berkeley: 
Programmable RNA-Guided Genome Defense in Bacteria.
H. Chang, Stanford University, California: Genome 
Regulation by Long Noncoding RNAs.
N. Djodji, S. Marquez J. Witkowski, M. Gierszewska J. Bergmann
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Noncoding RNAs in Prokaryotes and RNA Modifi cation
Chairpersons: J. van der Oost, Wageningen University, The 
Netherlands; A. Ferre D’Amare, National Heart, Lung, 
and Blood Institute/NIH, Bethesda, Maryland; J. Vogel, 
University of Würzburg, Germany
Transcriptional Gene Silencing and Genome Integrity
Chairperson: S. Jacobsen, University of California, Los Angeles
Mechanisms of miRNA-Mediated Gene Silencing
Chairpersons: D. Bartel, HHMI. Whitehead Institute, 
Massachusetts Institute of Technology, Cambridge; 
A. Pasquinelli, University of California, San Diego
Biological Functions of miRNAs
Chairpersons: V. Ambros, University of Massachusetts Medical 
School, Worcester; J. Mendell, Johns Hopkins University 
School of Medicine, Baltimore, Maryland
siRNAs and piRNAs
Chairpersons: M. Siomi, Keio University School of Medicine, 
Tokyo, Japan; J. Brennecke, IMBA-Institute of Molecular 
Biotechnology, Vienna, Austria
Long Noncoding RNAs
Chairperson: T. Gingeras, Cold Spring Harbor Laboratory
Transcriptional Gene Silencing
Chairpersons: D. Moazed, Harvard Medical School, Boston, 
Massachusetts; S. Grewal, National Cancer Institute/NIH, 
Bethesda, Maryland
M. Hafner
G. Hayes, R. Batey
A. Martinez-Sanchez
C. Ronda
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Translational Control
September 4–8 389 Participants
ARRANGED BY Thomas Dever, National Institutes of Health
 Ian Mohr, New York University
 Tatyana Pestova, SUNY Downstate Medical Center
This meeting attracted participants from around the world, 
and included Richard Jackson, Samie Jaffrey, and David Sabi-
tini as invited speakers, eight platform sessions, and three 
poster sessions that covered 313 abstracts. Of special note, the 
meeting marked the 25th anniversary of the fi rst Cold Spring 
Harbor Meeting on Translational Control held in September 
1987. This anniversary was marked by Richard Jackson’s key-
note talk highlighting the progress over the last 25 years as 
well as interesting questions for the future. Novel fi ndings on 
the mechanism of translation included high-resolution cryo-
EM structures of eukaryotic 80S ribosomes that revealed 
substantial rRNA expansions as well as an unexpected rolling 
of the 40S ribosomal subunit during translation elongation. 
Complementary biochemical and structural studies revealed 
how the ATP-binding protein EttA binds in the ribosomal E 
site to control translation in response to cellular energy status. 
In addition, studies examining the regulation of ribosomal activity by antibiotics and regulatory 
proteins were also presented. Studies on translation elongation revealed the important role of the 
factor EF-P in synthesizing polyproline, whereas genome-wide ribosomal profi ling studies high-
lighted the use of alternative translation initiation sites on mRNAs, globally assessed pause sites 
during translation elongation, and highlighted the importance of Dom34 in ribosome recycling. 
Several breakthroughs were reported regarding the mechanism of translation initiation, including 
novel activities of initiation factors. The guanine nucleotide exchange factor eIF2B was reported 
to catalyze the dissociation of the eIF2-GDP • eIF5 complex, and yeast eIF4B was reported to 
bind directly to 40S ribosomal subunits to promote the recruitment of mRNAs. Evidence was 
presented that the m7G cap-binding protein eIF4E, besides tethering eIF4G to the cap, strongly 
stimulates the RNA helicase activity of eIF4A in the presence of eIF4G and eIF4B, explaining 
how elevated levels of eIF4E promote the translation of oncogenic mRNAs with highly structured 
5′-UTRs. In addition, a novel mechanism was described for generating peptides for presentation 
by the HMC that involves cryptic initiation with Leu-tRNA at CUG, not AUG, codons.
The prominent role of the protein kinase mTOR in regulating protein synthesis was docu-
mented in several presentations. This protein is a nexus, connecting inputs such as nutrient supply 
and hormone signaling to outputs that control the translation of particular mRNAs and overall 
protein synthesis rates in the cell. Discoveries showed how the synthesis of proteins central to 
plant growth is controlled and revealed the participation of mTOR in the synthesis (on cytosolic 
ribosomes) of mitochondrial proteins. Other themes included the functions of stress granules and 
initiation factors, and of modifi cations of the ribosome itself, in translational control. Studies of 
the protein kinase PKR, and its inhibitors made by viruses, illuminated the evolutionary contest 
waged between cells and infectious agents. Finally, fresh vistas were opened up by an investiga-
tion revealing the potential for additional layers of complexity in regulating viral gene expres-
sion. Several talks highlighted the important role of translational control in disease. Interestingly, 
T. Dever, T. Pestova, I. Mohr
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loss of the phosphatase-targeting subunit GADD34 was found to ameliorate some of the defects 
observed in a mouse model of vanishing white matter disease caused by mutations in eIF2B. Simi-
larly, deletion of the translational regulator CEBP rescued phenotypic defects in a mouse model 
of fragile-X syndrome. Translational control in learning and memory, prion disease, and schizo-
phrenia were also discussed. Moreover, overexpression of eIF4G or eIF4B was shown to promote 
cancer cell growth, while deleting one of the eIF4E genes in mice specifi cally impaired oncogenic 
transformation. Finally, the metabolic enzyme GAPDH was reported to protect ribosomal protein 
L13a in its extraribosomal role to regulate translation of infl ammation-related proteins.
New insights into the mechanism of miRNA-mediated translational repression were also 
reported. Poly(A)-binding protein (PABP) was found to facilitate the recruitment of RISC to 
 miRNA-binding sites in target transcripts. Upon binding, GW182 facilitates the release of PABP 
to repress translation prior to deadenylation. In studies using IRES-containing mRNA reporters, 
the eIF4AII helicase was found to be required for miRNA-induced translational repression. In 
support of this fi nding, mRNAs with conserved miRNA target sites were found to have longer 
5′-untranslated regions and higher GC content than mRNAs without miRNA target sites. Ad-
ditional talks provided insights into both global strategies used by cells to regulate translation and 
more specifi c novel mechanisms at work to control protein synthesis. An example of the former 
was a presentation on efforts to catalog the entire mRNA regulatory element “interactome” with 
trans-acting proteins in yeast; data gleaned from these studies are sure to seed new hypotheses 
and avenues of experimentation in the coming years. In another more targeted study, a new role 
for Dicer-2 in polyadenylation of cytoplasmic mRNAs was reported. Finally, a series of talks il-
lustrated the ability of internal ribosome entry sites (IRESs) to use protein binding, specifi c cell 
types, and RNA structural changes to control translation initiation via mechanisms that still 
remain largely mysterious.
PROGRAM
Ribosome
Chairperson: R. Beckmann, University of Munich, Germany
Cell Signaling and Viruses
Chairperson: M. Mathews, University of Medicine and 
Dentistry of New Jersey, Newark
Initiation
Chairperson: J. Hershey, University of California, Davis
Cancer and Disease
Chairperson: N. Sonenberg, McGill University, Montréal, 
Canada
M. Mathews, N. Sonenberg, N. Ashourian D. Ruggero, C. Calkhoven
299-418_Meetings & Courses.indb   336 9/17/2013   8:20:36 AM
Translational Control  337
mRNA Turnover and miRNAs
Chairperson: P. Anderson, Brigham and Women’s Hospital, 
Harvard University, Boston, Massachusetts
Development and CNS
Chairperson: N. Gray, University of Edinburgh, United 
Kingdom
Regulatory Elements
Chairperson: J. Kieft, University of Colorado Denver School of 
Medicine, Aurora
Elongation and Termination
Chairperson: M. Sachs, Texas A&M University, College 
Station
I. Aznarez Da Silva, G. Singh Posing for the caricaturist
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Epigenetics and Chromatin
September 11–15 389 Participants
ARRANGED BY Shelley Berger, University of Pennsylvania
 Robert Kingston, Massachusetts General Hospital and Harvard Medical School
 Juerg Mueller, Max-Planck Institute of Biochemistry, Germany
This inaugural meeting was a great launch, with lively dis-
cussion of the roles for chromatin structure in regulation of 
regulatory processes. The focus was on the role for chroma-
tin in the epigenetic mechanisms that create regulatory phe-
notypes that are more diverse than can be generated solely 
by genotype.
The high attendance, large numbers of posters (232), 
and sustained involvement of the participants throughout 
the meeting were testaments to the success of the meeting 
and the successful balance of the sessions. Scientists from 
25 countries attended, and for over half of these scientists, it 
was their fi rst visit to Cold Spring Harbor. This is a complex 
fi eld with continually emerging mechanistic themes, which 
fostered sustained interest by the large and diverse audience 
as the topics shifted throughout the eight sessions.
These sessions covered covalent modifi cation of DNA and of histones (two sessions) and the 
histone variants that can be used during regulation of chromatin function (one session). Mecha-
nisms that allow repression of chromatin and the long-range effects of chromatin structure on 
regulatory processes were each discussed in a session, with the latter topic providing reports on the 
emerging technologies used to map three-dimensional interactions along and between chromo-
somes. The remaining three sessions covered enzymatic functions on chromatin, including those 
involved in remodeling nucleosomes, the mechanisms involved in the regulation of development, 
and the chromatin-based processes involved in DNA repair and recombination.
Among the highlights of the conference were studies directed toward development of therapeu-
tics based on targeting proteins that bind chromatin modifi cations, the emerging roles for long 
noncoding RNAs in regulation, the dynamic nature of nucleosomes including the exchange of 
histone variants, and new studies concerning derivatives of methylated DNA.
B. Kingston, S. Berger, J. Mueller
S. Elgin, S. Heinkoff C. Wang, J. Platt, A. Harwood
299-418_Meetings & Courses.indb   338 9/17/2013   8:20:37 AM
Epigenetics and Chromatin  339
PROGRAM
Assembly, Repair, and Metabolism
Chairperson: G. Almouzni, Institute Curie, Paris, France
Enzymatic Function on Chromatin
Chairpersons: J. Workman, Stowers Institute for Medical 
Research, Kansas City, Missouri; T. Jenuwein, Max-Planck 
Institute of Immunobiology, Freiburg, Germany
DNA Methylation and Derivatives
Chairperson: C. Peterson, University of Massachusetts 
Medical Center, Worcester
Keynote Speaker
A. Bird, University of Edinburgh, United Kingdom
Repression
Chairpersons: D. Duboule, University of Geneva and EPFL, 
Switzerland; A. Shilatifard, Stowers Institute for Medical 
Research, Kansas City, Missouri
Histone Variants and Regulation
Chairperson: K. Luger, Howard Hughes Medical Institute, 
Colorado State University, Fort Collins
Keynote Speaker
C. Wu, National Cancer Institute/NIH, Bethesda, Maryland
Development and Inheritance of State
Chairpersons: B. Meyer, HHMI/University of California, 
Berkeley; R. Martienssen, Cold Spring Harbor Laboratory
Long-Range Effects
Chairperson: C. Dean, John Innes Centre, Norwich, United 
Kingdom
Covalent Modifi cation and Regulation
Chairpersons: E. Heard, Institut Curie, Paris, France; 
S. Grewal, National Cancer Institute/NIH, Bethesda, 
Maryland
D. Duboule, N. Loufat
K. Sanbonmatsu J. Van der Knaap, P. Verrigner T. Jenuwein, G. Bloble
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Axon Guidance, Synapse Formation, and Regeneration
September 18–22 296 Participants
ARRANGED BY Alain Chedotal, Vision Institute, INSERM, Paris
 Graeme Davis, University of California, San Francisco
 Yishi Jin, University of California, San Diego
 Carol Mason, Columbia University
The human brain has billions of nerve cells (neurons) and 
each neuron is typically connected to hundreds of other 
neurons via synapses in a highly precise fashion. This com-
plex neural wiring underlies the ability of humans, and 
other animals, to interact with the outside world, to learn, 
and to perform complex behaviors. Defects in the develop-
ment of neural connections are being increasingly linked 
to the cause of neurological disease. One of the major chal-
lenges for the fi eld of neuroscience is to understand how 
nerve connections are made accurately and reliably. In the 
past decade, our understanding of the mechanisms that 
control axon growth and guidance, synaptogenesis, and the 
remodeling of neural circuits during development has pro-
gressed rapidly from phenomenology to the identifi cation 
of specifi c molecular control mechanisms.
This eighth meeting in the series focused on key issues in axon guidance, circuit formation, 
synaptogenesis, and axon regeneration and included sessions devoted to particular problems in the 
assembly, plasticity, and repair of the nervous system, with speakers chosen from among the partici-
pants submitting abstracts by session chairs who are leaders in the fi eld. The response of the fi eld to 
the 2012 conference was one of overwhelming enthusiasm—with more than 296 participants, 240 
of whom submitted abstracts, despite several Gordon Conferences held late in the summer on simi-
lar topics and the concurrent Japanese Neuroscience meeting. A total of 49 abstracts were selected 
for talks, in seven sessions, the remaining abstracts being presented as posters. Senior research-
ers, starting assistant professors, postdoctoral fellows, and graduate students were well-represented 
as speakers and participants. Session chairs at the meeting were well-balanced between men and 
women, and the meeting had a clear international presence with participants from Europe and Asia. 
Many of the outstanding talks this year were by graduate students. All of the major areas of research 
in the fi eld were covered, as were all of the major approaches (cellular, physiological, anatomical, 
molecular, dynamic imaging, biochemical, and genetic). In addition, there were three keynote ad-
dresses. The fi rst, by a speaker outside of the fi eld of neural development, was given by Professor 
Charles Zuker and reviewed his work on taste sensory perception. The second and third keynote 
lectures were a pairing of speakers whose early work had major roles in moving the fi eld of axon 
guidance and synapse formation forward. Jeff Lichtman focused on his recent work that combines 
ultrastructural reconstruction of brain anatomy with computation and functional dissection to 
decipher the logic of the mammalian brain. Barry Dickson spoke on his recent work that has led to 
the elucidation of the complete neural map underlying Drosophila sex behavior.
Also for the fi rst time, this meeting held an informal event on professional development. Top-
ics included how to search for mentors (postdoc or faculty), how to prepare for job interviews 
(academic or industry), how to write grants, managing teaching and research, how to balance life 
and work, and how to handle paper reviews. Two special discussion sessions were dedicated to 
A. Chedotal, C. Mason, Y. Jin, G. Davis
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publishing by the attending journal editors and to careers as a physician-scientist by investigators 
with an M.D. or M.D.-Ph.D. degree and clinical experience. About half of the senior investiga-
tors participated in the event. The students and postdocs expressed high appreciation for the close 
interaction and valuable advice they gained through this event.
Overall, this meeting provided an important forum for ideas and approaches and helped scien-
tists in the fi eld get the most up-to-date information, as well as enabling them to meet, to network, 
and to establish collaborations. As at the previous meeting, a need was identifi ed for an additional 
poster session because the number and quality of abstracts submitted for posters was so high. The 
three poster sessions were extremely well-attended. In addition, fewer talks were scheduled in the 
evening, and a talk session after the evening keynote was eliminated to allow time for discussion 
and attendee interactions. Based on the enthusiastic comments of the participants, the intensity 
of the oral and poster sessions, and the large crowds that stayed up late every night at the bar to 
discuss science, the meeting was a great success.
This meeting was funded in part by National Institute of Neurological Disorders and Stroke, 
a branch of the National Institutes of Health, and Merck.
PROGRAM
Axon to Synapse I
Chairpersons: G. Bashaw, University of Pennsylvania, 
Philadelphia; L. Erskine, University of Aberdeen, United 
Kingdom
Regeneration and Disease I
Chairpersons: J. Goldberg, University of Miami, Florida; 
A. Bonni, Harvard Medical School, Boston, Massachusetts
Special Lecture: Common Sense about Taste: From the 
Tongue to the Brain
C. Zuker, Columbia University, New York
Synapse to Circuit I
Chairpersons: H. Baier, Max-Planck Institute of Neurobiology, 
Martinsried, Germany; P. Arlotta, Massachusetts General 
Hospital, Boston
Axon to Synapse II
Chairpersons: R. Murphy, Florida Atlantic University, Boca 
Raton, V. Castellani, CNRS, University of Lyon 1, France
Synapse to Circuit II
Chairpersons: K. Shen, Stanford University, California; 
M. Goulding, The Salk Institute, La Jolla, California
Regeneration and Disease II
Chairpersons: E. Engle, Children’s Hospital, HHMI/Harvard 
Medical School, Boston, Massachusetts; G. Rouleau, 
University of Montréal, Canada
Special Lectures
J. Lichtman, Harvard University, Cambridge, Massachusetts: 
Seeking Circuit Motifs with Connectomics.
B. Dickson, Research Institute of Molecular Pathology, Vienna, 
Austria: Wired for Sex; The Neurobiology of Drosophila 
Mating Decisions.
Axon to Synapse III
Chairpersons: D. Schmucker, Vesalius Research Center, 
University Leuven, Belgium; C. Hoogenraad, Utrecht 
University, the Netherlands
L. Goodrich, C. Mason A. Erturk, A. Yaron A. Davy, A. Kania
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Dynamic Organization of Nuclear Function
September 27–October 1 222 Participants
ARRANGED BY Edith Heard, Curie Institute, France
 Martin Hetzer, The Salk Institute for Biological Studies
 David Spector, Cold Spring Harbor Laboratory
This meeting focused on the relationships between nuclear 
structure and function. The opening session highlighted cur-
rent studies on Nuclear Function in Development and Disease, 
with the session chair (Jane Skok) giving a very nice introduc-
tion with an overview of nuclear and chromosome dynam-
ics and raising several of the critical questions that would be 
touched on during the session. She also presented her own work 
on the dynamic choreography of higher-order looping and 
nuclear dynamics of antigen receptor loci during their recom-
bination in mouse lymphocytes. Carolyn Larabell presented a 
talk on the powerful technique of soft X-ray tomography for the 
exploration of changes in euchromatin and heterochromatin or-
ganization, at high resolution, during development in olfactory 
neurons. The Friday morning session was dedicated to chromo-
some conformation capture approaches, which have come into 
the limelight in recent years and have provided major insights 
into the short- and long-range organization of the genome, at the molecular level. The session was 
one of the highlights of the meeting, with a signifi cant amount of new data presented, including 
a talk by Peter Fraser on single-cell analysis of X-chromosome topology using novel 3C technol-
ogy, as well as several presentations describing new levels of chromosome organization, such as 
topological domains, and discussions about the technical issues related to such techniques. After 
a very active poster session and discussions at the wine-and-cheese get-together, John Lis chaired 
the Transcriptional Regulation session. His introduction beautifully illustrated the refi ned picture 
that is emerging of how RNA polymerase navigates through different genes during transcription. 
The session covered several aspects of transcription, in particular features of genes that can greatly 
infl uence elongation rates, such as exon number (J. Lis), as well as epigenetic marks and nuclear 
proteins that can lead to transcriptional priming, and perpetuate the memory of such priming, for 
example, Nup98 (J. Brickner). A recurring theme in this meeting was single-molecule resolution 
where nascent mRNA quantifi cation was undertaken.
The Nucleocytoplasmic Transport session on Saturday morning was chaired by Karsten Weis, 
who gave a broad introduction to the nuclear pore complex and transport mechanisms and pre-
sented new data on the role of Dbp5 in mRNA export including single-molecule imaging in yeast. 
The session included an update on the role of nuclear pores in Tetrahymena differentiation, the 
misregulation of mRNA export in human disease, links between signaling and mRNA export, 
and the description of a Ran-independent import pathway for Hsp70. The fi nal talk addressed the 
ubiquitylation of nuclear pore proteins, a poorly understood but exciting new area.
The afternoon session on Epigenetics and Nuclear Organization was ably chaired by Wendy 
Bickmore. This was another animated session touching on chromatin and chromosome structure, 
as well as nuclear organization. Several talks focused on the long-range interactions in the nuclear 
genome. W. Bickmore described her work on Hox cluster genes using imaging and 3C techniques 
and raised some important technical considerations for HiC methods and data analysis. The 
D. Spector, E. Heard, M. Hetzer
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session also provided mechanistic insights into the role of JMJD3 in transcriptional induction 
(M. Huebner) as well as the distribution of polycomb proteins on mitotic chromosomes (N.J. 
Francis). In addition, topics as diverse as asymmetric sister chromatid segregation and condensin-
mediated chromosome compaction were presented.
On Sunday morning, M. Carmo-Fonseca chaired an exciting session on the Biology of Nuclear 
RNAs. She presented impressive new data using a system in which two RNA tags located in dif-
ferent introns within a transgene could be used to visualize RNA splicing in living cells. A host 
of new long and short noncoding RNAs were also discussed in this session. The nuclear RNA 
universe is clearly still expanding, and in addition to their more classical roles, RNAs are emerging 
as central actors for gene regulation, chromatin structure, and nuclear architecture.
The Sunday afternoon session on the nuclear pore complex and nuclear lamina was chaired 
by Yixian Zheng, who gave an exciting talk about the role of Nup153 in EGF signaling during 
germ cell differentiation. Three talks discussed aspects of the intranuclear life of nucleoporins, 
nuclear pore assembly, and the longevity of NPC proteins. Other exciting new fi ndings provided 
insights into the targeting and structure of inner nuclear membrane proteins, nuclear membrane 
formation, and NPC assembly. The role of lamins in Hutchinson-Gilford progeria and chromatin 
organization was also discussed in great detail.
The meeting ended with a session on Cell Cycle and DNA Repair chaired by Julian Blow, who 
presented exciting data on replication complex assembly and the regulation of DNA replication. 
David Gilbert’s lab presented data to demonstrate a relationship between the establishment and 
developmental regulation of replication timing to the topological boundaries of structural chro-
mosome domains and how these properties can be uncoupled. In addition, several talks addressed 
the problem of DNA repair including its relation to cell cycle phase (R. Ileng Kumaran), the dy-
namics of chromosomal translocations (V. Roukos), and the effect of nuclear architecture on the 
effi ciency of repair (E. Fabre).
The enthusiasm of the meeting participants was overwhelming, and it is remarkable how with 
each successive meeting the interest has grown and strengthened. The slightly smaller number of 
participants compared to previous meetings was partly due to the fact that the last meeting was the 
Symposium and that a new meeting (Epigenetics) with overlapping topics had actually taken place 
just a few weeks earlier. All of the feedback on the scientifi c interest and quality of the meeting 
was extremely positive and it is anticipated that the CSHL 2014 meeting will be an even greater 
success!
M. Ekersley, K. Sengupta P.E. Gleizes, M. Ruault
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PROGRAM
Nuclear Function in Development and Disease
Chairperson: J. Skok, New York University School of Medicine, 
New York
Chromosome Conformation
Chairperson: P. Fraser, Babraham Institute, Cambridge, 
United Kingdom
Transcriptional Regulation
Chairperson: J. Lis, Cornell University, Ithaca, New York
Nucleocytoplasmic Transport
Chairperson: K. Weis, University of California, Berkeley
Epigenetics and Nuclear Organization
Chairperson: W. Bickmore, MRC Human Genetics Unit, 
Edinburgh, United Kingdom
Biology of Nuclear RNAs
Chairperson: M. Carmo-Fonseca, University of Lisbon, Portugal
The Nuclear Pore Complex and Nuclear Lamina
Chairperson: Y. Zheng, Carnegie Institution, Baltimore, 
Maryland
Cell Cycle and DNA Repair
Chairperson: J. Blow, University of Dundee, United Kingdom
S. Parker Break time M. Mechali, M. Prioleau
299-418_Meetings & Courses.indb   344 9/17/2013   8:20:43 AM
345
Germ Cells
October 2–6 205 Participants
ARRANGED BY Laurinda Jaffe, University of Connecticut Health Center
 Erika Matunis, Johns Hopkins University School of Medicine
 Tim Schedl, Washington University School of Medicine
This meeting began with fi ve speakers in Session 1 focusing 
on issues of epigenetics, including Azim Surani as keynote 
speaker. As with all of the sessions, lively discussion fol-
lowed each of the talks and continued after the conclusion 
of the sessions. Likewise the diversity in the model systems 
used for study, including mammals, fi sh, plants, and a wide 
range of invertebrates, highlighted deeply conserved emerg-
ing mechanisms.
Session 2 focused on germ cell specifi cation and migra-
tion, a theme revisited with different emphasis throughout 
the meeting, particularly in Session 4, which focused on 
germline stem cells and their niches, and Session 5 con-
cerned with environmental, hormonal, and somatic infl u-
ences on germ cells. Evolving concepts about the nature of the germ cell niche and the molecules 
driving stem cell dynamics provoked considerable discussion. Talks included presentations of how 
Royalactin induces germ cell development during queen differentiation in honeybees, and how 
the bacterium Wolbachia infl uences mosquito oogenesis and the implications of this for disease 
control.
Poster Sessions (Sessions 3 and 6) presented studies on virtually all aspects of germ cell develop-
ment in diverse model species. This meeting, compared to previous meetings, included a number 
of posters on how metabolic signaling (e.g., TOR) and environmental inputs control germ cell de-
velopment and function, particularly in stem cells and during gametogenesis. Sessions 7 through 
9 reported advances in our understanding of the regulation of meiosis, posttranscriptional con-
trol, and the cell biology of germ cells. Highlights included remarkable imaging of chromosome 
pairing during meiosis, and the discovery of a protein that mediates nuclear fusion during early 
development. The meeting concluded with Session 10 on sex determination, including new in-
sights on sex chromosome evolution. There has been remarkable progress since the last Germ Cells 
meeting (in 2010). Recent fi ndings in two areas stimulated much discussion. The fi rst concerns 
the two major processes that occur during the formation of gametes, the meiotic events that lead 
to recombination, and appropriate chromosome segregation and the differentiation events that 
form oocytes or sperm. A surprising report from the Page and Eppig laboratories indicates that the 
entire process of gametogenesis to form fertilizable oocytes can occur completely independently of 
the meiosis. The second concerns the recent controversial proposal that the adult female ovary in 
mammals contains a population of stem cells, contrary to the long-held belief that the full endow-
ment of oocytes in the mammalian ovary is present prior to birth. In a very elegant lineage study 
in the mouse system from the Spradling laboratory, no evidence was found that adult stem cells 
produce oocytes; instead, oocytes all arise from germ cells set aside before birth. An international 
cast, including speakers from Argentina, Australia, Canada, China, Czech Republic, France, Ger-
many, India, Israel, Japan, Mexico, Netherlands, Norway, Poland, Portugal, Singapore, Spain, 
and the United Kingdom, participated in this meeting. There was general excitement about con-
tinued advances that will affect broad basic and clinical fi elds of development, reproduction, and 
L. Jaffe, T. Schedl, E. Matunis
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clinical sciences. Once again, the ease of interactions between established and new participants 
and the strong representation of unpublished, cutting-edge work were highly valued aspects of this 
meeting. The next Germ Cells meeting will be held at Cold Spring Harbor October 7–11 of 2014 
and will be organized by Mary Ann Handel, Jane Hubbard, and Steve DiNardo.
This meeting was funded in part by the National Institute of Child Health and Human De-
velopment, a branch of the National Institutes of Health, and the Lalor Foundation.
PROGRAM
Epigenetics
Chairperson: S. DiNardo, University of Pennsylvania School of 
Medicine, Philadelphia
Keynote Address: Principles and Programming of the 
Mammalian Germ Line
A. Surani, University of Cambridge, Cambridge, United 
Kingdom
Germ Cell Specifi cation and Migration
Chairperson: S. Strome, University of California, Santa Cruz
Germline Stem Cells and Their Niches
Chairperson: D. Zarkower, University of Minnesota, 
Minneapolis
Environmental, Hormonal and Somatic Infl uences on 
Germ Cells
Chairperson: M. Fuller, Stanford University School of 
Medicine, California
Meiosis
Chairperson: E. Gavis, Princeton University, New Jersey
Posttranscriptional Control
Chairperson: P. Newmark, HHMI/University of Illinois at 
Urbana-Champaign
Cell Biology of Germ Cells
Chairperson: P. Hunt, Washington State University, Pullman
Sex Determination
Chairperson: M. Matzuk, Baylor College of Medicine, 
Houston, Texas
A. Surani, F.J. Berger C. Silva
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Molecular Genetics of Aging
October 9–13 245 Participants
ARRANGED BY Steven Austad, University of Texas Health Science Center, San Antonio
 Judith Campisi, Buck Institute for Age Research/Lawrence Berkeley National Laboratory
 David Sinclair, Harvard University Medical School
Aging is the largest single risk factor for developing a pano-
ply of diseases, ranging from neurodegeneration to cancer. 
In recent years, enormous progress has been made in un-
derstanding how genetics and the environment infl uence 
the pace of aging and disease. Among the remarkable fi nd-
ings is the identifi cation of molecular pathways that con-
trol aging in diverse species, from yeast to humans. This 
conference provided an intense forum for the latest results 
and emerging ideas in aging research at the molecular and 
organismal levels. The conference opened with a session 
on genetic variation—an exploration into why species, and 
particularly individuals within a species, age at different 
rates. A related session discussed genetic and epigenetic 
stability, which focused on the mechanisms that maintain 
the DNA sequence and its packaging (chromatin), how 
these entities change during aging, and how such changes affect organismal health and fi tness. 
A subsequent session highlighted the role of mitochondria and energy metabolism in preserving 
organismal health and longevity, and the molecules that are crucial for optimal energy production 
and utilization. One session was devoted to cellular stress responses, and the intimate relation-
ship between stress resistance and longevity. The conference then featured a session on stem cells, 
which emphasized recent fi ndings on how these important sources of tissue repair and regenera-
tion change with age, and how aging alters the tissue environment in which stem cells must func-
tion. Another session discussed protein homeostasis, with a focus on why proteins aggregate and 
how they may be prevented or eliminated to prevent aging and disease. A session then focused on 
the power of genetic manipulations of conserved pathways to alter the rates and outcome of aging. 
The fi nal session highlighted the latest fi ndings on the role of nutrition and nutrient sensing in 
D. Sinclair, J. Campisi, S. Austad
S. Helfand, S. Ahmed H. Bussemaker, J. Tollervey
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aging and discussed interventional strategies that are currently being developed. The conference 
brought together scientists from diverse fi elds, mirroring the expanding multidisciplinarity of the 
fi eld, and refl ected the excitement and growing understanding of the processes that drive aging 
and the possibilities for developing interventions that could slow the aging process and treat com-
mon diseases of aging.
This meeting was funded in part by the National Institute on Aging, a branch of the National 
Institutes of Health.
PROGRAM
Genetic Variation
Chairpersons: Y. Suh, Albert Einstein College of Medicine, 
Bronx, New York; C. Franceschi, University of Bologna, 
Italy
Epigenetic Stability
Chairpersons: A. Brunet, Stanford University, California; J. 
Vijg, Albert Einstein College of Medicine, Bronx, New York
Metabolism and Energetics
Chairpersons: D. Wallace, Children’s Hospital of Philadelphia/
University of Pennsylvania, Philadelphia; M. Hansen, 
Sanford-Burnham Medical Research Institute, La Jolla, 
California
Genetics Stability and Cell Senescence
Chairpersons: J. Van Deursen, Mayo Clinic, Rochester, 
Minnesota; P. Hasty, University of Texas Health Science 
Center, San Antonio
Stem Cells
Chairpersons: I. Conboy, University of California, Berkeley; 
H. Jasper, University of Rochester, New York
Protein Homeostasis
Chairpersons: D. Sinclair, Harvard Medical School, Boston, 
Massachusetts; D. Green, St. Jude Children’s Research 
Hospital, Memphis, Tennessee
Genetic Manipulation
Chairpersons: P. Kapahi, Buck Institute, Novato, California; 
S.-i. Imai, Washington University School of Medicine, 
St. Louis, Missouri
Nutrient Sensing and Interventions
Chairpersons: M. Tatar, Brown University, Providence, 
Rhode Island; R. Miller, University of Michigan, 
Ann Arbor
J. Wright, B. Schneider J. Wilkowski, D. Wallace O. Pougovkin
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Nuclear Receptors and Disease
October 30–November 3 188 Participants
ARRANGED BY Keith Yamamoto, University of California, San Francisco
 Ron Evans, Salk Institute Biological Studies
 Susanne Mandrup, University of Southern Denmark
This meeting has been held biennially since 2006 and is the fourth of its 
kind. Nuclear receptors constitute a unique group of transcription factors 
that regulate transcription in response to small lipophilic biomolecules that 
bind to the receptors. These proteins have very important roles as regula-
tors of cellular growth, differentiation, and metabolism, and dysregulation 
can lead to metabolic diseases and different types of cancer. Accordingly, 
the meeting focused on basic mechanisms of nuclear receptor function as 
well as the role of nuclear receptors in metabolism and cancer.
As a result of Hurricane Sandy, the beginning of meeting had to be 
rescheduled to November 1. Furthermore, since many speakers and par-
ticipants could not make it, the meeting was restructured to a workshop 
format and many younger scientists were given the opportunity to give 
talks. This allowed for excellent discussions between talks and also an evening discussion session. 
In addition, many participants gave short talks.
This meeting was funded in part by the National Institute of Diabetes and Digestive and Kid-
ney Diseases, a branch of the National Institutes of Health, and Novo Nordisk.
PROGRAM BEFORE SANDY
Keynote Speakers
C. Sawyers, HHMI/Memorial Sloan-Kettering Cancer Center, 
New York; G.L. Hager, National Cancer Institute/NIH, 
Bethesda, Maryland
Chromatin and Transcription
Chairperson: G. Hager, National Cancer Institute, NIH, 
Bethesda, Maryland
S. Mandrup, K. Yamamoto
Welcome notice
Science beats Sandy!
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Cofactors
Chairperson: R.M. Evans, HHMI/Salk Institute for Biological 
Studies, La Jolla, California
Metabolism and Metabolic Disorders I
Chairperson: S. Mandrup, University of Southern Denmark, 
Odense
Metabolism and Metabolic Disorders II
Chairperson: C. Glass, University of California, San Diego
Cancer
Chairperson: A. Kralli, Scripps Research Institute, La Jolla, 
California
Development and Aging
Chairperson: A. Maggi, University of Milan, Italy
Structure and Ligands
Chairperson: D. Moore, Baylor College of Medicine, 
Houston, Texas
DURING SANDY
Keynote Speaker
G.L. Hager, National Cancer Institute/NIH, Bethesda, 
Maryland
Chromatin and Cofactors
Chairperson: G. Hager, National Cancer Institute/NIH, 
Bethesda, Maryland
Metabolism and Metabolic Disorders
Chairperson: S. Mandrup, University of Southern Denmark, 
Odense
Cancer
Chairperson: A. Kralli, Scripps Research Institute, La Jolla, 
California
M. Malewicz, G. Hager, D. Kelly
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Personal Genomes and Medical Genomics
November 14–17 228 Participants
ARRANGED BY Evan Eichler, University of Washington
 Deanna Kroetz, University of California, San Francisco
 Richard Lifton, Yale University School of Medicine
 James R. Lupski, Baylor College of Medicine
 Richard Weinshilboum, Mayo Clinic
For the fi rst time, this fi fth meeting on Personal Genomes combined both the content of the Per-
sonal Genomes Meeting and that of the Pharmacogenomics Meeting to bring together scientifi c 
communities interested in gleaning medically actionable information from individual personal 
genomes. The meeting was entitled “Personal Genomes and Medical Genomics” and was a step 
toward precision medicine, which utilizes genomic information to guide differential diagnoses and 
potentially to optimize and direct therapeutic interventions. The meeting was initiated with an out-
standing presentation from Retta Beery, whose fraternal twin children underwent personal genome 
sequencing to identify variants causative for a dopa-responsive dystonia. A specifi c gene mutation 
that was identifi ed helped optimize therapy for the children. Mrs. Beery presented a very moving 
talk on dealing with this medical odyssey and how it affected their family for many years. The 
keynote speaker was followed by a series of talks in a session on “Genomics to guide differential 
diagnosis and therapy” in which it became obvious that personal genomes are being used around 
the world at the leading medical institutions by thoughtful leaders in genomics who are trying to 
leverage the clinical utility of information that can be gleaned from personal genomes. The sec-
ond session dealt with somatic cell genomics and cancer pharmacogenomics, and the third with 
germline genomics emphasizing Mendelizing traits and locus heterogeneity. Three other sessions 
included genomic variation and common traits/disease, clinical integration of genomic variation, 
and evolving genomic technologies. A lively and informative ethics panel was presented in which 
challenges of clinical information on genomic variation were discussed in detail. Furthermore, 
the President’s commission on Bio-Ethics presented the fi rst public report of their fi ndings related 
to human genome sequence information and its utility. Their deliberations stressed the desire for 
safeguarding and maintaining privacy of genomic information. Finally, a keynote address, given by 
Maynard Olson, enthusiastically embraced the rapid movement of genomic sequence information 
into the clinical arena; it also enlightened us by “cautionary notes” as we move into a molecular era 
J. Lupski welcomes group D. Kroetz E. Eichler, center
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in which precision medicine is delivered by virtue of molecular knowledge of the disease process in 
each individual as elucidated through the information embodied in their personal genome.
This meeting was funded in part by the National Institute of General Medical Sciences, a 
branch of the National Institutes of Health, and Illumina.
PROGRAM
Genomics to Guide Differential Diagnosis and Therapy
Chairperson: J. Lupski, Baylor College of Medicine, Houston, 
Texas
Keynote Address: The Beery Family Journey: A Sequencing 
Success
R. Beery, Encinitas, California
Somatic Cell Genomics and Cancer Pharmacogenomics
Chairperson: D. Kroetz, University of California, San Francisco
Germline Genomics, Mendelizing Traits and Locus 
 Heterogeneity
Chairperson: R. Lifton, Yale University School of Medicine, 
New Haven, Connecticut
Genomic Variation in Common Traits/Disease
Chairperson: E. Eichler, University of Washington, Seattle
Clinical Integration of Genomic Variation
Chairperson: R. Weinshilboum, Mayo Clinic, Rochester, 
Minnesota
Ethics Panel: Challenges of Clinical Implementation of 
Genomic Variation
Moderator: S. Plon, Baylor College of Medicine, Houston, 
Texas
Evolving Genomic Technologies
Chairperson: M. Hurles, Wellcome Trust Sanger Institute, 
Hinxton, United Kingdom
Keynote Address: Three Cautions about Personalized 
Medicine
M.V. Olson, University of Washington, Seattle, Washington
Ethics panelists (left to right): G. Lyon, A. Beaudet, J. Beckmann, A. Allen
C. Aquadro F. De La Vega R. Beery, J. Watson
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Neurodegenerative Diseases: Biology and Therapeutics
November 28–December 1 122 Participants
ARRANGED BY Karen Duff, Columbia University Medical Center
 Jeffrey Rothstein, Johns Hopkins University School of Medicine
 John Trojanowski, University of Pennsylvania School of Medicine
Up to one-half of those aged 85 years or older will develop de-
bilitating degenerative disease of the central nervous system. 
These various diseases include Alzheimer’s disease (AD), 
Parkinson’s disease (PD), frontal temporal lobe degeneration 
(FTD), Huntington’s disease (HD), and amyotrophic lateral 
sclerosis (ALS). To refl ect some of the newest and most rel-
evant research while providing diverse base topics, the 2012 
meeting included prion-like spread of diseases including 
AD, PD, and tauopathies; new thoughts about biomarkers 
and comorbidities; the role of RNA in the pathogenesis of 
neurodegenerative diseases; the role of glia, especially their 
potential as targets for therapy; and a number of therapeutic 
targets and approaches including immunomodulation, small 
molecules, and gene inactivation strategies.
Although most forms of neurodegenerative disease occur 
in the absence of obvious heritability or identifi able genetic mutations, it has been possible during 
the past 20 years to discover uncommon genetic mutations as well as risk-modifying DNA chang-
es in some examples and predictable causative changes in others. For some of the neurodegenera-
tive diseases, common genetic abnormalities lead to a spectrum of disease phenotypes, which is 
clearly seen for FTD and ALS. New insight into disease mechanisms and possible overlapping 
therapeutic approaches are implicated. From these fi ndings, transgenic technology has rapidly led 
to the development of mouse, fruit fl y, and nematode model systems that partially recapitulate the 
clinical abnormalities of the human diseases as well as some of the hallmark molecular and mor-
phological pathology of the conditions. Of particular relevance in this respect is the emergence of 
new ideas about the spread of disease entities within the brain and from the periphery, similar to 
that seen in the prion diseases, which has become a dominant topic in AD, FTD, and PD research. 
This new and exciting fi eld of research was well-represented at the 2012 meeting.
The biannual meeting series started in 2000, and as in previous years, the explicit goal of the 
meeting focuses on identifying disease pathways and facilitating the translation of “breakthrough” 
science into effective medicines. At this year’s meeting, numerous academic labs and commercial 
drug discovery organizations presented data on novel compounds, clinical trial results, or new 
druggable pathways for AD, PD, FTD, HD, ALS, spinal muscular atrophy, spinocerebellar ataxia, 
and prion diseases. In recent years, various molecular, biochemical, and cell-based screens have 
led to the development of small-molecule, peptide, and oligonucleotide compounds that show 
promise in neurodegenerative disease models. Importantly, the emergence of gene inactivation 
strategies using stabilized oligonucleotides has shown particular promise both as a tool for study-
ing pathogenesis and, more importantly, as a clinically relevant therapeutic agent that could be 
used to knock down pathological proteins or pathways affected in several diseases.
For this meeting, platform sessions were organized around common technological themes. 
Chairpersons, invited speakers, and speakers selected from submitted abstracts were drawn from 
J. Rothstein, K. Duff, J. Trojanowski
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the academic and pharma sectors, representing 20+ countries. The discussion of new, unpub-
lished data was emphasized and adequate time was left for discussion of each presentation. Poster 
presentations also covered a wide range of neurodegenerative disease pathways, new animal and 
insect models, and novel therapeutic insights. Posters were displayed for an extended period dur-
ing the meeting, and poster viewing was especially encouraged during the cocktail hours before 
the evening meals. In general, the meeting was most notable for its breadth of coverage of different 
neurodegenerative diseases, insightful and novel presentations and discussions, and the insight 
gleaned from lively interaction between the diverse participants.
PROGRAM
Prion-Like Neurodegeneration: Initiation and Disease 
Spread
Chairperson: V. Lee, University of Pennsylvania School of 
Medicine, Philadelphia
Risk Factors and Comorbidities: Aging, Biomarkers, and 
Genetics
Chairperson: G. Schellenberg, University of Pennsylvania 
School of Medicine, Philadelphia
RNA Metabolism in Neurodegenerative Disease
Chairperson: D. Cleveland, University of California, San Diego
Submitted Abstracts
Chairperson: P. Brundin, Van Andel Research Institute, Grand 
Rapids, Michigan, and Lund University, Sweden
Glial Biology: New Targets for Therapy in 
 Neurodegeneration
Chairperson: J. Rothstein, Johns Hopkins University School 
of Medicine, Baltimore, Maryland
Immune and Small-Molecule Therapy for AD and PD
Chairperson: J. Trojanowski, University of Pennsylvania 
School of Medicine, Philadelphia
Gene Inactivation Strategies
Chairperson: A. Krainer, Cold Spring Harbor Laboratory
D. Cleveland N. Kfoury L. McConlogue, M. Diamond
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Blood Brain Barrier
December 5–8 124 Participants
ARRANGED BY Richard Daneman, University of California, San Francisco
 Britta Engelhardt, University of Bern, Switzerland
 Ryan Watts, Genentech, Inc.
This conference focused on molecular mechanisms con-
trolling blood brain barrier (BBB) development and func-
tion. The conference encouraged new conceptual approaches 
and novel methods to our understanding of the neuropro-
tective physiologies of BBB structures, pairing  genetics of 
model organisms and associated biological methods with 
recent insights into vertebrate BBB physiology and develop-
ment. The conference fostered cross- disciplinary exchange 
of ideas and expertise between developmental vascular and 
BBB biologists and disease-oriented industry scientists in-
terested in targeting drugs across the BBB. The keynote ad-
dress was given by N. Joan Abbott on the evolution of the 
BBB. Topics addressed by the conference are listed below 
in the Program. As is traditional at Cold Spring Harbor 
meetings, selection of material for oral and poster presentation was made by the organizers and 
individual session chairs on the basis of scientifi c merit.
R. Daneman, B. Engelhardt, R. Watts
S. Wang, C. Chen
PROGRAM
Molecular Control of BBB Development and Function
Chairpersons: S. Liebner, Goethe University Clinic, Frankfurt 
am Main, Germany; A. Prat, CHUM-Université de 
Montréal, Canada
Cellular and Acellular Elements
Chairpersons: C. Betsholtz, Karolinska Institute, Stockholm, 
Sweden; L. Sorokin, University of Münster, Germany
Model Organisms
Chairpersons: B. Anand-Apte, Cleveland Clinic Lerner 
College of Medicine, Ohio; R. Bainton, University of 
California, San Francisco
Retinal Vasculature and Other Tissue Barriers
Chairpersons: C.Y. Cheng, The Rockefeller University, 
Population Council, New York; H. Gerhardt, London 
Research Institute-Cancer Research, United Kingdom
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BBB in Infl ammation and Disease
Chairpersons: E. Tournier-Lasserve, Université Paris 
Diderot - Paris 7, France; E. de Vries, MS Center, 
Amsterdam, The Netherlands
Keynote Address: Evolution of the Blood Brain Barrier and 
Neurovascular Unit
N.J. Abbott, King’s College London, United Kingdom
Crossing the BBB
Chairpersons: M. Bynoe, Cornell University Veterinary 
Medical College, Ithaca, New York; M. Wood, University of 
Oxford, United Kingdom
U. Frevert D. Wilhelms C. Klämbt
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the 
special need for training in interdisciplinary subjects that are either so new or so specialized that 
universities do not adequately teach them. Our aim is to provide intensive study in the most re-
cent developments and techniques in these subjects and to prepare students to enter directly into 
research in a particular area. To ensure up-to-date coverage of current research work, we bring 
together course faculty from many laboratories around the world and supplement this staff with a 
series of seminar speakers.
Cold Spring Harbor Laboratory Workshop on Leadership 
in Biosciences
February 24–27
INSTRUCTORS C.M. Cohen, Science Management Associates, Newton, Massachusetts
 D. Kennedy, Massachusetts School of Professional Psychology, Newton, Massachusetts
In this highly interactive workshop, participants learned and developed the skills to lead and 
interact effectively with others in both one-on-one and group settings. The workshop focused on 
techniques, situations, and challenges that relate specifi cally to leading and managing in the sci-
entifi c workplace. It emphasized learning by doing and involved role playing, giving and receiving 
feedback, and group problem solving. The workshop’s goal was to help participants identify areas 
where they needed guidance and growth, as well as how to capitalize on areas of strength. Par-
ticipants had the opportunity to share their experiences and challenges with others and to receive 
feedback and guidance from others with experience in leading scientists in a variety of settings. 
Key focus areas of the workshop included recognizing and understanding leadership in a science 
setting; using negotiation as a tool in scientifi c discussions and problem solving; identifying and 
resolving confl icts in the lab; dealing with diffi cult people and situations; communicating ideas 
and plans in a way that engages others; leading effective and productive meetings; and leveraging 
scientifi c skills in the community and in public settings.
This course was supported with funds provided by American Express Philanthropy.
PARTICIPANTS
Azad, N., Ph.D., Hampton University, Hampton, Virginia
Chen, K., Ph.D., Mount Sinai School of Medicine, New York
Cohen, D., Ph.D., HHMI/Harvard University, Cambridge, 
Massachusetts
Dean, H., Ph.D., New York University, New York
Dorer, M., Ph.D., Fred Hutchinson Cancer Research Center, 
Seattle, Washington
Eriksson, C., Ph.D., Uppsala University, Sweden
Fehrenbacher, N., Ph.D., New York University, New York
Ganesan, R., Ph.D., MedImmune, Gaithersburg, Maryland
Goto, D., Ph.D., Hokkaido University, Japan
Gutierrez-Nava, M. de la Luz, Ph.D., DuPont Agricultural 
Biotechnology, Wilmington, Delaware
Iyer, A., Ph.D., Hampton University, Seattle
Lucs, A., Ph.D., Feinstein Institute for Medical Research, 
New York
Lyssenko, N., Ph.D., University of Pennsylvania, 
Philadelphia
299-418_Meetings & Courses.indb   357 9/17/2013   8:20:57 AM
358  Postgraduate Courses
Malone, C., Ph.D., New York University Medical School, 
New York
Mar, J., Ph.D., Albert Einstein College of Medicine, Bronx, 
New York
Miller, J., Ph.D., Mayo Clinic and Foundation, Rochester, 
Minnesota
Mishra, R., Ph.D., University of Illinois, Chicago
Murray, D., Ph.D., Royal College of Surgeons in Ireland, 
Dublin
Nieminen, J., B.S., Laval University, Quebec, Canada
Noriega-Lopez, L., Ph.D., INCMNSZ, Tlalpan, Mexico
Nowak, D., Ph.D., Cold Spring Harbor Laboratory
Ramsook, C., Ph.D., Brooklyn College, New York
Scherrer S., B.S., Feinstein Institute for Medical Research, 
Manhasset, New York
Seeliger, J., Ph.D., Stony Brook University, New York
Seeliger, M., Ph.D., Stony Brook University, New York
Stratford, E., Ph.D., Oslo University Hospital, Norway
Troemel, E., Ph.D., University of California, San Diego
SEMINARS
Barker, K., Author, Seattle, Washington: At the helm.
Miller, K., Brown University, Providence, Rhode Island: 
 Science in the public eye.
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359
Protein Puriﬁ cation and Characterization
April 11–24
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
 A. Courey, University of California, Los Angeles
 S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
 M. Marr, Brandeis University, Waltham, Massachusetts
ASSISTANTS J. Cao, University of California, Los Angeles
 R. Chumanov, University of Wisconsin, Madison
 M. Donovan, Brandeis University, Waltham, Massachusetts
 P. Kuhn, University of Wisconsin, Madison
 P. Kwong, University of California, Los Angeles
 Y.-C. Lee, M.D. Anderson Cancer Center, University of Texas, Houston
 C. Olson, Brandeis University, Waltham, Massachusetts
 K. Pennington, Brandeis University, Waltham, Massachusetts
 A. Ponce, University of California, Los Angeles
 M. Spellberg, Brandeis, Waltham, Massachusetts
 N. Thompson, University of Wisconsin, Madison
This course was for scientists who were not familiar with techniques of protein isolation and char-
acterization. It was a rigorous program that included laboratory work all day and a lecture with a 
discussion session every evening. Each student became familiar with each of the major techniques 
in protein purifi cation by actually performing four separate isolations including (1) a regulatory 
protein from muscle tissue, (2) a sequence-specifi c, DNA-binding protein, (3) a recombinant 
protein overexpressed in Escherichia coli, and (4) a membrane-bound receptor. A variety of bulk 
fractionation, electrophoretic, and chromatographic techniques included precipitation by salts, 
pH, and ionic polymers; ion exchange, gel-fi ltration, hydrophobic interaction, and reverse-phase 
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chromatography; lectin affi nity, ligand affi nity, oligonucleotide affi nity, and immunoaffi nity 
chromatography; polyacrylamide gel electrophoresis, and electroblotting; and high-performance 
liquid chromatography. Procedures were presented for solubilizing proteins from inclusion bodies 
and refolding them into active monomeric forms. Methods of protein characterization included 
immunological and biochemical assays, peptide mapping, amino acid analysis, protein sequenc-
ing, and mass spectrometry. Emphasis was placed on strategies of protein purifi cation and char-
acterization. Guest lecturers discussed protein structure, modifi cation of proteins, methodologies 
for protein purifi cation and characterization, and applications of protein biochemistry to cell and 
molecular biology.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Adeyo, O., B.S., University of California, Los Angeles
Aquirre-Chen, C., Ph.D., Cold Spring Harbor Laboratory
Bergmann, J., Ph.D., Cold Spring Harbor Laboratory
Dzialo, M., B.S., University of California, Los Angeles
Hooper, C., B.A., University of Wisconsin, Madison
Jackson, S., B.S., University of Wisconsin, Madison
Li, W., B.S., Cold Spring Harbor Laboratory
Martinez, L., Ph.D., Long Island University, Brookville, 
New York
Ni, S., Ph.D., Cold Spring Harbor Laboratory
Pai, M., B.A., University of California, Los Angeles
Sabari, B., Ph.D., The Rockefeller University, New York
Schneider, L., B.A., University of Wisconsin, Madison
Shi, J., B.S., Cold Spring Harbor Laboratory
Tsou, Wi.-L., B.Sc., Wayne State University School of 
Medicine, Detroit, Michigan
Wang, A., D.Phil., The Rockefeller University, New York
Woo, J.-R., M.S., University of California, Los Angeles
Yan, D., Ph.D., Harvard Medical School, Boston, 
Massachusetts
SEMINARS
Burgess, R., University of Wisconsin, Madison: Welcome 
and introduction to course; Introduction to protein 
purifi cation; Rapid isolation of weakly binding proteins 
with the IFAST system.
Chumanov, R., University of Wisconsin, Madison: Halo tag 
and purifi cation of kinases in mammalian cells.
Courey, A., University of California, Los Angeles: System-wide 
analyses of Groucho and SUMO in Drosophila development.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas: 
Prostate cancer bone metastasis secretome.
Marr, M., Brandeis University, Waltham, Massachusetts: 
Stress-induced changes in gene expression.
Thompson, N., University of Wisconsin, Madison: MAbs 
and immunoaffi nity chromatography.
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Cell and Developmental Biology of Xenopus
April 13–24
INSTRUCTORS A. Sater, University of Houston, Texas
 G. Thomsen, Stony Brook University, New York
ASSISTANTS B. Dzamba, University of Virginia, Charlottesville
 T. Nakayama, University of Virginia, Charlottesville
 K. Pfi ster, University of Virginia, Charlottesville
Xenopus is the leading vertebrate model for the analysis of gene function in development. The 
combination of lineage analysis, gene-knockout strategies, experimental manipulation of the 
embryo, and genomic/bioinformatic techniques makes it ideal for studies on the molecular 
control of embryo patterning, morphogenesis, and organogenesis. Moreover, recent advances in 
Xenopus genomics offer new opportunities to integrate computational strategies with experi-
mental approaches. The course combined intensive laboratory training with daily lectures from 
recognized experts in the fi eld. Students learned both emerging technologies and classical tech-
niques to study gene function in Xenopus development. An important element was the informal 
interaction between students and course faculty.
Technologies covered included oocyte and embryo culture, lineage analysis and experimen-
tal manipulation of embryos, time-lapse imaging of morphogenesis, gain- and loss-of-function 
analyses using mRNAs and antisense oligonucleotides, whole-mount in situ hybridization, im-
munocytochemistry, genomics and bioinformatics, chromatin immunoprecipitation, preparation 
of transgenic embryos, and use of Xenopus tropicalis for genetic analyses. This course was designed 
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for those new to the Xenopus fi eld, as well as for those wanting a refresher course and/or exposure 
to the emerging technologies. The course was open to investigators from all countries.
This course was supported with funds provided by the National Institute of Child Health 
and Human Development, the National Science Foundation, and the Howard Hughes Medical 
Institute.
PARTICIPANTS
Bouissou, C., Ph.D., MRC National Institute for Medical 
Research, London, United Kingdom
Ciarleglio, C., Ph.D., Brown University, Providence, Rhode 
Island
Diaz, B., B.Pharm., UNAM, Mexico City, Mexico
Fuentealba, J., M.S., Universidad de Concepcion, Chile
Gonzalez, S., Ph.D., University College London, United 
Kingdom
Kuo, H.-C., M.S., University of Alaska, Anchorage
Lee, M., B.S., University of Texas/M.D. Anderson Cancer 
Center, Houston, Texas
Lobikin, M., B.SE., Tufts University, Medford, Massachusetts
Louza, M., M.S., Cincinnati Children’s Hospital, Ohio
Oomen-Hajagos, J., B.S., Stony Brook University, New York
Ota, Y., Ph.D., University of Maryland, Baltimore
Rosinbum, S., Ph.D., Food and Drug Administration, 
Bethesda, Maryland
Schuler, F., B.S., Tufts University, Medford, Massachusetts
Spruce, T., Ph.D., MRC National Institute for Medical 
Research, London, United Kingdom
Xu, M., Ph.D., University of Miami, Florida
Yang, Y., B.S., University of Michigan, Ann Arbor
SEMINARS
Blythe, S., University of Princeton, New Jersey: Chromatin 
immunoprecipitation in Xenopus laevis.
El-Hodiri, H., Ohio State University, Columbus: The retinal 
homeobox (Rx) gene plays essential roles in the normal and 
regenerating retina.
Gilchrist, M., National Institute for Medical Research, 
London, United Kingdom: Xenopus: Genomes, genomics, 
and computational biology.
Keller, R., University of Virginia, Charlottesville: 
Gastrulation and morphogenesis.
Khokha, M., Yale University School of Medicine, New 
Haven, Connecticut: Analysis of congenital heart disease 
genes in Xenopus.
Klein, P., HHMI/University of Pennsylvania, Philadelphia: 
Signaling and pattern before the MBT.
Nakayama, T., University of Virginia, Charlottesville: 
Approaches for manipulating gene expression in Xenopus.
Robert, G., University of Virginia, Charlottesville: Analysis 
of eye formation in Xenopus: Model system for studies of 
determination, induction, and organogenesis.
Sater, A., University of Houston, Texas: Xenopus as a 
model system: History and prospects; Adventures in 
Ago-RNP isolation from Xenopus embryos.
Slack, J., University of Minnesota, Minneapolis: 
Stimulation of Xenopus limb regeneration by cell 
transplants; Regeneration of the Xenopus tadpole tail.
Thomsen, G., Stony Brook University, New York: The 
Xenopus organizer.
Wallingford, J., University of Texas, Austin: The awesome 
power of live imaging in Xenopus.
Zimmerman, L., MRC National Institute for Medical 
Research, London, United Kingdom: Genetic tools 
in Xenopus.
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Workshop on Schizophrenia and Related Disorders
June 6–12
INSTRUCTORS J. Hall, University of Edinburgh, United Kingdom
 A. Law, National Institute of Mental Health/NIH, Bethesda, Maryland
 A. Malhotra, The Zucker Hillside Hospital, Glen Oaks, New Jersey [Au: check City/state]
ASSISTANT K. Olive, Columbia University, New York
This workshop provided students with the most current understanding of the molecular, cellular, 
and neural systems underlying the disturbances in brain function in these devastating illnesses. 
During the 7-day workshop, students learned about the clinical aspects of schizophrenia, schizoaf-
fective disorder, and bipolar disorder, and also explored in detail the genetic and neurobiological 
underpinnings of these complex psychiatric disorders. The Workshop included sessions focused 
on The Clinical Syndrome, Basic Neurobiology, Cognitive Neuroscience, Neuroimaging, Genet-
ics and Genomics, Endophenotypes, and Gene Expression and Gene Modulation. In addition to 
hearing about the most recent research in these areas, controversial topics and challenges to basic 
assumptions in the fi eld were explored and discussed. A diverse faculty brought the most up-to-
date results and theories to the students, making this workshop a valuable resource for young 
researchers starting out in this fast-moving and expansive fi eld. Not only did it help them build 
the foundation for their future research, it also introduced them to many potential collaborators 
working to understand schizophrenia and similar disorders from different perspectives. Although 
these 7 days featured intense lecture sessions throughout, students also had free time for reading, 
informal discussions, and recreation on the beautiful campus of the Banbury Center, which in-
cludes a beach, a pool, and a tennis court.
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PARTICIPANTS
Atkin, T., Ph.D., Columbia University, New York
Butt, M., B.S., University of Edinburgh, United Kingdom
Pereira, F.C.R., B.S., Friedrich Miescher Institute, Basel, 
Switzerland
Garvey, M., Ph.D., National Institute of Mental Health/
NIH, Rockville, Maryland
Goonawardena, A., Ph.D., SRI International, Menlo Park, 
California
Guha, S., Ph.D., Zucker Hillside Hospital, Glen Oaks, 
New York
Heremes, G., B.S., Yale University, New Haven, Connecticut
Keane, B., B.S., Robert Wood Johnson Medical School, 
Piscataway, New Jersey
Manley, W., B.S., Rutgers University, Piscataway, New Jersey
McCollum, L., B.S., University of Alabama, Birmingham
Miller, B., Ph.D., The Scripps Research Institute, Florida
Mukherjee, S., B.S., Zucker Hillside Hospital, Glen Oaks, 
New York
Paterson, C., B.S., National Institutes of Health, Bethesda, 
Maryland
Perez, S., B.S., University of Texas, San Antonio
Peters, B., Ph.D., Hillside Hospital, Glen Oaks, New York
Pouget, J., B.S., University of Toronto, Ontario, Canada
Rodrigue, A., B.S., University of Georgia, Athens
Salum, C., Ph.D., Federal University of ABC, Santo Andre, 
Brazil
Sauer, A., B.S., Max-Planck Institute of Brain Research, 
Frankfurt, Germany
Sprooten, E., B.S., University of Edinburgh, United 
Kingdom
Thomases, D., B.S., Rosalind Franklin University, Chicago, 
Illinois
Vieker, H., Ph.D., University Hospital, Goettingen, 
Germany
Wilkins, H., B.S., Washington University, St. Louis, 
Missouri
Zamberletti, E., B.S., University of Insurbia, Busto Arsizio, 
Italy
SEMINARS
Abi-Dargham, A., Columbia University, New York: PET 
imaging in schizophrenia.
Anderson, S., Weill Cornell Medical College, New York: 
GABA systems in schizophrenia.
Brennand, K., University of California, San Diego: 
Neurogenesis and iPS in schizophrenia.
Cornblatt, B., Zucker Hillside Hospital, Glen Oaks, New 
York: Cognitive and psychosocial risk factors.
Fletcher, P., University of Cambridge, United Kingdom: A 
cognitive neuroscientifi c model of the positive symptoms 
of schizophrenia.
Glahn, D., Yale University, New Haven, Connecticut: 
Cognition of schizophrenia.
Grace, A., University of Pittsburgh, Pennsylvania: The 
dopaminergic system.
Hall, J., University of Edinburgh, United Kingdom: 
Introduction of meeting and participants; Functional 
MR in schizophrenia.
Jones, J., University of Cambridge, United Kingdom: 
Epidemiology and environmental risk factors.
Kane, J., Zucker Hillside Hospital, Glen Oaks, New York: 
Treatment strategies.
Kleinman, J., National Institute of Mental Health/NIH, 
Bethesda, Maryland: Postmortem gene expression in 
neurodevelopment.
Law, A., National Institute of Mental Health/NIH, 
Bethesda, Maryland: Genetics of neurodevelopment, gene 
regulation, and risk for schizophrenia. Lessons from the 
NRG/ErbB4-PI3 K/AKT pathway.
Lencz, T., Zucker Hillside Hospital, Glen Oaks, New York: 
Rare variants/CNVs and sequencing in schizophrenia. 
Malhotra, A., Zucker Hillside Hospital, Glen Oaks, New 
York: Pharmacogenomics in schizophrenia.
Malhotra, A., Zucker Hillside Hospital, Glen Oaks, New 
York; Law, A., National Institute of Mental Health/NIH, 
Bethesda, Maryland
McIntosh, A., University of Edinburgh, United Kingdom: 
Structural imaging in schizophrenia.
Moghaddam, B., University of Pittsburgh, Pennsylvania: 
The glutamatergic system.
Murray, R., Kings College, London, United Kingdom: 
The clinical syndrome.
Petronis, A., University of Toronto, Canada: Epigenetic 
approaches to mental illness.
Purcell, S., Mount Sinai School of Medicine, New York: 
Candidate gene and whole-genome approaches to 
schizophrenia.
Thomson, P., University of Edinburgh, United Kingdom: 
Introduction to schizophrenia genetics and the DISC1 
example.
Weinberger, D., National Institute of Mental Health/
NIH, Bethesda, Maryland: Intermediate phenotypes and 
schizophrenia-associated genes.
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Single-Cell Analysis
June 6–19
INSTRUCTORS J. Eberwine, University of Pennsylvania Perelman School of Medicine, Philadelphia
 C. McMurray, University of California, Berkeley/Lawrence Berkeley Laboratory
ASSISTANTS P. Buckley, University of Pennsylvania Medical School, Philadelphia
 C. Canaria, Lawrence Berkeley National Laboratory, California
 D.-Y. Lee, Lawrence Berkeley National Laboratory, California
 J. Morris, University of Pennsylvania School of Medicine, Philadelphia
The goal of this new 2-week course was to familiarize students with the most recent cutting-edge 
technologies for characterization of cells. Important in this process was highlighting the advantages 
to analysis of single cells in isolation and in their natural microenvironment. Sections of the course 
were taught by scientists who are experts in particular areas of single-cell analysis. Topics covered 
included quantitative single-cell analysis by RNA-Seq, genomic DNA analysis, epigenetics, RNA 
localization analysis, proteomics, protein translation, and metabolomics. The techniques included 
real-time live-cell quantifi cation where appropriate. In addition, multiple techniques to isolate 
specifi c cell populations and individual cells were taught. The course included the use of model 
systems such as Caenorhabditis elegans, Drosophila, and mouse.
PARTICIPANTS
Daniele, T., M.S., IGBMC, France
Engelstoft, M., M.S., Copenhagen University, Denmark
Erdel, F., Dipl., BioQuant/DKFZ Heidelberg, Germany
Fedorenko, I., B.S., University of South Florida, Tampa
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Frank, A.-K., M.Sc., University of Copenhagen, Denmark
Glenn, H., Ph.D., Arizona State University, Tempe
Hughes, A., B.S., University of California, Berkeley
Kim, H., Ph.D., New York University, New York
Li, Q., M.S., Karolinska Institutet, Sweden
Park, J., B.S., Cold Spring Harbor Laboratory
Pfi sterer, U., M.S., Lund University, Lund, Sweden
Prudhomme, J., B.Sc., Institut Pasteur, France
Reed, J., Ph.D., University of California, Los Angeles
Shruti, S., Ph.D., Brandeis University, Boston, Massachusetts
van Wolfswinkel, J., M.S., Whitehead Institute/
Massachusetts Institute of Technology, Cambridge
Varma, S., Ph.D., Children’s Hospital, Los Angeles, 
California
Wood, L., Ph.D., Johns Hopkins University School of 
Medicine, Baltimore, Maryland
SEMINARS
Brenner, D., Columbia University, New York: Irradiating 
and monitoring single cells and their neighbors, in vitro 
and in vivo.
Eberwine, J., University of Pennsylvania, Philadelphia: 
Functional consequences of single-cell transcriptome 
variability.
Gratton, E., University of California, Irvine: Cellular 
dynamics using phosphor and FLIM imaging.
Hicks, J., Cold Spring Harbor Laboratory: Single-cell 
methods in cancer.
Lao, K., Life Technologies, Foster, California: Development 
and applications of single-cell RNA-Seq analysis.
Larabell, C., University of California, Berkeley: Single-cell 
CT scans at 50-nm resolution.
Lippincott-Schwartz, J., National Institutes of Health, 
Bethesda, Maryland: Nanoscopic imaging with 
photoactivatable fl uorescent proteins: Windows into 
molecular organization and dynamics within cells.
McMurray, C., University of California, Berkeley: The basis 
for region-specifi c neuronal death in Huntington’s disease.
Petronis, A., Krembil Family Epigenetics Laboratory, 
Toronto, Canada: Epigenomics of complex disease.
Sweedler, J., University of Illinois, Urbana: Using mass 
spectrometry to measure the brain’s chemistry a cell at a time.
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Advanced Bacterial Genetics
June 6–26
INSTRUCTORS D. Hughes, Uppsala University, Sweden
 B. Lazazzera, University of California, Los Angeles
 F. Yildiz, University of California, Santa Cruz
ASSISTANTS J. Bergman, Uppsala Biomedical Center, Sweden
 A. Cheng, University of California, Santa Cruz
 S. Hoover, University of California, Los Angeles
This course presented logic and methods used in the genetic dissection of complex biological pro-
cesses in diverse bacteria. Laboratory methods included classical mutagenesis using transposons, 
mutator strains, and chemical mutagens; recombineering with single- and double-stranded DNA; 
detection of gene expression changes using various reporter genes; the mapping of mutations using 
genetic and physical techniques; modern approaches to the generation and analysis of targeted 
gene disruptions and fusions using PCR and cloning methods; epitope insertion mutagenesis; site-
directed mutagenesis; and fl uorescence microscopy. Key components of the course were the use 
of sophisticated genetic methods in the analysis of model bacteria (including Escherichia coli, Sal-
monella, Bacillus subtilis, and Vibrio cholerae) and the use of the wealth of new genomic sequence 
information to motivate these methods. Invited lecturers presented various genetic approaches to 
study bacterial mechanisms of metabolism, development, and pathogenesis.
The course admits 16 students, both foreign and United States residents, from diverse back-
grounds and career levels for intensive (but fun) instruction in microbial genetics.
This course was supported with funds provided by the National Science Foundation.
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PARTICIPANTS
Adler, M., M.S., Uppsala University, Sweden
Akabayov, B., Ph.D., Harvard Medical School, Cambridge, 
Massachusetts
Banning, E., Ph.D., Marine Biological Laboratory, 
Woods Hole, Massachusetts
Boyle, K., B.S., Weill Cornell Medical College, New York
Chevereau, G., Ph.D., Institute of Science and Technology, 
Klosterneuberg, Austria
Colavin, A., B.S., Stanford University, California
Croney, C., B.S., University of Alabama, Birmingham
Kath, J., B.A., Harvard Medical School, Cambridge, 
Massachusetts
Levinson, K., B.S., Wadsworth Center/University at Albany, 
Ohio
Shkundina, I., Ph.D., Institute of Molecular Genetics, 
Prague, Czech Republic
Snitkin, E., Ph.D., National Human Genome Research 
Institute, Bethesda, Maryland
Steinrueck, M., B.S., Institute of Science and Technology, 
Austria
Taheri-Araghi, S., B.Sc., Harvard University, Cambridge, 
Massachusetts
Vtyurina, N., M.S., Delft University of Technology, 
the Netherlands
Wang, N.,, B.A., Northwestern University, Chicago, 
Illinois
Wu, Y., Ph.D., Harvard University, Cambridge, 
Massachusetts
SEMINARS
Britton, R., Michigan State University, East Lansing: 
Recombineering in gram-positive bacteria.
Hughes, K., University of Utah, Salt Lake City: The 
biogenesis of the bacterial fl agellum and coupled gene 
regulatory mechanisms; A genetic approach to measure the 
speed of ribosome translation through specifi c codon pairs.
Ibba, M., Ohio State University, Columbus: Adaptation of the 
translation quality control machinery to amino acid stress.
Klose, K., University of Texas Health Science Center, 
San Antonio: Genetic techniques in Vibrio cholera and 
Francisella tularensis.
Roth, J., University of California, Davis: Selection 
and mutation in genetic analysis (the tyranny of the 
obvious).
Ruiz, N., Ohio State University, Columbus: Envelope 
biogenesis in E. coli.
Salama, N., University of Washington, Seattle: Next-
generation mutant hunts in Helicobacter pylori.
Sawitzske, J., National Institutes of Health, Frederick, 
Maryland: An update on recombineering mechanisms.
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Ion Channels and Synaptic Transmission
June 6–26
INSTRUCTORS S. Brenowitz, NIDCD/National Institutes of Health, Bethesda, Maryland
 I. Duguid, University of Edinburgh, United Kingdom
 P. Kammermeier, University of Rochester Medical Center, Rochester, New York
ASSISTANTS C. Bladen, University of Calgary, Alberta, Canada
 A. Graves, Northwestern University, Evanston, Illinois
 V. Lu, NIH/NIAAA/LMP, Rockville, Maryland
 J. Lueck, University of Iowa Carver College of Medicine, Iowa City, Iowa
 M. Rigby, University College London, United Kingdom
 Z. Rosen, Columbia University, New York 
 V. Stempel, Charite Berlin, Germany
The primary goal of this course was to investigate, through lectures and laboratory work, the 
properties of ion channels that allow neurons to carry out their unique physiological functions in 
a variety of neural systems. Areas of particular interest included channels that (1) are activated by 
neurotransmitter at central and peripheral synapses, (2) are activated by voltage changes in axons 
and dendrites, (3) respond to neuromodulators with changes in functional properties, (4) are de-
velopmentally required and regulated, or (5) are light gated and engineered to express in specifi c 
neural subtypes. The research interests of guest lecturers refl ected these areas of emphasis.
The laboratory component of the course introduced students to state-of-the-art electrophysi-
ological approaches for the study of ion channels in their native environments. Hands-on exercises 
included patch-clamp recording of ion channel activity in acutely isolated or cultured cells or 
neurons in brain slice preparations. Different recording confi gurations were used (e.g., whole-cell, 
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cell-attached, and dendritic patches and use of voltage- and current-clamp confi gurations) to ex-
amine macroscopic or single-channel activity. Similarly, various methods of ligand and drug ap-
plication were demonstrated. The advantages and disadvantages of each method, preparation, and 
recording technique were considered in relation to the specifi c scientifi c questions being asked. 
Admissions priority was given to students and postdocs with a demonstrated interest, specifi c 
plans, and a supportive environment to apply these techniques to a defi ned problem.
This course was supported by the Howard Hughes Medical Institute.
PARTICIPANTS
Ball, J., Ph.D., National Institutes of Health, Bethesda, 
Maryland
Griffi th, T., B.A., Northwestern University, Boston, 
Massachusetts 
Herold, C., M.S., University of California, Berkeley
Hyser, J., Ph.D., Baylor College of Medicine, Houston, Texas 
Kougioumtzidou, E., MSc., University College London, 
United Kingdom
Kuchibhotla, K., Ph.D., Harvard Medical School, Boston, 
Massachusetts
Meikle, L, Ph.D., University of Edinburgh, 
United Kingdom
Ng, D, Ph.D., Columbia University, New York
Penrod-Martin, R, B.S., University of Minnesota, 
Twin Cities
Ruka, K, B.S., University of Michigan, Ann Arbor
Rutlin, M, Ph.D., Brandeis University, Boston, 
Massachusetts
Vlasits, A, B.A., University of California, Berkeley
SEMINARS
Brenowitz, S., NIDCD/National Institutes of Health, 
Bethesda, Maryland: V-clamp-Rs/Analysis.
Farrant, M., University College London, United Kingdom: 
Synapses/GABA/IPSCs.
Freidman, M., State University of Buffalo, New York: 
Synapses, EPSCs. 
Hausser, M., University College London, United Kingdom: 
Synaptic integration.
Ikeda, S., National Institute on Alcohol Abuse and 
Alcoholism, Bethesda, Maryland: Modulation; RGK 
Proteins and Calcium Channel Function.
Kaczmarek, L., Yale University School of Medicine, 
New Haven, Connecticut.
Kammermeier, P., University of Rochester Medical Center, 
New York; Duguid, I., University of Edinburgh, United 
Kingdom: Introduction/Resting potential.
Khaliq, Z., National Institutes of Health, Bethesda, 
Maryland: Voltage-gated sodium channels; Spontaneous 
and high-frequency fi ring in central neurons.
Martens, J., University of Michigan, Ann Arbor: Voltage-
gated channels.
Miller, C., Brandeis University, Waltham, Massachusetts: 
Chloride channels: What are they good for, anyway?; 
The CLC family of chloride transporters and channels: 
Weird and weirder.
Nolan, M., University of Edinburgh, United Kingdom: 
HCN channel structure, physiology, and function; Circuit 
mechanisms for oscillations and representation of space in 
the medial entorhinal cortex.
Plested, A., Leibnitz Institute for Molecular Pharmacology, 
Germany: Glutamate receptors.
Shuttleworth, T., University of Rochester, New York: Store-
operated calcium entry: Stim/oral channels.
Sjöstrom, J., Montreal General Hospital, Canada: Synaptic 
Plasticity and LTP.
Stanley, E., Toronto Western Research Institute, Canada: 
Ca channels.
Strowbridge, B., Case Western Reserve University, Cleveland, 
Ohio: Intrinsic plasticity, microcircuits. 
Zador, A., Cold Spring Harbor Laboratory: In vivo 
electrophysiology.
Zhang, F., Massachusetts Institute of Technology, 
Cambridge, Massachusetts: Channel engineering.
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Molecular Embryology of the Mouse
June 6–26
INSTRUCTORS K. Hadjantonakis, Memorial Sloan-Kettering Cancer Institute, New York
 J. Rivera-Perez, University of Massachusetts Medical School, Worcester
CO-INSTRUCTORS R. Johnson, M.D. Anderson Cancer Center, Houston, Texas
 X. Sun, University of Wisconsin, Madison
ASSOCIATE 
CO-INSTRUCTOR D. Escalante-Alcalde, Institute of Cellular Physiology-UNAM, Mexico
ASSISTANTS Y. Furuta, M.D. Anderson Cancer Center, Houston, Texas
 E. Hines, University of Wisconsin, Madison
 M. Kang, Memorial Sloan-Kettering Cancer Institute, New York
 J. Mager, University of Massachusetts, Amherst
 S. Nowotschin, Memorial Sloan-Kettering Cancer Institute, New York
This intensive laboratory and lecture course was designed for biologists interested in using mouse 
models to study mammalian development, stem cells, and cancer. Lectures provided the con-
ceptual basis for contemporary research in embryogenesis, organogenesis, embryonic, adult, 
and induced pluripotent stem cells, and cancer biology. Laboratory practicals provided extensive 
hands-on introduction to engineering of mouse models, phenotyping, and stem cell technologies. 
Experimental techniques included isolation, in vitro culture and manipulation of pre- and post-
implantation embryos, embryo transfer, genetic manipulation of embryonic stem cells, produc-
tion of chimeras by embryo aggregation and by embryonic stem cell injection, and transgenesis 
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by pronuclear microinjection. The course also introduced the generation and differentiation of 
embryonic stem cells as well as induced pluripotent stem cells, isolation of mouse embryonic fi bro-
blasts, focus formation assay, teratoma formation assay, time-lapse microscopy of early embryos, 
and organ cultures. In addition, this year’s practicals featured increased emphasis on phenotypic 
analysis of mutants, including vibratome and cryosectioning, in situ hybridization, immunostain-
ing, skeletal preparation, tissue recombination, and confocal and ultrasound imaging.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Benitez Hernandez, J., Ph.D., Ludwig Institute for Cancer 
Research, La Jolla, California
Fetting, J., Ph.D., Maine Medical Center Research Institute, 
Scarborough
Grindheim, J., B.S., University of Pennsylvania, 
Philadelphia
Hansen, M., B.S., Hagedorn Research Institute, Gentofte, 
Denmark
Laugesen, A., M.Sc., University of Copenhagen, Denmark
Lay, K.W.J., B.Sc., The Rockefeller University, New York
Ohlstein, B., Ph.D., Columbia University Medical Center, 
New York
Olsen, R., Ph.D., St. Jude Children’s Research Hospital, 
Memphis, Tennessee
Savov, V., M.Sc., Uppsala University, Sweden
Siegrist, S., Ph.D., University of California, Berkeley
Tiklova, K., Ph.D., Ludwig Institute for Cancer Research, 
Stockholm, Sweden
Vardam, T., Ph.D., Roswell Park Cancer Institute, Buffalo, 
New York
Zhong, X., Ph.D., The Johns Hopkins University, Baltimore, 
Maryland
Zhou, W., M.S., University of Texas/M.D. Anderson Cancer 
Center, Houston
SEMINARS
Capel, B., Duke University Medical Center, Durham, North 
Carolina: Germ cells and gonadal development.
Duncan, S., Medical College of Wisconsin, Milwaukee: iPS 
cells and applications.
Egeblad, M., Cold Spring Harbor Laboratory: Live imaging 
in mouse models of cancer.
Flores, E., University of Texas/MD Anderson Cancer Center, 
Houston: DNA repair, mouse models, and cancer.
Hadjantonakis, K., Memorial Sloan-Kettering Cancer 
Center, New York: Mouse embryo imaging: Confocal 
approaches.
Johnson, R., M.D. Anderson Cancer Center, Houston, Texas: 
Liver development and hippo signaling.
Li, J., University of Connecticut Health Center, Farmington: 
Brain development.
Lovell-Badge, R., MRC National Institute for Medicine, 
London, United Kingdom: Sex determination.
Mager, J., University of Massachusetts, Amherst: Epigenetics.
Martin, J., Baylor College Medicine, Houston, Texas: Heart 
development.
Mills, A., Cold Spring Harbor Laboratory: Chromosome 
engineering and cancer.
Pevny, L, University of North Carolina, Chapel Hill: 
Retinogenesis and eye development.
Rivera, J., University of Massachusetts Medical School, 
Worcester: Early postimplantation development: 
Morphogenesis and cell lineage.
Shen, M., Columbia University Medical Center, New York: 
Prostate development, stem cells, and cancer.
Solter, D., Institute of Medical Biology, Singapore: 
Preimplantation development.
Soriano, P., Mount Sinai School of Medicine, New York: 
Gene targeting, gene traps, and recombinases; Pdgf and 
Eph signaling.
Sun, X., University of Wisconsin, Madison: Lung 
development.
Tam, P., Children’s Medical Research Institute, Australia: 
Gastrulation and establishment of the germ layers; Neural 
induction and patterning.
Threadgill, D., North Carolina State University, Raleigh: 
Historical overview of the mouse as a model system; 
Quantitative genetic traits and genomics.
Trainor, P, Stowers Institute for Medical Research, Kansas 
City, Missouri: Craniofacial development and the 
neural crest.
Wellik, D., University of Michigan Medical Center, Ann 
Arbor: Kidney development; Hox genes, development, 
and cancer.
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Workshop on Cognitive Aging
June 13–17
INSTRUCTORS A. Gazzaley, University of California, San Francisco
 S. Small, Columbia University, New York
ASSISTANT U. Khan, Columbia University Medical Center, New York
This workshop provided students with the most current understanding of the cognitive aging 
fi eld by bringing together researchers who apply complementary analytical approaches to, and 
offer diverse biological perspectives on, research in neuroscience and aging. Topics included the 
hippocampal formation, the frontal lobe, human neuroimaging techniques, animal models, the 
molecular cell biology of cognitive aging, emerging interventions and therapies, and the bioethics 
of cognitive enhancement.
This workshop was generously supported with funds provided by the Ellison Medical Founda-
tion, the McKnight Brain Research Foundation®, and the Alzheimer’s Drug Discovery Foundation.
PARTICIPANTS
Arum, O., Ph.D., Southern Illinois University School of 
Medicine, Springfi eld
Baqri, R., Ph.D., Harvard University, Cambridge, 
Massachusetts
Bender, A., M.A., Wayne State University, Detroit, Michigan
Berman, D., M.S., Columbia University, New York
Browning, P., Ph.D., Mount Sinai School of Medicine, 
New York
Das, D., Ph.D., Australian National University, Canberra 
Faraco, C., M.S., University of Georgia, Athens
Gordon, B., Ph.D., Washington University, St. Louis, 
Missouri
Guerreiro, M., Ph.D., Maastricht University, the 
Netherlands
Harrison, F., B.Sc., Vanderbilt University Medical Center, 
Nashville, Tennessee
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Lo, J., Ph.D., Duke–NUS Graduate Medical School, 
Singapore
Maass, A., M.Sc., OvG University Magdeburg, Magdeburg, 
Germany
Monti, J., M.A., University of Illinois, Urbana Champaign
Puccioni, O., M.S., SISSA–International School for 
Advanced Studies, Italy
Puigdellivol Canadell, M del Mar, M.A., University of 
Barcelona, Spain
Reaves, Z., B.S., Georgia Institute of Technology, Atlanta
Seaman, K., The Catholic University of America, 
Washington, D.C.
Villarreal, A., B.S., INDICASAT-AIP, Panama
Xuan, Z., B.S., Mount Sinai School of Medicine, New York
SEMINARS
Arnsten, A., Yale University, New Haven, Connecticut: 
Molecular mechanism of age-related frontal lobe 
dysfunction.
Barnes, C., University of Arizona, Tucson: The aging 
hippocampal formation in animal models.
Brickman, A., Columbia University, New York: The 
neuroscience of aging.
Buckner, R., Harvard University, Cambridge, Massachusetts: 
Imaging the aging brain.
Buxton, R., University of California, San Diego, La Jolla: 
Controversies in fMRI.
Cabeza, R., Duke University, Durham, North Carolina: 
The cognitive neuroscience of aging.
Gazzaley, A., University of California, San Francisco: The 
functions of the frontal lobe; Imaging the aging frontal 
lobes.
Hen, R., Columbia University, New York: Neurogenesis 
and aging.
Morrison, J., Mount Sinai School of Medicine, New York: 
Keynote lecture.
Rapp, P., National Institute on Aging/NIH, Baltimore, 
Maryland: Controversies in animal models.
Small, S., Columbia University, New York; Stark, C., 
University of California, Irvine: Imaging the aging 
hippocampal formation II; Isolating molecular mechanisms 
of hippocampal dysfunction.
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Computational Neuroscience: Vision
June 20–July 3
INSTRUCTORS G. Boynton, University of Washington, Seattle
 G. Horwitz, University of Washington, Seattle
 S. Treue, German Primate Center, Goettingen, Germany
ASSISTANTS J. Freeman, New York University, New York
 L. Jepson, Salk Institute for Biological Studies, La Jolla, California
TECHNICIAN R. Dotson, New York University, New York
Computational approaches to neuroscience will produce important advances in our understanding 
of neural processing. Prominent success will come in areas where strong inputs from neurobiologi-
cal, behavioral, and computational investigation can interact. The theme of the course was that an 
understanding of the computational problems, the constraints on solutions to these problems, and 
the range of possible solutions can help guide research in neuroscience. Through a combination of 
lectures and hands-on experience with MATLAB-based computer tutorials and projects, this inten-
sive course examined visual information processing from the retina to higher cortical areas, spatial 
pattern analysis, motion analysis, neuronal coding, and decoding, attention, and decision making.
PARTICIPANTS
Azevedo, F.A., B.S., Max-Planck Institute for Biological 
Cybernetics, Tuebingen, Germany
Benson, N., Ph.D., University of Pennsylvania, Philadelphia
Cutrone, E., B.S., New York University, New York
Glasser, D., B.S., University of Rochester, New York
Goddard, E., Ph.D., The University of Sydney, Australia
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Isola, P., B.S., Massachusetts Institute of Technology, 
Cambridge
Kohler, P., B.S., Dartmouth College, Hanover, New 
Hampshire
Meister, M., B.S., University of Texas, Austin
Mineault, P., B.S., McGill University, Montreal, Canada
Oleskiw, T., B.S., University of Washington, Seattle
Pagan, M., B.S., University of Pennsylvania, Philadelphia
Popovic, M., B.S., Brandeis University, Waltham, 
Massachusetts
Purcell, B., B.S., Vanderbilt University, Nashville, Tennessee
Radonjic, A., Ph.D., University of Pennsylvania, Philadelphia
Schwedhelm, P., B.S., German Primate Center, Goettingen, 
Germany
So, N., B.S., University of Washington, Seattle
Sprague, T., B.S., University of California, San Diego, 
La Jolla
Urgen, B., B.S., University of California, San Diego, La Jolla
Ziemba, C., B.S., New York University, New York
Zuiderbaan, W., B.S., Utrecht University, Utrecht, the 
Netherlands
SEMINARS
Boynton, G., University of Washington, Seattle: fMRI 
in the LGN and V1; Psychophysics and signal detection 
theory.
Boynton, G. and Horwitz, G., University of Washington, 
Seattle; Treue, S., German Primate Center: Welcome.
Brainard, D., University of Pennsylvania, Philadelphia: Color 
vision.
Carandini, M., University College London, United 
Kingdom: V1.
Carrasco, M., New York University, New York: Psychophysics 
of attention.
Chichilnisky, E.J., The Salk Institute, La Jolla, California: 
Retina.
Cohen, M., Harvard Medical School, Boston, Massachusetts: 
Attention and population coding.
DeAngelis, G., University of Rochester, New York: MT: 
Motion and depth.
Fine, I., University of Washington, Seattle: Retinal 
prosthesis.
Geisler, W., University of Texas, Austin: Filter estimation 
from perceptual data.
Heeger, D., New York University, New York: Contrast 
normalization.
Horwitz, G., University of Washington, Seattle: White noise 
analysis.
Kohn, A., Albert Einstein College of Medicine, Bronx, 
New York: Population coding: Dorsal stream.
Kriegeskorte, N., Medical Research Council, Cambridge, 
United Kingdom: fMRI of higher-level vision.
Maunsell, J., Harvard Medical School, Boston, 
Massachusetts: Physiology of attention II: Normalization, 
correlation, and oscillation.
Moore, T., Stanford University, California: Frontal infl uences 
on sensory information processing.
Movshon, A., New York University, New York: What vision 
(and the course) is all about.
Rust, N., University of Pennsylvania, Philadelphia: 
Population coding: Ventral stream.
Shadlen, M., University of Washington, Seattle: Decision 
making.
Simoncelli, E., New York University, New York: Linear 
systems.
Simoncelli, E., New York University, New York: Optimal 
encoding and decoding.
Treue, S., German Primate Center, Goettingen, Germany: 
Physiology of attention I: Single cells.
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Statistical Analysis of Genome Scale Data
June 22–July 3
INSTRUCTORS N. Altman, Penn State University, University Park
 H. Bussemaker, Columbia University, New York
 O. Elemento, Weill Cornell Medical College, New York
 S. Horvath, University of California, Los Angeles
 M. Reimers, VCU School of Medicine, Richmond, Virginia
ASSISTANTS M. Behnke, VCU School of Medicine, Richmond, Virginia
 R. Braun, Northwestern University, Chicago, Illinois
 E. Giannopoulou, Weill Cornell Medical College, New York
 P. Gomez-Alcala, Columbia University, New York
 A. Lazarovici, Columbia University, New York
 P. Manser, VCU School of Medicine, Richmond, Virginia
 T. Riley, Columbia University, New York
 A. Wolen, VCU School of Medicine, Richmond, Virginia
High-throughput genomics assays have become pervasive in modern biological research. To prop-
erly interpret these data, experimental and computational biologists need to have a fi rm grasp of 
statistical methodology. This course was designed to build competence in quantitative methods 
for the analysis of high-throughput molecular biology data. Detailed lectures and presentations by 
guest speakers in the morning and evening were combined with hands-on computer tutorials in 
the afternoon. The methods covered in the lectures were applied to public high-throughput data 
sets, primarily human, and mouse and yeast data. Students were expected to have a basic familiar-
ity with the R programming language at the start of the course.
The following topics were covered: review of R and introduction to the Bioconductor; re-
view of statistical methods for genomics; microarray technologies; high-throughput sequencing 
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technologies; basic analysis (quality control, normalization); analysis using predefi ned gene sets; 
cis-regulatory sequence analysis; modeling of transcriptional networks; DNA methylation assays 
and DNase I footprinting; expression profi ling by RNA-Seq; analysis of ChIP-chip and ChIP-Seq 
data; integration of multiple data types; and expression QTL analysis.
This course was supported with funds provided by the National Institute of General Medical 
Sciences.
PARTICIPANTS
Akagi, K., Ph.D., Ohio State University, Columbus
Alshafai, K., M.Sc., Qatar Foundation, Doha
Bowman, R., B.A., Memorial Sloan-Kettering Cancer 
Center, New York
Garrett-Bakelman, F., Ph.D., Weill Cornell Medical College, 
New York
Gibney, P., Ph.D., Princeton University, New Jersey
Golenberg, E., Ph.D., Wayne State University, Detroit, 
Michigan
Kantor, D., Ph.D., Children’s Hospital Boston, 
Massachusetts
Kruczyk, M., M.Sc., Uppsala University, Sweden
Krug, L., Ph.D., Stony Brook University, New York
Liscovitch, N., B.Sc., Bar IIan University, Ramat Gan, Israel
Liu, Y., Ph.D., Lovelace Respiratory Research Institute, 
Albuquerque, New Mexico
Miranda, T., Ph.D., National Institutes of Health, Bethesda, 
Maryland
Mukamel, E., Ph.D., University of California, San Diego, 
La Jolla
Nair, S., Ph.D., University of Texas, Brownsville
Nikulova, A., M.S., Lomonosov Moscow State University, 
Russia
Pai, S., Ph.D., Centre for Addiction and Mental Health, 
Toronto, Canada
Qin, J., Ph.D., Duke University, Durham, North Carolina
Rotenberg, D., Ph.D., Kansas State University, Manhattan, 
Kansas
Schetter, A., Ph.D., Center for Cancer Research, NCI, 
Bethesda, Maryland
Shepherd, J., B.S., Baylor College of Medicine, Houston, 
Texas
Singh, N., B.A., Massachusetts General Hospital, 
Charlestown
Sun, X., Ph.D., Columbia University, New York
Vaka, D., M.S., Stanford University, California
Yang, W., Ph.D., Johns Hopkins University School of 
Medicine, Baltimore, Maryland
SEMINARS
Elemento, O., Weill Cornell Medical College, New York: 
Modeling the impact of transcription factor binding, 
chromatin marks, and DNA looping on gene expression.
Futcher, B., Stony Brook University, New York: Lessons 
learned from a successful microarray experiment.
Hughes, T., University of Toronto, Canada: Exploring the 
sequence specifi city of eukaryotic DNA and RNA binding 
proteins.
Ingolia, N., Carnegie Institution, Baltimore, Maryland: 
Genome-wide profi ling of translation initiation and protein 
synthesis.
Leslie, C., Memorial Sloan-Kettering Cancer Center, New 
York: New insights into regulatory transcriptomics with 
next-generation sequencing.
Mardis, E., Washington University School of Medicine, 
St. Louis, Missouri: New-generation sequencing and 
analysis of the cancer genome.
Reimers, M., VCU School of Medicine, Richmond, Virginia: 
The BrainSpan project.
Stamatoyannopoulos, J., University of Washington, Seattle: 
Mapping and analysis of human regulatory DNA.
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Frontiers and Techniques in Plant Science
June 29–July 19
INSTRUCTORS S. Harmer, University of California, Davis
 R. Last, Michigan State University, E. Lansing
 J. Maloof, University of California, Davis
ASSISTANTS S. Bush, University of California, Davis
 J. Corwin, University of California, Davis
 C. Peng, Michigan State University, E. Lansing
 A. Schilmiller, Michigan State University, E. Lansing
This course provided an intensive overview of topics in plant physiology, biochemistry, and devel-
opment, focusing on genomic, analytical, computational, and other high-throughput approaches 
to understanding plant biology. It emphasized recent results from model organisms including 
Arabidopsis, maize, and tomato, as well as a variety of other plants, and provided an introduction 
to current methods used in basic and applied plant biology. It is designed for scientists with some 
experience in molecular techniques or in plant biology who wish to work with plants using the 
latest molecular, genomic, and computational technologies. The course consisted of a vigorous 
lecture series, a hands-on laboratory, and informal discussions. The instructors and a stellar group 
of invited speakers, acknowledged leaders in their fi elds, presented up-to-the-moment research on 
a wide range of topics in plant research.
These seminars included plant evolution, morphology, and anatomy; various topics in plant de-
velopment (including development of meristems, gametophytes, and roots); light perception and 
photomorphogenesis; cell wall biosynthesis and biofuels; function and perception of hormones; 
small RNAs; biotic and abiotic interactions; and applications addressing current agronomic prob-
lems. Lectures describing bioinformatics tools available to the plant community and the resources 
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provided by plant genome projects were also included. Speakers provided expert overviews of their 
fi elds, followed by in-depth discussions of their own work. The laboratory sessions provided expo-
sure to cutting-edge techniques currently used in plant research. These included studies of plant 
development and genome evolution, transient gene expression, applications of fl uorescent pro-
teins, automated phenotyping, analysis of polysomal mRNA, analysis of global gene expression 
data (microarray and short-read sequencing), construction of genetic networks, and metabolome 
analysis. Students were introduced to leading computational environments and programs includ-
ing R, Bioconductor, and ImageJ. The course also included several short workshops on important 
themes in plant research.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Bendix, C., B.A., University of California, Berkeley
De Souza, A., Ph.D., Centro de Citricultura Sylvio Moreira–
IAC, Brazil
Franke, K., Ph.D., University of Delaware, Newark
Jones, V., B.A., University of Oxford, United Kingdom
Kapitzky, L., Ph.D., Mendel Biotechnology, Inc., Hayward, 
California
Lee, S., Ph.D., University of Massachusetts, Amherst
Lor, V., Ph.D., University of Minnesota, Twin Cities
Moss, B., Ph.D., University of Washington, Seattle
Nielsen, B., Ph.D., Brigham Young University, Provo, Utah
Novikova, P., B.S., Gregor Mendel Institute of Molecular 
Plant Biology, Vienna, Austria
Pabon Mora, N., B.S., City University of New York, New York
Ires, I., M.S., New York University, New York
Rattner, R., B.S., University of California, Riverside
Smith, L., Ph.D., Central Baptist College, Conway, Arizona
Urton, J., Ph.D., University of Washington, Seattle
Wilson, M., B.A., University of Minnesota, Twin Cities
SEMINARS
Alonso, J., Salk Institute for Biological Studies, La Jolla, 
California: Functional genomics and recombineering.
Brady, S., University of California, Davis: Root development.
Dinesh-Kumar, S., University of California, Davis: Plant 
immune responses.
Hall, A., University of Liverpool, United Kingdom: Modern 
approaches to crop genetics.
Heard, J., Monsanto Company, Chesterfi eld, Missouri: Plant 
yield: An industry perspective.
Poethig, S., University of Pennsylvania, Philadelphia: 
Introduction to anatomy.
Harmer, S., University of California, Davis: Circadian 
rhythms.
Kellogg, E., University of Missouri, St. Louis: Molecular 
systematics.
McSteen, P., University of Missouri, Columbia: Development 
of the apical meristem.
Nemhauser, J., University of Washington, Seattle: 
Interactions between hormone signaling networks.
Niyogi, K., University of California, Berkeley: 
Photosynthesis.
Noel, J., HHMI/Salk Institute for Biological Sciences, La 
Jolla, California: Structural approaches to understanding 
metabolism.
Pappin, D., Cold Spring Harbor Laboratory: Mass 
spectrometry: Theory and practice.
Oldroyd, G., John Innes Centre, Norwich, United Kingdom: 
Plant/rhizobial interactions.
Provart, N., University of Toronto, Canada: Genomic 
approaches to plant biology.
Shiu, S.-H., Michigan State University, East Lansing: 
Evolutionary genomics.
Spalding, E., University of Wisconsin, Madison: Plant 
growth.
Timmermans, M., Cold Spring Harbor Laboratory: RNA 
interface pathways.
Walling, L., University of California, Riverside: Plant/pest 
interactions.
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Drosophila Neurobiology: Genes, Circuits, and Behavior
July 2–19
INSTRUCTORS G. Macleod, University of Texas Health Science Center, San Antonio
 K. O’Connor-Giles, University of Wisconsin, Madison
 A. Rothenfl uh, University of Texas Southwestern, Dallas
ASSISTANTS D. Gonzalez, University of Texas Southwestern, Dallas
 S. Gratz, University of Wisconsin, Madison
 A. Rossano, University of Texas Health Science Center, San Antonio
 M. Zwart, University of Cambridge, United Kingdom
This laboratory/lecture course was intended for researchers at all levels from beginning graduate 
students through established primary investigators who wanted to use Drosophila as an experi-
mental system for nervous system investigation. The two and a half-week course was designed to 
introduce students to a wide variety of topics and techniques, including the latest approaches to 
study nervous system development, connectivity, and activity. Daily research seminars presented 
comprehensive overviews of specifi c subfi elds of nervous system function or focused on specifi c 
techniques and approaches to study fl y neurobiology. Expert guest lecturers discussed their fi nd-
ings and approaches and brought along their own assays and techniques for students to learn in the 
laboratory part of the course. The hands-on portion of the course was centered around student-
led projects, where gene mutants were discovered and analyzed throughout the course utilizing 
the different morphological and physiological measurements and behavioral paradigms at hand. 
These included electrophysiological and in vivo calcium recordings, anatomical examination and 
circuit mapping, and numerous quantitative behavioral measures. Collectively, the course pro-
vided a comprehensive and practical introduction to modern experimental methods for studying 
the Drosophila nervous system.
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This course was supported with funds provided by the National Institute of Drug Abuse, the 
National Institute of Neurological Disorders and Stroke, and the National Science Foundation.
PARTICIPANTS
Dunlap, A., Ph.D., University of Arizona, Tucson
Gala, U., B.S., Baylor College of Medicine, Waco, Texas
Jordanova, A., Ph.D., VIB and University of Antwerp, 
Belgium
Krench, M., B.S., Massachusetts Institute of Technology, 
Cambridge
Li, J., B.S., University of Michigan, Ann Arbor
MacNamee, S., B.A., University of Arizona, Tucson
Quiroz, E., Ph.D., Universidad Central del Caribe, Puerto Rico
Robinson, J., Ph.D., University of California, San Diego
Antonio Sanchez-Alcaniz, J.A., M.S., University of Lausanne, 
Switzerland
Schneider-Mizell, C., Ph.D., ETH/University of Zurich, 
Switzerland
Schwarz, O., M.Sc., Friedrich Miescher Institute for 
Biomedical Research, Switzerland
Warren, T., Ph.D., University of California, San Francisco
SEMINARS
Allada, R., Northwestern University, Evanston, Illinois: 
Circadian rhythms.
Daniels, R., University of Wisconsin, Madison: NMJ 
physiology.
Dubnau, J., Cold Spring Harbor Laboratory: Learning and 
memory.
Kravitz, E., Harvard Medical School, Boston, Massachusetts: 
Aggression.
Lee, C.-H., National Institute of Child Health and Human 
Development/NIH, Bethesda, Maryland: Circuit 
development in the visual system.
Levitan, E., University of Pittsburgh, Pennsylvania: Imaging; 
Imaging neuropeptide release.
MacLeod, G., University of Texas Health Science Center, 
San Antonio pH1uorin imaging; Ca2+ imaging.
McKellar, C., Janelia Farm Research Campus, Sterling, 
Virginia: Mapping the circuits underlying motor behavior.
O’Connor-Giles, K., University of Wisconsin, Madison: 
NMJ development/synapse formation.
Pulver, S., Janelia Farms Research Campus, Sterling, 
Virginia: CNS physiology.
Reist, N., Colorado State University, Fort Collins: 
Mechanisms of NT release.
Rolls, M., Pennsylvania State, University Park: Cell biology 
of the neuron.
Rothenfl uh, A., University of Texas Southwestern, Dallas: 
Ethanol screen.
Rothenfl uh, A., University of Texas Southwestern, Dallas; 
MacLeod, G., University of Texas Health Science Center, 
San Antonio; O’Connor-Giles, K., University of Wisconsin, 
Madison; Lee, C.-H., National Institute of Child Health 
and Human Development/NIH, Bethesda, Maryland: 
Genetic screens.
Ruta, V., The Rockefeller University, New York: Circuit 
mapping.
Simpson, J., HHMI/Janelia Farm Research Campus, 
Sterling, Virginia: Neuroanatomy; Circuit mapping and 
manipulation.
Turner, G., Cold Spring Harbor Laboratory: Whole-cell 
patch clamp.
Yoshihara, M., University of Massachusetts, Worcester: 
Drosophila feeding circuit.
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Advanced Techniques in Molecular Neuroscience
July 3–19
INSTRUCTORS C. Lai, Indiana University, Bloomington
 R. Lansford, California Institute of Technology, Pasadena
 J. Loturco, University of Connecticut, Storrs
 B. Stevens, Children’s Hospital Boston/Harvard Medical School, Boston, Massachusetts
ASSOCIATE
INSTRUCTORS  L. Fenno, Stanford University, California
  K. Haas, University of British Columbia, Canada
TEACHING 
ASSISTANTS B. Benazeraf, Institut de Genetique Biologie Moleculaire et Cellulaire, France
 A. Brosius Lutz, Stanford University, California
 A. Che, University of Connecticut, Storrs
 F. Chen, University of Connecticut, Storrs
 M. Girgenti, University of Connecticut, Storrs
 D. Huss, California Institute of Technology, Pasadena
 A. Kaur, Indiana University, Bloomington
 B. Maher, Johns Hopkins Medical School, Baltimore, Maryland
 E. Munroe, Columbia University, New York
 K. Podorski, University of British Columbia, Canada
 A. Rosen, Harvard Medical School, Boston, Massachusetts
This laboratory and lecture course was designed to provide neuroscientists at all levels with a con-
ceptual and practical understanding of several of the most advanced techniques in molecular neu-
roscience. The course curriculum was divided into three sections: an extensive and up-to-date set 
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of laboratory exercises, daily lectures covering the theoretical and practical aspects of the various 
methods used in the laboratory, and a series of evening research seminars. The informal and inter-
active evening lectures were given by leading molecular neuroscientists and served to illustrate the 
ways in which the various experimental approaches have been used to advance specifi c areas of neu-
robiology. In this year’s course, the laboratory portion included topics such as an introduction to 
the design and use of animal virus vectors in neurobiology; the use of small interfering RNAs (siR-
NAs) for regulating the expression of specifi c genes in neurons; practical exercises in gene delivery 
systems including mammalian cell transfection protocols and single-cell electroporation techniques 
for targeted gene transfer in vivo; an introduction to overall strategies, use and design of BAC 
transgenic vectors; multiplex and whole-genome expression analyses using the most recent DNA 
microarray technologies (including labeled probe preparation, data analyses, mining, and interpre-
tation); quantitative real-time RT-PCR analyses from small numbers of cells (RNA purifi cation, 
PCR optimization, interpretation of results); single-cell PCR and cDNA library construction; and 
methods and application of RNA amplifi cation (aRNA). Each laboratory module was followed by 
comprehensive data analyses and interpretation, protocol troubleshooting, and suggestions for ways 
to improve or modify the existing technique. Finally, course participants were introduced to bio-
informatics and a wide range of Internet resources that are available to molecular neuroscientists. 
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Baysinger, A., M.Sc., Yale University, New Haven, Connecticut
Cedernaes, J., M.D., Uppsala University, Sweden
Chen, M., B.A., Stanford University, California
Dang, C., B.S., Fred Hutchinson Cancer Research Center, 
Seattle, Washington
Ekin Demir, I., M.D., Technische Universitat Muenchen, 
Germany
DeWitt, S., B.S., Emory University, Atlanta, Georgia
Fuchs Lokensgard, R., Ph.D., University of North Carolina, 
Chapel Hill
Garcia-Olivares, J., Ph.D., University of Pittsburgh, 
Pittsburgh, Pennsylvania
Herrmann, U., M.D., University Hospital Zurich, Switzerland
Hormigo, A., Ph.D., University of Rochester Medical Center, 
New York
Alexandre Kihara, A., Ph.D., Universidade Federal do ABC, 
Santo Andre, Brazil
Moore, A., B.S., Brandeis University, Waltham, 
Massachusetts
Munch, A., M.A., University of Copenhagen, Denmark
Nagy, C., B.Sc., Douglas Mental Health University Institute, 
Verdun, Canada
Tabor, K., Ph.D., University of Washington, Seattle
Zhang, C., Ph.D., The Rockefeller University, New York
SEMINARS
Barres, B., Stanford University School of Medicine, 
California: What do astrocytes do?
Darnell, R.B., The Rockefeller University, New York: Maps 
of the RNA world.
Eberwine, J., University of Pennsylvania Perelman School of 
Medicine, Philadelphia: Functional consequences of single-
cell transcriptome variability.
Huang, Z.J., Cold Spring Harbor Laboratory: Genetic 
dissection of GABAergic circuits in the neocortex: 
Chandeliers light up the path.
Lichtman, J., Harvard University, Cambridge, 
Massachusetts: Using connectomics to reveal circuit 
motifs.
Schnitzer, M., Stanford University, California: Visualizing 
the dynamics of the neuronal orchestra in awake behaving 
animals.
Stevens, B., Children’s Hospital Boston/Harvard Medical 
School, Boston, Massachusetts: Pruning CNS synapses: 
An active role for glia and the complement cascade.
Trainor, P., Stowers Institute for Medical Research, Kansas 
City, Missouri: Distinguished Alumni Lecture: Studies of 
head development while wearing tight speedos.
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Proteomics
July 7–July 22
INSTRUCTORS M. Bereman, University of Washington, Seattle
 M. Cilia, U.S. Department of Agriculture/Agriculture Research Service, Ithaca, New York
 I. Cristea, Princeton University, New Jersey
 C. Dufresne, Thermo Fisher Scientifi c, West Palm Beach, Florida
 D. Pappin, Cold Spring Harbor Laboratory
ASSISTANTS S. DeBlasio, U.S. Department of Agriculture/Agriculture Research Service, Ithaca, New York
 B. Diner, Princeton University, New Jersey
 T. Greco, Princeton University, New Jersey
 T. Li, Princeton University, New Jersey
 S. Peacock, Cold Spring Harbor Laboratory
 K. Rivera, Cold Spring Harbor Laboratory
 A. Roberts, Thermo Fisher Scientifi c, West Palm Beach, New York
 E. Rowland, Cornell University, Ithaca, New York
 C. Ruse, Cold Spring Harbor Laboratory
 J. Wilson, Cold Spring Harbor Laboratory
This intensive laboratory and lecture course focused on cutting-edge proteomic approaches and 
technologies. Students gained practical experience purifying and identifying protein complexes 
and posttranslational modifi cations. In a section focused on quantitative whole-proteome analyses 
or top-down proteomics, students gained hands-on experience using two-dimensional gel electro-
phoresis and mass spectrometry analysis. Students used differential in-gel electrophoresis (DIGE) 
for gel-based protein quantifi cation. Differentially expressed proteins were recognized by statisti-
cal methods using advanced gel analysis software and identifi ed using MALDI mass spectrometry. 
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For shotgun proteomic analysis sections or bottom-up proteomics, students used label-free and 
covalent isotopic-labeling quantitative approaches to differentially profi le changes in protein 
complexes and whole proteomes. Students were trained in high-sensitivity microcapillary liquid 
chromatography coupled with nanospray-ESI and tandem mass spectrometry analysis. Students 
learned both single-dimension and multidimensional separation methods. In a section focused on 
targeted proteomics, students learned to analyze and process shotgun proteomic data for the de-
velopment of SRM/MRM assays that accurately identify and quantify targeted proteins. Students 
designed transitions for selected peptides and performed SRM/MRM mass spectrometry assays. 
They learned to process and interpret the acquired data to measure changing quantities of targeted 
proteins in a variety of biological samples. For all sections of the course, a strong emphasis was 
placed on data analysis. A series of outside lecturers discussed various proteomics topics including 
imaging by mass spectrometry, de novo sequence analysis, advanced mass spectrometry methods, 
protein arrays, and functional proteomics. The aim of the course was to provide each student with 
the fundamental knowledge and hands-on experience necessary for performing and analyzing 
proteomic experiments. The overall goal was to train students to identify new opportunities and 
applications for proteomic approaches in their biological research.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Ayoglu, B., M.Sc., Royal Institute of Technology–KTH, 
Stockholm, Sweden
Bumgardner, E., B.S., Newport Laboratories, Worthington, 
Minnesota
Carter, D., B.S., Medical College of Wisconsin, Milwaukee
Chan, A., Ph.D., J. Craig Venter Institute, La Jolla, 
California
Chaturvedi, R., Ph.D., University of North Texas, Denton
Fleming, R., Ph.D., Durham VAMC and Duke University 
Medical Center, North Carolina
Garnett, S., B.Sc., University of Cape Town, South Africa
Grzmil, M., Ph.D., Friedrich Miescher Institute, 
Switzerland
Kaczorowski, C., Ph.D., Medical College of Wisconsin, 
Milwaukee
James Koerber, J., Ph.D., University of California, 
San Francisco
Freddyson Martinez, F., B.S., University of Puerto Rico, 
San Juan
Jason Maynard, J., Ph.D., National Institute of 
Environmental Health Sciences/NIH, Bethesda, Maryland
Kathleen Noon, K., Ph.D., Medical College of Wisconsin, 
Milwaukee
Jiqing Peng, J., Ph.D., Iowa State University, Ames
Rooney, M., B.S., Massachusetts Institute of Technology, 
Cambridge
Semba, R., M.D., Johns Hopkins University School of 
Medicine, Baltimore, Maryland
Sivagnanam, K., B.Tech., McGill University, Montreal, 
Canada
SEMINARS
Bereman, M., University of Washington, Seattle: Making 
columns for nano-scale liquid chromatography; 
Introduction to mass spectrometry.
Chait, B., The Rockefeller University, New York: Proteomics 
analysis of protein complexes.
Cilia, M., Boyce Thompson Institute and U.S. Department 
of Agriculture/Agriculture Research Service, Ithaca, 
New York: Course introduction; Introduction to 
2-D DIGE.
Clauser, K., Broad Institute of Massachusetts Institute 
of Technology and Harvard University, Cambridge, 
Massachusetts: De novo interpretation of tandem 
mass spectra.
Conlon, F., University of North Carolina, Chapel Hill: 
Directed proteomics approaches in stem cell and 
developmental biology.
Costello, C., Zaia, J., Boston University, Massachusetts: 
Deciphering glycosylation: The most intriguing PTM.
Cristea, I., Princeton University, New Jersey: Studying 
protein complexes using mass spectrometry.
MacCoss, M., University of Washington, Seattle: Targeted 
proteomics using the Skyline software environment and 
selection reaction.
Medzihradszky, K., University of California, San Francisco: 
How to interpret/evaluate MS/MS spectra: Focus on PTM 
assignments.
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Muddiman, D., North Carolina State University, Raleigh: 
Mass-spectrometry-based absolute protein quantifi cation; 
MALDI, ESI, and hybrids of the two.
Nesvizhskii, A., University of Michigan, East Lansing: 
Analysis of AP-MS protein–protein interaction data.
Pappin, D., Cold Spring Harbor Laboratory: Identifi cation of 
peptides and proteins using mass spectrometry; Peptide and 
protein quantities using mass spectrometry.
Smolks, M., Cornell University, Ithaca, New York: Studying 
cell signaling networks with quantitative mass spectrometry.
Wolf-Yadlin, A., University of Washington, Seattle: 
Introduction of phosphoproteomics.
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Workshop on Biology of Social Cognition 
July 11–17
INSTRUCTORS J. Mitchell, Harvard University, Cambridge, Massachusetts
 D. Skuse, University College London, United Kingdom
ASSISTANT C. Startin, University College London, United Kingdom
The past few years have seen remarkable advances in our knowledge of the genetic, molecular, and 
neural factors that contribute to social behavior. At the same time, sophisticated analytical and 
theoretical approaches have helped to make sense of the data. This week-long workshop aimed to 
provide a comprehensive overview of these topics. Although the emphasis was on social cognition 
in humans, there were also study days dedicated to state-of-the-art presentations on comparative 
approaches and evolutionary models. Finally, all themes were related to the clinical consequences 
of dysfunctional social cognition, and the role of translational research. The course included in-
troductory seminars on key themes, offered every morning. There were afternoons devoted largely 
to practical sessions that provided hands-on experiments in consultation with seminar leaders, 
rounded out by after-supper keynote lectures by leading scientists that refl ected cutting-edge and 
future views related to our theme for that day. Ample breaks allowed time not only for informal 
interactions between lecturers and students, but also for reading, swimming, tennis, and other 
outdoor activities available at the Banbury Center.
PARTICIPANTS
Aparicio Betancourt, M., B.S, University of Illinois, Urbana-
Champaign
Bastiaansen, J., Ph.D., University Medical Center Groningen, 
the Netherlands
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Elision, J., Ph.D., California Institute of Technology, 
Pasadena
Fisher, G., B.S., California Institute of Technology, Pasadena
Goddings, A.-L., B.S., University College London, United 
Kingdom
Ha, C., B.S., University of Houston, Texas
Hillebrandt, H., B.S., University College London, United 
Kingdom
Kim, J., B.S., Dartmouth College, Hanover, New Hampshire
Kim, Y., Ph.D., Cold Spring Harbor Laboratory
Lapate, R., B.S., University of Wisconsin, Madison
Mattek, A., B.S., Dartmouth College, Hanover, New 
Hampshire
Mills, K., B.S., National Institutes of Health, Bethesda, 
Maryland
Palmer, A., B.S., Dartmouth College, Hanover, New 
Hampshire
Raio, C., B.S., New York University, New York
Sullivan, N., B.S., California Institute of Technology, 
Pasadena, California
Tritt, S., B.S., University of Toronto, Toronto, CANADA
Venta, A., B.S., University of Houston, Houston, TX
Von Der H., Ph.D., Temple University, Conshohocken, 
Pennsylvania
Wolf, L., B.S., University College London, United Kingdom
Yoon, J., B.S., Stanford University, California
Youssef, F., B.S., University of the West Indies, St. Augustine, 
Trinidad and Tobago
SEMINARS
Binder, E., Emory University, Atlanta, Georgia: Biology of 
stress, epigenetics, and depression.
Blakemore, S.-J., University College London, United 
Kingdom: Social cognition in adolescence.
Brennand, K., Mount Sinai School of Medicine, New York: 
Modeling schizophrenia using human-induced pluripotent 
stem cells. 
Buckholtz, J., Princeton University, New Jersey: 
Neuroscience of self-control.
Cushman, F., Brown University, Providence, Rhode Island: 
Moral development.
de Waal, F., Emory University, Atlanta, Georgia: The age of 
empathy.
Giedd, J., National Institute of Mental Health/NIH, 
Bethesda, Maryland: Neurodevelopment of the brain.
Haig, D., Harvard University, Cambridge, Massachusetts: 
Genomic imprinting and the divided brain.
Mitchell, J., Harvard University, Cambridge, Massachusetts: 
Investigating theory of mind; Welcome and introduction 
to the course.
Munafo, M., University of Bristol, United Kingdom: Gene–
environment interactions.
Murray, R., King’s College London, United Kingdom: Social 
cognition in major mental illness.
Navarro, A., Institute of Evolutionary Biology, University 
of Pompeu Fabrue, Barcelona, Spain: Introduction to 
genetics.
O’Doherty, J., California Institute of Technology, Pasadena: 
Decision making.
Santos, L., Yale University, New Haven, Connecticut: 
Economic models of comparative cognition.
Schultz, R., Children’s Hospital of Philadelphia, 
Pennsylvania: Autism and the brain.
Shaw, P., National Institute of Mental Health/NIH, 
Bethesda, Maryland: Functional neuroimaging of social 
cognition.
Simmons, J., National Institute of Mental Health/NIH, 
Bethesda, Maryland: NIMH and social neuroscience.
Skuse, D., University College London, United Kingdom: 
X-linked genes and social cognition.
Szekely, T., Bath University, United Kingdom: Cross-species 
studies of cooperative behavior.
Whalen, P., Dartmouth College, Hanover, New Hampshire: 
Anxiety and the amygdala.
Young, L., Emory University, Atlanta, Georgia: 
Neuropeptides and social bonding.
Zaki, J., Stanford University, California: Empathic accuracy, 
social infl uences, and altruism.
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Brain Tumors
July 19–25
INSTRUCTORS Gutmann, D., Washington University School of Medicine, St. Louis, Missouri
 Holland, E., Memorial Sloan-Kettering Cancer Center, New York
 Majumder, S., University of Texas M.D. Anderson Cancer Center, Houston
ASSISTANT Sathyan, P., University of Texas M.D. Anderson Cancer Research Center, Houston
This 1-week discussion course provided a clinical overview of brain tumors and emphasized molec-
ular mechanisms involved in the growth and development of brain tumors, with special emphasis 
on neural differentiation, signaling mechanisms, DNA replication, chromatin modulation, stem 
cells, mouse models, genomics, imaging techniques, genetically modifi ed mouse techniques, nano-
technology, mechanism-based therapeutic strategies, and biobanks and ethical concerns. Attendees 
were able to interact with senior investigators on a one-to-one basis in an informal environment. 
All nonfaculty students were provided with a generous stipend depending on stated need. Appli-
cations were invited from medical and graduate students, postdoctoral fellows, faculty, clinicians, 
and scientists.
PARTICIPANTS
Blacher, E., Ph.D., Tel-Aviv University, Israel
Colquhoun, A., B.Sc., University of Sao Paulo, Brazil
Coutinho, F., B.S., University of Toronto/Hospital for Sick 
Children, Canada
Garancher, A., Ph.D., Curie Institute, Orsay Cedex, France
Hamerlik, P., M.Sc., Danish Cancer Society Research 
Center, Copenhagen, Denmark
Khuong Quang, D.A., Ph.D., McGill University, Montreal, 
Canada
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Kim, Y., Ph.D., Cleveland Clinic Lerner Research Institute, 
Ohio
Kimmell, K., B.A., University of Rochester Medical Center, 
New York
Lin, C.-T., M.D., University of Vermont, Burlington
Liu, X., B.S., McGill University, Longueuil, Canada
Maherally, Z., Ph.D., University of Portsmouth, United 
Kingdom
Marisetty, A., Ph.D., University of Texas/M.D. Anderson 
Cancer Center, Houston
Matlaf, L., Ph.D., California Pacifi c Medical Center, San 
Francisco
Pattwell, S., Ph.D., Weill Cornell Medical College, New York
Rakopoulos, P., Ph.D., University of Toronto, Canada
Semenkow, S., Ph.D., Johns Hopkins Medical Institute, 
Baltimore, Maryland
Sin, W.C., B.Sc., University of British Columbia, Vancouver, 
Canada
Srinivasan, V., M.D., University of Rochester, New York
Stringer, B., Ph.D., Queensland Institute of Medical 
Research, Brisbane, Australia
Sturm, D., M.D., German Cancer Research Center, 
Heidelberg, Germany
Tang, Y., Ph.D., Stanford University, California
Veo, B., Ph.D., University of Texas/M.D. Anderson Cancer 
Center, Houston
Xie, Q., Ph.D., Van Andel Research Institute, Grand Rapids, 
Michigan
SEMINARS
Baker, S., St. Jude Children’s Research Hospital, Memphis, 
Tennessee: Pediatric brain tumors.
Berens, M., Translational Genomics Research Institute, 
Phoenix, Arizona: Right drug…  right glioma patient.
Bondy, M., Baylor College of Medicine, Houston, Texas: 
Molecular and genetic epidemiology of brain tumors: State 
of the science.
Brennan, C., Memorial Sloan-Kettering Cancer Center, 
New York: Genomic analysis of glioblastoma.
Eberhart, C., Johns Hopkins University School of Medicine, 
Baltimore, Maryland: Notch signaling in brain tumors.
Enikolopov, G., Cold Spring Harbor Laboratory.
Fuller, G., University of Texas/M.D. Anderson Cancer 
Center, Houston: Clinical aspects of brain tumors: 
Neuropathology.
Furnari, F., University of California, San Diego: EGF 
receptors in glioma biology: Therapeutic targets and 
multifaceted drivers of pathogenicity.
Gladson, C., Cleveland Clinic, Ohio: Regulation of 
angiogenesis by TNF-α /TNFR1 in glioblastoma.
Gutmann, D., Washington University School of Medicine, 
St. Louis, Missouri: Using neurofi bromatosis-1 to 
understand pediatric brain tumors.
Holland, E., Chan, T., Memorial Sloan-Kettering Cancer 
Center, New York: Epigenomic drivers of glioma 
oncogenesis. 
James, D., University of California, San Francisco: 
Engraftment approaches and models for the study 
of brain tumors.
Kenney, A.M., Harvard Medical School/Dana Farber 
Cancer Institute, Boston, Massachusetts: Signaling 
pathway interactions in the developing brain and 
medulloblastoma.
Kornblum, H., University of California, Los Angeles: If a brain 
tumor stem cell falls in the woods, will anybody hear it?
Majumder, S., University of Texas/M.D. Anderson Cancer 
Center, Houston; Rich, J., Cleveland Clinic, Ohio
Mietz, J., National Cancer Institute/NIH, Bethesda, Maryland: 
Funding opportunities at the National Cancer Institute.
Pieper, R., University of California, San Francisco: The 
multiple roles of ubiquitination in the development and 
treatment of brain cancer.
Reilly, K., National Cancer Institute/NIH, Bethesda, 
Maryland: Cross-species comparisons to better understand 
epistatic relationships in brain tumor susceptibility.
Roussel, M., St. Jude Children’s Research Hospital, 
Memphis, Tennessee: Molecular networks and cell of origin 
in pediatric medulloblastoma.
Sawaya, R., University of Texas/M.D. Anderson Cancer 
Center, Houston: Clinical aspects of brain tumors and 
clinical trials.
Snyder, E., Sanford-Burnham Medical Research Institute, La 
Jolla, California: The role of neural stem cell biology in the 
genesis and treatment of neoplasms of the CNS.
Verma, I., The Salk Institute, La Jolla, California: 
Transdifferentiation of gliomas into endothelial cells.
Yu, J., Cedars-Sinai Medical Center, Los Angeles, California: 
Immunotherapy for brain tumors.
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Computational Cell Biology
July 24–August 13
INSTRUCTORS R. Albert, Pennsylvania State University, University Park
 L. Loew, University of Connecticut Health Center, Farmington
 S. Scarlata, Stony Brook University, New York
 G. Smith, The College of William and Mary, Williamsburg, Virginia
ASSISTANTS L. Harris, University of Pittsburgh School of Medicine, Pennsylvania
 M. Huertas, University of Texas Medical School of Houston
 O. Marchenko, University of Connecticut Health Center, Farmington
 O. Walch, University of Michigan, Ann Arbor
 X. Wang, The College of William and Mary, Williamsburg, Virginia
Computational cell biology is the fi eld of study that applies the mathematics of dynamical systems, 
together with computer simulation techniques, to the study of cellular processes. The fi eld encom-
passes several topics that have been studied long enough to be well established in their own right, 
such as calcium signaling, molecular motors and cell motility, the cell cycle, and gene expression dur-
ing development. In addition to providing a recognizable larger community for topics such as these, 
this course provided a base for the development of newer areas of inquiry, for example, the dynamics 
of intracellular second-messenger signaling, of programmed cell death, of mitotic chromosome 
movements, and of synthetic gene networks. Unlike computational genomics or bioinformatics, 
computational cell biology is focused on simulation of the molecular machinery (genes-proteins-
metabolites) that underlies the physiological behavior (input-output characteristics) of living cells.
This 3-week course incorporated a series of didactic lectures on the mathematics of dynamical 
systems, computational simulation techniques, cell biology, and molecular biology. Practicing the-
oreticians and experimentalists rotated in for 1–3-day visits during the course to give lectures and 
interact with the students. Midway through the course, students selected an area for independent 
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study, and the focus of the last week of the course was largely on these projects, supplemented by 
continued visiting lecturers.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Betizeau, M., B.S., Inserm, Bron, France
Carulli, A., B.S., University of Michigan, Ann Arbor
Chu, L., B.S., Johns Hopkins University, Baltimore, 
Maryland
Fink, M., B.A., Long Island University, Brookville, 
New York
Ikeda, F., B.S., College of William and Mary, Williamsburg, 
Virginia
Liu, Y., Ph.D., University of Duisburg-Essen, Germany
Maitra, A., Ph.D., Stony Brook University, New York
Nilsson, E., M.Sc., Karolinska Institutet, Stockholm, Sweden
Perez, N., M.S., Cinvestav, Ecatepec de Morelos, Mexico
Ropski, A., B.S., University of Illinois, Chicago
Rubio Garcia, A., B.Sc., Technical University of Denmark, 
Lyngby
Sambarey, A., M.S., Indian Institute of Science, Bangalore, 
India
Sedzinski, J., Ph.D., University of Texas, Austin
Selem, N., M.S., Langebio, Irapuato Guanajuato, Mexico
Sharifai, N., B.S., University of Miami Miller School of 
Medicine, Coral Gables, Florida
Stefan, D., B.S., INRIA, Montbonnot, St. Ismier, France
Tikhonov, M., Ph.D., Institute of Gene Biology RAS, 
Moscow, Russia
Tokarev, A., M.S., Federal Research and Clinical Centre of 
Pediatrics, Moscow, Russia
Wang, S., B.S., Duke University, Durham, North Carolina
Watanabe, K., B.S., The University of Tokyo, Japan
Waters, R., Ph.D., Montana State University, Bozeman
Weinberg, S., Ph.D., College of William and Mary, 
Williamsburg, Virginia
Wu, F., B.S., Delft University of Technology, the 
Netherlands
Zhu, C., B.S., University of Iowa, Iowa City
SEMINARS
Albert, R., Pennsylvania State University, University 
Park: Discrete dynamic modeling of signal transduction 
networks.
Cohen D., Asawri, S., The Mathworks, Inc., Natick, 
Massachusetts: An overview of MATLAB and the 
SimBiology toolbox.
Cytrynbaum, E., University of British Colombia, Vancouver, 
Canada: Michaelis Menten enzyme kinetics.
Feinberg, M., Ohio State University, Columbus: Chemical 
reaction network theory.
Harris, L., University of Pittsburg, Pennsylvania: Rule-based 
modeling.
Hucka, M., California Institute of Technology, Pasadena: 
The Systems Biology Markup Language (SBML): Model 
databases and translation.
Iyengar, R., Mount Sinai School of Medicine, New York: 
Models of cell signaling.
Keener, J., University of Utah, Salt Lake City: Cardiac 
models.
Lechleiter, J., University of Texas, San Antonio: Calcium 
signaling.
Ma’ayan, A., Mount Sinai School of Medicine, New York: 
Network analysis in systems biology.
Mendes, P., University of Manchester, United Kingdom: 
Optimization and parameter estimation with COPASI; 
COPASI and parameter estimation: Part 1; COPASI and 
parameter estimation: Part 2.
Moraru, I., Loew, L., University of Connecticut, Storrs: 
Modeling with virtual cell; Virtual cell and ODEs.
Moraru, I., Schaff, J., University of Connecticut, Storrs: 
Virtual cell, stochastic reaction networks, and stochastic 
spatial modeling.
Phair, R., Integrative Bioinformatics, Mountain View, 
California: Molecular cell biology and ODEs; Fluorescent 
proteins and tracer kinetics.
Sachs, K., Stanford University, Palo Alto, California: 
Bayesian analysis of signal transduction networks.
Scarlata, S., Stony Brook University, New York: G-protein 
signaling; Experimental methods.
Schaff, J., Loew, L., University of Connecticut, Storrs: 
Virtual cell and PDEs; Actin and dendritic nucleation.
Smith, G.D., College of William and Mary, Williamsburg, 
Virginia: Cellular biophysics and modeling: Part 1; 
Cellular biophysics and modeling: Part 2; Random 
walks and diffusion; Stochastic modeling in cell biology: 
Chemical reaction networks.
Sobie, E., Mount Sinai Medical College, New York: Calcium 
sparks and local control of excitation contraction coupling 
in cardiac myocytes.
Terman, D., Ohio State University, Columbus: Dynamical 
systems: Part 1; Dynamical systems, Part 2.
Tyson, J., Virginia Polytechnic Institute and State University, 
Blacksburg: Regulation of the cell cycle: Part 1; Regulation 
of the cell cycle: Part 2.
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Eukaryotic Gene Expression
July 24–August 13
INSTRUCTORS J. Espinosa, HHMI/University of Colorado, Boulder
 W.L. Kraus, University of Texas Southwestern Medical Center, Dallas
 A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
 D.Taatjes, University of Colorado, Boulder
ASSISTANTS B. Gibson, University of Texas Southwestern Medical Center, Dallas
 J. Nichol, McGill University, Montreal, Canada
 N. Mohaghegh, Stowers Institute for Medical Research, Kansas City, Missouri
 S.-c. Lin, University of Colorado, Boulder
This course was designed for students, postdocs, and principal investigators who have recently 
ventured into the exciting area of gene regulation. The course focused on state-of-the-art strategies 
and techniques used in the fi eld. Emphasis was placed on both in vitro and in vivo protein–DNA 
interactions and on novel methodologies to study gene regulation. Students made nuclear extracts, 
performed in vitro transcription reactions, and measured RNA levels using primer extension. 
Characterizations of the DNA-binding properties of site-specifi c transcription factors were carried 
out using electrophoretic mobility-shift and DNase I footprinting assays. In addition, students 
learned techniques for the assembly and analysis of chromatin in vitro, including transcription 
assays, chromatin footprinting, and chromatin remodeling assays. During the past few years, the 
gene regulation fi eld has developed in vivo approaches to study gene regulation. Students were ex-
posed to the chromatin immunoprecipitation technique. They also used RNAi for specifi c knock-
down experiments in mammalian cells. In addition, determining cellular gene expression profi les 
has been accelerated tremendously by DNA microarray technology. Students received hands-on 
training in performing and interpreting results from DNA microarrays.
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Experience with basic recombinant DNA techniques was a prerequisite for admission to this 
course. Lectures by the instructors covered the current status of the gene expression fi eld, theo-
retical aspects of the methodology, and broader issues regarding strategies for investigating the 
regulation of gene expression in eukaryotes. Guest lecturers discussed contemporary problems in 
eukaryotic gene regulation and technical approaches to their solution. 
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Ask, K., M.S., BRIC, Copenhagen, Denmark
Bednarova, K., M.S., CEITEC–Masaryk University, Brno, 
Czech Republic
Benjamin, J., B.S., Johns Hopkins Medical Institute, 
Baltimore, Maryland
Bukowski, J.-P., B.Sc., University of Copenhagen, Denmark
Cheung, K.L., Ph.D., Mount Sinai Hospital, New York
Christianson, M., Ph.D., Duke University, Durham, North 
Carolina
Ferguson, M., B.S., National Cancer Institute/NIH, 
Bethesda, Maryland
Fernando, T., B.S., Weill Cornell Medical College, New York
Frasca, A., B.A., Mount Sinai School of Medicine, New York
Hames, M., B.S., University of Alabama, Huntsville
Pedersen, K., Ph.D., University of Maryland Greenebaum 
Cancer Center, Baltimore
Rengasamy, M., M.S., Mount Sinai School of Medicine, 
New York
Ripkens, K., B.S., University Duisburg-Essen, Germany
Siggers, T., Ph.D., Brigham & Woman’s Hospital/Harvard 
Medical School, Boston, Massachusetts
Soltau, W., B.S., Purdue University, West Lafayette, Indiana
Tarradas, A., B.S., University of Girona, Spain
SEMINARS
Adelman, K., National Institute of Environmental Health 
Sciences, Research Triangle Park, North Carolina: Probing 
the dynamics and function of promoter-paused RNA 
polymerase II.
Boyer, L., Massachusetts Institute of Technology, 
Cambridge: Dynamic and coordinate regulation of gene 
expression programs in lineage commitment.
Cairns, B., University of Utah, Salt Lake City: Regulations 
and mechanisms of chromatin remodeling.
Crabtree, G., Stanford University, California: Chromatin 
regulation: New methods, new concepts, and human 
disease.
Henikoff, S., Fred Hutchinson Cancer Research Center, 
Seattle, Washington: Histone variants, nucleosome 
dynamics, and epigenetic inheritance.
Jones, K., Salk Institute, La Jolla, California: Transcription 
elongation in cell signaling and disease.
Kingston, R., Harvard University, Boston, Massachusetts: 
Chromatin-based mechanisms and their regulation by 
lncRNAs.
Levine, M., University of California, Berkeley: 
Transcriptional precision in the Drosophila embryo and the 
importance of gene regulation in animal evolution.
Liu, X., University of Texas Southwestern, Dallas: Molecular 
basis of transcription initiation by RNA pol II.
Meyer, B., University of California, Berkeley: Chromosome-
wide repression via molecular machines.
Panning, B., University of California, San Francisco: 
Chromatin regulation in embryonic stem cells.
Pugh, F., Penn State University, University Park: Global 
organization of chromatin, their regulators, and the 
transcription machinery.
Roeder, R., The Rockefeller University, New York: 
Biochemical studies of transcriptional regulatory 
mechanisms in animal cells.
Rogatsky, I., Hospital for Special Surgery/Weill Cornell, 
New York: Transcriptional mechanisms underlying anti-
infl ammatory actions of glucorticoids.
Roy, A., Tufts University School of Medicine, Boston, 
Massachusetts: Proliferative functions of the transcription 
factor TFII-I.
Tyler, J., University of Texas/M.D. Anderson Cancer Center, 
Houston: Chromatin assembly and disassembly.
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Imaging Structure and Function in the Nervous System
July 24–August 13
INSTRUCTORS D. DiGregorio, Institut Pasteur, France
 J. Waters, Northwestern University, Chicago, Illinois
ASSISTANTS G. Moneron, Institut Pasteur, Paris, France
 F. Munoz-Cuevas, University of California, San Francisco
 A. Scimemi, National Institutes of Health, Bethesda, Maryland
 R. Thereau, Bordeaux University, France
 A. Tran-Van-Minh, Institut Pasteur, Paris, France
Advances in light microscopy, digital image processing, and the development of a variety of pow-
erful fl uorescent probes presented expanding opportunities for investigating the nervous system, 
from synaptic spines to networks in the brain. This intensive laboratory and lecture course pro-
vided participants with the theoretical and practical knowledge to utilize emerging imaging tech-
nologies. The primary emphasis of the course was on vital light microscopy. Students learned the 
principles of light microscopy, as well as use of different types of electronic cameras, laser-scanning 
systems, functional fl uorophores, delivery techniques, and digital image-processing software. In 
addition to transmitted light microscopy for viewing cellular motility, the course examined a 
variety of molecular probes of cell function, including calcium-sensitive dyes, voltage-sensitive 
dyes, photo-activated (“caged”) compounds, and exocytosis tracers. Issues arising in the combina-
tion of imaging with electrophysiological methods were covered. Particular weight was given to 
multiphoton laser-scanning microscopy and to newly available biological fl uorophores, especially 
green fl uorescent protein (GFP) and its variants. A spectrum of neural and cell biological systems 
were used, including living animals, brain slices, and cultured cells. Applicants had a strong back-
ground in the neurosciences or in cell biology. In their personal statements, applicants specifi ed 
(1) their experience with optical techniques, (2) how they applied optical methods in their current 
projects, (3) the microscope systems available to them, and (4) their long-term goals in learning 
more about optical methods.
299-418_Meetings & Courses.indb   396 9/17/2013   8:21:24 AM
Imaging Structure and Function in the Nervous System  397
This course was supported with funds provided by the Howard Hughes Medical Institute, Carl 
Zeiss Microscopy, and Coherent, Inc.
PARTICIPANTS
Akbergenova, Y., M.A., Massachusetts Institute of 
Technology, Cambridge
Fedorchak, A., B.S., University of California, Berkeley
Grienberger, C., M.D., Technical University Munich, Germany
Iurilli, G., M.Sc., Italian Institute of Technology, Genova, Italy
Kim, Y., Ph.D., Cold Spring Harbor Laboratory
Lefort, S., B.A., Brandeis University, Waltham, 
Massachusetts
Macé, E., B.A., Institut de la Vision, Paris, France
Maurer, C., Ph.D., Max-Planck Institute for Medical 
Research, Heidelberg, Germany
Palmer, L., M.S., University of Bern, Switzerland
Phillips, M., Ph.D., University of Wisconsin, Madison
Scholl, B., B.S., University of Texas, Austin
Smith, K., Ph.D., Northwestern University, 
Chicago, Illinois
SEMINARS
Canepari, M., INSERM, Grenoble, France: VSDs.
De Grand, A., Olympus America, Inc., Center Valley, 
Pennsylvania: BX51 optics and objective cleaning.
Deisseroth, K., Stanford University, California; Weninger, 
K., North Carolina State University, Raleigh; University 
of California, Los Angeles: Single-molecule FRET.
DiGregorio, D., Institut Pasteur, Paris, France: Flash photolysis.
DiGregorio, D., Institut Pasteur, Paris, France; Waters, 
J., Northwestern University, Chicago, Illinois: Projects–
Examples.
Dittman, J., Weill Cornell Medical College, New York: 
Photoactivable XFPs.
Dombeck, D., Northwestern University, Evanston, Illinois: 
Awake imaging in hippocampus.
Emiliani, V., CNRS, INSERM, University Paris Descartes, 
Paris, France: SLM.
Engert, F., Harvard University, Cambridge, Massachusetts: 
Shot noise; Image J and Fiji; 2P microscopy.
Feller, M., University of California, Berkeley: Imaging in 
the retina.
Griesbeck, O., Max-Planck Institute of Neurobiology, 
Martinsried, Germany: XFP calcium indicators.
Huebener, M., Max-Planck Institute of Neurobiology, 
Martinsried, Germany: Intrinsic imaging.
Kilborn, K., Intelligent Imaging Innovations, Inc., Denver, 
Colorado: Deconvolution; Optogenetics. 
Lanni, F., Carnegie Mellon University, Pittsburgh, 
Pennsylvania: Basic microscopy.
Lichtman, J., Harvard University, Cambridge, 
Massachusetts: Confocal microscopy.
Mertz, J., Boston University, Massachusetts: Phase-contrast 
microscopy.
Moneron, G., Institut Pasteur, Paris, France: STED.
Moomaw, L.; Pritchard, K., Hamamastu Photonic Systems, 
Spring Branch, Texas: Cameras and PMTs.
Naegerl, V., Max-Planck Institute of Neurobiology, Munich, 
Germany: Imaging spines with STED.
Nimmerjahn, A., Salk Institute, La Jolla, California: 
Acquisition and automated analysis of large-scale calcium 
imaging data.
Prakriya, M., Northwestern University, Chicago, Illinois: 
FRET and FLIM.
Shih, A., University of California, San Diego, La Jolla: 
Imaging blood fl ow.
Tsai, P., University of California, San Diego, La Jolla: 
Optics bench lab exercises: Basics Koehler; Ray 
matrices; Optics bench lab exercises: Basics, Koehler; 
Scanning and fl uorescence; Optics bench lab exercises: 
Scanning; Saturation; Optics bench lab exercises: 
Confocal.
Waters, J., Northwestern University, Chicago, Illinois: 
Week one recap; Organic calcium indicators; Homebrew 
microscope including laser safety.
Wilbrecht, L., University of California, San Francisco: GFP 
applications spine morphology.
Winifred, D., Max-Planck Institute for Medical Research, 
Heidelberg, Germany: Extended 2P imaging and 
block-face EM.
Witkowski, J., Cold Spring Harbor Laboratory: Ethics.
Zhuang, X., Harvard University, Cambridge, Massachusetts: 
PALM/STORM.
Zito, K., University of California, Davis: 2P photolysis and 
applications.
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Yeast Genetics and Genomics
July 24–August 13
INSTRUCTORS M. Dunham, University of Washington, Seattle
 S. Jaspersen, Stowers Institute for Medical Research, Kansas City, Missouri
 J. Smith, University of Virginia Health System, Charlottesville
ASSISTANTS A. Brosius, University of Washington, Seattle City, Missouri
 J. Chen, Stowers Institute for Medical Research, Kansas
 M. Wierman, University of Virginia Health System, Charlottesville
This course is a modern, state-of-the-art laboratory course designed to teach students the full 
repertoire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces 
cerevisiae. Combinations of classical genetic approaches were emphasized, including the isolation 
and characterization of mutants, tetrad analysis, complementation, and mitotic recombination. 
Molecular genetic techniques, including various types of yeast transformations, gene replacement 
with plasmids and PCR, construction and analysis of gene fusions, and generation of mutations 
in cloned genes, were emphasized. Classical and molecular approaches allowed students to gain 
experience in identifying and interpreting various kinds of genetic interactions including suppres-
sion and synthetic lethality. Students were immersed in yeast genomics and performed and inter-
preted experiments with DNA arrays. They gained fi rst-hand experience in modern cytological 
approaches such as epitope tagging and imaging yeast cells using indirect immunofl uorescence, 
GFP–protein fusions, and a variety of fl uorescent indicators for various subcellular organelles. 
Lectures on fundamental aspects of yeast genetics were presented along with seminars given by 
outside speakers on topics of current interest.
This course was supported with funds provided by National Human Genome Research Insti-
tute and the Howard Hughes Medical Institute.
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PARTICIPANTS
Aksnes, H., M.S., University of Bergen, Norway
Balakrishnan, L., Ph.D., University of Rochester School of 
Medicine, New York
Beierlein, J., Ph.D., Brandeis University, Waltham, 
Massachusetts
Bouklas, T., B.S., Albert Einstein College of Medicine, 
Bronx, New York
Budin, I., Ph.D., Harvard University, Boston, Massachusetts
Conlin, P., B.S., University of Washington, Seattle
Freschi, L., M.Sc., Laval University, Quebec, Canada
Garde, C., Ph.D., Technical University of Denmark, Kgs. 
Lyngby, Denmark
Georgiev, D., Ph.D., University of West Bohemia in Pilsen, 
Czech Republic
Goetz, A., Ph.D., University of Helsinki, Finland
Kim, J., Ph.D., Tufts University, Medford, Massachusetts
Langerak, A., M.Sc., Heineken, Zoeterwoude, The 
Netherlands
Lindberg, L., M.S., Chalmers University of Technology, 
Gothenburg, Sweden
Schreiber, A., Ph.D., ETH Zurich, Switzerland
Stavrou, E., Ph.D., University of Cyprus, Nicosia
Zhang, Y., M.S., Stowers Institute for Medical Research, 
Kansas City, Missouri
SEMINARS
Amon, A., HHMI/Massachusetts Institute of Technology, 
Cambridge: Causes and consequences of aneuploidy.
Andrews, B., University of Toronto, Ontario, Canada: Using 
yeast functional genomics to explore biological pathways 
and networks.
Burke, D., University of Virginia, Charlottesville: Mitotic 
regulation in Saccharomyces cerevisiae.
Caudy, A., University of Toronto, Ontario, Canada: 
Discovering new metabolic pathways using small-molecule 
metabolomics and the awesome power of yeast genetics.
Cherry, M., Stanford University, California: Discover using 
the Saccharomyces Genome Database.
Gresham, D., New York University, New York: Watching 
evolution in real time.
Hieter, P., University of British Columbia, Canada: 
Chromosome instability in yeast and cancer.
Li, R., Stowers Institute for Medical Research, Kansas 
City, Missouri: Fluorescence correlation spectroscopy 
as a tool for in vivo analysis of protein dynamics and 
interaction.
Nislow. C.; Giaever, G., University of Toronto, Ontario, 
Cananda: Chemogenomic profi ling: Exploring the yeast 
druggable genome; Chromatin architecture and gene 
expression, mutants, drugs, and evolution.
Pugh, F., Penn State University, University Park: Genome 
interplay between chromatin and the transcription 
machinery.
Strathern, J., National Cancer Institute/NIH, Bethesda, 
Maryland: The fi delity of transcription.
Winey, M., University of Colorado, Boulder: Centrosome 
assembly as viewed from budding yeast.
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Stem Cells
July 27–August 5
INSTRUCTORS McKay, R., Lieber Institute, Baltimore, Maryland
 Shen, M., Columbia University Medical Center, New York
 Tanaka, E., University of Dresden, Germany
ASSISTANT Chenoweth, J., Lieber Institute, Baltimore, Maryland
Stem cells construct organs and tissues in development. They sustain tissues in the adult and 
restore them after injury. Because of these properties, isolating and manipulating stem cells have 
become major new elements in biomedical science. This workshop course covered a series of bio-
logical subjects relating to stem cells and regenerative medicine. Topics included embryology and 
development, reprogramming, degenerative disease, cancer stem cells, and human genetics.
This 10-day-long discussion course brought together leading researchers in the stem cell fi eld 
with a small group of international students. The purpose of the workshop was to provide par-
ticipants with an opportunity to achieve an advanced understanding of the scientifi c and clinical 
importance of stem cells. A major aim of the workshop was to discuss in considerable detail the 
relationship between stem cells and disease. The signifi cance of this relationship with respect to 
developing new approaches to treating and understanding human disease was explored.
A key feature of the course is easy access to the workshop leaders and the invited lecturers for 
informal discussion. The course was held at the Laboratory’s Banbury Conference Center located 
on the North Shore of Long Island. All participants stayed within walking distance of the Center, 
close to a tennis court, pool, and private beach.
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PARTICIPANTS
Battistoni, G., B.S., Scuola Normale Superiore, Pisa, Italy
Battula, V., B.S., M.D. Anderson Cancer Center, Houston, 
Texas
Bell, D., M.D., M.D. Anderson Cancer Center, Houston, 
Texas
Bertacchi, M., B.S., Scuola Normale Superiore, Pisa, Italy
Carey, J., Ph.D., M.D. Anderson Cancer Center, Houston, 
Texas
Dequeant, M.-L., Ph.D., Harvard Medical School, Boston, 
Massachusetts
Eichler, F., M.D., Massachusetts General Hospital, Boston
Han, L., Ph.D., M.D. Anderson Cancer Center, Houston, 
Texas
Huang, L., B.S., University of Texas/M.D. Anderson Cancer 
Center, Houston
Iommelli, F., B.S., National Research Council (CNR), 
Naples, Italy
Kim, S.-K., B.S., Lieber Institute for Brain Development, 
Baltimore, Maryland
McMahon, R., Ph.D., M.D. Anderson Cancer Center, 
Houston, Texas
Medelnik, J.-P., B.S., Technical University, Dresden, 
Germany
Mishra, S., B.S., University of Texas Health Science Center, 
San Antonio
Raykova, D., B.S., Uppsala University, Sweden
Seo, S., B.S., Mayo Clinic, Rochester, Minnesota
Sgualdino, J., B.S., European Institute of Oncology, Milan, 
Italy
Shutova, M., Ph.D., Vavilov Institute of General Genetics, 
RAS, Moscow, Russia
Stemann Andersen, M., B.S., Harvard University, 
Cambridge, Massachusetts
Thompson, H., B.S., University of California, Merced
Zhang, Y., B.S., Regeneron Pharmaceuticals Inc., Tarrytown, 
New York
SEMINARS
Aznar Benitah, S., Center for Genomic Regulation, 
Barcelona, Spain: Adult stem cells.
Brickman, J., University of Edinburgh, United Kingdom: 
Lineage priming in embryonic stem cells.
Butler, J., Weill Cornell Medical College, New York: 
Endothelial-derived angiocrine signals in stem cell 
maintenance, organ regeneration, and tumor growth.
Hadjantonakis, K., Memorial Sloan-Kettering Cancer 
Institute, New York: Imaging lineage commitment and 
morphogenesis of early mouse embryos.
Klein, K., Harvard Medical School, Boston, Massachusetts: 
Principles of clonal analysis and patterns of stem cell fate 
in adult tissues.
Konrad Hochedlinger, K., Harvard Medical School, Boston, 
Massachusetts: Strategies to study cellular reprogramming 
to pluripotency.
McKay, R., Lieber Institute, Baltimore, Maryland: Stem cells 
in science and medicine.
Meissner, A., Broad Institute, Cambridge, Massachusetts: 
Epigenetics, stem cells, and development.
Mills, A., Cold Spring Harbor Laboratory: Chromatin-
mediated dynamics and stem cells.
Park, C., Memorial Sloan-Kettering Cancer Center, New 
York: Cancer stem cells: Opportunities and controversies.
Robertson, E., University of Oxford, United Kingdom: Early 
mouse development.
Shen, M., Columbia University Medical Center, New York; 
Prostate development, stem cells, and cancer.
Tanaka, E., University of Dresden, Germany: Principles of 
vertebrate regeneration.
Tesar, P., Case Western Reserve University School of 
Medicine, Cleveland, Ohio: Derivation and utilization of 
distinct pluripotent stem cell states.
Testa, G., European Institute of Oncology, Milan, Italy: The 
epigenetic basis of genome programming and reprogramming.
Xiao, A., Yale University School of Medicine, New Haven, 
Connecticut: Epigenetic regulation in pluripotent stem 
cells, development, and behavior.
Young, R., Whitehead Institute/Massachusetts Institute of 
Technology, Cambridge: Transcriptional control of cell state.
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Genetics of Complex Human Diseases
August 7–13
INSTRUCTORS A. Al-Chalabi, Kings College, London, United Kingdom
 L. Almasy, Southwest Foundation for Biomedical Research, San Antonio, Texas
Complex diseases are conditions that are infl uenced by the actions of multiple genes and their 
interactions with each other and with the environment. This lecture course considered the dif-
fi culties in studying the genetic basis of complex disorders such as diabetes, cardiovascular dis-
ease, cancer, Alzheimer’s disease, schizophrenia, and epilepsy. We discussed genetic-epidemiologic 
study designs, including family, twin, case/control, and adoption studies, as well as methods for 
quantifying the strength of the genetic infl uences on a disease. A major focus was the identifi ca-
tion of specifi c gene effects using both linkage and association analysis and their variants. We 
discussed the effi ciency and robustness of different designs for such analysis and how evidence 
from epidemiologic studies informs both the design and interpretation of molecular genetic stud-
ies. Study design and methods for analysis of quantitative risk factors related to complex diseases 
were covered as well as haplotype mapping, SNP tagging, meta-analysis, and gene-environment 
interaction. An overview of high-throughput laboratory methods was given to provide partici-
pants with insight into the applications of these techniques. Illustrations were provided through 
discussion of results from ongoing studies of a variety complex diseases and related risk factors.
PARTICIPANTS
Chen, G., B.S., Stowers Institute for Medical Research, 
Kansas City, Missouri
Crutchley, R., Pharm.D., University of Houston, College of 
Pharmacy, Texas
Deik, A., M.D., Beth Israel Medical Center, New York
Feng, Y., Ph.D., Columbia University, New York
Glerup, S., Ph.D., Aarhus University, Aarhus, Denmark
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Jones, A., Ph.D., Institute of Psychiatry, King’s College 
London, United Kingdom
Jones, G., Ph.D., Frederick National Laboratory for Cancer 
Research, Maryland
Knox, R., Ph.D., University of California, San Francisco
Østergaard, S., M.D., Unit for Psychiatric Research, Aalborg, 
Denmark
Perea, C., M.Sc., Universidad Antonio Nariño, Bogotá, 
Colombia
Puccio, A., Ph.D., University of Pittsburgh, Pennsylvania
Quillen, E., Ph.D., Texas Biomedical Research Institute, San 
Antonio
Scott, K., M.Phil., University of Cambridge, United Kingdom
Scott, R., Ph.D., Addenbrooke’s Hospital, Cambridge, 
United Kingdom
Vinson, A., Ph.D., Oregon Health & Science University, 
Beaverton
Xu, H., Ph.D., National Institutes of Health, Bethesda, 
Maryland
Zeevi, D., Ph.D., Weizmann Institute of Science, Rehovot, Israel
SEMINARS
Sinsheimer, J., University of California, Los Angeles: 
Statistics 101.
Borecki, I., Washington University School of Medicine, 
St. Louis, Missouri: Introduction to genetic 
epidemiology.
Loos, R., Mount Sinai School of Medicine, New York: 
Gene–environment interaction and common disease.
Petronis, A., University of Toronto, Ontario, Canada: 
Epigenomics of complex disease.
Knight, J., Centre of Addiction and Mental Health, Toronto, 
Canada: GWAS and principles of association.
Nickerson, D., University of Washington, Seattle: 
Sequencing: The fi nal frontier in genetic analysis.
Sham, P., University of Hong Kong, China: Power 
calculations for genetic studies.
Purcell, S., Mount Sinai School of Medicine, New York: 
Analysis of data from next-generation sequencing studies: 
Population-based targeted resequencing and PLINK/SEQ 
practical.
Neale, B., Massachusetts General Hospital, Boston: Exome 
arrays and analyzing de novo variation.
MacArthur, D., Massachusetts General Hospital, Boston.
Breen, G., King’s College London, United Kingdom: 
Linkage analysis in human complex disorders: Examples 
from current studies in neuropsychiatry; miRNAs: An 
introduction and their role in human diseases.
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X-Ray Methods in Structural Biology
October 15–30
INSTRUCTORS W. Furey, V.A. Medical Center & University of Pittsburgh, Pennsylvania
 G. Gilliland, Janssen R&D, LLC, Johnson & Johnson, Radnor, Pennsylvania
 A. McPherson, University of California, Irvine
 J. Pfl ugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT R. Cardoso, Janssen R&D, LLC, Johnson & Johnson, Radnor, Pennsylvania
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable 
through other methods. This intensifi ed laboratory/computational course focused on the major 
techniques used to determine the three-dimensional structures of macromolecules. It was de-
signed for scientists with a working knowledge of protein structure and function, but who 
are new to macromolecular crystallography. Topics covered included basic diffraction theory, 
crystallization (proteins, membrane proteins, nucleic acids, and complexes), crystal character-
ization, X-ray sources and optics, synchrotrons, crystal freezing, data collection, data reduction, 
multiple isomorphous replacement, multiwavelength anomalous diffraction, molecular replace-
ment, solvent fl attening, noncrystallographic symmetry averaging, electron density interpreta-
tion, molecular graphics, structure refi nement, structure validation, coordinate deposition, and 
structure presentation. Participants learned through extensive hands-on experiments. One or 
more proteins were crystallized and the structure(s) determined by several methods, in parallel 
with lectures on the theory and informal discussions behind the techniques.
This course was supported with funds provided by the National Institute of General Medical 
Sciences.
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PARTICIPANTS
Baker, P., Ph.D., The Hospital for Sick Children, Toronto, 
Canada
Basilio, D., Ph.D., Weill Cornell Medical College, New York
Bedford, R., B.S., University of North Carolina, Chapel Hill
Chappie, J., Ph.D., National Institute of Diabetes and 
Digestive and Kidney Disease/NIH, Bethesda, Maryland
Cuello, L., Ph.D., Texas Tech University Health Sciences 
Center, Lubbock
Deis, S., B.A., Indiana University, Bloomington
Duerr, K., Ph.D., Oregon Health and Science University, 
Portland
Feklistov, A., Ph.D., The Rockefeller University, New York
Kassube, S., M.Sc., University of California, Berkeley
Lin, D., B.S., California Institute of Technology, Pasadena
Malinauskaite, L., B.S., Aarhus University, Aarhus, 
Denmark
Mikaelsson, C., M.S., Karolinska Institute, Stockholm, 
Sweden
Rouge, L., M.S., Genentech, South San Francisco, California
Soumana, D., Ph.D., University of Massachusetts Medical 
School, Worcester
Wangkanont, K., B.S., University of Wisconsin, Madison
Winkler, D., Ph.D., HHMI/Colorado State University, 
Fort Collins
SEMINARS
Caffrey, M., Trinity College Dublin, Ireland: Crystallizing 
membrane proteins for structure-function studies using 
lipidic mesophases.
Chen, Y.-h., Columbia University, New York: Crystallization 
of TehA membrane protein.
Cohen, A., Stanford Linear Accelerator Center, California: 
Remote synchrotron data collection.
Emsley, P., University of Glasgow, Oxford, United Kingdom: 
Model-building tools in coot.
Furey, W., V.A. Medical Center & University of Pittsburgh, 
Pennsylvania: Anomalous data collection consideration; 
Patterson group therapy; Isomorphous replacement 
and anomalous scattering; Solvent fl attening/phase 
combination; Noncrystallographic symmetry averaging; 
MAD phasing: A classical approach. The role of direct 
methods in macromolecular crystallography.
Furukawa, H., Cold Spring Harbor Laboratory: Structural 
dissection of NMDA receptor pharmacology.
Gilliland, G., Janssen R&D, LLC, Johnson & Johnson, 
Radnor, Pennsylvania: Welcome and introduction; Course 
overview: The structure determination of biological 
macromolecules; Maximizing crystallization success 
through seeding.
Hendrickson, W., Columbia University, New York: MAD 
and SAD phasing.
Holton, J., University of California, San Francisco: Signal 
vs. noise: Where they come from and how to tip the 
balance in your favor; Tips and tricks for improving 
diffraction.
Kleywegt, G., European Bioinformatics Institute, 
Cambridge, United Kingdom: Just because it’s in 
Nature, doesn’t mean it’s true (macromolecular 
structure validation).
McPherson, A., University of California, Irvine: 
Crystallization of macromolecules I; Crystallization of 
macromolecules II; Symmetry, periodicity, unit cells, space 
groups, miller planes, and lattices; Waves, vectors, and 
complex numbers; Fundamental diffraction relationships 
and Bragg’s Law; Diffraction patterns, reciprocal space, and 
Ewald’s Sphere; Fourier transforms and the electron density 
equation; Patterson methods.
Perrakis, A., The Netherlands Cancer Institute, Amsterdam: 
Automated model building and rebuilding: From ARP/
WARP to PDB REDO; Macromolecular animation.
Pfl ugrath, J., Rigaku Americas Corporation, The 
Woodlands, Texas: Data collection: Design and setup; 
Cryocrystallography; HKL2000 tutorial; Scaling and 
merging synchrotron data.
Ready, R., University of Cambridge, United Kingdom: Using 
SAD data in phase; Molecular replacement: New structures 
from old.
Richardson, D., Duke University Medical Center, Durham, 
North Carolina: Structure presentation; Detection and 
repair of model errors using MolProbity.
Sweet, R., Brookhaven National Laboratory, Upton, 
New York: A slightly different view of fundamental 
crystallography; X-ray sources and optics.
Terwilliger, T., Los Alamos National Laboratory, New 
Mexico: Automated structure solution and model-building.
Tronrud, D., Oregon State University, Corvalis: 
Macromolecular refi nement I; Macromolecular refi nement 
II; Electron density maps.
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Programming for Biology
October 15–30
INSTRUCTOR S. Prochnick, DOE-Joint Genome Institute, Berkeley, California
CO-INSTRUCTOR S. Robb, University of California, Riverside
ASSISTANTS J. Bredeson, University of California, Berkeley
 S. Kocher, Harvard University, Cambridge, Massachusetts
 D. Messina, Cofactor Genomics, St. Louis, Missouri
 R. Ramamurthy, University of California, Riverside
 E. Ross, Stowers Institute for Medical Research/HHMI, Kansas City, Missouri
 S. Rynearson, University of Utah, Salt Lake City
 D. Triant, University of Virginia, Charlottesville
A computer is already an indispensable tool for database searches, but the use of web-based tools 
alone is not enough for today’s biologist who needs to access and work with data from myriad 
sources in disparate formats. This need will become ever more important as new technologies in-
crease the already exponential rate at which biological data is generated. Designed for students and 
researchers with little or no prior programming experience, this 2-week course gave biologists the 
299-418_Meetings & Courses.indb   406 9/17/2013   8:21:27 AM
Programming for Biology  407
bioinformatics skills necessary to exploit this abundance of biological data. The course was based 
around the Perl scripting language because of its ease of learning and incredible wealth of ready-
built modules such as Bioperl, which was designed to solve common biological problems. Starting 
with introductory coding and continuing with a survey of available biological libraries and practical 
topics in bioinformatics, students end by learning how to construct and run powerful and extensible 
analysis pipelines in a straightforward manner. The course combined formal lectures with hands-on 
sessions in which students worked to solve problem sets covering common scenarios in the acquisi-
tion, validation, integration, analysis, and visualization of biological data. For their fi nal projects, 
which run during the second week of the course, students were posed problems using their own data 
and worked with each other and the faculty to solve them. Final projects have formed the basis of 
publications as well as public biological websites (see, e.g., http://bio.perl.org/wiki/Deobfuscator).
The prerequisite for the course was basic knowledge of UNIX. Lectures and problem sets 
covering this background material were available online from previous years and students studied 
this material before starting the course. Note that the primary focus of this course was to provide 
students with practical programming experience, rather than to present a detailed description of 
the algorithms used in computational biology. For the latter, we recommend the Computational 
and Comparative Genomics course.
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Andino, G., B.S., Purdue University, W. Lafayette, Indiana
Bazzini, A., Ph.D., Yale University School of Medicine, New 
Haven, Connecticut
Borhan, H., Ph.D., AAFC, Saskatoon, Canada
Boundy, K., M.D., University of Massachusetts Medical 
School, Worcester
Cavinder, B., Ph.D., University of California, Riverside
Hall, M., B.S., Pennsylvania State University, University Park
Hartmaier, R., Ph.D., University of Pittsburgh, Pennsylvania
Law, M.-Y., Ph.D., University of Utah, Salt Lake City
Leung, M., B.S., University of Texas/M.D. Anderson Cancer 
Center, Houston
Low, L., Ph.D., Malaysian Palm Oil Board, Kajang, Malaysia
Martin, L., M.S., Cornell University, Ithaca, New York
Murray, P., B.A., Yale University, New Haven, Connecticut
Ngara, M., M.Sc., International Institute of Tropical 
Agriculture, Nairobi, Kenya
Nickel, N., Ph.D., Case Western Reserve University, 
Cleveland, Ohio
Oetjens, M., Ph.D., Vanderbilt University, Nashville, 
Tennessee
Panda, K., M.S., Ohio State University, Columbus
Seda Miro, J., Ph.D., Pontifi cal Catholic University of Puerto 
Rico, Ponce
Shah, S., Memorial Sloan-Kettering Cancer Center, 
New York
Tasdemir-Yilma, O., B.S., University of Massachusetts 
Medical School, Worcester
Zinovyeva, A., Ph.D., University of Massachusetts Medical 
School, Worcester
SEMINARS
Cain, S., Ontario Institute of Cancer Research, Canada: 
Gbrowse genome browser tutorial and workshop.
Chia, J.-M., Cold Spring Harbor Laboratory: Databases 
and SQL.
Haas, B., Broad Institute, Cambridge, Massachusetts: 
RNA-Seq II: Lecture: RNA-Seq assembly and differential 
expression; RNA-Seq III: Workshop: RNA-Seq assembly.
Hide, W., Harvard University, Boston, Massachusetts: RNA-
Seq I: mRNA sequencing and assembly.
J. Tisdall, DuPont Experimental Station, Wilmington, 
Delaware: Scientifi c computing.
Marques, T., Universitat Popeu Fabra, Barcelona, Spain: 
DNA sequence III: Structira; variation.
Marth, G., Boston College, Chestnut, Massachusetts: DNA 
sequence II: Haplotypes, variants.
Pearson, W., University of Virginia, Charlottesville: Protein 
sequence I. Lecture: Sequence searching, blast, homology; 
Protein sequence II. Workshop: Sequence searching.
Schatz, M., Cold Spring Harbor Laboratory
Stajich, J., University of California, Riverside: DNA 
sequence I: Handling NGS data, fi ltering, aligning, 
SNP calling.
Thomas, P., University of Southern California, Los Angeles: 
Protein function prediction and annotation.
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Antibody, Engineering, and Phage Display
October 17–30
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
 D. Siegel, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
 G. Silverman, New York University School of Medicine, New York
ASSISTANTS S. Kacir, University of Pennsylvania, Philadelphia
 C. Noren, New England Biolabs, Ipswich, Massachusetts
 K. Noren, New England Biolabs, Ipswich, Massachusetts
 L. Novinger, University of Vermont College of Medicine, Burlington
Recent advances in the generation and selection of antibodies from combinatorial libraries allow 
for the rapid production of antibodies from immune and nonimmune sources. This intensive 
laboratory/lecture course focused on the construction of combinatorial antibody libraries ex-
pressed on the surface of phage and selection of desired antibodies from the library. Students 
learned the theoretical and practical aspects of constructing combinatorial libraries from im-
mune and nonimmune sources to the construction of synthetic antibody libraries. Antibodies 
were selected from the library by panning. Production, purifi cation, and characterization of Fab 
fragments expressed in Escherichia coli were also covered. Epitopes were selected from peptide 
libraries and characterized.
The lecture series, presented by a number of invited speakers, emphasized PCR of immuno-
globulin genes, the biology of fi lamentous phage and the utility of surface expression libraries, 
expression of antibodies in E. coli and mammalian cells, antibody structure and function, cata-
lytic antibodies, directed protein evolution, yeast and cell display libraries, the immunobiology 
of the antibody response, and recent results on the use of antibodies in therapy for cancer, 
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HIV, and Alzheimer’s disease. The theory and practical implications for selection from phage-
displayed libraries of random peptides, cDNA products, and semisynthetic proteins were also 
explored.
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Blosser, T., Ph.D., Technical University of Delft, the 
Netherlands
Freire, M., Ph.D., Harvard University, Cambridge, 
Massachusetts
George, M., B.S., University of South Florida, Tampa
Gilgunn, S., B.Sc., Dublin City University, Ireland
Hammond, M., M.Sc., Uppsala University, Sweden
Jores, J., Ph.D., University of Alberta, Edmonton, Canada
Kanje, S., M.S., Royal Institute of Technology, Stockholm, 
Sweden
Lu, X., Ph.D., Celgene, Warren, New Jersey
Matochko, W., Ph.D., University of Alberta, Edmonton, 
Canada
Pohl, M.A., Albert Einstein College of Medicine, Bronx, 
New York
Ribiero, J., Ph.D., New York University, New York
Sabetzadeh, B.S., B.S., University of Sydney, Australia
Sall, S., M.Sc., Lund University, Sweden
Seijsing, J., M.Sc., Royal Institute of Technology, Stockholm, 
Sweden
Tafreshi, N., B.S., Moffi tt Cancer Center and Research 
Institute, Tampa, Florida
Volk, A.-L., M.S., Royal Institute of Technology, Stockholm, 
Sweden
SEMINARS
Barbas, C., The Scripps Research Institute, La Jolla, 
California: New approaching to therapeutic antibodies.
Chung, J., Seoul National University School of Medicine, 
South Korea: Anti-hapten antibody as a carrier of 
peptides or aptamers; Intracellular expression of 
antiphosphotyrosine residue antibody.
Derda, R., University of Alberta, Edmonton, Canada: 
Organic chemistry on phage, evolution of reactivity, and 
genetically encoded libraries of nonpeptidic molecules.
Noren, C., New England BioLabs, Beverly, Massachusetts: 
Phage peptide libraries: The Ph.D. for peptides Ipswich.
Rader, C., The Scripps Research Institute, Jupiter, Florida: 
Monoclonal antibody drug and target discovery for cancer 
therapy.
Scholler, N., Perelman School of Medicine at the 
University of Pennsylvania, Philadelphia: Saccharomyces 
cerevisiae for display and expression of tagged 
antibodies.
Sidhu, S., University of Toronto, Ontario, Canada: Synthetic 
proteins: New tools for new biology.
Siegel, D., Perelman School of Medicine at the University of 
Pennsylvania, Philadelphia: Use of antibody phage display 
to study human immune repertoires.
Silverman, G., New York University School of Medicine, 
New York: Overview of innate and adaptive immune 
systems.
Stahl, S., KTH Royal Institute of Technology, Stockholm, 
Sweden: Affi body molecules and their applications in 
cancer and Alzheimer’s disease.
Stansfi eld, R., The Scripps Research Institute, La Jolla, 
California: Structural biology of the immune 
system.
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Advanced Sequencing Technologies and Applications
October 18–30
INSTRUCTORS E. Mardis, Washington University School of Medicine, St. Louis, Missouri
 G. Marth, Boston College, Chestnut Hill, Massachusetts
 W. McCombie, Cold Spring Harbor Laboratory
 A. Quinlan, University of Virginia, Charlottesville
 M. Zody, Broad Institute, Cambridge, Massachusetts
ASSISTANTS A. Farrell, Boston College, Chestnut Hill, Massachusetts
 M. Griffi th, Washington University School of Medicine, St. Louis, Missouri
 O. Griffi th, Washington University School of Medicine, St. Louis, Missouri
 M. Kramer, Cold Spring Harbor Laboratory
 V. Magrini, Washington University School of Medicine, St. Louis, Missouri
 S. McGrath, Washington University School of Medicine, St. Louis, Missouri
 J. Walker, Washington University School of Medicine, St. Louis, Missouri
During the last decade, large-scale DNA sequencing has markedly impacted the practice of mod-
ern biology and is beginning to affect the practice of medicine. With the recent introduction of 
several advanced sequencing technologies, costs and timelines have been reduced by orders of 
magnitude, encouraging investigators to conceptualize and perform sequencing-based projects 
that had been impractical. Furthermore, the application of these technologies to answer ques-
tions previously not experimentally approachable is broadening their impact and application.
This intensive 2-week course explored applications of next-generation sequencing technologies, 
with a focus on commercially available methods. Students were instructed in the detailed op-
eration of several revolutionary sequencing platforms, including sample preparation procedures, 
general data handling through pipelines, and in-depth data analysis. A diverse range of biological 
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questions was explored, including DNA resequencing of human genomic regions (using cancer 
samples as a test case), de novo DNA sequencing of bacterial genomes, and the use of these tech-
nologies in studying small RNAs, among others. Guest lecturers highlighted their own applica-
tions of these revolutionary technologies. We encouraged applicants from a diversity of scientifi c 
backgrounds including molecular evolution, development, neuroscience, cancer, plant biology, 
and microbiology.
This course was supported by the National Human Genome Research Institute, Illumina & 
Life Technologies, and with major equipment provided by Illumina & Life Technologies.
PARTICIPANTS
Altinas, A., Ph.D., Technical University of Denmark, 
Kongens Lyngby, Denmark
Aruda, A., Ph.D., MIT/WHOI Joint Program in 
Oceanography, Woods Hole, Massachusetts
Augustine, R., B.S., University of Wisconsin, Madison
Barnard-Kubow, K., Ph.D., University of Virginia, 
Charlottesville
Cembrowski, M., Ph.D., Howard Hughes Medical Institute, 
Ashburn, Virginia
Dali, R., Ph.D., McGill University, Montreal, Canada
Finberg, K., M.D., Duke University Medical Center, 
Durham, North Carolina
Fink, S., Ph.D., Case Western Reserve University, Cleveland, 
Ohio
Hu, W., Ph.D., Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts
Justice IV, J., Ph.D., Johns Hopkins University, Baltimore, 
Maryland
Pereira, J., Ph.D., Fox Chase Cancer Center, Philadelphia, 
Pennsylvania
Platt, M., M.D., Massachusetts General Hospital, Boston
Estrada, V., Ph.D., The Rockefeller University, New York
Reuther, J., Ph.D., M.D. Anderson Cancer Center, Houston, 
Texas
Schrader, K., Ph.D., Memorial Sloan-Kettering Cancer 
Center, New York
Thomas, R., Ph.D., USMHRP, Walter Reed Army Institute 
of Research, Silver Spring, Maryland
SEMINARS
Brayer, J., Oxford Nanopore Technologies, Essex, 
United Kingdom: Nanopore sequencing.
Goldstein, T., University of California, Santa Cruz: 
PARADIGM, DIPSC, and PATHMARK software in 
pathway-based analyses.
Griffi th, M., Washington University School of Medicine, 
St. Louis, Missouri: RNA-Seq.
Haas, B., The Broad Institute of MIT and Harvard, 
Cambridge, Massachusetts: Trinity RNA-Seq assembly 
software.
Hall, I., University of Virginia, Charlottesville: Structural 
variant detection.
Mardis, E., Washington University School of Medicine, 
St. Louis, Missouri: NGS in cancer genomics studies.
McCombie, W., Cold Spring Harbor Laboratory
Quinlan, A., University of Virginia, Charlottesville: Mining 
the genome.
Robertson, A., Life Technologies, Inc., Carlsbad, California: 
Ion torrent and ion proton sequencers.
Robinson, J., The Broad Institute of MIT and Harvard, 
Cambridge, Massachusetts: The IGV viewer.
Schadt, E., Mount Sinai School of Medicine, New York: 
Build better models of disease in the era of big data.
Schatz, M., Cold Spring Harbor Laboratory: Assembly of 
NGS data.
Sisneros, N., Pacifi c Biosciences, Menlo Park, California: 
SMRT sequencing with the Pacifi c Biosciences Sequencer.
Smith, A., University of Southern California, Los Angeles: 
Methylation by NGS bisulfi te data analysis.
Smith, G., Illumina, Chesterford, United Kingdom: Illumina 
presentation.
Stolovitsky, G., IBM, Yorktown Heights, New York: 
Nanopore sequencing development.
Yandell, M., University of Utah, Salt Lake City: VAAST and 
VAAST pedigree analysis.
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Computational and Comparative Genomics
November 28–December 4
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
 L. Stubbs, University of Illinois, Urbana-Champaign
ASSISTANTS X. Cao, University of Illinois, Urbana-Champaign
 L. Mills, University of Virginia, Charlottesville
This course presented a comprehensive overview of the theory and practice of computational 
methods for the identifi cation and characterization of functional elements from DNA sequence 
data. The course focused on approaches for extracting the maximum amount of information from 
protein and DNA sequence similarity through sequence database searches, statistical analysis, and 
multiple sequence alignment. Additional topics included alignment and analysis of “next-gen” 
sequencing data, with applications from metagenomic, RNA-Seq, and ChIP-Seq experiments; the 
Galaxy environment for high-throughput analysis; regulatory element and motif identifi cation 
from conserved signals in aligned and unaligned sequences; integration of genetic and sequence 
information in biological databases; and the ENSEMBL genome browser and BioMart.The course 
combined lectures with hands-on exercises; students were encouraged to pose challenging se-
quence analysis problems using their own data. The course was designed for biologists seeking ad-
vanced training in biological sequence and genome analysis, computational biology core resource 
directors and staff, and for individuals in other disciplines (e.g., computer science) who wish to 
survey current research problems in biological sequence analysis. Advanced programming skills 
were not required. The primary focus of this course was the theory and practice of algorithms in 
computational biology, with the goals of using current methods more effectively for biological 
discovery and developing new algorithms. Students more interested in the practical aspects of 
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software development were encouraged to apply to the course on Programming for Biology. Stu-
dents who liked in-depth training in the analysis of next-generation sequencing data (e.g., SNP 
calling and the detection of structural variants) should apply to the course on Advanced Sequenc-
ing Technologies and Applications.
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Bjoerklund, S., B.S., University of Oslo, Radium Hospital, 
Norway
Copin, R., Ph.D., New York University School of Medicine, 
New York
Dali, R., B.Sc., McGill University, Montreal, Canada
Davis, M., B.S., Yale Medical and Graduate School, New 
Haven, Connecticut
DeHart, J., B.S., The Salk Institute, La Jolla, California
Edgington, N., Ph.D., Southern Connecticut State 
University, New Haven
Froekjaer Jensen, C., Ph.D., University of Utah, Salt Lake City
Ingram, C., Ph.D., University of Virginia, Charlottesville
Kazmierczak, B., Ph.D., Yale University School of Medicine, 
New Haven, Connecticut
Labo, N., M.P.H., Frederick National Laboratories for 
Cancer Research, Maryland
Lam, D., Ph.D., Ohio University, Athens
Malone, J., Ph.D., Florida State University, Tallahassee
Meihls, L., Ph.D., The Boyce Thompson Institute for Plant 
Research, Ithaca, New York
Rehan, S., Ph.D., University of Pennsylvania, 
Philadelphia
Sandel, M., B.S., University of Alabama, Birmingham
Sawicka, A., M.S., Medical University of Vienna, Austria
Sleckman, B., Ph.D., Washington University School of 
Medicine, St. Louis, Missouri
Stojanova, Z., M.S., House Research Institute, Los Angeles, 
California
Tavera-Mendoza, L.E., Ph.D., Dana-Farber Cancer Institute/
Harvard Medical School, Boston, Massachusetts
Zacharias, A., Ph.D., University of Pennsylvania, 
Philadelphia
SEMINARS
Mackey, A., University of Virginia, Charlottesville: Genome 
annotation (HMM basics); Sequencing technologies/tools; 
SNP discovery and variation; Whole-genome de novo 
assembly; RNA-Seq.
Ouellette, F., Ontario Institute for Cancer Research, Toronto, 
Canada: Databases for computational biology; The 
Ensembl database of genomes; Review/panel discussion: 
Ensembl/UCSC–Which browser when?; ENSEMBL/
BioMart; Ensembl API; Gene lists, interaction, and 
pathway databases.
Pearson, W., University of Virginia, Charlottesville: Protein 
evolution and sequence similarity sequencing; Alignment 
algorithms and scoring matrices; Multiple sequence 
alignment, PSSMs, HMMs, and Pfam; Phenotype 
prediction PolyPhen/SIFT.
Pearson, W., University of Virginia, Charlottesville; Stubbs, L., 
University of Illinois, Urbana-Champaign: Introduction 
and overview.
Sinha, S., University of Illinois, Urbana-Champaign: 
Identifying functional DNA motifs; Tying functional 
elements to biology.
Sinha, S., University of Illinois, Urbana-Champaign; 
Zhong, S., University of California, San Diego: Integrating 
genomics data sets for biological inference.
Stubbs, L., University of Illinois, Urbana-Champaign: 
Introduction to genome biology.
Taylor, J., Emory University, Atlanta, Georgia; Mills, L., 
University of Virginia, Charlottesville; Ouellette, F., 
Ontario Institute for Cancer Research, Toronto, Canada: 
The Galaxy computing environment; Galaxy for high-
throughput analysis.
Zhong, S., University of California, San Diego: Functional 
elements: II–Epigenomics.
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The Genome Access Course
April 29–May 1, November 12–14
TRAINERS A. Gordon, Cold Spring Harbor Laboratory
 G. Howell, The Jackson Laboratory
 B. King, Mount Desert Island Biological Laboratories
 C. Lambert, Cold Spring Harbor Laboratory
This course is an intensive 2-day introduction to bioinformatics that was held twice in 2012 and 
trained almost 70 participants in total. The core of the course was designed to cover the manipula-
tion and analysis of sequence information. The course was broken into modules designed to give 
a broad overview of a given topic, with ample time for examples chosen by the instructors. Each 
module included three parts, consisting of a discussion of theory and methods, coverage of software 
and web resources, and use of selected tools with examples (including those supplied by the stu-
dents). The modular design allowed the instructors to tailor the presentation to the interests of the 
students. Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; 
Multiple Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein 
Classifi cation and Structural Analysis; Proteomics; and Phylogenetic Analysis. Applications to the 
course were open to all on a fi rst-come-fi rst-served basis, subject to basic eligibility requirements. 
Each student was provided with a PC laptop with wireless modem for the duration of the course. 
Students were encouraged to supply problem sets and sequences of interest to the trainers for pos-
sible incorporation as examples in the modules. Materials were made available on the web and 
students continued to ask questions of the trainers as they applied what they had learned in their 
individual endeavors.
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April 29 –May 1
Biais, N., Columbia University, New York
Boncristiani, H., University of North Carolina, Greensboro
Brownstein, C., Boston Children’s Hospital, Massachusetts
Castellano-Torres, L., Universidad de Guanajuato, 
Guanajuato, Mexico
Cheung, H.-W., Dana-Farber Cancer Institute, Boston, 
Massachusetts
Cimmino, L., New York University, New York
Cooper, M., Washington University, St. Louis, Missouri
Fabius, A., Memorial Sloan-Kettering Cancer Center, 
New York
Fakhro, K., Cornell University, New York
Feng, J., Mount Sinai School of Medicine, New York
Guryanova, O., Memorial Sloan-Kettering Cancer Center, 
New York
Hurwitz, M., Yale University School of Medicine, New 
Haven, Connecticut
Kosova, G., Northwestern University, Chicago, Illinois
Lebowitz, J., BioMarin Pharmaceutical, Novato, California
Lopez, D., U.S. Department of Agriculture/Agricultural 
Research Service, Beltsville, Maryland
Miller, A., St. Louis University, Missouri
Ostrovnaya, I., Memorial Sloan-Kettering Cancer Center, 
New York
Petukhova, L., Columbia University, New York
Qin, W., The Jackson Laboratory, Bar Harbor, Maine
Rabara, R., South Dakota State University, Brookings
Rapp, J., University of Toledo, Ohio
Riddle, S., Life Technologies Corp., Madison, Wisconsin
Schatz, J., Memorial Sloan-Kettering Cancer Center, 
New York
Simard, L., University of Manitoba, Winnipeg, Canada
Tarbox, J., Washington University, St. Louis, Missouri
Vogel, K, Life Technologies Corp., Madison, Wisconsin
Wang, E., BioMarin Pharmaceuticals Inc., San Francisco, 
California
Xu, J., Tufts University, North Grafton, Massachusetts
Yu, D., University of Texas/M.D. Anderson Cancer Center, 
Houston
Zhang, P., University of Texas/M.D. Anderson Cancer 
Center, Houston
November 12–14
Allen, V., University of Toronto, Ontario, Canada
Basson, M., King’s College London, United Kingdom
Belanger, R., Laval University, Quebec, Canada
Colaneri, A., University of North Carolina, Chapel Hill
Dowar, M., Samuel Lunenfeld Research Institute, Mount 
Sinai, Toronto, Canada
Feinstein, P., Hunter College, CUNY, New York,
Gubbay, J., Public Health Ontario Laboratory, Toronto, Canada
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Haffner, M., Johns Hopkins University, Baltimore, Maryland
Harke, M., Stony Brook University, Southampton, New York
Ingraham, S., Nationwide Children’s Hospital, Columbus, 
Ohio,
Jafarifar, F., Cleveland Clinic–Lerner Research Institute, 
Cleveland, Ohio
Jain, S., M.D. Anderson Cancer Center, Houston, Texas
Ji, Y., Mayo Clinic, Rochester, Minnesota
Lukasiewicz, K., National Institutes of Health, Bethesda, 
Maryland
Maness, P., University of North Carolina School of Medicine, 
Chapel Hill
McIvor, E., University of Texas/M.D. Anderson Cancer 
Center, Smithville
Mootha, V., University of Texas Southwestern Medical 
Center, Dallas
Napierala, M., University of Texas/M.D. Anderson Cancer 
Center, Smithville
Palangat, M., National Cancer Institute/NIH, Bethesda, 
Maryland
Park, H.J., University of Cambridge, United Kingdom
Patel, S., Public Health Ontario, Toronto, Canada
Ragan, S., Amgen, Seattle, Washington
Raznahan, A., National Institute of Mental Health/NIH, 
Bethesda, Maryland
Reed, D., Monell Chemical Senses Center, Philadelphia, 
Pennsylvania
Royal, M.A., Rutgers University, Piscataway, New Jersey
Ruhl, S., SUNY Buffalo, New York,
Sanda, T., Dana-Farber Cancer Institute, Boston, 
Massachusetts
Sayed, S., BRAC University, Dhaka, Bangladesh
Soliman, G., Western Michigan University, Kalamazoo
Swartz, K., Northwestern University, Chicago, Illinois
Tran, N.Q., University of Tennessee Health Science Center, 
Memphis
The Laboratory acknowledges the generosity of the following companies that loaned equipment and 
reagents to the various courses:
Agilent Technologies Inc. 
Andor Technology 
Applied Biosystems
Applied Precision 
Art Robbins Institute 
ASI Imaging
Astro-Med Inc. 
BD Biosciences 
Berthold Technologies 
USA, LLC 
Bio-Rad Laboratories 
Cairn Research LTD 
Caliper Life Sciences 
Carl Zeiss Inc. 
Chroma Technology 
Corporation 
Coherent Laser 
ConOptics
CoolLED
Corning Inc. 
Covaris, Inc. 
CrystaLaser
Dagan Corporation 
Dage
Doric Lenses 
Drummond Scientifi c 
Company 
Eppendorf North America 
Fludigm; Fotodyne Inc. 
GE Life Sciences 
Hamamatsu Photonic 
Systems 
Hamilton Thorne 
Biosciences 
Hampton Research 
Harvard Apparatus Inc. 
Heka Instruments 
Illumina Inc. 
Intelligent Imaging 
Innovations Inc. 
Invitrogen
Jackson Immunoresearch 
Laboratories 
Kinetic Systems Inc. 
Kopf Instruments 
Leica Microsystems Inc. 
LI-COR 
Life Technologies 
Luigs & Neumann 
Millipore Corporation 
Miltenyi Biotec Inc. 
Molecular Devices 
Nalge Nunc International 
Nanodrop Technologies 
Narishige International 
USA Inc.
NeoBiosystems
New England BioLabs Inc. 
Newport Instruments 
Nikon Inc. 
Nonlinear Dynamics 
NuGEN
Olympus America Inc. 
PerkinElmer Life and 
Analytical Sciences 
Photometrics
Prairie Technologies
Qiagen Inc. 
RC Testing Services 
Red Shirt Imaging, LLC 
Roche Applied Science 
Roche Nimblegen
Scientifi ca Ltd. 
SciGene
Singer Instruments 
Spectra-Physics Lasers Inc. 
Stanford Photonics 
Stanford Research Systems 
Stratagene
Sutter Instruments 
Tecan US, Inc. 
Thermo Fisher Scientifi c 
Thor Labs 
VDS Vosskuhler GmbH 
Warner Instruments 
Waters Corporation 
World Precision 
Instruments
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SEMINARS
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present 
their research fi ndings. These weekly seminars keep the CSHL staff current on the latest scientifi c 
developments and broaden their perspectives. Graduate students and postdoctoral fellows meet 
with the seminar speakers for lunch immediately after the seminar, providing an opportunity for 
the exchange of ideas in an informal setting.
Title Host
January
Dr. Mark Bear, Massachusetts Institute of 
Technology
Synaptic plasticity: From amblyopia to autism. Stephen Shea
Dr. Bonnie Basler, Princeton University Manipulating quorum sensing to control 
bacterial pathogenicity.
Terri Grodzicker
Dr. Rachel Green, Johns Hopkins University 
School of Medicine
Quality control during translation in bacteria 
and eukaryotes.
Leemor Joshua-Tor
Dr. Matthew Meyerson, Dana Farber Cancer 
Institute
Genomic studies of human cancer. Hongwu Zheng
February
Dr. Alejandro Sánchez Alvarado, Stowers 
Institute for Medical Research
Stem cells, regeneration, and the planarian 
Schmidtea mediterranea.
Christopher Hammell
Dr. Ed Luk, Stony Brook  University Mechanism of histone H2A.Z replacement by 
the SWR1 chromatin remodeling complex.
David L. Spector
Dr. Mike Levine, University of California, 
Berkeley
Mechanisms of transcriptional precision in the 
Drosophila embryo. 
Marja Timmermans
Dr. Carol Robinson, University of Oxford Mass spectrometry from micelles to  motors. Leemor Joshua-Tor
March
Dr. Robert Langer, Massachusetts Institute 
of Technology
Biomaterials and biotechnology: From the 
discovery of the fi rst angiogenesis inhibitors to 
the development of controlled drug delivery 
systems and the foundation of tissue engineering.
Postdocs
Dr. Ronald Breaker, Yale  University New and mysterious riboswitches and ribozymes. Christopher Hammell
Dr. Guoping Feng, Massachusetts Institute 
of Technology
Synaptic and circuitry mechanisms of 
compulsive/repetitive behavior.
Joshua Huang
Dr. Mina Bissell, Lawrence  Berkeley 
National Laboratory
Everything is context dependent: Tales of glucose 
metabolism, MyC, and other players!
Mikala Egeblad
April
Dr. Michael Karin, University of California, 
San Diego
Lymphocyte-produced cytokines and the control of 
tumor development and metastatic progression.
Mikala Egeblad
May
Dr. Qiang Wu, Shanghai Jiao Tong 
University, China
Molecular diversity and genetic analysis of 
variable and constant gene clusters.
Adrian R. Krainer
October
Dr. Dirk Schübeler, Friedrich Miescher Insti-
tute for Biomedical Research, Switzerland
DNA sequence determinants of the  epigenome. Keerthi Krishnan
Dr. Songhai Shi, Memorial Sloan-Kettering 
Institute for Cancer Research
Structural and functional development of the 
neocortex.
Joshua Huang
November
Craig Thompson, Memorial Sloan-Kettering 
Cancer Center
Metabolic inputs into cancer genetics. Lloyd Trotman
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Title Host
November (continued)
Dr. Ali Shilatifard, Stowers  Institute 
for  Medical Research
Chromatin modifi cations, transcriptional  elongation 
control, and childhood  leukemia.
Christopher Vakoc
December
Dr. John D. Scott, University of 
Washington School of Medicine
Guiding signals for enzyme complexes. Nicholas Tonks
Dr. Robert Tjian, Howard Hughes 
Medical Institute
Controlling cell-type-specifi c gene expression: An old 
problem tackled by modern tools to reveal new insights.
Terri Grodzicker
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor Laboratory’s In-House Seminars were initiated to provide a semiformal 
 avenue for communication among the various research groups at the Laboratory. The seminars 
also afford a necessary opportunity for the graduate students and postgraduate staff to develop 
their skills in organizing, presenting, and defending their research.
Speaker Title
January
Florin Albeanu Understanding neuronal circuits underlying mammalian olfaction.
Ivan Iossifov Molecular function view of the genetics of autism.
Wanhe Li (Dubnau lab) Small regulatory RNAs in olfactory arousal, memory, and cognitive decline.
February
Pavel Osten Serial two-photon (STP) tomography for automated ex vivo mouse brain imaging.
Dan Levy (Wigler lab) Rare copy-number variation in autistic spectrum disorders.
Justin Kinney Dissecting, decoding, and reprogramming multiprotein DNA complexes.
March
Mikala Egeblad Tumor-associated myeloid cells: The good, the bad, and the ugly.
Alex Krasnitz Recurrent properties and clustering of cancer genomes: Tools and results.
Tony Zador Sequencing the connectome.
Molly Hammell Two tales of small RNA: From plant leaf development to neurodegeneration.
Marja Timmermans Patterning the leaf: A new StART and old small RNAs.
April
Zachary Lippman It’s spring! Time to start thinking about tomatoes.
Partha Mitra Mouse brain architecture project.
October
Gholson Lyon Finding and analyzing human genetic variation in neuropsychiatric disorders.
Raffaella Sordella Resistance to chemotherapy: New treatments and novel insights into an old problem.
Mads Aaboe Jensen (Krainer lab) Splicing factor SRSF6 regulates somatic stem-cell fate in mouse skin.
November
Manzar Hossein (Stillman lab) Meier–Gorlin syndrome mutations disrupt an Orcl CDK inhibitory domain and cause 
centrosome reduplication.
David Tuveson Solving cancer at CSHL.
Astrid Haase and Jonathan Ipsaro 
(Hannon and Joshua-Tor labs)
The structural biochemistry of zucchini implicates it as a nuclease in piRNA biogenesis.
December
Joshua Dubnau Neurodegeneration and the transposon storm.
Kate Creasey (Martienssen lab) Caught in the act: How transposons are controlled when methylation fails.
Jesse Gillis Network-based interpretation of gene function from postsynaptic protein interaction to 
schizophrenia coexpression.
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BANBURY CENTER 
EXECUTIVE DIRECTOR’S REPORT
Any account of the events of 2012 must begin with what is offi cially called “posttropical  cyclone” 
Sandy, but more appropriately named “Superstorm Sandy.” It reached the north shore of Long 
 Island in the evening and night of Monday, October 29, with devastating effects. Trees fell through-
out the area, bringing down power lines and causing extensive blackouts. More than 30 trees fell 
at Banbury, including one that fell on the roof of Robertson House; fortunately, this was the only 
building damaged by the storm. We lost power in the evening of October 29, and the Banbury 
offi ce thus moved into temporary quarters in the Meetings and Courses offi ces in Grace Audi-
torium. Because we could not move back to Banbury until November 14, two Banbury Center 
meetings had to be cancelled—the fi rst time that we have had to do so in at least 25 years, and two 
meetings were moved to the main campus.
Nevertheless, 2012 was a busy year for Banbury, with 18 meetings, two Watson School of Bio-
logical Science courses, six summer courses, and 10 other events. The 517 meeting participants 
were drawn from 30 states in the U.S.A. and from 19 foreign countries.
There have been a number of Banbury Center meetings that have dealt with science-related 
 issues rather than research topics. Among the most notable are those on patenting. The fi rst meet-
ing, Patenting of Life Forms, was held in October 1981, and the second, Intellectual Property and Bio-
technology, was held in 1991. Norton Zinder was prescient when he spoke on “Using Data from the 
Human Genome Project” at the 1991 meeting. The patenting of human genes and gene  sequences 
has become an area of great controversy, highlighted by the recent Myriad case  involving patents 
covering the BRCA gene and the decision in the Prometheus case. Thus, the 2012 meeting on 
Patenting Genes: New Developments, New Questions was particularly timely, examining the cur-
rent state of gene patents, especially those covering diagnostic tests and the implications of whole-
genome sequencing.
Another meeting relating to human genetics was held in May. Jim Watson, Mila Pollock, and 
I have been advancing the argument that as the Human Genome Project (HGP) was one of the 
great scientifi c accomplishments, it more than justifi es serious historical analysis. A major pre-
liminary to such a study would be locating and cataloging materials relating to the HGP. This 
has been explored in collaboration with the Wellcome Trust Library. Another component must 
be recording the personal experiences of scientists who worked on key aspects of the HGP, and 
Watson proposed that this should be done as soon as possible. The Alfred P. Sloan Foundation 
became interested in the archival project and the book of essays about the HGP. The suggestion 
was made that we should explore a possible long-term project to produce a history (or histories) of 
the HGP that will be useful and interesting to the public and scholars. This meeting, Toward a 
History of the Human Genome Project, was funded by the Sloan Foundation with the goal of laying 
the groundwork for such a book and other media productions. We brought a particularly inter-
esting set of participants for the discussions, including those involved with the HGP (scientists, 
bioethicists), as well as archivists, historians, and publishers of books and documentaries. The 
participants helped to defi ne the purpose of the book, what would distinguish it from other HGP 
books, its audience, and style.
A third meeting that was not directly based on biomedical research was organized by  Suzanne 
Nalbantian: Interdisciplinary Symposium on Literature, Memory, and Neuroscience. This was a fol-
low-up to a meeting held in 2007 on Memory in Neuroscience and the Humanities, the thesis of 
which was that just as the neuroscientist explores the physical workings of the brain with the tools 
of electrophysiology and molecular biology, so writers and artists explore and record the mental 
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experiences of human beings. The 2012 meeting, held under the auspices of the International 
Comparative Literature Association, continued this theme, with, for example, papers on “Marcel 
Proust and Memory: A Neuropsychological Perspective” and “Nonconscious Memory and the 
Surrealist Mind.”
Cancer meetings have long had a large role in the Banbury Center calendar, and 2012 was no 
exception. The fi rst cancer meeting, Transcription and Cancer, examined how the new insights in 
transcriptional and chromatin biology that have come with the application of modern analytical 
techniques may pave the way for the development of therapies directed against transcription fac-
tors. These have been traditionally thought of as undruggable, but participants in this meeting 
faced up to the challenge of developing direct-acting inhibitors of gene regulatory complexes.
The metabolism of cancer cells has held a fascination ever since Otto Warburg’s observations in 
the early part of the 20th century that cancer cells metabolized glucose via glycolysis even in the 
presence of oxygen. This is a general metabolic feature of cancer cells, but its causal relationship 
to the origins of cancer cells and cancer progression is still unclear. However, understanding this 
process better could lead to the identifi cation of new therapeutic targets. The main objectives of 
the meeting Regulation of Metabolism in Cancer were to discuss (1) biophysical and biochemical 
studies of the unique metabolic requirements and pathway utilizations of transformed cells, (2) 
emerging sequencing and computational technologies that can rapidly analyze cancer genomes 
and transcriptional profi les, and (3) biomedical informatic and physical approaches to integrating 
the metabolic, genomic, and transcriptional interactions of cancer.
It is generally thought that a key event in the development of cancer is the transformation of 
cells from an epithelial state to having the properties of mesenchymal cells. This epithelial-mes-
enchymal transition (EMT) is accompanied by the loss of epithelial cell junction proteins leading 
to weakening of cell adhesion and an increase in cell motility. Furthermore, cellular sensitivity to 
multiple targeted therapies, chemotherapy, and radiotherapy has been shown to be governed by 
the extent to which cells have undergone an EMT transition. Resistance associated with cellular 
plasticity and heterogeneity has been observed in multiple systems derived from adenocarcinomas 
and squamous carcinomas. Participants in the meeting Cell Plasticity in Cancer Evolution dis-
cussed data on the molecular and pathobiological signifi cance of cellular plasticity in carcinomas, 
and how to explore, and exploit for treatments, the signaling pathways that promote cell plasticity.
The year of Superstorm Sandy was a hard one for us all. Janice Tozzo and Pat Iannotti contin-
ued the work of the Banbury offi ce while Basia Polakowski had to cope with the tree that came 
crashing down on the Robertson House roof. It was the grounds crew of Sonny Leute, Fredy 
Vasquez, and Joseph McCoy, assisted by reinforcements from the main campus, who bore the 
brunt of the effects of the storm, and three months later, they were still removing tree trunks and 
branches. Jon Parsons and Connie Brukin continue to be indispensable for AV and photographs, 
respectively, and Culinary Services and Housekeeping cope admirably with the rapid turnover of 
guests.
Jan Witkowski
Executive Director
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Tree brought down by storm
Downed power lines
Reduced to wood chips
A stump remains
Clearing the mess
Cutting up trees
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BANBURY CENTER MEETINGS
Communicating Science
February 10–15
FUNDED BY  Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine, Heidesheim, 
  Germany
ARRANGED BY S. Schedler, Boehringer Ingelheim Fonds, Heidesheim, Germany
 C. Walther, Boehringer Ingelheim Fonds, Heidesheim, Germany
The Boehringer Ingelheim Fonds (BIF) has an international program of support for Ph.D. fellow-
ships. It fi rst brought its fellows to the Banbury Center for their annual North American retreat 
in 2005, and it has been a great pleasure to have them return. Their 2012 stay at Banbury was the 
fi fth occasion that they have been here. At Banbury, fellows receive intensive instruction in mat-
ters such as giving presentations and writing papers, topics usually learned by default (and often 
poorly) during graduate research.
Opening Remarks and All About BIF: C. Walther, Boehringer Ingelheim Fonds, Heidesheim,  Germany
SESSION 1: First Writing Assignment
W. Wells, Global Alliance for TB Drug Development, 
New York: Writing techniques and how to structure papers
SESSION 2: Presentation of Graphic Information and How to Prepare and Deliver a Scientifi c Talk
W. Tansey, Vanderbilt University Medical Center, Nashville, 
Tennessee
SESSION 3
Group A: Four-minute PowerPoint presentations and reviews.
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SESSION 4: Second Writing Assignment
SESSION 5
Group B: Four-minute PowerPoint presentations and reviews.
Group A: Preparation of 3-minute PowerPoint presentations.
SESSION 6
Group B: Preparation of 3-minute PowerPoint presentation.
SESSION 7
Groups A and B: Three-minute PowerPoint presentations 
and reviews.
SESSION 8: What Makes Success in Science?
G. Hannon, Cold Spring Harbor Laboratory
SESSION 9: How to Design Figures
M. Hansen and M. Corral, Nature Publishing Group, New York
SESSION 10: Walking Tour of Cold Spring Harbor 
Laboratory Campus
Students hard at work W. Tansey reviewing student presentations
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Leading Science Workshop
February 24−27
FUNDED BY The American Express Foundation, New York, New York
ARRANGED BY C.M. Cohen, Science Management Associates, Newton, Massachusetts
 D. Kennedy, Worklab Consulting LLC, New York
This workshop, the second in a series supported by the American Express Foundation, brought 
together life scientists making, or recently having made, the transition to a leadership or mana-
gerial position in academia, not-for-profi t organizations, or the private sector. It focused on the 
techniques, situations, and challenges that relate specifi cally to leading and managing in the scien-
tifi c workplace. Participants were able to share their experiences and challenges with one another 
and to receive feedback and guidance from others with similar experience. The workshop helped 
participants identify areas where they needed guidance, as well as how to capitalize on areas of 
strength. Participants learned and developed the necessary skills to lead and interact effectively 
with others in both one-on-one and group settings.
SESSION 1: Who We Are
Participants read 50−100-word essay “Who I am and 
what do I hope to get from this workshop?” aloud to 
the entire group.
SESSION 2: Introduction: What Is Leadership and What Makes a Great Scientist/Leader?
Small groups proposed attributes of leadership, espe-
cially in a scientifi c context, and discussed examples 
of effective and  ineffective leadership based on their 
own experience and obser vations. This was followed 
by the entire group deciding on  attributes of excellent 
leaders.
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SESSION 3: Diffi cult Conversations and Interactions
The group reviewed the types of situations and interactions that 
scientists fi nd diffi cult as they transition into leadership posi-
tions. There was discussion of the fundamental tools needed for 
negotiating diffi cult conversations with diffi cult people.
SESSION 4: Keynote Speaker: K. Barker
The author and laboratory management expert spoke of her 
experiences.
SESSION 5: Science in the Public Eye
Facilitator: K.R. Miller, Brown University, Providence, 
Rhode Island
Dr. Miller reviewed what he has learned debating complex sci-
entifi c issues in sometimes contentious circumstances. He led 
the group in an exercise simulating a lively public interchange 
about the teaching of evolution in public schools. Participants 
got fi rst-hand experience in dealing with a public audience and 
received valuable guidance and pointers on how to comport 
themselves in such circumstances.
SESSION 6: Group Dynamics and Meetings
• How to run and lead meetings
• How to structure and encourage open discussion, ensuring 
participation
• How to deal with silence and nonparticipants
• How to recognize and manage impediments to effective 
group problem solving
SESSION 7: Projecting Leadership
Volunteers were selected to deliver a “pitch” about their in-
stitution, department, or group, with participants providing 
feedback in the context of what had been learned so far in the 
workshop.
SESSION 8: Case Studies
Attendees were instructed to bring a one-page case study de-
scribing a diffi cult management situation or leadership chal-
lenge they faced or are facing. In small groups, each attendee 
read their case aloud. A structured discussion guide was 
used to elicit comments, discussion, and suggestions from 
the group, which then selected one case that best illustrated 
a key leadership challenge for presentation in summary to 
meeting.
SESSION 9: Concluding Group Discussion
Participants reviewed the defi nition of leadership constructed 
at the beginning of the workshop and asked, “What did we 
learn?” and “What didn’t we learn that we would have liked 
to learn?”
Entrance to the Banbury Center
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The Fourth NIMH-Sponsored Brain Camp
March 16−18
FUNDED BY National Institute of Mental Health, Bethesda, Maryland
ARRANGED BY M. Akil, National Institute of Mental Health, Bethesda, Maryland
 T. Insel, National Institute of Mental Health, Bethesda, Maryland
Once again, we were delighted to host the National Institute of Mental Health (NIMH)-spon-
sored “Brain Camp.” The goal of the Brain Camp is to identify areas of neuroscience that are of 
interest and relevance to psychiatrists and to communicate these to a small group of outstanding 
psychiatry residents and research fellows. Some of the most distinguished and thoughtful neuro-
scientists in the country came as guest speakers to the meeting. The goal of the series of meetings 
is to develop a neuroscience curriculum that can eventually be shared with psychiatry training 
programs around the country.
Opening Remarks: M. Akil, National Institute of Mental Health, Bethesda, Maryland
SESSION 1: Developmental Neurobiology
F. Lee, Weill Cornell Medical College, New York: Role of 
neurotrophins in psychiatric disorders: A neurodevelopmental 
approach.
D. Amaral, University of California, Davis: Neurobiological 
and neuroimmune approaches to understanding autism.
Introduction and Charge: T. Insel, National Institute of Mental Health, Bethesda, Maryland
Special Lecture: Studies of Rett Syndrome and MeCP2 and Their Relevance to Neuropsychiatric Disorders
 H. Zoghbi, Baylor College of Medicine, Houston, Texas
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SESSION 2: Innovators in Psychiatry
S. Lisanby, Columbia University, New York: Innovations in 
brain stimulation: Game changer for clinical neuroscience.
X. Castellanos, New York University Child Study Center, 
New York: Spontaneous neural/BOLD fl uctuations reveal 
intrinsic functional connectivity circuits.
SESSION 3: The Rational Development of Novel 
Therapeutics
K. Ressler, Emory University, Atlanta, Georgia: Targeting 
neural plasticity to treat fear and anxiety.
R. Duman, Yale University School of Medicine, New Haven, 
Connecticut: Keeping neurons alive, healthy, and connected.
Special Lecture: Cognitive Neuroscience: Tools that Facilitate Research on Novel Therapeutics
B. Cuthbert, National Institute of Mental Health, Rockville, Maryland;
New cognitive neuroscience tools for novel therapeutics: Dimensions and data sets.
H. Zoghbi
SESSION 4: Neuroscience and Psychiatry
J. Krystal, Yale University School of Medicine, New Haven, 
Connecticut: Glutamatergic treatment strategies for schizo-
phrenia: A translational neuroscience perspective.
SESSION 5: Development of Novel Therapeutics
S. Paul, Weill Cornell Medical College, New York: Drug dis-
covery and development: Current challenges and opportuni-
ties. “It is the worst of times—It is the best of times.”
Round Table Discussion with All Speakers and NIMH Staff
How to sustain the research careers of physician scientists in 
psychiatry.
SESSION 6: Development of Novel Therapeutics
C. Austin, National Human Genome Research Institute, 
Bethesda, Maryland: Translational therapeutics develop-
ment at the NIH.
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Envisioning the Future of Science Libraries
at Academic Research Institutions
April 1–3
FUNDED BY  The Alfred P. Sloan Foundation and the Rockefeller University, New York, New York
ARRANGED BY  C. Feltes, the Rockefeller University, New York
 D. Gibson, Memorial Sloan-Kettering Cancer Center, New York
 C. Norton, Marine Biological Laboratory, Woods Hole, Massachusetts
 L. Pollock, Cold Spring Harbor Laboratory
As a result of social, economic, and technological factors, the role of libraries in society and aca-
demia is changing rapidly and signifi cantly. As key service providers, libraries are expected to be 
up-to-date technologically and to adapt to changing circumstances and the changing needs of 
their users. This is particularly true of libraries catering to scientists where the changes in science 
publishing have been remarkable, and where the users are more likely to expect the latest tech-
nologies. This has been a source of confl ict, uncertainty, and concern at many institutions. For 
this reason, this meeting brought together librarians, researchers, administrators, and experts in 
various topics relating to future developments in library science to discuss the future of science 
libraries at academic research institutions.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: L. Pollock, Library and Archives, Cold Spring Harbor Laboratory
SESSION 1: Overview of Scientifi c Research Libraries
Chairperson: C. Rinaldo, Ernst Mayr Library of the Museum of Comparative Zoology, Harvard University, 
Cambridge, Massachusetts
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C. DeRosa, H. Miller
M. Marlino, R. Luce
C. Feltes, the Rockefeller University, New York and F. Norman, 
National Institute for Medical Research, Mill Hill, London: 
The current state of scientifi c research libraries in the U.S. 
and the U.K.
K. Douglas, California Institute of Technology, Pasadena: 
Economic factors affecting scientifi c research libraries.
A. Raymond-Denise, Pasteur Institute, Paris, France: Re-
search libraries in France: A future in progress.
K. Holmes, Washington University, St Louis, Missouri: Un-
derstanding research impact on the individual, group, and 
organization level: A critical role for libraries.
R. James King, National Institutes of Health Library, Bethes-
da, Maryland: Facilitating collaboration with researchers 
and clinicians.
SESSION 2: Our Changing System of Scholarly 
Communication
Chairperson: R. Akerman, National Research Council Na-
tional Science Library, Ontario, Canada
T.S. Plutchak, University of Alabama at Birmingham: What is 
the true value of scientifi c literature?
J. Neal, Columbia University, New York: Disseminating new 
scientifi c and medical fi ndings.
M. Ackerman, National Library of Medicine, Bethesda, Mary-
land: The image as the future primary research data source.
SESSION 3: Transforming Scientifi c Research Libraries
Chairperson: K. Chad, Kenchad Consulting, United Kingdom
Moderators: P. Mitra, Cold Spring Harbor Laboratory, and 
P. Thibodeau, Duke University, Durham, North Carolina
Discussion: Researchers’ Expectations for Future Library Col-
lections and Services
M. Tennant, University of Florida, Gainesville: Looking for-
ward: A critical role for the library in research, education, 
and assessment.
R. Luce, Emory University, Atlanta, Georgia: Transforming 
research library roles into workfl ow support.
SESSION 4: Envisioning the Future of Scientifi c Research 
Libraries
Chairperson: D. Gibson, Memorial Sloan-Kettering Cancer 
Center, New York
M. Marlino, National Center for Atmospheric Research, Boul-
der, Colorado: Seven times around Jericho: How do we bring 
down the walls?
F. Heath, University of Texas, Austin: A model for scientifi c 
research libraries of the future.
T. Hickerson, University of Calgary, Alberta, Canada: Shared 
mission, converged programs: Libraries, archives, and the 
scientifi c record.
H. Miller, Marine Biological Laboratory, Woods Hole Ocean-
ographic Institute, Woods Hole, Massachusetts: Data and 
informatics: A new realm for libraries.
General Discussion and Future Direction
M. Pollock, Cold Spring Harbor Laboratory
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Transcription and Cancer
April 9−12
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY  J. Bradner, Dana-Farber Cancer Institute, Boston, Massachusetts
 R. Young, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
Genetic alterations that alter signaling, transcription, and chro-
matin are hallmarks of cancer. New insights in transcriptional 
and chromatin biology, coupled with technical advances in dis-
covery chemistry, have allowed unprecedented progress toward 
therapeutics that target this traditionally undruggable class of 
proteins. Motivated by the historic and pressing challenge of 
 developing direct-acting inhibitors of gene regulatory complex-
es, participants in this meeting included leaders in the fi elds of 
transcriptional biology, chromatin biology, protein biochemis-
try, and cancer drug discovery.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring 
Harbor Laboratory
Introductory Remarks: J.D. Watson, Cold Spring Harbor Laboratory
SESSION 1: Biology of Transcription in Cancer
M. Ptashne, Memorial Sloan-Kettering Cancer Center, New 
York: Nucleosomes and the logic of gene regulation.
K. Adelman, National Institute of Environmental Health, 
 Research Triangle Park, North Carolina: Pol II pausing at 
genes involved in cell proliferation.
A. Koehler, J. Bradner
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K. Jones, Salk Institute for Biological Studies, La Jolla, 
 California: SKIP connects signaling to P-TEFb elongation 
and splicing.
J. Espinosa, University of Colorado, Boulder, Colorado: 
The role of mediator in oncogenesis.
A. Shilatifard, Stowers Institute for Medical Research, Kansas 
City, Missouri: Trithorax/MLL (COMPASS) family of 
H3K4 methylases in cancer.
S. Orkin, Harvard Medical School, Boston, Massachusetts: 
Polycomb complex and cancer.
SESSION 2: Targeting Transcription Factors
A. Mapp, University of Michigan, Ann Arbor: Small-molecule 
transcriptional modulators.
A. Koehler, Broad Institute of Harvard and Massachusetts 
Institute of Technology, Cambridge, Massachusetts: 
 Small-molecule probe development for transcription factors.
J. Toretsky, Georgetown University, Washington, D.C.: 
Small-molecule targeting of fusion protein transcription 
factors and the biochemistry of intrinsically disordered 
proteins.
SESSION 3: Myc: A Master Regulator of Cancer 
Pathogenesis
G. Evan, University of Cambridge, United Kingdom: The role 
of Myc in tumor maintenance.
R. Young, Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts: Transcriptional amplifi cation in 
tumor cells with elevated c-Myc.
SESSION 4: Epigenetic Reader Proteins
J. Bradner, Dana-Farber Cancer Institute, Boston, Massachu-
setts: Targeting epigenetic reader proteins.
S. Frye, University of North Carolina, Chapel Hill: Chemical 
biology of methyl lysine.
SESSION 5: Structural Insights into Gene Regulatory 
Complexes
C. Arrowsmith, University of Toronto, Canada: Structural 
and chemical biology of the readers and writers of histone 
marks.
D. Patel, Memorial Sloan-Kettering Cancer Center, New 
York: Structural biology of maintenance DNA methylation 
in mammals.
C. Wolberger, Johns Hopkins School of Medicine, Baltimore, 
Maryland: Structural insights into the assembly and activa-
tion of SAGA.
M. Lei, University of Michigan Medical Center, Ann Arbor: 
The same pocket in menin binds both MLL and JunD but 
oppositely regulates transcription.
M. Luo, Memorial Sloan-Kettering Cancer Center, New York: 
Profi le nonhistone targets of protein methyltransferases.
K. Adelman D. Weinberg, M. Ptashne, J. Darnell, R. Young
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SESSION 6: Identifi cation and Targeting of Tumor 
Dependencies
C. Vakoc, Cold Spring Harbor Laboratory: RNAi screening to 
identify roles for chromatin regulators in cancer.
S. Armstrong, Dana-Farber Cancer Institute, Boston, 
 Massachusetts: Targeting DOT1L in MLL-rearranged 
leukemias.
V. Richon, Epizyme, Inc., Cambridge, Massachusetts: Target-
ing histone methyltransferases.
J. Grembecka, University of Michigan, Ann Arbor: Therapeu-
tic targeting of MLL fusion proteins in leukemia.
J. Jin, University of North Carolina, Chapel Hill: Discovery of 
chemical probes for histone methyltransferases.
Review and Summary
A presentation at the meeting
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Phage and Phage-Based Therapies
April 15−17
FUNDED BY  GangaGen, Inc., Newark, California
ARRANGED BY  S. Adhya, National Cancer Institute, Bethesda, Maryland
 J. Ramachandran, GangaGen Inc., Palo Alto, California
 G. Schoolnik, Stanford University Medical Center, Palo Alto, California
The fi rst Banbury conference on phage therapy was held in November 2002. Since that discussion 
of the potential value of phage therapy and the challenges it faced, there has been much progress 
in both phage science and the development of phage-based therapies. As more and more pathogens 
are developing resistance to the current antibiotics, there is a pressing and ever-increasing need for 
new therapies. This second conference on Phage Therapy was organized to review the progress 
in phage science, the preclinical development of phage-based therapies, and clinical experience.
Welcoming Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: J.D. Watson, Cold Spring Harbor Laboratory
SESSION 1: Phage Genomics and Evolution
Chairperson: D. Court, National Cancer Institute, National 
Institutes of Health, Bethesda, Maryland
A. Kuchment, Scientifi c American, New York: Cowboy medicine.
G. Hatfull, University of Pittsburgh, Pennsylvania: Phage 
 genomics and evolution.
M. Krupovic, Institute Pasteur, Paris, France: Diversity of pro-
karyotic viruses.
S. Moineau, Université Laval, Quebec, Canada: Phage resistance.
J. Gill, Texas A&M University, College Station: Informing 
phage therapy with phage genomics.
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I. Connerton, University of Nottingham, Leicestershire, Unit-
ed Kingdom: The ecology of campylobacter phages and the 
carrier state.
E. Semenova, Waksman Institute, Piscataway, New Jersey: 
CRISPR/Cas: Bacterial adaptive immunity and memory 
system guided by short RNAs.
SESSION 2: Effi cacy of Phage-Derived Products
Chairperson: S. Adhya, National Cancer Institute, National 
Institutes of Health, Bethesda, Maryland
J. Ramachandran, GangaGen Inc, Palo Alto,  California: 
Lysis-defi cient phages and phage tails: Potential 
 therapeutics.
B. Sriram, GangaGen Biotechnologies Pvt Ltd., Bangalore, 
India: Development of a novel phage-derived antistaphylo-
coccal protein.
V.A. Fischetti, the Rockefeller University, New York: Exploit-
ing a billion years of phage evolution to develop novel anti-
infectives.
B. Peddie, University of Maryland, College Park: Engineering 
phage as a drug delivery vector.
R. Danner, National Institutes of Health, Bethesda, Mary-
land: Hospital outbreak of Klebsiella pneumoniae producing 
carapenemase (KPC).
SESSION 3: Phage Therapy
Chairperson: G.K. Schoolnik, Stanford University, California
R. Adamia, Eliava Institute, Tbilsi, Georgia: Prospects of 
phage therapy: East and west.
E. Stibitz, Food and Drug Administration, Bethesda, Mary-
land: FDA’s perspective on phage therapy and specifi c issues 
involved in these proposals.
H. Brussow, Nestle Research Center, Lausanne, Switzerland: 
Toward a treatment of E. coli diarrhea with T4 phages.
A. Gorski, Polish Academy of Sciences, Warsaw, Poland: Immu-
nomodulating effects of phage: Their implications for therapy.
J.A. Fralick, Texas Tech University Health Sciences Center, 
Lubbock: Applemans protocol for the generation of thera-
peutic bacteriophages.
B. Biswas, Naval Medical Research Center, Fort Detrick, Mary-
land: Applications of phage therapy in military medicine.
General Discussion and Future Directions
E. Ching, S. Subramani E. Semenova
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Interdisciplinary Symposium on Literature, Memory, 
and Neuroscience
April 19−21
FUNDED BY  Haig R. Nalbantian, New York, New York
  The Satenik and Adom Ourian Educational Foundation, New York, New York
  Mr. and Mrs. Howard Phipps, Jr., Westbury, New York
  The Daniel and Joanna S. Rose Fund, Inc., New York, New York
ARRANGED BY  S. Nalbantian, Long Island University, Brookville, New York
It is now more than 50 years since C.P. Snow gave his controversial Reith Lectures on The Two 
Cultures, discussing the gulf, as Snow saw it, between the humanities and science. Snow was mak-
ing specifi c reference to the British education system, but the phrase soon came into widespread 
use. This meeting, held under the auspices of the International Comparative Literature Associa-
tion, might be regarded as a contribution to uniting the two cultures. Its purpose was to create 
cross-disciplinary exchange and collaboration between neuroscientists and literary scholars on 
topics of memory, emotion, consciousness, and creativity.
Keynote Speaker: S. Park, University of Oxford, United Kingdom: Cognitive Literary Criticism and the Two 
Cultures: With Reference to T.S. Eliot, Virginia Woolf, and Samuel Beckett.
Introduction to the Banbury Center: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor Laboratory
Background and Introduction to the Meeting: S. Nalbantian, Chair of ICLA Research Committee on 
 Literature & Neuroscience, Long Island University, Brookville, New York
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SESSION 1
L. Squire, University of California, San Diego: Conscious and 
unconscious memory systems of the mammalian brain.
H. Mancing, Purdue University, West Lafayette, Indiana: 
Struggling with memory in Spanish fi ction: Miguel de 
 Unamuno, Camilo José Cela, and Carmen Martin Gaite.
R. Epstein, University of Pennsylvania, Philadelphia: Marcel 
Proust and memory: A neuropsychological perspective.
SESSION 2
P. Matthews, GlaxoSmithKline, United Kingdom, and Impe-
rial College, London, United Kingdom: Alzheimer’s disease 
and fragmentation of the self.
J. Bickle, Mississippi State University, Mississippi State: Ma-
nipulating brain genes and proteins to affect social learning 
and memory.
F. Vidal, Max-Planck Institute for the History of Science, 
Berlin, Germany and F. Ortega, State University of Rio de 
Janeiro, Brazil: Brains in literature/literature in the brain: 
Memory and identity in Anglo-American neurofi ction.
Visit to Cold Spring Harbor Laboratory Main Campus
SESSION 3
R. Stickgold, Harvard University, Boston, Massachusetts: 
Nonconscious memory processing in sleep and dreams.
S. Nalbantian, Long Island University, Brookville, New York: 
Nonconscious memory and the surrealist mind.
G. Starr, New York University, New York: Memory and 
aesthetics: Probing the role of imagery in literature and 
the visual arts.
R. Stickgold, S. NalbantianG. Starr, L. Squire
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Patenting Genes: New Developments, New Questions
April 22−25
FUNDED BY   Baxter Healthcare Corporation of Westlake Village, California 
 DRI Capital, Inc., Vancouver, British Columbia, Canada
 Eli Lilly & Company, Indianapolis, Indiana
 Genentech, Inc., South San Francisco, California
  Jones Day LLP , New York, New York
 Kaye Scholer LLP , New York, New York
 King & Spalding, LLP, New York, New York
 Novartis Pharma AG, Basel, Switzerland
 Novo Nordisk Inc., Princeton, New Jersey
 Ropes & Gray
ARRANGED BY K. Sonnenfeld, King & Spalding, LLP, New York
 M. Brivanlou, King & Spalding, LLP, New York
In 1981, more than 30 years ago and soon after the Supreme Court’s decision in Diamond v. 
Chakrabarty, the Banbury Center held a discussion meeting called Patenting of Life Forms. 
A second meeting in 1991 was held, and now, 20 years later, many of the very same issues raised 
at those two meetings continue to be contentious and the subject of intense debate. They have 
been brought into sharp focus by the recent Myriad case involving patents covering the BRCA 
gene, and so it seemed the right time to convene a third meeting. By bringing together lawyers, 
judges, clinicians, scientists, academicians, investors, and others who are directly impacted by gene 
patents, the conference provided a unique opportunity to examine fundamental assumptions that 
have provided fuel on both sides of the debate for or against gene patents.
Welcoming Remarks: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor Laboratory
Introduction: K. Sonnenfeld and M. Brivanlou, King & Spalding, New York, and S. Brenner, Salk Institute for 
Biological  Studies, San Diego, California
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SESSION 1: Gene Patents: Where Are We Now?
Chairperson: L. Coruzzi, Jones Day, LLP, New York
T. Stanek Rea, United States Patent and Trademark Offi ce, 
Alexandria, Virginia: PTO perspective after Prometheus.
H. Sauer, Biotechnology Industry Organization, Washington, 
D.C.: Refl ections on the right and wrong of gene patenting: 
Normative considerations in ethics and law.
D. Leonard, Weill Cornell Medical College, New York: 
 SACGHS task force on gene patents.
B. Barrett, Eli Lilly & Company, Indianapolis, Indiana: 
 Patenting genes: A biopharmaceutical company’s perspective.
SESSION 2: Gene Patents Covering Diagnostics: Different 
Approaches
Chairperson: P. Fehlner, Novartis Pharma AG, Basel, 
 Switzerland
R. Cook-Deegan, Duke University, Durham, North Carolina: 
Gene patents and diagnostics: The many paths not taken.
W. Grody, American College of Medical Genetics, Los Ange-
les, California: Impact of gene patents on an academic medi-
cal center laboratory.
D. Brenner, Dysautonomia Foundation, Inc., New York: Stra-
tegic use of patents by nonprofi ts.
P. Fehlner, Novartis Pharma AG, Basel, Switzerland: Accel-
erating personalized medicine: Pools, consortia, and open 
innovation.
R. Marsh, Myriad Genetics, Inc., Salt Lake City, Utah: The 
Myriad perspective.
Panel: Follow-Up Discussion of Session
SESSION 3: Gene Patents: Relevance to Development
Chairperson: C. Shepherd, DRI Capital Inc., Toronto, 
Canada
S. Chandrasekharan, Duke University, Durham, North Caro-
lina: The shadow of patent thickets on emerging genomic 
diagnostics and whole-genome sequencing: What do empiri-
cal studies tell us?
F. Toneguzzo, Partners HealthCare, Charlestown, Massa-
chusetts: Gene patents and implementation of diagnostic 
tests.
J. Elliott, Genentech, South San Francisco, California: Gene 
patents and business concerns.
C. Shepherd, DRI Capital Inc., Toronto, Canada: Relevance 
of patent claims to life sciences investing.
Panel: Follow-Up Discussion of Session
SESSION 4: Enforcement of Gene Patents
Chairperson: P. Eagleman, Baxter Healthcare Corporation, 
Westlake Village, California
K. Sonnenfeld, King & Spalding, LLP, New York: Mayo v 
Prometheus: Implications of the Supreme Court’s decision.
R. Dreyfuss, New York University School of Law, New York: 
Interpreting the opinions of the Federal Circuit in the Myri-
ad case: Will the Supreme Court grant review?
L. Ben-Ami, Kaye Scholer, LLP, New York: Litigating the ge-
nome: What the future holds for patent litigation.
Panel: Follow-Up Discussion of Session
K. Sonnenfeld, S. Brenner J. Elliott
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SESSION 5: Claiming Genes: In the Beginning and Today
Chairperson: M. Brivanlou, King & Spalding, New York
J. Haley, Jr., Ropes & Gray LLP, New York: Changes in claim 
language since Chakrabarty.
H.-R. Jaenichen, Vossius & Partner, Munich, Germany: The 
patenting of genes by the European Patent Offi ce.
J. Broughton and R. Bizley, Avidity IP, Epping, United King-
dom: Whose genes are they anyway?
J. Cherry, Freehills Patent & Trade Mark Attorneys, Melbourne, 
Australia: Gene patents in Australia: Past, present and future.
Panel: Follow-Up Discussion of Session
SESSION 6: Where Next?
Review and Summary
T. Rea R. Desnick
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A History of the Human Genome Project
May 3−5
FUNDED BY The Alfred P. Sloan Foundation, New York, New York
ARRANGED BY L. Pollock, Cold Spring Harbor Laboratory
 J.A. Witkowski, Cold Spring Harbor Laboratory
The International Human Genome Project (HGP) was one of the great 
scientifi c accomplishments, ranking with the Manhattan Project, the 
Hubble Telescope, and the Large Hadron Collider. However, it is only 
during the past few years that a movement has begun to lay the ground-
work for a history of the HGP. As a fi rst step, CSHL and the Wellcome 
Trust initiated a project to locate and catalog primary materials relating 
to the origins of the HGP by holding a meeting at Banbury in 2009. 
This 2012 meeting reviewed the current state of the HGP history proj-
ect and plans for producing a book on the HGP, what might be needed 
for a long-term project, and the goals and organization of long-term 
projects. Participants included scientists, writers, documentary direc-
tors, social scientists, media experts, historians, and archivists.
Welcoming Remarks and Background: J.A. Witkowski, Banbury Center, Cold Spring Harbor
J.A. Witkowski
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SESSION 1: The History of the HGP and the Public 
Communication
This session reviewed and discussed current projects under 
way relating to the history of the HGP and how these are ex-
pected to contribute to the long-term public communication 
about the HGP.
L. Pollock, Cold Spring Harbor Laboratory: HGP original 
materials.
R. Aspin and J. Shaw, Wellcome Trust, London, United King-
dom: HGP original materials.
R. Cook-Deegan, Duke University, Durham, North Carolina: 
DNA sequencing: Technology history, sharing practices, and 
applications to medicine and personal genomics.
J. Durant, Massachusetts Institute of Technology, Cambridge: 
Museum Genomics Consortium.
General Discussion: The opportunities for long-term public 
communication on the history of the HGP and its impact.
SESSION 2: General Issues and Current Book Outline
This session began with a brief review of the current book out-
line and then moved on to examine topics for chapters based 
on lists made by participants. This was a free-fl owing session 
and each discussion ran for as long as necessary.
G. Weinstock, Washington University, St. Louis, Missouri: 
Introduction to the book. Discussion of the scope of the 
book and the current book outline.
C.T. Caskey, Baylor College of Medicine, Houston, Texas: 
Origins of the HGP in the United States.
J. Weissenbach, Centre National de Sequençage, Evry, France: 
Origins of the HGP in France.
M. Olson, University of Washington, Seattle: Cloning and 
mapping.
L. Smith, University of Wisconsin, Madison: Development of 
automated sequencing.
M. Adams, J. Craig Venter Institute, San Diego, California: 
Shotgun sequencing.
J. Rogers, Genome Analysis Centre, Norwich, 
 United  Kingdom: Completing the genome.
W.R. McCombie, Cold Spring Harbor Laboratory: Computa-
tional/bioinformatics.
R. Cook-Deegan, Duke University, Durham, North Carolina: 
Social-legal issues.
K. Davies, Cambridge Healthtech Institute, Needham, 
 Massachusetts: Current and future genomic science and 
medicine.
SESSION 3: Wrap-Up and Future Developments
The Sloan Foundation has expressed an interest in a long-
term project on the history of the HGP and for bringing the 
achievements of the HGP and future implications for health 
to the public. The discussions in the session could focus on 
the question: What advice would participants give to the 
Sloan Foundation about what a long-term project might in-
clude?
M. Olson, G. Weinstock J. Rogers, J. Shaw
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Regulation of Metabolism in Cancer
May 14−17
FUNDED BY Brown Cancer Center, University of Louisville, Kentucky
ARRANGED BY J. Chesney, University of Louisville, Louisville, Kentucky
 J.D. Watson, Cold Spring Harbor Laboratory
Genetic and epigenetic alterations of transformed cells confer 
selective advantages that ultimately change their metabolic 
phenotype. For example, transformed cells transport increased 
glucose for energetic and anabolic pathways. Approaches to in-
tegrate the metabolic with the genomic, epigenetic, and tran-
scriptional alterations of cancer should lead to the identifi cation 
of novel cancer therapeutic targets. The main objectives of this 
meeting were to discuss (1) the biophysical and biochemical 
studies of the unique metabolic requirements and pathway 
utilizations of transformed cells, (2) emerging sequencing and 
computational technologies that can rapidly analyze cancer ge-
nomes and transcriptional profi les, and (3) biomedical infor-
matics and physical approaches to integrating the metabolic, 
genomic, and transcriptional interactions of cancer.
Introduction: The Basics and Some History: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcoming Remarks: Origins of the Banbury Center and Concept Behind Its Conference Center: J.D. Watson, 
Cold Spring Harbor Laboratory
R. Kalluri, J. Watson
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Brief Introductory Comments: J. Chesney, Brown Cancer Center, University of Louisville, Louisville, Kentucky
Comments: Warburg, Keilin, and Energy Metabolism: W. Koppenol, Swiss Federal Institute of Technology, 
 Zurich, Switzerland
SESSION 1: Approaches to Understanding Metabolic 
Networks in Cancers
Chairperson: D. Miller, University of Louisville, Kentucky
G. Stephanopoulos, Massachusetts Institute of Technology, 
Cambridge: Linking cancer and metabolism via isotopic 
 labeling and metabolic network analysis.
M. Cascante, Universitat De Barcelona, Barcelona, Spain: 
Metabolic fl ux alterations associated with cancer: Applica-
tion to target discovery.
A. Lane, University of Louisville, Kentucky: Tracer method-
ologies, platforms, and models for cancer metabolism.
T. Fan, University of Louisville, Kentucky: How can stable 
isotope-resolved metabolomics bridge bench-to-bedside un-
derstanding of human cancer?
SESSION 2: Systems Biology and Epigenomics of Cancer
Chairperson: T. Rouault, National Institute of Child Health 
and Development, NIH, Bethesda, Maryland
A. Califano, Columbia University Medical Center, New York:
Cancer systems biology: Assembling and interrogating the 
regulatory logic of the cancer cell.
J. Ernst, University of California, Los Angeles: Epigenomic 
signatures for interpreting disease associated genomic loci.
SESSION 3: Cancer Metabolism I (Imaging, mTOR and 
H+ATP Synthase)
Chairperson: C. Dang, University of Pennsylvania, Philadelphia
J. Koutcher, Memorial Sloan-Kettering Cancer Center, New 
York: Noninvasive magnetic resonance studies of tumor 
 metabolism and inhibition.
D. Sabatini, Whitehead Institute, Massachusetts Institute 
of Technology, Cambridge: Regulation of growth by the 
mTOR pathway.
J. Manuel Cuezva, Universidad Autonoma de Madrid, Spain: 
The mitochondrial H+ATP synthase in cancer.
SESSION 4: Cancer Metabolism II (PI3K, Myc, and Rb)
Chairperson: C. Thompson, Memorial Sloan-Kettering 
 Cancer Center, New York
F. Morrish, Fred Hutchinson Cancer Research Center, Seattle, 
Washington: Metabolic circuit fl exibility in triple-negative 
breast cancer cells.
M. Yuneva, University of California, San Francisco: Glucose 
and glutamine metabolism as targets for cancer therapy.
C. Dang, University of Pennsylvania, Philadelphia: Tar-
geting oncogenic alterations of glucose and glutamine 
 metabolism.
B. Clem, University of Louisville, Kentucky: Retinoblas-
toma protein regulation of glucose and glutamine me-
tabolism.
R. Kalluri, Beth Israel Deaconess Medical Center, Boston, 
Massachusetts: Metabolism and metastasis.
C. Thompson, Memorial Sloan-Kettering Cancer Center, 
New York: Where does NADPH come from?
SESSION 5: Tumor Microenvironment, Nutrient Sensing, 
and AMPK
Chairperson: L. Cantley, Harvard Medical School, Boston, 
Massachusetts
T. Schroeder, Duke University School of Medicine, Durham, 
North Carolina: The metabolic tumor microenvironment as 
a synthetic lethal condition.
D. Carling, MRC Clinical Sciences Centre, London, England: 
Regulation of lipid metabolism and role of AMPK in cancer 
cells.
D. Ayer, University of Utah, Salt Lake City: Integrating nutri-
ent sensing and growth control.
N. Hay, University of Illinois, Chicago: AMPK regulates 
NADPH homeostasis to promote tumor cell survival during 
energy stress.
L. Cantley, Harvard Medical School, Boston, Massachusetts: 
PI3 K and cancer metabolism.
SESSION 6: Metabolism of Noncancer Cells in Neoplastic 
Tumors
Chairperson: T. Schroeder, Duke University School of Medi-
cine, Durham, North Carolina
P. Carmeliet, Katholieke Universiteit, Leuven, Belgium: Tar-
geting endothelial cell metabolism.
J. Rathmell, Duke University Medical Center, Durham, 
North Carolina: Lymphocyte metabolism in immunity and 
leukemogenesis.
SESSION 7: Fumarate Hydratase, 6-Phosphofructo-Kinase, 
and Metabolic Therapeutics
Chairperson: J. Eaton, University of Louisville, Kentucky
T. Rouault, National Institute of Child Health and Develop-
ment, NIH, Bethesda, Maryland: Remodeling of metabolism 
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in familial renal cancer caused by mutations of fumarate hy-
dratase (HLRCC) and SDHB.
E. Gottlieb, the Beatson Institute for Cancer Research, Glasgow, 
Scotland: Revealing metabolic adaptations and therapeutic 
strategies to renal cancer with fumarate hydratase mutations.
S. Telang, University of Louisville, Kentucky: Regulation of 
glycolysis by fructose-2,6-bisphosphate.
J. Chesney, University of Louisville, Kentucky: Develop-
ment of small-molecule inhibitors of 6-phosphofructo-2-
kinases.
J. Nelson, I. JainD. Sabatini
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Emerging Approaches in Oncology: A Brainstorming Think Tank
June 13–15
FUNDED BY University of Southern California, NCI Physical Sciences in Oncology Center, Los Angeles
ARRANGED BY D. Hillis, Applied Minds, Inc. Glendale, California
 D. Agus, University of Southern California, Los Angeles
 P. Mallick, Stanford School of Medicine, California
 T. Tombrello, California Institute of Technology, Pasadena
The goal of this meeting was to identify critical challenges in oncology and to evaluate the  potential 
of innovative approaches for solving them. The meeting had a rather unusual structure for a Ban-
bury Center meeting. Prior to the meeting, each participant was assigned to one of two groups 
(biological/clinical or technology/engineering) and selected a collaborator from the other who 
could engage in the project. Unlike traditional meetings, in which people present their fi ndings, 
it was hoped that this would be an opportunity for participants to share emerging research chal-
lenges and to identify and evaluate creative approaches for solving them. Team meetings were held 
in the Conference Room and Meier House, followed by joint sessions in the Conference Room.
SESSION 1: Presentations of Teams 1 and 2
Team 1: N. Marko, Cancer Research UK, Cambridge 
Research Institute, United Kingdom; S. Maurer, D.E. Shaw 
& Co., New York.
Team 2: L. Xie, Hunter College, New York; J. Brody, 
Thomas Jefferson University, Philadelphia, Pennsylvania; 
A. Tito Fojo, National Cancer Institute, Bethesda, Maryland.
SESSION 2: Presentations of Teams 3 and 4
Team 3: D. Ruderman, University of Southern California, 
Los Angeles; J. Schnitzer, Proteogenomics Research Institute 
for Systems Medicine, San Diego, California.
Team 4: D. Levitin, McGill University, Montreal, Quebec, 
Canada; D. Agus, University of Southern California, 
Beverly Hills.
S. Hingorani P. Mallick
419-466_Banbury.indb   447 9/17/2013   8:22:45 AM
448  Banbury Center
SESSION 3: Presentations of Teams 5 and 6
Team 5: A. Lo, Massachusetts Institute of Technology, 
Cambridge; L. Nagahara, National Cancer Institute, 
Bethesda, Maryland.
Team 6: M. Gross, University of Southern California, 
Westside Cancer Center, Beverly Hills; E. Gradman, 
Eric Gradman, Inc., Los Angeles, California.
SESSION 4: Presentations of Teams 7–9
Team 7: M. Meyer, University of Utah, Salt Lake City; 
P. Mallick, Stanford School of Medicine, California; 
S. Hingorani, Fred Hutchinson Cancer Research Center, 
Seattle, Washington.
Team 8: A. Sharif, Daedalus Software, Inc., Cambridge, 
Massachusetts; M. Vander Heiden, Massachusetts Institute 
of Technology, Cambridge; D. Byrd, Seattle Cancer Care 
Alliance, Washington.
Team 9: B. Chaudhry, Healthcare Analytics IBM Research, 
Washington, DC; A. Minn, University of Pennsylvania, 
Philadelphia; S. Hanlon, National Cancer Institute, NIH, 
Bethesda, Maryland.
SESSION 5: Presentations of Teams 1−4
Team 1: N. Marko, Cancer Research UK, Cambridge 
Research Institute, United Kingdom; S. Maurer, 
D.E. Shaw & Co., New York
Team 2: L. Xie, Hunter College, New York; J. Brody, 
Thomas Jefferson University, Philadelphia, Pennsylvania; 
A. Tito Fojo, National Cancer Institute, Bethesda, Maryland.
Team 3: D. Ruderman, University of Southern California, 
Los Angeles; J. Schnitzer, Proteogenomics Research Institute 
for Systems Medicine, San Diego, California.
Team 4: D. Levitin, McGill University, Montreal, Quebec, 
Canada; D. Agus, University of Southern California, 
Beverly Hills.
SESSION 6: Presentations of Teams 5−9
Team 5: A. Lo, Massachusetts Institute of Technology, 
Cambridge; L. Nagahara, National Cancer Institute, 
Bethesda, Maryland.
Team 6: M. Gross, University of Southern California, 
Westside Cancer Center, Beverly Hills; E. Gradman, Eric 
Gradman, Inc., Los Angeles, California.
Team 7: M. Meyer, University of Utah, Salt Lake City; 
P. Mallick, Stanford School of Medicine, California; 
S. Hingorani, Fred Hutchinson Cancer Research Center, 
Seattle, Washington.
Team 8: A. Sharif, Daedalus Software, Inc., Cambridge, 
Massachusetts; M. Vander Heiden, Massachusetts Institute 
of Technology, Cambridge; D. Byrd, Seattle Cancer Care 
Alliance, Washington.
Team 9: B. Chaudhry, Healthcare Analytics IBM Research, 
Washington, DC; A. Minn, University of Pennsylvania, 
Philadelphia; S. Hanlon, National Cancer Institute, NIH, 
Bethesda, Maryland.
General Discussion and Wrap-Up
E. Gradman
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Systems Biology of Autism: From Basic Science 
to Therapeutic Strategies
September 9–12
FUNDED BY  Marie Robertson Research Fund and Roberston Research Fund, Cold Spring Harbor 
   Laboratory, New York; Pfi zer Inc., Memphis, Tennessee; Simons Foundation, New York, 
New York; Certerra, Inc., Cold Spring Harbor, New York
ARRANGED BY P. Osten, Cold Spring Harbor Laboratory
 M. Sur, Massachusetts Institute of Technology, Cambridge
Genetic analyses of autism have identifi ed a confusingly large number of genes associated with 
autism. One way of trying to bring some order to the fi eld is to try to group these genes based on 
common pathways. A combination of different systems biology methods (mouse and other animal 
models, human iPS cells, genetics, and bioinformatics) could result in a powerful research synergy 
and lead to formulation of generalizable hypotheses about neurodevelopmental changes in autism. 
This meeting explored whether this was feasible. Ultimately, the goal of such research must be to 
develop therapies, and this requires deciding on what experimental endophenotypes will provide 
the most useful platforms for drug discovery. Participants included scientists studying autism 
genes in animal models and using human iPS cells for screening of cellular functions; geneticists 
and bioinformaticists; representatives from pharmaceutical companies interested in autism drug 
development; and systems neuroscientists.
Introduction: P. Osten, Cold Spring Harbor Laboratory
SESSION 1: Genetics and Gene Networks
Theme: There are many genes implicated in autism. How to 
guide the selection of the best candidates?
Chairperson: M. Wigler, Cold Spring Harbor Laboratory
M. Wigler, Cold Spring Harbor Laboratory: What to do with 
candidate gene data?
I. Iossifov, Cold Spring Harbor Laboratory: Role of de novo 
and rare variants in the genetics of autism.
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D. Vitkup, Columbia University, New York: Discovering gene 
networks associated with ASD.
J. Darnell, the Rockefeller University, New York: Genome-
wide identifi cation of mRNA targets of translational repres-
sion by the fragile-X mental retardation protein, FMRP.
D. Geschwind, University of California, Los Angeles: Pathway 
convergence in autism: What might it mean?
J. Gillis, Cold Spring Harbor Laboratory: Assessing bias in 
network analysis of gene function.
SESSION 2: Genetics and Epigenetics in Cell and Animal 
Models
Continued Theme: There are many genes implicated in autism. 
How to guide the selection of the best candidates?
Chairperson: L. Kadiri, Certerra, Inc., Cold Spring Harbor
H. Song, Johns Hopkins University, Baltimore, Maryland: 
Systems biology of epigenetic mechanisms in autism.
P. Jin, Emory University School of Medicine, Atlanta, Geor-
gia: New DNA modifi cation(s) in neurodevelopment and 
autism.
R. Dolmetsch, Stanford University, California: Using stem 
cells and mice to study genetic forms of autism.
F. Vaccarino, Yale University, New Haven, Connecticut: 
 Induced pluripotent stem cells to study autism: Promise and 
challenges.
R. Greenspan, University of California, San Diego: Exploring 
the broad network of behavioral gene interactions.
SESSION 3: Animal Models: Genes, Brain Circuits, and 
Synapses
Theme: Mouse models of selected autism genes are beginning 
to show a broad range of circuit and synaptic phenotypes. 
How to interpret the results? How to address the differences 
between the animal and human brain?
Chairperson: G. Fischbach, Simons Foundation, New York
Z.J. Huang, Cold Spring Harbor Laboratory: Altered 
maturation of GABAergic interneurons, critical period 
plasticity, and visual perception in a mouse model of Rett 
syndrome.
A. Mills, Cold Spring Harbor Laboratory: Engineered mouse 
models of 16p11.2CNVs.
D. Page, the Scripps Research Institute, Jupiter, Florida: To-
ward a mechanistic understanding of autism-relevant pheno-
types in Pten haploinsuffi cient mice.
R. Tsien, New York University, New York: Deciphering un-
derpinnings of autism and oxytocin enhancement of circuit 
signal to noise. K. Huber, University of Texas Southwestern 
Medical Center, Dallas: Destabilized mGluR5 synaptic scaf-
folds, fragile X, and autism.
SESSION 4: Animal Models: Behavioral Studies and 
Translational Opportunities
Theme: Can animal behavior and other animal assays be used 
as biomarkers in preclinical drug discovery?
Chairperson: C. Schutt, Princeton University, the Nancy 
Lurie Marks Family Foundation, New Jersey
H. Sive, Whitehead Institute, Cambridge, Massachusetts: 
Lessons from zebra fi sh.
J. Crawley, University of California, Davis, Sacramento: Phar-
macological reversal of social defi cits and repetitive behaviors 
in mouse models of autism.
A. Kepecs, Cold Spring Harbor Laboratory: Sniff and decide: 
Quantitative assessments of social behavior in mice.
M. Sur, Massachusetts Institute of Technology, Cambridge: 
Signals that affect synapses in autism: Insights from Rett 
syndrome.
P. Osten, Cold Spring Harbor Laboratory: Mapping brain cir-
cuits in genetic mouse models of autism and preclinical drug 
discovery.
J. Darnell D. Geschwind, G. Dawson
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L. Young, Emory University, Atlanta, Georgia: Oxytocin and 
social cognition: Implications for novel therapies for autism.
SESSION 5: Therapeutic Work and Clinical Trials
Theme: How basic research can help and guide clinical work 
and starting clinical trials?
Chairperson: W. Chung, Columbia University, New York
J. Spiro, Simons Foundation, New York and W. Chung, 
Columbia University, New York: Studying ASD through 
the context of an identifi ed recurrent genetic event 
(16p11.2).
A. Healy, Seaside Therapeutics, Cambridge, Massachusetts: 
Clinical trials in FXS: Effects on neurobehavioral function 
and strategies to develop molecular biomarkers
E. Anagnostou, Bloorview Research Institute, Toronto, 
Canada: Oxytocin and social cognition/function: Early 
clinical studies.
G. Dawson, University of North Carolina, Autism Speaks, 
Chapel Hill: Autism spectrum disorders: Challenges in 
bridging the gap from preclinical research to clinical trials.
G. Lyon, Cold Spring Harbor Laboratory: Clinical progress in 
autism genetics and treatment.
Review and Summary
C. Schutt, R. Greenspan
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Inspire2Live
September 14–16
FUNDED BY Inspire2Live, Utrecht, Netherlands
ARRANGED BY  Inspire2Live Discovery Network Team, Amsterdam, Cambridge, Oxford, Paris, 
New York, Boston, Seattle
The Inspire2Live Foundation was created with the aim of motivating as many people as possible to 
constantly challenge and expand their boundaries and to raise funds to fi ght cancer by organizing 
fund-raising events. The Foundation has shifted its funding strategy toward mobilizing a team of 
committed sponsors. To this end, the presidents of the Alp d’HuZes fund-raiser and the Dutch 
Cancer Foundation KWF came to Banbury Center together with senior members of the cancer re-
search community. The meeting began with updates on the scientifi c research of the Foundation’s 
program, followed by presentations on the clinical aspects of the program. Discussion then turned 
to the Foundation’s funding plans, followed by a detailed focus on setting up the organizational 
necessities needed in 2012 in preparation for 2013.
Welcoming Remarks: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Update on the Scientifi c Parts
Moderator: A. Eggermont, President, Institut Gustave 
 Roussey, Paris, France
M. Stratton, Sanger Institute, Cambridge: Overall program 
need and impact.
H. Clevers, the Hebrecht Institute, the Netherlands: 
 Organoids.
M. Stratton, the Sanger Institute, Cambridge, 
 United  Kingdom: Screening.
M. Meyerson, Dana-Farber Cancer Institute, Boston, 
 Massachusetts: Sequencing.
S. Friend, Sage Bionetworks, Seattle, Washington:  Model 
sharing.
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SESSION 2: Update on the Clinical Parts
J. Baselga, Massachusetts General Hospital, Boston: Plan of 
a breast program and team incorporating organoids, other 
models, screening, sequencing, and trials.
D. Tuveson, Cold Spring Harbor Laboratory: Plan of the 
pancreas program and team incorporating organoids, other 
models, screening, sequencing, and trials.
C. Sawyers, Memorial Sloan-Kettering Cancer Center, New 
York: Plan of the prostate program and team incorporating 
organoids, other models, screening, sequencing, and trials.
E. Coen van Veenendaal/Rob Snelders, Inspire2Live Founda-
tion: Overall program  approach and funding requests.
The Science Team met in the conference room and focused 
on setting up the organization and planning for the program.
Moderators: H. Clevers, S. Friend, P. Kapitein
The Funders Team discussed the necessary steps during 2012 
to get the program up and running in 2013 and beyond.
Moderators: A. Eggermont, E. Coen van Veenendaal, 
R. Snelders
Feedback of Funders Team and Science Team Moderators on 
Their Approach
General Wrap-Up Discussion
J. Watson, E. Coen van Veenendaal, A. Trounson B. Conley
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Plant–Environment Interactions 
September 18–21
FUNDED BY CSHL/DuPont Pioneer Joint Collaborative
ARRANGED BY M. Timmermans, Cold Spring Harbor Laboratory
 M. Komatsu, DuPont Pioneer, Wilmington, Delaware
 R. Martienssen, Cold Spring Harbor Laboratory
 S. Tingey, DuPont Pioneer, Wilmington, Delaware
The goals of this meeting were to review the latest advances in our understanding of plants’ re-
sponses to abiotic environmental cues and pathogens, and during the establishment of symbiotic as-
sociations. These reviews were expected to drive discussions on current research addressing natural 
variation and adaptation to biotic and abiotic stresses. The meeting included, in addition to members 
of the CSHL/DuPont Pioneer Joint Collaborative, speakers from outside the collaboration.
Welcoming Remarks: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor
Introduction: M. Komatsu, DuPont Pioneer, Wilmington, Delaware
SESSION 1: Infl orescence Development
Chairperson: M. Komatsu, DuPont Pioneer, Wilmington, 
Delaware
Z. Lippman, Cold Spring Harbor Laboratory: A surprising 
link between meristem maintenance and pollen develop-
ment in tomato and Arabidopsis.
B. Il Je, Cold Spring Harbor Laboratory: Fasciated ear3, 
a  potential new CLAVATA receptor.
O. Danilevskaya, DuPont Pioneer, Johnston, Iowa: Maize ear 
development under drought stress.
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SESSION 2: Small RNAs and Cell Fate Specifi cation
Chairperson: D. Ware, Cold Spring Harbor Laboratory
F. Van Ex, Cold Spring Harbor Laboratory: Argonautes, small 
RNA, and germ cell fate.
M. Dotto, Cold Spring Harbor Laboratory: Update on col-
laborative projects: tasiR-RNA pathways in maize and new 
players in leaf polarity.
M. Timmermans, Cold Spring Harbor Laboratory: Small 
RNAs as instructive signals in development.
SESSION 3: Regulation of Yield
Chairperson: B. Williams, DuPont Pioneer, Wilmington, 
Delaware
D. Jackson, Cold Spring Harbor Laboratory: Maize meristem 
signaling and yield.
A. Mohanty, DuPont Pioneer, Hyderabad, India: Mapping of 
novel genetic loci in rice for improvement of hybrid produc-
ibility and defensive traits.
R. Williams, DuPont Pioneer, Wilmington, Delaware: 
Drought lead characterization: Using Arabidopsis as a model 
to support Ag traits.
K. Jiang, Cold Spring Harbor Laboratory: Molecular dynam-
ics of dosage in tomato single gene heterosis.
SESSION 4: Epigenetic Gene Regulation
Chairperson: Z. Lippman, Cold Spring Harbor Laboratory
J. Reinders, DuPont Pioneer, Wilmington, Delaware: Maize 
methylome project: Pilot study review and update on epigen-
etic variation induced by drought stress.
A. Olson, Cold Spring Harbor Laboratory: Building and clas-
sifying coding and noncoding gene models with transcrip-
tome and methylome sequencing data.
R. Martienssen, Cold Spring Harbor Laboratory: The maize 
methylome.
SESSION 5: Responses to Abiotic Environmental Cues
Chairperson: M. Timmermans, Cold Spring Harbor 
 Laboratory
C. Fankhauser, University of Lausanne, Switzerland: Light 
regulation of plant growth and development.
J. Dinneny, Stanford University, California: Spatiotemporal 
control of environmental response.
J. Schroeder, University of California, San Diego: Drought/
abscisic acid signaling and chemical genetic dissection of im-
mune: ABA interference mechanisms.
T. Mitchell-Olds, Duke University, Durham, North Carolina: 
Complex traits in complex environments.
D. Ware, Cold Spring Harbor Laboratory: Understanding 
stress-related traits through root-specifi c gene networks.
SESSION 6: Symbiosis and Biotic Stress Responses
Chairperson: M. Komatsu, DuPont Pioneer, Wilmington, 
Delaware
U. Paszkowski, University of Lausanne, Switzerland: Arbuscu-
lar mycorrhizal symbiosis in cereals.
H. Bouwmeester, Wageningen University, the Nether-
lands: The role of strigolactones in plant−environment 
interaction.
M. Albertsen, Z. LippmanM. Timmermans, H. Bouwmeester
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O. Danilevskaya, D. Jackson
H. Bouwmeester, P. Wolters
G. Oldroyd, John Innes Center, BBSRC, Norwich, United 
Kingdom: Nutrient acquisition by plants through symbiotic 
associations.
D. Bulgarelli, Max-Planck Institute, Koln, Germany: Struc-
ture and functional signifi cance of the root-inhabiting bacte-
rial microbiota.
P. Wolters, DuPont Pioneer, Wilmington, Delaware: Disease 
resistance in maize: Identifi cation of genes involved in resis-
tance to Colletotrichum graminicola and their use in maize 
breeding.
G. Rairdan, DuPont Pioneer, Wilmington, Delaware: Exploit-
ing the plant-pathogen “arms race” to engineer resistance to 
Asian soybean rust.
SESSION 7: Molecular Analysis of Developmental 
Progressions
Chairperson: P. Wolters, DuPont Pioneer, Wilmington, 
 Delaware
S.-J. Park, Cold Spring Harbor Laboratory: Genetic and mo-
lecular dissection of tomato shoot architecture.
M. Javelle, Cold Spring Harbor Laboratory: An expression 
atlas of functional domains in the shoot apical meristem.
J. Calarco, Cold Spring Harbor Laboratory: The pollen meth-
ylome.
A. Eveland, Cold Spring Harbor Laboratory: Unraveling the 
developmental networks controlling determinacy and infl o-
rescence architecture in maize.
General Discussion: S. Tingey and R. Martienssen
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Decoding Clinical Trials to Improve Treatment of ME/CFS
September 30−October 3
FUNDED BY  CFIDS Association of America, Charlotte, North Carolina, Centers for Disease  
  Control and Prevention, Atlanta, Georgia
ARRANGED BY S. Vernon, CFIDS Association of America, Charlotte, North Carolina
 R. Silverman, Cleveland Clinic Lerner Research Institute, Ohio
 E. Unger, Centers for Disease Control and Prevention, Atlanta, Georgia
 J.A. Witkowski, Cold Spring Harbor Laboratory
The focus of this meeting was on chronic fatigue syndrome treatment trials. Chronic fatigue 
syndrome, now referred to as ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome), is 
a severe and debilitating illness characterized by a constellation of nonspecifi c symptoms includ-
ing fatigue, cognitive impairment, muscle pain, joint pain, disturbed sleep, and general weakness. 
The objective of this workshop was to review the science behind the effi cacy or lack of effi cacy 
of treatment trials in ME/CFS. This was to be accomplished by bringing investigators who have 
conducted ME/CFS pharmacological randomized controlled trials (RCTs) that have a high level 
of evidence together with experts in clinical methodology, pharmacology, molecular biology, and 
ME/CFS. The output of this meeting is to be a peer-reviewed publication describing the workshop 
fi ndings and proposing a set of guidelines that will help optimize study design and clinical meth-
odology of future RCTs for ME/CFS.
SESSION 1: Background and Clinical Impressions
Chairpersons: R. Dodd, American Red Cross, Rockville, 
Maryland, and A. Waring (rapporteur), University of Cali-
fornia, Los Angeles, Torrance
Guidelines for Session 1: Chairpersons captured key points 
from each presentation to use these during the breakout 
sessions. Speakers included relevance of topic to CFS charac-
teristics of CFS populations and cohorts being discussed.
J.A. Witkowski, Director, Banbury Center, Cold Spring Har-
bor Laboratory: Welcoming remarks.
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V. Racaniello, Columbia University, New York: Viruses and 
chronic disease.
K.K. McCleary, CFIDS Association, Charlotte, North Caro-
lina: Evidence for and against microbial pathogens in CFS.
J.-M. Lin, Centers for Disease Control and Prevention, 
 Atlanta, Georgia: Healthcare utilization in CFS.
M. Cooperstock, University of Missouri Health Care, Colum-
bia: Clinical perspectives on pediatric postinfection CFS.
F. Maldarelli, National Cancer Institute, Bethesda, Maryland: 
Clinical perspectives on an adult CFS population selected to 
study XMRV.
D. Cook, University of Wisconsin, Madison: The metabolic 
profi le of PEM.
SESSION 2: Lessons Learned from CFS Treatment Trials
Chairpersons: V. Racaniello, Columbia University, New 
York, and K.K. McCleary (rapporteur), CFIDS Association 
of America, Charlotte, North Carolina
Guidelines for Session 2: Chairpersons captured key points 
from each presentation to use these during the breakout ses-
sions. Speakers described study design (e.g., case/control), se-
lection of study subjects (e.g., volunteer and advertisement), 
inclusion/exclusion criteria, trial setting, and outcome mea-
sures and characteristics of CFS populations/cohort being 
discussed.
P. Rowe, Johns Hopkins University, Baltimore, Maryland: 
Lessons from the fl orinef trial.
C.-G. Gottfries, Gottfries Clinic, Moindal, Sweden: The use 
of dopaminergic stabilizer OSU6162 in treatment of fatigue.
K. Rowe, the Royal Children’s Hospital, Victoria, Australia: 
Lessons from gamma globulin treatment trial.
J. G. Montoya, Palo Alto Medical Foundation, California: 
Viral and immune profi les of responders to valcyte.
L. Bateman, the Fatigue Consultation Clinic, Salt Lake 
City, Utah: Lessons from treatment of CFS patients with 
 ampligen.
N. Klimas, University of Miami School of Medicine, Florida: 
Can response to drugs help us reverse-engineer CFS?
SESSION 3: Considerations for CFS Treatment Trial Design
Chairpersons: R. Bromley, TRAC Consulting, Redwood 
City, California, and K. Morren, ServiceSource, Denver, 
Colorado
Guidelines for Session 3: Chairpersons captured key points 
from each presentation to use these during the breakout ses-
sions. Speakers described aspects of the clinical trial study de-
sign impacted by their presentation topic.
Ø. Fluge, Department of Oncology and Medical Physics, 
Haukeland University Hospital, Bergen, Norway: Benefi t 
from B-cell depletion in CFS.
E. Crawley, University of Bristol, United Kingdom: Consider-
ations when planning trials in children with ME/CFS.
J. Jones, Center for Disease Control and Prevention, Atlanta, 
Georgia: Choice of control subjects in CFS clinical trials.
L. Chang, David Geffen School of Medicine at UCLA, Los 
Angeles, California: Comorbid conditions and impact of 
CFS treatment trials.
M. Cooperstock, S. Vernon, L. Bateman, K. Rowe
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E. Unger, Centers for Disease Control and Prevention, At-
lanta, Georgia: Deconstructing CFS: Search for endopheno-
types refl ecting pathogenesis.
M. Demitrack, Neuronetics, Inc., Malvern, Pennsylvania: 
Treatment resistance: Real or just not the right drug?
SESSION 4: Plausible Therapeutic Targets
Chairpersons: S. Deftereos, Biovista, Inc., Charlottesville, 
Virginia, and A Persidis (rapporteur), Biovista Inc., Char-
lottesville, Virginia
Guidelines for Session 4: Chairpersons captured key points 
from each presentation to use these during the breakout ses-
sions. Speakers described where in the biomarker and clinical 
trial pipeline the data in their presentation “fi ts” and what is 
required to move it to the next phase.
I. Biaggioni, Vanderbilt University School of Medicine, Nash-
ville, Tennessee: Is sympathetic tone a target in CFS?
G. Broderick, University of Alberta, Canada: Network analy-
sis for druggable target identifi cation.
S. Shukla, Marshfi eld Clinic Research Foundation, Marsh-
fi eld, Wisconsin: The “CFS” microbiome as a possible thera-
peutic target.
M. Medow, New York Medical College, Hawthorne, New 
York: Brain blood fl ow and brain fog in CFS.
P. McGowan, University of Toronto, Scarborough, Canada: 
Targeting methylation as a CFS treatment.
S. Deftereos, Biovista Inc., Charlottesville, Virginia: Prelimi-
nary drug repurposing fi ndings in CFS.
B. Munos, InnoThink Center for Research in Biomedical In-
novation, Indianapolis, Indiana: How to energize drug in-
novation for CFS.
SESSION 5: Advancing the Science of Medicine for CFS
Three breakout groups met from 9 am to 10 am to brainstorm 
questions and issues generated by the session chairpersons. 
Each group produced an outline that was presented to the 
workshop participants following the break.
Breakout Group 1: Subtypes vs. symptoms: What is the best 
strategy for CFS treatment trials? (Sessions 1 and 3)
Led By: I. Biaggioni and L. Bateman
Group 1 Participants: M. Cooperstock, E. Crawley, C.-G. 
Gottfries, M. Medow, K. Rowe, P. Rowe, E. Unger, A. Waring
Breakout Group 2: Moving treatment forward now: How and 
who are the players? (Session 2)
Led By: B. Munos and N. Klimas
Group 2 Participants: M. Demitrack, S. Deftereos, R. Dodd, 
J. Jones, N. Klimas, F. Maldarelli, K.K. McCleary, J. Mon-
toya, S. Vernon
Breakout Group 3: Strategies for data analysis to identify 
therapeutic targets. (Session 4)
Led By: R. Bromley and A. Persidis
Group 3 Participants: G. Broderick, D. Cook, J.-M. Lin, P. 
McGowan, K. Morren, V. Racaniello, S. Shukla, R. Silver-
man, A. Waring
Presentation and Discussion of Group 1 Report: L. Bateman
Presentation and Discussion of Group 2 Report: N. Klimas
Presentation and Discussion of Group 3 Report: A. Persidis
Review of Workshop Outcome(s): S. Vernon
S. Vernon, S. Shukla K.K. McCleary
419-466_Banbury.indb   459 9/17/2013   8:22:57 AM
460
Grand Challenges in Organismal Biology
November 8–11
FUNDED BY National Science Foundation through a grant to Stony Brook University
ARRANGED BY D. Padilla, Stony Brook University, New York
 B. Swalla, University of Washington, Seattle
 B. Tsukimura, California State University, Fresno
The National Research Foundation has established Research Coordination Networks (RCNs) in 
various fi elds, intended to “. . .advance a fi eld or create new directions in research or education by 
supporting groups of investigators to communicate and coordinate their research, training, and ed-
ucational activities across disciplinary, organizational, geographic, and international boundaries.” 
Investigators came to Banbury to consider the potential value of an RCN for metazoan organismal 
biology, specifi cally the issue “How organisms walk the tightrope between stability and change” 
and, more broadly, “What will be needed as far as infrastructure to solve complex problems and 
interactions across scales?” One of the goals of the meeting was to plan a full-scale workshop on 
the topic.
Welcoming Remarks: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Goals of Meeting, Introductions, and Approaches to Answering Big Questions
D. Padilla, Stony Brook University, New York: Background 
and goals; Introductions−Who are we?
B. Swalla, University of Washington, Seattle: What is an 
RCN and how can they work? EDEN−the Evo-Devo-Eco 
Network RCN.
D. Padilla, Stony Brook University, New York: Synthesis Centers.
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B. Tsukimura, California State University, Fresno: iPlant.
D. Manahan, University of Southern California, Los Angeles: 
Thinking integratively in organismic biology: Lessons from 
decade-long NSF graduate training programs.
T. Daniel, University of Washington, Seattle: New approaches 
needed to address big questions.
Group Discussion: Think big—”Blue sky” ideas about needs 
associated with specifi c plans of attack on the GCOB.
SESSION 2: Breakout Groups
Priorities for making progress on this GCOB (more data, more 
cross disciplinary collaboration, a new generation of think-
ers?), and best paths to getting there (cyberinfrastructure, syn-
thesis of existing data, new mathematical models?).
Wrap-Up Discussion
SESSION 3: Agenda for the Next Workshop
General Discussion: Setting agenda for the big workshop, 
types of participants, and scientifi c expertise needed.
Breakout Groups: Recommendations, narrowing scope.
Reports and Discussion: Agenda for workshop, homework 
for workshop participants, recommended areas of expertise, 
and action plan for Steering Committee.
Breakout Groups: Additional elements that need to be 
included.
Group Discussion
Breakout Groups: Agenda for workshop and homework for 
workshop participants.
Report Out and Group Discussion
SESSION 4: Finalize Action Plans
For agenda, homework, and types of scientists to include in 
next workshop.
For Steering Committee.
Wrap-Up Discussion
Final Thoughts: Set dates for the workshop, nominating 
participants/research areas
C. Hayashi T. Daniel, W. Zamer
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Cell Plasticity in Cancer Evolution
November 11–14
FUNDED BY Astellas-OSI Oncology, Farmingdale, New York
ARRANGED BY J. Condeelis, Albert Einstein College of Medicine, Bronx, New York
 D. Epstein, Astellas-OSI Oncology, Farmingdale, New York
 J. Haley, Astellas-OSI Oncology, Farmingdale, New York
Banbury Center has been the location for several meetings on the epithelial-mesenchymal transi-
tion (EMT) in cancer. This is the most studied form of cellular plasticity and is characterized by 
the combined loss of epithelial cell junction proteins and cell polarity and the gain of mesenchy-
mal markers. More recently, EMTs have been characterized in which the interconversion of vessels 
and fi broblastic elements can contribute to cancer pathogenesis and fi brosis. These fi ndings have 
important implications for cancer treatment and prevention. For example, cellular sensitivity to 
multiple targeted therapies, chemotherapy, and radiotherapy was shown to be governed by the 
extent to which cells have undergone an EMT-like transition. Resistance associated with cellular 
plasticity and heterogeneity has been observed in multiple systems derived from adenocarcinomas 
and squamous carcinomas. The aim of this conference was to explore the molecular and patho-
biological signifi cance of cellular plasticity in carcinomas and to further elucidate the signaling 
pathways that promote plasticity.
Welcoming Remarks: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor Laboratory
Introduction: R. Kalluri, Harvard Medical School, Boston, Massachusetts
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SESSION 1: Epithelial, Endothelial, and Neuroendocrine 
Plasticity
R. Kalluri, Harvard Medical School, Boston, Massachusetts: 
Cell plasticity and its energy requirements.
D. Lyden, Weill Cornell Medical College, New York: Tumor-
derived exosomes promote plasticity at the premetastatic 
niche.
J. Condeelis, Albert Einstein College of Medicine, Bronx, 
New York: EMT and trans-endothelial migration during 
breast tumor cell dissemination.
W. Lowry, University of California, Los Angeles: Molecular 
mechanisms of stem-cell-initiated carcinoma.
T. Brabletz, University of Freiburg Medical Center, Germany: 
MicroRNAS, EMT, and cancer stem cells.
General Discussion
SESSION 2: Cell Plasticity in Model Systems
B. Stanger, University of Pennsylvania, Philadelphia: Analysis 
of cellular plasticity in an autochthonous model of pancre-
atic cancer.
A. Biddle, University of London, England: Developing an in 
vitro model for characterization of heterogeneous and plastic 
cancer stem cell phenotypes, and for therapeutic development.
W. Guo, Albert Einstein College of Medicine, Bronx, New 
York: Plasticity of epithelial cell hierarchy: induction of the 
stem-cell state in the breast.
A. Patsialou, Albert Einstein College of Medicine, Bronx, New 
York: Cell plasticity in breast tumor invasion: The cell’s deci-
sion to go or grow.
General Discussion
SESSION 3: Signaling Networks in EMT and CSCs
A. Cano, Instituto de Investigaciones Biomedicas, Madrid, 
Spain: Regulation of cellular plasticity and the tumor micro-
environment by lysyl oxidases (LOX, LOXL1-4).
D. McClay, Duke University, Durham, North Carolina: 
Transcriptional control of EMT-subcircuits control each 
cell biological component.
R. Carstens, University of Pennsylvania, Philadelphia: The 
role of alternative splicing in EMT and cancer.
H. Nakagawa, University of Pennsylvania, Philadelphia: 
Notch regulation in squamous cancer cell plasticity and mi-
tochondrial functions.
P. Keely, University of Wisconsin, Madison: Matrix stiffness 
in regulating the proliferation and metabolic plasticity of 
cancer cells.
General Discussion
SESSION 4: Epigenetics and Cellular Conversions
S. Baylin, Johns Hopkins University, Baltimore, Maryland: 
DNA methylation, cancer stem cells and implications for 
cell plasticity.
C. Chaffer, Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts: Cellular plasticity: The role of 
epigenetics in generating CSCs from non-CSCs.
C. Kleer, University of Michigan Medical School, Ann Arbor: 
Role of the epigenetic regulator EZH2 in breast cancer ini-
tiation and progression.
R. Thompson, St. Vincents Hospital, Melbourne, Australia: 
Epithelial Mesenchymal Plasticity (EMP) in Breast Cancer 
Dissemination–What to target and when?
G. Van der Pluijm, Leiden University Medical Centre, the 
Netherlands: BMP7, epithelial plasticity, and metastasis.
General Discussion
SESSION 5: Impacts of Cell Conversion on Cancer Therapy
J. Engelman, Massachusetts General Hospital, Charlestown: 
Evolution of cancers through tyrosine kinase inhibitors in 
lung cancer.
R. Sordella, Cold Spring Harbor Laboratory: An epigenetic 
switch modulates cancer cell-state plasticity by regulating 
Mir-335 expression.
J. Rosen, Baylor College of Medicine, Houston, Texas: 
EMT programs, therapeutic resistance, and cancer stem 
cells.
J. Haley, Astellas-OSI Oncology, Farmingdale, New York: 
Cell plasticity and drug resistance.
S. Alford, Massachusetts Institute of Technology Center for 
Cancer Research, Cambridge: Dysregulation of EGFR 
 signaling during invasion and metastasis.
J. Condeelis, Albert Einstein College of Medicine, Bronx, 
New York:
Wrap-Up: Specifi c Issues and Priorities
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Inﬂ ammation, Cancer, and Metabolism
November 26–29
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY D. Green, St. Jude Children’s Hospital, Memphis, Tennessee
 L. O’Neill, Trinity College, Dublin, Ireland
Otto Warburg showed that tumor cells performed aerobic glycolysis and proposed that this metabol-
ic change was fundamental for pathogenesis of cancer. Mutations in important metabolic enzymes 
have been shown to be important for tumorigenesis, and more recently, molecular insights into the 
basis of the Warburg effect have emerged, including the roles of the transcription factor HIF-1α and 
also enzymes such as PKM2. Immunologists have also recently turned their attention to changes 
in immune cell function, and the Warburg effect is now known to occur in activated macrophages 
and certain T-cell lineages. Other metabolic processes, including those involving AMP kinase and 
mTOR, are also now seen as important for the immune and infl ammatory processes. A number of 
questions arise. Why are these metabolic changes occurring and what is their mechanistic basis? 
Might changes in metabolism during cancer and infl ammation be critical for disease development? 
Might these metabolic changes provide an explanation for the link between infl ammation and can-
cer? Is there a prospect here that new treatments might emerge from these insights?
Welcoming Remarks: J.A. Witkowski, Director, Banbury Center, Cold Spring Harbor
Introduction and Meeting Goals: L. O’Neill, Trinity College, Dublin, Ireland
SESSION 1: Cancer
E. Gottlieb, Beatson Institute for Cancer Research, 
Glasgow, United Kingdom: Metabolomics approaches 
in cancer  research.
R. DeBerardinis, University of Texas Southwestern Medical 
Center, Dallas, Texas: Diversity of core metabolic pathways 
in human cancer cells.
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M. VanderHeiden, Massachusetts Institute of Technology, 
Cambridge: Regulation of anabolic metabolism.
G. Kroemer, Institut Gustave Roussy, Villejuif, France: Im-
munosurveillance induced by conventional anticancer thera-
pies: Metabolism matters.
General Discussion
SESSION 2: Macrophages/TLRs
L. O’Neill, Trinity College, Dublin, Ireland: Metabolic regu-
lation of infl ammatory signaling by Toll-like receptors and 
infl ammasomes.
D. Underhill, Cedars-Sinai Medical Center, Los Angeles, Cal-
ifornia: Linking phagocytosis and microbial degradation to 
infl ammatory signaling.
D. Green, St Jude Children’s Research Hospital, Memphis, 
Tennessee: Noncanonical autophagy in innate immunity.
M. Netea, Radboud University, Nijmegen, the Netherlands: 
Trained immunity: Metabolic pathways involved in innate 
monocyte reprogramming.
General Discussion
SESSION 3: Microbiome, Infl ammation, and Obesity
M. Murphy, University of Cambridge, United Kingdom: How 
mitochondrial ROS can modulate metabolism.
J. Ayres, Salk Institute for Biological Studies, San Diego, Cali-
fornia: Host−microbiota interactions in health and disease.
M. Saleh, McGill University, Montreal, Canada: Innate detection 
mechanisms and infl ammation in obesity and type-2 diabetes.
V. Stambolic, University of Toronto, Princess Margaret Hospi-
tal, Ontario, Canada: The relationship between obesity and 
cancer: The insulin connection.
General Discussion
SESSION 4: T Cells
R. Xavier, Massachusetts General Hospital, Boston: Metabolic 
pathways in immunity.
D. Cantrell, University of Dundee, Scotland: Metabolism, 
 migration, and memory in cytotoxic T cells.
N. Chandel, Northwestern University, Chicago, Illinois: 
 Mitochondrial ROS regulate T cells.
R. Siegel, National Institute of Arthritis and Musculoskel-
etal and Skin diseases, NIH, Bethesda, Maryland: Mito-
chondrial reactive oxygen species and autoinfl ammatory 
disease.
G. Matarese, University of Salerno, Italy: Oscillatory intracel-
lular metabolic pathways control immune tolerance.
General Discussion
SESSION 5: T Cells
H. Chi, St Jude Children’s Research Hospital, Memphis, 
Tennessee: mTOR and metabolic pathways in T-cell fate 
decisions.
J. Powell, Johns Hopkins University, Baltimore, Maryland: 
mTOR: Master integrator of T-cell metabolism, differentia-
tion, and function.
J. Rathmell, Duke University Medical Center, Durham, 
North Carolina: Glucose uptake in lymphocyte activation 
and subsets.
E. Pearce, Washington University School of Medicine, St 
Louis, Missouri: Posttranscriptional control of T-cell func-
tion by Warburg metabolism.
M. Karin, University of California, San Diego: Virchow ex-
plained: The origin of tumor elicited infl ammation and its 
signifi cance.
General Discussion
M. Saleh R. Xavier, M. Murphy
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DNA LEARNING CENTER
EXECUTIVE DIRECTOR’S REPORT
ADMINISTRATION INSTRUCTION BIOMEDIA
Lauren Correri Elna Carrasco Anthony Biondo
Mary Lamont Jennifer Galasso Cornel Ghiban
Valerie Meszaros Natalia Hanson Eun-Sook Jeong
David Micklos Melissa Lee Mohammed Khalfan
Carolyn Reid Christine Marizzi Susan Lauter
 Kathleen McAuley Sheldon McKay
 Amanda McBrien Amy Nisselle
 Erin McKechnie Christian Weidler
 Bruce Nash Jason Williams
 Oscar Pineda-Catalan Chun-hua Yang
 Brooke Roeper
 Jermel Watkins
Many science educators search for ways to scale student research from local, individual projects 
to distributed, class-based experiments that involve many students working simultaneously on 
aspects of the same problem. DNA barcoding fulfi lls the promise of modern, Internet-enabled 
biology—allowing students to work with the same data, with the same tools, at the same time as 
high-level researchers. Just as the unique pattern of bars in a universal product code (UPC) iden-
tifi es each consumer product, a short “DNA barcode” (~600 nucleotides in length) is a unique 
pattern of DNA sequence that can potentially identify any living thing. DNA barcoding projects 
can stimulate independent student thinking across different levels of biological organization, link-
ing molecular genetics to ecology and evolution, with the potential to contribute new scientifi c 
knowledge about biodiversity, conservation biology, and human effects on the environment. DNA 
barcoding also integrates different methods of scientifi c investigation, from in vivo observations to 
in vitro biochemistry to in silico bioinformatics.
DNA barcoding provides a practical way to bring open-ended experimentation into biology 
classes. Projects can operate at various scales, from working with other students to investigate a 
local ecosystem, museum collection, or conservation issue, to joining an International Barcode of 
Life “campaign” to explore an entire taxonomic group or global biome. Projects may also take on 
a forensic slant, when students attempt to identify product fraud (such as mislabeled food items) 
or to identify the sources of commercial products (such as plants or animals used in traditional 
medicines). The core lab and phylogenetic analysis can be mastered in a relatively short time, 
allowing students to reach a satisfying research endpoint within a single academic term. Using 
DNA barcoding as the common method across a range of projects decreases the need for intensive, 
expert preparation and mentoring, thus providing a practical means to engage large numbers of 
students in meaningful research.
To help realize this promise, during the past 2 years, we have devoted ourselves to developing 
an integrated biochemical and bioinformatics (B&B) workfl ow for DNA barcode analysis. The 
biochemistry uses noncaustic reagents to isolate DNA from plant, animal, or fungal organisms. 
The barcode region is amplifi ed by polymerase chain reaction (PCR) and visualized by agarose 
gel electrophoresis. The barcode amplicons are mailed to GENEWIZ Inc., a company that pro-
vides inexpensive sequencing—$3.00 per forward and reverse read. Within 48 hours, the fi nished 
barcode sequences are automatically uploaded to DNA Subway, the DNALC’s intuitive bioinfor-
matics workfl ow for education developed under the National Science Foundation (NSF) iPlant 
Collaborative (described below).
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The Blue Line of DNA Subway includes all tools needed to visualize and edit barcode se-
quences, search GenBank (www.ncbi.nlm.nih.gov/genbank) for matches, align sequences, and 
construct phylogenetic trees. The Blue Line features web applications that heretofore could only 
be used as stand-alone applications, including an electropherogram viewer/editor and a “zoom-
able” sequence aligner/barcode viewer. An export feature simplifi es barcode sequence submissions 
to GenBank, automatically providing sequence fi les, associated metadata, and sequence annota-
tions in the required National Center for Biotechnology Information (NCBI) format.
The barcode experiment, including extensive teacher prep and planning for both lab and 
 bioinformatics components, is available in three formats: the online lab notebook at www. 
dnabarcoding101.org, the lab-text Genome Science: A Practical and Conceptual Introduction to Molecular 
Genetic Analysis in Eukaryotes (Cold Spring Harbor Laboratory Press), and a stand-alone kit marketed 
by our collaborator, Carolina Biological Supply Company (CBSC).
Urban Barcode Project
With a grant from the Alfred P. Sloan Foundation, we 
tested the B&B workfl ow in the context of the Urban 
Barcode Project (UBP), a high school science compe-
tition spanning the fi ve boroughs of New York City 
(NYC). A dedicated Internet site (www.urbanbarcode-
project.org) supported all aspects of the project, in-
cluding vodcasts on barcoding and student projects, 
protocols, guidelines for proposal preparation, and da-
tabase management tools for tracking student projects 
and metadata. Participating during the 2011–2012 
academic year were more than 100 teams compris-
ing more than 300 students (37% Asian, 32% White, 
and 31% Latino or African-American) from 31 public 
and nine private high schools. Students worked on their 
A UBP student works on her project during an Open 
Lab at Harlem DNA Lab.
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projects in the schools—often using freely available DNALC footlockers—or at 70 Open Lab ses-
sions at Harlem DNA Lab, and Genspace, a nonprofi t citizen science center in Brooklyn. DNALC 
staff also made more than 40 school visits to assist with experiments and phylogenetic analyses. 
Teams collected and processed over 1000 samples for DNA sequencing, with over 2500 single 
sequences provided by GENEWIZ.
Seventy-fi ve teams—comprising 218 students from 30 high schools—completed their projects 
in time to present their results at two poster sessions held at the American Museum of Natural His-
tory (AMNH) on May 31 and June 1. The projects spanned fi ve categories: (1) wildlife in parks 
and public spaces, (2) commercial products and trade in endangered species, (3) food mislabeling, 
(4) public health and disease vectors, and (5) exotic and invasive species. A jury of 34 experts in 
biodiversity, conservation biology, DNA barcoding, and education selected the top 10 teams, who 
gave oral presentations at the AMNH on June 6. The Grand Prize team from Hostos Academy of 
Sciences in the Bronx won $10,000 for their fi nding that many herbal Ginkgo products contained 
little to no Ginkgo biloba DNA. Other fi nalists shared $10,000 in prizes for projects including the 
fi rst DNA barcoding census of fungi in Central Park, mapping clades of Atlantic silversides and 
killifi sh in New York coastal waters, identifying species of bed bugs in Brooklyn through bacte-
rial DNA, comparing morphological identifi cation versus DNA barcoding of ants in the South 
Bronx, and improving the identifi cation of insects seized by U.S. Customs and Border Protection 
at Newark International Airport.
Importantly, UBP students produced 65 novel DNA sequences that did not match exist-
ing GenBank data. These barcodes included new sequence differences (polymorphisms), as 
well as new records of species for which no barcode had been previously reported. Using the 
simplifi ed export feature of DNA Subway, these sequences were submitted to GenBank with 
student and teacher authors. The published sequences represented animals, plants, and fungi 
collected in a range of student projects: 36 from wild organisms collected in parks or natural 
areas; 13 from products purchased in markets and shops around the city; seven from exotic or 
invasive species; six from invertebrate disease vectors; and three from investigations of food 
mislabeling.
Surveys of participating teachers suggested that the UBP will potentially improve science in-
struction for many students beyond those who actually did barcoding projects. A majority said 
they plan to implement barcoding concepts, independent research, and bioinformatics exercises 
into a range of general biology, AP Biology, and biology electives. Surveys and structured inter-
views overwhelmingly showed that students appreciated the ownership of their projects and the 
sense of “doing real science.” For most, it was their fi rst experience with open-ended research. 
Following the UBP Symposium award ceremony at AMNH, the 10 ﬁ nalist teams display their prizes with UBP staff and judges.
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Compared to previous experiences with science fairs or competitions, the vast majority of students 
thought the UBP had provided “much more” experience in learning science, doing independent 
inquiry, understanding the scientifi c process, developing critical thinking skills, and increasing 
interest in science careers. Thus, in the context of the nation’s largest school system, we have dem-
onstrated that DNA barcoding projects can be scaled to introduce large numbers of students to 
authentic research.
Barcode Long Island
During the summer, we explored a different format for student 
DNA barcoding—a sustained “campaign” to explore the biodiver-
sity of Cold Spring Harbor. The diversity of biological niches found 
at the interface of land and water was the impetus for founding the 
Biological Laboratory at Cold Spring Harbor in 1890 as a fi eld sta-
tion for the study of evolution in the natural world. For several de-
cades, naturalists came for summer courses to study organisms of 
the intertidal zone, salt marshes, sand spit, and open waters of the 
harbor and Long Island Sound. Their sustained and detailed work 
formed the basis for the modern fi eld of ecology. When Cold Spring 
Harbor Laboratory’s (CSHL) research shifted toward genetics, sev-
eral generations of local school students carried on the ecological 
tradition during summer Nature Study Courses conducted from the 
1940s through to the mid 2000s.
The Barcoding Biodiversity student workshops marked a return to CSHL’s roots. Naturalist 
photographer David Liittschwager joined us for the fi rst workshop. David’s stunning photo-
graphs of life in 1 cu ft samples from habitats in Costa Rica, French Polynesia, South Africa, 
Tennessee, and New York appeared in the February 2010 issue of National Geographic. David 
instructed students in how to tease out all of the visible plants and animals (1 mm 
or larger) in a “biocube” and trained DNALC staff how to take publication-quality 
photographs.
Ninety-seven students, including 20 students from Beijing No. 166 High School, 
participated in six workshops. The students  collected and processed more than 300 
samples, obtaining 165 high-quality DNA barcodes. Most DNA barcodes came 
from aquatic invertebrates such as bryozoans, hydrozoans, gastropods, amphipods, 
isopods, and crustaceans. We published 30 novel sequences to GenBank with stu-
dents as  primary authors. Among the organisms 
for which there were published barcode sequenc-
es was a still unidentifi ed “mini” nudibranch (a 
3-mm snail without a shell) and an inch-long mud 
crab (Eurypanopeus depressus). Students identifi ed 
three sequence polymorphisms in the mud crab, 
indicating a great deal of genetic diversity and sug-
gesting that the southern members of this group may be a 
different species.
New Experiments in Epigenetics
We continued a collaboration with CSHL professor Rob Martienssen and North Carolina State 
researcher Bill Thompson on their NSF-funded project “Epigenome Dynamics during DNA Rep-
lication.” Epigenetics describes heritable phenomena that affect gene expression without changing 
David Liittschwager (above, in hat) works with 
barcoding students collecting specimens at CSHL and 
photographing specimens (below) at the DNALC.
An unidentiﬁ ed nudibranch specimen.
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the DNA sequence. Methylation—the addition of methyl groups (CH3) to DNA—is one type of 
epigenetic effect. In the simplest case, methyl groups attached to a promoter region block bind-
ing of transcription factors needed to express a gene. The pattern of DNA methylation is stably 
inherited through at least several generations.
Although epigenetics is an increasingly important area of genome research, it is not widely 
taught in classes. Thus, during the year, we completed development of two labs that demonstrate 
epigenetic effects in model plants: maize and Arabidopsis thaliana. The experiments will be re-
leased as kits in 2013 from CBSC.
A simple observational experiment looks at epigenetic inheritance of the R gene, which con-
trols the expression of a dark red pigment in maize kernels. The R allele is dominant over the r 
allele, which produces no pigment (yellow kernels). At fi rst glance, kernels from a cross between 
two heterozygous plants (Rr) conform to the expected 3:1 phenotypic ratio of red pigmented to 
unpigmented kernels. However, close inspection reveals that one-third of pigmented kernels are 
actually yellow-speckled. Methylation at the R promoter (R*) disrupts pigment production in 
some cells in the developing kernels and the kernels show a yellow-speckled pattern. Extending 
molecular analysis to the maize R locus is diffi cult, because the imprinted region has not yet been 
precisely mapped. The methylated R* is inherited from the male pollen, making this an example 
of imprinting.
An advanced experiment examines the molecular 
basis of epigenetics in plants by relating fl owering 
time to DNA methylation. In Arabidopsis, methyla-
tion of the FWA-1 promoter region in DNA silences 
the gene in wild-type adults, whereas loss of meth-
ylation causes late fl owering in FWA-1 mutants. To 
study this phenomenon, students isolate DNA from 
wild-type and FWA-1 mutant plants. Digestion with 
the restriction enzyme McrBc, which recognizes 
methylated regions, cleaves the methylated wild-type 
promoter but leaves the unmethylated FWA-1 pro-
moter intact. Subsequent PCRs amplify a product 
from the intact FWA-1 DNA, but none from the 
wild-type DNA.
Genome Science Published
At year’s end, we received the fi rst copies of Genome Science: A Practical and Conceptual Intro-
duction to Molecular Genetic Analysis in Eukaryotes. The work is the culmination of 15 years of 
development by co-authors Dave Micklos, Bruce Nash, and Uwe Hilgert, with artwork by Susan 
Lauter and former DNALC designer Stephen Blue and help from many staff, students, teachers, 
and granting organizations. Genome Science follows the DNALC’s original lab text DNA Science: 
A First Course in Recombinant DNA Technology. Now in its second edition, DNA Science has sold 
more than 90,000 copies and is credited with helping catalyze the movement to bring hands-on 
experiments with DNA into high school and beginning college classrooms. Two experiments are 
now found in the AP Biology curriculum, giving them a nationwide audience. Associated kits from 
CBSC reach well over 100,000 students per year.
Like its predecessor, Genome Science aims to help beginners use modern tools to explore the 
unseen world of genes. However, the new book aims to take students to a higher level of biological 
and technological integration to study the function of eukaryotic genes and genomes. Nineteen 
laboratories focus on four revolutionary technologies—PCR, DNA sequencing, RNA interfer-
ence (RNAi), and bioinformatics—across three eukaryotic systems—humans, plants, and the 
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roundworm Caenorhabditis elegans. The work includes our newest labs 
on DNA barcoding and the FWA-1 epigenetic switch in Arabidopsis. All 
labs stress the modern synthesis of molecular biology and computation, 
integrating in vitro experimentation with in silico bioinformatics. In ad-
dition to well-tested biochemical methods, Genome Science introduces 
DNA Subway to make easy work of gene and genome analysis.
The four major technologies are organized into chapters with exten-
sive text introductions that place related labs into a common historical 
and conceptual framework. This modular approach provides easy op-
tions to integrate sets of labs into existing courses, provide the basis 
for new courses, or serve as the foundation for student research projects. 
Genome Science borrows many user-friendly features from its predeces-
sor, including fl ow charts, marginal notes, reagent recipes, and extensive 
instructor information. To ease implementation, most labs are available 
as CBSC kits.
iPlant Collaborative
In contemplating the cosmos in 1927, the great mathematical geneticist J.B.S. Haldane famously 
said, “My own suspicion is that the universe is not queerer than we suppose, but queerer than we 
can suppose.” Had he been alive today, Haldane would almost certainly have the same suspicion 
about the genomes of higher organisms. In this sense, genome scientists are the new cosmolo-
gists of biology, uncovering the strange and beautiful structure of the genetic material that runs 
through all life. Like cosmology, genome science is based on the collaborative analysis of massive 
data sets that exceed the capacity of desktop computing and sometimes even outstrip the available 
resources of an entire institution.
The iPlant Collaborative is an NSF-funded project to develop a national computer infrastruc-
ture (CI) to support biologists working within the new paradigm of large-scale genomic, phe-
nomic, ecological, and phylogenetic data. The primary components of the iPlant CI include the 
Data Store, Atmosphere cloud computing, and the Discovery Environment analysis platform. The 
DNALC takes the lead in Education, Outreach, and Training (EOT) among consortium partners 
at the University of Arizona, the University of Texas, and CSHL. The EOT group has developed 
a sophisticated computational and Internet design group that occupies a unique niche in science 
education. EOT leverages scientifi c knowledge, teaching pedagogy, and bioinformatics expertise 
to translate the iPlant CI into workfl ows that are accessible across the continuum of research and 
education from “entry-level” and education-oriented users to sophisticated bioinformaticians and 
computational scientists.
We continued to evolve iPlant’s educational discovery environment, DNA Subway. In keeping 
with the increased use of the iPlant infrastructure across the diversity of life, the Red Line (for 
gene annotation) and Blue Line (for barcode and phylogenetic analysis) were upgraded with ap-
propriate algorithms to analyze mammals, birds, fi sh, insects, and fungi. The Blue Line became 
the analysis workhorse for the Urban Barcode and Barcode Long Island Projects described above, 
helping to double registered accounts to 4254 and increasing visitation 40% (to 33,376) over the 
previous year. We devoted substantial resources to develop the Green Line, which aims to make 
next-generation sequence (NGS) analysis of eukaryotic genomes accessible to a broad audience of 
fi rst-time users. The Green Line integrates the Tuxedo Protocol, a workfl ow incorporating open 
source components for all steps of RNA sequence (RNA-Seq) data analysis from the processing 
of raw data from major sequencing platforms through to publication-quality results. The Green 
Line will be integrated with the Red Line, where assembled transcripts can provide evidence for 
community (or class) annotation of sequenced genomes. The Green Line articulates directly with 
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high-performance clusters at the Texas Advanced Computing Center, providing what we believe 
to be the fi rst easy biological on-ramp to the national supercomputing highway.
We worked very hard to get the word out about iPlant, holding 24 2-day training workshops in 
2012, in addition to dozens of seminars and talks at professional meetings and universities. From 
Arkansas to Alaska, 340 researchers and 201 educators attended Tools and Services and Genomics 
in Education workshops, respectively, introducing them to advanced computational resources for 
science and teaching. This year, we provided additional travel awards for 40 minority faculty and 
faculty who reach large numbers of Hispanic or African American students, minorities that are 
underrepresented in science study and careers (awardees reported an average of 47% underrepre-
sented students in their classes).
In 2012, we assumed responsibility for internal iPlant project evaluation and began to co-
ordinate with East Main Educational Consulting, LLC, to complement its existing program 
of external evaluation. Of the respondents to a Genomics in Education workshop follow-up sur-
vey (n = 241), 80% had used the workshop materials, reaching more than 1600 students. The 
materials were used in a range of courses, including general biology (34%), genetics/genomics 
(30%), molecular biology (19%), and bioinformatics (13%). Materials were used for background 
information (59%), class resources (37%), and laboratory protocols (23%). One in fi ve (21%) 
had developed a new topic, wet lab, or bioinformatics lab. Participants also shared materials 
with colleagues (20%) and provided training in bioinformatics (15%). Of 60 respondents to a 
follow-up survey of the Tools and Services workshop, 57% had used at least one iPlant tool, with 
57% using Data Store and 31% using Atmosphere or the Discovery Environment. Respondents 
used the tools to analyze their own data (54%), a colleague’s data (30%), or to share data (27%). 
Encouragingly, 68% of respondents introduced iPlant tools and services to colleagues, and 41% 
provided training.
The DNA Subway Green Line includes visualizations of RNA-sequence reads and graphs detailing differences in gene expression.
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We distributed a “community” survey at the American Society of Plant Biologists meeting. 
Of 51 respondents, 88% said they currently used large data sets or expected to in the next 1–5 
years. This suggests that a large majority of plant researchers are potential users of the iPlant CI. 
Structured interviews with 15 attendees revealed major challenges in extracting, storing, and shar-
ing data; keeping abreast of current tools; collating tools into one workfl ow; and learning how to 
perform analyses.
Nationwide Faculty Training
The DNALC continued its tradition of providing cutting-edge biochemical and bioinformatics 
training for educators at sites nationwide. In 2012, 743 educators and scientists participated in 
workshops conducted at 30 sites across the United States. Overall, underrepresented minorities in 
science composed 19% of educators trained at 37 workshops of 1–10 days. An additional 466 edu-
cators and scientists attended seminars, short workshops, and presentations at professional meet-
ings, including the American Society of Plant Biologists, Botanical Society of America, CSHL 
President’s Council, International Barcode of Life, National Association of Biology Teachers, Na-
tional Science Teachers Association, International Plant & Animal Genome Conference, and the 
Purdue Statistics Symposium. (For a complete list of training activities and host sites, see “2012 
Workshops, Meetings, and Collaborations” at the end of this report.)
During the last 2 years, with funding from the NSF, we have collaborated with community 
college faculty and the National Advanced Technological Education (ATE) Center for Biotech-
nology (Bio-Link) to develop and disseminate Genomic Approaches in BioSciences. This work-
shop introduces the four key technologies included in Genome Science—PCR, DNA sequencing, 
RNAi, and bioinformatics—which provide a scientifi c foundation for biotechnology careers in 
the genome age. The fi rst seven workshops were held in 2011 and 2012, reaching 155 faculty 
(of 272 applicants). Forty-three percent of participants taught at 2-year colleges, 31% at 4-year 
colleges or universities, and 26% at high school. One-fourth of participants were minorities that 
are underrepresented in science. Summer workshops were conducted at Austin Community Col-
lege (Austin, Texas), Bluegrass Community and Technical College (Lexington, Kentucky), and 
Southern Maine Community College (South Portland, Maine). Follow-up activities were con-
ducted at 2011 workshop sites: Gwinnett Technical College (Lawrenceville, Georgia), Madison 
Area Technical College (Madison, Wisconsin), Shoreline Community College (Shoreline, Wash-
ington), and Universidad del Turabo (Gurabo, Puerto Rico). We are carefully tracking the impact 
of the Genomic Approaches in BioSciences Workshops. Pre-workshop (n = 145) and post-workshop 
(n = 142) surveys showed notable increases in faculty knowledge and confi dence. Before the work-
shop, only 12% of participants knew “a lot” about the key genomic concepts, compared with 
41% afterward. There was a marked increase in participants who felt confi dent in teaching the 
genomics labs (17% to 41%) and bioinformatics (8% to 34%). Follow-up surveys (n = 70) found 
strong classroom implementation of the four genomic technologies—DNA barcoding (41%), 
PCR (55%), RNAi (22%), and bioinformatics (42%)—as well as career modules (75%). These 
faculty reported 9029 student exposures to labs, 4796 to bioinformatics, and 2605 to biotech ca-
reers, with an average of 46% underrepresented minority students.
New York City Faculty Training
In 2012, we concluded the Howard Hughes Medical Institute (HHMI) teacher-training pro-
gram, which we administered in collaboration with the NYC Department of Education (DOE). 
This program was designed to develop a strong base of 8–12th grade science teachers who can 
com petently introduce six experiments in genetics and biotechnology at identifi ed points in state-
required science courses. During the 4-year term of the grant, 835 NYC teachers completed 
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an average of 15 hours of training each, ac-
counting for 1642 lab exposures and 9852 
workshop hours. In 2012, 101 teachers took 
one or more workshop sessions, and 45 com-
pleted a 24-hour sequence of certifi cate 
training. Eighty-fi ve percent of workshop 
participants taught 8th–10th grades, our 
target audience, including 38% African or 
Hispanic American teachers. Preworkshop 
and postworkshop surveys showed signifi -
cant knowledge gains, and 13 faculty also 
participated in advanced leadership training.
To ease classroom implementation, in 
2010 funding from the Richard Lounsbery 
Foundation allowed us to develop 15 bio-
technology Footlocker Kits for use by teach-
ers trained in the HHMI program. Each Footlocker contains equipment and expendable supplies 
suffi cient for three to four classes; a modest restocking fee of $50 per class of 32 students is less 
than half the cost of a commercial reagent kit. During a 2-year period, Footlockers were used to 
do experiments with 5708 students, 68% of whom were underrepresented minorities. Footlocker 
rental fees were waived for 75% of schools with high proportions of disadvantaged students, based 
on Title I status. An experimental study compared outcomes for students in classes that imple-
mented the HHMI labs versus classes that did not. We focused on restriction analysis, because a 
paper-based lab simulation is a mandatory component of the NYS Regents biology curriculum, 
Living Environment. To control for teacher profi ciency, we recruited study participants from the 
pool of HHMI-trained teachers, who taught the mandated Living Environment curriculum. To 
control for student variance we chose 9th or 10th grade general studies classes. Student learning 
was assessed using a standardized quiz, which incorporated Regents exam questions on DNA 
structure and function, restriction enzymes, gel electrophoresis, and applications of restriction 
analysis.
Teachers who had completed an HHMI workshop on restriction analysis were in the experi-
mental arm of the study and implemented the wet lab using a Footlocker. Teachers who had 
completed a different HHMI workshop were in the control arm and used the mandated paper-
based activity. Twelve teachers and 294 students (115 experimental, 179 control) participated in 
the study. Results showed that doing the hands-on DNALC biotechnology lab improved student 
learning by almost a full letter grade over the pen-and-paper equivalent (68% versus 60% quiz 
scores, p < 0.001). The wet lab also impacted students’ interest in science more than the paper-
based lab, with 46% versus 35% of students saying they were now more interested in science.
Student Lab Programs
On October 29, Hurricane Sandy made an appearance along the northeastern seaboard, leaving 
parts of New York and New Jersey completely immobilized. The DNALC and most school sys-
tems were without power for at least a week. School closings and adjustments in school calendars 
to make up for lost days resulted in 25 cancelled lab fi eld trips. Despite this unanticipated setback, 
19,327 students attended lab fi eld trips at our three facilities: Dolan DNALC, DNALC West, and 
Harlem DNA Lab. An additional 7221 students received in-school instruction from DNALC staff 
members.
Summer camp enrollment reached an all-time high in 2012, with 1069 student participants 
in 55 weeks of camps conducted at eight locations on Long Island and NYC: Dolan DNALC, 
Melissa Lee (far left), Harlem DNA Lab Manager, works with NYC teachers.
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DNALC West, Stony Brook University (SBU), Brookhaven National Laboratory, Mulligan El-
ementary School, the Chapin School, and Trinity School. Among the campers were 20 students 
from Beijing No. 166 High School, the fi rst specialized school of life sciences in the Chinese 
capital. This was the second cohort of students from Beijing to participate in a 3-week immersion 
program that included classical genetics, human and plant genomics, and independent research 
using DNA barcoding.
We focused considerable resources on underserved youth. Grants from the Dana Foundation 
and the William Townsend Porter Foundation provided scholarships totaling $51,000 for 2209 
students to attend lab fi eld trips at the Harlem DNA Lab. Three-quarters of the students receiving 
scholarships were underrepresented minorities from Title I schools. We also provided intensive 
enrichment to students from two schools housed with the Harlem DNA Lab in the John S. Roberts 
Educational Complex. Students from the Coalition School for Social Justice participated in three 
biotechnology laboratories, and 6th–8th graders from MS 45 enjoyed seven introductory genetics 
laboratories. A $15,000 grant from the National Grid Foundation supported in-school instruction 
for 996 5th–7th graders from Central Islip School District. Students used microscopes to view 
plant and animal cells, extracted DNA from living cells, and observed mutations in fruit fl ies. 
Twelve 5th–6th graders received scholarships to participate in a Fun with DNA summer camp at 
Central Islip’s Mulligan Elementary School.
During the spring, fall, and winter, 249 students (10 years and older) and parents participated 
in monthly Saturday DNA! sessions. DNALC staff members provided hands-on investigations 
of a variety of topics, including family genealogy, unicellular organisms, dinosaur evolution, the 
Romanov family mystery, DNA extraction, protein purifi cation, gene regulation, the agricultural 
revolution, and the role of carbon dioxide in our lives.
We continued to work intensively with Trinity School and the Chapin School, who belong 
to our Charter Membership program for independent schools in the New York metro area. The 
program includes fi eld trips to the DNALC and in-school instruction by DNALC instructors, 
as well as exclusive, on-site summer camps for students. In September, Convent of the Sacred 
Heart School in Greenwich, Connecticut, became the third Charter Member school. Together, 
we planned an extensive program of in-school visits for their environmental science, biology, AP 
Biology, and chemistry across 5th through 8th grade classes. With a strong research program 
already in place, they wasted no time organizing workshops using C. elegans as a model to study 
gene function and launching several student projects with roundworms.
Amanda McBrien, DNALC Assistant Director for Education, teaches pipetting techniques 
to Green Genes summer camp students.
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In May, we celebrated the 10th anniversary of 
DNALC West, the fi rst licensed DNALC affi liate. De-
veloped in collaboration with the North Shore–Long 
Island Jewish (NS-LIJ) Health System, DNALC West 
opened in 2002 in space adjacent the NS-LIJ Clinical 
Core Laboratory in Lake Success. During its fi rst dec-
ade, DNALC West provided lab fi eld trips for 28,163 
students, and intensive summer camps were attended 
by 1919 students. With strong support from CSHL 
Trustee Arthur Spiro, DNALC West was originally 
supported by a core grant from NS-LIJ’s Feinstein In-
stitute for Medical Research. When Feinstein funding 
lapsed in 2011 and there was no ready source of funds during the recession, Bob Stallone, Vice 
President of NS-LIJ Laboratories, stepped up to continue funding for DNALC West. Thus, we 
were doubly thankful when Bob hosted a cocktail reception to honor the long collaboration—
with guest of honor, CSHL Chancellor Emeritus James Watson and NS-LIJ leaders, including 
Dr. James Crawford, Senior Vice President for Laboratory Services and Chair of Pathology, 
and Dr. Christine Ginocchio, Senior Director of Infectious Disease Diagnostics.
By year’s end, the Dolan DNALC had received a mini-facelift. A larger lunchroom was 
created within former exhibit space and the former lunchroom was redesigned as our fourth 
teaching lab. Although our exhibit space shrank, we maintained most of the popular elements 
of the “Genes We Share” exhibit. The room on genetic origins and evolution, affectionately 
called “the Cave,” was recreated in the main exhibit area. New Lab #4 is our smallest teaching 
space; at 525 square feet, it demonstrates the most compact fl oor plan that can accommodate 
24 students. It is also our most beautiful lab. A wall of windows, with mullions designed as a 
visual metaphor for the DNA bands in an electrophoresis gel, looks serenely out onto a patio 
and landscaped hillside. The Dolan DNALC prep labs, carved out of the crusty basement in 
1989 and not updated since, were remodeled and reorganized to better support a range of ac-
tivities, including inorganic reagent preparation, bacterial and C. elegans culture, microscopy, 
student research, and new experiment development. We also reorganized the storeroom as 
a center to restock the Footlockers that support in-school instruction by DNALC staff and 
are used independently by classroom teachers. These Footlockers were used by 8937 students 
in 2012.
Bob Stallone, James Watson, and Dave Micklos at the DNALC West 
celebration.
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Graduate Training and Student Research
We continued to support the graduate training of the CSHL Watson School of Biological Sciences 
(WSBS) students. From January through March, the students work under the watchful eye of 
experienced DNALC instructors to learn effective teaching techniques that prepare them to be 
better science communicators. During the fi rst phase of training, each student team observed a 
DNALC instructor performing a restriction analysis experiment with a class of local high school 
students. Phase two, co-instruction, involved preparing a lesson plan that integrated their own 
perspectives, then delivering the practical portion of the lab to high school students. DNALC 
instructors provided constructive critique to help the WSBS students prepare for the third phase 
of training: team teaching the entire experiment to a high school class. After additional refl ection, 
this learning cycle was repeated with a DNA extraction lab for middle school students, which 
required increased pacing. Upon completion of both high school and middle school teaching 
rotations, each WSBS student team delivered three additional lessons to demonstrate mastery of 
instructional and classroom management skills.
We continued our collaboration with the New York Academy of Sciences, training young sci-
entists to help improve science literacy among high-needs students throughout NYC. DNALC 
instructors worked with 67 graduate students and postdoctoral researchers participating in the 
Academy’s after-school mentoring program. Each mentor received 6 hours of training in effective 
strategies to provide hands-on laboratories to middle school students.
Our partnership with Cold Spring Harbor High School 
(CSHHS) to offer a college-level laboratory course entitled Molec-
ular and Genomic Biology continued. Co-instructed by DNALC 
staff members and CSHHS faculty member Jaak Raudsepp, the 
year-long course occupies the last two periods of the day and alter-
nates instruction between CSHHS and the Dolan DNALC. The 
2011–2012 cohort, our seventh class, focused on hands-on experi-
mentation and independent projects across a range of biological 
systems. Highlights of the year included units presented by WSBS 
graduate students Colleen Carlston, Katie Liberatore, and Eugene 
Plavskin. Colleen assisted in setting up a genetic screen in the 
roundworm C. elegans that identifi ed three new genes that affect 
RNAi function. Katie taught a unit, “Cell Signaling: Communi-
cation, Development and Disease.” Eugene guided experiments 
on environmental factors that affect fi tness and natural selection 
in bacteria. Joan Kiely, of SBU’s Biotechnology Teaching Center, 
followed up with a unit on modeling proteins involved in cell signaling. Student teams selected 
proteins, developed computer fi les describing their structure, and then used a 3D printer to out-
put small-scale models. The students presented their work during a poster session of the CSHL 
“Cell Cycle” meeting on May 18.
Building on the success of the CSHHS partnership, we offered a similar course for students 
from St. Dominic High School in Oyster Bay. The course capitalized on St. Dominic’s new sci-
ence building, made possible through a major gift from a parishioner. In collaboration with sci-
ence teacher Teresa Kuehhas, DNALC staff introduced students to experimental methods for 
future independent projects: species diversity using DNA barcoding, gene function using RNAi 
in C. elegans, and human variation using PCR.
The annual Great Moments in DNA Science seminar series attracted 185 top Long Is-
land high school students for presentations on current biological research at CSHL. Michael 
Feigin explained how cells generate and maintain shape and how defects in these processes 
can lead to human disease. Jonathan Ipsaro discussed new scientifi c methods to study the 
CSH high school students discuss their project poster on 
the MAD2 protein with a CSHL “Cell Cycle” meeting 
participant.
467-492_DNALCe.indd   480 9/17/2013   8:25:40 AM
Executive Director’s Report  481
micro-scale orchestration of DNA and proteins that sustain life. Shane McCarthy discussed 
advances in genome technology that provide insights into the neurobiology and treatment of 
schizophrenia.
BioMedia Projects and Visitation
In spring 2012, we launched the Weed to Wonder e-book and enhanced website, developed as 
outreach for an NSF research project with CSHL’s Marja Timmermans and Mike Scanlon at 
Cornell University. Weed to Wonder shows the continuity of research on corn—from Native 
American agriculturalists to agricultural breeders, corn geneticists, plant physiologists, and mo-
lecular biologists—that culminated in the Maize Genome Sequencing Project. The interactive 
e-book is available as a website, tablet app, or printable PDF. Six chapters tell the story of the 
development of modern maize, including domestication and hybrid vigor, genome sequencing 
and transposon complexity, and genetic modifi cation and biofortifi cation. The e-book revolves 
around video footage from Mexico, interviews with prominent scientists, and animations of 
different approaches to sequencing the maize genome. The history of maize research is brought 
to life through reconstructions of George Shull and Barbara McClintock’s work at CSHL, rare 
photographs, and links to original publications and artifacts. The e-book also includes a time-
lapse video of growing maize plants, from germination, through growth spurts, to pollination, 
senescence, and harvest.
We also completed the Lab Center microsite (http://labcenter.dnalc.org/harlem), which sup-
ports the six genetics and biotechnology labs in the HHMI-funded program. The fi nal task was 
the production of New York Stories, a series of minidocumentaries about past or current work of 
notable scientists based at New York institutions. Students from NYC high schools contributed 
signifi cantly to writing and production of the last three videos 
in the set. Teams of 9th and 11th grade students from Trin-
ity School worked on productions about DNA fi ngerprinting 
and restriction enzyme analysis, while a team of 11th and 12th 
graders from Brooklyn International High School worked on a 
production about Thomas Hunt Morgan’s “Fly Room” at Co-
lumbia University. Each video features a scientist “explainer”: 
Larry Kobilinsky of John Jay College of Criminal Justice on 
the use of DNA fi ngerprinting in forensics; former CSHL sci-
entist Scott Lowe, now of Memorial Sloan-Kettering Cancer 
Center, on the use of restriction analysis techniques in cancer 
research; and CSHL researcher Glenn Turner on the use of 
“Morgan’s fl y,” Drosophila melanogaster, as a model in neurosci-
ence research. The videos are featured on the Lab Center web-
site and on YouTube (www.youtube.com/dnalearningcenter). 
To date, the set has received more than 5000 views.
During the year, we continued our effort to disaggregate 
and redistribute content across different multimedia plat-
forms. The majority of BioMedia content is now available in 
an original content site or app, as well as through our search-
able database on www.dnalc.org and our YouTube channel. 
We also feature and cross-link resources in our social media 
accounts (Facebook and Twitter), blogs, presentations, and 
publications. A good example of multitasking is the Punnett 
square interactive originally developed for our iPhone app, 
Trinity School students interview their teacher (above) and 
classmates for New York Stories.
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Gene Screen. It was reformatted for iPad, and as a 
website for personal use or on a classroom Smart-
board.
Counting visitors to the DNALC family of 
21 websites is important, but complicated. Web-
trends was the dominant analytic software at the 
inception of many of our websites, and we used it 
faithfully over the years to track long-term trends 
in visitation to all of our websites. So it was with 
some trepidation that in 2012, we transitioned all 
of our websites to the Google Analytics package, 
which has become the de facto standard for meas-
uring web visitation.
To ensure that we can analyze trends retrospectively, we compared 2011 visitation data for the 
DNALC homepage (www.dnalc.org) using Web trends, Google Analytics, and a third tool, AWStats. 
As shown above, the three tools use different rules to analyze the same web logs, resulting in dif-
ferent numbers of visitors. This is primarily because Google Analytics defi nes one visit as up to 60 
minutes of viewing versus 20 minutes for Webtrends. (For example, if a visitor spends 60 minutes at 
a site, Google Analytics counts one visit whereas Webtrends counts three.) There are also other differ-
ences in how the tools count views of images, videos, and Flash animation fi les.
Although the overall trends are similar—with March and November peaks, and a July trough—
the results from Webtrends and Google Analytics cannot be accurately scaled to compare year-to-
year changes in visitation across all of our websites. We used Google Analytics to compare 2011 and 
2012 data for the DNALC homepage, revealing a 42% increase to 1.48 million visitors. Over-
all, Google Analytics counted 4,213,086 visits to our suite of 21 DNALC websites in 2012. Our 
 YouTube videos received 865,899 views, and the 3D Brain, Weed to Wonder, and Gene Screen apps 
were downloaded 568,879 times. Therefore, total multimedia visitation—websites, YouTube, and 
smartphone/tablet apps—was 5.65 million. This will become the new baseline against which we 
measure future visitation.
Staff and Interns
In 2012, the DNALC bid farewell to two staff members: Tedhar (Tedi) Setton, middle and high 
school educator, and Dr. Alexandra Manaia, Ph.D., UBP outreach team member. Tedi left the 
DNALC to begin a master’s program in human genetics at Tulane University, where she will pur-
sue a degree in medicine. She joined our educational team in 2008, following studies in biological 
science at Wellesley College and forensic pathology at the Suffolk County Medical Examiner’s 
Offi ce. Tedi brought spirit and high energy to her teaching, helping us establish a new summer 
camp in forensic biology for middle school students.
Dr. Alexandra Manaia returned to her native Portugal to coordinate the Ph.D. program at 
Lisbon Medical School. Alexandra’s internship at the DNALC, including a key role in estab-
lishing the UBP, fulfi lled the fi nal phase of her Fulbright Fellowship and master’s degree in 
International Education Development at Columbia University. Alexandra met Dave Micklos 
in 2003 at a kickoff meeting of the European Learning Laboratory for the Life Sciences, an 
education and outreach facility at the European Molecular Biological Laboratory in Heidelberg, 
where she was then a science offi cer.
In December 2012, we welcomed Brooke Roeper and Katie McAuley to our DNALC teach-
ing staff. Raised in northeastern Ohio, high school educator Brooke Roeper received a bachelor’s 
degree in biology from Kenyon College. After doing research on West Nile virus at Case Western 
Reserve University, she earned a master’s in science at Tulane University’s School of Public Health 
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and Tropical Medicine and a master’s in ecology at Col-
orado State University. She went on to work as a middle 
school science teacher in Wyoming, a ranger at Wind 
Cave National Park, and, most recently, outreach coor-
dinator at Teddy Roosevelt Sanctuary in Oyster Bay.
Katie McAuley, a native Long Islander and graduate 
of Harborfi elds High School, has come full circle to the 
DNALC in the role of middle school educator. Solving 
the “Mystery of Anastasia” on a class fi eld trip to the 
DNALC inspired her to pursue science in college. As an 
undergraduate at the University of Rhode Island, Katie 
added education to biology for a double major. Her life 
experiences included studying abroad at Macquarie 
University in Sydney, Australia, and the University of 
the South Pacifi c, Fiji, and helping students build robots 
in Lego’s Bricks 4 Kidz program.
Our year-round internship program continued to draw some of Long Island’s most talented 
high school and college students, engaging them in science research and providing practical labo-
ratory experience. We were pleased to accept new high school interns Matthew Angeliadis,  Rachel 
Bosco, Brittany Coscio, Pauline McGlone, and Robert Scott (all from Huntington); Anne Bode 
(St. Anthony’s); Magdalene Economou (Syosset); Nathaniel Hogg (Friends Academy); Jack Manzi 
(Kings Park); Anant Mehrotra (Oyster Bay); Sophie Podhurst (Walt Whitman); and  Daliah Ross 
(Harborfi elds). The new hires joined veterans Katie Bellissimo (Walt Whitman) and Anna Saum 
(home school).
We bid farewell to a number of high school interns as they left for their freshman year at col-
lege: Cyril Danielcutty (Stony Brook University), Alexa DeAngelis (Georgetown), Jack Green-
fi eld (Massachusetts Institute of Technology), Devika Gupta (Lehigh), Frieda Haerter (Renssalear 
Institute of Technology), Julie Hemphill (University of Pittsburgh), Paras Patel (Hofstra), and 
Gianna Torre (Hunter).
Our busy summer season of camps requires additional help. Returning interns Becky Hirsch 
(Friends Academy) and Paul Donat (SUNY Geneseo) were joined at our Dolan facility by newbies 
Sabrina Gallego (Half Hollow Hills), William Harlow (Trinity School), Grant Murphy (Friends 
Academy), and Steven Kunis (Seton Hall Prep). Veteran Juliet Jacobson (Hebrew Academy of 
Nassau County) returned to help at our DNALC West location, with newbies Arvind Rajabhathor 
and Shenika Shah (both Herricks), Kalliopi Chatzis (Bayside), and Angell Xiang (Great Neck).
College interns mentor younger interns and fulfi ll requests for DNA sequencing and RNAi 
targeting vectors from faculty nationwide. Returning in 2012 were David Dopfel and Lina-Mari 
Varghese (both Stony Brook University), Arielle Scardino (City College of New York), Katherine 
Villalon (John Jay College of Criminal Justice), and Sulaiman Usman (New York Institute of 
Technology). Arielle and Sulaiman also had key roles in the UBP in Manhattan.
Some high school interns compete in research competitions, including the Siemens Science 
Competition and the New York and Long Island Science and Engineering Fairs. Matt Angeliadis 
(Huntington) is studying the effects of ultraviolet radiation on the population growth of yeast, 
while Robert Scott (also of Huntington) is exploring a method to counteract toxins released by a 
species of garlic mustard.
Brooke Roeper (left) and Katie McAuley.
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2012 Workshops, Meetings, and Collaborations
January 4 Urban Barcode Project Open Lab, Harlem DNA Lab
January 7 Urban Barcode Project Open Lab, Harlem DNA Lab
January 10 Site visit by Kelley Remole, Columbia University, Harlem DNA Lab
January 11 Urban Barcode Project Open Lab, Harlem DNA Lab
January 12 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project presentation at the Vienna Open Lab, Vienna, Austria
January 13 Urban Barcode Project Open Lab, Harlem DNA Lab
January 14 Saturday DNA! “When Genes are Switched Off,” Dolan DNALC
January 14–18 International Plant & Animal Genome XX Conference 2012, “DNA Subway Places Students on the Fast Track 
to Genome Analysis,” Town and Country Convention Center, San Diego, California
January 17 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
January 18 Urban Barcode Project Open Lab, Harlem DNA Lab
January 19 Urban Barcode Project Open Lab, Harlem DNA Lab
January 20 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
January 21 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
January 25 Urban Barcode Project Open Lab, Harlem DNA Lab
January 26 Urban Barcode Project Open Lab, Harlem DNA Lab
January 28 STEM Mentor Training, New York Academy of Sciences, New York
January 30 STEM Mentor Training, New York Academy of Sciences, New York
February 2 Urban Barcode Project Open Lab, Harlem DNA Lab
February 4 Urban Barcode Project Open Lab, Harlem DNA Lab
February 7 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 8 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
Site visit by Larry Kingsley, Pall Corporation, Port Washington, New York
February 10 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
February 11 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
Saturday DNA! “Selection Detection,” Dolan DNALC
February 13 Urban Barcode Project Open Lab, Harlem DNA Lab
February 14 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 15 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
Urban Barcode Project Open Lab, Harlem DNA Lab
Ecology and Evolutionary Biology Graduate Programs Presentation, “Bushmeat Trade and Diseases,” 
Columbia University, New York
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 16 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 20 New York City Department of Education Professional Development Workshop, “DNA Barcoding,” American 
Museum of Natural History, New York
February 21 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 22 Urban Barcode Project Open Lab, Harlem DNA Lab
New York City Department of Education Professional Development Workshop, “DNA Barcoding,” American 
Museum of Natural History, New York
February 23 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 24 City College of New York Teacher Academy Professional Development, “DNA Extraction,” Harlem DNA Lab
New York City Department of Education Professional Development Workshop, “DNA Barcoding,” American 
Museum of Natural History, New York
February 27–28 HHMI CUREnet Meeting, Howard Hughes Medical Institute, Chevy Chase, Maryland
February 28 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
February 29 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 2 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
March 3 NSF ATE Professional Development Genomic Approaches in BioSciences Follow-up Workshop, Universidad del 
Turabo, Gurabo, Puerto Rico
HHMI New York Stories, “Restriction Analysis,” fi lming Ileana Rios and the Trinity School 11th Grade 
 Laboratory Class, New York
March 5 Urban Barcode Project Open Lab, Harlem DNA Lab
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March 7 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 8 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 10 Saturday DNA! “Genetics of HIV Resistance,” Dolan DNALC
March 12–13 NSF iPlant Collaborative Professional Development, Tools and Services Workshop, University of California, 
Davis
March 13 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 14 Urban Barcode Project Open Lab, Harlem DNA Lab
March 15 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
HHMI Professional Development Workshop, “Bacterial Transformation,” Harlem DNA Lab
March 17 HHMI Professional Development Workshop, “Bacterial Transformation,” Harlem DNA Lab
March 19 Urban Barcode Project Open Lab, Harlem DNA Lab
March 21 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 22 Urban Barcode Project Open Lab, Harlem DNA Lab
Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 24 Urban Barcode Project Open Lab, Harlem DNA Lab
March 27 Urban Barcode Project Open Lab, Genspace, Brooklyn, New York
March 27–28 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, Purdue University, 
West Lafayette, Indiana
March 28 Urban Barcode Project Open Lab, Harlem DNA Lab
March 29 Urban Barcode Project Open Lab, Harlem DNA Lab
March 29–April 1 National Science Teachers Association 2012 National Conference on Science Education, “Exploring Genetics 
with C. elegans,” “Silencing Genomes,” “DNA Subway,” “DNA Barcoding in Your Classroom,” Indianapolis, 
Indiana
March 31 Urban Barcode Project Open Lab, Harlem DNA Lab
April 2 Urban Barcode Project Open Lab, Harlem DNA Lab
April 4 Presentation for Master’s Course in Conservation Medicine, “Parasites and Bushmeat: Molecular Identifi cation 
of Parasites Found in Wildlife Traded in Markets,” Columbia University, New York
April 11 Urban Barcode Project Open Lab, Harlem DNA Lab
New York City Department of Education Professional Development Workshop, “DNA Barcoding,” American 
Museum of Natural History, New York
April 13 New York City Department of Education Professional Development Workshop, “DNA Barcoding,” American 
Museum of Natural History, New York
April 14 NSF ATE Professional Development Genomic Approaches in BioSciences Follow-up Workshop, Gwinnett 
Technical College, Lawrenceville, Georgia
April 17–18 2012 Student Research Conference, “Eugenics in 20th Century America: The Kirksville Connection,” Truman 
State University, Kirksville, Missouri
April 19 Urban Barcode Project Open Lab, Harlem DNA Lab
April 20 HHMI New York Stories, “DNA Fingerprinting,” fi lming Bob Hipkens, Ileana Rios, and the Trinity School 9th 
Grade Laboratory Class, New York
HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
New York City Department of Education STEM Expo/Fair, “DNA Extraction,” The Armory Track and Field 
Center, New York
April 21 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
Saturday DNA! “The Extraction Attraction,” Dolan DNALC
NSF ATE Professional Development Genomic Approaches in BioSciences Follow-up Workshop, Shoreline 
Community College, Shoreline, Washington
April 23 HHMI New York Stories, “Fly Lab,” interview with Glenn Turner, CSHL
April 24 Urban Barcode Project Open Lab, Harlem DNA Lab
April 25 Urban Barcode Project Open Lab, Harlem DNA Lab
BioCube Project Planning Meeting, Smithsonian National Museum of Natural History, Washington, D.C.
April 26 Great Moments in DNA Science Honors Seminar, “Can Cell Shape Infl uence Human Cancer?” Dr. Michael 
Feigin, CSHL, Dolan DNALC
Urban Barcode Project Open Lab, Harlem DNA Lab
HHMI New York Stories, “DNA Fingerprinting,” interview with Larry Kobilinsky, John Jay College of 
Criminal Justice, New York
April 26–27 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, Southern University at 
New Orleans, New Orleans, Louisiana
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April 28 NSF ATE Professional Development Genomic Approaches in BioSciences Follow-up Workshop, Madison Area 
Technical College, Madison, Wisconsin
April 28–29 USA Science and Engineering Festival, Walter E. Washington Convention Center, Washington, D.C.
April 30 Site visit by Richard Snyder and Melanie Jardim, GENEWIZ Inc., South Plainfi eld, New Jersey
May 1 Great Moments in DNA Science Honors Seminar, “Seeing the Invisible: Atomic Pictures of DNA in Action,” 
Dr. Jonathan Ipsaro, CSHL, Dolan DNALC
May 2 Urban Barcode Project Open Lab, Harlem DNA Lab
May 3 Urban Barcode Project Open Lab, Harlem DNA Lab
May 4 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1,” Harlem DNA Lab
May 8 10-Year Anniversary Celebration, DNALC West
May 9 Urban Barcode Project Open Lab, Harlem DNA Lab
May 10 Urban Barcode Project Open Lab, Harlem DNA Lab
Great Moments in DNA Science Honors Seminar, “Next-Generation Schizophrenia Genetics: Finding Needles 
in the Haystack with Help from Your Family,” Dr. Shane McCarthy, CSHL, Dolan DNALC
May 11 Site visit by Vence Bonham and Belen Hurle, National Human Genome Research Institute, Bethesda, 
Maryland
Urban Barcode Project Open Lab, DNA Learning Center West
May 12 Saturday DNA! “Micro RNAs: Tiny RNAs to Turn Off Genes,” Dolan DNALC
May 14 Site visit by Science, Education, and Governmental Delegation, Kuala Lumpur, Malaysia
May 17–18 NSF iPlant Collaborative Professional Development Tools and Services Workshop, University of Arkansas, Little 
Rock
HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
May 21–22 NSF iPlant Collaborative Professional Development Tools and Services Workshop, Purdue University, 
Indianapolis, Indiana
May 21–25 NSF ATE Professional Development Genomic Approaches in BioSciences Workshop, Austin Community 
College, Austin, Texas
May 23 Urban Barcode Project Evaluators Workshop, American Museum of Natural History, New York
May 29 Site visit by Association Relative à la Télévision Européenne (ARTE) for “Naturopolis” documentary fi lming, 
Strasbourg Cedex, France, Harlem DNA Lab
May 31 Urban Barcode Project Symposium–Poster Session 1, American Museum of Natural History, New York
NSF iPlant Collaborative Professional Development Tools and Services Workshop, North Carolina State 
University, Raleigh
June 1 Urban Barcode Project Symposium–Poster Session 2, American Museum of Natural History, New York
June 3 Urban Barcode Project presentation, World Science Festival, New York
June 6 Urban Barcode Project Symposium Award Ceremony, American Museum of Natural History, New York
Site visit by Phil Ferralli, Carolina Biological Supply Company, Burlington, North Carolina
Site visit by Mardi Matheson, Mill Neck, New York
June 7 New York City Department of Education Professional Development Workshop, P.S. 69, Brooklyn, New York
June 8 Site visit by Kim Jasmin, JP Morgan Foundation, New York
June 9 Saturday DNA! “Food for Thought,” Dolan DNALC
June 11 Site visit by Indra Nooyi and Mehmood Khan, PepsiCo, Inc., Purchase, New York
June 12 19th Annual Golf Outing, Piping Rock Club, Locust Valley, New York
June 13 HHMI New York Stories, “Restriction Analysis,” interview with Scott Lowe, Memorial Sloan-Kettering Cancer 
Center, New York
June 16 New York City Department of Education Professional Development Workshop, “DNA Barcoding,” American 
Museum of Natural History, New York
June 18 Site visit by Her Serene Excellency, Dr. Zsana Kawar, Royal Family of Jordan
June 18–22 DNA Science Workshop, The Chapin School, New York
Fun with DNA Workshop, The Chapin School, New York
World of Enzymes Workshop, The Chapin School, New York
World of Enzymes Workshop, Trinity School, New York
June 20–21 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, Tulsa Community 
College, Tulsa, Oklahoma
June 21 NSF iPlant Collaborative Professional Development Tools and Services Workshop, 8th International Purdue 
Statistics Symposium, Purdue University, Indianapolis, Indiana
June 25–29 DNA Science Workshop, Dolan DNALC
Fun with DNA Workshop, Dolan DNALC
World of Enzymes Workshop, Dolan DNALC
Fun with DNA Workshop, DNALC West
Forensics Workshop, The Chapin School, New York
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June 26–28 NSF iPlant Collaborative Professional Development RNA-Sequencing with the iPlant Collaborative 
Workshop, and “The iPlant Collaborative: Bringing Together High Performance Computing and 
Biology,” The International Symposium on Genetics in Aquaculture XI, Auburn University, Auburn, 
Alabama
June 28 New York City Department of Education Professional Development Workshop, “Barcoding,” American 
Museum of Natural History, New York
June 29–30 NSF iPlant Collaborative Professional Development Workshop Genomics in Education, North Dakota State 
University, Fargo
 NSF iPlant Collaborative Professional Development Tools and Services Workshop, North Dakota State 
University, Fargo
July 2–6 HHMI Professional Development Workshop, “Living Environment,” Harlem DNA Lab
DNA Barcoding: The Biocube Workshop, Dolan DNALC
Forensic Detectives Workshop, Dolan DNALC
Green Genes Workshop, Dolan DNALC
Plant Genomics Workshop, Dolan DNALC
World of Enzymes Workshop, DNALC West
July 2–13 Site visit by David Liittschwager, National Geographic Society, Washington, D.C.
July 8–10 Botanical Society of America Conference, NSF iPlant Collaborative Professional Development Workshop, Tools 
and Services and DNA Subway, Columbus, Ohio
July 9–12 HHMI Professional Development Workshop, “AP Biology,” Harlem DNA Lab
July 9–13 NSF ATE Professional Development Genomic Approaches in BioSciences Workshop, Bluegrass Community and 
Technical College, Lexington, Kentucky
DNA Barcoding: The Biocube Workshop, Dolan DNALC
DNA Science Workshop, Dolan DNALC
Human Genomics Workshop, Dolan DNALC
World of Enzymes Workshop, Dolan DNALC
Green Genes Workshop, DNALC West
July 12 Site visit by Ethan Berman, Roxbury Latin School, West Roxbury, Massachusetts
July 16–20 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Silencing Genomes Workshop, DNALC
Fun with DNA Workshop, Central Islip
DNA Science Workshop, DNA Learning Center West
July 16–27 HHMI New York City Leadership Symposium, Harlem DNA Lab
July 19–20 Woodrow Wilson Teaching Fellows Conference, “DNA Barcoding in the Classroom,” Columbus Hilton, 
Columbus, Ohio
July 20–24 American Association of Plant Biologists, “E-Books,” “Educational Genome Interfaces,” and “Distributed 
Student Research: Model Outreach Methods for Plant Research Collaborations,” Austin, Texas
July 23–27 Barcoding Biodiversity Workshop, Dolan DNALC
Forensic Detectives Workshop, Dolan DNALC
Fun with DNA Workshop, Dolan DNALC
Genomics Workshop, Dolan DNALC
Fun with DNA Workshop, DNALC West
July 25–26 NSF iPlant Collaborative Professional Development Tools and Services Workshop, U.S. Department of 
Agriculture Arid-Land Agriculture Research Center, University of Arizona Maricopa Agricultural Center, 
Maricopa
July 27 NSF iPlant Collaborative Professional Development RNA Sequencing with iPlant Collaborative Workshop, 
University of Arizona, Tucson
July 30–August 2 HHMI Professional Development Workshop, “Living Environment,” Harlem DNA Lab
July 30–August 3 DNA Barcoding Workshop, Dolan DNALC
DNA Science Workshop, Dolan DNALC
World of Enzymes Workshop, Dolan DNALC
DNA Science Workshop, DNALC West
DNA Science Workshop, Stony Brook University, Stony Brook, New York
August 6–9 HHMI Professional Development Workshop, “AP Biology,” Harlem DNA Lab
August 6–10 NSF ATE Professional Development Genomic Approaches in BioSciences Workshop, Southern Maine 
Community College, South Portland
Barcoding Biodiversity Workshop, Dolan DNALC
Fun with DNA Workshop, Dolan DNALC
Green Genes Workshop, Dolan DNALC
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Human Genomics Workshop, Dolan DNALC
World of Enzymes Workshop, DNALC West
August 13–14 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, Montana State 
University, Bozeman
August 13–17 DNA Science Workshop, Dolan DNALC
Fun with DNA Workshop, Dolan DNALC
Green Genes Workshop, Dolan DNALC
World of Enzymes Workshop, Dolan DNALC
Human Genomics Workshop, DNALC West
August 16–17 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, Brigham Young 
University, Provo, Utah
August 20–21 NSF iPlant Collaborative Professional Development Tools and Services Workshop, University of Wisconsin, 
Madison
August 20–24 DNA Science Workshop, Dolan DNALC
Fun with DNA Workshop, Dolan DNALC
Green Genes Workshop, Dolan DNALC
Silencing Genomes Workshop, Dolan DNALC
Barcoding Biodiversity Workshop, DNALC West
August 22 Site visit by Dr. Pola Rosen, Education Update, New York
August 22–23 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, University of Wisconsin, 
Madison
August 27–31 Barcoding Biodiversity Workshop, Dolan DNALC
Forensic Detectives Workshop, Dolan DNALC
World of Enzymes Workshop, Dolan DNALC
August 28 NSF iPlant Collaborative Professional Development Using the Generic Synteny Browser Workshop, Genetic 
Model Organism Database Project, The National Evolutionary Synthesis Center, Durham, North Carolina
September 12–14 NSF iPlant Collaborative Professional Development Tools and Services Workshop, and “The iPlant 
Collaborative: Bringing Together High-Performance Computing and Biology,” U.S. Department of 
Agriculture Livestock Cyberinfrastructure, Hinxton, England
September 13 Interviews with Caroline Dean, John Innes Centre, Norfolk, United Kingdom and Ali Shilatifard, Stowers 
Institute for Medical Research, Kansas City, Missouri, CSHL
September 14 STEM Mentor Training, New York Academy of Sciences, New York
September 15 STEM Mentor Training, New York Academy of Sciences, New York
September 17–18 Site visit by Steve Goff, iPlant Collaborative, University of Arizona, Tucson
September 20–21 Site visit by Julia Willingale-Theune, Wellcome Trust Sanger Institute, Hinxton, Cambridge, England
September 27 Interview with Edith Herd, Institut Curie, Paris, France, CSHL
October 5 Site visit by Katarina Nordqvist, Nobel Museum, Stockholm, Sweden
October 10 NSF iPlant Collaborative Professional Development DNA Subway Workshop, University of Washington, Seattle
October 13 Saturday DNA! “Captivating Carbon Dioxide,” Dolan DNALC
CSHL Presidents Council, “Engineering Society: The American Eugenics Movement,” CSHL
October 22–23 Site visit by Winship Herr, Severine Trouilloud, and Vincent Parisy, University of Lausanne Eprouvette, 
Lausanne, Switzerland
October 26–27 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, Schoolcraft College, 
Livonia, Michigan
October 29 Bay Area Biotechnology Education Consortium (BABEC), “DNA Barcoding and DNA Subway: Integrating 
B&B Workfl ows,” San Mateo, California
October 30–31 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, University of Alaska, 
Anchorage
November 1–3 National Association of Biology Teachers Annual Meeting, “Sense in Molecules,” “What DNA Says about Our 
Human Family,” “Silencing Genomes,” “DNA Subway in the Classroom,” Dallas, Texas
November 6 Center for Educational Innovation–Public Education Association (CEI-PEA) Professional Development 
Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
November 10 Saturday DNA! “Protein Explosion!” Dolan DNALC
December 1 KidCreate Art, Music, and Science Fair, “DNA Extraction,” O’Shea Educational Complex, New York
December 8 Saturday DNA! “Single Cell-ebration!” Dolan DNALC
December 10–11 NSF iPlant Collaborative Professional Development Tools and Services Workshop, University of Hawaii at 
Manoa, Honolulu
December 13–14 NSF iPlant Collaborative Professional Development Genomics in Education Workshop, University of Hawaii at 
Manoa, Honolulu
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Sites of Major Faculty Workshops 1985–2012
Program Key: Middle School High School College
ALABAMA University of Alabama, Tuscaloosa 1987–1990
ALASKA University of Alaska, Anchorage 2012
University of Alaska, Fairbanks 1996
ARIZONA Arizona State University, Tempe 2009
Tuba City High School 1988
University of Arizona, Tucson 2011
United States Department of Agriculture, Maricopa 2012
ARKANSAS Henderson State University, Arkadelphia 1992
University of Arkansas, Little Rock 2012
CALIFORNIA California State University, Dominguez Hills 2009
California State University, Fullerton 2000
California Institute of Technology, Pasadena 2007
Canada College, Redwood City 1997
City College of San Francisco 2006
City College of San Francisco 2011
Contra Costa County Offi ce of Education, Pleasant Hill 2002, 2009
Foothill College, Los Altos Hills 1997
Harbor-UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute (LA Biomed), Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Oxnard Community College, Oxnard 2009
Pasadena City College 2010
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001, 2008
San Francisco State University 1991
San Diego State University 2012
San Jose State University 2005
Santa Clara University, Santa Clara 2010
Stanford University, Palo Alto 2012
University of California, Berkeley 2010, 2012
University of California, Davis 1986
University of California, Davis 2012
University of California, Northridge 1993
University of California, Riverside 2011
University of California, Riverside 2012
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994, 2007
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998, 2009–2010
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University, Washington 1992, 1996, 2009–2010
FLORIDA Armwood Senior High School, Tampa 1991
Florida Agricultural & Mechanical University, Tallahassee 2007–2008
Florida Agricultural & Mechanical University, Tallahassee 2011
North Miami Beach Senior High School 1991
University of Miami School of Medicine 2000
University of Western Florida, Pensacola 1991
GEORGIA Fernbank Science Center, Atlanta 1989, 2007
Gwinnett Technical College, Lawrenceville 2011, 2012
Morehouse College, Atlanta 1991, 1996–1997
Spelman College, Atlanta 2010
HAWAII Kamehameha Secondary School, Honolulu 1990
University of Hawaii at Manoa 2012
ILLINOIS Argonne National Laboratory 1986–1987
iBIO Institute/Harold Washington College, Chicago 2010
Illinois Institute of Technology, Chicago 2009
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University of Chicago 1992, 1997, 2010
INDIANA Butler University, Indianapolis 1987
Purdue University, West Lafayette 2012
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Bluegrass Community & Technical College, Lexington 2012
Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Bossier Parish Community College 2009
Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
Southern University at New Orleans 2012
MAINE Bates College, Lewiston 1995
Southern Maine Community College 2012
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Bowie State University 2011
Frederick Cancer Research Center 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990–1992
National Center for Biotechnology Information, Bethesda 2002
St. John’s College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Arnold Arboretum of Harvard University, Roslindale 2011
Beverly High School 1986
Biogen Idec, Cambridge 2002, 2010
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
The Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
Schoolcraft College, Livonia 2012
MINNESOTA Minneapolis Community and Technical College 2009
University of Minnesota, St. Paul 2005
University of Minnesota, St. Paul 2010
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990–1991
Rust College, Holly Springs 2006–2008, 2010
MISSOURI St. Louis Science Center 2008–2010
Stowers Institute for Medical Research, Kansas City 2002, 2008
University of Missouri, Columbia 2012
Washington University, St. Louis 1989, 1997, 2011
MONTANA Montana State University, Bozeman 2012
NEVADA University of Nevada, Reno 1992
NEW HAMPSHIRE Great Bay Community College, Portsmouth 2009
New Hampshire Community Technical College, Portsmouth 1999
St. Paul’s School, Concord 1986–1987
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
Raritan Valley Community College, Somerville 2009
NEW MEXICO Biolink Southwest Regional Meeting, Albuquerque 2008
NEW YORK Albany High School 1987
American Museum of Natural History, New York 2007
Bronx High School of Science 1987
Canisius College, Buffalo 2007
Canisius College, Buffalo 2011
City College of New York 2012
Cold Spring Harbor High School 1985, 1987
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Columbia University, New York 1993
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
Dolan DNA Learning Center 1988–1995, 2001–2004, 
2006–2009
Dolan DNA Learning Center 1990, 1992, 1995, 
2000–2011
Dolan DNA Learning Center 1990–1992
DNA Learning Center West 2005
Fostertown School, Newburgh 1991
Harlem DNA Lab, East Harlem 2008–2009, 2011, 2012
Huntington High School 1986
Irvington High School 1986
John Jay College of Criminal Justice 2009
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mount Sinai School of Medicine, New York 1997
New York City Department of Education 2007, 2012
New York Institute of Technology, New York 2006
New York Institute of Technology, New York 2006
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987–1990
Stuyvesant High School, New York 1998–1999
The Rockefeller University, New York 2003
The Rockefeller University, New York 2010
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Saranac Lake 2001
Union College, Schenectady 2004
United States Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Center for Health Research, Triangle Park 2003
North Carolina Agricultural & Technical State University, 
Greensboro
2006–2007, 2009–2011
North Carolina School of Science, Durham 1987
North Carolina State University, Raleigh 2012
NORTH DAKOTA North Dakota State University, Fargo 2012
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
Langston University, Langston 2008
North Westerville High School 1990
OKLAHOMA Oklahoma City Community College 2000
Oklahoma City Community College 2006–2007, 2010
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
Tulsa Community College 2009
Tulsa Community College 2012
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
Kimmel Cancer Center, Philadelphia 2008
RHODE ISLAND Botanical Society of America, Providence 2010
SOUTH CAROLINA Clemson University 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TENNESSEE NABT Professional Development Conference, Memphis 2008
TEXAS Austin Community College–Rio Grande Campus 2000
Austin Community College–Eastview Campus–Roundrock 
Campus
2007–2009
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Austin Community College–Roundrock Campus 2012
Houston Community College Northwest 2009–2010
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
University of Lone Star College, Kingwood 2011
Midland College 2008
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Texas A&M, AG Research and Extension Center, Weslaco 2007
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004, 2010, 2012
University of Texas, Brownsville 2010
UTAH Brigham Young University, Provo 2012
University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
Utah Valley State College, Orem 2007
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
Virginia Polytechnic Institute and State University, Blacksburg 2005, 2008–2009
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001, 2008
Shoreline Community College 2011, 2012
University of Washington, Seattle 1993, 1998, 2010
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999, 2009, 2011, 2012
Marquette University, Milwaukee 1986–1987
University of Wisconsin, Madison 1988–1989
University of Wisconsin, Madison 2004, 2012
WYOMING University of Wyoming, Laramie 1991
PUERTO RICO Universidad del Turabo, Gurabo 2011, 2012
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
AUSTRIA Vienna Open Lab 2007, 2012
CANADA Red River Community College, Winnipeg, Manitoba 1989
CHINA Ho Yu College, Hong Kong 2009
GERMANY Urania Science Center, Berlin 2008
ITALY International Institute of Genetics and Biophysics, Naples 1996
Porto Conte Research and Training Laboratories, Alghero 1993
MEXICO ASPB Plant Biology, Merida 2008
PANAMA University of Panama, Panama City 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001–2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University 2000
THE NETHERLANDS International Chromosome Conference, Amsterdam 2007
UNITED KINGDOM Wellcome Trust Conference Center, Hinxton, UK 2012
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Serials
Genes & Development, Vol. 26 (www.genesdev.org)
Genome Research, Vol. 22 (www.genome.org)
Learning & Memory, Vol. 19 (www.learnmem.org)
RNA, Vol. 18 (www.rnajournal.org)
Cold Spring Harbor Symposia in Quantitative Biology, Vol. 76: 
Metabolism and Disease, edited by Terri Grodzicker, 
Bruce Stillman, and David Stewart
Cold Spring Harbor Protocols (www.cshprotocols.org)
Cold Spring Harbor Perspectives in Biology (www.cshperspectives.org)
Cold Spring Harbor Perspectives in Medicine 
(www.perspectivesinmedicine.org)
Laboratory Manuals
Molecular Cloning: A Laboratory Manual, Fourth Edition, 
by Michael R. Green and Joseph Sambrook
Handbooks
Lab Dynamics: Management and Leadership Skills for Scientists, 
Second Edition, by Carl M. Cohen and Suzanne L. Cohen
Basic Stereology for Biologists and Neuroscientists, by Mark J. West
Next-Generation DNA Sequencing Informatics, edited by Stuart 
M. Brown
Textbooks
Genome Science, by David Micklos, Bruce Nash, and Uwe Hilgert
Monographs (Topic Collections from Perspectives 
in Biology and Perspectives in Medicine)
The Synapse, edited by Morgan Sheng, Bernardo L. Sabtini, and 
Thomas C. Südhof
Type 1 Diabetes, edited by Jeffrey A. Bluestone, 
Mark A. Atkinson, and Peter Arvan
Protein Synthesis and Translational Control, edited 
by John W.B. Hershey, Nahum Sonenberg, and 
Michael B. Mathews
Parkinson’s Disease, edited by Serge Przedborski
Wnt Signaling, edited by Roel Nusse, Xi He, and Renée van 
Amerongen
Addiction, edited by R. Christopher Pierce and Paul J. Kenny
History
The Annotated and Illustrated Double Helix, by James D. Watson, 
edited by Alexander Gann and Jan Witkowski
Other
At the Bench: A Laboratory Navigator, Updated Edition, 
by Kathy Barker
At the Helm: Leading Your Laboratory, Second Edition, 
by Kathy Barker
CSHL Annual Report 2011, Yearbook Edition
CSHL Annual Report 2011, Executive Summary
Banbury Center Annual Report 2011
Watson School of Biological Sciences Annual Report 2011
E-books (Kindle editions)
RNA: Life’s Indispensable Molecule, by James Darnell
Incurable: A Life After Diagnosis, by Charles Harris
Lab Dynamics: Management and Leadership Skills for Scientists, 
Second Edition, by Carl M. Cohen and Suzanne L. Cohen
Websites
Cold Spring Harbor Monographs Archive Online 
(www.cshmonographs.org)
Cold Spring Harbor Symposium on Quantitative Biology 
Archive (symposium.cshlp.org)
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EXECUTIVE DIRECTOR’S REPORT
Cold Spring Harbor Laboratory has a unique presence and an admired reputation in the inter-
national scientifi c community, and its publications have contributed much to that status. The 
research and review journals and books published by the Laboratory’s Press are a vital part of how 
the institution connects with scientists worldwide. What began in 1933 as one printed symposium 
proceedings volume each year is now a digitally based publishing program with seven online 
journals and more than 170 print and electronic books. In 2012, CSHL journal articles were elec-
tronically downloaded a remarkable 10 million times, a 12% increase year-on-year, and 38,000 
print books were shipped to 150 countries. In this way, the Press continues to fulfi ll its mission of 
helping scientists succeed while promoting the Laboratory’s reputation for excellence and support-
ing its work fi nancially.
The journals once again had an exceptional year. Subscriptions to every title increased, a sig-
nifi cant result in an increasingly challenging library market. There was revenue growth of 6% 
even in the four long-established research journals and, gratifyingly, the review journals—more 
recent in origin and creatively straddling the boundaries of book and journal content—grew by 
more than 15%. Despite their maturity, Genes & Development (celebrating its 25th anniversary) 
and Genome Research continued to attract new subscribers, particularly in emerging scientifi c 
communities abroad. Although the impact factor is an increasingly embattled metric of a journal’s 
quality or value—justifi ably, given its willfully distorted application to the worth of individuals in 
academic circles—it remains important to those who must decide which journals to purchase for 
institutions and also to scientists seeking a vehicle for the publication of work that will enhance 
their careers. Judged by impact factor, Genome Research and Genes & Development remained with-
in the top 1% of all published journals. They are two of the top three research journals in genetics, 
continuing to publish important work that has received careful and fair peer review.
Learning & Memory was founded as a specialized journal within the broad sweep of neurosci-
ence, but in the past 2 years, it has expanded its scope into the advancing fi eld of molecular cogni-
tion. RNA, published on behalf of the RNA Society, maintained its position as the leading journal 
of RNA biology, enhancing both the reputation and the fi nancial health of the Society.
Our research journals retain a subscription basis. However, the Press was among the fi rst 
publishers to embrace three practices intended to widen access to the published scientifi c re-
cord: deposition of research articles for indexing and access at the government-funded database 
PubMedCentral; release of all journal content online for access without charge 6 or 12 months 
after publication; and the opportunity for individual scientists to make their papers freely acces-
sible immediately on publication in return for a fee. In 2012, 19% of the articles published by 
the Press research journals became immediately available on publication, the largest proportion 
yet recorded. To enhance the re-usability of content in Genome Research, a new license to publish 
was adopted. Papers released for free access 6 months after publication now have a Creative Com-
mons BY-NC license that permits their noncommercial re-use and adaptation by the academic 
community.
The editorial excellence of the review journal Cold Spring Harbor Perspectives in Biology in its 
fi rst 3 years was rewarded with a substantial fi rst-impact factor. As planned, a sister publication, 
Cold Spring Harbor Perspectives in Medicine, was launched this year. Both these journals have an 
innovative print plus online publishing model that strongly appeals to both authors and readers. 
Their important and well-received collections of articles gained audience and scholarly recogni-
tion, with widely ranging themes that included diabetes, addiction, and Parkinson’s disease, as 
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well as protein synthesis and signal transduction. These journals have taken the place of print-only 
monographs as a means of providing authoritative, in-depth surveys of specifi c research fi elds—
but in a more immediately discoverable way online. Our fi rst foray into the journal-based delivery 
of information formerly published in books was the methods journal Cold Spring Harbor Labora-
tory Protocols. Launched 6 years ago, this online-only publication is now well-established fi nan-
cially, with an expanding circulation and a record number of downloads. 
Twelve new print books and fi ve new e-books were added to the Press list in 2012. Most print 
volumes were themed collections of articles derived from the Perspectives journals. The additional 
titles included Genome Science, a new collection of laboratory exercises by the teaching staff at the 
Dolan DNA Learning Center. Most notably, a new edition of the laboratory manual Molecular 
Cloning was published in June. Long established as the gold standard for molecular biology tech-
niques, and by far the most successful book ever published by the Press, with more than 200,000 
copies sold, this new edition was a complete revision by founding author Joe Sambrook and his 
new coauthor Michael Green, assisted by a dozen expert contributors. Another classic, of a differ-
ent sort, was copublished by the Press and Simon & Schuster: an annotated and illustrated edi-
tion of James Watson’s 1968 autobiographical account of the discovery of the structure of DNA, 
The Double Helix. Laboratory Professors Alex Gann and Jan Witkowski expanded the text with 
footnotes, photos, correspondence, and other documents that placed this most famous account of 
scientifi c discovery in its social, intellectual, and historical context. 
In 2012, there were two further organizational changes. After more than 20 years of owning 
systems for book warehousing and order processing, these functions were contracted out to a 
large-scale, technologically sophisticated and more cost-effi cient facility run by Oxford Univer-
sity Press in North Carolina. In addition, the marketing operations for books and journals were 
merged, and a sales agreement with Oxford was reached that will improve our market reach and 
relationships with book resellers. For more than a decade, advancing digital technologies and 
changing reader inclinations have transformed the learning landscape in which the Press operates. 
As methods of content delivery have continued to evolve, so has the Press, revising its approaches, 
restructuring its operations, and adjusting its business models. The process must continue, but 
2012 provided very satisfactory evidence of success.
Staff
During the year, we said farewell to Richard Abreu, Matthew D’Amico, Pauline Henick, Lauren 
Schmidt, and Hashanthi Wijayatilaki, and also to Jacqueline Matura and Sharon Story, both of 
whom dedicated long years of excellent service to our customer service and fulfi llment operations. 
We also welcomed Christina Kary to the editorial staff of Genes & Development. And we congratu-
lated Alex Gann as he assumed the role of Dean of the Watson School of Biological Studies at the 
end of December, retaining a part-time editorial role at the Press. A full list of staff members of 
the Press at December 31, 2012, is listed elsewhere in this volume. An effective publishing team 
must combine people with a variety of skills. The Laboratory is fortunate to have skilled and 
dedicated individuals in all of the operations of the Press. But I am particularly grateful for the 
quiet and cheerful effi ciency of my assistant Mala Mazzullo and to the talented and hard-working 
individuals who have important leadership roles in the activities of the Press: Jan Argentine, Terri 
Grodzicker, Wayne Manos, Stephen Nussbaum, Richard Sever, Marcie Siconolfi , Hillary Suss-
man, Linda Sussman, and Denise Weiss.
John Inglis
Executive Director 
and Publisher
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 2012 2011
Assets:
 Cash and cash equivalents $  75,471,404 58,055,329
 Grants receivable 10,012,401 5,733,104
 Contributions receivable, net 145,289,626 163,144,645
 Publications inventory 2,767,427 3,292,898
 Investments 296,611,329 269,786,326
 Restricted use assets 3,597,846 2,882,590
 Other assets 15,891,942 15,027,787
 Land, buildings, and equipment, net 240,625,332  241,828,796
Total assets $  790,267,307  759,751,475
Liabilities and net assets:
 Liabilities:
 Accounts payable and accrued expenses $  10,456,412 11,135,584
 Deferred revenue 5,258,525 5,467,566
 Interest rate swap 35,556,347 37,726,697
 Bonds payable    97,200,000 97,200,000
  Total liabilities  148,471,284  151,529,847
 Net assets:
 Unrestricted 243,281,390 205,967,407
 Temporarily restricted 293,464,158 298,351,339
 Permanently restricted  105,050,475  103,902,882
  Total net assets  641,796,023 608,221,628
Total liabilities and net assets $   790,267,307  759,751,475
FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET 
December 31, 2012
(with comparative ﬁ nancial information as of December 31, 2011)
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  Temporarily Permanently 2012 2011
 Unrestricted Restricted Restricted Total Total
Revenue and other support:
Public support–contributions and 
 nonfederal grant awards $ 19,618,621 40,079,983 1,147,593 60,846,197 113,684,017
Federal grant awards 28,711,510 –- --- – ---- 28,711,510 34,490,267
Indirect cost allowances 24,445,726 –- ---- – ---- 24,445,726 25,623,148
Investment return utilized 23,396,825 – ----- – ---- 23,396,825 22,585,474
Program fees 8,049,856 – ----- – ---- 8,049,856 6,963,110
Publications sales 10,957,863 – ----- – ---- 10,957,863 9,848,446
Dining services 4,614,691 – ----- – ---- 4,614,691 4,309,694
Rooms and apartments 3,770,473 –- ---- – ---- 3,770,473 3,345,273
Miscellaneous 2,527,870 –- ---- – ---- 2,527,870 3,745,958
Net assets released from restrictions   58,423,282   (58,423,282)            – ----            – ----              –  ---  
Total revenue and other support  184,516,717   (18,343,299)      1,147,593  167,321,011  224,595,387  
Expenses:
Research 88,821,283 –- ---- –- --- 88,821,283 91,848,784
Educational programs 17,815,388 –- ---- – ---- 17,815,388 16,117,941
Publications 10,092,372 –-- --- – ---- 10,092,372 9,323,927
Banbury Center conferences 1,389,048 –- ---- –- --- 1,389,048 1,409,384
DNA Learning Center programs 1,578,211 –- ---- –- --- 1,578,211 1,857,078
Watson School of Biological Sciences 
 programs 3,356,033 – ----- – ---- 3,356,033 3,584,716
General and administrative 16,860,891 – ----- –- --- 16,860,891 15,596,163
Dining services     5,642,788               – ------              –   ---     5,642,788      5,717,278  
Total expenses  145,556,014               – -----              – ----  145,556,014  145,455,271  
Excess (defi ciency) of revenue and other 
support over (under) expenses 38,960,703 (18,343,299) 1,147,593 21,764,997 79,140,116
Other changes in net assets:
Investment (loss) return excluding 
amount utilized (3,817,070) 13,456,118 – ---- 9,639,048 (22,610,255)
Change in fair value of interest 
rate swap     2,170,350                – ----              – ----      2,170,350  (21,287,538)
Increase (decrease) in net assets 37,313,983 (4,887,181) 1,147,593 33,574,395 35,242,323
Net assets at beginning of year 205,967,407  298,351,339   103,902,882 608,221,628  572,979,305  
Net assets at end of year $ 243,281,390  293,464,158   105,050,475 641,796,023  608,221,628  
CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2012
(with summarized ﬁ nancial information for the year ended December 31, 2011)
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   2012 2011
Cash fl ows from operating activities:
Increase in net assets  $  33,574,395 35,242,324
Adjustments to reconcile increase in net assets
 to net cash provided by operating activities:
Change in fair value of interest rate swap  (2,170,350) 21,287,538
Depreciation and amortization  15,422,891 14,697,263
Net (appreciation) depreciation in fair value of investments  (29,322,335) 4,173,189
Contributions restricted for long-term investment  (10,527,878) (13,475,213)
Changes in assets and liabilities:
Grants receivable  (4,279,297) 1,992,555
Contributions receivable, net of fi nancing activities  25,176,987 (53,517,765)
Publications inventory  525,471 262,295
Other assets  (912,934) (5,008,296)
Restricted use assets  (715,256) (302,119)
Accounts payable and accrued expenses, net of fi nancing activities  (139,990) 1,835,064
Deferred revenue        (209,041)   (2,743,102) 
Net cash provided by operating activities   26,422,663)    4,443,733)
Cash fl ows from investing activities:
Capital expenditures  (14,219,427) (17,748,180)
Proceeds from sales and maturities of investments  73,005,504 33,325,960
Purchases of investments  (70,508,172) (30,860,745)
Net change in investment in employee residences           48,779)         (97,394) 
Net cash used in investing activities   (11,673,316) (15,380,359)
Cash fl ows from fi nancing activities:
Contributions restricted for long-term investment  1,147,593 1,600,563
Contributions restricted for investment in capital  9,380,285 11,874,650
Increase in contributions receivable  (7,321,968) (5,354,289)
(Decrease) increase in accounts payable relating 
 to capital expenditures       (539,182)        104,669  
Net cash provided by fi nancing activities      2,666,728)    8,225,593 
Net increase (decrease) in cash and cash equivalents  17,416,075   (2,711,033)
Cash and cash equivalents at beginning of year   58,055,329)  60,766,362  
Cash and cash equivalents at end of year  $  75,471,404)  58,055,329 
Supplemental disclosure:
  Interest paid   $    3,683,436)    3,614,370  
Noncash investing and fi nancing activity:
  Contributed property  $          50,000)    1,095,000  
CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2012
(with comparative ﬁ nancial information for the year ended December 31, 2011)
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive 
a substantial portion of their funding through grants from the federal government and through 
grants, capital gifts, and annual contributions from New York State, private foundations, corpo-
rations, and individuals. The following section summarizes funding that occurred during 2012.
GRANTS January 1–December 31, 2012
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Project and Center Support Drs. Hannon/Krainer/Spector/Stillman 05/25/12 12/31/16 $ 4,486,042 *
Dr. Stillman, Cancer Center Core 08/17/11 07/31/16 4,346,720
Cooperative Research Agreement Support2 Dr. Gingeras 09/21/12 07/31/16 1,975,096 *
Drs. Lowe/Hannon/Hicks/Powers 09/01/09 08/31/14 564,230
Drs. Powers/Hannon/Krasnitz/Sordella 05/01/12 04/30/17 1,013,392 *
Equipment Support Dr. Hannon 04/01/12 03/31/13 519,814 *
Research Support Dr. Churchland 09/01/10 08/31/13 247,403
Dr. Dubnau 09/15/09 08/31/14 466,125
Drs. Enikolopov/Koulakov 09/15/11 08/31/16 411,276
Dr. Furukawa 03/01/10 02/28/15 457,875
Dr. Hannon 09/01/09 08/31/13 378,401
Dr. Huang 07/01/11 03/31/16 560,565
Drs. Kepecs/Huang 07/01/11 05/31/16 411,250
Drs. Koulakov/Enikolopov 07/15/10 02/28/14 356,621
Dr. Krainer 04/01/12 03/31/17 728,529 *
Dr. Krainer 09/01/12 08/31/14 235,416 *
Dr. Li 07/01/10 03/31/15 560,038
Dr. Martienssen 09/15/11 08/31/15 344,865
Dr. Martienssen 01/20/12 11/30/15 737,743 *
Dr. McCombie 07/23/10 02/28/15 1,069,587
Dr. Mills 12/26/07 11/30/12 37,605
Dr. Mitra 09/30/09 03/31/14 975,957
Dr. Mitra 08/01/10 05/31/13 406,574
Dr. Muthuswamy 02/01/09 12/31/13 405,930
Dr. Osten 04/01/12 03/31/17 485,438 *
Dr. D. Spector 04/01/11 03/31/15 740,360
Dr. Stenlund 12/01/06 06/30/13 470,000
Dr. Stillman 06/01/12 05/31/16 696,400 *
Dr. Tonks 07/01/10 04/30/15 761,643
Dr. Tonks 01/11/10 12/31/13 434,648
Dr. Trotman 04/01/10 01/31/14 301,376
Dr. Turner 07/15/10 06/30/15 454,960
1Includes direct and indirect costs
2Cooperative research agreement funding amounts include only CSHL portion of award
*New or competing renewal grants awarded in 2012
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*New or competing renewal grants awarded in 2012
Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
Dr. Van Aelst 07/01/08 03/31/14 $  417,658
Dr. Van Aelst 01/01/09 12/31/13 376,384
Dr. Zador 09/18/08 07/31/13 354,339
Dr. Zador 09/27/10 05/31/15 464,475
Dr. Zador 09/01/12 08/31/17 400,209 *
Dr. Zhong 06/01/10 05/31/13 368,154
Research Subcontracts
NIH/Allen Institute for Brain Science 
Consortium Agreement
Dr. Mitra 09/15/09 08/31/13 186,076
NIH/Cornell University Consortium 
Agreement
Dr. Mitra 04/03/08 01/31/13 21,091
NIH/Georgia Institute of Technology 
Consortium Agreement
Dr. D. Spector 09/30/06 07/31/15 290,000
NIH/The Johns Hopkins University 
Consortium Agreement
Dr. Schatz 09/21/11 08/31/14 161,013
NIH/The Scripps Research Institute 
Consortium Agreement
Dr. Osten 09/30/12 08/31/13 75,600 *
NIH/University of California - San 
Francisco Consortium Agreement
Dr. Egeblad 09/01/09 08/31/14 174,905
NIH/University of Southern California 
Consortium Agreement
Dr. Hannon 07/01/10 06/30/14 117,450
NIH/University of Texas Consortium 
Agreement
Dr. Krainer 08/01/10 03/31/13 44,732
NIH/University of Texas Consortium 
Agreement
Dr. Furukawa 09/30/11 05/31/15 50,514
Fellowship Support Dr. Ipsaro 09/01/11 08/31/13 52,190
Dr. Jansen 01/01/11 07/31/14 47,756
J. Tucciarone 09/16/12 09/15/15 32,582 *
Institutional Training Program Support Dr. Joshua-Tor, Watson School of 
Biological Sciences
07/01/12 06/30/17 267,927 *
Dr. Mills 09/01/11 08/31/16 181,564
Course Support Advanced Immunocytochemistry: In Situ 
Hybridization and Live Cell Imaging
09/01/10 08/31/15 100,323
Advanced Sequencing Technologies 
and Applications
04/10/12 03/31/15 52,885 *
Cell and Developmental Biology 
of Xenopus
04/01/09 03/31/14 63,345
Cellular Biology of Addiction 03/01/11 02/29/16 80,694
Computational and Comparative 
Genomics
08/01/08 07/31/13 51,792
Drosophila Neurobiology: Genes, 
Circuits, and Behavior
07/15/12 06/30/17 35,000 *
Eukaryotic Gene Expression 04/01/12 03/31/17 114,306 *
Mouse Development, Stem Cells, and 
Cancer
04/01/12 03/31/17 110,288 *
Programming for Biology 09/01/09 08/31/14 63,654
Protein Purifi cation and Characterization 04/01/12 03/31/17 95,019 *
Proteomics 08/01/12 04/30/17 105,068 *
X-Ray Methods in Structural Biology 09/01/12 08/31/17 81,540 *
Yeast Genetics and Genomics 09/18/10 06/30/13 53,462
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*New or competing renewal grants awarded in 2012
Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
Meeting Support Automated Imaging and High-
Throughput Phenotyping
04/01/12 03/31/13 $   5,000 *
Axon Guidance, Synapse Formation, 
and Regeneration
07/01/12 06/30/13 10,000 *
Bacteria, Archaea, and Phages 05/15/12 04/30/13 6,000 *
The Biology of Genomes 04/01/08 03/31/13 39,339
Evolution of Caenorhabditis and Other 
Nematodes
04/01/12 03/31/13 15,000 *
Gene Expression and Signaling in the 
Immune System
04/01/08 03/31/13 10,000
Germ Cells 07/01/08 06/30/13 6,000
Mechanisms and Models of Cancer 08/01/08 07/31/13 8,500
Molecular Chaperones and Stress 
Responses
05/01/10 04/30/13 20,602
Molecular Genetics of Aging 03/01/08 02/28/13 31,600
Neurodegenerative Diseases: Biology 
and Therapeutics
09/26/12 09/25/13 23,000 *
Neuronal Circuits 03/01/12 02/28/13 15,000 *
Nuclear Receptors and Disease 09/21/12 08/31/13 20,025 *
Pharmacogenomics and Personalized 
Therapy
09/30/10 08/31/15 10,000
PTEN Pathways and Targets 09/30/11 08/31/12 3,000
Retroviruses 03/15/12 02/28/17 36,645 *
Systems Biology: Global Regulation 
of Gene Expression
03/01/10 02/28/15 5,000
Vertebrate Organogenesis 04/01/11 03/31/15 6,000
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Jackson 10/01/10 09/30/15  1,115,265
Drs. Lippman/Schatz 11/01/12 10/31/15 854,233 *
Dr. Ware 06/01/12 05/31/17 1,762,326 *
Research Support Dr. Churchland 08/01/11 07/31/14 43,156
Dr. Jackson 09/01/10 08/31/13 150,000
Dr. Timmermans 08/15/10 07/31/13 150,000
Drs. Timmermans/Hammell 05/01/12 04/30/16 181,550 *
Research Subcontracts
NSF/Cornell University Consortium 
Agreement
Dr. Timmermans 09/01/08 08/31/12 16,000
NSF/New York University Consortium 
Agreement
Drs. McCombie/Martienssen 08/01/10 07/31/14 407,632
NSF/North Carolina State University 
Consortium Agreement
Dr. Martienssen 03/01/11 02/29/16 510,779
NSF/University of Arizona Consortium 
Agreement
Dr. Ware 08/15/10 07/31/14 583,136
NSF/University of Arizona Consortium 
Agreement
Drs. Ware/Micklos/Schatz/Stein 02/01/12 01/31/13 1,863,578 *
NSF/University of California - Berkeley 
Consortium Agreement
Dr. Jackson 08/01/06 07/31/12 269,815
NSF/University of Maryland 
Consortium Agreement
Dr. Schatz 02/01/12 03/31/13 60,000 *
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Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
NSF/Washington University Consortium 
Agreement
Dr. Ware 03/01/10 02/28/13 $  92,150
Fellowship Support Dr. Liberatore 06/01/10 05/31/13 43,500
Dr. Carlston 06/01/10 05/31/13 42,000 *
Undergraduate Training Program Support Dr. Lippman 04/01/12 03/31/15 115,000 *
Course Support Advanced Bacterial Genetics 07/01/09 06/30/14 95,634
Computational Cell Biology 08/01/12 07/31/15 70,000 *
Frontiers and Techniques in Plant 
Science
05/15/12 04/30/15 97,675 *
Neurobiology of Drosophila 08/01/12 07/31/14 20,000 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 01/15/11 01/14/15 120,963
Dr. McCombie 09/11/12 09/10/13 224,106 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 09/15/12 09/14/17 1,069,481 *
Dr. Hannon 09/01/08 08/31/13 709,165
Drs. Hicks/Trotman 09/30/12 09/29/14 276,672 *
Dr. Zhong 06/15/10 06/14/13 302,572
Research Subcontracts
US Army/University of Pittsburgh 
Consortium Agreement
Dr. Hicks 09/01/12 08/31/13 152,921 *
Fellowship Support E. Nakasone 01/01/11 03/13/12 10,800
Dr. Park 04/01/12 03/31/15 187,500 *
Dr. Sheppard 09/01/12 08/31/15 38,927 *
UNITED STATES DEPARTMENT OF ENERGY
Research Subcontracts
DOE/Brookhaven National Laboratory 
Consortium Agreement
Drs. Ware/Schatz 11/29/11 09/30/16 1,076,238
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
Academy for Medical Development and 
Collaboration (AMDeC)
Dr. Stillman 01/01/12 12/31/12 60,000 *
Edward P. Evans Foundation Dr. Vakoc 08/01/12 07/31/13 120,000 *
Memorial Sloan-Kettering Cancer 
Center/Helena Rubinstein Foundation
Dr. Wigler 03/30/12 03/29/13 300,000 *
New York State Urban Development 
Corporation
Dr. Stillman 05/01/12 04/30/13 2,000,000 *
Edith and Alan Seligson Dr. Wigler 06/01/11 05/31/14 250,000
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Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
Program Project Support
Pfi zer Inc. Dr. Stillman 01/01/12 12/31/13 $ 2,050,000 *
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lippman/Martienssen/
Timmermans/Ware
07/01/12 06/30/17 1,600,000 *
The Simons Foundation/Autism Dr. Wigler 01/01/12 12/31/15 6,557,422 *
The Simons Foundation/Center for 
Quantitative Biology
Dr. Wigler 09/01/08 08/31/15 1,500,000
Theodore R. and Vada S. Stanley Drs. Watson/McCombie 06/01/11 05/31/14 5,000,000
Research Support
Aboff ’s Inc. Dr. Tonks 12/19/12 12/18/13 10,318 *
Paul G. Allen Family Foundation Dr. Zador 10/01/10 09/30/13 575,200
Rita Allen Foundation Dr. Hammell 09/01/12 08/31/17 110,000 *
American Association for Cancer 
Research
Dr. Egeblad 07/01/12 06/30/14 100,000 *
American Cancer Society Dr. Wigler 01/01/12 08/31/12 10,000 *
Dr. Wigler 01/01/11 08/31/13 47,000
American Legion Auxiliary Dr. Egeblad 11/30/12 11/29/13 250 *
Anonymous Drs. Mitra/Huang 02/01/12 01/31/14 300,000 *
Banfi  Vineyards Dr. Martienssen 01/01/12 12/31/12 5,679 *
The Breast Cancer Research Foundation Drs. Wigler/Hicks 10/01/12 09/30/13 240,000 *
Burroughs Wellcome Fund Dr. Vakoc 09/01/11 08/31/16 151,250
Caring for Carcinoid Foundation Dr. Tuveson 07/01/12 06/30/14 150,000 *
The H.A. and Mary K. Chapman 
Foundation
Dr. Churchland 12/27/12 12/26/13 170,000 *
The Mary K. Chapman Foundation Dr. Osten 12/31/11 12/30/13 150,000
Coferon Inc. Dr. Vakoc 09/17/12 09/16/13 115,316 *
Dart Neuroscience LLC Dr. Dubnau 12/01/12 11/30/13 250,000 *
Dysautonomia Foundation Inc. Dr. Krainer 07/01/12 06/30/14 90,000 *
Lee MacCormick Edwards, Ph.D. Dr. Stillman 12/01/12 11/30/13 5,000 *
The Ellison Medical Foundation Dr. Enikolopov 09/09/09 09/08/13 252,000
Entertainment Industry Foundation Dr. Hannon 11/01/12 10/31/13 100,000 *
Edward P. Evans Foundation Dr. Vakoc 11/01/12 10/31/13 500,000 *
Charitable Lead Annuity Trust under the 
Will of Louis Feil
Drs. Albeanu/Kepecs/Li/Osten 12/15/12 12/14/13 1,000,000 *
Find a Cure Today Long Island 
Foundation
Dr. Egeblad 03/01/12 02/28/13 5,000 *
The Joni Gladowsky Breast Cancer 
Foundation
Dr. Tonks 05/01/12 04/30/13 55,000 *
Glen Cove C.A.R.E.S., Inc. Dr. Egeblad 02/01/12 01/31/13 10,000 *
The Irving A. Hansen Memorial 
Foundation
Dr. Tonks 07/01/12 06/30/13 25,000 *
Jo-Ellen and Ira Hazan Drs. Osten/Tonks/Krainer 12/01/12 11/30/13 200,000 *
Hearts for Cancer Dr. Egeblad 04/01/12 03/31/13 28,456 *
The Hope Foundation Dr. Egeblad 07/01/12 06/30/14 125,000 *
Howard Hughes Medical Institute–
Gordon and Betty Moore Foundation
Dr. Martienssen 12/01/11 11/30/16 333,333
Isis Pharmaceuticals, Inc. Dr. Krainer 11/01/11 10/26/13 150,000
Japan Science and Technology Agency Dr. Taniguchi 03/01/12 07/31/12 54,799 *
Sidney Kimmel Foundation for Cancer 
Research
Dr. Zheng 07/01/11 06/30/13 100,000
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F.M. Kirby Foundation, Inc. Dr. Vakoc 12/15/12 12/14/13 $ 150,000 *
The Susan G. Komen Breast Cancer 
Foundation, Inc.
Dr. Egeblad 04/13/10 04/12/13 150,000
Mara and Thomas Lehrman Charitable 
Fund
Drs. Hammell/Schatz 03/01/12 02/28/13 65,000 *
The Lehrman Institute Dr. Hammell 03/01/12 02/28/13 200,000 *
Long Island Cruzin’ For a Cure Inc. Drs. Hicks/Trotman 08/01/12 07/31/13 20,000 *
The Long Island 2-Day Walk to Fight 
Breast Cancer
Dr. Egeblad 08/15/12 08/14/13 33,000 *
The Lustgarten Foundation Dr. Hannon 01/01/10 12/31/12 835,531
Dr. Tuveson 06/15/12 06/14/17 50,000 *
Drs. Tuveson/Pappin 09/01/12 08/30/17 1,000,000 *
The Manhasset Women’s Coalition 
Against Breast Cancer, Inc.
Dr. Egeblad 01/01/11 12/31/12 50,744
Carol Marcincuk Fund Dr. Tonks 01/01/12 12/31/12 6,800 *
In Honor of Carissa Maringo Dr. Egeblad 10/01/12 09/30/13 5,310 *
The G. Harold and Leila Y. Mathers 
Charitable Foundation
Dr. Mitra 09/01/10 08/31/13 203,920
Breast Cancer Awareness Day in Memory 
of Elizabeth McFarland
Dr. Wigler 01/01/12 12/31/13 64,805 *
The McKnight Endowment Fund for 
Neuroscience
Dr. Churchland 07/01/12 06/30/15 75,000 *
The Melanoma Research Alliance Drs. Hannon/Hammell/Vakoc 08/01/11 07/31/14 200,000
The John Merck Fund Dr. Churchland 06/01/11 05/31/15 75,000
Dr. Kepecs 06/01/10 05/31/14 75,000
The Don Monti Memorial Research 
Foundation
Dr. Stillman 03/01/12 02/28/13 400,000 *
Louis Morin Charitable Trust Dr. Stillman 12/01/12 11/30/13 75,000 *
National Alliance for Research on 
Schizophrenia and Depression 
(NARSAD)
Dr. Li 07/15/11 07/14/13 30,000
Pancreatic Cancer UK Dr. Tuveson 10/23/12 10/22/15 65,000 *
Panera Bread/Doherty Breads, LLC Dr. Tonks 12/15/12 12/14/13 8,466 *
The Pew Charitable Trusts Dr. Albeanu 08/01/12 07/31/17 60,000 *
Dr. Hannon 01/01/11 12/31/15 349,452
Pioneer Hi-Bred International, Inc. Dr. Ware 03/15/12 06/30/15 65,385 *
The Hazen Polsky Foundation Dr. Vakoc 01/01/12 12/31/14 50,000 *
The Prostate Cancer Foundation Dr. Vakoc 01/20/12 01/19/14 150,000 *
Christina Renna Foundation Inc. Dr. Van Aelst 05/01/12 04/30/13 20,300 *
The Research Foundation for the State 
University of New York
Dr. Furukawa 10/10/12 03/31/14 25,000 *
Dr. Jackson 10/10/12 03/31/14 22,500 *
Marie Robertson Memorial Fund CSHL Neuroscience Program Support 01/01/12 12/31/12 137,500 *
Damon Runyon Cancer Research 
Foundation
Dr. Sordella 01/01/10 12/31/12 150,000
Diane Emdin Sachs Memorial Fund Dr. Sordella 09/01/12 08/31/13 8,461 *
Eleanor Schwartz Charitable Foundation Dr. Churchland 07/15/11 07/14/14 200,000
The Seraph Foundation Dr. Vakoc 12/21/12 12/20/13 125,000 *
Ms. Constance Silveri Dr. Tonks 12/27/12 12/26/13 15,000 *
The Simons Foundation Dr. Mills 07/01/10 06/30/13 350,000
Drs. Mitra/Huang 12/01/11 11/30/14 300,000
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Dr. Osten 10/01/11 09/30/13 $ 175,000
Dr. Osten 07/01/12 06/30/13 60,000 *
Mary F. Smith Family Foundation Dr. Tonks 12/01/12 11/30/13 5,000 *
Smithtown Steakhouse LLC D/B/A 
Insignia Prime Steak: Sushi
Dr. Sordella 01/01/12 12/31/13 75,000 *
Starr Cancer Consortium Dr. Hannon 08/01/11 07/31/13 216,000
Dr. Hannon 08/01/11 07/31/13 270,000
Drs. Hicks/Wigler 08/01/11 07/31/13 320,760
Dr. Sordella 08/01/11 07/31/13 216,000
Drs. Sordella/Pappin 08/01/11 07/31/13 221,988
Dr. Vakoc 08/01/11 07/31/13 270,000
Swim Across America Dr. Sordella 12/15/11 12/14/14 75,000
U.S.–Israel Binational Agricultural 
Research and Development Fund
Dr. Krainer 10/01/10 09/30/14 10,000
Dr. Lippman 06/01/10 05/31/13 42,000
Dr. Zador 10/01/10 09/30/14 5,750
University Health Network Dr. Muthuswamy 01/01/11 12/31/12 28,339
University of Pennsylvania Dr. Krainer 08/22/12 08/31/14 150,000 *
The V Foundation Dr. Vakoc 11/01/12 10/31/14 100,000 *
Dr. Zheng 11/01/11 10/31/13 100,000
Whitehall Foundation, Inc. Dr. Albeanu 01/01/12 12/31/14 75,000 *
Dr. Shea 09/01/11 08/31/15 75,000
West Islip Breast Cancer Coalition for 
Long Island Inc.
Dr. Tonks 11/01/12 10/31/13 10,000 *
Elisabeth R. Woods Foundation Inc. Dr. Sordella 08/16/12 08/15/13 27,000 *
Yale University/Gilead Sciences Inc. Dr. Sordella 07/16/12 07/15/14 410,058 *
The Bradley Zankel Foundation, Inc. Dr. Zheng 02/22/12 02/21/13 15,000 *
Fellowship Support
American Cancer Society Dr. Feigin 01/01/11 12/31/12 52,000
Dr. Preall 10/01/11 09/30/14 50,000
Cashin Family Fund Watson School of Biological Sciences 09/01/10 08/31/12 80,000
CSHL Association Fellowship Dr. Tuveson 01/01/12 12/31/12 280,000 *
Genentech Foundation Watson School of Biological Sciences 10/01/12 09/30/15 58,751 *
German Academic Exchange Service Dr. Bergmann 09/01/11 08/31/13 38,000
Lola A. Goldring Dr. Stillman 09/01/12 08/31/13 80,000 *
Hope Funds for Cancer Research Dr. Knott 07/01/12 06/30/15 45,500 *
Human Frontier Science Program Dr. Benkovics 05/01/12 04/30/13 39,400 *
Annette Kade Charitable Trust Watson School of Biological Sciences 09/01/12 08/31/13 25,000 *
Karp Foundation Inc. Dr. Penzo 08/01/12 07/31/13 50,000 *
Estate of Gale Kavaliuskas Watson School of Biological Sciences 09/01/12 08/31/13 293,849 *
The Esther A and Joseph Klingenstein 
Fund Inc.
Dr. Shea 07/01/10 06/30/13 50,000
Life Sciences Research Foundation Dr. MacAlister 08/01/11 07/31/14 56,000
Muscular Dystrophy Association Dr. Sahashi 02/01/12 01/31/15 60,000 *
National Alliance for Research on 
Schizophrenia and Depression 
(NARSAD)
Dr. Mirrione 07/15/11 07/14/13 30,000
National Agriculture and Food Research 
Organization (Japan)
Dr. Hiraga 09/17/12 09/16/13 14,642 *
Mr. and Mrs. John C. Phelan Watson School of Biological Sciences 09/01/10 08/31/15 100,000
Damon Runyon Cancer Research 
Foundation
Dr. Sabin 01/01/12 12/31/14 52,000 *
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Sass Foundation for Medical Research Inc. Dr. Vakoc 11/01/10 10/31/12 $  8,752
Lauri Strauss Leukemia Foundation Dr. Kawaoka 09/01/12 08/31/13 10,000 *
The Swartz Foundation Dr. Zador 01/01/12 12/31/12 75,000 *
Drs. Koulakov/Wei 01/01/12 12/31/12 55,000 *
Drs. Kepecs/Hangya 01/01/12 12/31/12 55,000 *
Dr. Zador 01/01/12 12/31/12 15,000 *
The Swedish Society of Medicine Dr. Ohlund 10/08/12 12/31/12 8,300 *
Training Support
Clare College Undergraduate Research Program 06/01/12 05/31/13 5,645 *
The Lita Annenberg Hazen Foundation Undergraduate Research Program 05/01/08 04/30/18 10,000
Howard Hughes Medical Institute Undergraduate Research Program 06/01/12 05/31/13 8,250 *
William Townsend Porter Foundation Undergraduate Research Program 04/01/12 03/31/13 12,000 *
Steamboat Foundation Undergraduate Research Program 05/01/12 04/30/13 12,000 *
Trinity College Undergraduate Research Program 06/01/12 05/31/13 3,970 *
Course Support
Alzheimer’s Drug Discovery Foundation Workshop on Cognitive Aging 11/01/11 10/31/12 2,500
American Brain Tumor Association Brain Tumors 02/01/12 01/31/13 45,000 *
American Express Foundation Leadership in Bioscience 11/01/11 10/31/14 65,000
American Federation for Aging Research Workshop on Cognitive Aging 01/01/12 12/31/12 2,500 *
Carl Zeiss Microscopy, LLC Imaging Structure and Function in the 
Nervous System
06/15/12 06/14/13 5,000 *
The Ellison Medical Foundation Workshop on Cognitive Aging 05/01/12 04/30/13 15,000 *
Howard Hughes Medical Institute Course Support 01/01/07 12/31/12 600,000
Nancy Lurie Marks Family Foundation Workshop on Biology of Social 
Cognition
07/01/12 06/30/16 25,000 *
Roche Diagnostics Corporation Advanced Sequencing Technologies 
and Applications
02/01/12 01/31/13 30,000 *
Society for Neuroscience/International 
Brain Research Organization
Summer Neuroscience Course 07/01/12 06/30/13 17,210 *
Meeting Support
Abbott Laboratories Gene Expression and Signaling in the 
Immune System
04/01/12 03/31/13 3,000 *
Amgen, USA Molecular Pathways in Organ 
Development and Disease
09/01/11 08/31/12 5,000
Gene Expression and Signaling in the 
Immune System
04/01/12 03/31/13 5,000 *
Art Guild, Inc. Corporate Exhibitors 03/01/12 02/28/13 5,000 *
Clontech Laboratories, Inc. Single-Cell Analysis 11/01/12 10/31/13 5,000 *
The Company of Biologists LTD Molecular Pathways in Organ 
Development and Disease
09/01/11 08/31/12 7,898
Complete Genomics, Inc. Corporate Exhibitors 03/01/12 02/28/13 14,000 *
Constellation Pharmaceuticals Gene Expression and Signaling in the 
Immune System
04/01/12 03/31/13 2,000 *
Enzo Life Sciences Molecular Chaperones and Stress 
Responses
04/01/12 03/31/13 2,500 *
Exiqon, Inc. Corporate Exhibitors 03/01/12 02/28/13 500 *
Forest Research Institute Inc. Blood Brain Barrier 12/01/12 11/30/13 25,000 *
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The Gatsby Charitable Foundation 77th CSHL Symposium: The Biology 
of Plants
02/01/12 01/31/13 $  3,150 *
Gilead Sciences Inc. Retroviruses 05/01/12 04/30/13 12,500 *
Illumina, Inc. Corporate Exhibitors 03/01/12 02/28/13 19,000 *
Life Technologies Corporation Personal Genomes and Medical 
Genomics
12/15/12 12/14/13 10,000 *
March of Dimes Foundation Molecular Pathways in Organ 
Development and Disease
04/01/12 09/30/12 5,000 *
MedImmune, LLC Molecular Genetics of Bacteria 
and Phage
11/07/11 11/06/12 5,000
Merck Sharp and Dohme Corporation Molecular Pathways in Organ 
Development and Disease
03/01/12 02/28/13 15,000 *
Molecular Devices Corporation Corporate Exhibitors 03/01/12 02/28/13 5,000 *
Gordon and Betty Moore Foundation 77th CSHL Symposium: The Biology 
of Plants
02/01/12 01/31/13 10,000 *
Nature America Inc. Molecular Genetics of Bacteria 
and Phage
11/07/11 11/06/12 750
Novartis Pharmaceuticals Corp. PTEN Pathways and Targets 11/18/11 03/16/13 25,000
Christine O’Neil Corporate Exhibitors 03/01/12 02/28/13 6,000 *
Opgen, Inc. Corporate Exhibitors 03/01/12 02/28/13 7,000 *
Phytotechnology Laboratories Corporate Exhibitors 03/01/12 02/28/13 500 *
Promega Corporation Molecular Genetics of Bacteria 
and Phage
11/07/11 11/06/12 750
Martin Reese Corporate Exhibitors 03/01/12 02/28/13 4,000 *
Rutgers, the State University of New 
Jersey
Protein Data Bank 40th Anniversary 12/01/10 11/30/12 2,300
Society for Developmental Biology Molecular Pathways in Organ 
Development and Disease
09/01/11 08/31/12 4,000
Lemna Tec Corporate Exhibitors 03/01/12 02/28/13 2,500 *
Library Support
The Ellen Brenner Memorial Fund 12/15/12 12/14/13 2,000 *
The New York State Education 
Department
07/01/10 06/30/12 3,497
The New York State Education 
Department
07/01/11 06/30/12 16,584
Wellcome Trust 08/01/11 07/31/13 302,364
Library Meeting Support
Alfred P. Sloan Foundation 04/01/12 05/01/12 20,000 *
The Rockefeller University 04/01/12 03/31/13 15,000 *
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Grantor Program
Duration 
of Grant
2012 
 Funding†
FEDERAL GRANTS
National Science Foundation, 
University of Arizona
Educational Outreach for iPlant Collaborative: 
A Cyberinfrastructure for Plant Sciences
2/08–1/13 860,267
National Science Foundation, 
North Carolina State University
GEPR: Epigenome Dynamics during DNA Replication 3/11–2/13 73,108
National Science Foundation Advanced Technology Education (ATE) Program: Genomic 
Approaches in BioSciences
4/11–3/14 157,894
NONFEDERAL GRANTS
Victor Centers for Prevention 
of Jewish Genetic Diseases, 
Albert Einstein Healthcare 
Center/Marcus Jewish Genetic 
Disease Consortium
Gene Screen iPhone/iPad Application 12/10–12/12 31,900
Alfred P. Sloan Foundation DNA Barcoding Experiments by New York City High School 
Students (Urban Barcode Project)
1/11–7/12 74,533
Howard Hughes Medical 
Institute
Pre-College Science Education Initiative: NYC Teacher Professional 
Development
9/07–8/12 145,319
Dana Foundation Harlem DNA Lab Operating Support 3/09–2/12 27,700
William Townsend Porter 
Foundation
Scholarships for Minority and Underserved Students at Harlem 
DNA Lab
3/11–3/12 17,000
National Grid Foundation Scholarships for Minority and Underserved Students in the Central 
Islip Union Free School District
1/12 –12/12 15,000
Spinal Muscular Atrophy 
Foundation
Learn About SMA Internet site 4/11–4/13 78,965
The following schools and school districts each contributed $1,000 or more for participation in the Curriculum Study Program:
Elwood Union Free School District $ 1,500 Locust Valley Central School District 1,500
Fordham Preparatory School 3,000 Northport-East Northport Union Free School District 3,000
Great Neck Union Free School District 1,500 Oceanside Union Free School District 3,000
Half Hollow Schools Central School District 3,000 Port Washington Union Free School District 3,000
Herricks Union Free School District 1,500 Ramaz Upper School 1,500
Huntington Union Free School District 1,500 Sachem Central School District 3,000
Levittown Union Free School District 3,000 Yeshiva University High School for Girls 3,000
The following schools and school districts each contributed $1,000 or more for participation in the Genetics as a Model for 
Whole Learning Program:
Adelphi STEP $ 1,050 Lynbrook Union Free School District 1,000
Bay Shore Union Free School District 2,800 Merrick Union Free School District 3,400
Bellmore Union Free School District 2,800 M.S. 447, Brooklyn 1,800
Bellmore–Merrick Union Free School District 10,000 North Bellmore Union Free School District 2,600
Cold Spring Harbor Central School District 14,400 North Shore Central School District 1,750
Commack Union Free School District 6,900 North Shore Hebrew Academy 1,050
East Meadow Union Free School District 3,730 Oceanside Union Free School District 1,625
East Williston Union Free School District 2,900 Oyster Bay–East Norwich Central School District 5,625
Elwood Union Free School District 3,425 Plainedge Union Free School District 2,100
Floral Park–Bellerose Union Free School District 7,800 Port Washington Union Free School District 9,600
Friends Academy 2,100 Rockville Centre Union Free School District 6,240
Garden City Union Free School District 4,000 Roslyn Union Free School District 4,200
Great Neck Union Free School District 6,000 Sachem Union Free School District 2,925
Half Hollow Hills Union Free School District 9,150 Saint Dominic Elementary School 4,550
Herricks Union Free School District 2,275 Scarsdale Union Free School District 12,600
Hofstra STEP 1,050 Smithtown Union Free School District 1,680
Holy Child Academy 3,100 Syosset Union Free School District 36,600
IHM Home School Program 1,050 Three Village Central School District 4,200
Huntington Union Free School District 4,600 Trinity Regional School 1,300
Jericho Union Free School District 8,250 Valley Stream 13 Union Free School District 1,050
Locust Valley Central School District 8,859 Yeshiva of Flatbush 2,000
†Includes direct and indirect costs.
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BANBURY CENTER GRANTS
Grantor Program
Duration 
of Grant
2012 
Funding
FEDERAL SUPPORT
Centers for Disease Control and Prevention Decoding Clinical Trials to Improve Treatment 
of ME/CFS
2012 $18,440
NIH–National Institute of Mental Health The Fourth Annual NIMH Brain Camp 2012 35,662
National Science Foundation through a grant 
to Stony Brook University
Grand Challenges in Organismal Biology 2012 9,045
NONFEDERAL SUPPORT
Astellas-OSI Oncology Cell Plasticity in Cancer Evolution 2012 49,602
Baxter Healthcare Corporation Patenting Genes: New Developments, New Questions 2012 5,000
Boehringer Ingelheim Fonds Communicating Science 2012 50,549
Certerra, Inc. Systems Biology of Autism: From Basic Science to 
 Therapeutic Strategies
2012 4,266
CFIDS Association of America Decoding Clinical Trials to Improve Treatment 
of ME/CFS
2012 39,107
Cold Spring Harbor Laboratory Corporate 
Sponsor Program
Transcription and Cancer 2012 43,261
Cold Spring Harbor Laboratory Corporate 
Sponsor Program
Infl ammation, Cancer, and Metabolism 2012 46,068
Cold Spring Harbor Laboratory Library 
and Archives
Envisioning the Future of Science Libraries at 
Academic Research Institutions
2012 4,512
Cold Spring Harbor Laboratory/DuPont 
Pioneer Joint Collaborative
Plant–Environment Interactions 2012 50,000
Discovery Network Inspire2Live 2012 21,203
DRI Capital, Inc. Patenting Genes: New Developments, New Questions 2012 7,500
GangaGen, Inc. Phage and Phage-Based Therapies 2012 39,857
Genentech, Inc. Patenting Genes: New Developments, New Questions 2012 10,000
Individual participants The Fourth Annual NIMH Brain Camp 2012 8,070
Individual participants Patenting Genes: New Developments, New Questions 2012 1,335
Individual participants Emerging Approaches in Oncology: A Brainstorming 
Think Tank
2012 2,000
Individual participants Grand Challenges in Organismal Biology 2012 1,005
Individual participants Decoding Clinical Trials to Improve Treatment 
of ME/CFS
2012 2,982
Jones Day LLP Patenting Genes: New Developments, New Questions 2012 2,000
Kaye Scholer LLP Patenting Genes: New Developments, New Questions 2012 5,000
King & Spalding, LLP Patenting Genes: New Developments, New Questions 2012 5,000
Eli Lilly & Company Patenting Genes: New Developments, New Questions 2012 5,000
Haig R. Nalbantian Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 1,000
Novartis Pharma AG Patenting Genes: New Developments, New Questions 2012 5,000
Novo Nordisk Inc. Patenting Genes: New Developments, New Questions 2012 5,000
Pfi zer, Inc. Systems Biology of Autism: From Basic Science to 
Therapeutic Strategies
2012 5,000
Mr. and Mrs. Howard Phipps, Jr. Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 10,000
Marie Robertson Research Fund Systems Biology of Autism: From Basic Science to 
 Therapeutic Strategies
2012 20,000
Robertson Fund Systems Biology of Autism: From Basic Science to 
 Therapeutic Strategies
2012 10,000
The Rockefeller University Envisioning the Future of Science Libraries at Academic 
Research Institutions
2012 15,000
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Ropes & Gray Patenting Genes: New Developments, New Questions 2012 5,000
The Daniel and Joanna S. Rose Fund, Inc. Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 10,000
The Satenik and Adom Ourian Educational 
Foundation
Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 1,000
Simons Foundation Systems Biology of Autism: From Basic Science to 
T herapeutic Strategies
2012 10,000
The Alfred P. Sloan Foundation A History of the Human Genome Project 2012 50,000
The Alfred P. Sloan Foundation Envisioning the Future of Science Libraries at Academic 
Research Institutions
2012 20,000
University of Louisville, Brown Cancer 
Center
Regulation of Metabolism in Cancer 2012 45,625
University of Southern California, NCI 
Physical Sciences in Oncology Center
Emerging Approaches in Oncology: A Brainstorming 
Think Tank
2012 32,663
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CORPORATE SPONSOR PROGRAM 
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings 
program held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main 
Laboratory campus or at the  Banbury Center. Without the strong foundation provided by the 
Program, we could neither plan with confi dence for the year’s meetings nor introduce new and 
unusual topics.
We are especially grateful to the companies that joined us in 2012 as the economic diffi culties 
have persisted. The year 2013 is going to be especially challenging as the number of companies 
shrinks through takeovers, and companies and foundations adopt austerity measures. The mem-
bers of the Program receive special privileges in acknowledgment of their contributions. We waive 
all on-site fees for eight representatives of the Corporate Sponsors at our meetings. Three scientists 
from Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by 
invitation of the organizers. Member companies also receive gratis copies of Cold Spring Harbor 
Laboratory Press publications, including the journals Genes & Development, Learning & Memory, 
CSH Protocols, and Genome Research.
We acknowledge our Sponsors in all relevant publications, including the books of abstracts 
given to each of the 7000 participants who come to the meetings each year. The names of the 
sponsoring companies are listed on the poster describing the meetings, and this is mailed to ap-
proximately 17,000 scientists throughout the world. In addition, the companies are listed on the 
Cold Spring Harbor Laboratory website on the Meetings Offi ce and Banbury Center pages. Mem-
bers in 2012 were the following:
CORPORATE BENEFACTORS PLANT CORPORATE SPONSORS
Astellas-OSI Pharmaceuticals, Inc. Monsanto Company
 DuPont-Pioneer International, Inc.
CORPORATE SPONSORS 
Agilent Technologies, Inc. 
Bristol-Myers Squibb Company 
Genentech, Inc.
GlaxoSmithKline
Life Technologies
New England BioLabs, Inc.
Sanofi  US
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DEVELOPMENT
Capital and Endowment Campaign Support: 
Donations help to secure the fi nancial stability 
of CSHL and provide resources to expand the 
facilities and staff.
Research Support: Donations in specifi c areas 
of research help to increase the speed at which 
genetic discoveries are translated into diagnostic 
tests and therapeutics.
Annual Fund: Donations provide funding for 
some of the most innovative young researchers 
in science today and constitute an important in-
vestment in groundbreaking research in cancer, 
neuroscience, plant biology, and bioinformatics.
Science Education: Donations support pro-
grams at the DNA Learning Center and the 
Watson School of Biological Sciences, where the 
next generation learns about genetics in an excit-
ing and interactive environment.
Planned and Estate Gifts: Individuals who in-
form us of their intention to make a gift to CSHL 
from their estate are invited to become members 
of the Harbor Society. Estate gifts help to ensure 
that CSHL will continue to pursue its mission for 
many years to come.
For additional information, please contact Charlie Prizzi, Vice President for Development, Cold Spring Harbor Laboratory, 
One Bungtown Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6961. E-mail: prizzi@cshl.edu
With the support of our many generous donors, Cold Spring Harbor Laboratory had one of the 
most successful years in our history. For the fi rst time, more than $6 million was raised for unre-
stricted support. The 2012 Double Helix Medals dinner was also hugely successful as we honored 
Michael J. Fox, Art Levinson, and Mary Lindsay. In their unique ways, each of these individuals 
has made the world a better place, and we were very proud to recognize their achievements.
In July, John Cleary’s family and friends gathered to celebrate the dedication of a laboratory in his 
memory. The John P. Cleary Laboratory is located in the DeMatteis building and is home to Dr. 
Michael Wigler’s lab. John was involved with the Laboratory for many years as CSHL Associa-
tion’s President, Trustee, and then as an Honorary Trustee. His friendship to the Laboratory, the 
scientists, the employees, and all who walked on our grounds will never be forgotten.
With support from the Lustgarten Foundation, Cold Spring Harbor Laboratory welcomed 
Dr. Dave  Tuveson, one of the world’s most preeminent researchers and clinicians in the fi eld of 
pancreatic cancer research. Dave was formerly at the Cancer Research UK Cambridge Research 
Institute, and he came to the Laboratory to direct our Cancer Therapeutics Initiative. This ambi-
tious initiative will focus on moving advanced-stage drug candidates from the laboratory to the 
clinic. With more space needed to accommodate sophisticated technology and additional people, 
plans are set to expand our Woodbury facility. We will be breaking ground on the project in the 
second quarter of 2013.
All our successes during this past year could not have happened without the support of our donors 
and we are extremely thankful for all of their contributions.
  Charles V. Prizzi, Vice President for Development
Cold Spring Harbor Laboratory is a nonprofi t research and educational institution chartered by 
the State of New York. Less than half of the Laboratory’s annual revenues are derived from federal 
grants and contracts, and thus, it relies heavily upon support from the private sector: foundations, 
corporations, and individuals. CSHL takes this occasion to sincerely thank each and every donor 
whose generous contributions have made possible the discoveries we report in this publication. 
There are a variety of ways to give to the Laboratory:
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President’s Council
This year’s topic—Ethical Dilemmas in Medicine—enabled us to shine light on CSHL’s human 
genetics research, strides that we are making in cancer profi ling, and the Laboratory’s early role in the 
20th-century eugenics movement. Three of our October talks were presented by key CSHL individu-
als: Dave Micklos, founder and head of CSHL DNA Learning Center; David Spector, CSHL Direc-
tor of Research; and Lloyd Trotman, Assistant Professor of cancer research. Gholson Lyon, M.D., 
PhD., a new CSHL Assistant Professor of neuroscience, spoke at the Council reception in May hosted 
by Claudia and Gunnar Overstrom in their magnifi cent New York City apartment.
Dartmouth Professor H. Gilbert Welch, M.D., opened the October meeting with a captivating pre-
sentation on the downside of routine preclinical medical screening. Saturday talks featured a thought-
ful lecture on informed consent of incapacitated human subjects and the ethics of gene patenting. In 
addition, an extraordinary keynote lecture by Andrew Solomon moved most of our guests to tears 
with his moving account of the love and special meaning that parents fi nd in raising children who are 
different, the topic of his newest book Far from the Tree: Parents, Children and the Search for Identity.
President
Bruce Stillman
Chairpersons
Howard L. Morgan
Cynthia R. Stebbins
Members
Dr. and Mrs. Lalit Bahl
Mr. and Mrs. Roger L. Bahnik
Ms. Jamie Nicholls and 
Mr. Fran Biondi
Mr. and Mrs. David Boies
Mr. and Mrs. Hans E.R. Bosch
Ms. Louise Parent and Mr. John 
Casaly
Mr. and Mrs. Richard M. Cashin
Dr. Gerald Chan
Mr. and Mrs. Edward A. Chernoff
Mr. and Mrs. Roderick H. 
Cushman
Mr. and Mrs. Norris W. Darrell
Mr. and Mrs. Yves C. de Balmann
Mr. and Mrs. Geoffrey de Lesseps
Mr. Martin Elias
Ms. Carol Feil
Mr. and Mrs. Robert A. Gay
Mrs. Allen A. Goldring
Dr. Leo A. Guthart
Mr. Matthew Haines
Mrs. Charles E. Harris II
Mr. and Mrs. Ira Hazan
Mr. Harvey L. Karp
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. Peter J. Klein
Mr. and Mrs. David M. Knott
Mr. David H. Koch
Dr. Betsy and Mr. Bryan 
H. Lawrence
Mr. and Mrs. Richard Leeds
Mr. and Mrs. Thomas D. Lehrman
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
Mrs. Nancy Abeles Marks
Dr. Marcia Kramer Mayer
Drs. Laurie J. Landeau and 
Robert Maze
Dr. Gillian and Mr. Eduardo Mestre
Mr. and Mrs. William R. Miller
Mr. and Mrs. Thomas A. Moore
Dr. and Mrs. Howard L. Morgan
Mr. and Mrs. Douglas P. Morris
Mr. and Mrs. John C. Phelan
Mr. Thomas C. Quick
Drs. Maria and Charles Ryan
Mr. and Mrs. Arthur J. Saladino
Ms. Susan Wasserstein and Mr. 
George Sard
Mr. and Mrs. Alan Seligson
Drs. Marilyn and James Simons
Ms. Loren Eng and Mr. Dinakar 
Singh
Mr. and Mrs. Harry Slatkin
Mr. Andrew Solomon and Mr. 
John Habich Solomon
Mr. and Mrs. Erwin P. Staller
Mr. and Mrs. Theodore R. Stanley
Mr. and Mrs. James F. Stebbins
Dr. and Mrs. Charles L. Stone, Jr.
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz
Mr. and Mrs. Paul J. Taubman
Mrs. Robert W. Tilney
Mr. and Mrs. Howard J. Tytel
Dr. and Mrs. James D. Watson
Mr. Roy J. Zuckerberg
Fran Biondi, Russell Byers, Casey Cogut, and 
Ian Snow
President’s Council speaker, Andrew Solomon 
signing copies of his books for attendees
Freddie Staller, Gilbert Welch, and Erwin Staller
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Cold Spring Harbor Laboratory Association
With 1200 members, the Cold Spring Harbor Laboratory Association (CSHLA) continues to 
increase community awareness of CSHL, and this year they helped raise more than $6 million in 
unrestricted support for the Laboratory. Events spearheaded by the Directors of the Association 
included Labapalooza, the 77th Symposium dinner parties, the Women’s Partnership for Science 
luncheon, and a variety of receptions and dinners that introduced new friends to the exception-
ally talented young scientists at CSHL. Members also had a signifi cant role in the success of the 
Double Helix Medals Dinner in New York City and the 19th annual golf tournament at the Pip-
ing Rock Club. Special thanks go to Sandy Tytel, president, as she continues to enthusiastically 
lead the CSHLA directors to new levels of participation.
2012 CSHLA Directors
Directors
Executive Committee Offi cers
Sandy Tytel, President
Frank O’Keefe, Vice President
W. Fifi eld Whitman, Vice 
President
James A. Woods, Treasurer
Pearl F. Staller, Secretary
Elizabeth Ainslie
Hans E.R. Bosch
Michele Munn Celestino
Edward A. Chernoff
Maria de Lesseps
Nelson DeMille
Charles B. Goodwin, M.D.
Carolyn Gulotta
Nancy Lippman 
Israeli, M.D.
Joel J. Kassimir, M.D.
Kassahun Kebede
Virginia Knott
Laureen Stanton Knutsen
Suzanne Leeds
Timothy Q. O’Neill
Lauryl Palatnick
David Peikon
Olga Pharr
Whitney F. Posillico
Charles S. Ryan, J.D., Ph.D.
Tracey DeMatteis Serko
Debbie Parmet Sondock
Heather Lane Spehr
Lara S. Trafelet
Marjorie J. van de Stouwe, M.D.
Honorary Directors
Mary D. Lindsay
Anne R. Meier
Cathy Cyphers Soref
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Cold Spring Harbor Laboratory Corporate Advisory Board
The Corporate Advisory Board (CAB) is a vital liaison between Cold Spring Harbor Laboratory 
and the tri-state business community. Established more than 20 years ago, the CAB is the driving 
force behind the Laboratory’s annual golf outing at Piping Rock Club; this outing raises critical 
unrestricted funding for research and educational programs.
Serving as CAB Chair for more than 10 years and Golf Chair for 6 years, Eddie Chernoff con-
tinues to provide leadership and support and we truly appreciate all of his efforts.
Corporate Advisory Board
Chairperson: Edward A. Chernoff, MARS
CSHL Trustee Liaison: Laurie Landeau, V.M.D.
Michael Aboff, Aboff ’s Inc.
Paul Amoruso, Oxford & Simpson 
Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale 
Sotheby’s International Realty
Jeffrey Carstens, Capital One
Richard A. Catalano, KPMG, L.L.P.
Jonathan Connors, Wells Fargo
Marian Conway, New York Community 
Bank Foundation
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall 
Corporation
David Epstein, Ph.D., OSI 
Pharmaceuticals, Inc.
Kevin Foley, Fidelity
Brian Fox, McKinsey & Company
Brian Goldstein, M.D.
Lawrence Goodman, Curtis, 
Mallet-Prevost, Colt & Mosle L.L.P.
Mary Jane Helenek, Luitpold 
Pharmaceuticals
Diana Hoadley, JP Morgan
Robert Isaksen, Bank of America
M. Patricia Janco
Neil M. Kaufman, Abrams Fensterman
John C. Kean III, Kean Development 
Corporation
Norman Kelker, Enzo BioChem
Robert Keller, National Grid Foundation
Amy Koreen, M.D.
Victoria Meagher
John Molloy, H2M Group
Rob Palatnick, DTTC
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sotheby’s 
International Realty
Stephen Ross, Ph.D., Nikon Instruments
Raju Sarwal, M.D.
Kurt Timmel, Marsh USA
Edward Travaglianti, TD Bank
Andrew Whiteley, Enzo BioChem
Hans Zobel
CAB Chairman Eddie Chernoff with his wife Donna and Drs. Mona 
and David Spector
CAB member Michael Aboff and his son Matthew present a check to 
Dr. Bruce Stillman for breast cancer research
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Honor Roll of Donors
Contributions of $5 million+ lifetime
Anonymous
The Donald Everett Axinn Trust*
The Arnold and Mabel Beckman 
Foundation
Jamie Nicholls and Fran Biondi*
Mr. and Mrs. David Boies*
The Breast Cancer Research Foundation
Mr. and Mrs. Landon T. Clay
The Dana Foundation
Dart Neurosciences LLC
Kathryn W. Davis
The DeMatteis Family Foundation*
Mr. and Mrs. Charles F. Dolan–Dolan 
Family Foundation
The William Stamps Farish Fund*
The Hon. and Mrs. Leon Polsky–Hazen 
Polsky Foundation*
Howard Hughes Medical Institute*
W.M. Keck Foundation
Mr. and Mrs. David H. Koch*
Laurie Landeau Foundation LLC*
Mr. and Mrs. Robert D. Lindsay and 
Family*
The Lustgarten Foundation*
Lucille P. Markey Charitable Trust
Nancy Abeles Marks
The Don Monti Memorial Research 
Foundation*
New York State Empire State 
Development Corporation
The Quick Family
The Robertson Family–Banbury Fund
Marilyn and Jim Simons*
The Simons Foundation*
Diana Davis Spencer Foundation 
(formerly The Kathryn W. Davis 
Foundation)*
Mr. and Mrs. Theodore R. Stanley–The 
Stanley Medical Research Institute*
The Starr Foundation
GEN*NY*sis grant from the New York 
State Dormitory Authority
Mr. and Mrs. Henry Wendt III
Gifts of $100,000 or $1 million+ 
lifetime
Paul G. Allen Foundation*
Angel Foundation
Anonymous (4)*
Gonzalo Río Arronte Foundation
Bristol-Myers Squibb Company
Burroughs Wellcome Fund
The Carson Family Charitable Trust*
The H.A. and Mary K. Chapman 
Charitable Trust and The Mary 
K. Chapman Foundation*
Mr. and Mrs. Norris W. Darrell
Michel David-Weill
Ira W. DeCamp Foundation
Edward P. Evans Foundation*
Charitable Lead Annuity Trust Under the 
Will of Louis Feil
The Samuel Freeman Charitable Trust
Coleman Fung Foundation
Mr. Robert A. Gay
Genentech, Inc.*
Kenyon Gillespie
Jacob Goldfi eld*
Lola Goldring
The Florence Gould Foundation
The Grace Family
Leo A. Guthart*
The Harrison Foundation and The Mary 
Anderson Harrison Foundation
The Thomas Hartman Foundation for 
Parkinson’s Research
Janet Strauss and Jeff Hawkins
Jo-Ellen and Ira Hazan
William Randolph Hearst Foundation
The Karches Foundation
Estate of Gale Kavaliauskas
F.M. Kirby Foundation, Inc.
Mr. and Mrs. Walter B. Kissinger*
Mr. and Mrs. John Klingenstein–The 
Esther A. & Joseph Klingenstein 
Fund, Inc.
Mrs. Townsend J. Knight
The Forrest C. and Frances H. Lattner 
Foundation
Mara and Thomas Lehrman
The Lehrman Institute
Mr. and Mrs. Stephen M. Lessing
Mary D. Lindsay
The Litchfi eld Charitable Trust
Estate of Elisabeth Sloan Livingston
Mr. and Mrs. David L. Luke III
Josiah Macy, Jr. Foundation
The G. Harold & Leila Y. Mathers 
Charitable Foundation*
Melanoma Research Alliance*
Gillian and Eduardo Mestre
Mr. and Mrs. William R. Miller
Dr. and Mrs. Howard L. Morgan*
Louis Morin Charitable Trust
Estate of Thomas C. Nelson
William C. and Joyce C. O’Neil 
Charitable Trust*
OSI Pharmaceuticals, LLC
The Pew Charitable Trusts
Mr. and Mrs. John C. Phelan*
William and Maude Pritchard Charitable 
Trust
Prostate Cancer Foundation*
Fannie E. Rippel Foundation
The Robertson Foundation
Mr. and Mrs. David M. Rubenstein
Eleanor Schwartz Charitable Foundation*
Edith and Alan Seligson*
The Seraph Foundation
Mr. and Mrs. Herbert J. Siegel
Alfred P. Sloan Foundation
CSHL Trustee Leo Guthart (left) with Jim Simons
*Denotes multiyear commitment
The Don Monti Memorial Research Foundation provides critical support to 
CSHL’s cancer research program. Featured are President Caroline Monti- 
Saladino and Chairmen Richard Monti (left) and Artie Saladino
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President’s Council speaker Andrew Solomon 
with his father, Howard Solomon
Mr. and Mrs. Joel E. Smilow
Mr. and Mrs. Howard Solomon
St. Giles Foundation
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz–Swartz Charitable 
Trust
Swim Across America Nassau/Suffolk
Waclaw Szybalski, D.Sc.
Mr. and Mrs. Paul J. Taubman*
The V Foundation for Cancer Research*
Dr. and Mrs. James D. Watson
Whitehall Foundation*
The Roy J. Zuckerberg Family 
Foundation
Gifts of $50,000+
Elizabeth and Lee Ainslie
American Express Foundation*
Anonymous
Kavita and Lalit Bahl
Mr. and Mrs. Richard M. Cashin
Mr. and Mrs. Edward A. Chernoff–MARS*
Casey and Ellen Cogut
Mr. and Mrs. Roderick H. Cushman
Joni Gladowsky Breast Cancer Foundation
Mr. and Mrs. Louis Jagoda
The Charles and Ann Johnson Foundation
The Karp Foundation
Mr. and Mrs. David M. Knott
Betsy and Bryan H. Lawrence
Marc and Jennifer Lipschultz
Breast Cancer Awareness Day in memory 
of Elizabeth McFarland
Doug and Monique Morris
The Sass Foundation for Medical 
Research, Inc.*
Freddie and Erwin Staller
The Thompson Family Foundation, Inc.
Mr. and Mrs. Howard J. Tytel
Wodecroft Foundation
Gifts of $25,000+
The Bahnik Foundation, Inc.
Pien and Hans Bosch
Dr. and Mrs. Herbert W. Boyer
Louise Parent and John Casaly
Lester Crown*
Mr. and Mrs. Yves C. de Balmann
Maria and Geoff de Lesseps–Alpha/
Omega Charitable Foundation, Inc.
John M. Desmarais
Ike, Molly and Steven Elias Foundation
Claire Friedlander Family Foundation
The Gilder Foundation
Mr. and Mrs. Ronald Gottlieb
The Marc Haas Foundation
The Irving A. Hansen Memorial 
Foundation
Susan T. Harris
The Hastings Foundation, Inc.
Hearts for Cancer
Mr. and Mrs. J. Tomilson Hill III
Drs. Nancy and Ron Israeli
Annette Kade Charitable Trust
The Fay J. Lindner Foundation*
Long Island 2 Day Walk to Fight Breast 
Cancer
Nancy Lurie Marks Family Foundation
Dr. Marcia Kramer Mayer
The Morningside Foundation
The Pershing Square Foundation
Pfi zer, Inc.
William Townsend Porter Foundation
Thomas C. Quick
Amy Falls and Hartley Rogers
Dr. Charles Ryan–Forest Laboratories, Inc.
Susan Wasserstein and George Sard
Mr. and Mrs. Irwin Sicherman
Loren Eng and Dinakar Singh
Laura and Harry Slatkin
Mr. and Mrs. James F. Stebbins
Uta von Schwedler Prize
Elisabeth R. Woods Foundation
Gifts of $10,000+
Aboff ’s
Alexandria Real Estate Equities, Inc.
Amy Anthony
Mr. and Mrs. Louis Moore Bacon
The Bank of America Charitable 
Foundation, Inc.
JoAnn and Morgan Browne
Trudy and Tom Calabrese
Mr. and Mrs. George W. Carmany III
Michele and Jim Celestino
Dr. and Mrs. Bayard Delafi eld Clarkson
Rita M. Cleary
Samara P. Cohen
Cutler Family Education and Animal 
Welfare Fund
Davidson Kempner Capital Management 
LLC
Dan Decker–Eppendorf North America
Drs. Stephen and Pamela Hurst-
DellaPietra
Barbara J. Amonson and Vincent J. 
DellaPietra
Drs. Miki and David Donoho
Farrell Fritz, P.C.
Fortunato Sons Contracting, Inc.
Brian Fox–McKinsey & Company
Glen Cove C.A.R.E.S.
Dr. and Mrs. Charles B. Goodwin
Google, Inc.
Oliver R. Grace, Jr.–OBX
Michael J. Griffi n
Mr. and Mrs. Thomas Campbell 
Jackson–The Zeitblom Fund
Paul E. Jefferson
Kappa Alpha Order
Dr. and Mrs. Joel J. Kassimir
The Kebede Family Foundation
Laureen and Ragnar M. Knutsen
Suzanne and Richard Leeds
CSHL researchers Mikala Egeblad and Nick Tonks with Jason Gladowsky and Alison 
Gladowsky of the Joni Gladowsky Breast Cancer Foundation
*Denotes multiyear commitment
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Amanda and Tom Lister
Long Island Cruizin’ for a Cure
Edward E. Matthews
Mirus Bio LLC*
The Tom and Judy Moore Foundation
National Grid Foundation
Nikon Instruments, Inc.
Susanne C. Olin–Olin Family 
Foundation
Wendy O’Neill
Lauryl and Robert Palatnick
Dr. and Mrs. John G. Passarelli
David P. Pearson
Patricia Petersen–Daniel Gale Sotheby’s 
International Realty
Whitney Posillico
Mr. and Mrs. Thomas W. Purcell
Mr. and Mrs. John R. Reese
Christina Renna Foundation, Inc.
Constance Silveri
Deborah K. Solbert
Steamboat Foundation
The Lauri Strauss Leukemia Foundation
TD Bank
Mr. and Mrs. Alan P. Thomas
Joan P. Tilney
Mr. and Mrs. Remy W. Trafelet
Wilhelmus Johannes Van der Goes
Paul and Robin Vermylen
West Islip Breast Cancer Coalition for 
Long Island, Inc.
Michael and Deedee Wigler
Ann Eden Woodward Foundation
The Bradley Zankel Foundation, Inc.
The Zeldis Family Charitable Fund
Gifts of $5,000+
The Ashton Foundation
Mr. and Mrs. W. Dillaway Ayres, Jr.
Banfi  Vintners Foundation
Mr. and Mrs. Dominic P. Bencivenga
Tim and Lisa Broadbent
**Helen M. Brooks*
Barbara and Christopher Callaghan
David T. Cleary
Mr. and Mrs. Jonathan Connors
Cottage Pharmacy & Surgical
Mr. and Mrs. Richard T. Cunniff
Craig E. Dallmeyer
Sandy and Nelson DeMille
Lee MacCormick Edwards, Ph.D.
Bob and Diane Fagiola
Michael L. Focazio–Carissa Maringo 
Fund
James A. Greer II*
Dr. and Mrs. Ronald J. Gulotta
H2M
The Randall and Mary Hack Foundation
Robin T. Hadley
Walter J. Hawrys
Dr. Mark Hoffman
J. Fallon’s Tap Room
Irving F. Jensen, Jr.
Andrew and Peggy Kahn
Kean Development Company
Andrea B. and Peter D. Klein
Suzanne and Richard Kleinknecht
Henry and Marsha Laufer
George N. Lindsay, Jr. and Nancy Metz
Peter Lindsay and Katie Murphy
Steve and Jo Lindsay
Mr. and Mrs. Robert W. Lourie
Luitpold Pharmaceuticals, Inc.
John and Bridget Macaskill
Mrs. David J. Mahoney
Carol Marcincuk Fund
Robert L. Marcus
Jeff and Mickie Nagel and Family
National Basketball Association
New York Community Bank Foundation
NMS Management
Ashley and Frank O’Keefe
Mr. and Mrs. George D. O’Neill
Mr. and Mrs. Timothy Q. O’Neill
Panera Bread
Mr. and Mrs. Simon Pharr
Mrs. Richardson Pratt, Jr. and Family–
The Spionkop Charitable Trust
Nicole and Charlie Prizzi
Mr. and Mrs. Preston V. Pumphrey
Patricia Quick
Mr. and Mrs. Peter Quick
Dr. Amy Rappaport Koreen and Dr. 
Judith Rappaport
Diane Emdin Sachs Memorial Walk
Anne McMillen and Benno C. Schmidt
Schwab-Silfen Foundation
Mr. and Mrs. Jonathan R. Serko
Mr. and Mrs. Michael Shoff
Mr. and Mrs. Owen T. Smith
Mary F. Smith Family Foundation
Hope and Ted Smith
Debra Parmet Sondock and Cliff Sondock
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. Richard A. Spehr–Mayer 
Brown LLP
Mr.** and Mrs. Arthur M. Spiro
Lee Steinberg
Grace and Bruce Stillman
Daniel B. Strickler, Jr.
Mr. and Mrs. Edward Travaglianti
John B. Vermylen
Holle von Schwedler
Marjorie M. von Stade
Mr. and Mrs. W. Fifi eld Whitman
The Worthington Charitable Foundation
Gifts of $2,500+
Mr. and Mrs. Robert H.B. Baldwin
Fred H. Baron
Dilworth & Barrese, LLP
Constance Bernstein, D.D.S.
Bliss Pest Protection Services, LLC
Dr. Steven Brenner*
M.J. Otsea and Richard H. Brown
Mr. and Mrs. William J. Candee III
Mrs. Robert L. Clarkson, Jr.
Mr. and Mrs. Glenn G. Cohen
Jim and Nancy Cook
*Denotes multiyear commitment
**Deceased
Rich and Heather Spehr at Labapalooza
Jennifer and Marc Lipschultz with Ellen Cogut
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Kristina and Harry Davison
Deutsche Bank
Mr. and Mrs. Joseph T. Donohue
Dvirka & Bartilucci Consulting 
Engineers
Fidelity Investments
Christopher A. Forster
Michael J. Fox and Tracy Pollan
G & M Earth Moving, Inc.
Margaret M. Hargraves
James B. Hicks, Ph.D.
Diana Hoadley
Johnston Family Foundation
Norman Kelker-Enzo Biochem, Inc.
KPMG LLP
Steven J. Kumble
The Litwin Foundation
Mr. and Mrs. Michael G. Mandelker
Neil and Amy McGoldrick
Oheka Castle Hotel & Estate
Mr. and Mrs. Gunnar S. Overstrom III
Oxford & Simpson Realty Svcs., Inc.
Mr. and Mrs. Jeffrey Pash
David Rockefeller
Miriam K. Rothenberg
Pamela & Richard Rubinstein Foundation
Frank and Lari Russo
Ruth Sagenschneider
Mr. and Mrs. Walter Scott
Samuel L. Stanley, Jr., M.D. and Ellen Li, 
M.D., Ph.D.
Mary Stolfa Cancer Foundation
Doris M. and Peter S. Tilles Foundation
Mr. and Mrs. Stanley S. Trotman, Jr.
Drs. Marjorie van de Stouwe and 
Scott J. Ratner
Sophie von Schwedler
Almut von Schwedler
The von Schwedler Family
Mr. and Mrs. Douglas A. Warner
Stuart and Leslie Weisbrod
Lise and Jeffrey Wilks
The Diane and Howard Wohl Family 
Foundation, Inc.
Gifts of $1,000+
Mr. and Mrs. Robert J. Adams
Advantage Title Agency, Inc.
Dr. Christopher R. Aiken
Erica and Henry Babcock
Mr. and Mrs. David L. Banker
Rose Ann Bencivenga
Dr. and Mrs. Arthur M. Bernhang
William Bernhard and Catherine Cahill
Gene and Pam Bernstein–PGJM 
Foundation
Dr. and Mrs. Giuseppe Bertani
Jan and Don Bettencourt
Mr. and Mrs. Xerxes K. Bhote
Sarah and Chris Blundin
David Botstein
Dr. William Braden III–Porter Braden 
Endowment Fund
Elizabeth B. Borden–Katharine Bradford 
Foundation
W. Murray Buttner
Nancy and Frank Bynum–The Bynum 
Family Foundation
Ann and Peter B. Cannell
Carol and Stephen Canter
Dr. Andrea R. Carlsen
Muffy and Bob Carlstrom
Jane H. Choate
Chubb Group of Insurance Companies
David C. Clark
Jean and Stephen Cleary
Mark D. Cleary
Mr. and Mrs. William A. Cleary, Jr.
James W. Cleary
Sharon Cleary
Donald K. Clifford, Jr.
Cosel-Pieper Family Foundation
Susan Tysk-Cosgrove and David 
Cosgrove
Curtis, Mallet-Prevost, 
Colt & Mosle LLP
2012 Double Helix honorees Michael J. Fox with his wife Tracy Pollan, Mary 
Lindsay and Art Levinson with Board Chair Jamie Nicholls and  President 
Bruce Stillman
Joshua Bell, Michael J. Fox and Jim Watson at the 2012 Double Helix 
Medals Dinner
Maureen Brennan, Isobel Coleman, Bruce Stillman, Gabrielle Bacon, Arianna Boardman 
at the Women’s Partnership for Science Luncheon
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Mr. and Mrs. Curtis Cushman
Lucy P. Cutting
David and Ide Dangoor
Mr. and Mrs. David H. Deming
Meleanor and Donald Deming
Mr. and Mrs. Jack DiMaio
Dr. and Mrs. Thomas J. Dowling, Jr.
Dr. Lester Dubnick
Carol Durkin
Electronix Systems Central Station 
Alarms, Inc.
Johnston and Lisa Evans
Donald Eversoll
Dr. Robert and Marjorie Feeney
James R. Feramisco
Douglas and Christine Fox
Mr. and Mrs. Roger Fradin
E. Maxwell Geddes, Jr.
**Robert Joy Glaser, M.D.
Mr. and Mrs. William H. Grover
Frank and Lynn Gundersen
Rev. Linda Peyton Hancock
Gil and Sheila Henoch
Allan and Carole Herzog
Mr. and Mrs. Joseph Heyenoort–Cold 
Spring Motors
Lori and Chris Homer–A.L.L. Caring 
Foundation
Theodora W. Hooton
Mr. and Mrs. Robert E. Hughes
Joan M. Hutchins
Frederic B. Ingraham
Virginia P. Jacobsen
Stephen Juelsgaard
Dolores Fredrich and Jeffrey Keller
Edward M. Lamont
Mr. and Mrs. James Large
Claudia Lawrence
Mr. and Mrs. Anthony V. Leness
Brett MacInnes
Mr. and Mrs. Patrick H. Mackay
Mr. and Mrs. Robert G. MacLean
Kevin G. Mahony
Simone Mailman
Mr. and Mrs. John Maroney
Marsh USA, Inc.
Marshs
Victoria S. Meagher
Mercer Health & Benefi ts LLC
MetLife
Dr. Jeffrey H. Miller
Leo Model Foundation
Mrs. Keith M. Moffat
Kathleen Mooney
John Moore
Mr. and Mrs. Stephen J. Moore
Catherine Moraetis
Mr. and Mrs. Francis W. Murray III
Mr. and Mrs. Paul Napoli
Richard P. and Faye Nespola Charitable 
Foundation
New England Foundation
Mr. and Mrs. James H. Norris
Dr. Larry Norton
Mr. and Mrs. Michael S. O’Brien
Hugh & Patricia O’Kane Family 
Foundation
Mr. and Mrs. Richard S. Overton
Tracy Dellomo and Clifford 
Packingham
Anthony Panebianco
Rhoda Parmet
Mr. and Mrs. Nicholas B. Paumgarten
Dave and Terry Peikon
Cecile Pickart Student Travel Award
Louise S. Pickart
Mr. and Mrs. Robert A. Pilkington
Carol and George C. Pratt
Mark Ptashne and Lucy Gordon
Mr. and Mrs. Thomas L. Pulling
K.J. Quinn Charitable Foundation
Curtis S. Read
Russell S. Reynolds, Jr.
Mr. and Mrs. Arthur M. Rogers, Jr.
Susan & Elihu Rose Foundation, Inc.
Michele Rosenberg
Mr. and Mrs. J. Wright Rumbough, Jr.
Drs. Maria and Charles S. Ryan
Raju Sarwal, M.D.
Mr. and Mrs. Lee Schalop
Robin and Enrique Senior
Dr. Jack Skalicky
Mr. and Mrs. Trevor A. Smith
Drs. Mona and David Spector
Mr. and Mrs. James L. Spingarn
Dr. Wesley I. Sundquist
Judith and Irwin Tantleff
Mrs. David S. Taylor
Pamela M. Thye
Mr. and Mrs. Bart T. Tiernan
Lynn and Pat Tone
Robert H. Trust and Sarah Vermylen 
Trust
George Vande Woude
Helene P. Victor
Jackie and Warren Wasp
Mr. and Mrs. Ted Weiss
Mr. and Mrs. Karl G. Wellner
Neil Westreich
Gerald I. White
Wolfensohn Family Foundation
**Deceased
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CORPORATE AND FOUNDATION MATCHING GIFT CONTRIBUTORS
American Express Charitable Fund
American Express PAC Match Program
Bank of America Matching Gifts
Bristol-Myers Squibb Foundation
Dow Jones & Company, Inc.
FBR Capital Markets Charitable Foundation
Honeywell Matching Gift Program
iStar Financial, Inc.
The J.P. Morgan Chase Foundation
McKinsey & Company, Inc.
David and Lucile Packard Foundation
Pfi zer Foundation 
RLI Charitable Fund
United Way of New York City
Wells Fargo Foundation
IN HONOR OF
Elinor Bettencourt
Jamie Nicholls and Fran Biondi
Bonnie and Steve Brenner
Eddie Chernoff
Rhonda Federman
Jessie Friedman’s Bat Mitzvah
Dr. Candido Fuentes
Mary Goldberg
Mrs. Oliver R. Grace
Dr. Nancy Israeli
Suzanne Leeds
Mary D. Lindsay
Cathryn MacInnes
Justin Rosati
Scheman-Villani
Edith Seligson
Drs. Marilyn and James Simons
Page Underwood
Dr. James D. Watson
Dr. Michael Wigler
Dr. Jan Witkowski
IN MEMORY OF
Elaine Abrams
T.J. Arcati
C. A. Beach
Anthony Biondolillo
Richard Blackman
Patricia Boudreau
Ellen Brenner
Ahmad Bukhari
Carol A. Buonaiuto
Robert Cafferkey
Mark A. Calace
Patricia May Duke Card
Josephine and Ted Chodkowski
John P. Cleary
Tina Duque Corbett
Randie Switko Delmont
Dr. Milislav Demerec
George and Evelyn Diehl
James Eisenman
Daniel Fishman
Ardell Bierman Fox
Albert L. Freedman
Paul Garrett
Nancy Slaughter Gay
Joni Gladowsky
Dr. Christopher G. Goff
Teresa Haire
Skip Hargraves
Walter Hein
Dr. Andy Kaplan
Townsend Knight
Lydia A. Krawec
James Laas
Cathy Lipstein
Lisa MacInnes
Carol Marcincuk
Carissa Maringo
Elizabeth McFarland
Steven Michalik
Rose M. Mooney
Monica Mowery
Donald J. Parmet
Dr. Cecile Pickart
Dorothy Pirozzi
G. Jeffrey Poletti
Christina Renna
Elizabeth Roberts
Dolores Ann Roman
Dr. Susan Rose
Diane Edmin Sachs
Howard Roy Schwartz
Iris Schwartzman
Martha Seidel
Andrew Seligson
Arnold Stanley Solomon
Becky Stephens
Edward M. Thomas
Harold Umansky
Linda Vernam
Dr. Uta von Schwedler
Fay Wallace
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 2012 2011
Assets:
 Cash and cash equivalents $  75,471,404 58,055,329
 Grants receivable 10,012,401 5,733,104
 Contributions receivable, net 145,289,626 163,144,645
 Publications inventory 2,767,427 3,292,898
 Investments 296,611,329 269,786,326
 Restricted use assets 3,597,846 2,882,590
 Other assets 15,891,942 15,027,787
 Land, buildings, and equipment, net 240,625,332  241,828,796
Total assets $  790,267,307  759,751,475
Liabilities and net assets:
 Liabilities:
 Accounts payable and accrued expenses $  10,456,412 11,135,584
 Deferred revenue 5,258,525 5,467,566
 Interest rate swap 35,556,347 37,726,697
 Bonds payable    97,200,000 97,200,000
  Total liabilities  148,471,284  151,529,847
 Net assets:
 Unrestricted 243,281,390 205,967,407
 Temporarily restricted 293,464,158 298,351,339
 Permanently restricted  105,050,475  103,902,882
  Total net assets  641,796,023 608,221,628
Total liabilities and net assets $   790,267,307  759,751,475
FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET 
December 31, 2012
(with comparative ﬁ nancial information as of December 31, 2011)
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  Temporarily Permanently 2012 2011
 Unrestricted Restricted Restricted Total Total
Revenue and other support:
Public support–contributions and 
 nonfederal grant awards $ 19,618,621 40,079,983 1,147,593 60,846,197 113,684,017
Federal grant awards 28,711,510 –- --- – ---- 28,711,510 34,490,267
Indirect cost allowances 24,445,726 –- ---- – ---- 24,445,726 25,623,148
Investment return utilized 23,396,825 – ----- – ---- 23,396,825 22,585,474
Program fees 8,049,856 – ----- – ---- 8,049,856 6,963,110
Publications sales 10,957,863 – ----- – ---- 10,957,863 9,848,446
Dining services 4,614,691 – ----- – ---- 4,614,691 4,309,694
Rooms and apartments 3,770,473 –- ---- – ---- 3,770,473 3,345,273
Miscellaneous 2,527,870 –- ---- – ---- 2,527,870 3,745,958
Net assets released from restrictions   58,423,282   (58,423,282)            – ----            – ----              –  ---  
Total revenue and other support  184,516,717   (18,343,299)      1,147,593  167,321,011  224,595,387  
Expenses:
Research 88,821,283 –- ---- –- --- 88,821,283 91,848,784
Educational programs 17,815,388 –- ---- – ---- 17,815,388 16,117,941
Publications 10,092,372 –-- --- – ---- 10,092,372 9,323,927
Banbury Center conferences 1,389,048 –- ---- –- --- 1,389,048 1,409,384
DNA Learning Center programs 1,578,211 –- ---- –- --- 1,578,211 1,857,078
Watson School of Biological Sciences 
 programs 3,356,033 – ----- – ---- 3,356,033 3,584,716
General and administrative 16,860,891 – ----- –- --- 16,860,891 15,596,163
Dining services     5,642,788               – ------              –   ---     5,642,788      5,717,278  
Total expenses  145,556,014               – -----              – ----  145,556,014  145,455,271  
Excess (defi ciency) of revenue and other 
support over (under) expenses 38,960,703 (18,343,299) 1,147,593 21,764,997 79,140,116
Other changes in net assets:
Investment (loss) return excluding 
amount utilized (3,817,070) 13,456,118 – ---- 9,639,048 (22,610,255)
Change in fair value of interest 
rate swap     2,170,350                – ----              – ----      2,170,350  (21,287,538)
Increase (decrease) in net assets 37,313,983 (4,887,181) 1,147,593 33,574,395 35,242,323
Net assets at beginning of year 205,967,407  298,351,339   103,902,882 608,221,628  572,979,305  
Net assets at end of year $ 243,281,390  293,464,158   105,050,475 641,796,023  608,221,628  
CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2012
(with summarized ﬁ nancial information for the year ended December 31, 2011)
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   2012 2011
Cash fl ows from operating activities:
Increase in net assets  $  33,574,395 35,242,324
Adjustments to reconcile increase in net assets
 to net cash provided by operating activities:
Change in fair value of interest rate swap  (2,170,350) 21,287,538
Depreciation and amortization  15,422,891 14,697,263
Net (appreciation) depreciation in fair value of investments  (29,322,335) 4,173,189
Contributions restricted for long-term investment  (10,527,878) (13,475,213)
Changes in assets and liabilities:
Grants receivable  (4,279,297) 1,992,555
Contributions receivable, net of fi nancing activities  25,176,987 (53,517,765)
Publications inventory  525,471 262,295
Other assets  (912,934) (5,008,296)
Restricted use assets  (715,256) (302,119)
Accounts payable and accrued expenses, net of fi nancing activities  (139,990) 1,835,064
Deferred revenue        (209,041)   (2,743,102) 
Net cash provided by operating activities   26,422,663)    4,443,733)
Cash fl ows from investing activities:
Capital expenditures  (14,219,427) (17,748,180)
Proceeds from sales and maturities of investments  73,005,504 33,325,960
Purchases of investments  (70,508,172) (30,860,745)
Net change in investment in employee residences           48,779)         (97,394) 
Net cash used in investing activities   (11,673,316) (15,380,359)
Cash fl ows from fi nancing activities:
Contributions restricted for long-term investment  1,147,593 1,600,563
Contributions restricted for investment in capital  9,380,285 11,874,650
Increase in contributions receivable  (7,321,968) (5,354,289)
(Decrease) increase in accounts payable relating 
 to capital expenditures       (539,182)        104,669  
Net cash provided by fi nancing activities      2,666,728)    8,225,593 
Net increase (decrease) in cash and cash equivalents  17,416,075   (2,711,033)
Cash and cash equivalents at beginning of year   58,055,329)  60,766,362  
Cash and cash equivalents at end of year  $  75,471,404)  58,055,329 
Supplemental disclosure:
  Interest paid   $    3,683,436)    3,614,370  
Noncash investing and fi nancing activity:
  Contributed property  $          50,000)    1,095,000  
CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2012
(with comparative ﬁ nancial information for the year ended December 31, 2011)
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive 
a substantial portion of their funding through grants from the federal government and through 
grants, capital gifts, and annual contributions from New York State, private foundations, corpo-
rations, and individuals. The following section summarizes funding that occurred during 2012.
GRANTS January 1–December 31, 2012
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Project and Center Support Drs. Hannon/Krainer/Spector/Stillman 05/25/12 12/31/16 $ 4,486,042 *
Dr. Stillman, Cancer Center Core 08/17/11 07/31/16 4,346,720
Cooperative Research Agreement Support2 Dr. Gingeras 09/21/12 07/31/16 1,975,096 *
Drs. Lowe/Hannon/Hicks/Powers 09/01/09 08/31/14 564,230
Drs. Powers/Hannon/Krasnitz/Sordella 05/01/12 04/30/17 1,013,392 *
Equipment Support Dr. Hannon 04/01/12 03/31/13 519,814 *
Research Support Dr. Churchland 09/01/10 08/31/13 247,403
Dr. Dubnau 09/15/09 08/31/14 466,125
Drs. Enikolopov/Koulakov 09/15/11 08/31/16 411,276
Dr. Furukawa 03/01/10 02/28/15 457,875
Dr. Hannon 09/01/09 08/31/13 378,401
Dr. Huang 07/01/11 03/31/16 560,565
Drs. Kepecs/Huang 07/01/11 05/31/16 411,250
Drs. Koulakov/Enikolopov 07/15/10 02/28/14 356,621
Dr. Krainer 04/01/12 03/31/17 728,529 *
Dr. Krainer 09/01/12 08/31/14 235,416 *
Dr. Li 07/01/10 03/31/15 560,038
Dr. Martienssen 09/15/11 08/31/15 344,865
Dr. Martienssen 01/20/12 11/30/15 737,743 *
Dr. McCombie 07/23/10 02/28/15 1,069,587
Dr. Mills 12/26/07 11/30/12 37,605
Dr. Mitra 09/30/09 03/31/14 975,957
Dr. Mitra 08/01/10 05/31/13 406,574
Dr. Muthuswamy 02/01/09 12/31/13 405,930
Dr. Osten 04/01/12 03/31/17 485,438 *
Dr. D. Spector 04/01/11 03/31/15 740,360
Dr. Stenlund 12/01/06 06/30/13 470,000
Dr. Stillman 06/01/12 05/31/16 696,400 *
Dr. Tonks 07/01/10 04/30/15 761,643
Dr. Tonks 01/11/10 12/31/13 434,648
Dr. Trotman 04/01/10 01/31/14 301,376
Dr. Turner 07/15/10 06/30/15 454,960
1Includes direct and indirect costs
2Cooperative research agreement funding amounts include only CSHL portion of award
*New or competing renewal grants awarded in 2012
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*New or competing renewal grants awarded in 2012
Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
Dr. Van Aelst 07/01/08 03/31/14 $  417,658
Dr. Van Aelst 01/01/09 12/31/13 376,384
Dr. Zador 09/18/08 07/31/13 354,339
Dr. Zador 09/27/10 05/31/15 464,475
Dr. Zador 09/01/12 08/31/17 400,209 *
Dr. Zhong 06/01/10 05/31/13 368,154
Research Subcontracts
NIH/Allen Institute for Brain Science 
Consortium Agreement
Dr. Mitra 09/15/09 08/31/13 186,076
NIH/Cornell University Consortium 
Agreement
Dr. Mitra 04/03/08 01/31/13 21,091
NIH/Georgia Institute of Technology 
Consortium Agreement
Dr. D. Spector 09/30/06 07/31/15 290,000
NIH/The Johns Hopkins University 
Consortium Agreement
Dr. Schatz 09/21/11 08/31/14 161,013
NIH/The Scripps Research Institute 
Consortium Agreement
Dr. Osten 09/30/12 08/31/13 75,600 *
NIH/University of California - San 
Francisco Consortium Agreement
Dr. Egeblad 09/01/09 08/31/14 174,905
NIH/University of Southern California 
Consortium Agreement
Dr. Hannon 07/01/10 06/30/14 117,450
NIH/University of Texas Consortium 
Agreement
Dr. Krainer 08/01/10 03/31/13 44,732
NIH/University of Texas Consortium 
Agreement
Dr. Furukawa 09/30/11 05/31/15 50,514
Fellowship Support Dr. Ipsaro 09/01/11 08/31/13 52,190
Dr. Jansen 01/01/11 07/31/14 47,756
J. Tucciarone 09/16/12 09/15/15 32,582 *
Institutional Training Program Support Dr. Joshua-Tor, Watson School of 
Biological Sciences
07/01/12 06/30/17 267,927 *
Dr. Mills 09/01/11 08/31/16 181,564
Course Support Advanced Immunocytochemistry: In Situ 
Hybridization and Live Cell Imaging
09/01/10 08/31/15 100,323
Advanced Sequencing Technologies 
and Applications
04/10/12 03/31/15 52,885 *
Cell and Developmental Biology 
of Xenopus
04/01/09 03/31/14 63,345
Cellular Biology of Addiction 03/01/11 02/29/16 80,694
Computational and Comparative 
Genomics
08/01/08 07/31/13 51,792
Drosophila Neurobiology: Genes, 
Circuits, and Behavior
07/15/12 06/30/17 35,000 *
Eukaryotic Gene Expression 04/01/12 03/31/17 114,306 *
Mouse Development, Stem Cells, and 
Cancer
04/01/12 03/31/17 110,288 *
Programming for Biology 09/01/09 08/31/14 63,654
Protein Purifi cation and Characterization 04/01/12 03/31/17 95,019 *
Proteomics 08/01/12 04/30/17 105,068 *
X-Ray Methods in Structural Biology 09/01/12 08/31/17 81,540 *
Yeast Genetics and Genomics 09/18/10 06/30/13 53,462
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*New or competing renewal grants awarded in 2012
Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
Meeting Support Automated Imaging and High-
Throughput Phenotyping
04/01/12 03/31/13 $   5,000 *
Axon Guidance, Synapse Formation, 
and Regeneration
07/01/12 06/30/13 10,000 *
Bacteria, Archaea, and Phages 05/15/12 04/30/13 6,000 *
The Biology of Genomes 04/01/08 03/31/13 39,339
Evolution of Caenorhabditis and Other 
Nematodes
04/01/12 03/31/13 15,000 *
Gene Expression and Signaling in the 
Immune System
04/01/08 03/31/13 10,000
Germ Cells 07/01/08 06/30/13 6,000
Mechanisms and Models of Cancer 08/01/08 07/31/13 8,500
Molecular Chaperones and Stress 
Responses
05/01/10 04/30/13 20,602
Molecular Genetics of Aging 03/01/08 02/28/13 31,600
Neurodegenerative Diseases: Biology 
and Therapeutics
09/26/12 09/25/13 23,000 *
Neuronal Circuits 03/01/12 02/28/13 15,000 *
Nuclear Receptors and Disease 09/21/12 08/31/13 20,025 *
Pharmacogenomics and Personalized 
Therapy
09/30/10 08/31/15 10,000
PTEN Pathways and Targets 09/30/11 08/31/12 3,000
Retroviruses 03/15/12 02/28/17 36,645 *
Systems Biology: Global Regulation 
of Gene Expression
03/01/10 02/28/15 5,000
Vertebrate Organogenesis 04/01/11 03/31/15 6,000
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Jackson 10/01/10 09/30/15  1,115,265
Drs. Lippman/Schatz 11/01/12 10/31/15 854,233 *
Dr. Ware 06/01/12 05/31/17 1,762,326 *
Research Support Dr. Churchland 08/01/11 07/31/14 43,156
Dr. Jackson 09/01/10 08/31/13 150,000
Dr. Timmermans 08/15/10 07/31/13 150,000
Drs. Timmermans/Hammell 05/01/12 04/30/16 181,550 *
Research Subcontracts
NSF/Cornell University Consortium 
Agreement
Dr. Timmermans 09/01/08 08/31/12 16,000
NSF/New York University Consortium 
Agreement
Drs. McCombie/Martienssen 08/01/10 07/31/14 407,632
NSF/North Carolina State University 
Consortium Agreement
Dr. Martienssen 03/01/11 02/29/16 510,779
NSF/University of Arizona Consortium 
Agreement
Dr. Ware 08/15/10 07/31/14 583,136
NSF/University of Arizona Consortium 
Agreement
Drs. Ware/Micklos/Schatz/Stein 02/01/12 01/31/13 1,863,578 *
NSF/University of California - Berkeley 
Consortium Agreement
Dr. Jackson 08/01/06 07/31/12 269,815
NSF/University of Maryland 
Consortium Agreement
Dr. Schatz 02/01/12 03/31/13 60,000 *
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Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
NSF/Washington University Consortium 
Agreement
Dr. Ware 03/01/10 02/28/13 $  92,150
Fellowship Support Dr. Liberatore 06/01/10 05/31/13 43,500
Dr. Carlston 06/01/10 05/31/13 42,000 *
Undergraduate Training Program Support Dr. Lippman 04/01/12 03/31/15 115,000 *
Course Support Advanced Bacterial Genetics 07/01/09 06/30/14 95,634
Computational Cell Biology 08/01/12 07/31/15 70,000 *
Frontiers and Techniques in Plant 
Science
05/15/12 04/30/15 97,675 *
Neurobiology of Drosophila 08/01/12 07/31/14 20,000 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 01/15/11 01/14/15 120,963
Dr. McCombie 09/11/12 09/10/13 224,106 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 09/15/12 09/14/17 1,069,481 *
Dr. Hannon 09/01/08 08/31/13 709,165
Drs. Hicks/Trotman 09/30/12 09/29/14 276,672 *
Dr. Zhong 06/15/10 06/14/13 302,572
Research Subcontracts
US Army/University of Pittsburgh 
Consortium Agreement
Dr. Hicks 09/01/12 08/31/13 152,921 *
Fellowship Support E. Nakasone 01/01/11 03/13/12 10,800
Dr. Park 04/01/12 03/31/15 187,500 *
Dr. Sheppard 09/01/12 08/31/15 38,927 *
UNITED STATES DEPARTMENT OF ENERGY
Research Subcontracts
DOE/Brookhaven National Laboratory 
Consortium Agreement
Drs. Ware/Schatz 11/29/11 09/30/16 1,076,238
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
Academy for Medical Development and 
Collaboration (AMDeC)
Dr. Stillman 01/01/12 12/31/12 60,000 *
Edward P. Evans Foundation Dr. Vakoc 08/01/12 07/31/13 120,000 *
Memorial Sloan-Kettering Cancer 
Center/Helena Rubinstein Foundation
Dr. Wigler 03/30/12 03/29/13 300,000 *
New York State Urban Development 
Corporation
Dr. Stillman 05/01/12 04/30/13 2,000,000 *
Edith and Alan Seligson Dr. Wigler 06/01/11 05/31/14 250,000
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Grantor Program/Principal Investigator Duration of Grant 2012 Funding1
Program Project Support
Pfi zer Inc. Dr. Stillman 01/01/12 12/31/13 $ 2,050,000 *
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lippman/Martienssen/
Timmermans/Ware
07/01/12 06/30/17 1,600,000 *
The Simons Foundation/Autism Dr. Wigler 01/01/12 12/31/15 6,557,422 *
The Simons Foundation/Center for 
Quantitative Biology
Dr. Wigler 09/01/08 08/31/15 1,500,000
Theodore R. and Vada S. Stanley Drs. Watson/McCombie 06/01/11 05/31/14 5,000,000
Research Support
Aboff ’s Inc. Dr. Tonks 12/19/12 12/18/13 10,318 *
Paul G. Allen Family Foundation Dr. Zador 10/01/10 09/30/13 575,200
Rita Allen Foundation Dr. Hammell 09/01/12 08/31/17 110,000 *
American Association for Cancer 
Research
Dr. Egeblad 07/01/12 06/30/14 100,000 *
American Cancer Society Dr. Wigler 01/01/12 08/31/12 10,000 *
Dr. Wigler 01/01/11 08/31/13 47,000
American Legion Auxiliary Dr. Egeblad 11/30/12 11/29/13 250 *
Anonymous Drs. Mitra/Huang 02/01/12 01/31/14 300,000 *
Banfi  Vineyards Dr. Martienssen 01/01/12 12/31/12 5,679 *
The Breast Cancer Research Foundation Drs. Wigler/Hicks 10/01/12 09/30/13 240,000 *
Burroughs Wellcome Fund Dr. Vakoc 09/01/11 08/31/16 151,250
Caring for Carcinoid Foundation Dr. Tuveson 07/01/12 06/30/14 150,000 *
The H.A. and Mary K. Chapman 
Foundation
Dr. Churchland 12/27/12 12/26/13 170,000 *
The Mary K. Chapman Foundation Dr. Osten 12/31/11 12/30/13 150,000
Coferon Inc. Dr. Vakoc 09/17/12 09/16/13 115,316 *
Dart Neuroscience LLC Dr. Dubnau 12/01/12 11/30/13 250,000 *
Dysautonomia Foundation Inc. Dr. Krainer 07/01/12 06/30/14 90,000 *
Lee MacCormick Edwards, Ph.D. Dr. Stillman 12/01/12 11/30/13 5,000 *
The Ellison Medical Foundation Dr. Enikolopov 09/09/09 09/08/13 252,000
Entertainment Industry Foundation Dr. Hannon 11/01/12 10/31/13 100,000 *
Edward P. Evans Foundation Dr. Vakoc 11/01/12 10/31/13 500,000 *
Charitable Lead Annuity Trust under the 
Will of Louis Feil
Drs. Albeanu/Kepecs/Li/Osten 12/15/12 12/14/13 1,000,000 *
Find a Cure Today Long Island 
Foundation
Dr. Egeblad 03/01/12 02/28/13 5,000 *
The Joni Gladowsky Breast Cancer 
Foundation
Dr. Tonks 05/01/12 04/30/13 55,000 *
Glen Cove C.A.R.E.S., Inc. Dr. Egeblad 02/01/12 01/31/13 10,000 *
The Irving A. Hansen Memorial 
Foundation
Dr. Tonks 07/01/12 06/30/13 25,000 *
Jo-Ellen and Ira Hazan Drs. Osten/Tonks/Krainer 12/01/12 11/30/13 200,000 *
Hearts for Cancer Dr. Egeblad 04/01/12 03/31/13 28,456 *
The Hope Foundation Dr. Egeblad 07/01/12 06/30/14 125,000 *
Howard Hughes Medical Institute–
Gordon and Betty Moore Foundation
Dr. Martienssen 12/01/11 11/30/16 333,333
Isis Pharmaceuticals, Inc. Dr. Krainer 11/01/11 10/26/13 150,000
Japan Science and Technology Agency Dr. Taniguchi 03/01/12 07/31/12 54,799 *
Sidney Kimmel Foundation for Cancer 
Research
Dr. Zheng 07/01/11 06/30/13 100,000
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F.M. Kirby Foundation, Inc. Dr. Vakoc 12/15/12 12/14/13 $ 150,000 *
The Susan G. Komen Breast Cancer 
Foundation, Inc.
Dr. Egeblad 04/13/10 04/12/13 150,000
Mara and Thomas Lehrman Charitable 
Fund
Drs. Hammell/Schatz 03/01/12 02/28/13 65,000 *
The Lehrman Institute Dr. Hammell 03/01/12 02/28/13 200,000 *
Long Island Cruzin’ For a Cure Inc. Drs. Hicks/Trotman 08/01/12 07/31/13 20,000 *
The Long Island 2-Day Walk to Fight 
Breast Cancer
Dr. Egeblad 08/15/12 08/14/13 33,000 *
The Lustgarten Foundation Dr. Hannon 01/01/10 12/31/12 835,531
Dr. Tuveson 06/15/12 06/14/17 50,000 *
Drs. Tuveson/Pappin 09/01/12 08/30/17 1,000,000 *
The Manhasset Women’s Coalition 
Against Breast Cancer, Inc.
Dr. Egeblad 01/01/11 12/31/12 50,744
Carol Marcincuk Fund Dr. Tonks 01/01/12 12/31/12 6,800 *
In Honor of Carissa Maringo Dr. Egeblad 10/01/12 09/30/13 5,310 *
The G. Harold and Leila Y. Mathers 
Charitable Foundation
Dr. Mitra 09/01/10 08/31/13 203,920
Breast Cancer Awareness Day in Memory 
of Elizabeth McFarland
Dr. Wigler 01/01/12 12/31/13 64,805 *
The McKnight Endowment Fund for 
Neuroscience
Dr. Churchland 07/01/12 06/30/15 75,000 *
The Melanoma Research Alliance Drs. Hannon/Hammell/Vakoc 08/01/11 07/31/14 200,000
The John Merck Fund Dr. Churchland 06/01/11 05/31/15 75,000
Dr. Kepecs 06/01/10 05/31/14 75,000
The Don Monti Memorial Research 
Foundation
Dr. Stillman 03/01/12 02/28/13 400,000 *
Louis Morin Charitable Trust Dr. Stillman 12/01/12 11/30/13 75,000 *
National Alliance for Research on 
Schizophrenia and Depression 
(NARSAD)
Dr. Li 07/15/11 07/14/13 30,000
Pancreatic Cancer UK Dr. Tuveson 10/23/12 10/22/15 65,000 *
Panera Bread/Doherty Breads, LLC Dr. Tonks 12/15/12 12/14/13 8,466 *
The Pew Charitable Trusts Dr. Albeanu 08/01/12 07/31/17 60,000 *
Dr. Hannon 01/01/11 12/31/15 349,452
Pioneer Hi-Bred International, Inc. Dr. Ware 03/15/12 06/30/15 65,385 *
The Hazen Polsky Foundation Dr. Vakoc 01/01/12 12/31/14 50,000 *
The Prostate Cancer Foundation Dr. Vakoc 01/20/12 01/19/14 150,000 *
Christina Renna Foundation Inc. Dr. Van Aelst 05/01/12 04/30/13 20,300 *
The Research Foundation for the State 
University of New York
Dr. Furukawa 10/10/12 03/31/14 25,000 *
Dr. Jackson 10/10/12 03/31/14 22,500 *
Marie Robertson Memorial Fund CSHL Neuroscience Program Support 01/01/12 12/31/12 137,500 *
Damon Runyon Cancer Research 
Foundation
Dr. Sordella 01/01/10 12/31/12 150,000
Diane Emdin Sachs Memorial Fund Dr. Sordella 09/01/12 08/31/13 8,461 *
Eleanor Schwartz Charitable Foundation Dr. Churchland 07/15/11 07/14/14 200,000
The Seraph Foundation Dr. Vakoc 12/21/12 12/20/13 125,000 *
Ms. Constance Silveri Dr. Tonks 12/27/12 12/26/13 15,000 *
The Simons Foundation Dr. Mills 07/01/10 06/30/13 350,000
Drs. Mitra/Huang 12/01/11 11/30/14 300,000
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Dr. Osten 10/01/11 09/30/13 $ 175,000
Dr. Osten 07/01/12 06/30/13 60,000 *
Mary F. Smith Family Foundation Dr. Tonks 12/01/12 11/30/13 5,000 *
Smithtown Steakhouse LLC D/B/A 
Insignia Prime Steak: Sushi
Dr. Sordella 01/01/12 12/31/13 75,000 *
Starr Cancer Consortium Dr. Hannon 08/01/11 07/31/13 216,000
Dr. Hannon 08/01/11 07/31/13 270,000
Drs. Hicks/Wigler 08/01/11 07/31/13 320,760
Dr. Sordella 08/01/11 07/31/13 216,000
Drs. Sordella/Pappin 08/01/11 07/31/13 221,988
Dr. Vakoc 08/01/11 07/31/13 270,000
Swim Across America Dr. Sordella 12/15/11 12/14/14 75,000
U.S.–Israel Binational Agricultural 
Research and Development Fund
Dr. Krainer 10/01/10 09/30/14 10,000
Dr. Lippman 06/01/10 05/31/13 42,000
Dr. Zador 10/01/10 09/30/14 5,750
University Health Network Dr. Muthuswamy 01/01/11 12/31/12 28,339
University of Pennsylvania Dr. Krainer 08/22/12 08/31/14 150,000 *
The V Foundation Dr. Vakoc 11/01/12 10/31/14 100,000 *
Dr. Zheng 11/01/11 10/31/13 100,000
Whitehall Foundation, Inc. Dr. Albeanu 01/01/12 12/31/14 75,000 *
Dr. Shea 09/01/11 08/31/15 75,000
West Islip Breast Cancer Coalition for 
Long Island Inc.
Dr. Tonks 11/01/12 10/31/13 10,000 *
Elisabeth R. Woods Foundation Inc. Dr. Sordella 08/16/12 08/15/13 27,000 *
Yale University/Gilead Sciences Inc. Dr. Sordella 07/16/12 07/15/14 410,058 *
The Bradley Zankel Foundation, Inc. Dr. Zheng 02/22/12 02/21/13 15,000 *
Fellowship Support
American Cancer Society Dr. Feigin 01/01/11 12/31/12 52,000
Dr. Preall 10/01/11 09/30/14 50,000
Cashin Family Fund Watson School of Biological Sciences 09/01/10 08/31/12 80,000
CSHL Association Fellowship Dr. Tuveson 01/01/12 12/31/12 280,000 *
Genentech Foundation Watson School of Biological Sciences 10/01/12 09/30/15 58,751 *
German Academic Exchange Service Dr. Bergmann 09/01/11 08/31/13 38,000
Lola A. Goldring Dr. Stillman 09/01/12 08/31/13 80,000 *
Hope Funds for Cancer Research Dr. Knott 07/01/12 06/30/15 45,500 *
Human Frontier Science Program Dr. Benkovics 05/01/12 04/30/13 39,400 *
Annette Kade Charitable Trust Watson School of Biological Sciences 09/01/12 08/31/13 25,000 *
Karp Foundation Inc. Dr. Penzo 08/01/12 07/31/13 50,000 *
Estate of Gale Kavaliuskas Watson School of Biological Sciences 09/01/12 08/31/13 293,849 *
The Esther A and Joseph Klingenstein 
Fund Inc.
Dr. Shea 07/01/10 06/30/13 50,000
Life Sciences Research Foundation Dr. MacAlister 08/01/11 07/31/14 56,000
Muscular Dystrophy Association Dr. Sahashi 02/01/12 01/31/15 60,000 *
National Alliance for Research on 
Schizophrenia and Depression 
(NARSAD)
Dr. Mirrione 07/15/11 07/14/13 30,000
National Agriculture and Food Research 
Organization (Japan)
Dr. Hiraga 09/17/12 09/16/13 14,642 *
Mr. and Mrs. John C. Phelan Watson School of Biological Sciences 09/01/10 08/31/15 100,000
Damon Runyon Cancer Research 
Foundation
Dr. Sabin 01/01/12 12/31/14 52,000 *
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Sass Foundation for Medical Research Inc. Dr. Vakoc 11/01/10 10/31/12 $  8,752
Lauri Strauss Leukemia Foundation Dr. Kawaoka 09/01/12 08/31/13 10,000 *
The Swartz Foundation Dr. Zador 01/01/12 12/31/12 75,000 *
Drs. Koulakov/Wei 01/01/12 12/31/12 55,000 *
Drs. Kepecs/Hangya 01/01/12 12/31/12 55,000 *
Dr. Zador 01/01/12 12/31/12 15,000 *
The Swedish Society of Medicine Dr. Ohlund 10/08/12 12/31/12 8,300 *
Training Support
Clare College Undergraduate Research Program 06/01/12 05/31/13 5,645 *
The Lita Annenberg Hazen Foundation Undergraduate Research Program 05/01/08 04/30/18 10,000
Howard Hughes Medical Institute Undergraduate Research Program 06/01/12 05/31/13 8,250 *
William Townsend Porter Foundation Undergraduate Research Program 04/01/12 03/31/13 12,000 *
Steamboat Foundation Undergraduate Research Program 05/01/12 04/30/13 12,000 *
Trinity College Undergraduate Research Program 06/01/12 05/31/13 3,970 *
Course Support
Alzheimer’s Drug Discovery Foundation Workshop on Cognitive Aging 11/01/11 10/31/12 2,500
American Brain Tumor Association Brain Tumors 02/01/12 01/31/13 45,000 *
American Express Foundation Leadership in Bioscience 11/01/11 10/31/14 65,000
American Federation for Aging Research Workshop on Cognitive Aging 01/01/12 12/31/12 2,500 *
Carl Zeiss Microscopy, LLC Imaging Structure and Function in the 
Nervous System
06/15/12 06/14/13 5,000 *
The Ellison Medical Foundation Workshop on Cognitive Aging 05/01/12 04/30/13 15,000 *
Howard Hughes Medical Institute Course Support 01/01/07 12/31/12 600,000
Nancy Lurie Marks Family Foundation Workshop on Biology of Social 
Cognition
07/01/12 06/30/16 25,000 *
Roche Diagnostics Corporation Advanced Sequencing Technologies 
and Applications
02/01/12 01/31/13 30,000 *
Society for Neuroscience/International 
Brain Research Organization
Summer Neuroscience Course 07/01/12 06/30/13 17,210 *
Meeting Support
Abbott Laboratories Gene Expression and Signaling in the 
Immune System
04/01/12 03/31/13 3,000 *
Amgen, USA Molecular Pathways in Organ 
Development and Disease
09/01/11 08/31/12 5,000
Gene Expression and Signaling in the 
Immune System
04/01/12 03/31/13 5,000 *
Art Guild, Inc. Corporate Exhibitors 03/01/12 02/28/13 5,000 *
Clontech Laboratories, Inc. Single-Cell Analysis 11/01/12 10/31/13 5,000 *
The Company of Biologists LTD Molecular Pathways in Organ 
Development and Disease
09/01/11 08/31/12 7,898
Complete Genomics, Inc. Corporate Exhibitors 03/01/12 02/28/13 14,000 *
Constellation Pharmaceuticals Gene Expression and Signaling in the 
Immune System
04/01/12 03/31/13 2,000 *
Enzo Life Sciences Molecular Chaperones and Stress 
Responses
04/01/12 03/31/13 2,500 *
Exiqon, Inc. Corporate Exhibitors 03/01/12 02/28/13 500 *
Forest Research Institute Inc. Blood Brain Barrier 12/01/12 11/30/13 25,000 *
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The Gatsby Charitable Foundation 77th CSHL Symposium: The Biology 
of Plants
02/01/12 01/31/13 $  3,150 *
Gilead Sciences Inc. Retroviruses 05/01/12 04/30/13 12,500 *
Illumina, Inc. Corporate Exhibitors 03/01/12 02/28/13 19,000 *
Life Technologies Corporation Personal Genomes and Medical 
Genomics
12/15/12 12/14/13 10,000 *
March of Dimes Foundation Molecular Pathways in Organ 
Development and Disease
04/01/12 09/30/12 5,000 *
MedImmune, LLC Molecular Genetics of Bacteria 
and Phage
11/07/11 11/06/12 5,000
Merck Sharp and Dohme Corporation Molecular Pathways in Organ 
Development and Disease
03/01/12 02/28/13 15,000 *
Molecular Devices Corporation Corporate Exhibitors 03/01/12 02/28/13 5,000 *
Gordon and Betty Moore Foundation 77th CSHL Symposium: The Biology 
of Plants
02/01/12 01/31/13 10,000 *
Nature America Inc. Molecular Genetics of Bacteria 
and Phage
11/07/11 11/06/12 750
Novartis Pharmaceuticals Corp. PTEN Pathways and Targets 11/18/11 03/16/13 25,000
Christine O’Neil Corporate Exhibitors 03/01/12 02/28/13 6,000 *
Opgen, Inc. Corporate Exhibitors 03/01/12 02/28/13 7,000 *
Phytotechnology Laboratories Corporate Exhibitors 03/01/12 02/28/13 500 *
Promega Corporation Molecular Genetics of Bacteria 
and Phage
11/07/11 11/06/12 750
Martin Reese Corporate Exhibitors 03/01/12 02/28/13 4,000 *
Rutgers, the State University of New 
Jersey
Protein Data Bank 40th Anniversary 12/01/10 11/30/12 2,300
Society for Developmental Biology Molecular Pathways in Organ 
Development and Disease
09/01/11 08/31/12 4,000
Lemna Tec Corporate Exhibitors 03/01/12 02/28/13 2,500 *
Library Support
The Ellen Brenner Memorial Fund 12/15/12 12/14/13 2,000 *
The New York State Education 
Department
07/01/10 06/30/12 3,497
The New York State Education 
Department
07/01/11 06/30/12 16,584
Wellcome Trust 08/01/11 07/31/13 302,364
Library Meeting Support
Alfred P. Sloan Foundation 04/01/12 05/01/12 20,000 *
The Rockefeller University 04/01/12 03/31/13 15,000 *
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DNA LEARNING CENTER GRANTS
Grantor Program
Duration 
of Grant
2012 
 Funding†
FEDERAL GRANTS
National Science Foundation, 
University of Arizona
Educational Outreach for iPlant Collaborative: 
A Cyberinfrastructure for Plant Sciences
2/08–1/13 860,267
National Science Foundation, 
North Carolina State University
GEPR: Epigenome Dynamics during DNA Replication 3/11–2/13 73,108
National Science Foundation Advanced Technology Education (ATE) Program: Genomic 
Approaches in BioSciences
4/11–3/14 157,894
NONFEDERAL GRANTS
Victor Centers for Prevention 
of Jewish Genetic Diseases, 
Albert Einstein Healthcare 
Center/Marcus Jewish Genetic 
Disease Consortium
Gene Screen iPhone/iPad Application 12/10–12/12 31,900
Alfred P. Sloan Foundation DNA Barcoding Experiments by New York City High School 
Students (Urban Barcode Project)
1/11–7/12 74,533
Howard Hughes Medical 
Institute
Pre-College Science Education Initiative: NYC Teacher Professional 
Development
9/07–8/12 145,319
Dana Foundation Harlem DNA Lab Operating Support 3/09–2/12 27,700
William Townsend Porter 
Foundation
Scholarships for Minority and Underserved Students at Harlem 
DNA Lab
3/11–3/12 17,000
National Grid Foundation Scholarships for Minority and Underserved Students in the Central 
Islip Union Free School District
1/12 –12/12 15,000
Spinal Muscular Atrophy 
Foundation
Learn About SMA Internet site 4/11–4/13 78,965
The following schools and school districts each contributed $1,000 or more for participation in the Curriculum Study Program:
Elwood Union Free School District $ 1,500 Locust Valley Central School District 1,500
Fordham Preparatory School 3,000 Northport-East Northport Union Free School District 3,000
Great Neck Union Free School District 1,500 Oceanside Union Free School District 3,000
Half Hollow Schools Central School District 3,000 Port Washington Union Free School District 3,000
Herricks Union Free School District 1,500 Ramaz Upper School 1,500
Huntington Union Free School District 1,500 Sachem Central School District 3,000
Levittown Union Free School District 3,000 Yeshiva University High School for Girls 3,000
The following schools and school districts each contributed $1,000 or more for participation in the Genetics as a Model for 
Whole Learning Program:
Adelphi STEP $ 1,050 Lynbrook Union Free School District 1,000
Bay Shore Union Free School District 2,800 Merrick Union Free School District 3,400
Bellmore Union Free School District 2,800 M.S. 447, Brooklyn 1,800
Bellmore–Merrick Union Free School District 10,000 North Bellmore Union Free School District 2,600
Cold Spring Harbor Central School District 14,400 North Shore Central School District 1,750
Commack Union Free School District 6,900 North Shore Hebrew Academy 1,050
East Meadow Union Free School District 3,730 Oceanside Union Free School District 1,625
East Williston Union Free School District 2,900 Oyster Bay–East Norwich Central School District 5,625
Elwood Union Free School District 3,425 Plainedge Union Free School District 2,100
Floral Park–Bellerose Union Free School District 7,800 Port Washington Union Free School District 9,600
Friends Academy 2,100 Rockville Centre Union Free School District 6,240
Garden City Union Free School District 4,000 Roslyn Union Free School District 4,200
Great Neck Union Free School District 6,000 Sachem Union Free School District 2,925
Half Hollow Hills Union Free School District 9,150 Saint Dominic Elementary School 4,550
Herricks Union Free School District 2,275 Scarsdale Union Free School District 12,600
Hofstra STEP 1,050 Smithtown Union Free School District 1,680
Holy Child Academy 3,100 Syosset Union Free School District 36,600
IHM Home School Program 1,050 Three Village Central School District 4,200
Huntington Union Free School District 4,600 Trinity Regional School 1,300
Jericho Union Free School District 8,250 Valley Stream 13 Union Free School District 1,050
Locust Valley Central School District 8,859 Yeshiva of Flatbush 2,000
†Includes direct and indirect costs.
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BANBURY CENTER GRANTS
Grantor Program
Duration 
of Grant
2012 
Funding
FEDERAL SUPPORT
Centers for Disease Control and Prevention Decoding Clinical Trials to Improve Treatment 
of ME/CFS
2012 $18,440
NIH–National Institute of Mental Health The Fourth Annual NIMH Brain Camp 2012 35,662
National Science Foundation through a grant 
to Stony Brook University
Grand Challenges in Organismal Biology 2012 9,045
NONFEDERAL SUPPORT
Astellas-OSI Oncology Cell Plasticity in Cancer Evolution 2012 49,602
Baxter Healthcare Corporation Patenting Genes: New Developments, New Questions 2012 5,000
Boehringer Ingelheim Fonds Communicating Science 2012 50,549
Certerra, Inc. Systems Biology of Autism: From Basic Science to 
 Therapeutic Strategies
2012 4,266
CFIDS Association of America Decoding Clinical Trials to Improve Treatment 
of ME/CFS
2012 39,107
Cold Spring Harbor Laboratory Corporate 
Sponsor Program
Transcription and Cancer 2012 43,261
Cold Spring Harbor Laboratory Corporate 
Sponsor Program
Infl ammation, Cancer, and Metabolism 2012 46,068
Cold Spring Harbor Laboratory Library 
and Archives
Envisioning the Future of Science Libraries at 
Academic Research Institutions
2012 4,512
Cold Spring Harbor Laboratory/DuPont 
Pioneer Joint Collaborative
Plant–Environment Interactions 2012 50,000
Discovery Network Inspire2Live 2012 21,203
DRI Capital, Inc. Patenting Genes: New Developments, New Questions 2012 7,500
GangaGen, Inc. Phage and Phage-Based Therapies 2012 39,857
Genentech, Inc. Patenting Genes: New Developments, New Questions 2012 10,000
Individual participants The Fourth Annual NIMH Brain Camp 2012 8,070
Individual participants Patenting Genes: New Developments, New Questions 2012 1,335
Individual participants Emerging Approaches in Oncology: A Brainstorming 
Think Tank
2012 2,000
Individual participants Grand Challenges in Organismal Biology 2012 1,005
Individual participants Decoding Clinical Trials to Improve Treatment 
of ME/CFS
2012 2,982
Jones Day LLP Patenting Genes: New Developments, New Questions 2012 2,000
Kaye Scholer LLP Patenting Genes: New Developments, New Questions 2012 5,000
King & Spalding, LLP Patenting Genes: New Developments, New Questions 2012 5,000
Eli Lilly & Company Patenting Genes: New Developments, New Questions 2012 5,000
Haig R. Nalbantian Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 1,000
Novartis Pharma AG Patenting Genes: New Developments, New Questions 2012 5,000
Novo Nordisk Inc. Patenting Genes: New Developments, New Questions 2012 5,000
Pfi zer, Inc. Systems Biology of Autism: From Basic Science to 
Therapeutic Strategies
2012 5,000
Mr. and Mrs. Howard Phipps, Jr. Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 10,000
Marie Robertson Research Fund Systems Biology of Autism: From Basic Science to 
 Therapeutic Strategies
2012 20,000
Robertson Fund Systems Biology of Autism: From Basic Science to 
 Therapeutic Strategies
2012 10,000
The Rockefeller University Envisioning the Future of Science Libraries at Academic 
Research Institutions
2012 15,000
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BANBURY CENTER GRANTS (Continued)
Grantor Program
Duration 
of Grant
2012 
Funding
Ropes & Gray Patenting Genes: New Developments, New Questions 2012 5,000
The Daniel and Joanna S. Rose Fund, Inc. Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 10,000
The Satenik and Adom Ourian Educational 
Foundation
Interdisciplinary Symposium on Literature, Memory, 
and  Neuroscience
2012 1,000
Simons Foundation Systems Biology of Autism: From Basic Science to 
T herapeutic Strategies
2012 10,000
The Alfred P. Sloan Foundation A History of the Human Genome Project 2012 50,000
The Alfred P. Sloan Foundation Envisioning the Future of Science Libraries at Academic 
Research Institutions
2012 20,000
University of Louisville, Brown Cancer 
Center
Regulation of Metabolism in Cancer 2012 45,625
University of Southern California, NCI 
Physical Sciences in Oncology Center
Emerging Approaches in Oncology: A Brainstorming 
Think Tank
2012 32,663
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CORPORATE SPONSOR PROGRAM 
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings 
program held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main 
Laboratory campus or at the  Banbury Center. Without the strong foundation provided by the 
Program, we could neither plan with confi dence for the year’s meetings nor introduce new and 
unusual topics.
We are especially grateful to the companies that joined us in 2012 as the economic diffi culties 
have persisted. The year 2013 is going to be especially challenging as the number of companies 
shrinks through takeovers, and companies and foundations adopt austerity measures. The mem-
bers of the Program receive special privileges in acknowledgment of their contributions. We waive 
all on-site fees for eight representatives of the Corporate Sponsors at our meetings. Three scientists 
from Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by 
invitation of the organizers. Member companies also receive gratis copies of Cold Spring Harbor 
Laboratory Press publications, including the journals Genes & Development, Learning & Memory, 
CSH Protocols, and Genome Research.
We acknowledge our Sponsors in all relevant publications, including the books of abstracts 
given to each of the 7000 participants who come to the meetings each year. The names of the 
sponsoring companies are listed on the poster describing the meetings, and this is mailed to ap-
proximately 17,000 scientists throughout the world. In addition, the companies are listed on the 
Cold Spring Harbor Laboratory website on the Meetings Offi ce and Banbury Center pages. Mem-
bers in 2012 were the following:
CORPORATE BENEFACTORS PLANT CORPORATE SPONSORS
Astellas-OSI Pharmaceuticals, Inc. Monsanto Company
 DuPont-Pioneer International, Inc.
CORPORATE SPONSORS 
Agilent Technologies, Inc. 
Bristol-Myers Squibb Company 
Genentech, Inc.
GlaxoSmithKline
Life Technologies
New England BioLabs, Inc.
Sanofi  US
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DEVELOPMENT
Capital and Endowment Campaign Support: 
Donations help to secure the fi nancial stability 
of CSHL and provide resources to expand the 
facilities and staff.
Research Support: Donations in specifi c areas 
of research help to increase the speed at which 
genetic discoveries are translated into diagnostic 
tests and therapeutics.
Annual Fund: Donations provide funding for 
some of the most innovative young researchers 
in science today and constitute an important in-
vestment in groundbreaking research in cancer, 
neuroscience, plant biology, and bioinformatics.
Science Education: Donations support pro-
grams at the DNA Learning Center and the 
Watson School of Biological Sciences, where the 
next generation learns about genetics in an excit-
ing and interactive environment.
Planned and Estate Gifts: Individuals who in-
form us of their intention to make a gift to CSHL 
from their estate are invited to become members 
of the Harbor Society. Estate gifts help to ensure 
that CSHL will continue to pursue its mission for 
many years to come.
For additional information, please contact Charlie Prizzi, Vice President for Development, Cold Spring Harbor Laboratory, 
One Bungtown Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6961. E-mail: prizzi@cshl.edu
With the support of our many generous donors, Cold Spring Harbor Laboratory had one of the 
most successful years in our history. For the fi rst time, more than $6 million was raised for unre-
stricted support. The 2012 Double Helix Medals dinner was also hugely successful as we honored 
Michael J. Fox, Art Levinson, and Mary Lindsay. In their unique ways, each of these individuals 
has made the world a better place, and we were very proud to recognize their achievements.
In July, John Cleary’s family and friends gathered to celebrate the dedication of a laboratory in his 
memory. The John P. Cleary Laboratory is located in the DeMatteis building and is home to Dr. 
Michael Wigler’s lab. John was involved with the Laboratory for many years as CSHL Associa-
tion’s President, Trustee, and then as an Honorary Trustee. His friendship to the Laboratory, the 
scientists, the employees, and all who walked on our grounds will never be forgotten.
With support from the Lustgarten Foundation, Cold Spring Harbor Laboratory welcomed 
Dr. Dave  Tuveson, one of the world’s most preeminent researchers and clinicians in the fi eld of 
pancreatic cancer research. Dave was formerly at the Cancer Research UK Cambridge Research 
Institute, and he came to the Laboratory to direct our Cancer Therapeutics Initiative. This ambi-
tious initiative will focus on moving advanced-stage drug candidates from the laboratory to the 
clinic. With more space needed to accommodate sophisticated technology and additional people, 
plans are set to expand our Woodbury facility. We will be breaking ground on the project in the 
second quarter of 2013.
All our successes during this past year could not have happened without the support of our donors 
and we are extremely thankful for all of their contributions.
  Charles V. Prizzi, Vice President for Development
Cold Spring Harbor Laboratory is a nonprofi t research and educational institution chartered by 
the State of New York. Less than half of the Laboratory’s annual revenues are derived from federal 
grants and contracts, and thus, it relies heavily upon support from the private sector: foundations, 
corporations, and individuals. CSHL takes this occasion to sincerely thank each and every donor 
whose generous contributions have made possible the discoveries we report in this publication. 
There are a variety of ways to give to the Laboratory:
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President’s Council
This year’s topic—Ethical Dilemmas in Medicine—enabled us to shine light on CSHL’s human 
genetics research, strides that we are making in cancer profi ling, and the Laboratory’s early role in the 
20th-century eugenics movement. Three of our October talks were presented by key CSHL individu-
als: Dave Micklos, founder and head of CSHL DNA Learning Center; David Spector, CSHL Direc-
tor of Research; and Lloyd Trotman, Assistant Professor of cancer research. Gholson Lyon, M.D., 
PhD., a new CSHL Assistant Professor of neuroscience, spoke at the Council reception in May hosted 
by Claudia and Gunnar Overstrom in their magnifi cent New York City apartment.
Dartmouth Professor H. Gilbert Welch, M.D., opened the October meeting with a captivating pre-
sentation on the downside of routine preclinical medical screening. Saturday talks featured a thought-
ful lecture on informed consent of incapacitated human subjects and the ethics of gene patenting. In 
addition, an extraordinary keynote lecture by Andrew Solomon moved most of our guests to tears 
with his moving account of the love and special meaning that parents fi nd in raising children who are 
different, the topic of his newest book Far from the Tree: Parents, Children and the Search for Identity.
President
Bruce Stillman
Chairpersons
Howard L. Morgan
Cynthia R. Stebbins
Members
Dr. and Mrs. Lalit Bahl
Mr. and Mrs. Roger L. Bahnik
Ms. Jamie Nicholls and 
Mr. Fran Biondi
Mr. and Mrs. David Boies
Mr. and Mrs. Hans E.R. Bosch
Ms. Louise Parent and Mr. John 
Casaly
Mr. and Mrs. Richard M. Cashin
Dr. Gerald Chan
Mr. and Mrs. Edward A. Chernoff
Mr. and Mrs. Roderick H. 
Cushman
Mr. and Mrs. Norris W. Darrell
Mr. and Mrs. Yves C. de Balmann
Mr. and Mrs. Geoffrey de Lesseps
Mr. Martin Elias
Ms. Carol Feil
Mr. and Mrs. Robert A. Gay
Mrs. Allen A. Goldring
Dr. Leo A. Guthart
Mr. Matthew Haines
Mrs. Charles E. Harris II
Mr. and Mrs. Ira Hazan
Mr. Harvey L. Karp
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. Peter J. Klein
Mr. and Mrs. David M. Knott
Mr. David H. Koch
Dr. Betsy and Mr. Bryan 
H. Lawrence
Mr. and Mrs. Richard Leeds
Mr. and Mrs. Thomas D. Lehrman
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
Mrs. Nancy Abeles Marks
Dr. Marcia Kramer Mayer
Drs. Laurie J. Landeau and 
Robert Maze
Dr. Gillian and Mr. Eduardo Mestre
Mr. and Mrs. William R. Miller
Mr. and Mrs. Thomas A. Moore
Dr. and Mrs. Howard L. Morgan
Mr. and Mrs. Douglas P. Morris
Mr. and Mrs. John C. Phelan
Mr. Thomas C. Quick
Drs. Maria and Charles Ryan
Mr. and Mrs. Arthur J. Saladino
Ms. Susan Wasserstein and Mr. 
George Sard
Mr. and Mrs. Alan Seligson
Drs. Marilyn and James Simons
Ms. Loren Eng and Mr. Dinakar 
Singh
Mr. and Mrs. Harry Slatkin
Mr. Andrew Solomon and Mr. 
John Habich Solomon
Mr. and Mrs. Erwin P. Staller
Mr. and Mrs. Theodore R. Stanley
Mr. and Mrs. James F. Stebbins
Dr. and Mrs. Charles L. Stone, Jr.
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz
Mr. and Mrs. Paul J. Taubman
Mrs. Robert W. Tilney
Mr. and Mrs. Howard J. Tytel
Dr. and Mrs. James D. Watson
Mr. Roy J. Zuckerberg
Fran Biondi, Russell Byers, Casey Cogut, and 
Ian Snow
President’s Council speaker, Andrew Solomon 
signing copies of his books for attendees
Freddie Staller, Gilbert Welch, and Erwin Staller
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Cold Spring Harbor Laboratory Association
With 1200 members, the Cold Spring Harbor Laboratory Association (CSHLA) continues to 
increase community awareness of CSHL, and this year they helped raise more than $6 million in 
unrestricted support for the Laboratory. Events spearheaded by the Directors of the Association 
included Labapalooza, the 77th Symposium dinner parties, the Women’s Partnership for Science 
luncheon, and a variety of receptions and dinners that introduced new friends to the exception-
ally talented young scientists at CSHL. Members also had a signifi cant role in the success of the 
Double Helix Medals Dinner in New York City and the 19th annual golf tournament at the Pip-
ing Rock Club. Special thanks go to Sandy Tytel, president, as she continues to enthusiastically 
lead the CSHLA directors to new levels of participation.
2012 CSHLA Directors
Directors
Executive Committee Offi cers
Sandy Tytel, President
Frank O’Keefe, Vice President
W. Fifi eld Whitman, Vice 
President
James A. Woods, Treasurer
Pearl F. Staller, Secretary
Elizabeth Ainslie
Hans E.R. Bosch
Michele Munn Celestino
Edward A. Chernoff
Maria de Lesseps
Nelson DeMille
Charles B. Goodwin, M.D.
Carolyn Gulotta
Nancy Lippman 
Israeli, M.D.
Joel J. Kassimir, M.D.
Kassahun Kebede
Virginia Knott
Laureen Stanton Knutsen
Suzanne Leeds
Timothy Q. O’Neill
Lauryl Palatnick
David Peikon
Olga Pharr
Whitney F. Posillico
Charles S. Ryan, J.D., Ph.D.
Tracey DeMatteis Serko
Debbie Parmet Sondock
Heather Lane Spehr
Lara S. Trafelet
Marjorie J. van de Stouwe, M.D.
Honorary Directors
Mary D. Lindsay
Anne R. Meier
Cathy Cyphers Soref
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Cold Spring Harbor Laboratory Corporate Advisory Board
The Corporate Advisory Board (CAB) is a vital liaison between Cold Spring Harbor Laboratory 
and the tri-state business community. Established more than 20 years ago, the CAB is the driving 
force behind the Laboratory’s annual golf outing at Piping Rock Club; this outing raises critical 
unrestricted funding for research and educational programs.
Serving as CAB Chair for more than 10 years and Golf Chair for 6 years, Eddie Chernoff con-
tinues to provide leadership and support and we truly appreciate all of his efforts.
Corporate Advisory Board
Chairperson: Edward A. Chernoff, MARS
CSHL Trustee Liaison: Laurie Landeau, V.M.D.
Michael Aboff, Aboff ’s Inc.
Paul Amoruso, Oxford & Simpson 
Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale 
Sotheby’s International Realty
Jeffrey Carstens, Capital One
Richard A. Catalano, KPMG, L.L.P.
Jonathan Connors, Wells Fargo
Marian Conway, New York Community 
Bank Foundation
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall 
Corporation
David Epstein, Ph.D., OSI 
Pharmaceuticals, Inc.
Kevin Foley, Fidelity
Brian Fox, McKinsey & Company
Brian Goldstein, M.D.
Lawrence Goodman, Curtis, 
Mallet-Prevost, Colt & Mosle L.L.P.
Mary Jane Helenek, Luitpold 
Pharmaceuticals
Diana Hoadley, JP Morgan
Robert Isaksen, Bank of America
M. Patricia Janco
Neil M. Kaufman, Abrams Fensterman
John C. Kean III, Kean Development 
Corporation
Norman Kelker, Enzo BioChem
Robert Keller, National Grid Foundation
Amy Koreen, M.D.
Victoria Meagher
John Molloy, H2M Group
Rob Palatnick, DTTC
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sotheby’s 
International Realty
Stephen Ross, Ph.D., Nikon Instruments
Raju Sarwal, M.D.
Kurt Timmel, Marsh USA
Edward Travaglianti, TD Bank
Andrew Whiteley, Enzo BioChem
Hans Zobel
CAB Chairman Eddie Chernoff with his wife Donna and Drs. Mona 
and David Spector
CAB member Michael Aboff and his son Matthew present a check to 
Dr. Bruce Stillman for breast cancer research
497-530_Finance.indb   517 9/17/2013   8:31:53 AM
518  Finance
Honor Roll of Donors
Contributions of $5 million+ lifetime
Anonymous
The Donald Everett Axinn Trust*
The Arnold and Mabel Beckman 
Foundation
Jamie Nicholls and Fran Biondi*
Mr. and Mrs. David Boies*
The Breast Cancer Research Foundation
Mr. and Mrs. Landon T. Clay
The Dana Foundation
Dart Neurosciences LLC
Kathryn W. Davis
The DeMatteis Family Foundation*
Mr. and Mrs. Charles F. Dolan–Dolan 
Family Foundation
The William Stamps Farish Fund*
The Hon. and Mrs. Leon Polsky–Hazen 
Polsky Foundation*
Howard Hughes Medical Institute*
W.M. Keck Foundation
Mr. and Mrs. David H. Koch*
Laurie Landeau Foundation LLC*
Mr. and Mrs. Robert D. Lindsay and 
Family*
The Lustgarten Foundation*
Lucille P. Markey Charitable Trust
Nancy Abeles Marks
The Don Monti Memorial Research 
Foundation*
New York State Empire State 
Development Corporation
The Quick Family
The Robertson Family–Banbury Fund
Marilyn and Jim Simons*
The Simons Foundation*
Diana Davis Spencer Foundation 
(formerly The Kathryn W. Davis 
Foundation)*
Mr. and Mrs. Theodore R. Stanley–The 
Stanley Medical Research Institute*
The Starr Foundation
GEN*NY*sis grant from the New York 
State Dormitory Authority
Mr. and Mrs. Henry Wendt III
Gifts of $100,000 or $1 million+ 
lifetime
Paul G. Allen Foundation*
Angel Foundation
Anonymous (4)*
Gonzalo Río Arronte Foundation
Bristol-Myers Squibb Company
Burroughs Wellcome Fund
The Carson Family Charitable Trust*
The H.A. and Mary K. Chapman 
Charitable Trust and The Mary 
K. Chapman Foundation*
Mr. and Mrs. Norris W. Darrell
Michel David-Weill
Ira W. DeCamp Foundation
Edward P. Evans Foundation*
Charitable Lead Annuity Trust Under the 
Will of Louis Feil
The Samuel Freeman Charitable Trust
Coleman Fung Foundation
Mr. Robert A. Gay
Genentech, Inc.*
Kenyon Gillespie
Jacob Goldfi eld*
Lola Goldring
The Florence Gould Foundation
The Grace Family
Leo A. Guthart*
The Harrison Foundation and The Mary 
Anderson Harrison Foundation
The Thomas Hartman Foundation for 
Parkinson’s Research
Janet Strauss and Jeff Hawkins
Jo-Ellen and Ira Hazan
William Randolph Hearst Foundation
The Karches Foundation
Estate of Gale Kavaliauskas
F.M. Kirby Foundation, Inc.
Mr. and Mrs. Walter B. Kissinger*
Mr. and Mrs. John Klingenstein–The 
Esther A. & Joseph Klingenstein 
Fund, Inc.
Mrs. Townsend J. Knight
The Forrest C. and Frances H. Lattner 
Foundation
Mara and Thomas Lehrman
The Lehrman Institute
Mr. and Mrs. Stephen M. Lessing
Mary D. Lindsay
The Litchfi eld Charitable Trust
Estate of Elisabeth Sloan Livingston
Mr. and Mrs. David L. Luke III
Josiah Macy, Jr. Foundation
The G. Harold & Leila Y. Mathers 
Charitable Foundation*
Melanoma Research Alliance*
Gillian and Eduardo Mestre
Mr. and Mrs. William R. Miller
Dr. and Mrs. Howard L. Morgan*
Louis Morin Charitable Trust
Estate of Thomas C. Nelson
William C. and Joyce C. O’Neil 
Charitable Trust*
OSI Pharmaceuticals, LLC
The Pew Charitable Trusts
Mr. and Mrs. John C. Phelan*
William and Maude Pritchard Charitable 
Trust
Prostate Cancer Foundation*
Fannie E. Rippel Foundation
The Robertson Foundation
Mr. and Mrs. David M. Rubenstein
Eleanor Schwartz Charitable Foundation*
Edith and Alan Seligson*
The Seraph Foundation
Mr. and Mrs. Herbert J. Siegel
Alfred P. Sloan Foundation
CSHL Trustee Leo Guthart (left) with Jim Simons
*Denotes multiyear commitment
The Don Monti Memorial Research Foundation provides critical support to 
CSHL’s cancer research program. Featured are President Caroline Monti- 
Saladino and Chairmen Richard Monti (left) and Artie Saladino
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President’s Council speaker Andrew Solomon 
with his father, Howard Solomon
Mr. and Mrs. Joel E. Smilow
Mr. and Mrs. Howard Solomon
St. Giles Foundation
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz–Swartz Charitable 
Trust
Swim Across America Nassau/Suffolk
Waclaw Szybalski, D.Sc.
Mr. and Mrs. Paul J. Taubman*
The V Foundation for Cancer Research*
Dr. and Mrs. James D. Watson
Whitehall Foundation*
The Roy J. Zuckerberg Family 
Foundation
Gifts of $50,000+
Elizabeth and Lee Ainslie
American Express Foundation*
Anonymous
Kavita and Lalit Bahl
Mr. and Mrs. Richard M. Cashin
Mr. and Mrs. Edward A. Chernoff–MARS*
Casey and Ellen Cogut
Mr. and Mrs. Roderick H. Cushman
Joni Gladowsky Breast Cancer Foundation
Mr. and Mrs. Louis Jagoda
The Charles and Ann Johnson Foundation
The Karp Foundation
Mr. and Mrs. David M. Knott
Betsy and Bryan H. Lawrence
Marc and Jennifer Lipschultz
Breast Cancer Awareness Day in memory 
of Elizabeth McFarland
Doug and Monique Morris
The Sass Foundation for Medical 
Research, Inc.*
Freddie and Erwin Staller
The Thompson Family Foundation, Inc.
Mr. and Mrs. Howard J. Tytel
Wodecroft Foundation
Gifts of $25,000+
The Bahnik Foundation, Inc.
Pien and Hans Bosch
Dr. and Mrs. Herbert W. Boyer
Louise Parent and John Casaly
Lester Crown*
Mr. and Mrs. Yves C. de Balmann
Maria and Geoff de Lesseps–Alpha/
Omega Charitable Foundation, Inc.
John M. Desmarais
Ike, Molly and Steven Elias Foundation
Claire Friedlander Family Foundation
The Gilder Foundation
Mr. and Mrs. Ronald Gottlieb
The Marc Haas Foundation
The Irving A. Hansen Memorial 
Foundation
Susan T. Harris
The Hastings Foundation, Inc.
Hearts for Cancer
Mr. and Mrs. J. Tomilson Hill III
Drs. Nancy and Ron Israeli
Annette Kade Charitable Trust
The Fay J. Lindner Foundation*
Long Island 2 Day Walk to Fight Breast 
Cancer
Nancy Lurie Marks Family Foundation
Dr. Marcia Kramer Mayer
The Morningside Foundation
The Pershing Square Foundation
Pfi zer, Inc.
William Townsend Porter Foundation
Thomas C. Quick
Amy Falls and Hartley Rogers
Dr. Charles Ryan–Forest Laboratories, Inc.
Susan Wasserstein and George Sard
Mr. and Mrs. Irwin Sicherman
Loren Eng and Dinakar Singh
Laura and Harry Slatkin
Mr. and Mrs. James F. Stebbins
Uta von Schwedler Prize
Elisabeth R. Woods Foundation
Gifts of $10,000+
Aboff ’s
Alexandria Real Estate Equities, Inc.
Amy Anthony
Mr. and Mrs. Louis Moore Bacon
The Bank of America Charitable 
Foundation, Inc.
JoAnn and Morgan Browne
Trudy and Tom Calabrese
Mr. and Mrs. George W. Carmany III
Michele and Jim Celestino
Dr. and Mrs. Bayard Delafi eld Clarkson
Rita M. Cleary
Samara P. Cohen
Cutler Family Education and Animal 
Welfare Fund
Davidson Kempner Capital Management 
LLC
Dan Decker–Eppendorf North America
Drs. Stephen and Pamela Hurst-
DellaPietra
Barbara J. Amonson and Vincent J. 
DellaPietra
Drs. Miki and David Donoho
Farrell Fritz, P.C.
Fortunato Sons Contracting, Inc.
Brian Fox–McKinsey & Company
Glen Cove C.A.R.E.S.
Dr. and Mrs. Charles B. Goodwin
Google, Inc.
Oliver R. Grace, Jr.–OBX
Michael J. Griffi n
Mr. and Mrs. Thomas Campbell 
Jackson–The Zeitblom Fund
Paul E. Jefferson
Kappa Alpha Order
Dr. and Mrs. Joel J. Kassimir
The Kebede Family Foundation
Laureen and Ragnar M. Knutsen
Suzanne and Richard Leeds
CSHL researchers Mikala Egeblad and Nick Tonks with Jason Gladowsky and Alison 
Gladowsky of the Joni Gladowsky Breast Cancer Foundation
*Denotes multiyear commitment
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Amanda and Tom Lister
Long Island Cruizin’ for a Cure
Edward E. Matthews
Mirus Bio LLC*
The Tom and Judy Moore Foundation
National Grid Foundation
Nikon Instruments, Inc.
Susanne C. Olin–Olin Family 
Foundation
Wendy O’Neill
Lauryl and Robert Palatnick
Dr. and Mrs. John G. Passarelli
David P. Pearson
Patricia Petersen–Daniel Gale Sotheby’s 
International Realty
Whitney Posillico
Mr. and Mrs. Thomas W. Purcell
Mr. and Mrs. John R. Reese
Christina Renna Foundation, Inc.
Constance Silveri
Deborah K. Solbert
Steamboat Foundation
The Lauri Strauss Leukemia Foundation
TD Bank
Mr. and Mrs. Alan P. Thomas
Joan P. Tilney
Mr. and Mrs. Remy W. Trafelet
Wilhelmus Johannes Van der Goes
Paul and Robin Vermylen
West Islip Breast Cancer Coalition for 
Long Island, Inc.
Michael and Deedee Wigler
Ann Eden Woodward Foundation
The Bradley Zankel Foundation, Inc.
The Zeldis Family Charitable Fund
Gifts of $5,000+
The Ashton Foundation
Mr. and Mrs. W. Dillaway Ayres, Jr.
Banfi  Vintners Foundation
Mr. and Mrs. Dominic P. Bencivenga
Tim and Lisa Broadbent
**Helen M. Brooks*
Barbara and Christopher Callaghan
David T. Cleary
Mr. and Mrs. Jonathan Connors
Cottage Pharmacy & Surgical
Mr. and Mrs. Richard T. Cunniff
Craig E. Dallmeyer
Sandy and Nelson DeMille
Lee MacCormick Edwards, Ph.D.
Bob and Diane Fagiola
Michael L. Focazio–Carissa Maringo 
Fund
James A. Greer II*
Dr. and Mrs. Ronald J. Gulotta
H2M
The Randall and Mary Hack Foundation
Robin T. Hadley
Walter J. Hawrys
Dr. Mark Hoffman
J. Fallon’s Tap Room
Irving F. Jensen, Jr.
Andrew and Peggy Kahn
Kean Development Company
Andrea B. and Peter D. Klein
Suzanne and Richard Kleinknecht
Henry and Marsha Laufer
George N. Lindsay, Jr. and Nancy Metz
Peter Lindsay and Katie Murphy
Steve and Jo Lindsay
Mr. and Mrs. Robert W. Lourie
Luitpold Pharmaceuticals, Inc.
John and Bridget Macaskill
Mrs. David J. Mahoney
Carol Marcincuk Fund
Robert L. Marcus
Jeff and Mickie Nagel and Family
National Basketball Association
New York Community Bank Foundation
NMS Management
Ashley and Frank O’Keefe
Mr. and Mrs. George D. O’Neill
Mr. and Mrs. Timothy Q. O’Neill
Panera Bread
Mr. and Mrs. Simon Pharr
Mrs. Richardson Pratt, Jr. and Family–
The Spionkop Charitable Trust
Nicole and Charlie Prizzi
Mr. and Mrs. Preston V. Pumphrey
Patricia Quick
Mr. and Mrs. Peter Quick
Dr. Amy Rappaport Koreen and Dr. 
Judith Rappaport
Diane Emdin Sachs Memorial Walk
Anne McMillen and Benno C. Schmidt
Schwab-Silfen Foundation
Mr. and Mrs. Jonathan R. Serko
Mr. and Mrs. Michael Shoff
Mr. and Mrs. Owen T. Smith
Mary F. Smith Family Foundation
Hope and Ted Smith
Debra Parmet Sondock and Cliff Sondock
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. Richard A. Spehr–Mayer 
Brown LLP
Mr.** and Mrs. Arthur M. Spiro
Lee Steinberg
Grace and Bruce Stillman
Daniel B. Strickler, Jr.
Mr. and Mrs. Edward Travaglianti
John B. Vermylen
Holle von Schwedler
Marjorie M. von Stade
Mr. and Mrs. W. Fifi eld Whitman
The Worthington Charitable Foundation
Gifts of $2,500+
Mr. and Mrs. Robert H.B. Baldwin
Fred H. Baron
Dilworth & Barrese, LLP
Constance Bernstein, D.D.S.
Bliss Pest Protection Services, LLC
Dr. Steven Brenner*
M.J. Otsea and Richard H. Brown
Mr. and Mrs. William J. Candee III
Mrs. Robert L. Clarkson, Jr.
Mr. and Mrs. Glenn G. Cohen
Jim and Nancy Cook
*Denotes multiyear commitment
**Deceased
Rich and Heather Spehr at Labapalooza
Jennifer and Marc Lipschultz with Ellen Cogut
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Kristina and Harry Davison
Deutsche Bank
Mr. and Mrs. Joseph T. Donohue
Dvirka & Bartilucci Consulting 
Engineers
Fidelity Investments
Christopher A. Forster
Michael J. Fox and Tracy Pollan
G & M Earth Moving, Inc.
Margaret M. Hargraves
James B. Hicks, Ph.D.
Diana Hoadley
Johnston Family Foundation
Norman Kelker-Enzo Biochem, Inc.
KPMG LLP
Steven J. Kumble
The Litwin Foundation
Mr. and Mrs. Michael G. Mandelker
Neil and Amy McGoldrick
Oheka Castle Hotel & Estate
Mr. and Mrs. Gunnar S. Overstrom III
Oxford & Simpson Realty Svcs., Inc.
Mr. and Mrs. Jeffrey Pash
David Rockefeller
Miriam K. Rothenberg
Pamela & Richard Rubinstein Foundation
Frank and Lari Russo
Ruth Sagenschneider
Mr. and Mrs. Walter Scott
Samuel L. Stanley, Jr., M.D. and Ellen Li, 
M.D., Ph.D.
Mary Stolfa Cancer Foundation
Doris M. and Peter S. Tilles Foundation
Mr. and Mrs. Stanley S. Trotman, Jr.
Drs. Marjorie van de Stouwe and 
Scott J. Ratner
Sophie von Schwedler
Almut von Schwedler
The von Schwedler Family
Mr. and Mrs. Douglas A. Warner
Stuart and Leslie Weisbrod
Lise and Jeffrey Wilks
The Diane and Howard Wohl Family 
Foundation, Inc.
Gifts of $1,000+
Mr. and Mrs. Robert J. Adams
Advantage Title Agency, Inc.
Dr. Christopher R. Aiken
Erica and Henry Babcock
Mr. and Mrs. David L. Banker
Rose Ann Bencivenga
Dr. and Mrs. Arthur M. Bernhang
William Bernhard and Catherine Cahill
Gene and Pam Bernstein–PGJM 
Foundation
Dr. and Mrs. Giuseppe Bertani
Jan and Don Bettencourt
Mr. and Mrs. Xerxes K. Bhote
Sarah and Chris Blundin
David Botstein
Dr. William Braden III–Porter Braden 
Endowment Fund
Elizabeth B. Borden–Katharine Bradford 
Foundation
W. Murray Buttner
Nancy and Frank Bynum–The Bynum 
Family Foundation
Ann and Peter B. Cannell
Carol and Stephen Canter
Dr. Andrea R. Carlsen
Muffy and Bob Carlstrom
Jane H. Choate
Chubb Group of Insurance Companies
David C. Clark
Jean and Stephen Cleary
Mark D. Cleary
Mr. and Mrs. William A. Cleary, Jr.
James W. Cleary
Sharon Cleary
Donald K. Clifford, Jr.
Cosel-Pieper Family Foundation
Susan Tysk-Cosgrove and David 
Cosgrove
Curtis, Mallet-Prevost, 
Colt & Mosle LLP
2012 Double Helix honorees Michael J. Fox with his wife Tracy Pollan, Mary 
Lindsay and Art Levinson with Board Chair Jamie Nicholls and  President 
Bruce Stillman
Joshua Bell, Michael J. Fox and Jim Watson at the 2012 Double Helix 
Medals Dinner
Maureen Brennan, Isobel Coleman, Bruce Stillman, Gabrielle Bacon, Arianna Boardman 
at the Women’s Partnership for Science Luncheon
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Mr. and Mrs. Curtis Cushman
Lucy P. Cutting
David and Ide Dangoor
Mr. and Mrs. David H. Deming
Meleanor and Donald Deming
Mr. and Mrs. Jack DiMaio
Dr. and Mrs. Thomas J. Dowling, Jr.
Dr. Lester Dubnick
Carol Durkin
Electronix Systems Central Station 
Alarms, Inc.
Johnston and Lisa Evans
Donald Eversoll
Dr. Robert and Marjorie Feeney
James R. Feramisco
Douglas and Christine Fox
Mr. and Mrs. Roger Fradin
E. Maxwell Geddes, Jr.
**Robert Joy Glaser, M.D.
Mr. and Mrs. William H. Grover
Frank and Lynn Gundersen
Rev. Linda Peyton Hancock
Gil and Sheila Henoch
Allan and Carole Herzog
Mr. and Mrs. Joseph Heyenoort–Cold 
Spring Motors
Lori and Chris Homer–A.L.L. Caring 
Foundation
Theodora W. Hooton
Mr. and Mrs. Robert E. Hughes
Joan M. Hutchins
Frederic B. Ingraham
Virginia P. Jacobsen
Stephen Juelsgaard
Dolores Fredrich and Jeffrey Keller
Edward M. Lamont
Mr. and Mrs. James Large
Claudia Lawrence
Mr. and Mrs. Anthony V. Leness
Brett MacInnes
Mr. and Mrs. Patrick H. Mackay
Mr. and Mrs. Robert G. MacLean
Kevin G. Mahony
Simone Mailman
Mr. and Mrs. John Maroney
Marsh USA, Inc.
Marshs
Victoria S. Meagher
Mercer Health & Benefi ts LLC
MetLife
Dr. Jeffrey H. Miller
Leo Model Foundation
Mrs. Keith M. Moffat
Kathleen Mooney
John Moore
Mr. and Mrs. Stephen J. Moore
Catherine Moraetis
Mr. and Mrs. Francis W. Murray III
Mr. and Mrs. Paul Napoli
Richard P. and Faye Nespola Charitable 
Foundation
New England Foundation
Mr. and Mrs. James H. Norris
Dr. Larry Norton
Mr. and Mrs. Michael S. O’Brien
Hugh & Patricia O’Kane Family 
Foundation
Mr. and Mrs. Richard S. Overton
Tracy Dellomo and Clifford 
Packingham
Anthony Panebianco
Rhoda Parmet
Mr. and Mrs. Nicholas B. Paumgarten
Dave and Terry Peikon
Cecile Pickart Student Travel Award
Louise S. Pickart
Mr. and Mrs. Robert A. Pilkington
Carol and George C. Pratt
Mark Ptashne and Lucy Gordon
Mr. and Mrs. Thomas L. Pulling
K.J. Quinn Charitable Foundation
Curtis S. Read
Russell S. Reynolds, Jr.
Mr. and Mrs. Arthur M. Rogers, Jr.
Susan & Elihu Rose Foundation, Inc.
Michele Rosenberg
Mr. and Mrs. J. Wright Rumbough, Jr.
Drs. Maria and Charles S. Ryan
Raju Sarwal, M.D.
Mr. and Mrs. Lee Schalop
Robin and Enrique Senior
Dr. Jack Skalicky
Mr. and Mrs. Trevor A. Smith
Drs. Mona and David Spector
Mr. and Mrs. James L. Spingarn
Dr. Wesley I. Sundquist
Judith and Irwin Tantleff
Mrs. David S. Taylor
Pamela M. Thye
Mr. and Mrs. Bart T. Tiernan
Lynn and Pat Tone
Robert H. Trust and Sarah Vermylen 
Trust
George Vande Woude
Helene P. Victor
Jackie and Warren Wasp
Mr. and Mrs. Ted Weiss
Mr. and Mrs. Karl G. Wellner
Neil Westreich
Gerald I. White
Wolfensohn Family Foundation
**Deceased
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CORPORATE AND FOUNDATION MATCHING GIFT CONTRIBUTORS
American Express Charitable Fund
American Express PAC Match Program
Bank of America Matching Gifts
Bristol-Myers Squibb Foundation
Dow Jones & Company, Inc.
FBR Capital Markets Charitable Foundation
Honeywell Matching Gift Program
iStar Financial, Inc.
The J.P. Morgan Chase Foundation
McKinsey & Company, Inc.
David and Lucile Packard Foundation
Pfi zer Foundation 
RLI Charitable Fund
United Way of New York City
Wells Fargo Foundation
IN HONOR OF
Elinor Bettencourt
Jamie Nicholls and Fran Biondi
Bonnie and Steve Brenner
Eddie Chernoff
Rhonda Federman
Jessie Friedman’s Bat Mitzvah
Dr. Candido Fuentes
Mary Goldberg
Mrs. Oliver R. Grace
Dr. Nancy Israeli
Suzanne Leeds
Mary D. Lindsay
Cathryn MacInnes
Justin Rosati
Scheman-Villani
Edith Seligson
Drs. Marilyn and James Simons
Page Underwood
Dr. James D. Watson
Dr. Michael Wigler
Dr. Jan Witkowski
IN MEMORY OF
Elaine Abrams
T.J. Arcati
C. A. Beach
Anthony Biondolillo
Richard Blackman
Patricia Boudreau
Ellen Brenner
Ahmad Bukhari
Carol A. Buonaiuto
Robert Cafferkey
Mark A. Calace
Patricia May Duke Card
Josephine and Ted Chodkowski
John P. Cleary
Tina Duque Corbett
Randie Switko Delmont
Dr. Milislav Demerec
George and Evelyn Diehl
James Eisenman
Daniel Fishman
Ardell Bierman Fox
Albert L. Freedman
Paul Garrett
Nancy Slaughter Gay
Joni Gladowsky
Dr. Christopher G. Goff
Teresa Haire
Skip Hargraves
Walter Hein
Dr. Andy Kaplan
Townsend Knight
Lydia A. Krawec
James Laas
Cathy Lipstein
Lisa MacInnes
Carol Marcincuk
Carissa Maringo
Elizabeth McFarland
Steven Michalik
Rose M. Mooney
Monica Mowery
Donald J. Parmet
Dr. Cecile Pickart
Dorothy Pirozzi
G. Jeffrey Poletti
Christina Renna
Elizabeth Roberts
Dolores Ann Roman
Dr. Susan Rose
Diane Edmin Sachs
Howard Roy Schwartz
Iris Schwartzman
Martha Seidel
Andrew Seligson
Arnold Stanley Solomon
Becky Stephens
Edward M. Thomas
Harold Umansky
Linda Vernam
Dr. Uta von Schwedler
Fay Wallace
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